data_2m9u_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m9u _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.039 -0.029 . . . . 99.989999999999995 111.017 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -61.57 108.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.418 -0.956 . . . . 99.989999999999995 108.418 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.429 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 117.13 11.28 9.1 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 118.755 -1.025 . . . . 99.989999999999995 114.278 -169.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 59.8 t0 -60.02 110.7 1.26 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.508 0.654 . . . . 99.989999999999995 109.418 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 m -74.32 108.77 7.31 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.021 0.528 . . . . 99.989999999999995 109.635 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 58' ' ' ALA . 34.6 m -131.48 172.96 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.903 1.281 . . . . 99.989999999999995 109.716 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -119.24 154.59 33.19 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.694 1.197 . . . . 99.989999999999995 107.999 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.51 108.44 25.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.1 -1.074 . . . . 99.989999999999995 108.1 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -82.55 92.32 7.08 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.338 -2.21 . . . . 99.989999999999995 108.635 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 122.773 0.429 . . . . 99.989999999999995 110.506 -171.244 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 110.456 -0.201 . . . . 99.989999999999995 110.456 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -78.93 143.79 35.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.852 0.358 . . . . 99.989999999999995 110.821 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -130.48 152.49 49.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.894 -1.15 . . . . 99.989999999999995 107.894 164.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.94 -174.32 38.71 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.792 -0.718 . . . . 99.989999999999995 112.983 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -92.43 112.66 1.4 Allowed 'Cis proline' 0 C--N 1.37 1.69 0 C-N-CA 124.184 -1.173 . . . . 99.989999999999995 112.696 -2.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -76.95 156.99 31.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.196 0.598 . . . . 99.989999999999995 109.392 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.429 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 36.4 p -126.48 112.51 15.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.555 0.342 . . . . 99.989999999999995 110.834 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 60.2 t -74.31 123.48 29.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 109.344 -0.613 . . . . 99.989999999999995 109.344 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 89.2 mt -93.12 -33.39 14.07 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.411 1.07 . . . . 99.989999999999995 110.12 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 55.2 tp -149.87 144.58 26.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.995 0.518 . . . . 99.989999999999995 109.626 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.457 HG21 HD22 ' A' ' 42' ' ' LEU . 64.0 p -109.72 144.12 38.55 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.523 -0.918 . . . . 99.989999999999995 108.523 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -135.86 149.31 68.33 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 105.542 -2.021 . . . . 99.989999999999995 105.542 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.78 106.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.209 2.606 . . . . 99.989999999999995 113.49 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m 62.15 27.66 16.64 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.662 1.585 . . . . 99.989999999999995 112.642 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -159.37 123.61 3.9 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 99.989999999999995 109.466 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 37' ' ' THR . 44.9 mt -111.37 128.43 55.97 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.68 -0.637 . . . . 99.989999999999995 110.194 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 25.3 ttpp -85.85 108.27 18.06 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.722 -1.214 . . . . 99.989999999999995 107.722 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 34' ' ' VAL . 60.6 t -115.47 149.05 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.533 1.133 . . . . 99.989999999999995 109.045 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.99 133.2 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.524 -0.547 . . . . 99.989999999999995 109.524 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.83 -11.68 67.83 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.359 0.412 . . . . 99.989999999999995 113.509 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.428 HG21 HG12 ' A' ' 51' ' ' ILE . 47.2 mm -97.4 151.21 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.879 0.872 . . . . 99.989999999999995 110.669 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.58 -51.07 70.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.114 0.965 . . . . 99.989999999999995 111.78 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -152.44 -59.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.567 0.347 . . . . 99.989999999999995 111.458 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.411 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.7 m-90 -142.53 147.92 36.75 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.12 0.568 . . . . 99.989999999999995 110.847 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.428 HG12 HG21 ' A' ' 47' ' ' ILE . 33.2 mm -114.69 130.32 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.503 -1.295 . . . . 99.989999999999995 107.503 166.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -55.93 123.51 14.56 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.801 -0.814 . . . . 99.989999999999995 108.801 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.45 -18.69 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.674 1.361 . . . . 99.989999999999995 114.674 -164.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.56 67.36 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.168 0.587 . . . . 99.989999999999995 112.141 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -96.94 15.25 22.81 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.44 1.096 . . . . 99.989999999999995 111.123 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.4 HG12 HD12 ' A' ' 42' ' ' LEU . 38.4 t -131.82 152.06 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.852 -1.166 . . . . 99.989999999999995 107.852 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -151.96 132.93 14.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.336 -0.986 . . . . 99.989999999999995 108.336 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HA ' HG11 ' A' ' 14' ' ' VAL . . . -60.33 151.72 27.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.854 0.461 . . . . 99.989999999999995 111.498 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.907 0.883 . . . . 99.989999999999995 109.915 -177.722 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.8 ptp . . . . . 0 C--O 1.242 0.689 0 CA-C-O 121.434 0.635 . . . . 99.989999999999995 112.227 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.91 140.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 114.165 -1.379 . . . . 99.989999999999995 113.14 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.28 8.95 42.96 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.475 -0.784 . . . . 99.989999999999995 112.568 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.604 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -62.59 103.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.483 0.713 . . . . 99.989999999999995 110.616 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 m -71.6 110.68 6.33 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.268 -0.642 . . . . 99.989999999999995 109.268 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 58' ' ' ALA . 30.1 m -132.83 179.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 99.989999999999995 110.292 -175.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -124.26 150.87 44.85 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.545 -1.28 . . . . 99.989999999999995 107.545 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.96 107.92 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.374 -0.602 . . . . 99.989999999999995 109.374 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -76.28 137.83 40.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.247 1.419 . . . . 99.989999999999995 110.401 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.667 179.214 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 109.258 -0.645 . . . . 99.989999999999995 109.258 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -103.7 163.41 12.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.572 0.749 . . . . 99.989999999999995 111.816 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.92 161.0 34.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.93 1.292 . . . . 99.989999999999995 108.635 172.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.64 -175.97 42.6 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.578 -0.568 . . . . 99.989999999999995 112.847 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -88.58 128.12 8.57 Favored 'Cis proline' 0 C--N 1.373 1.861 0 CA-C-N 119.276 1.538 . . . . 99.989999999999995 112.526 -6.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -93.96 176.46 6.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.043 0.937 . . . . 99.989999999999995 110.048 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 28.3 p -140.34 115.9 10.11 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.723 0.809 . . . . 99.989999999999995 110.102 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.2 t -72.42 133.48 31.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 109.127 -0.694 . . . . 99.989999999999995 109.127 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -97.26 -43.26 7.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.711 -1.131 . . . . 99.989999999999995 109.875 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.6 tp -141.73 141.05 33.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 116.048 -0.523 . . . . 99.989999999999995 109.739 -175.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.0 p -112.67 128.44 56.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.541 -0.54 . . . . 99.989999999999995 109.541 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -126.82 162.71 45.74 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.122 0.969 . . . . 99.989999999999995 109.263 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -43.44 114.96 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.582 2.855 . . . . 99.989999999999995 113.918 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t 63.23 5.68 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.132 2.173 . . . . 99.989999999999995 114.459 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -148.85 135.31 19.49 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.658 0.383 . . . . 99.989999999999995 110.01 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.76 124.93 50.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.01 0.524 . . . . 99.989999999999995 109.646 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.0 ttmm -83.89 107.99 16.62 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.27 -1.011 . . . . 99.989999999999995 108.27 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 34' ' ' VAL . 47.1 t -107.77 149.93 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.869 1.268 . . . . 99.989999999999995 108.22 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.33 140.85 54.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.85 0.46 . . . . 99.989999999999995 110.092 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 4.56 73.9 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.24 -0.436 . . . . 99.989999999999995 113.033 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.456 HG21 HG12 ' A' ' 51' ' ' ILE . 51.3 mm -116.74 150.49 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.16 0.984 . . . . 99.989999999999995 110.278 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.04 -51.53 68.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.957 0.903 . . . . 99.989999999999995 112.22 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.34 -56.81 0.17 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.516 -0.311 . . . . 99.989999999999995 111.312 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 16.8 m-90 -143.06 158.31 43.72 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.996 0.519 . . . . 99.989999999999995 111.403 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 47' ' ' ILE . 33.7 mm -122.32 118.59 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 106.802 -1.555 . . . . 99.989999999999995 106.802 165.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -56.91 127.24 30.83 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.385 -0.968 . . . . 99.989999999999995 108.385 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -23.75 18.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.846 1.795 . . . . 99.989999999999995 115.846 -158.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 -10.45 59.03 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.199 0.444 . . . . 99.989999999999995 112.199 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.11 17.66 22.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.756 1.222 . . . . 99.989999999999995 111.162 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.35 146.9 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.651 -0.87 . . . . 99.989999999999995 108.651 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -146.41 133.64 20.56 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.637 -0.875 . . . . 99.989999999999995 108.637 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.54 ' HA ' HG11 ' A' ' 14' ' ' VAL . . . -60.48 142.41 55.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.907 0.883 . . . . 99.989999999999995 111.614 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.943 . . . . 99.989999999999995 110.807 -176.356 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 109.874 -0.417 . . . . 99.989999999999995 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.62 133.04 29.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.252 0.549 . . . . 99.989999999999995 111.182 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 95.22 9.93 57.65 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.203 -0.908 . . . . 99.989999999999995 113.028 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.546 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 66.3 t0 -54.29 117.27 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.603 0.761 . . . . 99.989999999999995 111.351 -176.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 59' ' ' ALA . 29.6 m -73.42 113.88 11.01 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.997 0.519 . . . . 99.989999999999995 110.194 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.22 176.5 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.231 1.013 . . . . 99.989999999999995 110.146 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.497 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 35.4 m0 -123.9 136.48 54.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.31 1.044 . . . . 99.989999999999995 108.239 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.88 107.24 22.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 108.239 -1.023 . . . . 99.989999999999995 108.239 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 43.2 ttm180 -77.27 111.5 12.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.019 -1.446 . . . . 99.989999999999995 109.838 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 123.581 0.752 . . . . 99.989999999999995 109.222 178.832 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.8 ttm-85 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.354 0.121 . . . . 99.989999999999995 111.078 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 64.1 p-90 -75.88 143.98 41.44 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.441 0.696 . . . . 99.989999999999995 110.78 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -126.56 159.89 32.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.295 -1.002 . . . . 99.989999999999995 108.295 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.44 -172.6 44.14 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.475 -0.625 . . . . 99.989999999999995 112.428 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.59 115.38 3.51 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 119.137 1.469 . . . . 99.989999999999995 112.982 1.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 44' ' ' VAL . 78.2 m-85 -75.35 162.71 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.579 0.752 . . . . 99.989999999999995 110.766 172.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.579 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.5 p -131.63 111.5 11.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.091 0.556 . . . . 99.989999999999995 111.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 59.5 t -79.77 125.77 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.754 0.822 . . . . 99.989999999999995 110.404 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.4 -33.38 11.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.27 0.628 . . . . 99.989999999999995 110.251 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 42.7 tp -135.63 140.5 44.6 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.407 -0.361 . . . . 99.989999999999995 110.271 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -128.83 129.55 45.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.063 0.545 . . . . 99.989999999999995 110.096 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -134.96 163.12 53.52 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.19 1.396 . . . . 99.989999999999995 108.57 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -46.18 110.42 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.308 2.672 . . . . 99.989999999999995 114.543 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m 68.96 8.99 7.18 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 124.674 1.189 . . . . 99.989999999999995 112.59 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -146.97 121.93 10.02 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.788 -0.57 . . . . 99.989999999999995 110.133 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.469 HD11 HG13 ' A' ' 56' ' ' VAL . 22.6 mt -119.07 121.86 40.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.582 -0.895 . . . . 99.989999999999995 108.582 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 86.6 tttt -86.2 113.38 22.18 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.027 0.531 . . . . 99.989999999999995 110.977 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 74.1 t -88.61 149.22 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.887 1.275 . . . . 99.989999999999995 109.509 168.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.41 128.29 35.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.313 0.645 . . . . 99.989999999999995 110.374 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -27.78 16.68 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.014 -0.539 . . . . 99.989999999999995 111.959 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -74.53 146.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.565 0.746 . . . . 99.989999999999995 109.991 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.19 76.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.071 0.948 . . . . 99.989999999999995 112.413 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.22 -55.61 0.19 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.222 0.453 . . . . 99.989999999999995 112.222 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 19.6 m-90 -145.6 157.65 43.95 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.633 0.605 . . . . 99.989999999999995 112.633 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mm -112.64 135.66 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.845 1.258 . . . . 99.989999999999995 108.668 165.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -66.78 124.89 24.19 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.329 -0.989 . . . . 99.989999999999995 108.329 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.65 -19.42 63.8 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.733 1.213 . . . . 99.989999999999995 114.081 -164.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.85 -12.12 58.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.435 0.694 . . . . 99.989999999999995 112.374 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -98.0 -11.99 22.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.452 0.701 . . . . 99.989999999999995 111.251 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 42' ' ' LEU . 76.1 t -96.86 124.34 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 122.681 0.392 . . . . 99.989999999999995 110.596 -170.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -118.33 120.05 36.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.505 1.122 . . . . 99.989999999999995 108.986 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.48 106.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.41 0.684 . . . . 99.989999999999995 110.4 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.815 0.846 . . . . 99.989999999999995 110.947 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 111.623 0.231 . . . . 99.989999999999995 111.623 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 m -67.04 117.64 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.799 -0.815 . . . . 99.989999999999995 108.799 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 102.25 10.23 39.67 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.645 -1.086 . . . . 99.989999999999995 113.245 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -57.75 102.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 118.56 1.18 . . . . 99.989999999999995 109.906 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -72.71 113.29 9.58 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-O 121.492 0.663 . . . . 99.989999999999995 110.221 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.58 -179.86 2.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 113.933 -1.485 . . . . 99.989999999999995 109.05 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -125.0 150.66 46.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.994 -1.484 . . . . 99.989999999999995 106.994 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.21 104.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.246 -1.391 . . . . 99.989999999999995 107.246 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 37.9 ttt180 -81.33 92.4 6.39 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 112.686 -2.052 . . . . 99.989999999999995 109.651 -173.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 123.408 0.683 . . . . 99.989999999999995 111.424 -170.851 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 110.11 -0.33 . . . . 99.989999999999995 110.11 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.614 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.7 p-90 -68.27 143.11 55.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.298 0.639 . . . . 99.989999999999995 111.359 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.52 ' HB2' ' HZ3' ' A' ' 29' ' ' LYS . 10.9 mtmp? -121.5 146.54 46.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.06 0.944 . . . . 99.989999999999995 108.804 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.88 175.44 35.87 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.756 -0.469 . . . . 99.989999999999995 112.849 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.79 126.8 6.37 Favored 'Cis proline' 0 CA--C 1.564 2.007 0 CA-C-N 118.754 1.277 . . . . 99.989999999999995 113.215 -3.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.07 163.29 12.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 99.989999999999995 109.369 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.49 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.9 p -145.86 114.02 6.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.803 0.441 . . . . 99.989999999999995 111.15 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.573 HG21 HG22 ' A' ' 44' ' ' VAL . 24.2 t -67.99 133.07 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 99.989999999999995 110.781 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.82 -41.58 4.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.991 0.916 . . . . 99.989999999999995 109.936 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 43' ' ' LYS . 56.7 tp -135.26 151.2 50.35 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.401 -0.963 . . . . 99.989999999999995 108.401 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.414 HG21 HD21 ' A' ' 42' ' ' LEU . 69.6 p -124.32 153.19 42.14 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.865 -0.522 . . . . 99.989999999999995 111.048 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -136.44 147.65 60.81 Favored Pre-proline 0 CA--C 1.561 1.401 0 N-CA-C 106.501 -1.666 . . . . 99.989999999999995 106.501 171.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -40.85 109.72 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.288 2.659 . . . . 99.989999999999995 114.442 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 67.9 17.43 9.64 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.337 1.455 . . . . 99.989999999999995 112.903 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -156.42 121.61 4.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.42 0.688 . . . . 99.989999999999995 109.943 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 56' ' ' VAL . 27.5 mt -106.09 133.94 50.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.984 0.514 . . . . 99.989999999999995 110.308 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 54.8 tttp -85.57 107.53 17.54 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.799 -1.186 . . . . 99.989999999999995 107.799 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 34' ' ' VAL . 44.8 t -109.78 154.63 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.486 -1.234 . . . . 99.989999999999995 109.452 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.67 130.19 45.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.992 0.917 . . . . 99.989999999999995 110.789 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.01 79.55 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.16 -0.473 . . . . 99.989999999999995 113.782 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.437 HG22 HG12 ' A' ' 51' ' ' ILE . 40.8 mm -91.8 151.35 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.077 0.951 . . . . 99.989999999999995 110.539 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.08 73.56 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.194 0.998 . . . . 99.989999999999995 111.614 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.04 -57.53 0.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.047 0.388 . . . . 99.989999999999995 112.047 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 17.6 m-90 -143.35 153.3 42.58 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.029 0.531 . . . . 99.989999999999995 111.653 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.437 HG12 HG22 ' A' ' 47' ' ' ILE . 33.1 mm -123.44 120.22 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.699 1.2 . . . . 99.989999999999995 107.816 168.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -61.12 141.46 57.43 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.248 0.619 . . . . 99.989999999999995 109.469 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.82 48.81 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.566 1.691 . . . . 99.989999999999995 115.566 -162.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.041 0.536 . . . . 99.989999999999995 112.216 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -96.44 23.9 6.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.059 0.944 . . . . 99.989999999999995 110.661 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 42' ' ' LEU . 57.8 t -123.39 152.14 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.15 0.98 . . . . 99.989999999999995 108.555 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -155.87 110.6 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.982 0.513 . . . . 99.989999999999995 109.95 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.29 53.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.142 0.577 . . . . 99.989999999999995 111.327 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.936 0 C-N-CA 124.153 0.981 . . . . 99.989999999999995 109.192 -175.404 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ptm . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 120.533 0.206 . . . . 99.989999999999995 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.44 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 3.4 m -60.56 123.09 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.296 0.638 . . . . 99.989999999999995 110.533 174.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.37 9.36 60.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.057 -0.857 . . . . 99.989999999999995 113.466 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.696 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 51.2 t0 -56.02 106.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.942 0.871 . . . . 99.989999999999995 110.728 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 m -72.44 106.66 4.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.291 0.567 . . . . 99.989999999999995 110.012 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.97 173.86 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.527 1.131 . . . . 99.989999999999995 110.814 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.461 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.4 m0 -117.05 150.7 38.21 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.9 1.28 . . . . 99.989999999999995 108.168 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.43 109.31 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.052 -1.092 . . . . 99.989999999999995 108.052 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 38.8 ttp180 -87.12 90.61 8.42 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.116 -1.402 . . . . 99.989999999999995 109.808 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 124.449 1.1 . . . . 99.989999999999995 110.043 -176.565 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.489 0.185 . . . . 99.989999999999995 110.524 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 62.5 p-90 -73.85 149.33 41.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.739 0.816 . . . . 99.989999999999995 111.088 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -139.61 153.26 47.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.791 0.836 . . . . 99.989999999999995 109.649 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -168.0 179.39 41.26 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 119.894 -0.392 . . . . 99.989999999999995 113.492 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.71 133.72 19.12 Favored 'Cis proline' 0 C--N 1.378 2.103 0 CA-C-N 119.139 1.47 . . . . 99.989999999999995 113.838 0.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' A' ' 44' ' ' VAL . 76.0 m-85 -108.48 168.3 9.42 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 109.396 169.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.9 p -148.0 113.62 5.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.275 0.63 . . . . 99.989999999999995 110.883 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.696 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.4 t -73.21 134.32 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.756 0.822 . . . . 99.989999999999995 110.417 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 mt -106.58 -31.75 8.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.37 0.668 . . . . 99.989999999999995 110.812 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -149.59 159.2 44.52 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.777 -0.823 . . . . 99.989999999999995 108.777 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 p -139.38 163.7 31.81 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.559 0.695 . . . . 99.989999999999995 111.259 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.3 p -141.98 164.33 34.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 126.12 1.768 . . . . 99.989999999999995 107.695 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 107.85 0.17 Allowed 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.789 2.326 . . . . 99.989999999999995 113.47 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.69 22.15 12.54 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.432 1.493 . . . . 99.989999999999995 112.855 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.45 121.94 9.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.128 -0.693 . . . . 99.989999999999995 109.128 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.513 HD11 ' HB ' ' A' ' 56' ' ' VAL . 23.3 mt -106.69 123.5 48.22 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.243 1.017 . . . . 99.989999999999995 108.749 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -86.85 106.84 18.02 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 109.349 -0.611 . . . . 99.989999999999995 109.349 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 48.0 t -96.25 154.75 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.309 -1.314 . . . . 99.989999999999995 109.153 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.2 135.33 48.96 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.499 -0.556 . . . . 99.989999999999995 109.499 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.78 76.31 Favored Glycine 0 C--N 1.34 0.787 0 O-C-N 123.761 0.663 . . . . 99.989999999999995 112.798 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -92.66 147.67 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.171 0.588 . . . . 99.989999999999995 109.939 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.44 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.435 1.094 . . . . 99.989999999999995 111.38 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.19 -59.59 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.951 0.352 . . . . 99.989999999999995 111.951 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -145.31 158.65 43.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.297 0.639 . . . . 99.989999999999995 111.187 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.88 133.89 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.598 -1.26 . . . . 99.989999999999995 107.598 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -63.79 142.24 58.47 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 99.989999999999995 108.294 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -36.75 64.99 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 115.076 1.51 . . . . 99.989999999999995 115.076 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.27 1.32 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 112.33 0.493 . . . . 99.989999999999995 112.33 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.32 12.42 36.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.018 0.527 . . . . 99.989999999999995 109.816 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.513 ' HB ' HD11 ' A' ' 42' ' ' LEU . 99.1 t -139.15 140.75 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.692 -0.855 . . . . 99.989999999999995 108.692 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -138.17 152.17 48.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.56 -0.904 . . . . 99.989999999999995 108.56 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.32 126.85 28.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.667 0.787 . . . . 99.989999999999995 110.845 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 108.817 -0.809 . . . . 99.989999999999995 108.817 174.297 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 112.73 0.641 . . . . 99.989999999999995 112.73 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -62.1 150.64 8.15 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 115.076 -0.965 . . . . 99.989999999999995 110.828 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 11.37 69.83 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.995 -0.621 . . . . 99.989999999999995 112.49 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.4 t0 -62.1 111.83 2.11 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.355 0.577 . . . . 99.989999999999995 109.853 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.8 m -71.34 112.28 7.35 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.249 -0.649 . . . . 99.989999999999995 109.249 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 58' ' ' ALA . 30.2 m -136.38 164.2 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.797 -0.638 . . . . 99.989999999999995 111.124 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.456 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 41.8 m0 -122.39 145.56 48.16 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.235 1.014 . . . . 99.989999999999995 108.315 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.69 105.26 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.04 -0.726 . . . . 99.989999999999995 109.04 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.0 ttm180 -89.34 138.01 31.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.028 1.331 . . . . 99.989999999999995 110.378 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 122.607 0.363 . . . . 99.989999999999995 110.471 -178.43 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 C--O 1.238 0.459 0 N-CA-C 108.635 -0.876 . . . . 99.989999999999995 108.635 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.2 p-90 -96.35 163.7 12.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.537 0.735 . . . . 99.989999999999995 111.763 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -135.66 149.92 49.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.153 0.981 . . . . 99.989999999999995 108.586 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -175.77 179.2 47.07 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.256 -0.497 . . . . 99.989999999999995 112.618 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.02 148.72 21.57 Favored 'Cis proline' 0 C--N 1.368 1.573 0 CA-C-N 118.616 1.208 . . . . 99.989999999999995 113.834 0.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -120.54 176.0 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.91 1.284 . . . . 99.989999999999995 109.449 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 7.0 p -142.24 116.68 9.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.196 0.598 . . . . 99.989999999999995 111.381 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 44' ' ' VAL . 23.3 t -73.95 139.93 18.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.111 0 N-CA-C 109.766 -0.457 . . . . 99.989999999999995 109.766 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -113.02 -45.82 3.15 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.681 1.238 . . . . 99.989999999999995 109.984 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 61.8 tp -127.89 145.55 50.91 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.519 -0.764 . . . . 99.989999999999995 109.363 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.452 HG23 HD23 ' A' ' 42' ' ' LEU . 69.6 p -129.74 129.48 44.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.782 0.833 . . . . 99.989999999999995 109.189 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -126.29 162.63 45.09 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.618 1.167 . . . . 99.989999999999995 108.231 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -47.81 118.31 2.98 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.968 2.445 . . . . 99.989999999999995 114.261 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p 61.59 10.92 3.55 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.279 1.832 . . . . 99.989999999999995 113.972 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -149.09 123.32 9.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.17 0.441 . . . . 99.989999999999995 110.176 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 37' ' ' THR . 38.0 mt -110.87 124.54 52.27 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.422 -0.584 . . . . 99.989999999999995 109.422 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -85.92 108.63 18.27 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.657 -0.868 . . . . 99.989999999999995 108.657 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.587 HG22 HG21 ' A' ' 34' ' ' VAL . 18.4 t -109.99 146.87 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.338 -1.301 . . . . 99.989999999999995 108.606 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 132.78 46.7 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.757 -0.46 . . . . 99.989999999999995 109.757 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.82 -8.11 57.8 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.528 0.517 . . . . 99.989999999999995 111.976 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.502 HG22 HG12 ' A' ' 51' ' ' ILE . 40.6 mm -105.17 150.2 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.951 0.901 . . . . 99.989999999999995 110.403 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 -51.09 71.07 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.044 0.938 . . . . 99.989999999999995 111.966 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.22 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.248 0.342 . . . . 99.989999999999995 111.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 20.1 m-90 -142.9 149.89 39.07 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.743 0.417 . . . . 99.989999999999995 110.959 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.502 HG12 HG22 ' A' ' 47' ' ' ILE . 26.8 mm -121.52 128.32 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.955 -1.128 . . . . 99.989999999999995 107.955 167.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -59.97 136.1 57.91 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.903 0.481 . . . . 99.989999999999995 110.011 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.79 -33.59 49.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.009 1.485 . . . . 99.989999999999995 115.009 -163.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.45 67.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.396 0.517 . . . . 99.989999999999995 112.396 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -68.76 -25.03 64.52 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.648 0.379 . . . . 99.989999999999995 111.233 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -96.89 125.39 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 122.519 0.328 . . . . 99.989999999999995 110.444 -168.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -106.61 126.23 52.01 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.875 0.87 . . . . 99.989999999999995 108.809 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 14' ' ' VAL . . . -77.68 106.51 9.54 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.424 -0.584 . . . . 99.989999999999995 109.424 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 99.989999999999995 109.074 178.351 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.661 0.267 . . . . 99.989999999999995 111.273 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.97 125.74 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.439 -0.578 . . . . 99.989999999999995 109.439 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 33' ' ' THR . . . 108.53 8.5 28.52 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.296 -0.725 . . . . 99.989999999999995 112.484 -172.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.613 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -67.68 113.71 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.938 0.495 . . . . 99.989999999999995 109.885 -173.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.493 HG21 ' HB1' ' A' ' 59' ' ' ALA . 91.3 m -77.86 127.23 32.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.696 0.399 . . . . 99.989999999999995 111.236 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.22 -178.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 99.989999999999995 109.645 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 33.9 m0 -116.7 157.5 25.35 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.961 1.304 . . . . 99.989999999999995 108.478 169.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.38 103.32 15.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 106.463 -1.68 . . . . 99.989999999999995 106.463 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -78.94 91.03 4.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.077 -1.42 . . . . 99.989999999999995 108.872 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 123.826 0.85 . . . . 99.989999999999995 111.73 -171.001 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.052 -1.092 . . . . 99.989999999999995 108.052 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 60.9 p-90 -130.61 153.92 48.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.693 0.679 . . . . 99.989999999999995 110.521 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -126.71 148.23 49.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 99.989999999999995 108.714 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.507 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -164.58 -176.63 36.52 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.555 -0.58 . . . . 99.989999999999995 112.378 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.89 115.81 2.13 Favored 'Cis proline' 0 CA--C 1.564 1.998 0 CA-C-N 118.91 1.355 . . . . 99.989999999999995 112.786 -5.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -84.79 154.08 22.59 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.755 0.822 . . . . 99.989999999999995 111.918 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.602 HG21 ' HA2' ' A' ' 11' ' ' GLY . 98.3 m -107.08 117.77 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 99.989999999999995 110.201 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 46.8 t -95.24 136.52 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.119 0.968 . . . . 99.989999999999995 109.209 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.16 -28.74 8.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.827 . . . . 99.989999999999995 110.689 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 46.4 tp -146.95 144.46 29.23 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.767 -0.457 . . . . 99.989999999999995 109.767 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.9 p -132.4 128.89 38.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.936 0.894 . . . . 99.989999999999995 109.63 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -134.38 158.42 75.23 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.855 0.862 . . . . 99.989999999999995 109.226 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -48.16 124.67 10.67 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.271 2.647 . . . . 99.989999999999995 112.81 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m 75.34 -13.83 0.82 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.25 1.42 . . . . 99.989999999999995 112.953 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.39 122.01 11.82 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.429 -0.794 . . . . 99.989999999999995 110.693 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.476 HD13 HG11 ' A' ' 56' ' ' VAL . 32.0 mt -114.9 123.68 49.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.306 0.642 . . . . 99.989999999999995 109.343 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.3 tttp -84.46 107.16 16.57 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.68 0.752 . . . . 99.989999999999995 109.247 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 34' ' ' VAL . 34.5 t -101.81 142.84 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.963 -1.472 . . . . 99.989999999999995 108.047 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.34 136.54 58.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.411 0.684 . . . . 99.989999999999995 110.261 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.32 32.39 Favored Glycine 0 C--N 1.345 1.074 0 O-C-N 123.676 0.61 . . . . 99.989999999999995 113.096 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.66 153.92 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.583 0.753 . . . . 99.989999999999995 110.744 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.32 -51.16 56.81 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.058 1.343 . . . . 99.989999999999995 111.337 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.08 -56.18 0.14 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.485 0.49 . . . . 99.989999999999995 110.53 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -141.17 157.1 45.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.92 0.488 . . . . 99.989999999999995 110.91 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.99 130.88 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.83 1.252 . . . . 99.989999999999995 107.997 167.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -58.07 128.44 37.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.702 -0.851 . . . . 99.989999999999995 108.702 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -23.36 58.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.349 1.241 . . . . 99.989999999999995 114.349 -163.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.82 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 99.989999999999995 112.055 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -100.19 21.18 13.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.604 1.162 . . . . 99.989999999999995 110.514 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.476 HG11 HD13 ' A' ' 42' ' ' LEU . 61.2 t -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.743 -0.836 . . . . 99.989999999999995 108.743 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -129.81 109.99 11.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.444 -0.947 . . . . 99.989999999999995 108.444 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.46 131.86 51.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.091 0.956 . . . . 99.989999999999995 112.23 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.493 ' HB1' HG21 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.372 0.669 . . . . 99.989999999999995 110.074 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 120.728 0.299 . . . . 99.989999999999995 110.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.25 135.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.748 1.219 . . . . 99.989999999999995 110.277 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.711 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 94.33 11.12 57.63 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.222 -0.766 . . . . 99.989999999999995 113.504 -171.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.759 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -51.66 113.22 0.92 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.184 0.994 . . . . 99.989999999999995 111.342 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.445 HG21 ' HB1' ' A' ' 59' ' ' ALA . 23.3 m -72.85 108.2 5.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 99.989999999999995 110.289 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.406 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 34.3 m -132.39 179.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.19 0.996 . . . . 99.989999999999995 110.791 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.441 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -129.99 154.13 47.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.407 1.483 . . . . 99.989999999999995 108.23 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.5 104.56 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 121.625 0.726 . . . . 99.989999999999995 109.536 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -81.95 104.92 12.65 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.883 1.673 . . . . 99.989999999999995 109.652 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.3 ttm105 . . . . . 0 N--CA 1.484 1.267 0 O-C-N 121.608 -0.682 . . . . 99.989999999999995 112.13 -172.343 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 . . . . . 0 C--O 1.239 0.545 0 N-CA-C 109.929 -0.397 . . . . 99.989999999999995 109.929 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.77 141.83 33.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.99 0.516 . . . . 99.989999999999995 110.452 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -113.04 158.16 20.66 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.464 -0.939 . . . . 99.989999999999995 108.464 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -173.63 170.21 43.34 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.015 -0.612 . . . . 99.989999999999995 113.589 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.02 160.85 70.11 Favored 'Cis proline' 0 C--N 1.376 1.985 0 C-N-CA 123.93 -1.279 . . . . 99.989999999999995 112.978 -5.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.8 164.02 24.97 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.028 1.331 . . . . 99.989999999999995 109.361 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.711 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 57.6 p -137.05 111.7 8.72 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.516 0.726 . . . . 99.989999999999995 110.566 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.759 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.8 t -79.12 119.24 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 99.989999999999995 109.427 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.34 -21.11 22.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.553 0.741 . . . . 99.989999999999995 110.983 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.5 tp -156.11 140.2 16.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.622 0.369 . . . . 99.989999999999995 110.786 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.591 HG21 HD21 ' A' ' 42' ' ' LEU . 40.2 p -107.38 128.9 54.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.725 . . . . 99.989999999999995 109.877 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.407 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.3 p -125.82 165.18 28.54 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 124.382 1.073 . . . . 99.989999999999995 109.018 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -49.83 116.76 2.56 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.134 2.556 . . . . 99.989999999999995 112.194 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 t 54.74 17.22 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.996 2.118 . . . . 99.989999999999995 114.533 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -148.55 140.57 23.93 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.973 0.509 . . . . 99.989999999999995 110.054 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -115.11 123.0 47.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.023 0.529 . . . . 99.989999999999995 109.69 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.51 108.48 17.95 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.504 -0.924 . . . . 99.989999999999995 108.504 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.57 HG23 HG23 ' A' ' 34' ' ' VAL . 55.0 t -110.13 143.36 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.675 1.19 . . . . 99.989999999999995 109.938 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.9 135.27 57.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.452 1.101 . . . . 99.989999999999995 110.231 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.92 -21.99 27.72 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 123.195 0.426 . . . . 99.989999999999995 112.991 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.457 HG22 HG12 ' A' ' 51' ' ' ILE . 40.2 mm -82.18 153.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.551 1.14 . . . . 99.989999999999995 109.707 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.89 68.04 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.186 0.594 . . . . 99.989999999999995 111.407 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.42 -60.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.133 0.42 . . . . 99.989999999999995 112.133 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 17.5 m-90 -143.34 138.54 29.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.876 0.47 . . . . 99.989999999999995 110.944 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.457 HG12 HG22 ' A' ' 47' ' ' ILE . 42.9 mm -103.76 117.09 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 106.976 -1.49 . . . . 99.989999999999995 106.976 164.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -58.7 145.51 39.86 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.514 -0.55 . . . . 99.989999999999995 109.514 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.58 -34.82 52.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.853 1.261 . . . . 99.989999999999995 113.726 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -24.96 61.51 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.198 0.999 . . . . 99.989999999999995 113.035 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -107.31 24.56 12.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.5 1.12 . . . . 99.989999999999995 110.708 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 42' ' ' LEU . 24.9 t -128.28 149.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.655 -0.498 . . . . 99.989999999999995 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -133.77 122.65 23.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.26 -1.015 . . . . 99.989999999999995 108.26 166.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 109.77 1.33 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.477 0.711 . . . . 99.989999999999995 109.69 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.472 0.632 0 C-N-CA 123.767 0.827 . . . . 99.989999999999995 110.223 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 110.414 -0.217 . . . . 99.989999999999995 110.414 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.561 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 6.5 m -61.3 108.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.251 -1.018 . . . . 99.989999999999995 108.251 168.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.19 9.69 11.61 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.262 -0.743 . . . . 99.989999999999995 113.005 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.648 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.2 t0 -59.77 113.76 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.13 0.572 . . . . 99.989999999999995 109.556 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -72.56 114.1 10.32 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.587 . . . . 99.989999999999995 109.414 -172.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.13 176.57 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.906 1.282 . . . . 99.989999999999995 109.743 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -125.01 148.85 48.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.935 -1.506 . . . . 99.989999999999995 106.935 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.19 104.77 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.779 -0.823 . . . . 99.989999999999995 108.779 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 42.7 ttm180 -69.16 93.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.636 1.175 . . . . 99.989999999999995 109.496 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 . . . . . 0 C--O 1.244 0.802 0 CA-C-N 116.052 -0.522 . . . . 99.989999999999995 109.803 -176.582 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 . . . . . 0 C--O 1.24 0.558 0 N-CA-C 109.087 -0.709 . . . . 99.989999999999995 109.087 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 60.9 p-90 -76.67 149.17 36.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.101 0.477 . . . . 99.989999999999995 110.024 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -126.73 141.06 51.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.529 -1.286 . . . . 99.989999999999995 107.529 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.97 175.4 47.48 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.4 -0.667 . . . . 99.989999999999995 113.12 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -89.77 120.16 4.31 Favored 'Cis proline' 0 C--N 1.377 2.063 0 CA-C-N 119.112 1.456 . . . . 99.989999999999995 114.14 4.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.83 179.33 6.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.7 1.2 . . . . 99.989999999999995 111.512 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.6 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 41.4 p -138.81 113.75 9.29 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.944 0.898 . . . . 99.989999999999995 111.096 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.8 t -68.09 122.76 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 99.989999999999995 109.89 170.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 67.7 mt -93.87 -26.23 16.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.145 -0.934 . . . . 99.989999999999995 110.523 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 67.7 tp -152.29 144.04 23.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.254 0.549 . . . . 99.989999999999995 111.402 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.6 m -110.29 145.82 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 99.989999999999995 109.199 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 p -146.58 162.38 34.29 Favored Pre-proline 0 C--O 1.25 1.079 0 C-N-CA 124.717 1.207 . . . . 99.989999999999995 108.777 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.27 108.85 0.3 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.629 2.219 . . . . 99.989999999999995 112.728 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 65.61 23.48 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.864 1.666 . . . . 99.989999999999995 112.137 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -153.42 158.89 42.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.054 0.454 . . . . 99.989999999999995 110.957 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.8 123.63 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.569 1.148 . . . . 99.989999999999995 108.326 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.1 tttp -84.25 109.61 17.91 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.903 -1.147 . . . . 99.989999999999995 107.903 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 97.3 t -92.62 156.67 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.415 -1.266 . . . . 99.989999999999995 108.603 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.55 134.08 56.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.932 0.893 . . . . 99.989999999999995 110.094 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.53 73.29 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.42 -0.655 . . . . 99.989999999999995 113.682 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -85.83 144.98 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 117.739 0.77 . . . . 99.989999999999995 110.188 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.09 70.32 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.115 1.366 . . . . 99.989999999999995 111.79 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.91 -58.39 0.22 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.728 0.27 . . . . 99.989999999999995 111.728 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 8.6 m-90 -144.76 157.54 44.14 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.161 0.505 . . . . 99.989999999999995 111.752 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.8 mm -121.65 129.39 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.027 -1.471 . . . . 99.989999999999995 107.027 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -55.46 127.67 30.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.596 -0.89 . . . . 99.989999999999995 108.596 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.64 -38.66 55.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.937 1.295 . . . . 99.989999999999995 113.856 -164.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.23 -4.01 19.7 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.467 0.914 . . . . 99.989999999999995 113.467 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -97.56 15.69 22.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.148 0.979 . . . . 99.989999999999995 110.397 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.99 130.37 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.292 0.637 . . . . 99.989999999999995 109.564 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -112.47 122.07 46.64 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.712 0.805 . . . . 99.989999999999995 109.094 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HA ' HG13 ' A' ' 14' ' ' VAL . . . -65.63 126.79 29.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.911 -0.403 . . . . 99.989999999999995 109.911 176.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.955 0.902 . . . . 99.989999999999995 109.895 -179.106 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.853 0.686 . . . . 99.989999999999995 112.853 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 33.0 m -70.96 142.6 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 114.949 -1.023 . . . . 99.989999999999995 110.425 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.67 9.37 81.37 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.79 -1.005 . . . . 99.989999999999995 114.28 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.43 124.66 23.81 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.447 1.124 . . . . 99.989999999999995 110.249 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.5 m -71.61 114.4 9.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.13 0.572 . . . . 99.989999999999995 110.739 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.9 m -135.98 178.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.28 1.032 . . . . 99.989999999999995 110.621 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.417 ' HE3' ' HD3' ' A' ' 57' ' ' LYS . 34.5 m0 -126.77 153.2 45.87 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.9 1.28 . . . . 99.989999999999995 108.348 174.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.16 105.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 107.439 -1.319 . . . . 99.989999999999995 107.439 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 76.2 ttt180 -81.12 92.36 6.26 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.91 -1.041 . . . . 99.989999999999995 109.821 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 . . . . . 0 C--O 1.243 0.742 0 CA-C-N 115.421 -0.809 . . . . 99.989999999999995 110.316 -176.811 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.42 -0.215 . . . . 99.989999999999995 110.42 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 61.9 p-90 -74.01 150.06 40.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.977 0.511 . . . . 99.989999999999995 110.887 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.29 143.99 49.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.091 0.957 . . . . 99.989999999999995 108.624 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.9 -177.08 25.27 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 111.603 -0.599 . . . . 99.989999999999995 111.603 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.16 121.65 6.83 Favored 'Cis proline' 0 C--N 1.37 1.664 0 CA-C-N 119.564 1.682 . . . . 99.989999999999995 111.855 -9.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -106.99 170.2 8.09 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.522 0.729 . . . . 99.989999999999995 110.003 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -150.81 115.79 5.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.157 0.583 . . . . 99.989999999999995 111.498 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.67 127.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.104 0.562 . . . . 99.989999999999995 111.49 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 77.2 mt -95.49 -38.31 10.5 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.492 1.117 . . . . 99.989999999999995 110.475 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.455 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.4 tp -145.24 149.22 34.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.445 0.698 . . . . 99.989999999999995 110.06 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.435 HG22 HD23 ' A' ' 42' ' ' LEU . 37.1 p -112.97 130.4 56.14 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.744 0.818 . . . . 99.989999999999995 109.337 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -127.54 148.54 67.02 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 107.497 -1.297 . . . . 99.989999999999995 107.497 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.51 117.43 2.34 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.624 2.216 . . . . 99.989999999999995 113.031 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 m 75.58 -2.28 2.83 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.514 1.525 . . . . 99.989999999999995 112.812 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.821 -0.549 . . . . 99.989999999999995 110.586 -173.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 37' ' ' THR . 46.0 mt -108.75 125.23 51.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.927 0.491 . . . . 99.989999999999995 109.676 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.7 ttmm -83.91 110.89 18.76 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.862 -0.792 . . . . 99.989999999999995 108.862 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.34 146.14 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.822 1.249 . . . . 99.989999999999995 109.333 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.07 127.73 33.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.947 0.899 . . . . 99.989999999999995 109.771 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.25 -0.93 50.49 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.817 -0.629 . . . . 99.989999999999995 112.485 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.52 148.94 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.738 0.815 . . . . 99.989999999999995 109.242 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.07 86.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.182 0.993 . . . . 99.989999999999995 112.506 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.28 -58.03 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.327 0.251 . . . . 99.989999999999995 111.382 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 17.8 m-90 -143.76 147.13 33.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.241 0.616 . . . . 99.989999999999995 111.382 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.0 mm -101.55 138.71 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 107.968 -1.123 . . . . 99.989999999999995 107.968 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.25 119.55 8.12 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 107.721 -1.214 . . . . 99.989999999999995 107.721 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.11 20.94 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.266 1.426 . . . . 99.989999999999995 114.593 -164.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.48 -2.77 14.97 Favored 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 113.197 0.814 . . . . 99.989999999999995 113.197 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -115.76 17.34 16.15 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.525 1.13 . . . . 99.989999999999995 110.632 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -117.24 133.59 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.167 -0.679 . . . . 99.989999999999995 109.167 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HD3' ' HE3' ' A' ' 15' ' ' TRP . 64.4 tttp -121.49 121.24 37.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.976 0.911 . . . . 99.989999999999995 109.334 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -64.47 118.18 8.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.306 0.642 . . . . 99.989999999999995 110.709 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 99.989999999999995 109.879 179.878 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' MET . . . . . 0.473 ' HE2' ' HA ' ' A' ' 12' ' ' ASP . 25.3 ptt? . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 113.04 0.755 . . . . 99.989999999999995 113.04 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 35' ' ' LEU . 16.2 m -73.53 137.61 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.232 -1.025 . . . . 99.989999999999995 108.232 172.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.661 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 90.79 11.02 62.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-O 118.999 -0.89 . . . . 99.989999999999995 112.459 -172.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.673 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 64.0 t0 -57.62 97.74 0.03 OUTLIER 'General case' 0 C--N 1.365 1.275 0 C-N-CA 123.557 0.743 . . . . 99.989999999999995 109.062 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 m -71.52 118.59 14.53 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 109.484 -0.561 . . . . 99.989999999999995 109.484 -169.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 58' ' ' ALA . 29.4 m -135.57 170.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 C-N-CA 125.513 1.525 . . . . 99.989999999999995 109.741 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 50.4 m0 -117.68 142.14 47.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.617 1.167 . . . . 99.989999999999995 108.082 171.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.23 109.3 27.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 107.298 -1.371 . . . . 99.989999999999995 107.298 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 48.6 ttt180 -90.51 100.2 13.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.043 1.337 . . . . 99.989999999999995 109.963 -171.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 99.989999999999995 111.273 -172.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 109.207 -0.664 . . . . 99.989999999999995 109.207 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 67.5 p-90 -71.66 158.5 36.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.257 0.623 . . . . 99.989999999999995 111.032 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -133.95 149.12 51.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.741 0.816 . . . . 99.989999999999995 108.855 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.76 176.82 40.52 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.851 -0.416 . . . . 99.989999999999995 112.895 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -92.92 104.77 0.37 Allowed 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 118.601 1.201 . . . . 99.989999999999995 112.276 -1.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -74.74 161.26 29.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.646 -0.872 . . . . 99.989999999999995 108.646 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.661 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 59.7 p -141.5 111.9 6.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.41 0.284 . . . . 99.989999999999995 110.321 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 24.1 t -68.37 124.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 C-N-CA 123.41 0.684 . . . . 99.989999999999995 110.028 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.421 ' O ' HG11 ' A' ' 10' ' ' VAL . 48.1 mt -99.03 -20.68 16.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.591 1.156 . . . . 99.989999999999995 110.895 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 54.0 tp -153.73 137.36 16.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.677 0.791 . . . . 99.989999999999995 109.734 175.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.527 HG23 HD21 ' A' ' 42' ' ' LEU . 38.0 p -112.31 128.96 56.43 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.639 -0.874 . . . . 99.989999999999995 108.639 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.7 p -133.39 165.19 38.58 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.439 1.095 . . . . 99.989999999999995 109.148 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -46.82 108.98 0.17 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.559 2.839 . . . . 99.989999999999995 113.523 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.1 p 56.08 20.37 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 126.039 1.736 . . . . 99.989999999999995 113.737 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.0 138.83 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.809 -0.811 . . . . 99.989999999999995 108.809 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 37' ' ' THR . 64.4 mt -127.89 129.02 46.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.405 -0.591 . . . . 99.989999999999995 109.405 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -86.27 107.39 17.92 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.055 -1.461 . . . . 99.989999999999995 107.055 168.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 21.7 t -104.79 160.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.164 -0.926 . . . . 99.989999999999995 108.79 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -66.32 129.04 38.48 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.453 0.701 . . . . 99.989999999999995 109.51 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.21 -4.49 86.17 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.586 0.554 . . . . 99.989999999999995 113.039 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.95 137.54 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.875 0.87 . . . . 99.989999999999995 109.503 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.68 72.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.974 0.91 . . . . 99.989999999999995 111.441 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.35 -56.15 0.17 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.583 0.586 . . . . 99.989999999999995 112.583 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -141.19 138.24 33.22 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.344 0.52 . . . . 99.989999999999995 111.801 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.3 mm -120.45 127.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.191 -1.411 . . . . 99.989999999999995 107.191 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -56.64 122.84 13.0 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.221 -0.659 . . . . 99.989999999999995 109.221 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.39 -21.37 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.735 1.614 . . . . 99.989999999999995 114.817 -166.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.11 65.4 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.301 0.852 . . . . 99.989999999999995 113.301 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -87.74 -12.53 44.97 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.856 0.462 . . . . 99.989999999999995 111.218 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.6 t -101.76 139.83 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 99.989999999999995 109.81 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -138.99 129.75 26.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 99.989999999999995 109.62 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 14' ' ' VAL . . . -67.4 126.54 29.6 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.277 0.631 . . . . 99.989999999999995 112.342 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 C-N-CA 124.474 1.11 . . . . 99.989999999999995 111.304 -179.105 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.055 0.455 . . . . 99.989999999999995 111.478 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.8 m -67.87 135.54 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.265 -0.879 . . . . 99.989999999999995 111.053 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.57 62.63 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.672 -0.516 . . . . 99.989999999999995 112.613 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.1 t0 -65.57 115.98 6.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.694 0.798 . . . . 99.989999999999995 110.601 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.4 HG23 ' HB1' ' A' ' 59' ' ' ALA . 38.3 m -73.31 111.88 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.218 0.607 . . . . 99.989999999999995 110.328 -173.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.2 m -136.37 -176.56 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.818 1.247 . . . . 99.989999999999995 110.616 -174.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.7 m0 -131.95 157.71 43.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.516 1.526 . . . . 99.989999999999995 107.814 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.12 104.37 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.536 -0.913 . . . . 99.989999999999995 108.536 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 57' ' ' LYS . 67.5 ttt180 -79.01 96.53 5.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.466 1.106 . . . . 99.989999999999995 110.44 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.098 0.475 . . . . 99.989999999999995 111.833 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 110.017 -0.364 . . . . 99.989999999999995 110.017 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -81.35 153.18 27.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.498 0.666 . . . . 99.989999999999995 110.711 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.609 ' HB3' ' HZ1' ' A' ' 29' ' ' LYS . 9.5 mtpm? -127.62 137.87 52.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.574 -1.269 . . . . 99.989999999999995 107.574 170.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.91 38.05 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.306 -0.473 . . . . 99.989999999999995 112.79 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.14 122.09 5.86 Favored 'Cis proline' 0 CA--C 1.559 1.756 0 C-N-CA 123.753 -1.353 . . . . 99.989999999999995 112.878 -4.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.18 178.97 7.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.576 0.75 . . . . 99.989999999999995 110.0 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 25.6 p -138.15 113.34 9.33 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.908 0.483 . . . . 99.989999999999995 110.983 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.5 t -64.99 135.82 27.65 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 CA-C-O 121.242 0.544 . . . . 99.989999999999995 109.666 170.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 66.5 mt -104.53 -44.98 4.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.085 -0.961 . . . . 99.989999999999995 109.258 173.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.4 tp -142.19 147.67 36.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.727 -0.67 . . . . 99.989999999999995 109.765 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.445 HG23 HD22 ' A' ' 42' ' ' LEU . 30.9 p -104.63 144.27 31.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.781 0.833 . . . . 99.989999999999995 109.164 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -140.35 149.07 56.45 Favored Pre-proline 0 CA--C 1.556 1.198 0 N-CA-C 107.955 -1.128 . . . . 99.989999999999995 107.955 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -39.56 121.61 0.83 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.044 2.496 . . . . 99.989999999999995 114.021 170.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t 53.07 14.48 0.48 Allowed 'General case' 0 N--CA 1.504 2.261 0 C-N-CA 126.745 2.018 . . . . 99.989999999999995 114.826 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -153.82 124.58 7.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.794 0.438 . . . . 99.989999999999995 110.465 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.521 HD13 ' HB ' ' A' ' 56' ' ' VAL . 86.8 mt -103.0 126.05 50.02 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.269 -0.641 . . . . 99.989999999999995 109.269 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 51.5 tttm -86.85 108.96 18.98 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 108.706 -0.85 . . . . 99.989999999999995 108.706 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 34' ' ' VAL . 58.4 t -116.31 141.65 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.822 -1.081 . . . . 99.989999999999995 109.345 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.443 ' HB3' ' HG1' ' A' ' 33' ' ' THR . 27.6 t70 -65.95 137.64 57.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.393 0.677 . . . . 99.989999999999995 110.768 175.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.75 21.65 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.563 -0.744 . . . . 99.989999999999995 111.928 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.469 HG21 HG12 ' A' ' 51' ' ' ILE . 50.1 mm -87.0 146.77 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.975 0.91 . . . . 99.989999999999995 109.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.56 -49.43 64.96 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.225 1.01 . . . . 99.989999999999995 111.151 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -151.17 -59.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.16 0.287 . . . . 99.989999999999995 111.519 167.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 18.0 m-90 -135.5 144.95 46.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.931 -0.481 . . . . 99.989999999999995 112.0 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.469 HG12 HG21 ' A' ' 47' ' ' ILE . 35.9 mm -110.76 137.6 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.145 -1.428 . . . . 99.989999999999995 107.145 163.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -57.07 129.21 40.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.992 -0.744 . . . . 99.989999999999995 108.992 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.79 -32.44 65.67 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.048 1.129 . . . . 99.989999999999995 114.048 -163.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 -11.35 60.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.313 0.645 . . . . 99.989999999999995 112.415 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -102.39 22.8 12.8 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.406 1.082 . . . . 99.989999999999995 111.044 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.521 ' HB ' HD13 ' A' ' 42' ' ' LEU . 59.8 t -135.72 125.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.206 -0.664 . . . . 99.989999999999995 109.206 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD2' ' HD2' ' A' ' 17' ' ' ARG . 48.2 mtpt -114.45 129.82 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.601 0.761 . . . . 99.989999999999995 109.783 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.63 120.88 15.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.583 0.353 . . . . 99.989999999999995 110.181 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB1' HG23 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.251 0.62 . . . . 99.989999999999995 110.281 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.497 0.189 . . . . 99.989999999999995 111.495 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.403 ' HB ' HD23 ' A' ' 35' ' ' LEU . 21.3 m -69.46 139.26 20.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 116.045 -0.525 . . . . 99.989999999999995 109.888 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 101.11 9.78 44.17 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.559 -0.579 . . . . 99.989999999999995 112.875 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.5 t0 -58.28 109.39 0.76 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.026 0.53 . . . . 99.989999999999995 110.622 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.6 m -71.62 111.66 7.1 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.142 0.496 . . . . 99.989999999999995 109.843 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.15 -175.1 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.565 1.146 . . . . 99.989999999999995 109.806 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.44 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -124.38 156.77 36.52 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.053 1.341 . . . . 99.989999999999995 107.722 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 52.2 t -109.75 114.58 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.417 -0.956 . . . . 99.989999999999995 108.417 171.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' A' ' 55' ' ' HIS . 39.3 ttm180 -76.97 123.77 26.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.158 0.983 . . . . 99.989999999999995 110.108 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 108.854 -0.795 . . . . 99.989999999999995 108.854 168.246 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 108.834 -0.802 . . . . 99.989999999999995 108.834 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -146.21 163.34 35.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.383 0.673 . . . . 99.989999999999995 110.296 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -131.31 161.12 33.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.726 -0.842 . . . . 99.989999999999995 108.726 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -170.91 -177.55 40.9 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-O 119.402 -0.666 . . . . 99.989999999999995 111.896 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.32 116.73 3.64 Favored 'Cis proline' 0 C--N 1.376 2.013 0 CA-C-N 119.408 1.604 . . . . 99.989999999999995 113.117 -4.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.429 ' HB3' HG13 ' A' ' 44' ' ' VAL . 77.9 m-85 -80.45 169.41 17.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.825 0.85 . . . . 99.989999999999995 110.408 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.544 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.9 p -140.28 110.49 6.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.422 0.689 . . . . 99.989999999999995 110.685 -176.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 65.3 t -73.38 130.45 35.78 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 123.064 0.546 . . . . 99.989999999999995 109.743 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.403 HD23 ' HB ' ' A' ' 10' ' ' VAL . 41.1 mt -98.22 -54.66 3.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.302 -0.863 . . . . 99.989999999999995 109.393 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 28.9 tp -110.26 139.63 45.24 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.18 0.592 . . . . 99.989999999999995 109.651 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 42' ' ' LEU . 69.0 p -127.89 129.25 46.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.353 0.661 . . . . 99.989999999999995 109.353 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -145.15 161.09 43.65 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.094 1.358 . . . . 99.989999999999995 108.454 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -43.62 109.0 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.662 2.908 . . . . 99.989999999999995 114.832 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m 65.08 13.15 8.5 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.03 1.332 . . . . 99.989999999999995 112.456 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.85 121.89 14.64 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.705 -0.622 . . . . 99.989999999999995 110.012 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.481 HD13 HG13 ' A' ' 56' ' ' VAL . 62.1 mt -121.8 122.19 38.93 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.818 -1.179 . . . . 99.989999999999995 107.818 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 82.9 tttt -93.85 111.46 23.17 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.261 -0.644 . . . . 99.989999999999995 109.261 176.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 76.7 t -86.49 156.24 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.385 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.35 116.2 4.1 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.89 0.876 . . . . 99.989999999999995 110.706 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.44 -14.81 32.79 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.226 -0.443 . . . . 99.989999999999995 113.214 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.424 HG23 HG12 ' A' ' 51' ' ' ILE . 39.5 mm -77.96 143.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.532 0.733 . . . . 99.989999999999995 111.24 -177.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.4 -50.7 69.06 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.648 1.179 . . . . 99.989999999999995 112.259 -176.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.31 -58.1 0.18 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.219 0.451 . . . . 99.989999999999995 112.219 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -143.92 150.03 37.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.683 0.393 . . . . 99.989999999999995 111.111 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 47' ' ' ILE . 33.1 mm -112.98 122.27 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.439 -0.949 . . . . 99.989999999999995 108.439 166.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.54 124.78 22.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.855 -1.535 . . . . 99.989999999999995 106.855 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.32 -18.75 7.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.259 1.577 . . . . 99.989999999999995 115.259 -160.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.65 -4.93 34.04 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.537 0.735 . . . . 99.989999999999995 112.352 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 97.7 m-70 -104.11 17.35 24.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.099 0.96 . . . . 99.989999999999995 109.967 169.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.481 HG13 HD13 ' A' ' 42' ' ' LEU . 54.6 t -124.61 136.34 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.771 0.428 . . . . 99.989999999999995 109.902 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 52.7 mtpt -133.67 115.39 14.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 99.989999999999995 108.202 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.39 121.51 12.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 99.989999999999995 111.364 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 123.702 0.801 . . . . 99.989999999999995 111.252 -175.69 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.907 -0.405 . . . . 99.989999999999995 109.907 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.7 m -57.27 136.36 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.945 0.898 . . . . 99.989999999999995 110.861 -175.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.586 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.17 9.62 61.86 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 118.855 -0.97 . . . . 99.989999999999995 114.115 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.7 t0 -55.11 114.92 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.784 0.834 . . . . 99.989999999999995 111.645 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 m -74.82 107.59 7.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.307 -0.627 . . . . 99.989999999999995 109.307 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.31 165.49 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.46 0.704 . . . . 99.989999999999995 110.948 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.576 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -116.53 131.27 56.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.411 1.084 . . . . 99.989999999999995 108.188 172.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 56' ' ' VAL . 58.2 t -107.35 110.27 31.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.887 -1.153 . . . . 99.989999999999995 107.887 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.75 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 59.4 ttp180 -85.5 106.08 16.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 99.989999999999995 110.714 -174.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 N--CA 1.472 0.651 0 C-N-CA 124.707 1.203 . . . . 99.989999999999995 111.183 -177.154 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.925 -0.398 . . . . 99.989999999999995 109.925 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 69.0 p-90 -73.91 142.25 45.97 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.359 -0.608 . . . . 99.989999999999995 109.359 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.29 143.83 50.77 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.325 -0.991 . . . . 99.989999999999995 108.325 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.576 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 171.01 -173.87 44.72 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.683 -0.77 . . . . 99.989999999999995 113.555 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -88.02 115.98 3.22 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 118.446 1.123 . . . . 99.989999999999995 113.099 4.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -76.59 166.49 23.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.781 0.833 . . . . 99.989999999999995 110.672 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.586 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 69.4 p -129.96 111.42 12.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.983 0.513 . . . . 99.989999999999995 110.701 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 40.1 t -71.97 129.42 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 108.724 -0.843 . . . . 99.989999999999995 108.724 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 76.9 mt -105.77 -33.56 7.96 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.787 0.835 . . . . 99.989999999999995 109.789 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.8 tp -146.5 152.2 38.6 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.422 -0.808 . . . . 99.989999999999995 110.019 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -132.02 128.53 38.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.123 0.969 . . . . 99.989999999999995 108.985 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -123.56 162.88 37.89 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.501 1.52 . . . . 99.989999999999995 107.895 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.35 108.44 0.15 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.928 2.418 . . . . 99.989999999999995 113.777 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 m 73.98 0.02 3.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.854 1.662 . . . . 99.989999999999995 113.01 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -133.99 124.67 26.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.426 0.69 . . . . 99.989999999999995 110.119 -173.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.75 121.6 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 99.989999999999995 109.269 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.2 tttt -84.91 108.61 17.63 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 107.328 -1.36 . . . . 99.989999999999995 107.328 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 34' ' ' VAL . 57.3 t -117.51 146.39 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.578 -1.192 . . . . 99.989999999999995 109.482 -171.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.99 137.36 47.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.586 0.754 . . . . 99.989999999999995 109.558 173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.51 4.49 80.1 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.666 0.604 . . . . 99.989999999999995 112.784 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.458 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -117.13 147.91 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.62 1.168 . . . . 99.989999999999995 109.292 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.41 -51.41 64.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.996 0.919 . . . . 99.989999999999995 112.145 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.06 -57.59 0.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.589 0.356 . . . . 99.989999999999995 111.267 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 14.8 m-90 -142.16 157.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.633 0.773 . . . . 99.989999999999995 110.947 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 47' ' ' ILE . 34.8 mm -123.13 134.82 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.579 1.152 . . . . 99.989999999999995 108.454 168.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -61.49 113.47 2.69 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 108.034 -1.098 . . . . 99.989999999999995 108.034 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.61 -19.85 4.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.188 1.551 . . . . 99.989999999999995 115.188 -163.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.77 -29.85 69.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.73 0.812 . . . . 99.989999999999995 112.772 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -71.19 -24.72 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.252 0.621 . . . . 99.989999999999995 111.579 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.568 HG23 HG21 ' A' ' 16' ' ' VAL . 98.4 t -96.6 138.27 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 110.678 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -134.67 143.42 47.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.638 -1.245 . . . . 99.989999999999995 107.638 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.994 0.518 . . . . 99.989999999999995 110.79 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 123.531 0.732 . . . . 99.989999999999995 109.397 178.035 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 119.668 -0.206 . . . . 99.989999999999995 110.567 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.21 140.06 20.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 N-CA-C 109.211 -0.663 . . . . 99.989999999999995 109.211 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.742 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 82.9 11.14 81.97 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-O 118.657 -1.079 . . . . 99.989999999999995 113.176 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.471 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 53.2 t0 -50.13 119.86 3.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.688 0.744 . . . . 99.989999999999995 110.438 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 59' ' ' ALA . 35.3 m -73.66 110.86 8.28 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.693 -0.685 . . . . 99.989999999999995 109.259 -169.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.13 157.25 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.057 0.943 . . . . 99.989999999999995 110.279 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 30.7 m0 -101.2 143.11 31.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.279 -1.008 . . . . 99.989999999999995 108.279 168.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.91 112.95 42.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 N-CA-C 109.086 -0.709 . . . . 99.989999999999995 109.086 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.2 ttm180 -65.6 109.32 2.34 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.9 1.68 . . . . 99.989999999999995 110.745 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 124.175 0.99 . . . . 99.989999999999995 110.169 179.099 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 110.447 -0.205 . . . . 99.989999999999995 110.447 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 61.9 p-90 -76.08 151.69 37.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.657 0.383 . . . . 99.989999999999995 110.878 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -141.07 163.76 32.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.1 0.56 . . . . 99.989999999999995 109.743 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.412 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -167.93 -162.14 19.19 Favored Glycine 0 CA--C 1.538 1.471 0 N-CA-C 110.985 -0.846 . . . . 99.989999999999995 110.985 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.36 114.55 3.1 Favored 'Cis proline' 0 C--N 1.368 1.586 0 CA-C-N 119.365 1.583 . . . . 99.989999999999995 112.973 -2.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' HG11 ' A' ' 44' ' ' VAL . 74.5 m-85 -77.67 166.93 22.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.431 0.693 . . . . 99.989999999999995 110.072 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.742 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 17.2 p -140.33 111.87 7.34 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.285 0.634 . . . . 99.989999999999995 111.283 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 44' ' ' VAL . 60.0 t -84.03 125.43 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 122.888 0.475 . . . . 99.989999999999995 110.31 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.97 -45.47 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.746 0.818 . . . . 99.989999999999995 110.262 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 48.8 tp -132.58 153.71 50.74 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.438 -0.801 . . . . 99.989999999999995 109.486 -173.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.477 HG23 HD23 ' A' ' 42' ' ' LEU . 60.5 p -125.65 148.6 48.94 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.148 0.579 . . . . 99.989999999999995 110.027 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 40.3 p -140.03 165.93 27.32 Favored Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 125.372 1.469 . . . . 99.989999999999995 107.869 175.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.7 Cg_endo -51.92 108.18 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.572 2.182 . . . . 99.989999999999995 112.993 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 64.25 20.91 12.36 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.512 1.525 . . . . 99.989999999999995 112.581 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.57 129.44 11.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.167 -0.679 . . . . 99.989999999999995 109.167 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.676 HD11 HG11 ' A' ' 56' ' ' VAL . 33.8 mt -112.95 130.72 56.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.963 -0.46 . . . . 99.989999999999995 109.984 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -84.95 109.23 18.01 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.859 -0.793 . . . . 99.989999999999995 108.859 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HB ' HG13 ' A' ' 47' ' ' ILE . 86.7 t -97.26 149.05 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 113.984 -1.462 . . . . 99.989999999999995 109.277 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.45 130.2 42.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.885 0.874 . . . . 99.989999999999995 111.008 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.88 -7.31 70.22 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.051 -0.522 . . . . 99.989999999999995 112.959 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.494 HG13 ' HB ' ' A' ' 44' ' ' VAL . 49.0 mm -90.53 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.701 0.8 . . . . 99.989999999999995 110.056 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.75 -46.99 81.07 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.935 0.894 . . . . 99.989999999999995 111.813 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.79 -58.38 0.17 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.074 0.398 . . . . 99.989999999999995 112.074 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -143.28 156.92 44.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.888 0.475 . . . . 99.989999999999995 111.806 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 38.6 mm -120.44 118.24 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.109 1.364 . . . . 99.989999999999995 107.346 165.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -68.54 151.71 46.39 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.705 0.802 . . . . 99.989999999999995 109.268 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.3 61.02 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 115.846 1.795 . . . . 99.989999999999995 115.846 -161.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.57 -19.79 60.79 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.448 0.536 . . . . 99.989999999999995 112.448 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.27 -14.96 58.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.721 0.409 . . . . 99.989999999999995 110.446 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.676 HG11 HD11 ' A' ' 42' ' ' LEU . 40.5 t -99.22 137.75 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.992 0.425 . . . . 99.989999999999995 110.068 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.426 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 51.4 mtpt -136.38 137.52 40.62 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.379 1.072 . . . . 99.989999999999995 108.208 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 136.58 57.48 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.857 0.463 . . . . 99.989999999999995 110.491 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.111 0.965 . . . . 99.989999999999995 110.868 -175.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.674 -0.491 . . . . 99.989999999999995 109.674 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.584 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 3.3 m -63.45 106.27 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.128 -0.693 . . . . 99.989999999999995 109.128 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.443 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.08 9.08 12.42 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.061 -0.855 . . . . 99.989999999999995 113.166 -167.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.473 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 52.7 t0 -62.12 132.1 51.72 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 117.747 0.773 . . . . 99.989999999999995 111.434 -175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.446 HG21 ' HB2' ' A' ' 59' ' ' ALA . 19.2 m -82.44 106.56 14.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.478 0.711 . . . . 99.989999999999995 110.825 -173.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 24.6 m -131.76 -177.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.591 1.156 . . . . 99.989999999999995 109.874 177.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.464 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.6 m0 -128.1 154.22 45.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.411 1.484 . . . . 99.989999999999995 107.542 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.8 t -108.13 107.92 23.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.831 -1.174 . . . . 99.989999999999995 107.831 171.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 50.9 ttp180 -82.43 94.16 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.583 1.153 . . . . 99.989999999999995 109.422 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 109.432 -0.581 . . . . 99.989999999999995 109.432 -178.563 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.8 -0.815 . . . . 99.989999999999995 108.8 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.648 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.3 p-90 -86.84 152.59 22.34 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.033 0.444 . . . . 99.989999999999995 111.679 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.518 ' HB2' ' HZ1' ' A' ' 29' ' ' LYS . 10.5 mtmp? -136.09 164.05 28.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.745 1.218 . . . . 99.989999999999995 107.916 167.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.464 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.09 -159.98 32.71 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.563 -0.576 . . . . 99.989999999999995 112.608 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.74 120.05 6.52 Favored 'Cis proline' 0 C--N 1.376 2.02 0 CA-C-N 119.144 1.472 . . . . 99.989999999999995 112.964 -2.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' HG13 ' A' ' 44' ' ' VAL . 84.5 m-85 -81.98 154.39 25.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.987 0.915 . . . . 99.989999999999995 109.666 172.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 40.9 p -114.6 110.75 20.27 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.737 0.415 . . . . 99.989999999999995 111.442 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 44' ' ' VAL . 79.4 t -70.69 130.71 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.153 0.581 . . . . 99.989999999999995 109.498 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 62.4 mt -103.43 -58.66 1.84 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.043 0.937 . . . . 99.989999999999995 109.266 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 59.6 tp -123.65 155.97 36.75 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.215 -0.902 . . . . 99.989999999999995 109.659 -172.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.484 HG23 HD22 ' A' ' 42' ' ' LEU . 69.2 p -125.97 130.05 50.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.905 0.882 . . . . 99.989999999999995 109.724 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -140.07 95.28 8.53 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 124.247 1.019 . . . . 99.989999999999995 108.976 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -27.28 127.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 1 C-N-CA 125.632 4.221 . . . . 99.989999999999995 116.471 -166.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.8 m 86.79 -12.22 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.499 1.919 . . . . 99.989999999999995 111.65 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 50' ' ' TRP . . . -152.23 149.77 29.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.762 -0.586 . . . . 99.989999999999995 110.861 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.659 HD12 HG12 ' A' ' 56' ' ' VAL . 38.9 mt -120.42 134.45 55.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.536 -0.913 . . . . 99.989999999999995 108.536 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.8 tttm -83.47 108.9 16.92 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.604 -0.887 . . . . 99.989999999999995 108.604 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 34' ' ' VAL . 63.0 t -108.86 135.9 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.627 1.171 . . . . 99.989999999999995 109.512 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.467 ' HB3' ' HG1' ' A' ' 33' ' ' THR . 23.7 t70 -68.02 143.27 55.62 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.607 0.763 . . . . 99.989999999999995 110.646 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.59 -19.17 49.49 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.366 -0.379 . . . . 99.989999999999995 112.394 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -94.0 159.06 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.254 1.022 . . . . 99.989999999999995 110.01 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.44 -52.13 60.42 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 123.841 0.856 . . . . 99.989999999999995 111.538 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.12 -57.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.271 0.357 . . . . 99.989999999999995 111.666 169.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 19.1 m-90 -136.47 134.76 37.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.902 0.481 . . . . 99.989999999999995 111.74 -173.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.7 mm -94.72 125.24 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.26 -1.015 . . . . 99.989999999999995 108.26 166.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -64.28 136.62 57.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.548 -1.279 . . . . 99.989999999999995 107.548 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -28.65 64.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.793 1.405 . . . . 99.989999999999995 114.793 -160.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.9 27.19 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.451 0.537 . . . . 99.989999999999995 112.451 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -109.57 9.13 25.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.933 0.893 . . . . 99.989999999999995 110.201 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.659 HG12 HD12 ' A' ' 42' ' ' LEU . 37.2 t -105.86 125.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.597 -0.52 . . . . 99.989999999999995 109.597 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -125.24 110.94 14.65 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.425 -0.954 . . . . 99.989999999999995 108.425 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -58.98 117.46 4.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.53 0.732 . . . . 99.989999999999995 110.248 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 13' ' ' THR . . . . . . . . 0 C--O 1.24 0.56 0 N-CA-C 109.674 -0.491 . . . . 99.989999999999995 109.674 -175.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 109.685 -0.487 . . . . 99.989999999999995 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.0 131.12 28.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 122.653 0.381 . . . . 99.989999999999995 110.103 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.667 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.46 11.69 59.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.3 -0.722 . . . . 99.989999999999995 113.342 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 56.7 t0 -51.52 113.47 0.98 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.855 0.862 . . . . 99.989999999999995 111.314 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' THR . . . . . 0.445 HG22 ' HB2' ' A' ' 31' ' ' PRO . 95.5 m -73.11 115.63 12.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.369 0.668 . . . . 99.989999999999995 110.51 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.3 168.74 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.689 1.196 . . . . 99.989999999999995 110.328 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -112.5 130.75 55.89 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.271 -1.011 . . . . 99.989999999999995 108.271 169.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 56' ' ' VAL . 70.6 t -110.65 115.41 49.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.238 -0.653 . . . . 99.989999999999995 109.238 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.9 ttm180 -89.29 123.07 33.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.399 1.479 . . . . 99.989999999999995 110.438 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 107.763 -1.199 . . . . 99.989999999999995 107.763 174.91 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 109.469 -0.567 . . . . 99.989999999999995 109.469 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.4 p-90 -96.65 156.55 16.3 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.757 0.423 . . . . 99.989999999999995 110.711 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -138.13 172.0 13.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.92 0.888 . . . . 99.989999999999995 109.458 167.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.12 46.27 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 115.391 -0.822 . . . . 99.989999999999995 111.468 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HB2' HG22 ' A' ' 13' ' ' THR . 89.4 Cg_endo -88.37 106.28 0.71 Allowed 'Cis proline' 0 C--N 1.368 1.596 0 CA-C-N 119.286 1.543 . . . . 99.989999999999995 112.479 -2.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.426 ' HB3' HG11 ' A' ' 44' ' ' VAL . 53.0 m-85 -64.69 162.03 16.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.552 0.741 . . . . 99.989999999999995 110.384 172.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.667 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 14.0 p -134.01 111.14 10.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.009 0.524 . . . . 99.989999999999995 110.748 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 21.7 t -81.91 130.1 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.357 0.663 . . . . 99.989999999999995 109.553 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.9 mt -103.56 -32.74 9.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.421 0.689 . . . . 99.989999999999995 110.765 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.7 tp -142.89 143.26 31.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.13 -0.693 . . . . 99.989999999999995 109.13 -172.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.9 p -136.96 132.14 33.96 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.339 0.59 . . . . 99.989999999999995 111.01 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -117.42 164.99 16.88 Favored Pre-proline 0 CA--C 1.57 1.739 0 C-N-CA 126.068 1.747 . . . . 99.989999999999995 108.585 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -48.75 111.44 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.404 2.736 . . . . 99.989999999999995 113.541 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.71 12.24 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.936 1.694 . . . . 99.989999999999995 112.961 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -136.58 119.64 16.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.523 -0.918 . . . . 99.989999999999995 108.523 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.46 119.23 38.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.166 -1.05 . . . . 99.989999999999995 108.166 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 81.0 tttt -86.66 106.57 17.7 Favored 'General case' 0 C--O 1.255 1.347 0 N-CA-C 109.222 -0.659 . . . . 99.989999999999995 109.222 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 38.8 t -91.43 155.33 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 114.378 -1.283 . . . . 99.989999999999995 108.976 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.15 123.21 17.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 99.989999999999995 111.093 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.93 65.67 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.684 -0.689 . . . . 99.989999999999995 113.637 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.8 mm -89.05 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.409 0.684 . . . . 99.989999999999995 110.344 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.09 59.92 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.642 1.177 . . . . 99.989999999999995 112.04 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.19 -56.75 0.14 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.42 0.45 . . . . 99.989999999999995 111.345 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 20.6 m-90 -144.64 157.08 44.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.11 0.564 . . . . 99.989999999999995 111.173 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 mm -118.11 136.09 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.238 1.015 . . . . 99.989999999999995 108.355 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -64.24 127.94 33.64 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.474 -0.936 . . . . 99.989999999999995 108.474 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.85 -23.11 16.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.86 1.43 . . . . 99.989999999999995 114.86 -164.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.36 81.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.234 0.614 . . . . 99.989999999999995 111.95 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -77.54 2.11 17.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.456 0.702 . . . . 99.989999999999995 112.616 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG21 HG22 ' A' ' 16' ' ' VAL . 61.3 t -120.07 135.65 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.497 -0.557 . . . . 99.989999999999995 109.497 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -127.17 143.34 51.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.831 0.853 . . . . 99.989999999999995 108.865 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.45 122.35 16.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.14 0.576 . . . . 99.989999999999995 110.636 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.508 0.723 . . . . 99.989999999999995 110.37 176.63 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 C--O 1.242 0.7 0 N-CA-C 109.37 -0.604 . . . . 99.989999999999995 109.37 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.91 144.6 13.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 108.686 -0.857 . . . . 99.989999999999995 108.686 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.82 7.81 52.55 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.704 -0.498 . . . . 99.989999999999995 112.92 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . 0.753 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -68.0 110.75 4.05 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.399 0.679 . . . . 99.989999999999995 109.998 -175.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -71.31 117.19 12.53 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.301 0.572 . . . . 99.989999999999995 110.049 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.53 -175.67 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.478 1.111 . . . . 99.989999999999995 109.844 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 30.8 m0 -128.63 151.37 49.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.755 1.222 . . . . 99.989999999999995 107.738 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -109.53 104.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.368 -0.975 . . . . 99.989999999999995 108.368 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.639 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.1 ttp180 -88.61 93.62 9.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.579 -1.191 . . . . 99.989999999999995 110.29 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 115.905 -0.588 . . . . 99.989999999999995 110.363 -172.989 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.093 -0.706 . . . . 99.989999999999995 109.093 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 66.3 p-90 -93.91 146.64 23.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.615 0.721 . . . . 99.989999999999995 112.156 -177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -113.42 157.42 21.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.826 -1.534 . . . . 99.989999999999995 108.378 166.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.08 170.96 33.86 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 124.232 0.957 . . . . 99.989999999999995 110.934 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.48 161.25 76.77 Favored 'Cis proline' 0 C--N 1.366 1.491 0 CA-C-N 119.355 1.577 . . . . 99.989999999999995 111.73 -9.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.01 176.49 8.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.462 1.105 . . . . 99.989999999999995 110.196 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 t -152.27 111.88 3.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.63 -0.714 . . . . 99.989999999999995 111.372 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.753 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 89.9 t -67.83 124.23 22.83 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 C-N-CA 123.887 0.875 . . . . 99.989999999999995 109.345 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.95 -18.37 14.06 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.166 -0.924 . . . . 99.989999999999995 110.736 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 36.2 tp -145.73 138.65 25.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.89 0.476 . . . . 99.989999999999995 110.055 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -107.35 137.15 45.92 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.207 1.003 . . . . 99.989999999999995 108.597 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 m -141.16 148.83 53.16 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.115 -1.069 . . . . 99.989999999999995 108.115 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.74 108.4 0.15 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.125 1.883 . . . . 99.989999999999995 112.949 170.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m 70.45 17.74 6.79 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.516 1.526 . . . . 99.989999999999995 112.177 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -154.59 144.81 21.97 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.07 -0.514 . . . . 99.989999999999995 110.645 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.04 121.24 23.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.66 -0.867 . . . . 99.989999999999995 108.66 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 26.9 ttpp -85.44 109.38 18.41 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.081 -1.081 . . . . 99.989999999999995 108.081 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 34' ' ' VAL . 95.5 t -103.75 155.62 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 125.066 1.346 . . . . 99.989999999999995 108.902 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.04 121.26 11.99 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.299 0.639 . . . . 99.989999999999995 110.994 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.95 24.63 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.862 -0.608 . . . . 99.989999999999995 112.879 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.402 HG23 HG12 ' A' ' 51' ' ' ILE . 33.9 mm -76.72 147.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.702 0.801 . . . . 99.989999999999995 110.594 -176.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.38 74.11 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 123.688 0.618 . . . . 99.989999999999995 111.607 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 -58.21 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.183 0.438 . . . . 99.989999999999995 112.183 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . 0.573 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 21.2 m-90 -146.42 145.75 30.35 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.219 0.607 . . . . 99.989999999999995 112.206 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.402 HG12 HG23 ' A' ' 47' ' ' ILE . 28.3 mm -106.99 125.68 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.824 0.85 . . . . 99.989999999999995 108.899 168.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.36 122.06 12.34 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.266 -1.013 . . . . 99.989999999999995 108.266 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.41 -19.19 8.42 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.025 1.491 . . . . 99.989999999999995 115.025 -162.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.58 9.84 2.03 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.578 0.751 . . . . 99.989999999999995 112.363 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.27 18.63 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 99.989999999999995 109.909 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.86 125.33 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.724 0.409 . . . . 99.989999999999995 110.149 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 5.7 mtpm? -108.6 110.96 22.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.976 -0.749 . . . . 99.989999999999995 108.976 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.518 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.04 120.5 14.38 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.234 0.614 . . . . 99.989999999999995 111.448 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 123.634 0.773 . . . . 99.989999999999995 110.612 -176.571 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.836 0.351 . . . . 99.989999999999995 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.4 m -65.54 136.56 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.801 -0.636 . . . . 99.989999999999995 110.662 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.09 9.06 82.96 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-O 119.539 -0.59 . . . . 99.989999999999995 113.785 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -65.89 106.31 1.52 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.229 -0.656 . . . . 99.989999999999995 109.229 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.4 m -72.09 123.53 23.05 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.522 0.677 . . . . 99.989999999999995 111.062 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.7 m -139.1 -177.67 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.691 1.196 . . . . 99.989999999999995 110.165 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . 0.571 ' HZ3' ' HZ2' ' A' ' 57' ' ' LYS . 34.7 m0 -123.23 158.66 30.39 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.457 1.103 . . . . 99.989999999999995 108.194 169.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.45 102.48 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.54 -0.911 . . . . 99.989999999999995 108.54 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 56.0 ttp180 -74.08 93.16 2.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.969 1.308 . . . . 99.989999999999995 109.789 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 . . . . . 0 CA--C 1.558 1.281 0 C-N-CA 124.333 1.053 . . . . 99.989999999999995 109.08 176.916 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 120.522 0.201 . . . . 99.989999999999995 110.612 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 70.1 p-90 -73.6 139.7 45.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 167.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -121.04 147.97 44.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.801 0.84 . . . . 99.989999999999995 108.759 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.46 175.41 36.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 123.785 0.678 . . . . 99.989999999999995 112.49 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -85.34 141.2 30.69 Favored 'Cis proline' 0 C--N 1.374 1.898 0 CA-C-N 119.036 1.418 . . . . 99.989999999999995 112.901 -4.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -120.93 171.13 8.85 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.242 1.017 . . . . 99.989999999999995 109.569 174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 p -151.59 114.0 4.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 99.989999999999995 110.246 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.21 121.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 109.537 -0.542 . . . . 99.989999999999995 109.537 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 86.3 mt -98.51 -41.14 7.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.664 0.785 . . . . 99.989999999999995 109.712 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 40.8 tp -131.57 145.21 51.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.397 0.679 . . . . 99.989999999999995 110.252 -176.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.532 HG23 HD22 ' A' ' 42' ' ' LEU . 42.2 p -115.38 140.59 48.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 99.989999999999995 110.079 174.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.7 p -139.23 158.03 69.87 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 106.945 -1.502 . . . . 99.989999999999995 106.945 165.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.32 109.45 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.627 2.218 . . . . 99.989999999999995 113.769 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m 74.51 5.33 4.52 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.712 1.605 . . . . 99.989999999999995 113.135 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.8 124.22 16.77 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.824 -0.548 . . . . 99.989999999999995 110.046 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.532 HD22 HG23 ' A' ' 37' ' ' THR . 66.6 mt -113.0 125.49 54.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.164 -0.68 . . . . 99.989999999999995 109.164 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 62.5 tttm -84.08 108.69 17.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.549 -1.278 . . . . 99.989999999999995 107.549 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.9 t -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.106 -0.952 . . . . 99.989999999999995 109.227 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.05 138.36 55.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.163 0.585 . . . . 99.989999999999995 110.577 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.45 -38.54 3.06 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.92 -0.872 . . . . 99.989999999999995 110.92 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.544 HG22 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -80.67 151.62 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.871 0.869 . . . . 99.989999999999995 110.026 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.12 61.99 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.744 0.653 . . . . 99.989999999999995 112.602 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 -50.73 0.14 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.229 0.826 . . . . 99.989999999999995 113.229 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -143.92 154.63 43.53 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 119.191 0.905 . . . . 99.989999999999995 112.55 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.544 HG12 HG22 ' A' ' 47' ' ' ILE . 27.7 mm -129.34 133.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.579 1.552 . . . . 99.989999999999995 107.536 163.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 124.65 21.35 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.057 -1.09 . . . . 99.989999999999995 108.057 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.15 -19.39 13.22 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.851 1.426 . . . . 99.989999999999995 114.851 -164.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.51 -13.18 62.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.653 0.612 . . . . 99.989999999999995 112.653 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.74 -3.66 48.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.579 0.752 . . . . 99.989999999999995 110.983 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.5 129.0 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.054 -0.721 . . . . 99.989999999999995 109.054 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.571 ' HZ2' ' HZ3' ' A' ' 15' ' ' TRP . 81.5 tttt -124.9 122.1 36.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 99.989999999999995 109.323 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -59.62 123.59 17.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.463 0.705 . . . . 99.989999999999995 111.104 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 123.581 0.753 . . . . 99.989999999999995 111.011 -174.028 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 C--O 1.244 0.784 0 N-CA-C 109.037 -0.727 . . . . 99.989999999999995 109.037 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.463 HG12 ' O ' ' A' ' 35' ' ' LEU . 10.4 m -75.07 148.64 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.444 0.698 . . . . 99.989999999999995 109.173 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 86.89 10.53 72.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.97 -0.633 . . . . 99.989999999999995 112.407 -174.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -62.14 115.43 4.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.409 0.684 . . . . 99.989999999999995 110.26 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 m -73.38 114.61 11.79 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.988 0.423 . . . . 99.989999999999995 110.65 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.5 m -132.29 -177.55 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.915 1.286 . . . . 99.989999999999995 110.022 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -124.35 142.4 51.31 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.861 1.264 . . . . 99.989999999999995 107.677 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.29 106.58 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.031 -1.1 . . . . 99.989999999999995 108.031 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.755 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.4 ttp180 -84.66 93.64 8.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.505 -1.225 . . . . 99.989999999999995 110.635 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.725 1.21 . . . . 99.989999999999995 109.891 -175.175 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 C--O 1.245 0.854 0 N-CA-C 109.359 -0.608 . . . . 99.989999999999995 109.359 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TRP . . . . . 0.755 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 58.6 p-90 -80.77 146.45 30.98 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.912 0.387 . . . . 99.989999999999995 110.832 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.557 ' HZ3' ' HB3' ' A' ' 29' ' ' LYS . 7.7 mtpm? -119.78 141.52 49.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.613 -1.255 . . . . 99.989999999999995 107.613 174.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.87 164.99 36.76 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 119.665 -0.52 . . . . 99.989999999999995 112.127 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.55 136.97 19.25 Favored 'Cis proline' 0 C--N 1.373 1.865 0 CA-C-N 119.45 1.625 . . . . 99.989999999999995 112.946 -1.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -111.35 174.1 6.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.443 1.097 . . . . 99.989999999999995 110.151 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.541 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.6 p -142.34 112.72 7.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.642 0.777 . . . . 99.989999999999995 110.436 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.72 122.72 19.43 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 N-CA-C 109.32 -0.622 . . . . 99.989999999999995 109.32 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.463 ' O ' HG12 ' A' ' 10' ' ' VAL . 62.2 mt -93.64 -42.01 9.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.964 -1.016 . . . . 99.989999999999995 109.943 172.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 19.1 tp -133.54 144.52 49.41 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 122.107 -0.37 . . . . 99.989999999999995 110.65 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.6 m -119.2 129.16 54.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.138 0.975 . . . . 99.989999999999995 109.519 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 p -139.84 158.77 67.0 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.397 1.079 . . . . 99.989999999999995 108.81 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.53 108.91 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.284 2.656 . . . . 99.989999999999995 114.416 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 62.11 17.5 9.19 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.568 1.547 . . . . 99.989999999999995 113.051 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.69 134.18 24.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.494 0.718 . . . . 99.989999999999995 109.303 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.62 124.74 41.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.138 -0.69 . . . . 99.989999999999995 109.138 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -83.84 109.65 17.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.078 -1.453 . . . . 99.989999999999995 107.078 172.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.4 136.45 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.678 -1.146 . . . . 99.989999999999995 108.474 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.423 ' HB3' ' HG1' ' A' ' 33' ' ' THR . 31.9 t70 -66.06 139.1 58.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.481 -0.562 . . . . 99.989999999999995 109.481 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -15.39 63.17 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.964 -0.455 . . . . 99.989999999999995 111.964 -172.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . 0.542 HG21 HG12 ' A' ' 51' ' ' ILE . 46.5 mm -101.58 147.73 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.287 1.035 . . . . 99.989999999999995 109.382 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.01 -49.75 65.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.015 0.926 . . . . 99.989999999999995 112.344 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.45 -58.76 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.141 0.423 . . . . 99.989999999999995 112.141 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -143.18 157.22 44.7 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 123.174 0.59 . . . . 99.989999999999995 110.962 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.542 HG12 HG21 ' A' ' 47' ' ' ILE . 35.4 mm -126.56 139.95 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 108.246 -1.02 . . . . 99.989999999999995 108.246 167.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -64.42 139.74 58.8 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.545 0.738 . . . . 99.989999999999995 109.014 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.89 -22.13 61.96 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.478 1.288 . . . . 99.989999999999995 114.478 -168.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.89 -15.67 62.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.724 0.639 . . . . 99.989999999999995 112.724 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.3 24.12 11.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.903 0.881 . . . . 99.989999999999995 110.848 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.1 136.12 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.607 -1.257 . . . . 99.989999999999995 107.607 165.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -136.65 135.89 38.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.853 -0.795 . . . . 99.989999999999995 108.853 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.04 138.19 57.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.656 0.782 . . . . 99.989999999999995 112.201 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 125.142 1.377 . . . . 99.989999999999995 109.068 174.566 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.142 -0.318 . . . . 99.989999999999995 110.142 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.84 62.08 1.2 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.37 1.081 . . . . 99.989999999999995 109.774 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -102.23 122.1 43.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.77 -1.105 . . . . 99.989999999999995 108.913 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -125.27 154.35 41.83 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.63 0.772 . . . . 99.989999999999995 110.217 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -166.56 170.73 12.44 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.56 1.144 . . . . 99.989999999999995 108.281 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.75 89.04 0.15 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.931 0.872 . . . . 99.989999999999995 110.54 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.64 ' HB3' HD22 ' A' ' 80' ' ' LEU . 31.1 t -107.06 -176.43 3.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.41 1.484 . . . . 99.989999999999995 108.893 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -87.4 155.63 19.94 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.341 -0.985 . . . . 99.989999999999995 108.341 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -58.8 141.37 53.28 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 124.009 0.818 . . . . 99.989999999999995 111.017 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -61.57 108.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.418 -0.956 . . . . 99.989999999999995 108.418 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.462 ' HA2' HG22 ' A' ' 70' ' ' THR . . . 117.13 11.28 9.1 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 118.755 -1.025 . . . . 99.989999999999995 114.278 -169.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.665 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 59.8 t0 -60.02 110.7 1.26 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.508 0.654 . . . . 99.989999999999995 109.418 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 m -74.32 108.77 7.31 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.021 0.528 . . . . 99.989999999999995 109.635 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.555 HG11 ' HA ' ' A' ' 58' ' ' ALA . 34.6 m -131.48 172.96 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.903 1.281 . . . . 99.989999999999995 109.716 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -119.24 154.59 33.19 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.694 1.197 . . . . 99.989999999999995 107.999 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.51 108.44 25.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.1 -1.074 . . . . 99.989999999999995 108.1 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -82.55 92.32 7.08 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.338 -2.21 . . . . 99.989999999999995 108.635 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -145.3 148.93 33.99 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.773 0.429 . . . . 99.989999999999995 110.506 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.695 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 40.2 t-80 -155.5 136.78 13.94 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.545 -0.539 . . . . 99.989999999999995 109.545 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -61.76 142.17 57.44 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.042 -0.725 . . . . 99.989999999999995 109.042 172.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -66.34 85.43 0.1 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.71 0.767 . . . . 99.989999999999995 111.342 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -114.16 3.94 15.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.006 1.323 . . . . 99.989999999999995 110.845 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.1 t30 70.19 5.12 5.17 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.206 1.402 . . . . 99.989999999999995 111.729 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.505 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 mt -93.16 158.39 15.79 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.935 0.894 . . . . 99.989999999999995 109.517 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.89 145.99 97.39 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.072 0.949 . . . . 99.989999999999995 112.517 -170.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.695 ' HA ' ' HB2' ' A' ' 19' ' ' HIS . 31.9 Cg_endo -61.8 134.83 52.44 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 123.216 2.611 . . . . 99.989999999999995 112.838 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -110.66 130.67 55.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.585 0.754 . . . . 99.989999999999995 110.456 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -78.93 143.79 35.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.852 0.358 . . . . 99.989999999999995 110.821 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -130.48 152.49 49.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.894 -1.15 . . . . 99.989999999999995 107.894 164.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.94 -174.32 38.71 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.792 -0.718 . . . . 99.989999999999995 112.983 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -92.43 112.66 1.4 Allowed 'Cis proline' 0 C--N 1.37 1.69 0 C-N-CA 124.184 -1.173 . . . . 99.989999999999995 112.696 -2.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -76.95 156.99 31.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.196 0.598 . . . . 99.989999999999995 109.392 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.429 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 36.4 p -126.48 112.51 15.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.555 0.342 . . . . 99.989999999999995 110.834 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.665 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 60.2 t -74.31 123.48 29.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 109.344 -0.613 . . . . 99.989999999999995 109.344 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.483 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 89.2 mt -93.12 -33.39 14.07 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.411 1.07 . . . . 99.989999999999995 110.12 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 55.2 tp -149.87 144.58 26.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.995 0.518 . . . . 99.989999999999995 109.626 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.457 HG21 HD22 ' A' ' 42' ' ' LEU . 64.0 p -109.72 144.12 38.55 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.523 -0.918 . . . . 99.989999999999995 108.523 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -135.86 149.31 68.33 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 105.542 -2.021 . . . . 99.989999999999995 105.542 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.78 106.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.209 2.606 . . . . 99.989999999999995 113.49 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m 62.15 27.66 16.64 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.662 1.585 . . . . 99.989999999999995 112.642 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.411 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -159.37 123.61 3.9 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 99.989999999999995 109.466 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.457 HD22 HG21 ' A' ' 37' ' ' THR . 44.9 mt -111.37 128.43 55.97 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.68 -0.637 . . . . 99.989999999999995 110.194 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 25.3 ttpp -85.85 108.27 18.06 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.722 -1.214 . . . . 99.989999999999995 107.722 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.496 HG23 HG23 ' A' ' 34' ' ' VAL . 60.6 t -115.47 149.05 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.533 1.133 . . . . 99.989999999999995 109.045 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.99 133.2 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.524 -0.547 . . . . 99.989999999999995 109.524 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.83 -11.68 67.83 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.359 0.412 . . . . 99.989999999999995 113.509 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.428 HG21 HG12 ' A' ' 51' ' ' ILE . 47.2 mm -97.4 151.21 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.879 0.872 . . . . 99.989999999999995 110.669 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.58 -51.07 70.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.114 0.965 . . . . 99.989999999999995 111.78 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.408 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -152.44 -59.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.567 0.347 . . . . 99.989999999999995 111.458 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.411 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.7 m-90 -142.53 147.92 36.75 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.12 0.568 . . . . 99.989999999999995 110.847 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.428 HG12 HG21 ' A' ' 47' ' ' ILE . 33.2 mm -114.69 130.32 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.503 -1.295 . . . . 99.989999999999995 107.503 166.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -55.93 123.51 14.56 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.801 -0.814 . . . . 99.989999999999995 108.801 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.45 -18.69 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.674 1.361 . . . . 99.989999999999995 114.674 -164.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.56 67.36 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.168 0.587 . . . . 99.989999999999995 112.141 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -96.94 15.25 22.81 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.44 1.096 . . . . 99.989999999999995 111.123 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.4 HG12 HD12 ' A' ' 42' ' ' LEU . 38.4 t -131.82 152.06 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.852 -1.166 . . . . 99.989999999999995 107.852 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -151.96 132.93 14.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.336 -0.986 . . . . 99.989999999999995 108.336 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.555 ' HA ' HG11 ' A' ' 14' ' ' VAL . . . -60.33 151.72 27.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.854 0.461 . . . . 99.989999999999995 111.498 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.24 164.92 22.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.907 0.883 . . . . 99.989999999999995 109.915 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -97.87 111.74 59.85 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.465 -0.939 . . . . 99.989999999999995 108.465 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.83 -14.61 32.84 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.247 1.965 . . . . 99.989999999999995 112.783 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.65 -57.59 5.03 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 111.54 -0.624 . . . . 99.989999999999995 111.54 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.94 -166.54 32.5 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 111.159 -0.777 . . . . 99.989999999999995 111.159 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.13 -140.42 46.55 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 124.235 0.609 . . . . 99.989999999999995 114.519 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.418 ' HA ' ' HB3' ' A' ' 68' ' ' ARG . 6.1 Cg_exo -80.7 41.74 1.2 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.595 2.863 . . . . 99.989999999999995 113.323 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -100.34 -68.83 0.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.142 -0.688 . . . . 99.989999999999995 109.142 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.5 p -71.72 -24.54 61.81 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.1 0.56 . . . . 99.989999999999995 110.975 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.418 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 38.9 ttm180 -72.24 -35.59 68.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.353 1.061 . . . . 99.989999999999995 112.51 -172.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.86 76.16 5.36 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 120.994 0.426 . . . . 99.989999999999995 110.814 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.462 HG22 ' HA2' ' A' ' 11' ' ' GLY . 7.1 m -152.78 154.47 35.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.802 0.841 . . . . 99.989999999999995 109.693 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -50.83 119.13 3.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.618 1.167 . . . . 99.989999999999995 110.088 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.3 38.79 0.83 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.026 0.931 . . . . 99.989999999999995 111.831 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -51.59 -52.51 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.938 1.295 . . . . 99.989999999999995 111.808 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.433 ' H ' HG21 ' A' ' 10' ' ' VAL . 32.3 mm-40 -131.65 32.61 4.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.285 1.034 . . . . 99.989999999999995 110.015 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -69.08 89.88 0.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.849 0.833 . . . . 99.989999999999995 109.577 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.6 p -159.94 119.36 2.84 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 113.966 -1.47 . . . . 99.989999999999995 108.023 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -87.27 65.48 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.705 0.764 . . . . 99.989999999999995 110.279 -173.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -155.33 -58.14 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 114.82 -1.082 . . . . 99.989999999999995 109.259 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.65 -36.2 5.18 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.642 1.622 . . . . 99.989999999999995 111.787 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.64 HD22 ' HB3' ' A' ' 7' ' ' SER . 27.2 mt -106.27 125.25 50.77 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.321 0.648 . . . . 99.989999999999995 109.703 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -121.74 142.72 49.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.471 1.108 . . . . 99.989999999999995 110.246 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.6 pt -117.83 -171.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.179 0.991 . . . . 99.989999999999995 108.729 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -133.2 177.82 7.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.171 0.588 . . . . 99.989999999999995 110.117 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.89 122.8 16.32 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.286 0.634 . . . . 99.989999999999995 110.945 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 t -68.86 176.96 2.78 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.542 0.737 . . . . 99.989999999999995 110.211 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -65.12 -33.8 76.89 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.492 0.553 . . . . 99.989999999999995 112.492 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 64.44 89.99 0.09 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.28 0.988 . . . . 99.989999999999995 108.807 -168.197 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.43 115.92 10.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.137 0.975 . . . . 99.989999999999995 108.691 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--N 1.375 1.962 0 C-N-CA 122.664 2.243 . . . . 99.989999999999995 111.741 -179.088 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.489 -0.56 . . . . 99.989999999999995 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -140.63 159.38 42.33 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.979 0.512 . . . . 99.989999999999995 110.565 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -127.05 119.52 26.8 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.714 0.806 . . . . 99.989999999999995 109.993 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -75.26 137.84 41.47 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.385 0.674 . . . . 99.989999999999995 109.971 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -143.64 146.77 33.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.743 0.417 . . . . 99.989999999999995 111.965 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -115.12 83.39 1.9 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.081 -1.081 . . . . 99.989999999999995 108.081 167.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.432 ' HB3' ' H ' ' A' ' 37' ' ' THR . 15.0 m -97.15 169.47 9.78 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.18 -0.918 . . . . 99.989999999999995 111.182 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -75.82 131.55 39.82 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 107.595 -1.261 . . . . 99.989999999999995 107.595 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.435 ' HE2' HG23 ' A' ' 82' ' ' ILE . 17.8 ptp -67.77 162.36 24.07 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.462 0.705 . . . . 99.989999999999995 112.227 -174.584 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.91 140.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 114.165 -1.379 . . . . 99.989999999999995 113.14 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.28 8.95 42.96 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.475 -0.784 . . . . 99.989999999999995 112.568 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.604 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -62.59 103.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.483 0.713 . . . . 99.989999999999995 110.616 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 m -71.6 110.68 6.33 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.268 -0.642 . . . . 99.989999999999995 109.268 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.54 HG11 ' HA ' ' A' ' 58' ' ' ALA . 30.1 m -132.83 179.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 99.989999999999995 110.292 -175.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -124.26 150.87 44.85 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.545 -1.28 . . . . 99.989999999999995 107.545 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.96 107.92 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.374 -0.602 . . . . 99.989999999999995 109.374 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -76.28 137.83 40.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.247 1.419 . . . . 99.989999999999995 110.401 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -134.67 113.51 11.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 109.667 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -74.91 106.27 6.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.234 -1.024 . . . . 99.989999999999995 108.234 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.9 -62.01 1.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.883 0.739 . . . . 99.989999999999995 111.034 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.2 p -140.12 175.46 9.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.929 0.891 . . . . 99.989999999999995 109.076 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.33 -21.82 66.26 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.015 0.526 . . . . 99.989999999999995 110.766 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -83.44 -58.29 2.89 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.405 0.682 . . . . 99.989999999999995 109.617 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.4 113.59 11.81 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.159 0.584 . . . . 99.989999999999995 110.708 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.77 157.49 28.51 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.654 1.182 . . . . 99.989999999999995 111.712 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -57.82 124.46 16.05 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 123.16 2.573 . . . . 99.989999999999995 114.062 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -111.28 127.55 55.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.551 1.14 . . . . 99.989999999999995 109.258 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -103.7 163.41 12.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.572 0.749 . . . . 99.989999999999995 111.816 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.92 161.0 34.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.93 1.292 . . . . 99.989999999999995 108.635 172.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.64 -175.97 42.6 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.578 -0.568 . . . . 99.989999999999995 112.847 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -88.58 128.12 8.57 Favored 'Cis proline' 0 C--N 1.373 1.861 0 CA-C-N 119.276 1.538 . . . . 99.989999999999995 112.526 -6.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -93.96 176.46 6.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.043 0.937 . . . . 99.989999999999995 110.048 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 28.3 p -140.34 115.9 10.11 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.723 0.809 . . . . 99.989999999999995 110.102 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.604 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.2 t -72.42 133.48 31.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 109.127 -0.694 . . . . 99.989999999999995 109.127 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -97.26 -43.26 7.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.711 -1.131 . . . . 99.989999999999995 109.875 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.427 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.6 tp -141.73 141.05 33.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 116.048 -0.523 . . . . 99.989999999999995 109.739 -175.305 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.432 ' H ' ' HB3' ' A' ' 7' ' ' SER . 73.0 p -112.67 128.44 56.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.541 -0.54 . . . . 99.989999999999995 109.541 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -126.82 162.71 45.74 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.122 0.969 . . . . 99.989999999999995 109.263 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -43.44 114.96 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.582 2.855 . . . . 99.989999999999995 113.918 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t 63.23 5.68 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.132 2.173 . . . . 99.989999999999995 114.459 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.537 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -148.85 135.31 19.49 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.658 0.383 . . . . 99.989999999999995 110.01 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.76 124.93 50.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.01 0.524 . . . . 99.989999999999995 109.646 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.427 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.0 ttmm -83.89 107.99 16.62 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.27 -1.011 . . . . 99.989999999999995 108.27 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 34' ' ' VAL . 47.1 t -107.77 149.93 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.869 1.268 . . . . 99.989999999999995 108.22 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.33 140.85 54.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.85 0.46 . . . . 99.989999999999995 110.092 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 4.56 73.9 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.24 -0.436 . . . . 99.989999999999995 113.033 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.456 HG21 HG12 ' A' ' 51' ' ' ILE . 51.3 mm -116.74 150.49 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.16 0.984 . . . . 99.989999999999995 110.278 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.04 -51.53 68.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.957 0.903 . . . . 99.989999999999995 112.22 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.34 -56.81 0.17 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.516 -0.311 . . . . 99.989999999999995 111.312 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.537 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 16.8 m-90 -143.06 158.31 43.72 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.996 0.519 . . . . 99.989999999999995 111.403 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.456 HG12 HG21 ' A' ' 47' ' ' ILE . 33.7 mm -122.32 118.59 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 106.802 -1.555 . . . . 99.989999999999995 106.802 165.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -56.91 127.24 30.83 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.385 -0.968 . . . . 99.989999999999995 108.385 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -23.75 18.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.846 1.795 . . . . 99.989999999999995 115.846 -158.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 -10.45 59.03 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.199 0.444 . . . . 99.989999999999995 112.199 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.11 17.66 22.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.756 1.222 . . . . 99.989999999999995 111.162 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.35 146.9 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.651 -0.87 . . . . 99.989999999999995 108.651 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -146.41 133.64 20.56 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.637 -0.875 . . . . 99.989999999999995 108.637 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.54 ' HA ' HG11 ' A' ' 14' ' ' VAL . . . -60.48 142.41 55.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.907 0.883 . . . . 99.989999999999995 111.614 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.87 148.1 51.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.943 . . . . 99.989999999999995 110.807 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -85.29 121.25 73.83 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.389 -0.967 . . . . 99.989999999999995 108.389 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -63.76 -23.31 69.3 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.41 2.073 . . . . 99.989999999999995 112.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.68 -44.11 1.99 Allowed Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.936 -0.575 . . . . 99.989999999999995 112.054 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.28 42.16 0.73 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.691 -0.964 . . . . 99.989999999999995 110.691 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.55 178.37 53.97 Favored Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.676 -0.514 . . . . 99.989999999999995 113.367 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.88 167.28 26.35 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.08 2.52 . . . . 99.989999999999995 112.949 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -67.76 -27.59 66.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.525 0.73 . . . . 99.989999999999995 110.833 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.3 m -148.27 -61.38 0.25 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.656 0.783 . . . . 99.989999999999995 109.945 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 161.58 36.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.659 0.783 . . . . 99.989999999999995 109.35 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.5 mt -80.73 -76.64 0.23 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.015 -0.365 . . . . 99.989999999999995 110.015 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -169.33 112.9 0.52 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.314 1.045 . . . . 99.989999999999995 108.789 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -141.98 -60.55 0.46 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.103 0.961 . . . . 99.989999999999995 108.857 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp-105 62.48 81.97 0.19 Allowed 'General case' 0 C--N 1.364 1.213 0 C-N-CA 125.071 1.349 . . . . 99.989999999999995 111.237 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.4 t -106.62 -48.51 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.107 0.563 . . . . 99.989999999999995 109.612 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.685 ' HG2' ' HG ' ' A' ' 80' ' ' LEU . 54.0 tp60 -97.55 97.0 8.69 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.525 -0.546 . . . . 99.989999999999995 109.525 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -56.91 2.35 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.454 -0.943 . . . . 99.989999999999995 108.454 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -76.94 164.38 25.83 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.932 0.893 . . . . 99.989999999999995 111.187 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 59.9 57.29 3.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.706 1.202 . . . . 99.989999999999995 110.926 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 65.23 118.07 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 114.94 -1.027 . . . . 99.989999999999995 111.768 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.77 147.98 57.57 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.741 1.627 . . . . 99.989999999999995 111.027 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.685 ' HG ' ' HG2' ' A' ' 74' ' ' GLN . 84.7 mt -78.73 169.53 18.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.778 0.431 . . . . 99.989999999999995 110.342 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.21 116.89 0.85 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.05 -1.092 . . . . 99.989999999999995 108.05 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.435 HG23 ' HE2' ' A' ' 9' ' ' MET . 24.5 pt -110.3 174.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.367 -0.605 . . . . 99.989999999999995 109.367 177.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -155.97 88.56 1.11 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.195 0.998 . . . . 99.989999999999995 109.514 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.7 mt -115.79 88.45 2.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.61 0.764 . . . . 99.989999999999995 109.331 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 p -114.41 113.19 24.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.956 0.902 . . . . 99.989999999999995 108.949 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -109.8 127.25 54.53 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.827 -0.805 . . . . 99.989999999999995 108.827 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.98 105.92 12.85 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.487 1.115 . . . . 99.989999999999995 109.158 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.41 123.74 86.31 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 115.036 -0.984 . . . . 99.989999999999995 110.736 -178.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo . . . . . 0 C--N 1.378 2.089 0 C-N-CA 123.438 2.759 . . . . 99.989999999999995 112.477 -177.927 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.818 0.342 . . . . 99.989999999999995 110.35 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -132.08 127.92 37.1 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.211 1.004 . . . . 99.989999999999995 109.676 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -163.93 131.18 3.33 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.485 0.714 . . . . 99.989999999999995 110.417 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -130.45 125.14 33.69 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.74 -0.837 . . . . 99.989999999999995 108.74 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -127.85 169.18 14.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.176 0.59 . . . . 99.989999999999995 111.892 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -74.4 112.55 10.68 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.027 -0.988 . . . . 99.989999999999995 108.472 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.0 m -145.29 178.1 8.33 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.951 0.501 . . . . 99.989999999999995 112.049 -170.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -69.62 161.29 29.93 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.064 -0.971 . . . . 99.989999999999995 109.147 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.429 ' HB2' ' NE1' ' A' ' 71' ' ' TRP . 24.6 ptt? -59.23 133.5 56.15 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 123.688 0.617 . . . . 99.989999999999995 109.874 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.714 HG13 ' HB ' ' A' ' 73' ' ' VAL . 28.8 m -63.62 133.04 29.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.252 0.549 . . . . 99.989999999999995 111.182 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.579 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 95.22 9.93 57.65 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.203 -0.908 . . . . 99.989999999999995 113.028 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.546 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 66.3 t0 -54.29 117.27 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.603 0.761 . . . . 99.989999999999995 111.351 -176.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.492 HG22 ' HB2' ' A' ' 59' ' ' ALA . 29.6 m -73.42 113.88 11.01 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.997 0.519 . . . . 99.989999999999995 110.194 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.22 176.5 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.231 1.013 . . . . 99.989999999999995 110.146 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.497 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 35.4 m0 -123.9 136.48 54.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.31 1.044 . . . . 99.989999999999995 108.239 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.88 107.24 22.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 108.239 -1.023 . . . . 99.989999999999995 108.239 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.703 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 43.2 ttm180 -77.27 111.5 12.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.019 -1.446 . . . . 99.989999999999995 109.838 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -106.14 152.82 22.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.581 0.752 . . . . 99.989999999999995 109.222 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.55 ' HA ' ' HB3' ' A' ' 26' ' ' PRO . 93.1 m-70 -48.73 -55.69 10.72 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.098 0.874 . . . . 99.989999999999995 112.043 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.635 ' HG3' ' HB3' ' A' ' 27' ' ' ARG . 13.6 mm100 61.36 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.716 1.207 . . . . 99.989999999999995 109.919 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 p -78.09 164.44 25.01 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.059 1.343 . . . . 99.989999999999995 111.007 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.81 -51.7 6.24 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.986 0.514 . . . . 99.989999999999995 111.963 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -118.54 -21.25 8.05 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 99.989999999999995 111.848 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 165.12 22.67 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 120.705 0.288 . . . . 99.989999999999995 110.283 174.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -53.85 122.62 35.24 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.273 1.029 . . . . 99.989999999999995 110.87 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.55 ' HB3' ' HA ' ' A' ' 19' ' ' HIS . 18.4 Cg_endo -56.81 138.9 87.47 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.053 2.502 . . . . 99.989999999999995 111.441 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . 0.635 ' HB3' ' HG3' ' A' ' 20' ' ' GLN . 39.8 ttm-85 -99.41 130.98 45.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.421 0.688 . . . . 99.989999999999995 111.078 -171.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.703 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 64.1 p-90 -75.88 143.98 41.44 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.441 0.696 . . . . 99.989999999999995 110.78 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -126.56 159.89 32.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.295 -1.002 . . . . 99.989999999999995 108.295 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.497 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.44 -172.6 44.14 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.475 -0.625 . . . . 99.989999999999995 112.428 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.59 115.38 3.51 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 119.137 1.469 . . . . 99.989999999999995 112.982 1.271 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.42 ' HB3' HG13 ' A' ' 44' ' ' VAL . 78.2 m-85 -75.35 162.71 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.579 0.752 . . . . 99.989999999999995 110.766 172.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.579 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.5 p -131.63 111.5 11.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.091 0.556 . . . . 99.989999999999995 111.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.546 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 59.5 t -79.77 125.77 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.754 0.822 . . . . 99.989999999999995 110.404 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.4 -33.38 11.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.27 0.628 . . . . 99.989999999999995 110.251 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 42.7 tp -135.63 140.5 44.6 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.407 -0.361 . . . . 99.989999999999995 110.271 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -128.83 129.55 45.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.063 0.545 . . . . 99.989999999999995 110.096 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -134.96 163.12 53.52 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.19 1.396 . . . . 99.989999999999995 108.57 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -46.18 110.42 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.308 2.672 . . . . 99.989999999999995 114.543 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m 68.96 8.99 7.18 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 124.674 1.189 . . . . 99.989999999999995 112.59 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.467 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -146.97 121.93 10.02 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.788 -0.57 . . . . 99.989999999999995 110.133 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.469 HD11 HG13 ' A' ' 56' ' ' VAL . 22.6 mt -119.07 121.86 40.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.582 -0.895 . . . . 99.989999999999995 108.582 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 86.6 tttt -86.2 113.38 22.18 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.027 0.531 . . . . 99.989999999999995 110.977 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.472 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 74.1 t -88.61 149.22 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.887 1.275 . . . . 99.989999999999995 109.509 168.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.41 128.29 35.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.313 0.645 . . . . 99.989999999999995 110.374 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -27.78 16.68 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.014 -0.539 . . . . 99.989999999999995 111.959 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -74.53 146.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.565 0.746 . . . . 99.989999999999995 109.991 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.19 76.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.071 0.948 . . . . 99.989999999999995 112.413 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.22 -55.61 0.19 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.222 0.453 . . . . 99.989999999999995 112.222 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.467 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 19.6 m-90 -145.6 157.65 43.95 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.633 0.605 . . . . 99.989999999999995 112.633 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mm -112.64 135.66 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.845 1.258 . . . . 99.989999999999995 108.668 165.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -66.78 124.89 24.19 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.329 -0.989 . . . . 99.989999999999995 108.329 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.65 -19.42 63.8 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.733 1.213 . . . . 99.989999999999995 114.081 -164.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.85 -12.12 58.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.435 0.694 . . . . 99.989999999999995 112.374 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -98.0 -11.99 22.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.452 0.701 . . . . 99.989999999999995 111.251 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.469 HG13 HD11 ' A' ' 42' ' ' LEU . 76.1 t -96.86 124.34 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 122.681 0.392 . . . . 99.989999999999995 110.596 -170.273 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -118.33 120.05 36.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.505 1.122 . . . . 99.989999999999995 108.986 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.48 106.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.41 0.684 . . . . 99.989999999999995 110.4 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB2' HG22 ' A' ' 13' ' ' THR . . . -96.31 141.77 29.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.815 0.846 . . . . 99.989999999999995 110.947 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -102.09 110.51 62.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.361 -0.977 . . . . 99.989999999999995 108.361 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -86.17 4.76 6.3 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 123.001 2.467 . . . . 99.989999999999995 112.772 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.25 33.21 6.35 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.2 -1.16 . . . . 99.989999999999995 110.2 -167.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.07 -77.33 1.53 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 111.576 -0.61 . . . . 99.989999999999995 111.576 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.84 57.7 8.48 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 119.123 -0.821 . . . . 99.989999999999995 114.462 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -94.54 109.88 0.16 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.817 2.344 . . . . 99.989999999999995 112.205 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.1 p -159.88 -77.56 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.879 0.472 . . . . 99.989999999999995 111.079 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -71.94 -24.66 61.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.295 1.038 . . . . 99.989999999999995 111.535 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.48 -6.24 59.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.978 -0.556 . . . . 99.989999999999995 112.278 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.2 mt -81.69 58.47 3.79 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.624 0.726 . . . . 99.989999999999995 111.201 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.6 m -152.09 -54.49 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.553 1.141 . . . . 99.989999999999995 108.276 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 74' ' ' GLN . 10.2 m-90 54.05 49.86 17.9 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.12 -1.4 . . . . 99.989999999999995 111.613 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -57.25 -30.08 64.33 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.312 1.045 . . . . 99.989999999999995 113.352 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.714 ' HB ' HG13 ' A' ' 10' ' ' VAL . 40.1 t -77.95 -31.45 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.17 0.588 . . . . 99.989999999999995 110.346 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.488 ' HG2' HG11 ' A' ' 10' ' ' VAL . 31.0 mm-40 -83.36 -4.79 58.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.548 0.739 . . . . 99.989999999999995 111.501 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.409 HH21 HD13 ' A' ' 80' ' ' LEU . 2.2 mmp_? -72.93 72.67 1.12 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.147 -0.686 . . . . 99.989999999999995 109.147 170.35 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -144.91 -94.75 0.1 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 108.718 -0.845 . . . . 99.989999999999995 108.718 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -84.93 -31.12 23.8 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.911 -0.774 . . . . 99.989999999999995 108.911 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.0 t30 70.55 92.97 0.05 OUTLIER Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.196 1.398 . . . . 99.989999999999995 110.721 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.59 14.3 1.69 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.671 2.914 . . . . 99.989999999999995 112.376 171.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.419 HD22 ' HG3' ' A' ' 74' ' ' GLN . 79.3 mt -74.53 108.15 7.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.103 0.961 . . . . 99.989999999999995 110.324 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -95.92 149.37 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.246 0.618 . . . . 99.989999999999995 110.293 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 pt -66.18 108.81 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.573 0.749 . . . . 99.989999999999995 110.587 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -93.95 142.56 27.24 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.555 -0.748 . . . . 99.989999999999995 109.758 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.26 83.74 1.04 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.506 0.722 . . . . 99.989999999999995 109.87 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.3 m -100.07 138.11 37.59 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.606 -1.179 . . . . 99.989999999999995 110.193 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -75.49 89.53 2.69 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 99.989999999999995 110.663 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 96.69 10.79 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.241 -0.89 . . . . 99.989999999999995 109.839 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.41 77.82 19.29 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.252 0.621 . . . . 99.989999999999995 109.534 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo . . . . . 0 C--N 1.376 1.991 0 C-N-CA 123.161 2.574 . . . . 99.989999999999995 112.104 177.466 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.4 m80 . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.067 -0.716 . . . . 99.989999999999995 109.067 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -80.25 89.75 5.5 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.85 0.86 . . . . 99.989999999999995 109.987 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -77.54 -31.02 53.06 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.43 0.692 . . . . 99.989999999999995 109.772 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.1 t60 77.06 -31.03 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.965 1.706 . . . . 99.989999999999995 112.55 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -66.87 113.55 5.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.809 0.443 . . . . 99.989999999999995 110.438 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -64.46 127.84 33.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.339 1.055 . . . . 99.989999999999995 109.503 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.451 ' HA ' ' HG1' ' A' ' 37' ' ' THR . 27.5 t -96.48 167.87 10.89 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.67 0.606 . . . . 99.989999999999995 112.299 -169.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -76.45 159.86 30.05 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.691 -0.855 . . . . 99.989999999999995 108.691 165.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm -52.55 134.71 35.15 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.144 0.903 . . . . 99.989999999999995 111.623 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.498 HG23 HD22 ' A' ' 80' ' ' LEU . 13.8 m -67.04 117.64 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.799 -0.815 . . . . 99.989999999999995 108.799 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.49 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 102.25 10.23 39.67 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.645 -1.086 . . . . 99.989999999999995 113.245 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.509 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -57.75 102.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 118.56 1.18 . . . . 99.989999999999995 109.906 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -72.71 113.29 9.58 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-O 121.492 0.663 . . . . 99.989999999999995 110.221 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.58 -179.86 2.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 113.933 -1.485 . . . . 99.989999999999995 109.05 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -125.0 150.66 46.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.994 -1.484 . . . . 99.989999999999995 106.994 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.21 104.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.246 -1.391 . . . . 99.989999999999995 107.246 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.614 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 37.9 ttt180 -81.33 92.4 6.39 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 112.686 -2.052 . . . . 99.989999999999995 109.651 -173.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -84.32 125.56 32.39 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.408 0.683 . . . . 99.989999999999995 111.424 -170.851 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -118.98 109.54 16.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.904 0.882 . . . . 99.989999999999995 109.957 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -90.98 -56.8 3.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.866 0.467 . . . . 99.989999999999995 111.19 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.1 p -119.68 146.3 45.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.96 0.504 . . . . 99.989999999999995 111.223 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.94 -35.0 76.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.809 1.244 . . . . 99.989999999999995 112.385 -171.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.84 -29.57 70.54 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.732 0.645 . . . . 99.989999999999995 111.53 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -99.32 154.1 18.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.571 0.748 . . . . 99.989999999999995 111.006 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.32 145.94 69.45 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 99.989999999999995 109.739 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.599 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 15.1 Cg_exo -67.4 130.06 21.6 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.513 2.142 . . . . 99.989999999999995 111.316 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -97.5 116.86 30.51 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.622 0.769 . . . . 99.989999999999995 110.11 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.614 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.7 p-90 -68.27 143.11 55.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.298 0.639 . . . . 99.989999999999995 111.359 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.52 ' HB2' ' HZ3' ' A' ' 29' ' ' LYS . 10.9 mtmp? -121.5 146.54 46.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.06 0.944 . . . . 99.989999999999995 108.804 172.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.88 175.44 35.87 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.756 -0.469 . . . . 99.989999999999995 112.849 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.79 126.8 6.37 Favored 'Cis proline' 0 CA--C 1.564 2.007 0 CA-C-N 118.754 1.277 . . . . 99.989999999999995 113.215 -3.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.07 163.29 12.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 99.989999999999995 109.369 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.49 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.9 p -145.86 114.02 6.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.803 0.441 . . . . 99.989999999999995 111.15 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.573 HG21 HG22 ' A' ' 44' ' ' VAL . 24.2 t -67.99 133.07 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 99.989999999999995 110.781 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.82 -41.58 4.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.991 0.916 . . . . 99.989999999999995 109.936 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.401 ' HB3' ' HD3' ' A' ' 43' ' ' LYS . 56.7 tp -135.26 151.2 50.35 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.401 -0.963 . . . . 99.989999999999995 108.401 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.451 ' HG1' ' HA ' ' A' ' 7' ' ' SER . 69.6 p -124.32 153.19 42.14 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.865 -0.522 . . . . 99.989999999999995 111.048 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -136.44 147.65 60.81 Favored Pre-proline 0 CA--C 1.561 1.401 0 N-CA-C 106.501 -1.666 . . . . 99.989999999999995 106.501 171.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -40.85 109.72 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.288 2.659 . . . . 99.989999999999995 114.442 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 67.9 17.43 9.64 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.337 1.455 . . . . 99.989999999999995 112.903 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -156.42 121.61 4.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.42 0.688 . . . . 99.989999999999995 109.943 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.633 HD11 HG12 ' A' ' 56' ' ' VAL . 27.5 mt -106.09 133.94 50.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.984 0.514 . . . . 99.989999999999995 110.308 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 54.8 tttp -85.57 107.53 17.54 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.799 -1.186 . . . . 99.989999999999995 107.799 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.573 HG22 HG21 ' A' ' 34' ' ' VAL . 44.8 t -109.78 154.63 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.486 -1.234 . . . . 99.989999999999995 109.452 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.67 130.19 45.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.992 0.917 . . . . 99.989999999999995 110.789 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.01 79.55 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.16 -0.473 . . . . 99.989999999999995 113.782 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.437 HG22 HG12 ' A' ' 51' ' ' ILE . 40.8 mm -91.8 151.35 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.077 0.951 . . . . 99.989999999999995 110.539 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.08 73.56 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.194 0.998 . . . . 99.989999999999995 111.614 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.04 -57.53 0.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.047 0.388 . . . . 99.989999999999995 112.047 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.487 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 17.6 m-90 -143.35 153.3 42.58 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.029 0.531 . . . . 99.989999999999995 111.653 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.437 HG12 HG22 ' A' ' 47' ' ' ILE . 33.1 mm -123.44 120.22 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.699 1.2 . . . . 99.989999999999995 107.816 168.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -61.12 141.46 57.43 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.248 0.619 . . . . 99.989999999999995 109.469 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.82 48.81 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.566 1.691 . . . . 99.989999999999995 115.566 -162.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.041 0.536 . . . . 99.989999999999995 112.216 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -96.44 23.9 6.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.059 0.944 . . . . 99.989999999999995 110.661 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.633 HG12 HD11 ' A' ' 42' ' ' LEU . 57.8 t -123.39 152.14 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.15 0.98 . . . . 99.989999999999995 108.555 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -155.87 110.6 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.982 0.513 . . . . 99.989999999999995 109.95 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.29 53.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.142 0.577 . . . . 99.989999999999995 111.327 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.05 114.94 0.95 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.153 0.981 . . . . 99.989999999999995 109.192 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -78.98 126.48 82.04 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.076 0.95 . . . . 99.989999999999995 110.488 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 9.0 Cg_exo -70.72 -22.03 28.24 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.075 2.516 . . . . 99.989999999999995 112.749 174.902 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.8 74.63 0.06 OUTLIER Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.587 -0.605 . . . . 99.989999999999995 111.587 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.28 -0.65 63.96 Favored Glycine 0 C--N 1.351 1.406 0 C-N-CA 123.296 0.474 . . . . 99.989999999999995 112.845 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.12 158.63 29.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.345 -0.697 . . . . 99.989999999999995 111.97 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.17 90.72 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.162 1.908 . . . . 99.989999999999995 111.082 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -61.86 -31.14 71.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.312 -0.858 . . . . 99.989999999999995 109.789 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -65.45 129.34 39.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.882 0.873 . . . . 99.989999999999995 110.563 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -67.1 116.93 8.46 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 123.589 0.556 . . . . 99.989999999999995 109.821 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 mt -92.33 3.12 56.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.972 0.909 . . . . 99.989999999999995 110.851 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 t -141.87 178.24 7.64 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.953 1.701 . . . . 99.989999999999995 107.597 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -68.28 -62.88 1.2 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.971 -0.381 . . . . 99.989999999999995 109.971 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.553 ' HB3' ' HG2' ' A' ' 74' ' ' GLN . 99.1 mtt180 -139.57 -79.7 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.245 0.618 . . . . 99.989999999999995 109.465 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t 60.44 9.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 124.902 1.281 . . . . 99.989999999999995 111.451 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.553 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 13.9 pt20 -81.63 -0.69 43.63 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.522 1.129 . . . . 99.989999999999995 111.209 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -89.55 -4.57 57.82 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.734 1.214 . . . . 99.989999999999995 111.261 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -83.35 62.9 6.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.725 0.81 . . . . 99.989999999999995 111.128 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 58.9 44.9 15.96 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 99.989999999999995 111.432 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.2 m120 57.06 71.9 1.04 Allowed Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 124.4 1.08 . . . . 99.989999999999995 112.348 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -67.41 -53.06 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.053 2.502 . . . . 99.989999999999995 112.553 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.498 HD22 HG23 ' A' ' 10' ' ' VAL . 91.4 mt -63.16 99.74 0.19 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.3 1.0 . . . . 99.989999999999995 111.146 -172.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -130.58 155.84 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.792 1.237 . . . . 99.989999999999995 108.969 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.9 pt -85.37 16.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.705 0.802 . . . . 99.989999999999995 112.462 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -80.12 73.62 6.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.34 0.59 . . . . 99.989999999999995 109.491 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.94 128.02 33.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.375 -0.829 . . . . 99.989999999999995 109.222 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -73.28 178.83 4.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.063 0.545 . . . . 99.989999999999995 109.89 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -136.75 -83.7 0.36 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.493 0.588 . . . . 99.989999999999995 111.094 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -159.8 148.34 17.42 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.862 0.363 . . . . 99.989999999999995 110.853 -166.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.69 132.41 4.94 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.711 1.204 . . . . 99.989999999999995 107.842 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo . . . . . 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 99.989999999999995 110.797 174.14 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.064 -0.347 . . . . 99.989999999999995 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -97.65 130.16 44.68 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.509 -0.922 . . . . 99.989999999999995 108.509 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -64.89 133.72 52.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.854 0.862 . . . . 99.989999999999995 110.709 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.573 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 94.1 m-70 -98.7 144.01 28.44 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.66 1.184 . . . . 99.989999999999995 110.326 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -154.41 -174.42 4.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.51 0.724 . . . . 99.989999999999995 109.845 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -61.35 111.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.178 0.591 . . . . 99.989999999999995 110.092 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.3 m -141.02 -172.97 3.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.137 0.975 . . . . 99.989999999999995 109.861 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -83.54 150.22 26.1 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.259 -1.015 . . . . 99.989999999999995 108.259 167.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ptm -60.46 140.97 57.0 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.04 0.838 . . . . 99.989999999999995 110.892 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.538 HG11 ' HB ' ' A' ' 73' ' ' VAL . 3.4 m -60.56 123.09 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.296 0.638 . . . . 99.989999999999995 110.533 174.681 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.504 ' O ' HD12 ' A' ' 69' ' ' LEU . . . 93.37 9.36 60.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.057 -0.857 . . . . 99.989999999999995 113.466 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.696 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 51.2 t0 -56.02 106.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.942 0.871 . . . . 99.989999999999995 110.728 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 m -72.44 106.66 4.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.291 0.567 . . . . 99.989999999999995 110.012 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.97 173.86 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.527 1.131 . . . . 99.989999999999995 110.814 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.461 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.4 m0 -117.05 150.7 38.21 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.9 1.28 . . . . 99.989999999999995 108.168 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.43 109.31 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.052 -1.092 . . . . 99.989999999999995 108.052 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.588 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 38.8 ttp180 -87.12 90.61 8.42 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.116 -1.402 . . . . 99.989999999999995 109.808 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -98.17 127.71 44.26 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.449 1.1 . . . . 99.989999999999995 110.043 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.794 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 39.7 p-80 -67.68 138.65 56.48 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.147 0.279 . . . . 99.989999999999995 110.38 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -83.59 -47.36 11.37 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.252 -1.018 . . . . 99.989999999999995 108.252 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.451 ' HB ' ' H ' ' A' ' 24' ' ' LEU . 18.9 m -140.63 175.76 9.34 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 106.735 -1.58 . . . . 99.989999999999995 106.735 174.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -73.57 -36.34 65.59 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.216 -0.661 . . . . 99.989999999999995 109.216 167.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -65.78 -59.85 3.47 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 114.786 -1.097 . . . . 99.989999999999995 110.405 176.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.451 ' H ' ' HB ' ' A' ' 21' ' ' THR . 79.4 mt -68.84 136.73 53.14 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.391 0.676 . . . . 99.989999999999995 110.037 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.9 145.35 89.02 Favored Pre-proline 0 CA--C 1.552 1.029 0 O-C-N 123.812 0.695 . . . . 99.989999999999995 111.045 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.794 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 45.2 Cg_exo -57.46 118.65 5.56 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.015 2.477 . . . . 99.989999999999995 112.831 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -87.13 120.19 28.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 99.989999999999995 110.524 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 62.5 p-90 -73.85 149.33 41.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.739 0.816 . . . . 99.989999999999995 111.088 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -139.61 153.26 47.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.791 0.836 . . . . 99.989999999999995 109.649 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -168.0 179.39 41.26 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 119.894 -0.392 . . . . 99.989999999999995 113.492 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.71 133.72 19.12 Favored 'Cis proline' 0 C--N 1.378 2.103 0 CA-C-N 119.139 1.47 . . . . 99.989999999999995 113.838 0.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' HB3' HG13 ' A' ' 44' ' ' VAL . 76.0 m-85 -108.48 168.3 9.42 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.895 1.278 . . . . 99.989999999999995 109.396 169.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.9 p -148.0 113.62 5.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.275 0.63 . . . . 99.989999999999995 110.883 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.696 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.4 t -73.21 134.32 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.756 0.822 . . . . 99.989999999999995 110.417 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 mt -106.58 -31.75 8.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.37 0.668 . . . . 99.989999999999995 110.812 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -149.59 159.2 44.52 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.777 -0.823 . . . . 99.989999999999995 108.777 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 p -139.38 163.7 31.81 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.559 0.695 . . . . 99.989999999999995 111.259 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.3 p -141.98 164.33 34.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 126.12 1.768 . . . . 99.989999999999995 107.695 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 107.85 0.17 Allowed 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.789 2.326 . . . . 99.989999999999995 113.47 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.69 22.15 12.54 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.432 1.493 . . . . 99.989999999999995 112.855 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.45 121.94 9.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.128 -0.693 . . . . 99.989999999999995 109.128 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.513 HD11 ' HB ' ' A' ' 56' ' ' VAL . 23.3 mt -106.69 123.5 48.22 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.243 1.017 . . . . 99.989999999999995 108.749 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -86.85 106.84 18.02 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 109.349 -0.611 . . . . 99.989999999999995 109.349 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.574 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 48.0 t -96.25 154.75 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.309 -1.314 . . . . 99.989999999999995 109.153 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.2 135.33 48.96 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.499 -0.556 . . . . 99.989999999999995 109.499 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.78 76.31 Favored Glycine 0 C--N 1.34 0.787 0 O-C-N 123.761 0.663 . . . . 99.989999999999995 112.798 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -92.66 147.67 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.171 0.588 . . . . 99.989999999999995 109.939 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.44 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.435 1.094 . . . . 99.989999999999995 111.38 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.19 -59.59 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.951 0.352 . . . . 99.989999999999995 111.951 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -145.31 158.65 43.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.297 0.639 . . . . 99.989999999999995 111.187 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.88 133.89 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.598 -1.26 . . . . 99.989999999999995 107.598 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -63.79 142.24 58.47 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 99.989999999999995 108.294 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -36.75 64.99 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 115.076 1.51 . . . . 99.989999999999995 115.076 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.27 1.32 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 112.33 0.493 . . . . 99.989999999999995 112.33 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.32 12.42 36.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.018 0.527 . . . . 99.989999999999995 109.816 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.513 ' HB ' HD11 ' A' ' 42' ' ' LEU . 99.1 t -139.15 140.75 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.692 -0.855 . . . . 99.989999999999995 108.692 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -138.17 152.17 48.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.56 -0.904 . . . . 99.989999999999995 108.56 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.32 126.85 28.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.667 0.787 . . . . 99.989999999999995 110.845 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.52 143.16 31.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.817 -0.809 . . . . 99.989999999999995 108.817 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -77.06 111.85 19.19 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 108.712 -0.848 . . . . 99.989999999999995 108.712 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HB2' ' HD3' ' A' ' 65' ' ' PRO . 72.6 Cg_endo -84.57 -4.44 10.03 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.496 2.131 . . . . 99.989999999999995 112.271 178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.15 79.24 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.644 0.59 . . . . 99.989999999999995 112.889 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.46 67.91 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-O 119.886 -0.397 . . . . 99.989999999999995 112.82 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.02 79.64 0.22 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 111.141 -0.784 . . . . 99.989999999999995 111.141 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.405 ' HD3' ' HB2' ' A' ' 61' ' ' PRO . 17.9 Cg_endo -57.23 -20.21 37.78 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 124.094 3.196 . . . . 99.989999999999995 113.552 175.684 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m 63.54 30.66 15.09 Favored 'General case' 0 C--N 1.363 1.159 0 C-N-CA 124.393 1.077 . . . . 99.989999999999995 111.575 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -140.02 159.75 41.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.448 0.699 . . . . 99.989999999999995 110.438 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -69.21 102.7 1.75 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.142 0.577 . . . . 99.989999999999995 109.517 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 11' ' ' GLY . 79.3 mt -128.14 -13.99 4.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.64 1.176 . . . . 99.989999999999995 110.186 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.7 m -79.7 87.3 5.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.818 0.818 . . . . 99.989999999999995 109.901 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -135.63 144.59 46.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.665 -1.152 . . . . 99.989999999999995 108.596 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -93.84 45.34 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.251 0.621 . . . . 99.989999999999995 110.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.538 ' HB ' HG11 ' A' ' 10' ' ' VAL . 69.7 t -61.58 -61.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.481 -0.782 . . . . 99.989999999999995 109.39 174.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -82.78 81.05 8.68 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.444 -0.947 . . . . 99.989999999999995 108.444 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -142.07 85.26 1.92 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.118 -1.438 . . . . 99.989999999999995 107.118 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.573 ' HB3' ' HB2' ' A' ' 4' ' ' HIS . 13.8 p -92.45 -53.02 4.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.021 . . . . 99.989999999999995 109.117 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -153.92 -45.87 0.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.401 -1.272 . . . . 99.989999999999995 108.916 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -106.28 109.96 63.55 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.161 0.985 . . . . 99.989999999999995 109.95 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.17 130.3 17.41 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.295 1.997 . . . . 99.989999999999995 110.729 169.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.85 -9.41 59.46 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.82 1.044 . . . . 99.989999999999995 113.82 -166.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.89 92.8 3.12 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 108.595 -0.891 . . . . 99.989999999999995 108.595 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 pt -92.76 -178.96 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 C-N-CA 124.182 0.993 . . . . 99.989999999999995 110.486 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -66.53 149.71 50.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.614 -0.721 . . . . 99.989999999999995 110.6 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 64.1 mt -78.74 179.47 7.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.991 -0.55 . . . . 99.989999999999995 110.65 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.1 p -76.69 78.95 3.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.684 0.793 . . . . 99.989999999999995 111.932 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -141.87 127.83 19.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.208 1.003 . . . . 99.989999999999995 109.029 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -82.82 102.8 11.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.331 0.652 . . . . 99.989999999999995 110.045 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.32 146.56 9.43 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.085 0.954 . . . . 99.989999999999995 109.175 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--N 1.381 2.247 0 C-N-CA 123.547 2.831 . . . . 99.989999999999995 113.434 179.152 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.619 0.247 . . . . 99.989999999999995 110.591 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -115.39 69.69 0.73 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.896 -0.779 . . . . 99.989999999999995 108.896 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -166.87 94.55 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.429 -1.259 . . . . 99.989999999999995 108.713 175.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -159.87 137.65 9.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.507 0.723 . . . . 99.989999999999995 110.428 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -171.73 151.32 2.85 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.294 0.997 . . . . 99.989999999999995 109.764 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.1 m-70 -127.13 151.02 49.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.263 1.025 . . . . 99.989999999999995 109.074 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.446 ' HB3' ' NE2' ' A' ' 74' ' ' GLN . 7.8 t -166.4 -174.89 3.02 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.273 -1.01 . . . . 99.989999999999995 108.273 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -67.41 139.88 57.14 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.141 -1.059 . . . . 99.989999999999995 108.141 171.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -48.87 132.89 18.25 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 124.757 1.286 . . . . 99.989999999999995 112.73 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.631 HG22 ' HA ' ' A' ' 72' ' ' ARG . 30.3 m -62.1 150.64 8.15 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 115.076 -0.965 . . . . 99.989999999999995 110.828 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 11.37 69.83 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.995 -0.621 . . . . 99.989999999999995 112.49 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.4 t0 -62.1 111.83 2.11 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.355 0.577 . . . . 99.989999999999995 109.853 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.8 m -71.34 112.28 7.35 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.249 -0.649 . . . . 99.989999999999995 109.249 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 58' ' ' ALA . 30.2 m -136.38 164.2 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.797 -0.638 . . . . 99.989999999999995 111.124 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.456 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 41.8 m0 -122.39 145.56 48.16 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.235 1.014 . . . . 99.989999999999995 108.315 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.69 105.26 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.04 -0.726 . . . . 99.989999999999995 109.04 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.0 ttm180 -89.34 138.01 31.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.028 1.331 . . . . 99.989999999999995 110.378 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -150.41 139.01 20.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.607 0.363 . . . . 99.989999999999995 110.471 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 37.6 m80 -61.75 120.09 9.99 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.097 0.559 . . . . 99.989999999999995 110.746 176.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.66 -47.73 84.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.949 0.881 . . . . 99.989999999999995 108.839 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.51 HG23 ' H ' ' A' ' 23' ' ' ASN . 38.9 m -148.21 156.61 42.77 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.732 -1.576 . . . . 99.989999999999995 107.053 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.93 -27.72 66.01 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.614 0.643 . . . . 99.989999999999995 110.957 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.51 ' H ' HG23 ' A' ' 21' ' ' THR . 25.8 t-20 -70.47 -37.03 74.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.9 0.88 . . . . 99.989999999999995 110.68 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -90.15 174.09 7.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.367 0.667 . . . . 99.989999999999995 110.365 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.84 156.97 55.22 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.21 0.604 . . . . 99.989999999999995 109.886 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.456 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 70.8 Cg_endo -71.28 165.27 32.96 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.669 2.246 . . . . 99.989999999999995 113.249 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -143.61 136.65 27.68 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.635 -0.876 . . . . 99.989999999999995 108.635 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.566 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.2 p-90 -96.35 163.7 12.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.537 0.735 . . . . 99.989999999999995 111.763 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -135.66 149.92 49.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.153 0.981 . . . . 99.989999999999995 108.586 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.456 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -175.77 179.2 47.07 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.256 -0.497 . . . . 99.989999999999995 112.618 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.02 148.72 21.57 Favored 'Cis proline' 0 C--N 1.368 1.573 0 CA-C-N 118.616 1.208 . . . . 99.989999999999995 113.834 0.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -120.54 176.0 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.91 1.284 . . . . 99.989999999999995 109.449 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.452 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 7.0 p -142.24 116.68 9.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.196 0.598 . . . . 99.989999999999995 111.381 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.587 HG21 HG22 ' A' ' 44' ' ' VAL . 23.3 t -73.95 139.93 18.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.111 0 N-CA-C 109.766 -0.457 . . . . 99.989999999999995 109.766 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.583 HD22 ' HB ' ' A' ' 70' ' ' THR . 80.5 mt -113.02 -45.82 3.15 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.681 1.238 . . . . 99.989999999999995 109.984 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 61.8 tp -127.89 145.55 50.91 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.519 -0.764 . . . . 99.989999999999995 109.363 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.452 HG23 HD23 ' A' ' 42' ' ' LEU . 69.6 p -129.74 129.48 44.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.782 0.833 . . . . 99.989999999999995 109.189 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -126.29 162.63 45.09 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.618 1.167 . . . . 99.989999999999995 108.231 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -47.81 118.31 2.98 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.968 2.445 . . . . 99.989999999999995 114.261 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p 61.59 10.92 3.55 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.279 1.832 . . . . 99.989999999999995 113.972 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.42 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -149.09 123.32 9.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.17 0.441 . . . . 99.989999999999995 110.176 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.452 HD23 HG23 ' A' ' 37' ' ' THR . 38.0 mt -110.87 124.54 52.27 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.422 -0.584 . . . . 99.989999999999995 109.422 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -85.92 108.63 18.27 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.657 -0.868 . . . . 99.989999999999995 108.657 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.587 HG22 HG21 ' A' ' 34' ' ' VAL . 18.4 t -109.99 146.87 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.338 -1.301 . . . . 99.989999999999995 108.606 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 132.78 46.7 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.757 -0.46 . . . . 99.989999999999995 109.757 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.82 -8.11 57.8 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.528 0.517 . . . . 99.989999999999995 111.976 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.502 HG22 HG12 ' A' ' 51' ' ' ILE . 40.6 mm -105.17 150.2 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.951 0.901 . . . . 99.989999999999995 110.403 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 -51.09 71.07 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.044 0.938 . . . . 99.989999999999995 111.966 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.22 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.248 0.342 . . . . 99.989999999999995 111.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.42 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 20.1 m-90 -142.9 149.89 39.07 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.743 0.417 . . . . 99.989999999999995 110.959 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.502 HG12 HG22 ' A' ' 47' ' ' ILE . 26.8 mm -121.52 128.32 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.955 -1.128 . . . . 99.989999999999995 107.955 167.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -59.97 136.1 57.91 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.903 0.481 . . . . 99.989999999999995 110.011 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.79 -33.59 49.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.009 1.485 . . . . 99.989999999999995 115.009 -163.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.45 67.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.396 0.517 . . . . 99.989999999999995 112.396 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -68.76 -25.03 64.52 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.648 0.379 . . . . 99.989999999999995 111.233 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -96.89 125.39 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 122.519 0.328 . . . . 99.989999999999995 110.444 -168.3 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -106.61 126.23 52.01 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.875 0.87 . . . . 99.989999999999995 108.809 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' HG11 ' A' ' 14' ' ' VAL . . . -77.68 106.51 9.54 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.424 -0.584 . . . . 99.989999999999995 109.424 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.88 118.66 29.62 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 99.989999999999995 109.074 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -56.28 116.06 11.6 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.359 0.663 . . . . 99.989999999999995 109.968 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.75 -43.46 46.23 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.897 3.064 . . . . 99.989999999999995 112.772 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.6 -81.64 0.16 Allowed Glycine 0 C--N 1.356 1.64 0 O-C-N 124.056 0.848 . . . . 99.989999999999995 112.469 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.01 148.87 19.24 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.556 -1.018 . . . . 99.989999999999995 110.556 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 93.49 111.73 2.16 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.27 -0.739 . . . . 99.989999999999995 111.606 -176.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -82.24 30.97 0.52 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.42 2.746 . . . . 99.989999999999995 113.533 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -76.09 6.58 5.12 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.355 1.062 . . . . 99.989999999999995 112.384 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -74.58 -1.71 22.73 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.411 1.084 . . . . 99.989999999999995 112.908 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 73.84 87.46 0.1 Allowed 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.707 1.603 . . . . 99.989999999999995 110.009 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.7 93.18 0.37 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.733 -0.469 . . . . 99.989999999999995 109.733 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.583 ' HB ' HD22 ' A' ' 35' ' ' LEU . 5.5 m -77.81 149.22 34.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.812 -0.81 . . . . 99.989999999999995 108.812 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -63.45 144.72 56.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.953 0.501 . . . . 99.989999999999995 111.063 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.631 ' HA ' HG22 ' A' ' 10' ' ' VAL . 53.6 mtt180 -67.06 92.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.791 0.682 . . . . 99.989999999999995 110.868 -176.204 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.61 -36.99 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.969 -1.014 . . . . 99.989999999999995 110.79 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.451 ' HB3' ' HB2' ' A' ' 79' ' ' PRO . 75.7 mt-30 -78.39 80.17 4.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.533 0.682 . . . . 99.989999999999995 110.977 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -112.67 148.54 34.45 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.769 -1.105 . . . . 99.989999999999995 108.498 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.458 ' HB3' ' HG3' ' A' ' 79' ' ' PRO . 43.0 t -174.0 -66.1 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.385 -1.709 . . . . 99.989999999999995 106.385 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -147.3 -58.5 0.26 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 107.946 -1.131 . . . . 99.989999999999995 107.946 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -157.31 62.24 2.58 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 123.836 0.854 . . . . 99.989999999999995 110.249 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.458 ' HG3' ' HB3' ' A' ' 76' ' ' SER . 9.9 Cg_exo -73.62 -30.73 9.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.834 2.356 . . . . 99.989999999999995 113.175 -174.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.02 127.97 34.05 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.209 -0.905 . . . . 99.989999999999995 109.981 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HB2' ' HZ3' ' A' ' 81' ' ' LYS . 9.9 mtmp? -88.24 150.84 23.05 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.565 -0.743 . . . . 99.989999999999995 109.969 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.9 pt -90.74 165.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.006 0.522 . . . . 99.989999999999995 110.893 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -139.12 100.03 3.91 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.989 -0.745 . . . . 99.989999999999995 108.989 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.2 mt -98.77 132.75 43.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.267 -0.879 . . . . 99.989999999999995 108.875 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.7 m 68.59 100.26 0.06 Allowed 'General case' 0 CA--C 1.556 1.173 0 O-C-N 124.299 0.999 . . . . 99.989999999999995 111.327 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.426 ' HG2' ' N ' ' A' ' 87' ' ' GLU . 50.7 ttt180 -80.32 165.2 22.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.601 0.76 . . . . 99.989999999999995 109.05 169.178 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.426 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 3.2 mp0 -63.17 87.99 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.73 0.812 . . . . 99.989999999999995 110.081 174.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.77 126.14 33.62 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.3 0.64 . . . . 99.989999999999995 109.525 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 C--N 1.376 1.995 0 C-N-CA 122.945 2.43 . . . . 99.989999999999995 112.458 177.803 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.8 p80 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 111.362 0.134 . . . . 99.989999999999995 111.362 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -143.93 126.2 15.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.405 0.621 . . . . 99.989999999999995 109.595 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -156.63 28.27 0.33 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.925 1.29 . . . . 99.989999999999995 108.031 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -88.34 161.77 16.94 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.141 0.976 . . . . 99.989999999999995 108.712 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 71.13 93.76 0.08 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.511 1.124 . . . . 99.989999999999995 109.602 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -68.1 127.39 32.72 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.693 -0.855 . . . . 99.989999999999995 108.693 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.1 t -145.74 179.88 7.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.902 0.881 . . . . 99.989999999999995 111.237 -164.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -70.68 160.14 33.16 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.965 0.906 . . . . 99.989999999999995 108.68 164.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ptm -59.54 137.93 57.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.108 0.88 . . . . 99.989999999999995 111.273 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.672 HG23 ' HA ' ' A' ' 72' ' ' ARG . 30.7 m -63.97 125.74 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.439 -0.578 . . . . 99.989999999999995 109.439 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.602 ' HA2' HG21 ' A' ' 33' ' ' THR . . . 108.53 8.5 28.52 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.296 -0.725 . . . . 99.989999999999995 112.484 -172.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.613 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -67.68 113.71 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.938 0.495 . . . . 99.989999999999995 109.885 -173.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.493 HG21 ' HB1' ' A' ' 59' ' ' ALA . 91.3 m -77.86 127.23 32.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.696 0.399 . . . . 99.989999999999995 111.236 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.6 m -139.22 -178.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 99.989999999999995 109.645 176.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.517 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 33.9 m0 -116.7 157.5 25.35 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.961 1.304 . . . . 99.989999999999995 108.478 169.181 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.38 103.32 15.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 106.463 -1.68 . . . . 99.989999999999995 106.463 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -78.94 91.03 4.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.077 -1.42 . . . . 99.989999999999995 108.872 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -117.68 148.07 42.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.826 0.85 . . . . 99.989999999999995 111.73 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -175.42 147.91 0.9 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.857 1.663 . . . . 99.989999999999995 107.42 170.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.17 -67.3 0.8 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.593 -0.521 . . . . 99.989999999999995 109.593 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.5 p -81.75 140.86 34.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.752 0.821 . . . . 99.989999999999995 110.997 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -75.7 -20.49 58.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.43 1.092 . . . . 99.989999999999995 110.825 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -64.22 -35.28 80.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.484 0.713 . . . . 99.989999999999995 110.346 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -87.35 144.82 26.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.308 -0.627 . . . . 99.989999999999995 109.308 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.98 147.26 86.21 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.076 0.95 . . . . 99.989999999999995 111.236 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -64.98 104.02 0.54 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.298 1.999 . . . . 99.989999999999995 110.752 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -83.43 164.55 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.052 -1.092 . . . . 99.989999999999995 108.052 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.517 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 60.9 p-90 -130.61 153.92 48.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.693 0.679 . . . . 99.989999999999995 110.521 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -126.71 148.23 49.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 99.989999999999995 108.714 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.507 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -164.58 -176.63 36.52 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.555 -0.58 . . . . 99.989999999999995 112.378 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.89 115.81 2.13 Favored 'Cis proline' 0 CA--C 1.564 1.998 0 CA-C-N 118.91 1.355 . . . . 99.989999999999995 112.786 -5.237 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -84.79 154.08 22.59 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.755 0.822 . . . . 99.989999999999995 111.918 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.602 HG21 ' HA2' ' A' ' 11' ' ' GLY . 98.3 m -107.08 117.77 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 99.989999999999995 110.201 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 46.8 t -95.24 136.52 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.119 0.968 . . . . 99.989999999999995 109.209 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.16 -28.74 8.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.827 . . . . 99.989999999999995 110.689 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 46.4 tp -146.95 144.46 29.23 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.767 -0.457 . . . . 99.989999999999995 109.767 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.9 p -132.4 128.89 38.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.936 0.894 . . . . 99.989999999999995 109.63 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -134.38 158.42 75.23 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.855 0.862 . . . . 99.989999999999995 109.226 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -48.16 124.67 10.67 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.271 2.647 . . . . 99.989999999999995 112.81 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m 75.34 -13.83 0.82 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.25 1.42 . . . . 99.989999999999995 112.953 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.39 122.01 11.82 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.429 -0.794 . . . . 99.989999999999995 110.693 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.476 HD13 HG11 ' A' ' 56' ' ' VAL . 32.0 mt -114.9 123.68 49.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.306 0.642 . . . . 99.989999999999995 109.343 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.3 tttp -84.46 107.16 16.57 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.68 0.752 . . . . 99.989999999999995 109.247 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 34' ' ' VAL . 34.5 t -101.81 142.84 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.963 -1.472 . . . . 99.989999999999995 108.047 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.34 136.54 58.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.411 0.684 . . . . 99.989999999999995 110.261 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.32 32.39 Favored Glycine 0 C--N 1.345 1.074 0 O-C-N 123.676 0.61 . . . . 99.989999999999995 113.096 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.66 153.92 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.583 0.753 . . . . 99.989999999999995 110.744 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.32 -51.16 56.81 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.058 1.343 . . . . 99.989999999999995 111.337 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.08 -56.18 0.14 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.485 0.49 . . . . 99.989999999999995 110.53 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -141.17 157.1 45.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.92 0.488 . . . . 99.989999999999995 110.91 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.99 130.88 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.83 1.252 . . . . 99.989999999999995 107.997 167.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -58.07 128.44 37.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.702 -0.851 . . . . 99.989999999999995 108.702 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -23.36 58.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.349 1.241 . . . . 99.989999999999995 114.349 -163.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.82 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 99.989999999999995 112.055 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -100.19 21.18 13.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.604 1.162 . . . . 99.989999999999995 110.514 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG11 HD13 ' A' ' 42' ' ' LEU . 61.2 t -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.743 -0.836 . . . . 99.989999999999995 108.743 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -129.81 109.99 11.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.444 -0.947 . . . . 99.989999999999995 108.444 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -57.46 131.86 51.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.091 0.956 . . . . 99.989999999999995 112.23 -172.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.493 ' HB1' HG21 ' A' ' 13' ' ' THR . . . -119.93 144.72 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.372 0.669 . . . . 99.989999999999995 110.074 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -86.28 118.41 70.31 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.302 -0.999 . . . . 99.989999999999995 108.302 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HD3' ' HB ' ' A' ' 13' ' ' THR . 25.3 Cg_endo -62.16 -24.63 76.5 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.711 2.274 . . . . 99.989999999999995 112.374 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . 0.659 ' HA2' ' HB2' ' A' ' 86' ' ' ARG . . . 78.27 68.34 1.51 Allowed Glycine 0 C--N 1.344 1.017 0 O-C-N 124.007 0.817 . . . . 99.989999999999995 111.574 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.507 ' HA3' ' HG3' ' A' ' 89' ' ' PRO . . . 82.36 158.8 24.4 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.032 0.489 . . . . 99.989999999999995 112.2 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.46 113.01 3.59 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.393 -1.226 . . . . 99.989999999999995 110.234 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HG2' HD11 ' A' ' 69' ' ' LEU . 31.2 Cg_exo -61.47 142.67 96.01 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.945 2.43 . . . . 99.989999999999995 112.963 -176.315 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -66.64 -26.4 67.05 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.784 0.677 . . . . 99.989999999999995 110.495 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -75.81 142.13 42.34 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.077 0.951 . . . . 99.989999999999995 110.803 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -74.65 98.96 3.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.694 0.798 . . . . 99.989999999999995 109.131 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.4 HD11 ' HG2' ' A' ' 65' ' ' PRO . 84.3 mt -64.26 -54.14 38.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.592 0.757 . . . . 99.989999999999995 110.866 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -157.33 179.73 8.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.25 -0.886 . . . . 99.989999999999995 109.289 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -79.65 153.11 29.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.668 0.787 . . . . 99.989999999999995 109.874 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.672 ' HA ' HG23 ' A' ' 10' ' ' VAL . 61.9 mtp180 -78.96 100.07 7.11 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.141 -1.059 . . . . 99.989999999999995 108.141 170.026 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.5 -68.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.047 0.539 . . . . 99.989999999999995 109.908 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 72.97 5.12 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.472 -0.936 . . . . 99.989999999999995 108.472 170.108 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -71.69 89.23 1.01 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.913 -0.773 . . . . 99.989999999999995 108.913 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.3 p 176.03 136.8 0.05 Allowed 'General case' 0 C--O 1.245 0.832 0 C-N-CA 125.637 1.575 . . . . 99.989999999999995 108.98 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -91.57 72.59 5.94 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.725 0.774 . . . . 99.989999999999995 109.263 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.446 ' HB3' ' HD3' ' A' ' 79' ' ' PRO . 16.7 t-20 -159.86 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.705 -1.134 . . . . 99.989999999999995 110.477 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.446 ' HD3' ' HB3' ' A' ' 78' ' ' ASN . 9.2 Cg_exo -74.19 -42.34 0.74 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.943 1.762 . . . . 99.989999999999995 111.71 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.38 127.08 31.68 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.778 0.674 . . . . 99.989999999999995 111.337 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -106.19 119.79 40.15 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.105 0.962 . . . . 99.989999999999995 108.885 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.2 pt -67.72 143.71 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.538 -0.756 . . . . 99.989999999999995 110.542 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -109.02 137.53 46.8 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.92 0.888 . . . . 99.989999999999995 109.576 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.75 120.74 14.02 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.401 0.68 . . . . 99.989999999999995 109.925 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -114.42 178.11 4.4 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.107 0.963 . . . . 99.989999999999995 110.049 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.659 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 53.5 mtp85 -63.9 105.21 0.8 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.541 0.21 . . . . 99.989999999999995 110.953 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -65.7 121.69 15.56 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.765 -1.198 . . . . 99.989999999999995 107.765 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.14 84.54 0.17 Allowed Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.933 1.293 . . . . 99.989999999999995 109.776 -169.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.507 ' HG3' ' HA3' ' A' ' 63' ' ' GLY . 97.8 Cg_exo . . . . . 0 C--N 1.384 2.404 0 C-N-CA 123.912 3.075 . . . . 99.989999999999995 113.107 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.89 -0.411 . . . . 99.989999999999995 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -74.88 150.59 39.13 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.353 1.061 . . . . 99.989999999999995 110.188 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -56.95 112.31 1.29 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.585 1.154 . . . . 99.989999999999995 111.024 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -78.71 161.78 26.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.299 0.639 . . . . 99.989999999999995 110.184 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -141.79 5.59 1.77 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.696 0.798 . . . . 99.989999999999995 109.198 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -156.74 108.19 2.42 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 123.724 0.81 . . . . 99.989999999999995 109.614 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 m -92.53 -168.95 2.08 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.092 0.957 . . . . 99.989999999999995 108.675 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -54.94 127.48 28.97 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.594 -0.891 . . . . 99.989999999999995 108.594 164.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.3 ptp -59.05 132.84 55.24 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.275 0.985 . . . . 99.989999999999995 110.511 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.527 HG11 ' HB ' ' A' ' 73' ' ' VAL . 35.9 m -63.25 135.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.748 1.219 . . . . 99.989999999999995 110.277 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.711 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 94.33 11.12 57.63 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.222 -0.766 . . . . 99.989999999999995 113.504 -171.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.759 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -51.66 113.22 0.92 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.184 0.994 . . . . 99.989999999999995 111.342 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.445 HG21 ' HB1' ' A' ' 59' ' ' ALA . 23.3 m -72.85 108.2 5.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 99.989999999999995 110.289 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 34.3 m -132.39 179.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.19 0.996 . . . . 99.989999999999995 110.791 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.441 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -129.99 154.13 47.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.407 1.483 . . . . 99.989999999999995 108.23 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.5 104.56 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 121.625 0.726 . . . . 99.989999999999995 109.536 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -81.95 104.92 12.65 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.883 1.673 . . . . 99.989999999999995 109.652 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.3 ttm105 -128.51 133.29 48.41 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.608 -0.682 . . . . 99.989999999999995 112.13 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.441 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 10.0 p80 -124.23 141.95 51.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.868 1.267 . . . . 99.989999999999995 108.994 176.339 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.595 ' HB2' HD13 ' A' ' 24' ' ' LEU . 14.7 mm100 -67.39 -44.96 77.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.855 0.462 . . . . 99.989999999999995 110.299 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 t -137.64 171.61 14.2 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.587 0.755 . . . . 99.989999999999995 109.303 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -56.95 -43.41 81.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.444 1.098 . . . . 99.989999999999995 111.622 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -76.14 -27.38 57.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.205 1.002 . . . . 99.989999999999995 111.817 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.595 HD13 ' HB2' ' A' ' 20' ' ' GLN . 70.8 mt -75.45 148.17 39.28 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.695 0.283 . . . . 99.989999999999995 111.053 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 40.2 mt-10 -61.46 128.55 90.08 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.47 1.108 . . . . 99.989999999999995 111.047 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.441 ' HA ' ' HB3' ' A' ' 19' ' ' HIS . 8.7 Cg_exo -72.71 84.05 1.28 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.067 2.512 . . . . 99.989999999999995 111.138 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -71.93 116.34 12.22 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.275 1.03 . . . . 99.989999999999995 109.929 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.77 141.83 33.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.99 0.516 . . . . 99.989999999999995 110.452 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -113.04 158.16 20.66 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.464 -0.939 . . . . 99.989999999999995 108.464 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.441 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -173.63 170.21 43.34 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.015 -0.612 . . . . 99.989999999999995 113.589 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.02 160.85 70.11 Favored 'Cis proline' 0 C--N 1.376 1.985 0 C-N-CA 123.93 -1.279 . . . . 99.989999999999995 112.978 -5.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.8 164.02 24.97 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.028 1.331 . . . . 99.989999999999995 109.361 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.711 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 57.6 p -137.05 111.7 8.72 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.516 0.726 . . . . 99.989999999999995 110.566 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.759 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.8 t -79.12 119.24 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 99.989999999999995 109.427 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.34 -21.11 22.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.553 0.741 . . . . 99.989999999999995 110.983 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.434 HD22 HD11 ' A' ' 80' ' ' LEU . 62.5 tp -156.11 140.2 16.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.622 0.369 . . . . 99.989999999999995 110.786 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.591 HG21 HD21 ' A' ' 42' ' ' LEU . 40.2 p -107.38 128.9 54.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.725 . . . . 99.989999999999995 109.877 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.407 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.3 p -125.82 165.18 28.54 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 124.382 1.073 . . . . 99.989999999999995 109.018 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.407 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -49.83 116.76 2.56 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.134 2.556 . . . . 99.989999999999995 112.194 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 t 54.74 17.22 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.996 2.118 . . . . 99.989999999999995 114.533 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.488 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -148.55 140.57 23.93 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.973 0.509 . . . . 99.989999999999995 110.054 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.676 HD13 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -115.11 123.0 47.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.023 0.529 . . . . 99.989999999999995 109.69 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.51 108.48 17.95 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.504 -0.924 . . . . 99.989999999999995 108.504 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.57 HG23 HG23 ' A' ' 34' ' ' VAL . 55.0 t -110.13 143.36 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.675 1.19 . . . . 99.989999999999995 109.938 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.9 135.27 57.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.452 1.101 . . . . 99.989999999999995 110.231 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.92 -21.99 27.72 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 123.195 0.426 . . . . 99.989999999999995 112.991 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.457 HG22 HG12 ' A' ' 51' ' ' ILE . 40.2 mm -82.18 153.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.551 1.14 . . . . 99.989999999999995 109.707 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.89 68.04 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.186 0.594 . . . . 99.989999999999995 111.407 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.42 -60.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.133 0.42 . . . . 99.989999999999995 112.133 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 17.5 m-90 -143.34 138.54 29.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.876 0.47 . . . . 99.989999999999995 110.944 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.457 HG12 HG22 ' A' ' 47' ' ' ILE . 42.9 mm -103.76 117.09 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 106.976 -1.49 . . . . 99.989999999999995 106.976 164.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -58.7 145.51 39.86 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.514 -0.55 . . . . 99.989999999999995 109.514 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.58 -34.82 52.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.853 1.261 . . . . 99.989999999999995 113.726 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -24.96 61.51 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.198 0.999 . . . . 99.989999999999995 113.035 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -107.31 24.56 12.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.5 1.12 . . . . 99.989999999999995 110.708 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.676 HG11 HD13 ' A' ' 42' ' ' LEU . 24.9 t -128.28 149.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.655 -0.498 . . . . 99.989999999999995 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -133.77 122.65 23.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.26 -1.015 . . . . 99.989999999999995 108.26 166.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 109.77 1.33 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.477 0.711 . . . . 99.989999999999995 109.69 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.445 ' HB1' HG21 ' A' ' 13' ' ' THR . . . -85.36 142.7 29.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.767 0.827 . . . . 99.989999999999995 110.223 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -72.92 116.92 55.26 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.935 -0.765 . . . . 99.989999999999995 108.935 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.08 -5.12 16.64 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.473 2.115 . . . . 99.989999999999995 112.849 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.94 13.26 81.55 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.445 -0.343 . . . . 99.989999999999995 112.349 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 -76.06 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.398 -1.081 . . . . 99.989999999999995 110.398 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.0 126.59 0.95 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-O 118.79 -1.006 . . . . 99.989999999999995 111.618 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.425 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 67.7 Cg_endo -83.78 5.49 6.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.083 2.522 . . . . 99.989999999999995 112.324 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.0 p -47.14 -49.71 21.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.462 1.905 . . . . 99.989999999999995 113.366 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.4 t -65.56 -20.43 66.32 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.485 0.714 . . . . 99.989999999999995 112.317 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -111.01 -2.77 15.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.847 0.859 . . . . 99.989999999999995 112.835 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.425 ' HG ' ' O ' ' A' ' 65' ' ' PRO . 97.4 mt -70.05 88.87 0.6 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.509 0.595 . . . . 99.989999999999995 110.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.9 p -79.59 -15.62 57.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.672 0.789 . . . . 99.989999999999995 111.465 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -58.89 130.56 47.58 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.689 0.618 . . . . 99.989999999999995 109.644 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.411 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 12.3 ptp180 -125.35 78.84 1.76 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 122.028 0.918 . . . . 99.989999999999995 109.244 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.527 ' HB ' HG11 ' A' ' 10' ' ' VAL . 21.5 t -106.86 150.71 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 CA-C-N 114.759 -1.109 . . . . 99.989999999999995 108.586 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.482 ' HB2' HD12 ' A' ' 80' ' ' LEU . 45.8 tt0 65.51 40.65 4.5 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.467 1.507 . . . . 99.989999999999995 111.067 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.411 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 10.9 mmm180 -100.44 64.04 1.13 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.37 0.605 . . . . 99.989999999999995 111.273 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.7 p -172.83 -168.74 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.767 1.227 . . . . 99.989999999999995 108.774 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -74.79 79.35 2.08 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.162 0.506 . . . . 99.989999999999995 110.574 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.493 ' N ' HD21 ' A' ' 78' ' ' ASN . 0.7 OUTLIER 49.8 66.0 6.2 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.525 1.53 . . . . 99.989999999999995 112.17 176.673 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.03 -21.91 20.13 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.459 2.106 . . . . 99.989999999999995 112.014 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.482 HD12 ' HB2' ' A' ' 74' ' ' GLN . 78.7 mt -113.97 99.75 7.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.253 1.021 . . . . 99.989999999999995 108.485 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -75.37 91.51 2.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.921 -0.581 . . . . 99.989999999999995 109.71 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.4 pt -72.36 87.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.433 -0.803 . . . . 99.989999999999995 110.486 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -73.57 92.7 1.95 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.427 0.632 . . . . 99.989999999999995 110.164 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.59 155.93 24.2 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.762 -0.654 . . . . 99.989999999999995 109.843 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 m -57.06 128.22 35.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.068 0.947 . . . . 99.989999999999995 111.404 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -71.34 141.37 50.43 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.954 0.901 . . . . 99.989999999999995 110.133 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 155.17 41.03 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.076 -0.713 . . . . 99.989999999999995 109.076 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 54.37 74.25 0.77 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 124.279 1.031 . . . . 99.989999999999995 110.97 -172.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.152 2.568 . . . . 99.989999999999995 111.75 176.61 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 109.44 -0.578 . . . . 99.989999999999995 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -157.85 148.83 21.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.798 0.839 . . . . 99.989999999999995 109.178 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -84.35 179.65 7.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.514 0.726 . . . . 99.989999999999995 111.539 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.556 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 14.8 m170 -146.59 -160.78 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.585 1.154 . . . . 99.989999999999995 109.962 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -57.41 135.98 56.59 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.71 1.204 . . . . 99.989999999999995 110.811 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.42 117.54 5.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.583 0.753 . . . . 99.989999999999995 110.483 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 p -99.91 -171.7 2.1 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.555 1.142 . . . . 99.989999999999995 109.181 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -61.24 133.15 55.6 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.235 -1.024 . . . . 99.989999999999995 108.235 167.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -63.48 134.08 55.02 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.968 0.793 . . . . 99.989999999999995 110.414 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.588 HG23 ' HA ' ' A' ' 72' ' ' ARG . 6.5 m -61.3 108.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.251 -1.018 . . . . 99.989999999999995 108.251 168.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.6 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.19 9.69 11.61 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.262 -0.743 . . . . 99.989999999999995 113.005 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.648 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.2 t0 -59.77 113.76 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.13 0.572 . . . . 99.989999999999995 109.556 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -72.56 114.1 10.32 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.587 . . . . 99.989999999999995 109.414 -172.119 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.509 HG13 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.13 176.57 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.906 1.282 . . . . 99.989999999999995 109.743 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 47.9 m0 -125.01 148.85 48.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.935 -1.506 . . . . 99.989999999999995 106.935 171.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.19 104.77 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.779 -0.823 . . . . 99.989999999999995 108.779 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.552 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 42.7 ttm180 -69.16 93.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.636 1.175 . . . . 99.989999999999995 109.496 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.45 119.72 28.01 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 116.052 -0.522 . . . . 99.989999999999995 109.803 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -98.53 109.28 22.07 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.856 0.862 . . . . 99.989999999999995 109.313 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.09 -70.9 0.36 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.92 0.488 . . . . 99.989999999999995 110.685 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 p -117.09 156.11 28.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.292 0.637 . . . . 99.989999999999995 109.94 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -72.08 -28.15 63.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.023 0.929 . . . . 99.989999999999995 111.026 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -72.17 -35.67 69.06 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.139 0.576 . . . . 99.989999999999995 111.299 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.04 161.42 13.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.128 0.571 . . . . 99.989999999999995 110.783 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.37 152.25 87.81 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.311 -0.859 . . . . 99.989999999999995 110.459 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.406 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 98.6 Cg_endo -77.64 146.81 24.36 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.363 2.042 . . . . 99.989999999999995 111.848 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -117.35 130.18 56.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.087 -0.709 . . . . 99.989999999999995 109.087 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.552 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 60.9 p-90 -76.67 149.17 36.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.101 0.477 . . . . 99.989999999999995 110.024 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -126.73 141.06 51.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.529 -1.286 . . . . 99.989999999999995 107.529 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.97 175.4 47.48 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.4 -0.667 . . . . 99.989999999999995 113.12 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -89.77 120.16 4.31 Favored 'Cis proline' 0 C--N 1.377 2.063 0 CA-C-N 119.112 1.456 . . . . 99.989999999999995 114.14 4.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.83 179.33 6.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.7 1.2 . . . . 99.989999999999995 111.512 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.6 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 41.4 p -138.81 113.75 9.29 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.944 0.898 . . . . 99.989999999999995 111.096 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.648 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.8 t -68.09 122.76 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 99.989999999999995 109.89 170.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.561 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 67.7 mt -93.87 -26.23 16.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.145 -0.934 . . . . 99.989999999999995 110.523 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.619 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 67.7 tp -152.29 144.04 23.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.254 0.549 . . . . 99.989999999999995 111.402 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.6 m -110.29 145.82 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 99.989999999999995 109.199 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 p -146.58 162.38 34.29 Favored Pre-proline 0 C--O 1.25 1.079 0 C-N-CA 124.717 1.207 . . . . 99.989999999999995 108.777 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.496 ' HD3' ' HB2' ' A' ' 83' ' ' ARG . 9.5 Cg_endo -53.27 108.85 0.3 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.629 2.219 . . . . 99.989999999999995 112.728 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 65.61 23.48 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.864 1.666 . . . . 99.989999999999995 112.137 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -153.42 158.89 42.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.054 0.454 . . . . 99.989999999999995 110.957 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.8 123.63 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.569 1.148 . . . . 99.989999999999995 108.326 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.619 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.1 tttp -84.25 109.61 17.91 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.903 -1.147 . . . . 99.989999999999995 107.903 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.429 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 97.3 t -92.62 156.67 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.415 -1.266 . . . . 99.989999999999995 108.603 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.55 134.08 56.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.932 0.893 . . . . 99.989999999999995 110.094 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.53 73.29 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.42 -0.655 . . . . 99.989999999999995 113.682 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -85.83 144.98 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 117.739 0.77 . . . . 99.989999999999995 110.188 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.09 70.32 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.115 1.366 . . . . 99.989999999999995 111.79 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.91 -58.39 0.22 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.728 0.27 . . . . 99.989999999999995 111.728 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 8.6 m-90 -144.76 157.54 44.14 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.161 0.505 . . . . 99.989999999999995 111.752 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.8 mm -121.65 129.39 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.027 -1.471 . . . . 99.989999999999995 107.027 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -55.46 127.67 30.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.596 -0.89 . . . . 99.989999999999995 108.596 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.64 -38.66 55.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.937 1.295 . . . . 99.989999999999995 113.856 -164.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.23 -4.01 19.7 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.467 0.914 . . . . 99.989999999999995 113.467 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -97.56 15.69 22.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.148 0.979 . . . . 99.989999999999995 110.397 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.99 130.37 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.292 0.637 . . . . 99.989999999999995 109.564 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -112.47 122.07 46.64 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.712 0.805 . . . . 99.989999999999995 109.094 175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.509 ' HA ' HG13 ' A' ' 14' ' ' VAL . . . -65.63 126.79 29.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.911 -0.403 . . . . 99.989999999999995 109.911 176.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.04 145.01 40.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.955 0.902 . . . . 99.989999999999995 109.895 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -89.64 112.97 54.94 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.574 0.75 . . . . 99.989999999999995 109.145 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 -9.56 23.86 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.795 2.33 . . . . 99.989999999999995 112.769 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.41 30.01 2.16 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 123.577 0.608 . . . . 99.989999999999995 111.735 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.63 -51.4 0.77 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.925 -0.87 . . . . 99.989999999999995 110.925 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.84 -89.64 0.11 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.793 -0.923 . . . . 99.989999999999995 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.59 31.44 0.51 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.204 2.603 . . . . 99.989999999999995 113.27 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 p -73.52 -26.79 61.03 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.704 0.801 . . . . 99.989999999999995 110.71 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.8 t -91.15 -77.05 0.43 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.671 0.789 . . . . 99.989999999999995 109.011 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -148.72 172.73 14.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.126 0.971 . . . . 99.989999999999995 110.004 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.48 136.01 34.99 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.304 -0.628 . . . . 99.989999999999995 109.304 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.488 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.0 p -79.06 127.55 32.14 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.59 0.756 . . . . 99.989999999999995 110.591 -176.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -72.86 126.72 30.6 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.098 -0.704 . . . . 99.989999999999995 109.098 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.588 ' HA ' HG23 ' A' ' 10' ' ' VAL . 23.1 ptt-85 -80.53 58.76 3.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.533 1.133 . . . . 99.989999999999995 112.134 -171.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.35 -28.74 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.069 0.948 . . . . 99.989999999999995 112.807 -172.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -131.98 18.6 4.58 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.378 0.671 . . . . 99.989999999999995 110.904 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HD3' ' HB3' ' A' ' 79' ' ' PRO . 75.2 mmt-85 -122.52 6.21 9.54 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.987 0.515 . . . . 99.989999999999995 111.421 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -73.25 -33.35 65.24 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.08 0.552 . . . . 99.989999999999995 111.329 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -163.73 134.23 4.39 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.67 0.788 . . . . 99.989999999999995 109.527 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 45.01 68.6 3.14 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 125.155 1.382 . . . . 99.989999999999995 112.646 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.556 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 53.1 Cg_exo -58.44 121.01 9.26 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 99.989999999999995 111.804 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.409 ' HB2' HD13 ' A' ' 36' ' ' LEU . 60.9 mt -53.0 123.77 12.49 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.405 1.065 . . . . 99.989999999999995 110.112 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.84 140.26 45.65 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.466 0.706 . . . . 99.989999999999995 111.205 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 pt -110.04 154.33 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.51 -0.768 . . . . 99.989999999999995 110.817 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . 0.496 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . 72.2 mtp180 -138.47 164.25 29.86 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.925 0.89 . . . . 99.989999999999995 109.909 169.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.9 mt 51.6 61.39 3.25 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.17 1.388 . . . . 99.989999999999995 110.329 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.6 m -73.49 81.88 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.793 -1.549 . . . . 99.989999999999995 109.721 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -84.55 98.37 10.1 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.625 -1.17 . . . . 99.989999999999995 109.359 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.39 107.09 1.02 Allowed 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.868 -1.16 . . . . 99.989999999999995 107.868 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.86 91.44 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.963 0.905 . . . . 99.989999999999995 109.52 -165.762 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 C--N 1.376 2.002 0 C-N-CA 123.212 2.608 . . . . 99.989999999999995 112.856 -177.747 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.424 -0.584 . . . . 99.989999999999995 109.424 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -133.91 135.92 43.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.59 0.756 . . . . 99.989999999999995 109.368 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.476 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 46.5 m80 -141.51 155.28 45.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.61 0.764 . . . . 99.989999999999995 110.013 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . 0.506 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 82.8 t60 -89.15 161.83 16.27 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.396 0.679 . . . . 99.989999999999995 110.475 173.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -133.27 129.28 37.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.38 0.672 . . . . 99.989999999999995 109.675 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -84.73 93.02 8.35 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.688 -0.486 . . . . 99.989999999999995 109.688 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.1 p -166.56 -175.76 3.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.338 0.655 . . . . 99.989999999999995 110.5 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.21 101.97 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.415 -1.328 . . . . 99.989999999999995 107.415 164.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp -73.88 170.65 14.92 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.481 1.112 . . . . 99.989999999999995 112.853 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.606 HG22 ' H ' ' A' ' 72' ' ' ARG . 33.0 m -70.96 142.6 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 114.949 -1.023 . . . . 99.989999999999995 110.425 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.67 9.37 81.37 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.79 -1.005 . . . . 99.989999999999995 114.28 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.43 124.66 23.81 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.447 1.124 . . . . 99.989999999999995 110.249 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.5 m -71.61 114.4 9.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.13 0.572 . . . . 99.989999999999995 110.739 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.519 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.9 m -135.98 178.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.28 1.032 . . . . 99.989999999999995 110.621 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.417 ' HE3' ' HD3' ' A' ' 57' ' ' LYS . 34.5 m0 -126.77 153.2 45.87 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.9 1.28 . . . . 99.989999999999995 108.348 174.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.16 105.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 107.439 -1.319 . . . . 99.989999999999995 107.439 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.718 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 76.2 ttt180 -81.12 92.36 6.26 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.91 -1.041 . . . . 99.989999999999995 109.821 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -82.87 119.98 25.08 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.421 -0.809 . . . . 99.989999999999995 110.316 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.568 ' HE2' ' HA ' ' A' ' 22' ' ' LYS . 80.8 t60 -84.42 108.87 17.47 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.431 -0.804 . . . . 99.989999999999995 109.101 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -66.24 -72.51 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.42 0.688 . . . . 99.989999999999995 111.069 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.4 m -127.1 154.11 45.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.209 1.003 . . . . 99.989999999999995 108.309 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.568 ' HA ' ' HE2' ' A' ' 19' ' ' HIS . 34.8 mtmm -60.9 -37.83 83.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.026 0.93 . . . . 99.989999999999995 111.752 -176.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -87.82 9.63 21.23 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.117 0.567 . . . . 99.989999999999995 112.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -121.72 168.49 11.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.026 0.93 . . . . 99.989999999999995 109.836 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.87 148.85 65.86 Favored Pre-proline 0 CA--C 1.553 1.073 0 CA-C-N 115.708 -0.678 . . . . 99.989999999999995 111.278 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.494 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 Cg_exo -75.57 109.83 2.98 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.892 2.395 . . . . 99.989999999999995 111.3 169.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.307 0.643 . . . . 99.989999999999995 110.42 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.718 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 61.9 p-90 -74.01 150.06 40.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.977 0.511 . . . . 99.989999999999995 110.887 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.29 143.99 49.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.091 0.957 . . . . 99.989999999999995 108.624 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.9 -177.08 25.27 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 111.603 -0.599 . . . . 99.989999999999995 111.603 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.16 121.65 6.83 Favored 'Cis proline' 0 C--N 1.37 1.664 0 CA-C-N 119.564 1.682 . . . . 99.989999999999995 111.855 -9.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -106.99 170.2 8.09 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.522 0.729 . . . . 99.989999999999995 110.003 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.526 HG21 ' HB3' ' A' ' 65' ' ' PRO . 17.7 p -150.81 115.79 5.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.157 0.583 . . . . 99.989999999999995 111.498 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.67 127.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.104 0.562 . . . . 99.989999999999995 111.49 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.472 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 77.2 mt -95.49 -38.31 10.5 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.492 1.117 . . . . 99.989999999999995 110.475 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.542 HD21 HD13 ' A' ' 80' ' ' LEU . 38.4 tp -145.24 149.22 34.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.445 0.698 . . . . 99.989999999999995 110.06 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.435 HG22 HD23 ' A' ' 42' ' ' LEU . 37.1 p -112.97 130.4 56.14 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.744 0.818 . . . . 99.989999999999995 109.337 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -127.54 148.54 67.02 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 107.497 -1.297 . . . . 99.989999999999995 107.497 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.51 117.43 2.34 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.624 2.216 . . . . 99.989999999999995 113.031 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 m 75.58 -2.28 2.83 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.514 1.525 . . . . 99.989999999999995 112.812 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.821 -0.549 . . . . 99.989999999999995 110.586 -173.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.435 HD23 HG22 ' A' ' 37' ' ' THR . 46.0 mt -108.75 125.23 51.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.927 0.491 . . . . 99.989999999999995 109.676 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.455 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.7 ttmm -83.91 110.89 18.76 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.862 -0.792 . . . . 99.989999999999995 108.862 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.34 146.14 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.822 1.249 . . . . 99.989999999999995 109.333 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.07 127.73 33.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.947 0.899 . . . . 99.989999999999995 109.771 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.25 -0.93 50.49 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.817 -0.629 . . . . 99.989999999999995 112.485 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.52 148.94 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.738 0.815 . . . . 99.989999999999995 109.242 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.07 86.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.182 0.993 . . . . 99.989999999999995 112.506 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.28 -58.03 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.327 0.251 . . . . 99.989999999999995 111.382 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.504 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 17.8 m-90 -143.76 147.13 33.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.241 0.616 . . . . 99.989999999999995 111.382 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.0 mm -101.55 138.71 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 107.968 -1.123 . . . . 99.989999999999995 107.968 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.25 119.55 8.12 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 107.721 -1.214 . . . . 99.989999999999995 107.721 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.11 20.94 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.266 1.426 . . . . 99.989999999999995 114.593 -164.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.48 -2.77 14.97 Favored 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 113.197 0.814 . . . . 99.989999999999995 113.197 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -115.76 17.34 16.15 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.525 1.13 . . . . 99.989999999999995 110.632 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -117.24 133.59 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.167 -0.679 . . . . 99.989999999999995 109.167 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.417 ' HD3' ' HE3' ' A' ' 15' ' ' TRP . 64.4 tttp -121.49 121.24 37.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.976 0.911 . . . . 99.989999999999995 109.334 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.519 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -64.47 118.18 8.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.306 0.642 . . . . 99.989999999999995 110.709 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.89 166.45 11.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 99.989999999999995 109.879 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -74.29 117.0 58.26 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.459 0.704 . . . . 99.989999999999995 110.126 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.29 3.67 1.59 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.163 2.575 . . . . 99.989999999999995 114.364 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 92.98 0.06 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.489 0.566 . . . . 99.989999999999995 111.728 170.413 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 -63.89 0.4 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 109.424 -1.47 . . . . 99.989999999999995 109.424 -169.534 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.05 -164.85 54.79 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.714 -0.492 . . . . 99.989999999999995 113.686 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.526 ' HB3' HG21 ' A' ' 33' ' ' THR . 73.2 Cg_endo -76.95 111.82 3.31 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.521 2.148 . . . . 99.989999999999995 111.932 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -70.56 -19.38 62.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.591 0.756 . . . . 99.989999999999995 110.641 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -91.65 133.49 35.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.39 1.076 . . . . 99.989999999999995 110.209 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -74.28 103.04 4.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.013 -0.736 . . . . 99.989999999999995 109.013 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.64 -170.06 2.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.107 0.963 . . . . 99.989999999999995 111.092 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.2 p -64.36 98.82 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.606 -0.516 . . . . 99.989999999999995 109.606 172.22 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -73.53 114.54 11.88 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.417 -0.81 . . . . 99.989999999999995 110.547 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.606 ' H ' HG22 ' A' ' 10' ' ' VAL . 82.9 mtt180 56.52 77.6 0.25 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.122 1.369 . . . . 99.989999999999995 111.857 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.484 ' H ' HG12 ' A' ' 10' ' ' VAL . 57.9 t -65.45 -41.42 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 122.112 0.958 . . . . 99.989999999999995 108.454 167.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.517 ' HB3' HD11 ' A' ' 80' ' ' LEU . 17.5 pt20 -99.36 118.15 35.37 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.074 -1.421 . . . . 99.989999999999995 109.247 173.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -107.45 -175.23 2.73 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.512 -0.921 . . . . 99.989999999999995 108.512 173.599 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.2 t -65.61 176.88 1.35 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.25 0.62 . . . . 99.989999999999995 110.729 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.71 82.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.598 -1.26 . . . . 99.989999999999995 107.598 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -32.47 93.93 0.06 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 126.61 1.964 . . . . 99.989999999999995 113.62 -164.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -90.81 -19.73 0.95 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.122 2.548 . . . . 99.989999999999995 113.425 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.542 HD13 HD21 ' A' ' 36' ' ' LEU . 85.0 mt -141.33 143.54 34.08 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.871 1.268 . . . . 99.989999999999995 108.772 -168.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HZ2' ' HB3' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -90.63 118.32 29.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.025 0.53 . . . . 99.989999999999995 109.97 -178.617 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 pt -103.21 132.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.665 0.786 . . . . 99.989999999999995 109.567 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -170.68 108.06 0.31 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.537 0.735 . . . . 99.989999999999995 109.746 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.66 94.17 6.9 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.897 -0.779 . . . . 99.989999999999995 108.897 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.2 p -77.62 73.66 4.19 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.556 0.742 . . . . 99.989999999999995 110.419 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -85.63 98.05 10.45 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.406 -0.961 . . . . 99.989999999999995 108.406 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.39 148.88 21.66 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.887 0.875 . . . . 99.989999999999995 110.198 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.34 118.05 49.61 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.676 0.79 . . . . 99.989999999999995 110.475 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 122.828 2.352 . . . . 99.989999999999995 113.184 -178.757 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.71 -0.478 . . . . 99.989999999999995 109.71 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -129.77 138.6 51.16 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.178 0.991 . . . . 99.989999999999995 109.173 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.44 159.58 41.35 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 124.083 0.953 . . . . 99.989999999999995 110.196 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -68.5 163.97 22.24 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.417 -0.811 . . . . 99.989999999999995 109.305 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -132.55 -62.67 0.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.433 -0.58 . . . . 99.989999999999995 109.433 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 76' ' ' SER . 44.2 t-80 59.91 31.34 20.67 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.522 1.153 . . . . 99.989999999999995 109.676 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -99.11 179.16 4.7 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.203 -1.362 . . . . 99.989999999999995 109.582 -172.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -65.66 156.98 31.22 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.668 -0.493 . . . . 99.989999999999995 109.668 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.51 ' HB2' HD21 ' A' ' 80' ' ' LEU . 25.3 ptt? -48.22 133.27 15.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.838 1.255 . . . . 99.989999999999995 113.04 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.421 HG11 ' O ' ' A' ' 35' ' ' LEU . 16.2 m -73.53 137.61 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.232 -1.025 . . . . 99.989999999999995 108.232 172.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.661 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 90.79 11.02 62.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-O 118.999 -0.89 . . . . 99.989999999999995 112.459 -172.334 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.673 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 64.0 t0 -57.62 97.74 0.03 OUTLIER 'General case' 0 C--N 1.365 1.275 0 C-N-CA 123.557 0.743 . . . . 99.989999999999995 109.062 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 m -71.52 118.59 14.53 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 109.484 -0.561 . . . . 99.989999999999995 109.484 -169.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.551 HG11 ' HA ' ' A' ' 58' ' ' ALA . 29.4 m -135.57 170.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 C-N-CA 125.513 1.525 . . . . 99.989999999999995 109.741 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.428 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 50.4 m0 -117.68 142.14 47.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.617 1.167 . . . . 99.989999999999995 108.082 171.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.23 109.3 27.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 107.298 -1.371 . . . . 99.989999999999995 107.298 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.652 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 48.6 ttt180 -90.51 100.2 13.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.043 1.337 . . . . 99.989999999999995 109.963 -171.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -99.46 144.11 28.93 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 99.989999999999995 111.273 -172.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 2.2 p80 -151.69 137.81 18.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.718 0.807 . . . . 99.989999999999995 110.326 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.47 -48.1 57.44 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.159 0.584 . . . . 99.989999999999995 110.734 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 p -127.02 164.74 20.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.151 0.98 . . . . 99.989999999999995 109.146 172.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -72.56 -24.98 61.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.912 0.485 . . . . 99.989999999999995 110.754 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -64.25 -36.91 85.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.227 0.611 . . . . 99.989999999999995 110.682 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -79.74 130.21 35.15 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.894 -0.409 . . . . 99.989999999999995 109.894 171.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.413 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 38.7 mt-10 -67.83 130.43 92.89 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.437 0.695 . . . . 99.989999999999995 110.003 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.58 ' HA ' ' HB3' ' A' ' 19' ' ' HIS . 6.9 Cg_exo -71.62 123.53 9.52 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.101 2.534 . . . . 99.989999999999995 112.244 -172.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -100.15 125.63 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 99.989999999999995 109.207 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.652 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 67.5 p-90 -71.66 158.5 36.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.257 0.623 . . . . 99.989999999999995 111.032 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -133.95 149.12 51.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.741 0.816 . . . . 99.989999999999995 108.855 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.76 176.82 40.52 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.851 -0.416 . . . . 99.989999999999995 112.895 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -92.92 104.77 0.37 Allowed 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 118.601 1.201 . . . . 99.989999999999995 112.276 -1.439 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -74.74 161.26 29.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.646 -0.872 . . . . 99.989999999999995 108.646 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.661 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 59.7 p -141.5 111.9 6.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.41 0.284 . . . . 99.989999999999995 110.321 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.673 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 24.1 t -68.37 124.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 C-N-CA 123.41 0.684 . . . . 99.989999999999995 110.028 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.421 ' O ' HG11 ' A' ' 10' ' ' VAL . 48.1 mt -99.03 -20.68 16.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.591 1.156 . . . . 99.989999999999995 110.895 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 54.0 tp -153.73 137.36 16.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.677 0.791 . . . . 99.989999999999995 109.734 175.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.527 HG23 HD21 ' A' ' 42' ' ' LEU . 38.0 p -112.31 128.96 56.43 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.639 -0.874 . . . . 99.989999999999995 108.639 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.7 p -133.39 165.19 38.58 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.439 1.095 . . . . 99.989999999999995 109.148 -179.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_endo -46.82 108.98 0.17 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.559 2.839 . . . . 99.989999999999995 113.523 178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.1 p 56.08 20.37 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 126.039 1.736 . . . . 99.989999999999995 113.737 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.0 138.83 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.809 -0.811 . . . . 99.989999999999995 108.809 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.527 HD21 HG23 ' A' ' 37' ' ' THR . 64.4 mt -127.89 129.02 46.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.405 -0.591 . . . . 99.989999999999995 109.405 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -86.27 107.39 17.92 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.055 -1.461 . . . . 99.989999999999995 107.055 168.533 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.55 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 21.7 t -104.79 160.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.164 -0.926 . . . . 99.989999999999995 108.79 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -66.32 129.04 38.48 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.453 0.701 . . . . 99.989999999999995 109.51 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.21 -4.49 86.17 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.586 0.554 . . . . 99.989999999999995 113.039 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.95 137.54 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.875 0.87 . . . . 99.989999999999995 109.503 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.68 72.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.974 0.91 . . . . 99.989999999999995 111.441 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.35 -56.15 0.17 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.583 0.586 . . . . 99.989999999999995 112.583 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -141.19 138.24 33.22 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.344 0.52 . . . . 99.989999999999995 111.801 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.3 mm -120.45 127.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.191 -1.411 . . . . 99.989999999999995 107.191 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -56.64 122.84 13.0 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.221 -0.659 . . . . 99.989999999999995 109.221 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.39 -21.37 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.735 1.614 . . . . 99.989999999999995 114.817 -166.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.11 65.4 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.301 0.852 . . . . 99.989999999999995 113.301 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -87.74 -12.53 44.97 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.856 0.462 . . . . 99.989999999999995 111.218 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.6 t -101.76 139.83 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 99.989999999999995 109.81 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -138.99 129.75 26.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 99.989999999999995 109.62 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.551 ' HA ' HG11 ' A' ' 14' ' ' VAL . . . -67.4 126.54 29.6 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.277 0.631 . . . . 99.989999999999995 112.342 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.85 160.15 16.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.474 1.11 . . . . 99.989999999999995 111.304 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -97.21 117.59 65.49 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.808 -1.182 . . . . 99.989999999999995 107.808 173.321 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.26 -29.35 14.25 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.573 2.182 . . . . 99.989999999999995 113.41 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 -76.15 0.77 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 110.105 -1.198 . . . . 99.989999999999995 110.105 -163.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.7 -77.38 0.73 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 110.481 -1.048 . . . . 99.989999999999995 110.481 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.0 -123.4 33.0 Favored Glycine 0 CA--C 1.545 1.935 0 N-CA-C 114.846 0.699 . . . . 99.989999999999995 114.846 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.37 96.7 1.05 Allowed 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.299 2.666 . . . . 99.989999999999995 113.143 -171.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -114.58 -71.58 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.901 -0.777 . . . . 99.989999999999995 108.901 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 t -81.97 68.52 8.39 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.714 1.205 . . . . 99.989999999999995 111.152 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -168.35 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.628 1.171 . . . . 99.989999999999995 109.583 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.1 12.88 3.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.91 0.884 . . . . 99.989999999999995 112.893 -172.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -56.84 -22.33 35.92 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.285 1.434 . . . . 99.989999999999995 113.166 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.73 148.46 51.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.932 0.893 . . . . 99.989999999999995 112.028 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.444 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 12.6 ptp180 -95.76 59.24 2.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.828 1.299 . . . . 99.989999999999995 110.441 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -94.37 -17.0 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 113.988 -1.46 . . . . 99.989999999999995 108.874 171.158 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.39 27.25 1.1 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.501 1.12 . . . . 99.989999999999995 111.994 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.444 ' HD3' ' HB2' ' A' ' 72' ' ' ARG . 22.9 mmm180 -62.49 94.91 0.06 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.83 0.852 . . . . 99.989999999999995 111.536 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . 0.598 ' HB2' ' HA ' ' A' ' 6' ' ' HIS . 33.0 t -162.57 -171.15 2.64 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.527 1.531 . . . . 99.989999999999995 108.493 -177.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -61.89 -63.33 1.29 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.549 0.74 . . . . 99.989999999999995 110.646 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -169.24 79.77 0.7 Allowed Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.963 0.905 . . . . 99.989999999999995 109.257 171.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.561 ' HD3' ' HB3' ' A' ' 76' ' ' SER . 74.2 Cg_endo -75.04 -26.53 10.77 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.757 2.305 . . . . 99.989999999999995 112.753 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.51 HD21 ' HB2' ' A' ' 9' ' ' MET . 76.5 mt -78.89 172.96 13.04 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.556 0.693 . . . . 99.989999999999995 111.623 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -151.63 141.74 22.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.704 1.202 . . . . 99.989999999999995 108.516 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.2 pt -65.82 147.32 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.979 0.419 . . . . 99.989999999999995 110.012 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -122.39 10.78 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.598 0.759 . . . . 99.989999999999995 109.831 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.1 mt 58.36 19.71 6.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.234 1.414 . . . . 99.989999999999995 112.19 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -84.13 143.88 29.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.672 0.789 . . . . 99.989999999999995 109.481 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -74.62 96.38 2.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.561 0.744 . . . . 99.989999999999995 109.49 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.4 -57.37 3.39 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.836 0.854 . . . . 99.989999999999995 109.443 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.14 141.26 80.9 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.705 -0.479 . . . . 99.989999999999995 109.705 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.564 2.012 0 C-N-CA 122.343 2.029 . . . . 99.989999999999995 111.132 176.582 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 120.568 0.223 . . . . 99.989999999999995 110.841 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . 0.506 ' HB2' ' HA ' ' A' ' 89' ' ' PRO . 12.4 p-80 -160.68 148.55 16.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.901 1.28 . . . . 99.989999999999995 109.368 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -162.15 142.87 10.36 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.95 0.156 . . . . 99.989999999999995 110.772 -174.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -80.33 165.71 22.02 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.868 0.867 . . . . 99.989999999999995 112.005 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -153.46 123.53 6.95 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.621 -0.881 . . . . 99.989999999999995 108.621 167.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.36 72.54 8.4 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.301 1.048 . . . . 99.989999999999995 110.23 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.5 t -161.36 -171.1 2.86 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.511 -1.222 . . . . 99.989999999999995 109.283 -171.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -68.64 126.28 29.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.665 0.786 . . . . 99.989999999999995 109.796 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.6 ptp -92.42 174.65 7.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.254 0.622 . . . . 99.989999999999995 111.478 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.662 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.8 m -67.87 135.54 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.265 -0.879 . . . . 99.989999999999995 111.053 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.57 62.63 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.672 -0.516 . . . . 99.989999999999995 112.613 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.521 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.1 t0 -65.57 115.98 6.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.694 0.798 . . . . 99.989999999999995 110.601 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.4 HG23 ' HB1' ' A' ' 59' ' ' ALA . 38.3 m -73.31 111.88 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.218 0.607 . . . . 99.989999999999995 110.328 -173.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.2 m -136.37 -176.56 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.818 1.247 . . . . 99.989999999999995 110.616 -174.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.7 m0 -131.95 157.71 43.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.516 1.526 . . . . 99.989999999999995 107.814 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.12 104.37 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.536 -0.913 . . . . 99.989999999999995 108.536 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 57' ' ' LYS . 67.5 ttt180 -79.01 96.53 5.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.466 1.106 . . . . 99.989999999999995 110.44 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -98.43 119.18 36.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.098 0.475 . . . . 99.989999999999995 111.833 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -107.09 94.08 4.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.104 0.962 . . . . 99.989999999999995 108.409 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -57.94 -70.02 0.15 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.755 0.822 . . . . 99.989999999999995 111.912 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.7 p -117.36 173.97 6.4 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.536 0.734 . . . . 99.989999999999995 109.069 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -70.93 -21.57 62.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.705 0.802 . . . . 99.989999999999995 111.851 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -92.29 -31.73 15.28 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.864 0.466 . . . . 99.989999999999995 110.991 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.54 162.93 27.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.653 0.381 . . . . 99.989999999999995 110.751 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.98 159.26 54.74 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.879 0.872 . . . . 99.989999999999995 110.993 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.76 76.1 4.71 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.991 2.461 . . . . 99.989999999999995 110.673 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -76.61 116.54 17.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.175 -0.921 . . . . 99.989999999999995 110.017 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -81.35 153.18 27.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.498 0.666 . . . . 99.989999999999995 110.711 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.609 ' HB3' ' HZ1' ' A' ' 29' ' ' LYS . 9.5 mtpm? -127.62 137.87 52.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.574 -1.269 . . . . 99.989999999999995 107.574 170.124 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.91 38.05 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.306 -0.473 . . . . 99.989999999999995 112.79 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.14 122.09 5.86 Favored 'Cis proline' 0 CA--C 1.559 1.756 0 C-N-CA 123.753 -1.353 . . . . 99.989999999999995 112.878 -4.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.18 178.97 7.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.576 0.75 . . . . 99.989999999999995 110.0 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.493 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 25.6 p -138.15 113.34 9.33 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.908 0.483 . . . . 99.989999999999995 110.983 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.521 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.5 t -64.99 135.82 27.65 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 CA-C-O 121.242 0.544 . . . . 99.989999999999995 109.666 170.256 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.662 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 66.5 mt -104.53 -44.98 4.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.085 -0.961 . . . . 99.989999999999995 109.258 173.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.4 tp -142.19 147.67 36.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.727 -0.67 . . . . 99.989999999999995 109.765 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.445 HG23 HD22 ' A' ' 42' ' ' LEU . 30.9 p -104.63 144.27 31.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.781 0.833 . . . . 99.989999999999995 109.164 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -140.35 149.07 56.45 Favored Pre-proline 0 CA--C 1.556 1.198 0 N-CA-C 107.955 -1.128 . . . . 99.989999999999995 107.955 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -39.56 121.61 0.83 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.044 2.496 . . . . 99.989999999999995 114.021 170.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t 53.07 14.48 0.48 Allowed 'General case' 0 N--CA 1.504 2.261 0 C-N-CA 126.745 2.018 . . . . 99.989999999999995 114.826 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.471 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -153.82 124.58 7.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.794 0.438 . . . . 99.989999999999995 110.465 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.521 HD13 ' HB ' ' A' ' 56' ' ' VAL . 86.8 mt -103.0 126.05 50.02 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.269 -0.641 . . . . 99.989999999999995 109.269 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 51.5 tttm -86.85 108.96 18.98 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 108.706 -0.85 . . . . 99.989999999999995 108.706 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.474 HG23 HG23 ' A' ' 34' ' ' VAL . 58.4 t -116.31 141.65 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.822 -1.081 . . . . 99.989999999999995 109.345 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.443 ' HB3' ' HG1' ' A' ' 33' ' ' THR . 27.6 t70 -65.95 137.64 57.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.393 0.677 . . . . 99.989999999999995 110.768 175.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.75 21.65 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.563 -0.744 . . . . 99.989999999999995 111.928 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.469 HG21 HG12 ' A' ' 51' ' ' ILE . 50.1 mm -87.0 146.77 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.975 0.91 . . . . 99.989999999999995 109.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.56 -49.43 64.96 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.225 1.01 . . . . 99.989999999999995 111.151 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.525 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -151.17 -59.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.16 0.287 . . . . 99.989999999999995 111.519 167.47 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.471 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 18.0 m-90 -135.5 144.95 46.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.931 -0.481 . . . . 99.989999999999995 112.0 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.469 HG12 HG21 ' A' ' 47' ' ' ILE . 35.9 mm -110.76 137.6 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.145 -1.428 . . . . 99.989999999999995 107.145 163.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -57.07 129.21 40.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.992 -0.744 . . . . 99.989999999999995 108.992 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.79 -32.44 65.67 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.048 1.129 . . . . 99.989999999999995 114.048 -163.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 -11.35 60.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.313 0.645 . . . . 99.989999999999995 112.415 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -102.39 22.8 12.8 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.406 1.082 . . . . 99.989999999999995 111.044 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.521 ' HB ' HD13 ' A' ' 42' ' ' LEU . 59.8 t -135.72 125.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.206 -0.664 . . . . 99.989999999999995 109.206 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD2' ' HD2' ' A' ' 17' ' ' ARG . 48.2 mtpt -114.45 129.82 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.601 0.761 . . . . 99.989999999999995 109.783 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.63 120.88 15.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.583 0.353 . . . . 99.989999999999995 110.181 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.4 ' HB1' HG23 ' A' ' 13' ' ' THR . . . -86.15 157.71 19.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.251 0.62 . . . . 99.989999999999995 110.281 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -78.14 117.8 68.27 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.69 0.796 . . . . 99.989999999999995 109.971 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.412 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 52.8 Cg_exo -59.22 -17.67 40.44 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.27 2.647 . . . . 99.989999999999995 113.632 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.92 87.32 0.08 OUTLIER Glycine 0 C--N 1.347 1.188 0 CA-C-N 116.246 -0.434 . . . . 99.989999999999995 113.247 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.0 -13.78 0.31 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.457 0.551 . . . . 99.989999999999995 112.377 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.7 -73.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.481 -0.622 . . . . 99.989999999999995 112.154 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.443 ' HG3' HD12 ' A' ' 69' ' ' LEU . 35.9 Cg_exo -59.73 112.85 1.4 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.109 2.539 . . . . 99.989999999999995 112.386 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -64.08 -49.99 70.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.465 0.706 . . . . 99.989999999999995 109.91 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -151.16 -69.56 0.17 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 99.989999999999995 109.036 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -118.7 133.04 56.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.862 0.865 . . . . 99.989999999999995 109.789 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.443 HD12 ' HG3' ' A' ' 65' ' ' PRO . 90.9 mt -94.98 -71.01 0.69 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.932 0.493 . . . . 99.989999999999995 109.786 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -86.49 147.84 25.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.843 -0.617 . . . . 99.989999999999995 109.812 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -86.0 -63.49 1.31 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.488 0.715 . . . . 99.989999999999995 109.268 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.476 HH12 ' HB3' ' A' ' 2' ' ' HIS . 79.1 mtp180 -151.75 150.04 29.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.104 1.362 . . . . 99.989999999999995 109.101 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.454 HG13 HD23 ' A' ' 35' ' ' LEU . 35.6 m -120.12 -6.15 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 112.832 0.679 . . . . 99.989999999999995 112.832 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 78' ' ' ASN . 2.7 pt20 -68.59 -27.3 65.92 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.386 0.539 . . . . 99.989999999999995 112.24 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.01 -20.66 66.26 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.16 0.584 . . . . 99.989999999999995 111.005 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -89.11 -30.41 18.66 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.03 0.932 . . . . 99.989999999999995 112.024 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -161.28 -35.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.566 0.58 . . . . 99.989999999999995 112.566 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . 0.457 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 7.1 t30 75.56 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 125.036 1.334 . . . . 99.989999999999995 111.491 -176.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.415 ' HB3' ' HZ2' ' A' ' 43' ' ' LYS . 78.7 Cg_endo -81.23 -2.94 11.93 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.154 2.57 . . . . 99.989999999999995 111.7 169.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.549 HD11 ' HG3' ' A' ' 87' ' ' GLU . 43.0 mt -85.07 13.01 6.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.011 . . . . 99.989999999999995 112.493 -172.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.58 -10.45 58.21 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.406 0.683 . . . . 99.989999999999995 112.525 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.5 pt -85.05 -173.47 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.999 0.52 . . . . 99.989999999999995 109.905 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.76 -38.44 85.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.28 0.632 . . . . 99.989999999999995 111.668 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.539 HD21 HH21 ' A' ' 86' ' ' ARG . 72.4 mt -81.63 87.76 6.26 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.533 0.682 . . . . 99.989999999999995 109.354 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.486 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 9.3 t -113.48 64.19 0.65 Allowed 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 122.701 1.238 . . . . 99.989999999999995 110.288 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . 0.539 HH21 HD21 ' A' ' 84' ' ' LEU . 72.6 mtm180 -147.51 132.65 18.33 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.022 -0.99 . . . . 99.989999999999995 110.335 -174.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . 0.549 ' HG3' HD11 ' A' ' 80' ' ' LEU . 61.8 mt-10 -129.76 -80.69 0.55 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.828 0.851 . . . . 99.989999999999995 109.583 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -167.25 167.85 7.11 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 123.525 0.73 . . . . 99.989999999999995 110.076 -172.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . 0.506 ' HA ' ' HB2' ' A' ' 2' ' ' HIS . 18.2 Cg_exo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 122.962 2.441 . . . . 99.989999999999995 112.4 167.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.386 -0.598 . . . . 99.989999999999995 109.386 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -144.6 114.54 7.35 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.191 0.996 . . . . 99.989999999999995 109.503 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -157.24 52.07 0.48 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.194 0.597 . . . . 99.989999999999995 110.446 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.08 81.77 0.33 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.316 0.646 . . . . 99.989999999999995 110.446 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -76.63 -82.12 0.08 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.426 0.691 . . . . 99.989999999999995 109.154 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -168.62 142.8 3.19 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.052 0.541 . . . . 99.989999999999995 109.807 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -148.03 -173.92 4.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.338 0.655 . . . . 99.989999999999995 110.966 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -86.28 161.17 18.89 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.118 0.967 . . . . 99.989999999999995 108.731 171.216 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.437 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 27.2 ptt? -53.1 132.65 38.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.518 0.727 . . . . 99.989999999999995 111.495 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.642 HG12 ' HB ' ' A' ' 73' ' ' VAL . 21.3 m -69.46 139.26 20.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 116.045 -0.525 . . . . 99.989999999999995 109.888 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.544 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 101.11 9.78 44.17 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.559 -0.579 . . . . 99.989999999999995 112.875 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.5 t0 -58.28 109.39 0.76 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.026 0.53 . . . . 99.989999999999995 110.622 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.6 m -71.62 111.66 7.1 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.142 0.496 . . . . 99.989999999999995 109.843 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.15 -175.1 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.565 1.146 . . . . 99.989999999999995 109.806 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.44 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -124.38 156.77 36.52 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.053 1.341 . . . . 99.989999999999995 107.722 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.451 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 52.2 t -109.75 114.58 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.417 -0.956 . . . . 99.989999999999995 108.417 171.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.436 ' HB3' ' HA ' ' A' ' 55' ' ' HIS . 39.3 ttm180 -76.97 123.77 26.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.158 0.983 . . . . 99.989999999999995 110.108 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -138.29 140.38 39.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.854 -0.795 . . . . 99.989999999999995 108.854 168.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.653 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 10.9 m170 -57.95 -45.66 86.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.458 0.703 . . . . 99.989999999999995 111.897 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 65.99 -70.2 0.1 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 124.666 1.229 . . . . 99.989999999999995 109.735 -170.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.422 ' OG1' ' HB2' ' A' ' 24' ' ' LEU . 33.4 p -80.6 137.15 36.35 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.913 1.285 . . . . 99.989999999999995 109.2 168.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -61.94 -52.1 65.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.95 0.9 . . . . 99.989999999999995 112.905 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -108.03 -15.69 14.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.933 0.893 . . . . 99.989999999999995 112.415 -169.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.422 ' HB2' ' OG1' ' A' ' 21' ' ' THR . 68.2 mt -80.52 172.97 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 110.553 -0.166 . . . . 99.989999999999995 110.553 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -56.27 127.22 70.5 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.888 0.875 . . . . 99.989999999999995 111.847 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.653 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 52.1 Cg_exo -56.16 124.72 16.95 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.256 2.637 . . . . 99.989999999999995 112.434 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -93.67 179.61 5.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.184 0.993 . . . . 99.989999999999995 108.834 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -146.21 163.34 35.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.383 0.673 . . . . 99.989999999999995 110.296 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -131.31 161.12 33.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.726 -0.842 . . . . 99.989999999999995 108.726 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.44 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -170.91 -177.55 40.9 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-O 119.402 -0.666 . . . . 99.989999999999995 111.896 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.32 116.73 3.64 Favored 'Cis proline' 0 C--N 1.376 2.013 0 CA-C-N 119.408 1.604 . . . . 99.989999999999995 113.117 -4.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.429 ' HB3' HG13 ' A' ' 44' ' ' VAL . 77.9 m-85 -80.45 169.41 17.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.825 0.85 . . . . 99.989999999999995 110.408 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.544 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.9 p -140.28 110.49 6.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.422 0.689 . . . . 99.989999999999995 110.685 -176.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.567 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 65.3 t -73.38 130.45 35.78 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 123.064 0.546 . . . . 99.989999999999995 109.743 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.403 HD23 ' HB ' ' A' ' 10' ' ' VAL . 41.1 mt -98.22 -54.66 3.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.302 -0.863 . . . . 99.989999999999995 109.393 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.595 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 28.9 tp -110.26 139.63 45.24 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.18 0.592 . . . . 99.989999999999995 109.651 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.414 HG22 HD21 ' A' ' 42' ' ' LEU . 69.0 p -127.89 129.25 46.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.353 0.661 . . . . 99.989999999999995 109.353 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -145.15 161.09 43.65 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.094 1.358 . . . . 99.989999999999995 108.454 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -43.62 109.0 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.662 2.908 . . . . 99.989999999999995 114.832 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m 65.08 13.15 8.5 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.03 1.332 . . . . 99.989999999999995 112.456 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.85 121.89 14.64 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.705 -0.622 . . . . 99.989999999999995 110.012 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.481 HD13 HG13 ' A' ' 56' ' ' VAL . 62.1 mt -121.8 122.19 38.93 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.818 -1.179 . . . . 99.989999999999995 107.818 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.595 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 82.9 tttt -93.85 111.46 23.17 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.261 -0.644 . . . . 99.989999999999995 109.261 176.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 76.7 t -86.49 156.24 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 O-C-N 124.347 1.03 . . . . 99.989999999999995 109.385 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.35 116.2 4.1 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.89 0.876 . . . . 99.989999999999995 110.706 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.44 -14.81 32.79 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.226 -0.443 . . . . 99.989999999999995 113.214 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.424 HG23 HG12 ' A' ' 51' ' ' ILE . 39.5 mm -77.96 143.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.532 0.733 . . . . 99.989999999999995 111.24 -177.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.4 -50.7 69.06 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.648 1.179 . . . . 99.989999999999995 112.259 -176.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.31 -58.1 0.18 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.219 0.451 . . . . 99.989999999999995 112.219 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -143.92 150.03 37.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.683 0.393 . . . . 99.989999999999995 111.111 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.424 HG12 HG23 ' A' ' 47' ' ' ILE . 33.1 mm -112.98 122.27 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.439 -0.949 . . . . 99.989999999999995 108.439 166.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.54 124.78 22.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.855 -1.535 . . . . 99.989999999999995 106.855 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.32 -18.75 7.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.259 1.577 . . . . 99.989999999999995 115.259 -160.624 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.65 -4.93 34.04 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.537 0.735 . . . . 99.989999999999995 112.352 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . 0.451 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 97.7 m-70 -104.11 17.35 24.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.099 0.96 . . . . 99.989999999999995 109.967 169.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.481 HG13 HD13 ' A' ' 42' ' ' LEU . 54.6 t -124.61 136.34 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.771 0.428 . . . . 99.989999999999995 109.902 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.436 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 52.7 mtpt -133.67 115.39 14.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 99.989999999999995 108.202 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.39 121.51 12.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 99.989999999999995 111.364 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.17 155.6 20.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.702 0.801 . . . . 99.989999999999995 111.252 -175.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -100.43 113.83 65.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.195 0.998 . . . . 99.989999999999995 108.446 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.06 -17.37 13.59 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.639 2.226 . . . . 99.989999999999995 112.931 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.29 -63.25 4.45 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.745 -0.942 . . . . 99.989999999999995 110.745 -168.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.65 -117.51 0.44 Allowed Glycine 0 C--O 1.238 0.388 0 N-CA-C 109.107 -1.597 . . . . 99.989999999999995 109.107 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.25 64.97 3.9 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-O 119.554 -0.581 . . . . 99.989999999999995 113.787 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.446 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 64.0 Cg_endo -88.8 -0.09 6.4 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.766 2.311 . . . . 99.989999999999995 113.165 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -49.62 -60.93 2.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.279 1.431 . . . . 99.989999999999995 114.122 -166.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -77.27 -13.57 59.91 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.353 0.661 . . . . 99.989999999999995 111.309 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -98.97 2.04 46.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.87 0.868 . . . . 99.989999999999995 111.844 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' A' ' 65' ' ' PRO . 80.7 mt -71.22 -2.75 17.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.742 0.817 . . . . 99.989999999999995 112.712 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -65.86 -62.72 1.35 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.809 0.843 . . . . 99.989999999999995 111.423 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.464 ' HD1' HG21 ' A' ' 10' ' ' VAL . 7.3 m0 51.95 37.0 19.88 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.66 1.184 . . . . 99.989999999999995 113.594 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -69.84 -28.69 65.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 99.989999999999995 112.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.642 ' HB ' HG12 ' A' ' 10' ' ' VAL . 44.6 t -77.75 -21.61 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.538 0.735 . . . . 99.989999999999995 110.384 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.438 ' HG3' HD21 ' A' ' 80' ' ' LEU . 30.7 mm-40 -81.89 5.19 19.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.344 1.057 . . . . 99.989999999999995 112.186 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -81.3 75.65 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.739 0.78 . . . . 99.989999999999995 109.918 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -153.93 -141.0 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 106.354 -1.721 . . . . 99.989999999999995 106.354 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -63.93 109.81 1.9 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.164 -1.791 . . . . 99.989999999999995 106.164 160.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.66 108.14 1.27 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.914 0.886 . . . . 99.989999999999995 112.027 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.66 -1.83 6.6 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.609 2.872 . . . . 99.989999999999995 112.556 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.438 HD21 ' HG3' ' A' ' 74' ' ' GLN . 94.5 mt -75.62 90.45 2.8 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 123.412 0.685 . . . . 99.989999999999995 109.408 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -98.43 103.31 15.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.942 -0.762 . . . . 99.989999999999995 108.942 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.1 pt -73.76 100.24 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-O 122.124 0.964 . . . . 99.989999999999995 110.926 -174.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -88.74 -178.69 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.976 -1.011 . . . . 99.989999999999995 110.364 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.21 72.47 10.16 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.176 0.59 . . . . 99.989999999999995 110.642 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -86.28 134.67 33.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.548 -0.751 . . . . 99.989999999999995 109.363 174.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -71.94 90.64 1.15 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.485 0.714 . . . . 99.989999999999995 109.606 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -91.37 141.41 28.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.216 1.006 . . . . 99.989999999999995 110.648 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 102.44 45.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.514 0.726 . . . . 99.989999999999995 109.596 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.38 2.198 0 C-N-CA 123.206 2.604 . . . . 99.989999999999995 112.766 175.454 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.046 -0.724 . . . . 99.989999999999995 109.046 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -84.21 146.58 27.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.038 0.535 . . . . 99.989999999999995 109.899 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -157.65 148.95 21.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.992 0.917 . . . . 99.989999999999995 109.414 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -155.28 176.41 12.6 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.424 0.63 . . . . 99.989999999999995 111.184 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -130.16 -177.81 4.47 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.747 1.219 . . . . 99.989999999999995 107.981 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -80.47 79.21 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.805 -1.183 . . . . 99.989999999999995 107.805 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 m -109.1 -174.59 2.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.274 -1.33 . . . . 99.989999999999995 113.001 -162.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -71.95 141.57 49.44 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.441 -1.318 . . . . 99.989999999999995 107.441 161.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' MET . . . . . 0.501 ' HE1' HG12 ' A' ' 82' ' ' ILE . 24.6 ptt? -67.1 150.34 49.32 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 109.907 -0.405 . . . . 99.989999999999995 109.907 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.452 HG21 HE21 ' A' ' 74' ' ' GLN . 34.7 m -57.27 136.36 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.945 0.898 . . . . 99.989999999999995 110.861 -175.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.586 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.17 9.62 61.86 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 118.855 -0.97 . . . . 99.989999999999995 114.115 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.574 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.7 t0 -55.11 114.92 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.784 0.834 . . . . 99.989999999999995 111.645 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.561 HG21 ' HB3' ' A' ' 61' ' ' PRO . 3.7 m -74.82 107.59 7.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.307 -0.627 . . . . 99.989999999999995 109.307 -175.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.31 165.49 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.46 0.704 . . . . 99.989999999999995 110.948 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.576 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -116.53 131.27 56.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.411 1.084 . . . . 99.989999999999995 108.188 172.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.568 HG21 HG23 ' A' ' 56' ' ' VAL . 58.2 t -107.35 110.27 31.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.887 -1.153 . . . . 99.989999999999995 107.887 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.75 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 59.4 ttp180 -85.5 106.08 16.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 99.989999999999995 110.714 -174.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -92.65 139.37 30.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.707 1.203 . . . . 99.989999999999995 111.183 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -72.89 95.08 1.91 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.726 -0.842 . . . . 99.989999999999995 108.726 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -67.61 -36.04 80.09 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.577 -0.897 . . . . 99.989999999999995 108.577 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.485 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -140.29 147.71 40.32 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.275 1.43 . . . . 99.989999999999995 107.544 167.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.02 -47.71 19.92 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.249 0.62 . . . . 99.989999999999995 111.095 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -77.99 -20.3 52.86 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.279 0.474 . . . . 99.989999999999995 112.279 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.485 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 40.8 mt -95.87 161.03 14.18 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.691 -0.485 . . . . 99.989999999999995 109.691 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.443 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 38.2 mt-10 -67.63 131.71 92.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.018 0.527 . . . . 99.989999999999995 111.213 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.573 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 2.7 Cg_exo -74.35 153.73 45.39 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.197 2.598 . . . . 99.989999999999995 113.018 -171.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -98.06 123.94 42.33 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.144 0.978 . . . . 99.989999999999995 109.925 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.75 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 69.0 p-90 -73.91 142.25 45.97 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.359 -0.608 . . . . 99.989999999999995 109.359 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.29 143.83 50.77 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.325 -0.991 . . . . 99.989999999999995 108.325 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.576 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 171.01 -173.87 44.72 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.683 -0.77 . . . . 99.989999999999995 113.555 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -88.02 115.98 3.22 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 118.446 1.123 . . . . 99.989999999999995 113.099 4.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -76.59 166.49 23.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.781 0.833 . . . . 99.989999999999995 110.672 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.586 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 69.4 p -129.96 111.42 12.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.983 0.513 . . . . 99.989999999999995 110.701 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.574 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 40.1 t -71.97 129.42 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 108.724 -0.843 . . . . 99.989999999999995 108.724 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.411 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 76.9 mt -105.77 -33.56 7.96 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.787 0.835 . . . . 99.989999999999995 109.789 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.59 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.8 tp -146.5 152.2 38.6 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.422 -0.808 . . . . 99.989999999999995 110.019 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -132.02 128.53 38.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.123 0.969 . . . . 99.989999999999995 108.985 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -123.56 162.88 37.89 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.501 1.52 . . . . 99.989999999999995 107.895 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.35 108.44 0.15 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.928 2.418 . . . . 99.989999999999995 113.777 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 m 73.98 0.02 3.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.854 1.662 . . . . 99.989999999999995 113.01 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -133.99 124.67 26.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.426 0.69 . . . . 99.989999999999995 110.119 -173.693 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.75 121.6 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 99.989999999999995 109.269 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.59 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.2 tttt -84.91 108.61 17.63 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 107.328 -1.36 . . . . 99.989999999999995 107.328 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.529 HG23 HG21 ' A' ' 34' ' ' VAL . 57.3 t -117.51 146.39 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.578 -1.192 . . . . 99.989999999999995 109.482 -171.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.99 137.36 47.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.586 0.754 . . . . 99.989999999999995 109.558 173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.51 4.49 80.1 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.666 0.604 . . . . 99.989999999999995 112.784 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.458 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -117.13 147.91 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.62 1.168 . . . . 99.989999999999995 109.292 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.41 -51.41 64.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.996 0.919 . . . . 99.989999999999995 112.145 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.06 -57.59 0.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.589 0.356 . . . . 99.989999999999995 111.267 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 14.8 m-90 -142.16 157.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.633 0.773 . . . . 99.989999999999995 110.947 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.458 HG12 HG21 ' A' ' 47' ' ' ILE . 34.8 mm -123.13 134.82 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.579 1.152 . . . . 99.989999999999995 108.454 168.366 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -61.49 113.47 2.69 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 108.034 -1.098 . . . . 99.989999999999995 108.034 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.61 -19.85 4.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.188 1.551 . . . . 99.989999999999995 115.188 -163.515 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.77 -29.85 69.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.73 0.812 . . . . 99.989999999999995 112.772 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -71.19 -24.72 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.252 0.621 . . . . 99.989999999999995 111.579 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.568 HG23 HG21 ' A' ' 16' ' ' VAL . 98.4 t -96.6 138.27 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.283 0.633 . . . . 99.989999999999995 110.678 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -134.67 143.42 47.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.638 -1.245 . . . . 99.989999999999995 107.638 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.994 0.518 . . . . 99.989999999999995 110.79 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.26 26.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.531 0.732 . . . . 99.989999999999995 109.397 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -101.46 104.25 32.64 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.38 0.672 . . . . 99.989999999999995 109.248 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.561 ' HB3' HG21 ' A' ' 13' ' ' THR . 36.2 Cg_endo -89.12 -5.86 5.64 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.814 2.343 . . . . 99.989999999999995 112.636 174.906 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.75 -40.82 1.68 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 110.058 -1.217 . . . . 99.989999999999995 110.058 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.54 144.4 3.94 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 112.11 -0.396 . . . . 99.989999999999995 112.11 175.256 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -168.33 50.13 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.678 -0.512 . . . . 99.989999999999995 113.372 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.62 155.17 31.36 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.133 2.555 . . . . 99.989999999999995 112.898 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.466 ' HB3' HG23 ' A' ' 33' ' ' THR . 23.2 t -83.6 -47.45 11.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.314 0.646 . . . . 99.989999999999995 109.333 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -83.05 167.74 17.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.523 0.729 . . . . 99.989999999999995 111.0 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.56 136.65 34.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.641 -0.874 . . . . 99.989999999999995 108.641 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.1 28.58 0.6 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.134 0.974 . . . . 99.989999999999995 112.63 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.8 p -73.07 -34.42 66.23 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.77 0.828 . . . . 99.989999999999995 111.308 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -68.04 110.65 4.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.963 0.905 . . . . 99.989999999999995 111.554 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 75' ' ' ARG . 98.2 mtt180 -84.0 62.2 6.89 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.912 0.885 . . . . 99.989999999999995 110.053 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.9 t -80.15 -41.9 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.608 -1.256 . . . . 99.989999999999995 107.608 168.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.452 HE21 HG21 ' A' ' 10' ' ' VAL . 19.4 pt20 -85.23 11.11 10.64 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.329 -1.305 . . . . 99.989999999999995 113.235 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 13.4 ptm180 -58.36 120.41 8.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.45 0.7 . . . . 99.989999999999995 111.921 -172.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -157.12 -168.83 2.75 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.401 0.68 . . . . 99.989999999999995 109.616 -171.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -65.98 -43.39 87.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.499 0.72 . . . . 99.989999999999995 109.862 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -122.29 145.49 44.47 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.171 . . . . 99.989999999999995 109.338 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.44 149.21 62.2 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.373 2.049 . . . . 99.989999999999995 110.654 169.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 mt -77.49 171.2 15.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.332 0.653 . . . . 99.989999999999995 109.716 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -138.21 143.48 40.18 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.878 0.371 . . . . 99.989999999999995 111.131 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.501 HG12 ' HE1' ' A' ' 9' ' ' MET . 27.2 pt -123.22 154.26 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.337 1.055 . . . . 99.989999999999995 108.651 170.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -131.59 94.08 3.46 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.458 -0.941 . . . . 99.989999999999995 108.458 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.95 93.07 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.692 -0.855 . . . . 99.989999999999995 108.692 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -70.34 141.85 52.24 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.366 -0.833 . . . . 99.989999999999995 110.373 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -74.01 94.71 2.4 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.989 0.424 . . . . 99.989999999999995 110.438 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.83 142.55 36.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.717 -0.674 . . . . 99.989999999999995 109.776 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.47 123.4 80.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.713 -0.661 . . . . 99.989999999999995 109.686 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 122.935 2.423 . . . . 99.989999999999995 111.952 -175.334 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.032 -0.359 . . . . 99.989999999999995 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -80.03 91.3 5.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.187 -0.672 . . . . 99.989999999999995 109.187 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -151.13 128.63 11.4 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.403 -0.591 . . . . 99.989999999999995 109.403 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -139.65 173.33 11.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.493 1.117 . . . . 99.989999999999995 109.286 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -147.18 170.24 17.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.533 0.733 . . . . 99.989999999999995 110.67 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.538 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 23.3 m-70 -74.77 93.32 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.872 -1.058 . . . . 99.989999999999995 108.24 171.422 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -113.07 -176.68 2.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.48 0.657 . . . . 99.989999999999995 111.511 -168.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.65 163.14 25.71 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 114.508 -1.224 . . . . 99.989999999999995 108.402 169.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -49.02 136.9 13.82 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.643 0.777 . . . . 99.989999999999995 110.567 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.21 140.06 20.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 N-CA-C 109.211 -0.663 . . . . 99.989999999999995 109.211 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.742 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 82.9 11.14 81.97 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-O 118.657 -1.079 . . . . 99.989999999999995 113.176 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.471 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 53.2 t0 -50.13 119.86 3.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.688 0.744 . . . . 99.989999999999995 110.438 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.482 HG22 ' HB2' ' A' ' 59' ' ' ALA . 35.3 m -73.66 110.86 8.28 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.693 -0.685 . . . . 99.989999999999995 109.259 -169.591 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.13 157.25 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.057 0.943 . . . . 99.989999999999995 110.279 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.506 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 30.7 m0 -101.2 143.11 31.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.279 -1.008 . . . . 99.989999999999995 108.279 168.465 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.91 112.95 42.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 N-CA-C 109.086 -0.709 . . . . 99.989999999999995 109.086 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.2 ttm180 -65.6 109.32 2.34 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.9 1.68 . . . . 99.989999999999995 110.745 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -119.32 142.53 48.03 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.175 0.99 . . . . 99.989999999999995 110.169 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 0.2 OUTLIER -77.46 -78.32 0.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.869 0.467 . . . . 99.989999999999995 110.221 -178.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 56.08 22.44 5.95 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.366 1.066 . . . . 99.989999999999995 111.944 -168.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 p -144.26 142.97 30.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.012 1.325 . . . . 99.989999999999995 108.281 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.83 -35.16 20.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.797 0.439 . . . . 99.989999999999995 111.974 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -131.12 -29.57 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.083 0.553 . . . . 99.989999999999995 111.347 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.16 157.32 29.03 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.556 0.217 . . . . 99.989999999999995 110.592 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.87 144.76 96.69 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.892 0.877 . . . . 99.989999999999995 112.122 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.4 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 57.3 Cg_endo -69.19 114.41 3.6 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.775 2.317 . . . . 99.989999999999995 111.643 176.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -93.92 128.72 40.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.017 1.327 . . . . 99.989999999999995 110.447 -171.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 61.9 p-90 -76.08 151.69 37.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.657 0.383 . . . . 99.989999999999995 110.878 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -141.07 163.76 32.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.1 0.56 . . . . 99.989999999999995 109.743 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.412 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -167.93 -162.14 19.19 Favored Glycine 0 CA--C 1.538 1.471 0 N-CA-C 110.985 -0.846 . . . . 99.989999999999995 110.985 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.36 114.55 3.1 Favored 'Cis proline' 0 C--N 1.368 1.586 0 CA-C-N 119.365 1.583 . . . . 99.989999999999995 112.973 -2.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.452 ' HB3' HG11 ' A' ' 44' ' ' VAL . 74.5 m-85 -77.67 166.93 22.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.431 0.693 . . . . 99.989999999999995 110.072 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.742 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 17.2 p -140.33 111.87 7.34 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.285 0.634 . . . . 99.989999999999995 111.283 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.48 HG23 HG21 ' A' ' 44' ' ' VAL . 60.0 t -84.03 125.43 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 122.888 0.475 . . . . 99.989999999999995 110.31 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.54 ' HB3' HG21 ' A' ' 73' ' ' VAL . 81.0 mt -98.97 -45.47 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.746 0.818 . . . . 99.989999999999995 110.262 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.526 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 48.8 tp -132.58 153.71 50.74 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.438 -0.801 . . . . 99.989999999999995 109.486 -173.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.477 HG23 HD23 ' A' ' 42' ' ' LEU . 60.5 p -125.65 148.6 48.94 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.148 0.579 . . . . 99.989999999999995 110.027 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' THR . . . . . 0.429 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 40.3 p -140.03 165.93 27.32 Favored Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 125.372 1.469 . . . . 99.989999999999995 107.869 175.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . 0.429 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.7 Cg_endo -51.92 108.18 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.572 2.182 . . . . 99.989999999999995 112.993 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 64.25 20.91 12.36 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.512 1.525 . . . . 99.989999999999995 112.581 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.57 129.44 11.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.167 -0.679 . . . . 99.989999999999995 109.167 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.676 HD11 HG11 ' A' ' 56' ' ' VAL . 33.8 mt -112.95 130.72 56.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.963 -0.46 . . . . 99.989999999999995 109.984 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -84.95 109.23 18.01 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.859 -0.793 . . . . 99.989999999999995 108.859 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.494 ' HB ' HG13 ' A' ' 47' ' ' ILE . 86.7 t -97.26 149.05 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 113.984 -1.462 . . . . 99.989999999999995 109.277 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.45 130.2 42.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.885 0.874 . . . . 99.989999999999995 111.008 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.88 -7.31 70.22 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.051 -0.522 . . . . 99.989999999999995 112.959 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.494 HG13 ' HB ' ' A' ' 44' ' ' VAL . 49.0 mm -90.53 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.701 0.8 . . . . 99.989999999999995 110.056 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.75 -46.99 81.07 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.935 0.894 . . . . 99.989999999999995 111.813 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.79 -58.38 0.17 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.074 0.398 . . . . 99.989999999999995 112.074 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -143.28 156.92 44.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.888 0.475 . . . . 99.989999999999995 111.806 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 38.6 mm -120.44 118.24 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.109 1.364 . . . . 99.989999999999995 107.346 165.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -68.54 151.71 46.39 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.705 0.802 . . . . 99.989999999999995 109.268 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.3 61.02 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 115.846 1.795 . . . . 99.989999999999995 115.846 -161.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.57 -19.79 60.79 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.448 0.536 . . . . 99.989999999999995 112.448 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.27 -14.96 58.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.721 0.409 . . . . 99.989999999999995 110.446 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.676 HG11 HD11 ' A' ' 42' ' ' LEU . 40.5 t -99.22 137.75 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.992 0.425 . . . . 99.989999999999995 110.068 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.426 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 51.4 mtpt -136.38 137.52 40.62 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.379 1.072 . . . . 99.989999999999995 108.208 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 136.58 57.48 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.857 0.463 . . . . 99.989999999999995 110.491 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.482 ' HB2' HG22 ' A' ' 13' ' ' THR . . . -122.5 158.46 29.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.111 0.965 . . . . 99.989999999999995 110.868 -175.373 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -93.8 112.55 57.43 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 99.989999999999995 109.847 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.94 -15.14 7.09 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.565 2.177 . . . . 99.989999999999995 113.707 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.4 37.77 95.34 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 123.34 0.4 . . . . 99.989999999999995 112.175 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.33 -112.15 4.31 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 110.898 -0.881 . . . . 99.989999999999995 110.898 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.97 65.54 2.89 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-O 119.498 -0.612 . . . . 99.989999999999995 114.317 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -98.12 29.07 0.15 Allowed 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.823 3.015 . . . . 99.989999999999995 112.855 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.4 p -63.73 -30.67 71.74 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.328 0.862 . . . . 99.989999999999995 113.328 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -149.47 -21.88 0.28 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.303 0.483 . . . . 99.989999999999995 112.303 -170.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.55 -9.5 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.983 0.734 . . . . 99.989999999999995 112.983 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.46 -4.54 34.35 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.564 0.745 . . . . 99.989999999999995 112.201 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.7 m -64.29 -45.39 88.19 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.998 0.519 . . . . 99.989999999999995 110.134 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 7.3 m0 50.18 40.41 21.94 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.164 0.986 . . . . 99.989999999999995 112.059 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -59.7 -34.44 72.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.432 -0.804 . . . . 99.989999999999995 112.795 -170.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.54 HG21 ' HB3' ' A' ' 35' ' ' LEU . 46.5 t -76.75 -31.49 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.069 0.548 . . . . 99.989999999999995 110.067 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.504 ' HG3' HD22 ' A' ' 80' ' ' LEU . 31.1 mm-40 -86.8 -2.68 58.75 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.596 -0.729 . . . . 99.989999999999995 111.723 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.404 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 2.9 mmp_? -66.48 -25.05 66.52 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.684 0.394 . . . . 99.989999999999995 111.716 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.4 m -71.52 -8.11 51.85 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.561 0.949 . . . . 99.989999999999995 113.561 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.38 -52.13 0.09 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.133 -0.691 . . . . 99.989999999999995 109.133 -177.828 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 t30 70.79 74.92 0.25 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.402 1.481 . . . . 99.989999999999995 110.446 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.538 ' HG3' ' HA ' ' A' ' 6' ' ' HIS . 42.7 Cg_endo -91.27 20.55 0.91 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.44 2.76 . . . . 99.989999999999995 111.574 171.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.504 HD22 ' HG3' ' A' ' 74' ' ' GLN . 92.0 mt -75.72 100.32 4.65 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.425 1.09 . . . . 99.989999999999995 110.537 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -72.59 125.62 27.91 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.411 -1.268 . . . . 99.989999999999995 109.565 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.4 pt -72.84 79.94 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 122.139 0.971 . . . . 99.989999999999995 110.417 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -73.85 171.14 13.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.961 -1.018 . . . . 99.989999999999995 111.406 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.38 65.7 7.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.997 0.904 . . . . 99.989999999999995 110.377 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m -109.72 94.92 5.28 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.667 -1.152 . . . . 99.989999999999995 108.053 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.15 107.27 1.51 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.277 -0.874 . . . . 99.989999999999995 110.733 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.82 143.62 54.52 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.172 -0.922 . . . . 99.989999999999995 110.89 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.54 87.17 45.23 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.654 -0.869 . . . . 99.989999999999995 108.654 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 C--N 1.375 1.94 0 C-N-CA 123.205 2.603 . . . . 99.989999999999995 110.9 -178.551 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.04 0.448 . . . . 99.989999999999995 110.57 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.3 101.02 13.14 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.809 -0.811 . . . . 99.989999999999995 108.809 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -134.75 158.4 44.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.623 0.769 . . . . 99.989999999999995 110.106 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -151.06 155.16 38.41 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.309 1.044 . . . . 99.989999999999995 109.894 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -161.86 43.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.454 -0.943 . . . . 99.989999999999995 108.454 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.479 ' HB2' ' HG2' ' A' ' 77' ' ' GLN . 48.6 t-80 67.08 152.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.462 -1.245 . . . . 99.989999999999995 110.865 -170.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.5 p -158.89 179.56 8.97 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.481 0.657 . . . . 99.989999999999995 111.717 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -69.32 161.9 28.36 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 114.3 -1.318 . . . . 99.989999999999995 107.714 159.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -54.02 132.63 42.84 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.674 -0.491 . . . . 99.989999999999995 109.674 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.618 HG12 ' HB ' ' A' ' 73' ' ' VAL . 3.3 m -63.45 106.27 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.128 -0.693 . . . . 99.989999999999995 109.128 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.443 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.08 9.08 12.42 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.061 -0.855 . . . . 99.989999999999995 113.166 -167.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.473 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 52.7 t0 -62.12 132.1 51.72 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 117.747 0.773 . . . . 99.989999999999995 111.434 -175.259 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.446 HG21 ' HB2' ' A' ' 59' ' ' ALA . 19.2 m -82.44 106.56 14.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.478 0.711 . . . . 99.989999999999995 110.825 -173.709 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 24.6 m -131.76 -177.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.591 1.156 . . . . 99.989999999999995 109.874 177.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.464 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.6 m0 -128.1 154.22 45.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.411 1.484 . . . . 99.989999999999995 107.542 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.8 t -108.13 107.92 23.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.831 -1.174 . . . . 99.989999999999995 107.831 171.762 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.648 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 50.9 ttp180 -82.43 94.16 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.583 1.153 . . . . 99.989999999999995 109.422 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -77.31 112.16 13.73 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.432 -0.581 . . . . 99.989999999999995 109.432 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.413 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 14.8 t-80 -76.92 130.95 38.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.199 -0.667 . . . . 99.989999999999995 109.199 174.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -79.38 -155.51 0.1 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.328 -0.619 . . . . 99.989999999999995 109.328 173.297 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' THR . . . . . 0.488 HG21 ' H ' ' A' ' 22' ' ' LYS . 2.0 m -68.34 173.6 4.73 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.766 -0.584 . . . . 99.989999999999995 111.338 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.488 ' H ' HG21 ' A' ' 21' ' ' THR . 43.0 mtmt -52.36 -50.4 62.45 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.235 1.014 . . . . 99.989999999999995 112.722 -174.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -81.74 2.05 31.61 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.835 -0.621 . . . . 99.989999999999995 111.647 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -112.71 157.39 21.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.04 0.936 . . . . 99.989999999999995 110.359 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -94.43 162.55 25.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 124.726 1.211 . . . . 99.989999999999995 110.756 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.489 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 78.1 Cg_endo -83.2 172.06 10.93 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.604 2.203 . . . . 99.989999999999995 113.756 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -154.6 129.59 9.49 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.22 1.008 . . . . 99.989999999999995 108.8 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.648 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.3 p-90 -86.84 152.59 22.34 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.033 0.444 . . . . 99.989999999999995 111.679 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.518 ' HZ1' ' HB2' ' A' ' 29' ' ' LYS . 10.5 mtmp? -136.09 164.05 28.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.745 1.218 . . . . 99.989999999999995 107.916 167.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.464 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.09 -159.98 32.71 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.563 -0.576 . . . . 99.989999999999995 112.608 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.74 120.05 6.52 Favored 'Cis proline' 0 C--N 1.376 2.02 0 CA-C-N 119.144 1.472 . . . . 99.989999999999995 112.964 -2.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.41 ' HB3' HG13 ' A' ' 44' ' ' VAL . 84.5 m-85 -81.98 154.39 25.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.987 0.915 . . . . 99.989999999999995 109.666 172.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.471 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 40.9 p -114.6 110.75 20.27 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.737 0.415 . . . . 99.989999999999995 111.442 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.481 HG22 HG23 ' A' ' 44' ' ' VAL . 79.4 t -70.69 130.71 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.153 0.581 . . . . 99.989999999999995 109.498 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.584 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 62.4 mt -103.43 -58.66 1.84 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.043 0.937 . . . . 99.989999999999995 109.266 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.564 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 59.6 tp -123.65 155.97 36.75 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.215 -0.902 . . . . 99.989999999999995 109.659 -172.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.484 HG23 HD22 ' A' ' 42' ' ' LEU . 69.2 p -125.97 130.05 50.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.905 0.882 . . . . 99.989999999999995 109.724 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -140.07 95.28 8.53 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 124.247 1.019 . . . . 99.989999999999995 108.976 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -27.28 127.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 1 C-N-CA 125.632 4.221 . . . . 99.989999999999995 116.471 -166.268 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.8 m 86.79 -12.22 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.499 1.919 . . . . 99.989999999999995 111.65 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB3' ' HB3' ' A' ' 50' ' ' TRP . . . -152.23 149.77 29.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.762 -0.586 . . . . 99.989999999999995 110.861 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.659 HD12 HG12 ' A' ' 56' ' ' VAL . 38.9 mt -120.42 134.45 55.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.536 -0.913 . . . . 99.989999999999995 108.536 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.564 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.8 tttm -83.47 108.9 16.92 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.604 -0.887 . . . . 99.989999999999995 108.604 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.481 HG23 HG22 ' A' ' 34' ' ' VAL . 63.0 t -108.86 135.9 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.627 1.171 . . . . 99.989999999999995 109.512 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.467 ' HB3' ' HG1' ' A' ' 33' ' ' THR . 23.7 t70 -68.02 143.27 55.62 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.607 0.763 . . . . 99.989999999999995 110.646 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.59 -19.17 49.49 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.366 -0.379 . . . . 99.989999999999995 112.394 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -94.0 159.06 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.254 1.022 . . . . 99.989999999999995 110.01 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.44 -52.13 60.42 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 123.841 0.856 . . . . 99.989999999999995 111.538 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.12 -57.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.271 0.357 . . . . 99.989999999999995 111.666 169.391 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' HB3' ' HB3' ' A' ' 41' ' ' ALA . 19.1 m-90 -136.47 134.76 37.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.902 0.481 . . . . 99.989999999999995 111.74 -173.098 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.7 mm -94.72 125.24 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.26 -1.015 . . . . 99.989999999999995 108.26 166.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -64.28 136.62 57.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.548 -1.279 . . . . 99.989999999999995 107.548 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -28.65 64.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.793 1.405 . . . . 99.989999999999995 114.793 -160.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.9 27.19 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.451 0.537 . . . . 99.989999999999995 112.451 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -109.57 9.13 25.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.933 0.893 . . . . 99.989999999999995 110.201 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.659 HG12 HD12 ' A' ' 42' ' ' LEU . 37.2 t -105.86 125.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.597 -0.52 . . . . 99.989999999999995 109.597 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -125.24 110.94 14.65 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.425 -0.954 . . . . 99.989999999999995 108.425 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.414 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -58.98 117.46 4.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.53 0.732 . . . . 99.989999999999995 110.248 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.446 ' HB2' HG21 ' A' ' 13' ' ' THR . . . -81.42 154.05 26.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.674 -0.491 . . . . 99.989999999999995 109.674 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -103.47 97.5 10.52 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.36 0.664 . . . . 99.989999999999995 109.287 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -88.92 -3.39 6.28 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.572 2.181 . . . . 99.989999999999995 112.87 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.78 -75.86 0.87 Allowed Glycine 0 C--N 1.354 1.565 0 N-CA-C 110.56 -1.016 . . . . 99.989999999999995 110.56 -168.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.01 -80.66 1.12 Allowed Glycine 0 C--N 1.345 1.076 0 N-CA-C 110.219 -1.153 . . . . 99.989999999999995 110.219 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.64 -137.23 9.52 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.485 -1.175 . . . . 99.989999999999995 111.815 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 110.88 3.07 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.328 2.018 . . . . 99.989999999999995 110.769 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.5 p -65.71 -27.38 68.29 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.326 0.65 . . . . 99.989999999999995 111.387 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -82.16 9.84 7.88 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.584 -0.735 . . . . 99.989999999999995 111.316 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 49.34 40.82 19.33 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.058 1.743 . . . . 99.989999999999995 113.197 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.56 83.58 0.6 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.579 -1.191 . . . . 99.989999999999995 110.708 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.7 p -110.55 151.16 27.93 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.701 1.2 . . . . 99.989999999999995 108.493 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -67.18 -19.14 65.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.625 0.77 . . . . 99.989999999999995 112.02 -175.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 53.61 29.53 9.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 126.15 1.78 . . . . 99.989999999999995 113.46 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.618 ' HB ' HG12 ' A' ' 10' ' ' VAL . 61.2 t -70.07 -51.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.301 0.641 . . . . 99.989999999999995 109.997 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.446 ' HG2' HD11 ' A' ' 80' ' ' LEU . 5.8 tp-100 -86.55 84.72 7.35 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.414 0.626 . . . . 99.989999999999995 109.871 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -114.5 1.16 14.24 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.04 0.936 . . . . 99.989999999999995 109.506 167.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 m -67.97 -67.87 0.43 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.262 1.025 . . . . 99.989999999999995 110.479 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.479 ' HG2' ' HB2' ' A' ' 6' ' ' HIS . 22.8 tp60 -85.89 80.26 8.96 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.362 -0.977 . . . . 99.989999999999995 108.362 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.05 140.43 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.842 1.657 . . . . 99.989999999999995 111.807 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.8 107.58 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.878 1.719 . . . . 99.989999999999995 110.264 166.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.446 HD11 ' HG2' ' A' ' 74' ' ' GLN . 67.5 mt -66.81 145.24 55.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.569 0.747 . . . . 99.989999999999995 111.816 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.1 140.93 57.76 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.34 1.025 . . . . 99.989999999999995 110.663 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.41 7.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.253 1.021 . . . . 99.989999999999995 112.392 -173.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 73.26 -5.04 2.04 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.865 1.666 . . . . 99.989999999999995 112.483 171.704 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -78.84 156.52 28.66 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.22 0.533 . . . . 99.989999999999995 110.775 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 t -76.24 -161.15 0.17 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.661 1.184 . . . . 99.989999999999995 109.454 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -60.3 137.61 58.1 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-N 118.989 0.813 . . . . 99.989999999999995 110.773 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.57 147.04 25.76 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.211 -1.033 . . . . 99.989999999999995 108.211 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.11 94.22 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.426 1.09 . . . . 99.989999999999995 109.992 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo . . . . . 0 C--N 1.379 2.173 0 C-N-CA 122.852 2.368 . . . . 99.989999999999995 111.837 -179.551 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.39 -0.596 . . . . 99.989999999999995 109.39 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -136.54 116.03 12.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.064 0.946 . . . . 99.989999999999995 109.02 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -149.9 82.09 1.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.86 0.838 . . . . 99.989999999999995 109.514 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -88.95 141.05 28.82 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.693 0.797 . . . . 99.989999999999995 110.179 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -136.52 177.27 7.98 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.487 0.715 . . . . 99.989999999999995 110.513 -175.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -70.76 91.24 0.82 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.464 -0.939 . . . . 99.989999999999995 108.464 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -118.83 174.14 6.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.821 0.848 . . . . 99.989999999999995 111.228 -172.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -73.49 160.22 32.04 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.504 -0.554 . . . . 99.989999999999995 109.504 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -56.03 133.29 51.72 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.648 0.779 . . . . 99.989999999999995 109.685 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.0 131.12 28.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 122.653 0.381 . . . . 99.989999999999995 110.103 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.667 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.46 11.69 59.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.3 -0.722 . . . . 99.989999999999995 113.342 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.555 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 56.7 t0 -51.52 113.47 0.98 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.855 0.862 . . . . 99.989999999999995 111.314 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.445 HG22 ' HB2' ' A' ' 31' ' ' PRO . 95.5 m -73.11 115.63 12.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.369 0.668 . . . . 99.989999999999995 110.51 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.3 168.74 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.689 1.196 . . . . 99.989999999999995 110.328 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -112.5 130.75 55.89 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.271 -1.011 . . . . 99.989999999999995 108.271 169.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . 0.495 HG22 HG21 ' A' ' 56' ' ' VAL . 70.6 t -110.65 115.41 49.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.238 -0.653 . . . . 99.989999999999995 109.238 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.705 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.9 ttm180 -89.29 123.07 33.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.399 1.479 . . . . 99.989999999999995 110.438 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -120.22 148.41 43.71 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.763 -1.199 . . . . 99.989999999999995 107.763 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.557 ' HA ' ' HB3' ' A' ' 26' ' ' PRO . 7.9 t-160 -61.63 -53.27 58.43 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 122.828 0.451 . . . . 99.989999999999995 111.045 -169.521 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 60.65 13.88 4.6 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.081 0.952 . . . . 99.989999999999995 113.407 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 p -148.32 -179.71 7.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.099 0.96 . . . . 99.989999999999995 110.401 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.81 -53.46 2.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.884 . . . . 99.989999999999995 110.227 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -132.73 15.58 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.823 0.849 . . . . 99.989999999999995 111.492 -172.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.32 179.38 4.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.079 0.551 . . . . 99.989999999999995 110.065 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -72.0 149.8 92.42 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.801 0.84 . . . . 99.989999999999995 111.831 -174.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.557 ' HB3' ' HA ' ' A' ' 19' ' ' HIS . 7.0 Cg_exo -74.64 130.04 13.29 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.072 2.515 . . . . 99.989999999999995 111.22 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -93.59 132.8 37.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.469 -0.567 . . . . 99.989999999999995 109.469 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.705 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.4 p-90 -96.65 156.55 16.3 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.757 0.423 . . . . 99.989999999999995 110.711 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -138.13 172.0 13.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.92 0.888 . . . . 99.989999999999995 109.458 167.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.12 46.27 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 115.391 -0.822 . . . . 99.989999999999995 111.468 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . 0.445 ' HB2' HG22 ' A' ' 13' ' ' THR . 89.4 Cg_endo -88.37 106.28 0.71 Allowed 'Cis proline' 0 C--N 1.368 1.596 0 CA-C-N 119.286 1.543 . . . . 99.989999999999995 112.479 -2.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.426 ' HB3' HG11 ' A' ' 44' ' ' VAL . 53.0 m-85 -64.69 162.03 16.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.552 0.741 . . . . 99.989999999999995 110.384 172.465 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.667 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 14.0 p -134.01 111.14 10.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.009 0.524 . . . . 99.989999999999995 110.748 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 44' ' ' VAL . 21.7 t -81.91 130.1 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.357 0.663 . . . . 99.989999999999995 109.553 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.9 mt -103.56 -32.74 9.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.421 0.689 . . . . 99.989999999999995 110.765 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.7 tp -142.89 143.26 31.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.13 -0.693 . . . . 99.989999999999995 109.13 -172.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.9 p -136.96 132.14 33.96 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.339 0.59 . . . . 99.989999999999995 111.01 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -117.42 164.99 16.88 Favored Pre-proline 0 CA--C 1.57 1.739 0 C-N-CA 126.068 1.747 . . . . 99.989999999999995 108.585 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -48.75 111.44 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.404 2.736 . . . . 99.989999999999995 113.541 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.71 12.24 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.936 1.694 . . . . 99.989999999999995 112.961 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.414 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -136.58 119.64 16.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.523 -0.918 . . . . 99.989999999999995 108.523 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.46 119.23 38.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.166 -1.05 . . . . 99.989999999999995 108.166 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.525 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 81.0 tttt -86.66 106.57 17.7 Favored 'General case' 0 C--O 1.255 1.347 0 N-CA-C 109.222 -0.659 . . . . 99.989999999999995 109.222 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.58 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 38.8 t -91.43 155.33 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 114.378 -1.283 . . . . 99.989999999999995 108.976 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.15 123.21 17.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 99.989999999999995 111.093 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.93 65.67 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.684 -0.689 . . . . 99.989999999999995 113.637 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.8 mm -89.05 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.409 0.684 . . . . 99.989999999999995 110.344 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.09 59.92 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.642 1.177 . . . . 99.989999999999995 112.04 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.19 -56.75 0.14 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.42 0.45 . . . . 99.989999999999995 111.345 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.414 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 20.6 m-90 -144.64 157.08 44.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.11 0.564 . . . . 99.989999999999995 111.173 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 mm -118.11 136.09 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.238 1.015 . . . . 99.989999999999995 108.355 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -64.24 127.94 33.64 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.474 -0.936 . . . . 99.989999999999995 108.474 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.85 -23.11 16.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.86 1.43 . . . . 99.989999999999995 114.86 -164.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.36 81.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.234 0.614 . . . . 99.989999999999995 111.95 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -77.54 2.11 17.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.456 0.702 . . . . 99.989999999999995 112.616 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG21 HG22 ' A' ' 16' ' ' VAL . 61.3 t -120.07 135.65 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.497 -0.557 . . . . 99.989999999999995 109.497 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -127.17 143.34 51.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.831 0.853 . . . . 99.989999999999995 108.865 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.45 122.35 16.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.14 0.576 . . . . 99.989999999999995 110.636 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 156.92 19.62 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.508 0.723 . . . . 99.989999999999995 110.37 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -94.5 116.14 66.07 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.292 1.037 . . . . 99.989999999999995 109.782 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.58 -11.27 9.37 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.93 2.42 . . . . 99.989999999999995 113.442 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.59 -67.76 3.09 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 111.005 -0.838 . . . . 99.989999999999995 111.005 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.01 -105.76 0.25 Allowed Glycine 0 N--CA 1.454 -0.108 0 N-CA-C 109.21 -1.556 . . . . 99.989999999999995 109.21 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.42 62.01 5.21 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.243 -0.754 . . . . 99.989999999999995 114.854 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -86.16 105.46 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.5 2.133 . . . . 99.989999999999995 109.981 171.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -147.97 -82.87 0.12 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.669 0.387 . . . . 99.989999999999995 110.86 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 t -70.77 -24.84 62.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.26 0.624 . . . . 99.989999999999995 111.097 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.562 ' HG2' ' HA3' ' A' ' 11' ' ' GLY . 33.6 mtm180 -73.49 -24.42 60.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.089 0.956 . . . . 99.989999999999995 112.501 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.83 -18.06 58.62 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.374 0.67 . . . . 99.989999999999995 112.553 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.404 HG23 ' NH1' ' A' ' 72' ' ' ARG . 48.4 m -55.97 -51.92 66.0 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.541 1.136 . . . . 99.989999999999995 111.43 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . 0.469 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 10.1 m0 49.4 27.89 2.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.916 1.45 . . . . 99.989999999999995 114.916 174.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.404 ' NH1' HG23 ' A' ' 70' ' ' THR . 14.5 ptt-85 -63.56 -28.51 69.99 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.566 0.95 . . . . 99.989999999999995 113.566 -174.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -78.65 -28.15 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.312 0.577 . . . . 99.989999999999995 109.804 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -81.65 -11.95 58.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.649 0.779 . . . . 99.989999999999995 110.624 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.469 ' HG2' ' O ' ' A' ' 71' ' ' TRP . 3.4 mmp_? -81.89 66.57 7.52 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.468 0.707 . . . . 99.989999999999995 110.11 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -157.93 -76.53 0.08 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.33 1.052 . . . . 99.989999999999995 108.852 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -96.68 -25.55 15.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.895 0.878 . . . . 99.989999999999995 110.042 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.31 83.9 0.2 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.98 1.312 . . . . 99.989999999999995 110.969 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.45 4.24 6.49 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.962 2.441 . . . . 99.989999999999995 112.052 167.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.409 HD13 ' NH2' ' A' ' 75' ' ' ARG . 60.2 mt -75.47 84.08 2.56 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.04 0.936 . . . . 99.989999999999995 110.051 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -84.56 125.11 32.14 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.827 -0.805 . . . . 99.989999999999995 108.827 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.38 121.79 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.79 0.805 . . . . 99.989999999999995 111.3 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -116.99 137.43 52.23 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.6 1.16 . . . . 99.989999999999995 108.678 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.07 82.52 1.27 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.548 -0.908 . . . . 99.989999999999995 108.548 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.5 m -87.03 138.3 31.61 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.063 -1.426 . . . . 99.989999999999995 107.782 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -68.1 84.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.947 0.403 . . . . 99.989999999999995 110.523 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.66 108.12 11.84 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.249 -1.019 . . . . 99.989999999999995 108.249 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.72 80.74 24.43 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.488 0.715 . . . . 99.989999999999995 109.21 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--N 1.377 2.053 0 C-N-CA 122.894 2.396 . . . . 99.989999999999995 112.101 -177.721 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.8 m80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.555 0.217 . . . . 99.989999999999995 110.475 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -110.11 100.87 9.72 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.035 -1.098 . . . . 99.989999999999995 108.035 168.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -76.88 71.62 3.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.931 0.893 . . . . 99.989999999999995 110.861 -171.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -154.45 132.95 12.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.303 1.441 . . . . 99.989999999999995 108.762 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . 0.516 ' NE2' ' HB2' ' A' ' 67' ' ' SER . 11.4 p80 -173.88 86.17 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.666 1.186 . . . . 99.989999999999995 108.62 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -87.35 -25.62 23.78 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.665 -0.647 . . . . 99.989999999999995 109.315 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . 0.475 ' HG ' ' HG2' ' A' ' 81' ' ' LYS . 48.5 m -78.84 -171.15 2.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.551 -1.204 . . . . 99.989999999999995 110.231 165.557 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -68.0 157.36 35.29 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.089 0.555 . . . . 99.989999999999995 111.281 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -135.1 176.77 8.36 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.141 0.976 . . . . 99.989999999999995 109.37 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.57 HG22 HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -71.91 144.6 13.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 108.686 -0.857 . . . . 99.989999999999995 108.686 176.371 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.82 7.81 52.55 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.704 -0.498 . . . . 99.989999999999995 112.92 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . 0.753 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -68.0 110.75 4.05 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.399 0.679 . . . . 99.989999999999995 109.998 -175.757 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -71.31 117.19 12.53 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.301 0.572 . . . . 99.989999999999995 110.049 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.53 -175.67 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.478 1.111 . . . . 99.989999999999995 109.844 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 30.8 m0 -128.63 151.37 49.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.755 1.222 . . . . 99.989999999999995 107.738 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -109.53 104.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.368 -0.975 . . . . 99.989999999999995 108.368 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.699 ' HG2' ' HB2' ' A' ' 26' ' ' PRO . 44.1 ttp180 -88.61 93.62 9.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.579 -1.191 . . . . 99.989999999999995 110.29 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -94.08 128.09 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.905 -0.588 . . . . 99.989999999999995 110.363 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 7.8 t-160 -90.75 114.81 27.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.958 0.903 . . . . 99.989999999999995 109.13 178.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.04 -71.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.164 0.585 . . . . 99.989999999999995 110.738 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.3 p -111.42 153.51 25.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 99.989999999999995 110.126 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.81 -25.61 65.66 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.757 0.823 . . . . 99.989999999999995 111.335 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -66.33 -52.39 47.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.794 0.838 . . . . 99.989999999999995 110.084 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.98 159.38 24.89 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.863 -0.608 . . . . 99.989999999999995 110.623 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.17 154.85 72.42 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.553 0.741 . . . . 99.989999999999995 109.614 172.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.699 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 42.1 Cg_endo -63.82 126.19 16.9 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.482 2.122 . . . . 99.989999999999995 112.208 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -100.06 129.31 46.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.601 0.76 . . . . 99.989999999999995 109.093 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.639 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 66.3 p-90 -93.91 146.64 23.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.615 0.721 . . . . 99.989999999999995 112.156 -177.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -113.42 157.42 21.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.826 -1.534 . . . . 99.989999999999995 108.378 166.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.08 170.96 33.86 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 124.232 0.957 . . . . 99.989999999999995 110.934 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.48 161.25 76.77 Favored 'Cis proline' 0 C--N 1.366 1.491 0 CA-C-N 119.355 1.577 . . . . 99.989999999999995 111.73 -9.166 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.01 176.49 8.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.462 1.105 . . . . 99.989999999999995 110.196 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 t -152.27 111.88 3.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.63 -0.714 . . . . 99.989999999999995 111.372 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.753 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 89.9 t -67.83 124.23 22.83 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 C-N-CA 123.887 0.875 . . . . 99.989999999999995 109.345 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.95 -18.37 14.06 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.166 -0.924 . . . . 99.989999999999995 110.736 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.609 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 36.2 tp -145.73 138.65 25.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.89 0.476 . . . . 99.989999999999995 110.055 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -107.35 137.15 45.92 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.207 1.003 . . . . 99.989999999999995 108.597 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 m -141.16 148.83 53.16 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.115 -1.069 . . . . 99.989999999999995 108.115 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.74 108.4 0.15 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.125 1.883 . . . . 99.989999999999995 112.949 170.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m 70.45 17.74 6.79 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.516 1.526 . . . . 99.989999999999995 112.177 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 50' ' ' TRP . . . -154.59 144.81 21.97 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.07 -0.514 . . . . 99.989999999999995 110.645 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.04 121.24 23.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.66 -0.867 . . . . 99.989999999999995 108.66 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.609 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 26.9 ttpp -85.44 109.38 18.41 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.081 -1.081 . . . . 99.989999999999995 108.081 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.405 HG23 HG22 ' A' ' 34' ' ' VAL . 95.5 t -103.75 155.62 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 125.066 1.346 . . . . 99.989999999999995 108.902 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.04 121.26 11.99 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.299 0.639 . . . . 99.989999999999995 110.994 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.95 24.63 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.862 -0.608 . . . . 99.989999999999995 112.879 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.402 HG23 HG12 ' A' ' 51' ' ' ILE . 33.9 mm -76.72 147.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.702 0.801 . . . . 99.989999999999995 110.594 -176.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.38 74.11 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 123.688 0.618 . . . . 99.989999999999995 111.607 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 -58.21 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.183 0.438 . . . . 99.989999999999995 112.183 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . 0.573 ' HB3' ' HB2' ' A' ' 41' ' ' ALA . 21.2 m-90 -146.42 145.75 30.35 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.219 0.607 . . . . 99.989999999999995 112.206 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.402 HG12 HG23 ' A' ' 47' ' ' ILE . 28.3 mm -106.99 125.68 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.824 0.85 . . . . 99.989999999999995 108.899 168.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.36 122.06 12.34 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.266 -1.013 . . . . 99.989999999999995 108.266 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.41 -19.19 8.42 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.025 1.491 . . . . 99.989999999999995 115.025 -162.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.58 9.84 2.03 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.578 0.751 . . . . 99.989999999999995 112.363 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.27 18.63 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 99.989999999999995 109.909 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.86 125.33 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.724 0.409 . . . . 99.989999999999995 110.149 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.468 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 5.7 mtpm? -108.6 110.96 22.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.976 -0.749 . . . . 99.989999999999995 108.976 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.518 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.04 120.5 14.38 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.234 0.614 . . . . 99.989999999999995 111.448 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.25 137.95 47.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.634 0.773 . . . . 99.989999999999995 110.612 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -93.05 113.39 59.75 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.365 0.666 . . . . 99.989999999999995 110.046 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -90.12 -0.08 5.5 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.053 2.502 . . . . 99.989999999999995 113.588 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.06 -103.46 1.48 Allowed Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.347 -0.701 . . . . 99.989999999999995 111.347 -170.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.61 92.81 1.79 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.462 -0.655 . . . . 99.989999999999995 111.462 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.6 -151.66 7.71 Favored Glycine 0 CA--C 1.544 1.903 0 CA-C-O 119.292 -0.726 . . . . 99.989999999999995 113.889 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -57.31 -27.01 73.34 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.732 2.955 . . . . 99.989999999999995 114.731 -174.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 m 62.85 22.96 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.097 0.959 . . . . 99.989999999999995 113.241 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.516 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 8.5 t 67.27 13.8 9.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.19 1.396 . . . . 99.989999999999995 111.674 -175.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -84.81 -42.76 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.611 0.764 . . . . 99.989999999999995 109.02 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -92.82 19.65 7.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.366 -0.834 . . . . 99.989999999999995 111.369 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.57 HG22 HG22 ' A' ' 10' ' ' VAL . 75.6 p -106.45 106.08 16.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.095 0.558 . . . . 99.989999999999995 110.43 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -86.3 -80.25 0.24 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.201 0.601 . . . . 99.989999999999995 109.817 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -166.79 106.93 0.63 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.628 0.771 . . . . 99.989999999999995 110.482 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.7 t -137.9 -63.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.612 0.765 . . . . 99.989999999999995 109.185 170.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -121.76 41.4 3.38 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.659 0.742 . . . . 99.989999999999995 110.688 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -87.97 59.36 5.29 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 122.126 0.965 . . . . 99.989999999999995 108.569 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 m -89.03 177.61 6.61 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.23 -1.35 . . . . 99.989999999999995 111.76 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -69.81 -33.77 72.79 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.772 -0.649 . . . . 99.989999999999995 109.608 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -111.89 112.84 52.89 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 108.838 -0.801 . . . . 99.989999999999995 108.838 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.32 135.23 28.61 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.808 2.339 . . . . 99.989999999999995 111.123 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.07 99.2 6.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.812 0.845 . . . . 99.989999999999995 112.134 -166.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.475 ' HG2' ' HG ' ' A' ' 7' ' ' SER . 45.4 mtpt -81.36 91.38 6.25 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.173 0.589 . . . . 99.989999999999995 109.956 174.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.506 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 45.6 pt -76.74 139.91 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 109.665 -0.494 . . . . 99.989999999999995 109.665 168.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -108.81 32.56 4.8 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.703 0.801 . . . . 99.989999999999995 109.413 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . 0.506 ' HG ' ' HB ' ' A' ' 82' ' ' ILE . 74.9 mt -81.13 68.75 7.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.19 0.996 . . . . 99.989999999999995 110.764 -172.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.6 p -114.11 76.29 0.98 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.663 1.185 . . . . 99.989999999999995 108.723 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -90.86 -41.16 11.34 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.722 0.409 . . . . 99.989999999999995 111.132 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.64 72.47 5.16 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.297 1.039 . . . . 99.989999999999995 111.871 -168.313 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -177.34 59.43 0.15 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.241 1.816 . . . . 99.989999999999995 107.545 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo . . . . . 0 C--N 1.389 2.672 0 C-N-CA 122.574 2.182 . . . . 99.989999999999995 112.058 -175.107 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.6 t60 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.25 -1.018 . . . . 99.989999999999995 108.25 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -66.09 145.34 55.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.383 0.673 . . . . 99.989999999999995 111.366 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 66.15 17.67 10.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.781 1.232 . . . . 99.989999999999995 111.944 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -141.96 36.46 1.58 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.67 0.788 . . . . 99.989999999999995 109.99 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -68.67 -64.56 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.087 0.555 . . . . 99.989999999999995 111.476 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -161.59 123.52 2.91 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.42 0.288 . . . . 99.989999999999995 111.488 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.5 m -81.71 178.58 8.25 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.052 0.941 . . . . 99.989999999999995 110.567 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.464 ' H ' HG21 ' A' ' 37' ' ' THR . 4.7 m170 -82.09 148.65 28.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.359 -0.608 . . . . 99.989999999999995 109.359 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ptm -92.09 175.23 6.94 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.652 0.381 . . . . 99.989999999999995 111.136 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.447 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.4 m -65.54 136.56 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.801 -0.636 . . . . 99.989999999999995 110.662 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.09 9.06 82.96 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-O 119.539 -0.59 . . . . 99.989999999999995 113.785 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -65.89 106.31 1.52 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.229 -0.656 . . . . 99.989999999999995 109.229 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' THR . . . . . 0.489 HG22 ' HB3' ' A' ' 61' ' ' PRO . 53.4 m -72.09 123.53 23.05 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.522 0.677 . . . . 99.989999999999995 111.062 -168.391 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.7 m -139.1 -177.67 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.691 1.196 . . . . 99.989999999999995 110.165 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . 0.571 ' HZ3' ' HZ2' ' A' ' 57' ' ' LYS . 34.7 m0 -123.23 158.66 30.39 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.457 1.103 . . . . 99.989999999999995 108.194 169.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.45 102.48 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.54 -0.911 . . . . 99.989999999999995 108.54 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.634 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 56.0 ttp180 -74.08 93.16 2.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.969 1.308 . . . . 99.989999999999995 109.789 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -94.82 170.31 9.53 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.333 1.053 . . . . 99.989999999999995 109.08 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 80.26 113.99 0.06 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.878 1.671 . . . . 99.989999999999995 110.519 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -74.43 113.58 11.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.655 -0.702 . . . . 99.989999999999995 110.71 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 t -77.39 94.01 4.17 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.769 0.828 . . . . 99.989999999999995 110.927 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -109.15 -52.43 2.77 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.273 0.629 . . . . 99.989999999999995 110.465 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -131.33 -3.09 3.87 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.339 1.056 . . . . 99.989999999999995 109.481 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.17 163.18 24.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.496 1.118 . . . . 99.989999999999995 109.774 -173.309 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.12 142.59 64.18 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.572 0.749 . . . . 99.989999999999995 110.93 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.6 137.36 6.73 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.959 2.439 . . . . 99.989999999999995 111.671 176.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -97.56 108.05 20.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.522 0.329 . . . . 99.989999999999995 110.612 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.634 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 70.1 p-90 -73.6 139.7 45.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.333 -0.617 . . . . 99.989999999999995 109.333 167.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -121.04 147.97 44.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.801 0.84 . . . . 99.989999999999995 108.759 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.46 175.41 36.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 123.785 0.678 . . . . 99.989999999999995 112.49 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -85.34 141.2 30.69 Favored 'Cis proline' 0 C--N 1.374 1.898 0 CA-C-N 119.036 1.418 . . . . 99.989999999999995 112.901 -4.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.1 m-85 -120.93 171.13 8.85 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.242 1.017 . . . . 99.989999999999995 109.569 174.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 p -151.59 114.0 4.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 99.989999999999995 110.246 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -59.21 121.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 109.537 -0.542 . . . . 99.989999999999995 109.537 170.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.447 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 86.3 mt -98.51 -41.14 7.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.664 0.785 . . . . 99.989999999999995 109.712 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.69 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 40.8 tp -131.57 145.21 51.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.397 0.679 . . . . 99.989999999999995 110.252 -176.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.532 HG23 HD22 ' A' ' 42' ' ' LEU . 42.2 p -115.38 140.59 48.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 99.989999999999995 110.079 174.523 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.7 p -139.23 158.03 69.87 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 106.945 -1.502 . . . . 99.989999999999995 106.945 165.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.32 109.45 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.627 2.218 . . . . 99.989999999999995 113.769 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m 74.51 5.33 4.52 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.712 1.605 . . . . 99.989999999999995 113.135 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.8 124.22 16.77 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.824 -0.548 . . . . 99.989999999999995 110.046 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.532 HD22 HG23 ' A' ' 37' ' ' THR . 66.6 mt -113.0 125.49 54.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.164 -0.68 . . . . 99.989999999999995 109.164 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.69 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 62.5 tttm -84.08 108.69 17.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.549 -1.278 . . . . 99.989999999999995 107.549 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.9 t -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.106 -0.952 . . . . 99.989999999999995 109.227 -173.426 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.05 138.36 55.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.163 0.585 . . . . 99.989999999999995 110.577 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.45 -38.54 3.06 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.92 -0.872 . . . . 99.989999999999995 110.92 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.544 HG22 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -80.67 151.62 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.871 0.869 . . . . 99.989999999999995 110.026 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.12 61.99 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.744 0.653 . . . . 99.989999999999995 112.602 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 -50.73 0.14 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.229 0.826 . . . . 99.989999999999995 113.229 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -143.92 154.63 43.53 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 119.191 0.905 . . . . 99.989999999999995 112.55 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.544 HG12 HG22 ' A' ' 47' ' ' ILE . 27.7 mm -129.34 133.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.579 1.552 . . . . 99.989999999999995 107.536 163.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 124.65 21.35 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.057 -1.09 . . . . 99.989999999999995 108.057 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.15 -19.39 13.22 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.851 1.426 . . . . 99.989999999999995 114.851 -164.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.51 -13.18 62.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.653 0.612 . . . . 99.989999999999995 112.653 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.74 -3.66 48.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.579 0.752 . . . . 99.989999999999995 110.983 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.5 129.0 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.054 -0.721 . . . . 99.989999999999995 109.054 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.571 ' HZ2' ' HZ3' ' A' ' 15' ' ' TRP . 81.5 tttt -124.9 122.1 36.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 99.989999999999995 109.323 178.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -59.62 123.59 17.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.463 0.705 . . . . 99.989999999999995 111.104 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.52 138.24 52.16 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.581 0.753 . . . . 99.989999999999995 111.011 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -92.45 119.16 68.2 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.767 0.827 . . . . 99.989999999999995 109.297 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.489 ' HB3' HG22 ' A' ' 13' ' ' THR . 59.2 Cg_endo -87.18 -5.02 7.7 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.949 2.433 . . . . 99.989999999999995 113.842 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.99 15.73 80.11 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.322 0.389 . . . . 99.989999999999995 112.413 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.42 -87.18 0.07 OUTLIER Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.545 -0.622 . . . . 99.989999999999995 111.545 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.37 -165.52 36.49 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.356 -0.691 . . . . 99.989999999999995 112.243 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.85 107.67 0.47 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.128 2.552 . . . . 99.989999999999995 111.554 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.5 m -81.52 1.04 35.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.475 0.71 . . . . 99.989999999999995 111.82 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -124.24 163.17 22.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.185 0.594 . . . . 99.989999999999995 110.514 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -86.78 90.81 8.42 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.201 -1.037 . . . . 99.989999999999995 108.201 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.49 -175.36 5.69 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.274 0.63 . . . . 99.989999999999995 110.842 -175.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' THR . . . . . 0.412 ' HG1' HD12 ' A' ' 35' ' ' LEU . 77.6 p -83.39 68.75 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.83 -0.804 . . . . 99.989999999999995 108.83 174.141 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -64.78 -23.43 67.24 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.609 -1.178 . . . . 99.989999999999995 112.764 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -70.15 -53.35 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.637 -0.697 . . . . 99.989999999999995 110.882 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.416 HG11 ' HB2' ' A' ' 36' ' ' LEU . 91.8 t 63.14 -59.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.117 1.367 . . . . 99.989999999999995 113.906 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -50.45 85.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.275 1.43 . . . . 99.989999999999995 111.748 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.4 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 3.0 mmp_? -149.99 -4.34 0.36 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.387 1.075 . . . . 99.989999999999995 111.553 -174.411 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -155.4 99.56 2.06 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.806 0.299 . . . . 99.989999999999995 111.806 -172.439 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 63.89 31.41 13.94 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.558 1.143 . . . . 99.989999999999995 112.364 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 58.65 71.09 1.04 Allowed Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.75 1.22 . . . . 99.989999999999995 111.61 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.41 -35.95 1.45 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.461 2.107 . . . . 99.989999999999995 111.967 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.74 176.08 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.196 0.598 . . . . 99.989999999999995 111.14 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp 65.52 32.16 9.6 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.47 1.108 . . . . 99.989999999999995 110.61 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.04 5.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 123.631 0.772 . . . . 99.989999999999995 112.383 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -72.56 67.75 0.78 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.427 1.091 . . . . 99.989999999999995 109.709 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.77 115.53 22.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.835 -1.075 . . . . 99.989999999999995 108.572 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.1 p -68.79 -64.01 0.95 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.918 0.761 . . . . 99.989999999999995 109.382 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 71.25 168.76 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.07 1.348 . . . . 99.989999999999995 111.229 -173.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.75 157.51 42.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.593 0.757 . . . . 99.989999999999995 109.897 173.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.64 -51.54 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.468 -0.777 . . . . 99.989999999999995 111.111 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.384 2.412 0 CA-C-N 120.86 1.343 . . . . 99.989999999999995 111.527 167.572 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.447 -0.946 . . . . 99.989999999999995 108.447 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -126.72 87.4 2.65 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.324 0.583 . . . . 99.989999999999995 111.217 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.78 140.85 8.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.765 -1.107 . . . . 99.989999999999995 109.173 167.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -154.57 138.46 16.28 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.917 0.887 . . . . 99.989999999999995 110.062 -171.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -160.68 154.24 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.316 0.646 . . . . 99.989999999999995 109.729 170.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -71.54 122.36 20.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.764 -0.458 . . . . 99.989999999999995 109.764 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.6 t -143.86 -170.85 3.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.949 0.9 . . . . 99.989999999999995 108.669 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.476 ' NE2' ' HA ' ' A' ' 36' ' ' LEU . 52.5 p-80 -62.12 141.28 58.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.398 0.679 . . . . 99.989999999999995 110.274 172.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp -79.44 133.61 36.53 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.037 -0.727 . . . . 99.989999999999995 109.037 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.696 HG13 ' H ' ' A' ' 73' ' ' VAL . 10.4 m -75.07 148.64 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.444 0.698 . . . . 99.989999999999995 109.173 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.541 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 86.89 10.53 72.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.97 -0.633 . . . . 99.989999999999995 112.407 -174.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -62.14 115.43 4.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.409 0.684 . . . . 99.989999999999995 110.26 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 m -73.38 114.61 11.79 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.988 0.423 . . . . 99.989999999999995 110.65 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.452 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.5 m -132.29 -177.55 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.915 1.286 . . . . 99.989999999999995 110.022 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -124.35 142.4 51.31 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.861 1.264 . . . . 99.989999999999995 107.677 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.29 106.58 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.031 -1.1 . . . . 99.989999999999995 108.031 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.755 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.4 ttp180 -84.66 93.64 8.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.505 -1.225 . . . . 99.989999999999995 110.635 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -80.25 152.88 28.85 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.725 1.21 . . . . 99.989999999999995 109.891 -175.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 15.0 p80 -125.32 126.52 45.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.125 0.57 . . . . 99.989999999999995 110.528 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.07 -43.9 10.74 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.731 -0.84 . . . . 99.989999999999995 108.731 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.5 m -126.76 125.0 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.649 -1.159 . . . . 99.989999999999995 108.122 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LYS . . . . . 0.511 ' HB2' ' HZ1' ' A' ' 22' ' ' LYS . 10.3 mtmp? -70.51 -24.16 62.78 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.314 0.646 . . . . 99.989999999999995 111.639 179.087 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -73.72 -28.04 61.5 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.618 0.767 . . . . 99.989999999999995 111.42 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.2 mt -93.47 173.36 7.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.65 . . . . 99.989999999999995 110.723 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.49 126.19 92.2 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 115.722 -0.672 . . . . 99.989999999999995 110.34 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' PRO . . . . . 0.449 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 67.2 Cg_endo -71.45 133.69 23.02 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.418 2.079 . . . . 99.989999999999995 110.057 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -94.55 128.78 41.4 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.84 0.856 . . . . 99.989999999999995 109.359 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TRP . . . . . 0.755 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 58.6 p-90 -80.77 146.45 30.98 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.912 0.387 . . . . 99.989999999999995 110.832 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.557 ' HZ3' ' HB3' ' A' ' 29' ' ' LYS . 7.7 mtpm? -119.78 141.52 49.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.613 -1.255 . . . . 99.989999999999995 107.613 174.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.87 164.99 36.76 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 119.665 -0.52 . . . . 99.989999999999995 112.127 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.55 136.97 19.25 Favored 'Cis proline' 0 C--N 1.373 1.865 0 CA-C-N 119.45 1.625 . . . . 99.989999999999995 112.946 -1.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -111.35 174.1 6.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.443 1.097 . . . . 99.989999999999995 110.151 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.541 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.6 p -142.34 112.72 7.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.642 0.777 . . . . 99.989999999999995 110.436 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.72 122.72 19.43 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 N-CA-C 109.32 -0.622 . . . . 99.989999999999995 109.32 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.497 ' HB3' HG12 ' A' ' 73' ' ' VAL . 62.2 mt -93.64 -42.01 9.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.964 -1.016 . . . . 99.989999999999995 109.943 172.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . 0.63 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 19.1 tp -133.54 144.52 49.41 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 122.107 -0.37 . . . . 99.989999999999995 110.65 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.6 m -119.2 129.16 54.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.138 0.975 . . . . 99.989999999999995 109.519 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 p -139.84 158.77 67.0 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.397 1.079 . . . . 99.989999999999995 108.81 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.53 108.91 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.284 2.656 . . . . 99.989999999999995 114.416 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 62.11 17.5 9.19 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.568 1.547 . . . . 99.989999999999995 113.051 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.69 134.18 24.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.494 0.718 . . . . 99.989999999999995 109.303 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.62 124.74 41.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.138 -0.69 . . . . 99.989999999999995 109.138 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.63 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -83.84 109.65 17.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.078 -1.453 . . . . 99.989999999999995 107.078 172.371 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.4 136.45 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.678 -1.146 . . . . 99.989999999999995 108.474 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.423 ' HB3' ' HG1' ' A' ' 33' ' ' THR . 31.9 t70 -66.06 139.1 58.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.481 -0.562 . . . . 99.989999999999995 109.481 172.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -15.39 63.17 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.964 -0.455 . . . . 99.989999999999995 111.964 -172.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . 0.542 HG21 HG12 ' A' ' 51' ' ' ILE . 46.5 mm -101.58 147.73 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.287 1.035 . . . . 99.989999999999995 109.382 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.01 -49.75 65.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.015 0.926 . . . . 99.989999999999995 112.344 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.45 -58.76 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.141 0.423 . . . . 99.989999999999995 112.141 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -143.18 157.22 44.7 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 123.174 0.59 . . . . 99.989999999999995 110.962 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.542 HG12 HG21 ' A' ' 47' ' ' ILE . 35.4 mm -126.56 139.95 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 108.246 -1.02 . . . . 99.989999999999995 108.246 167.173 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -64.42 139.74 58.8 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.545 0.738 . . . . 99.989999999999995 109.014 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.89 -22.13 61.96 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.478 1.288 . . . . 99.989999999999995 114.478 -168.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 88' ' ' ALA . . . -71.89 -15.67 62.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.724 0.639 . . . . 99.989999999999995 112.724 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.3 24.12 11.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.903 0.881 . . . . 99.989999999999995 110.848 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.1 136.12 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.607 -1.257 . . . . 99.989999999999995 107.607 165.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -136.65 135.89 38.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.853 -0.795 . . . . 99.989999999999995 108.853 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.452 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.04 138.19 57.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.656 0.782 . . . . 99.989999999999995 112.201 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.02 169.33 9.49 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.142 1.377 . . . . 99.989999999999995 109.068 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -56.83 115.62 10.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-O 118.596 -0.716 . . . . 99.989999999999995 109.715 173.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -56.14 -19.2 26.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.807 3.005 . . . . 99.989999999999995 114.782 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.81 -6.51 72.7 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.413 -0.358 . . . . 99.989999999999995 113.869 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.06 -27.3 41.25 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 123.462 0.553 . . . . 99.989999999999995 112.51 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.37 -161.53 27.22 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 119.485 -0.619 . . . . 99.989999999999995 112.027 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.81 90.21 0.43 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.687 2.258 . . . . 99.989999999999995 112.256 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.2 t -74.14 -22.03 59.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.694 0.797 . . . . 99.989999999999995 110.656 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -70.99 -17.98 62.62 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.497 0.719 . . . . 99.989999999999995 110.752 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 62.5 88.12 0.1 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.36 1.464 . . . . 99.989999999999995 110.871 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.03 -54.04 25.51 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.077 0.465 . . . . 99.989999999999995 109.964 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.3 m -92.67 144.3 25.45 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.323 -0.853 . . . . 99.989999999999995 108.952 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -86.33 -56.53 3.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.657 -0.868 . . . . 99.989999999999995 108.657 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.465 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 88.8 mtm180 -148.07 115.14 6.15 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.013 -1.449 . . . . 99.989999999999995 108.433 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . 0.696 ' H ' HG13 ' A' ' 10' ' ' VAL . 7.5 p -65.61 -44.6 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.21 0.604 . . . . 99.989999999999995 109.908 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.465 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 1.9 mp0 -102.72 148.12 26.0 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.599 -1.26 . . . . 99.989999999999995 107.599 169.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -111.31 -26.03 9.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.543 0.737 . . . . 99.989999999999995 110.271 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 153.81 36.71 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.184 0.994 . . . . 99.989999999999995 112.095 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -73.41 -35.3 65.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.03 0.932 . . . . 99.989999999999995 111.974 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.11 -54.06 12.64 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-O 118.407 -0.806 . . . . 99.989999999999995 112.7 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.14 -34.87 12.54 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 121.819 1.679 . . . . 99.989999999999995 112.114 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.421 HD13 ' O ' ' A' ' 74' ' ' GLN . 64.6 mt -75.07 85.67 2.33 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.137 0.494 . . . . 99.989999999999995 109.795 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.8 176.47 10.37 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.183 -0.917 . . . . 99.989999999999995 109.958 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.7 pt -134.31 174.12 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.018 0.927 . . . . 99.989999999999995 109.739 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -156.06 150.3 25.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.684 -1.598 . . . . 99.989999999999995 106.684 162.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.57 82.31 0.41 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.437 0.637 . . . . 99.989999999999995 109.92 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.6 p -70.53 151.15 45.39 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.748 -1.114 . . . . 99.989999999999995 109.268 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -103.65 145.52 29.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.9 -0.778 . . . . 99.989999999999995 108.9 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -62.57 127.42 31.23 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.231 -0.655 . . . . 99.989999999999995 109.231 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ALA . . . . . 0.435 ' HB3' ' HA ' ' A' ' 54' ' ' ALA . . . -73.88 127.53 88.14 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-O 118.663 -0.684 . . . . 99.989999999999995 110.372 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo . . . . . 0 C--N 1.379 2.163 0 C-N-CA 123.408 2.738 . . . . 99.989999999999995 113.062 -178.94 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.039 -0.029 . . . . 75.0 111.017 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -61.57 108.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.424 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 117.13 11.28 9.1 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 118.755 -1.025 . . . . 50.0 114.278 -169.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.678 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 59.8 t0 -60.02 110.7 1.26 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.508 0.654 . . . . 50.0 109.418 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 m -74.32 108.77 7.31 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.021 0.528 . . . . 50.0 109.635 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 58' ' ' ALA . 34.6 m -131.48 172.96 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.903 1.281 . . . . 50.0 109.716 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -119.24 154.59 33.19 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.694 1.197 . . . . 50.0 107.999 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.51 108.44 25.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.1 -1.074 . . . . 50.0 108.1 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -82.55 92.32 7.08 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.338 -2.21 . . . . 75.0 108.635 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 122.773 0.429 . . . . 75.0 110.506 -171.244 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 110.456 -0.201 . . . . 75.0 110.456 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -78.93 143.79 35.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.852 0.358 . . . . 50.0 110.821 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -130.48 152.49 49.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.894 -1.15 . . . . 75.0 107.894 164.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.94 -174.32 38.71 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.792 -0.718 . . . . 50.0 112.983 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -92.43 112.66 1.4 Allowed 'Cis proline' 0 C--N 1.37 1.69 0 C-N-CA 124.184 -1.173 . . . . 50.0 112.696 -2.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -76.95 156.99 31.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.196 0.598 . . . . 50.0 109.392 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.424 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 36.4 p -126.48 112.51 15.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.555 0.342 . . . . 50.0 110.834 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 60.2 t -74.31 123.48 29.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 109.344 -0.613 . . . . 50.0 109.344 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 89.2 mt -93.12 -33.39 14.07 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.411 1.07 . . . . 50.0 110.12 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 55.2 tp -149.87 144.58 26.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.995 0.518 . . . . 50.0 109.626 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.477 HG22 HD22 ' A' ' 42' ' ' LEU . 64.0 p -109.72 144.12 38.55 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -135.86 149.31 68.33 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 105.542 -2.021 . . . . 50.0 105.542 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.78 106.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.209 2.606 . . . . 50.0 113.49 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m 62.15 27.66 16.64 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.662 1.585 . . . . 50.0 112.642 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -159.37 123.61 3.9 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 50.0 109.466 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.477 HD22 HG22 ' A' ' 37' ' ' THR . 44.9 mt -111.37 128.43 55.97 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.68 -0.637 . . . . 50.0 110.194 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 25.3 ttpp -85.85 108.27 18.06 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.722 -1.214 . . . . 75.0 107.722 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 34' ' ' VAL . 60.6 t -115.47 149.05 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.533 1.133 . . . . 50.0 109.045 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.99 133.2 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.524 -0.547 . . . . 50.0 109.524 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.83 -11.68 67.83 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.359 0.412 . . . . 50.0 113.509 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 51' ' ' ILE . 47.2 mm -97.4 151.21 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.879 0.872 . . . . 50.0 110.669 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.58 -51.07 70.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.114 0.965 . . . . 50.0 111.78 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -152.44 -59.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.567 0.347 . . . . 50.0 111.458 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.7 m-90 -142.53 147.92 36.75 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.12 0.568 . . . . 50.0 110.847 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 47' ' ' ILE . 33.2 mm -114.69 130.32 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.503 -1.295 . . . . 50.0 107.503 166.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -55.93 123.51 14.56 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.801 -0.814 . . . . 50.0 108.801 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.45 -18.69 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.674 1.361 . . . . 50.0 114.674 -164.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.56 67.36 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.168 0.587 . . . . 50.0 112.141 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -96.94 15.25 22.81 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.44 1.096 . . . . 50.0 111.123 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.413 HG11 HD12 ' A' ' 42' ' ' LEU . 38.4 t -131.82 152.06 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.852 -1.166 . . . . 50.0 107.852 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -151.96 132.93 14.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.336 -0.986 . . . . 75.0 108.336 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.556 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -60.33 151.72 27.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.854 0.461 . . . . 50.0 111.498 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.907 0.883 . . . . 50.0 109.915 -177.722 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.8 ptp . . . . . 0 C--O 1.242 0.689 0 CA-C-O 121.434 0.635 . . . . 75.0 112.227 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.91 140.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 114.165 -1.379 . . . . 50.0 113.14 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.28 8.95 42.96 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.475 -0.784 . . . . 50.0 112.568 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -62.59 103.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.483 0.713 . . . . 50.0 110.616 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 m -71.6 110.68 6.33 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.268 -0.642 . . . . 50.0 109.268 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 58' ' ' ALA . 30.1 m -132.83 179.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 50.0 110.292 -175.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -124.26 150.87 44.85 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.545 -1.28 . . . . 50.0 107.545 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.96 107.92 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.374 -0.602 . . . . 50.0 109.374 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -76.28 137.83 40.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.247 1.419 . . . . 75.0 110.401 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.283 0.633 . . . . 75.0 109.667 179.214 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 109.258 -0.645 . . . . 75.0 109.258 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -103.7 163.41 12.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.572 0.749 . . . . 50.0 111.816 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.92 161.0 34.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.93 1.292 . . . . 75.0 108.635 172.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.64 -175.97 42.6 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.578 -0.568 . . . . 50.0 112.847 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -88.58 128.12 8.57 Favored 'Cis proline' 0 C--N 1.373 1.861 0 CA-C-N 119.276 1.538 . . . . 50.0 112.526 -6.762 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -93.96 176.46 6.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.043 0.937 . . . . 50.0 110.048 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 28.3 p -140.34 115.9 10.11 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.723 0.809 . . . . 50.0 110.102 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.2 t -72.42 133.48 31.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 109.127 -0.694 . . . . 50.0 109.127 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -97.26 -43.26 7.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.711 -1.131 . . . . 50.0 109.875 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.6 tp -141.73 141.05 33.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 116.048 -0.523 . . . . 50.0 109.739 -175.305 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.0 p -112.67 128.44 56.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.541 -0.54 . . . . 50.0 109.541 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -126.82 162.71 45.74 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.122 0.969 . . . . 50.0 109.263 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -43.44 114.96 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.582 2.855 . . . . 50.0 113.918 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t 63.23 5.68 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.132 2.173 . . . . 50.0 114.459 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -148.85 135.31 19.49 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.658 0.383 . . . . 50.0 110.01 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.76 124.93 50.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.01 0.524 . . . . 50.0 109.646 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.0 ttmm -83.89 107.99 16.62 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.27 -1.011 . . . . 75.0 108.27 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 34' ' ' VAL . 47.1 t -107.77 149.93 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.869 1.268 . . . . 50.0 108.22 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.33 140.85 54.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.85 0.46 . . . . 50.0 110.092 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 4.56 73.9 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.24 -0.436 . . . . 50.0 113.033 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HG12 ' A' ' 51' ' ' ILE . 51.3 mm -116.74 150.49 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.16 0.984 . . . . 50.0 110.278 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.04 -51.53 68.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.957 0.903 . . . . 50.0 112.22 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.34 -56.81 0.17 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.516 -0.311 . . . . 50.0 111.312 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.541 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 16.8 m-90 -143.06 158.31 43.72 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.996 0.519 . . . . 50.0 111.403 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.464 HG12 HG21 ' A' ' 47' ' ' ILE . 33.7 mm -122.32 118.59 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 106.802 -1.555 . . . . 50.0 106.802 165.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -56.91 127.24 30.83 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.385 -0.968 . . . . 50.0 108.385 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -23.75 18.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.846 1.795 . . . . 50.0 115.846 -158.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 -10.45 59.03 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.199 0.444 . . . . 50.0 112.199 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.11 17.66 22.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.756 1.222 . . . . 50.0 111.162 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.35 146.9 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.651 -0.87 . . . . 50.0 108.651 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -146.41 133.64 20.56 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.637 -0.875 . . . . 75.0 108.637 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -60.48 142.41 55.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.907 0.883 . . . . 50.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.943 . . . . 50.0 110.807 -176.356 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 109.874 -0.417 . . . . 75.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.62 133.04 29.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.252 0.549 . . . . 50.0 111.182 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.596 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 95.22 9.93 57.65 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.203 -0.908 . . . . 50.0 113.028 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 66.3 t0 -54.29 117.27 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.603 0.761 . . . . 50.0 111.351 -176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 59' ' ' ALA . 29.6 m -73.42 113.88 11.01 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.997 0.519 . . . . 50.0 110.194 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.22 176.5 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.231 1.013 . . . . 50.0 110.146 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.508 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 35.4 m0 -123.9 136.48 54.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.31 1.044 . . . . 50.0 108.239 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.88 107.24 22.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 108.239 -1.023 . . . . 50.0 108.239 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 43.2 ttm180 -77.27 111.5 12.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.019 -1.446 . . . . 75.0 109.838 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 123.581 0.752 . . . . 75.0 109.222 178.832 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.8 ttm-85 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.354 0.121 . . . . 75.0 111.078 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 64.1 p-90 -75.88 143.98 41.44 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.441 0.696 . . . . 50.0 110.78 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -126.56 159.89 32.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.295 -1.002 . . . . 75.0 108.295 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.44 -172.6 44.14 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.475 -0.625 . . . . 50.0 112.428 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.59 115.38 3.51 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 119.137 1.469 . . . . 50.0 112.982 1.271 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB3' HG11 ' A' ' 44' ' ' VAL . 78.2 m-85 -75.35 162.71 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.579 0.752 . . . . 50.0 110.766 172.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.596 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.5 p -131.63 111.5 11.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.091 0.556 . . . . 50.0 111.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 59.5 t -79.77 125.77 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.754 0.822 . . . . 50.0 110.404 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.4 -33.38 11.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.27 0.628 . . . . 50.0 110.251 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 42.7 tp -135.63 140.5 44.6 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.407 -0.361 . . . . 50.0 110.271 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -128.83 129.55 45.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.063 0.545 . . . . 50.0 110.096 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -134.96 163.12 53.52 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.19 1.396 . . . . 50.0 108.57 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -46.18 110.42 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.308 2.672 . . . . 50.0 114.543 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m 68.96 8.99 7.18 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 124.674 1.189 . . . . 50.0 112.59 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -146.97 121.93 10.02 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.788 -0.57 . . . . 50.0 110.133 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD12 HG11 ' A' ' 56' ' ' VAL . 22.6 mt -119.07 121.86 40.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.582 -0.895 . . . . 50.0 108.582 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 86.6 tttt -86.2 113.38 22.18 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.027 0.531 . . . . 75.0 110.977 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 74.1 t -88.61 149.22 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.887 1.275 . . . . 50.0 109.509 168.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.41 128.29 35.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.313 0.645 . . . . 50.0 110.374 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -27.78 16.68 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.014 -0.539 . . . . 50.0 111.959 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -74.53 146.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.565 0.746 . . . . 50.0 109.991 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.19 76.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.071 0.948 . . . . 50.0 112.413 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.22 -55.61 0.19 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.222 0.453 . . . . 50.0 112.222 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.6 m-90 -145.6 157.65 43.95 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.633 0.605 . . . . 50.0 112.633 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mm -112.64 135.66 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.845 1.258 . . . . 50.0 108.668 165.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -66.78 124.89 24.19 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.329 -0.989 . . . . 50.0 108.329 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.65 -19.42 63.8 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.733 1.213 . . . . 50.0 114.081 -164.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.85 -12.12 58.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.435 0.694 . . . . 50.0 112.374 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -98.0 -11.99 22.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.452 0.701 . . . . 50.0 111.251 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG11 HD12 ' A' ' 42' ' ' LEU . 76.1 t -96.86 124.34 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 122.681 0.392 . . . . 50.0 110.596 -170.273 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -118.33 120.05 36.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.505 1.122 . . . . 75.0 108.986 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.48 106.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.41 0.684 . . . . 50.0 110.4 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.815 0.846 . . . . 50.0 110.947 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 111.623 0.231 . . . . 75.0 111.623 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 m -67.04 117.64 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.799 -0.815 . . . . 50.0 108.799 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 102.25 10.23 39.67 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.645 -1.086 . . . . 50.0 113.245 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -57.75 102.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 118.56 1.18 . . . . 50.0 109.906 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -72.71 113.29 9.58 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-O 121.492 0.663 . . . . 50.0 110.221 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.58 -179.86 2.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 113.933 -1.485 . . . . 50.0 109.05 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -125.0 150.66 46.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.994 -1.484 . . . . 50.0 106.994 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.21 104.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.246 -1.391 . . . . 50.0 107.246 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.587 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 37.9 ttt180 -81.33 92.4 6.39 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 112.686 -2.052 . . . . 75.0 109.651 -173.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 123.408 0.683 . . . . 75.0 111.424 -170.851 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 110.11 -0.33 . . . . 75.0 110.11 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.7 p-90 -68.27 143.11 55.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.298 0.639 . . . . 50.0 111.359 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mtmp? -121.5 146.54 46.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.06 0.944 . . . . 75.0 108.804 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.88 175.44 35.87 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.756 -0.469 . . . . 50.0 112.849 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.79 126.8 6.37 Favored 'Cis proline' 0 CA--C 1.564 2.007 0 CA-C-N 118.754 1.277 . . . . 50.0 113.215 -3.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.07 163.29 12.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 50.0 109.369 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.9 p -145.86 114.02 6.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.803 0.441 . . . . 50.0 111.15 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 44' ' ' VAL . 24.2 t -67.99 133.07 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 50.0 110.781 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.82 -41.58 4.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.991 0.916 . . . . 50.0 109.936 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HB3' ' HD3' ' A' ' 43' ' ' LYS . 56.7 tp -135.26 151.2 50.35 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.401 -0.963 . . . . 50.0 108.401 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.46 HG22 HD22 ' A' ' 42' ' ' LEU . 69.6 p -124.32 153.19 42.14 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.865 -0.522 . . . . 50.0 111.048 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -136.44 147.65 60.81 Favored Pre-proline 0 CA--C 1.561 1.401 0 N-CA-C 106.501 -1.666 . . . . 50.0 106.501 171.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -40.85 109.72 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.288 2.659 . . . . 50.0 114.442 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 67.9 17.43 9.64 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.337 1.455 . . . . 50.0 112.903 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -156.42 121.61 4.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.42 0.688 . . . . 50.0 109.943 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.667 HD12 HG11 ' A' ' 56' ' ' VAL . 27.5 mt -106.09 133.94 50.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.984 0.514 . . . . 50.0 110.308 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 54.8 tttp -85.57 107.53 17.54 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.799 -1.186 . . . . 75.0 107.799 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 34' ' ' VAL . 44.8 t -109.78 154.63 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.486 -1.234 . . . . 50.0 109.452 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.67 130.19 45.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.992 0.917 . . . . 50.0 110.789 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.01 79.55 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.16 -0.473 . . . . 50.0 113.782 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 HG12 ' A' ' 51' ' ' ILE . 40.8 mm -91.8 151.35 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.077 0.951 . . . . 50.0 110.539 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.08 73.56 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.194 0.998 . . . . 50.0 111.614 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.04 -57.53 0.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.047 0.388 . . . . 50.0 112.047 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.522 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.6 m-90 -143.35 153.3 42.58 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.029 0.531 . . . . 50.0 111.653 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 47' ' ' ILE . 33.1 mm -123.44 120.22 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.699 1.2 . . . . 50.0 107.816 168.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -61.12 141.46 57.43 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.248 0.619 . . . . 50.0 109.469 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.82 48.81 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.566 1.691 . . . . 50.0 115.566 -162.514 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.041 0.536 . . . . 50.0 112.216 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -96.44 23.9 6.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.059 0.944 . . . . 50.0 110.661 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.667 HG11 HD12 ' A' ' 42' ' ' LEU . 57.8 t -123.39 152.14 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.15 0.98 . . . . 50.0 108.555 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -155.87 110.6 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.982 0.513 . . . . 75.0 109.95 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.29 53.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.142 0.577 . . . . 50.0 111.327 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.936 0 C-N-CA 124.153 0.981 . . . . 50.0 109.192 -175.404 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ptm . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 120.533 0.206 . . . . 75.0 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 3.4 m -60.56 123.09 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.296 0.638 . . . . 50.0 110.533 174.681 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.37 9.36 60.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.057 -0.857 . . . . 50.0 113.466 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.705 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 51.2 t0 -56.02 106.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.942 0.871 . . . . 50.0 110.728 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 m -72.44 106.66 4.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.291 0.567 . . . . 50.0 110.012 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.97 173.86 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.527 1.131 . . . . 50.0 110.814 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.447 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.4 m0 -117.05 150.7 38.21 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.9 1.28 . . . . 50.0 108.168 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.43 109.31 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.052 -1.092 . . . . 50.0 108.052 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 38.8 ttp180 -87.12 90.61 8.42 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.116 -1.402 . . . . 75.0 109.808 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 124.449 1.1 . . . . 75.0 110.043 -176.565 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.489 0.185 . . . . 75.0 110.524 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 62.5 p-90 -73.85 149.33 41.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.739 0.816 . . . . 50.0 111.088 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -139.61 153.26 47.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.791 0.836 . . . . 75.0 109.649 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -168.0 179.39 41.26 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 119.894 -0.392 . . . . 50.0 113.492 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.71 133.72 19.12 Favored 'Cis proline' 0 C--N 1.378 2.103 0 CA-C-N 119.139 1.47 . . . . 50.0 113.838 0.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' HB3' HG11 ' A' ' 44' ' ' VAL . 76.0 m-85 -108.48 168.3 9.42 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.895 1.278 . . . . 50.0 109.396 169.411 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.9 p -148.0 113.62 5.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.275 0.63 . . . . 50.0 110.883 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.4 t -73.21 134.32 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.756 0.822 . . . . 50.0 110.417 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 mt -106.58 -31.75 8.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.37 0.668 . . . . 50.0 110.812 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -149.59 159.2 44.52 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.777 -0.823 . . . . 50.0 108.777 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 p -139.38 163.7 31.81 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.559 0.695 . . . . 50.0 111.259 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.3 p -141.98 164.33 34.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 126.12 1.768 . . . . 50.0 107.695 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 107.85 0.17 Allowed 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.789 2.326 . . . . 50.0 113.47 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.69 22.15 12.54 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.432 1.493 . . . . 50.0 112.855 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.45 121.94 9.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.128 -0.693 . . . . 50.0 109.128 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.515 HD12 ' HB ' ' A' ' 56' ' ' VAL . 23.3 mt -106.69 123.5 48.22 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.243 1.017 . . . . 50.0 108.749 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -86.85 106.84 18.02 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 109.349 -0.611 . . . . 75.0 109.349 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 48.0 t -96.25 154.75 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.309 -1.314 . . . . 50.0 109.153 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.2 135.33 48.96 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.499 -0.556 . . . . 50.0 109.499 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.78 76.31 Favored Glycine 0 C--N 1.34 0.787 0 O-C-N 123.761 0.663 . . . . 50.0 112.798 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -92.66 147.67 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.171 0.588 . . . . 50.0 109.939 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.44 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.435 1.094 . . . . 50.0 111.38 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.19 -59.59 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.951 0.352 . . . . 50.0 111.951 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -145.31 158.65 43.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.297 0.639 . . . . 50.0 111.187 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.88 133.89 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.598 -1.26 . . . . 50.0 107.598 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -63.79 142.24 58.47 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 50.0 108.294 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -36.75 64.99 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 115.076 1.51 . . . . 50.0 115.076 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.27 1.32 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 112.33 0.493 . . . . 50.0 112.33 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.32 12.42 36.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.018 0.527 . . . . 50.0 109.816 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' HB ' HD12 ' A' ' 42' ' ' LEU . 99.1 t -139.15 140.75 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -138.17 152.17 48.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.56 -0.904 . . . . 75.0 108.56 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.32 126.85 28.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.667 0.787 . . . . 50.0 110.845 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 108.817 -0.809 . . . . 50.0 108.817 174.297 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 112.73 0.641 . . . . 75.0 112.73 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -62.1 150.64 8.15 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 115.076 -0.965 . . . . 50.0 110.828 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 11.37 69.83 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.995 -0.621 . . . . 50.0 112.49 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.4 t0 -62.1 111.83 2.11 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.355 0.577 . . . . 50.0 109.853 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.8 m -71.34 112.28 7.35 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.249 -0.649 . . . . 50.0 109.249 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 58' ' ' ALA . 30.2 m -136.38 164.2 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.797 -0.638 . . . . 50.0 111.124 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.453 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 41.8 m0 -122.39 145.56 48.16 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.235 1.014 . . . . 50.0 108.315 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.69 105.26 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.0 ttm180 -89.34 138.01 31.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.028 1.331 . . . . 75.0 110.378 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 122.607 0.363 . . . . 75.0 110.471 -178.43 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 C--O 1.238 0.459 0 N-CA-C 108.635 -0.876 . . . . 75.0 108.635 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.2 p-90 -96.35 163.7 12.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.537 0.735 . . . . 50.0 111.763 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -135.66 149.92 49.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.153 0.981 . . . . 75.0 108.586 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -175.77 179.2 47.07 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.256 -0.497 . . . . 50.0 112.618 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.02 148.72 21.57 Favored 'Cis proline' 0 C--N 1.368 1.573 0 CA-C-N 118.616 1.208 . . . . 50.0 113.834 0.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -120.54 176.0 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.91 1.284 . . . . 50.0 109.449 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 7.0 p -142.24 116.68 9.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.196 0.598 . . . . 50.0 111.381 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 44' ' ' VAL . 23.3 t -73.95 139.93 18.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.111 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -113.02 -45.82 3.15 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.681 1.238 . . . . 50.0 109.984 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 61.8 tp -127.89 145.55 50.91 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.519 -0.764 . . . . 50.0 109.363 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.479 HG22 HD22 ' A' ' 42' ' ' LEU . 69.6 p -129.74 129.48 44.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.782 0.833 . . . . 50.0 109.189 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -126.29 162.63 45.09 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.618 1.167 . . . . 50.0 108.231 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -47.81 118.31 2.98 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.968 2.445 . . . . 50.0 114.261 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p 61.59 10.92 3.55 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.279 1.832 . . . . 50.0 113.972 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -149.09 123.32 9.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.17 0.441 . . . . 50.0 110.176 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 37' ' ' THR . 38.0 mt -110.87 124.54 52.27 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.422 -0.584 . . . . 50.0 109.422 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -85.92 108.63 18.27 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.657 -0.868 . . . . 75.0 108.657 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 34' ' ' VAL . 18.4 t -109.99 146.87 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.338 -1.301 . . . . 50.0 108.606 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 132.78 46.7 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.82 -8.11 57.8 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.528 0.517 . . . . 50.0 111.976 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.557 HG21 HG12 ' A' ' 51' ' ' ILE . 40.6 mm -105.17 150.2 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.951 0.901 . . . . 50.0 110.403 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 -51.09 71.07 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.044 0.938 . . . . 50.0 111.966 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.22 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.248 0.342 . . . . 50.0 111.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 20.1 m-90 -142.9 149.89 39.07 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.743 0.417 . . . . 50.0 110.959 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.557 HG12 HG21 ' A' ' 47' ' ' ILE . 26.8 mm -121.52 128.32 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 167.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -59.97 136.1 57.91 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.903 0.481 . . . . 50.0 110.011 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.79 -33.59 49.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.009 1.485 . . . . 50.0 115.009 -163.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.45 67.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.396 0.517 . . . . 50.0 112.396 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -68.76 -25.03 64.52 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.648 0.379 . . . . 50.0 111.233 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -96.89 125.39 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 122.519 0.328 . . . . 50.0 110.444 -168.3 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -106.61 126.23 52.01 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.875 0.87 . . . . 75.0 108.809 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -77.68 106.51 9.54 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.424 -0.584 . . . . 50.0 109.424 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 50.0 109.074 178.351 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.661 0.267 . . . . 75.0 111.273 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.97 125.74 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.439 -0.578 . . . . 50.0 109.439 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 108.53 8.5 28.52 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.296 -0.725 . . . . 50.0 112.484 -172.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -67.68 113.71 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.938 0.495 . . . . 50.0 109.885 -173.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 59' ' ' ALA . 91.3 m -77.86 127.23 32.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.696 0.399 . . . . 50.0 111.236 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.402 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 33.6 m -139.22 -178.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 50.0 109.645 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 33.9 m0 -116.7 157.5 25.35 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.961 1.304 . . . . 50.0 108.478 169.181 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.38 103.32 15.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 106.463 -1.68 . . . . 50.0 106.463 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -78.94 91.03 4.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.077 -1.42 . . . . 75.0 108.872 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 123.826 0.85 . . . . 75.0 111.73 -171.001 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.052 -1.092 . . . . 75.0 108.052 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 60.9 p-90 -130.61 153.92 48.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.693 0.679 . . . . 50.0 110.521 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -126.71 148.23 49.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 75.0 108.714 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.502 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -164.58 -176.63 36.52 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.555 -0.58 . . . . 50.0 112.378 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.89 115.81 2.13 Favored 'Cis proline' 0 CA--C 1.564 1.998 0 CA-C-N 118.91 1.355 . . . . 50.0 112.786 -5.237 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -84.79 154.08 22.59 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.755 0.822 . . . . 50.0 111.918 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.595 HG23 ' HA2' ' A' ' 11' ' ' GLY . 98.3 m -107.08 117.77 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 50.0 110.201 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 46.8 t -95.24 136.52 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.119 0.968 . . . . 50.0 109.209 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.16 -28.74 8.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.827 . . . . 50.0 110.689 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 46.4 tp -146.95 144.46 29.23 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.767 -0.457 . . . . 50.0 109.767 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.9 p -132.4 128.89 38.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.936 0.894 . . . . 50.0 109.63 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -134.38 158.42 75.23 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.855 0.862 . . . . 50.0 109.226 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -48.16 124.67 10.67 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.271 2.647 . . . . 50.0 112.81 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m 75.34 -13.83 0.82 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.25 1.42 . . . . 50.0 112.953 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.39 122.01 11.82 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.429 -0.794 . . . . 50.0 110.693 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.479 HD12 HG11 ' A' ' 56' ' ' VAL . 32.0 mt -114.9 123.68 49.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.306 0.642 . . . . 50.0 109.343 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.3 tttp -84.46 107.16 16.57 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.68 0.752 . . . . 75.0 109.247 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.604 HG22 HG22 ' A' ' 34' ' ' VAL . 34.5 t -101.81 142.84 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.963 -1.472 . . . . 50.0 108.047 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.34 136.54 58.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.411 0.684 . . . . 50.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.32 32.39 Favored Glycine 0 C--N 1.345 1.074 0 O-C-N 123.676 0.61 . . . . 50.0 113.096 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.66 153.92 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.583 0.753 . . . . 50.0 110.744 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.32 -51.16 56.81 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.058 1.343 . . . . 50.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.08 -56.18 0.14 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.485 0.49 . . . . 50.0 110.53 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -141.17 157.1 45.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.92 0.488 . . . . 50.0 110.91 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.99 130.88 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.83 1.252 . . . . 50.0 107.997 167.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -58.07 128.44 37.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.702 -0.851 . . . . 50.0 108.702 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -23.36 58.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.349 1.241 . . . . 50.0 114.349 -163.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.82 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 50.0 112.055 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -100.19 21.18 13.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.604 1.162 . . . . 50.0 110.514 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG11 HD12 ' A' ' 42' ' ' LEU . 61.2 t -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.743 -0.836 . . . . 50.0 108.743 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -129.81 109.99 11.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.444 -0.947 . . . . 75.0 108.444 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -57.46 131.86 51.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.091 0.956 . . . . 50.0 112.23 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB3' HG22 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.372 0.669 . . . . 50.0 110.074 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 120.728 0.299 . . . . 75.0 110.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.25 135.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.748 1.219 . . . . 50.0 110.277 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.717 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 94.33 11.12 57.63 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.222 -0.766 . . . . 50.0 113.504 -171.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.773 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -51.66 113.22 0.92 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.184 0.994 . . . . 50.0 111.342 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.432 HG22 ' HB3' ' A' ' 59' ' ' ALA . 23.3 m -72.85 108.2 5.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 50.0 110.289 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 34.3 m -132.39 179.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.19 0.996 . . . . 50.0 110.791 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.428 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -129.99 154.13 47.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.407 1.483 . . . . 50.0 108.23 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.5 104.56 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 121.625 0.726 . . . . 50.0 109.536 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -81.95 104.92 12.65 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.883 1.673 . . . . 75.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.3 ttm105 . . . . . 0 N--CA 1.484 1.267 0 O-C-N 121.608 -0.682 . . . . 75.0 112.13 -172.343 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 . . . . . 0 C--O 1.239 0.545 0 N-CA-C 109.929 -0.397 . . . . 75.0 109.929 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.77 141.83 33.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.99 0.516 . . . . 50.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -113.04 158.16 20.66 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.464 -0.939 . . . . 75.0 108.464 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -173.63 170.21 43.34 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.015 -0.612 . . . . 50.0 113.589 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.02 160.85 70.11 Favored 'Cis proline' 0 C--N 1.376 1.985 0 C-N-CA 123.93 -1.279 . . . . 50.0 112.978 -5.353 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' HB3' HG11 ' A' ' 44' ' ' VAL . 79.7 m-85 -129.8 164.02 24.97 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.028 1.331 . . . . 50.0 109.361 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.717 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 57.6 p -137.05 111.7 8.72 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.516 0.726 . . . . 50.0 110.566 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.773 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.8 t -79.12 119.24 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 50.0 109.427 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.34 -21.11 22.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.553 0.741 . . . . 50.0 110.983 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.5 tp -156.11 140.2 16.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.622 0.369 . . . . 50.0 110.786 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.629 HG22 HD22 ' A' ' 42' ' ' LEU . 40.2 p -107.38 128.9 54.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.725 . . . . 50.0 109.877 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.3 p -125.82 165.18 28.54 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 124.382 1.073 . . . . 50.0 109.018 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -49.83 116.76 2.56 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.134 2.556 . . . . 50.0 112.194 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 t 54.74 17.22 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.996 2.118 . . . . 50.0 114.533 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -148.55 140.57 23.93 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.973 0.509 . . . . 50.0 110.054 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.701 HD12 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -115.11 123.0 47.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.023 0.529 . . . . 50.0 109.69 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.51 108.48 17.95 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.504 -0.924 . . . . 75.0 108.504 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 34' ' ' VAL . 55.0 t -110.13 143.36 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.675 1.19 . . . . 50.0 109.938 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.9 135.27 57.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.452 1.101 . . . . 50.0 110.231 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.92 -21.99 27.72 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 123.195 0.426 . . . . 50.0 112.991 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 51' ' ' ILE . 40.2 mm -82.18 153.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.551 1.14 . . . . 50.0 109.707 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.89 68.04 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.186 0.594 . . . . 50.0 111.407 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.42 -60.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.133 0.42 . . . . 50.0 112.133 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.487 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.5 m-90 -143.34 138.54 29.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.876 0.47 . . . . 50.0 110.944 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 47' ' ' ILE . 42.9 mm -103.76 117.09 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 106.976 -1.49 . . . . 50.0 106.976 164.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -58.7 145.51 39.86 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.514 -0.55 . . . . 50.0 109.514 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.58 -34.82 52.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.853 1.261 . . . . 50.0 113.726 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -24.96 61.51 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.198 0.999 . . . . 50.0 113.035 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -107.31 24.56 12.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.5 1.12 . . . . 50.0 110.708 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.701 HG11 HD12 ' A' ' 42' ' ' LEU . 24.9 t -128.28 149.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -133.77 122.65 23.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.26 -1.015 . . . . 75.0 108.26 166.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 109.77 1.33 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.477 0.711 . . . . 50.0 109.69 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.472 0.632 0 C-N-CA 123.767 0.827 . . . . 50.0 110.223 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 110.414 -0.217 . . . . 75.0 110.414 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 6.5 m -61.3 108.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.251 -1.018 . . . . 50.0 108.251 168.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.576 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.19 9.69 11.61 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.262 -0.743 . . . . 50.0 113.005 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.668 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.2 t0 -59.77 113.76 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.13 0.572 . . . . 50.0 109.556 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -72.56 114.1 10.32 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.587 . . . . 50.0 109.414 -172.119 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.13 176.57 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.906 1.282 . . . . 50.0 109.743 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.407 ' CE3' ' HD2' ' A' ' 57' ' ' LYS . 47.9 m0 -125.01 148.85 48.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.935 -1.506 . . . . 50.0 106.935 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.19 104.77 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 42.7 ttm180 -69.16 93.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.636 1.175 . . . . 75.0 109.496 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 . . . . . 0 C--O 1.244 0.802 0 CA-C-N 116.052 -0.522 . . . . 75.0 109.803 -176.582 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 . . . . . 0 C--O 1.24 0.558 0 N-CA-C 109.087 -0.709 . . . . 75.0 109.087 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 60.9 p-90 -76.67 149.17 36.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.101 0.477 . . . . 50.0 110.024 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -126.73 141.06 51.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.529 -1.286 . . . . 75.0 107.529 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.97 175.4 47.48 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.4 -0.667 . . . . 50.0 113.12 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -89.77 120.16 4.31 Favored 'Cis proline' 0 C--N 1.377 2.063 0 CA-C-N 119.112 1.456 . . . . 50.0 114.14 4.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.83 179.33 6.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.7 1.2 . . . . 50.0 111.512 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.576 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 41.4 p -138.81 113.75 9.29 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.944 0.898 . . . . 50.0 111.096 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.668 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.8 t -68.09 122.76 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 50.0 109.89 170.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 67.7 mt -93.87 -26.23 16.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.145 -0.934 . . . . 50.0 110.523 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 67.7 tp -152.29 144.04 23.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.254 0.549 . . . . 50.0 111.402 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.6 m -110.29 145.82 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 50.0 109.199 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 p -146.58 162.38 34.29 Favored Pre-proline 0 C--O 1.25 1.079 0 C-N-CA 124.717 1.207 . . . . 50.0 108.777 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.27 108.85 0.3 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.629 2.219 . . . . 50.0 112.728 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 65.61 23.48 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.864 1.666 . . . . 50.0 112.137 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -153.42 158.89 42.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.054 0.454 . . . . 50.0 110.957 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.8 123.63 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.569 1.148 . . . . 50.0 108.326 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.1 tttp -84.25 109.61 17.91 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.903 -1.147 . . . . 75.0 107.903 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 97.3 t -92.62 156.67 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.415 -1.266 . . . . 50.0 108.603 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.55 134.08 56.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.932 0.893 . . . . 50.0 110.094 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.53 73.29 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.42 -0.655 . . . . 50.0 113.682 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -85.83 144.98 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 117.739 0.77 . . . . 50.0 110.188 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.09 70.32 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.115 1.366 . . . . 50.0 111.79 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.91 -58.39 0.22 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.728 0.27 . . . . 50.0 111.728 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 8.6 m-90 -144.76 157.54 44.14 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.161 0.505 . . . . 50.0 111.752 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.8 mm -121.65 129.39 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.027 -1.471 . . . . 50.0 107.027 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -55.46 127.67 30.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.596 -0.89 . . . . 50.0 108.596 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.64 -38.66 55.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.937 1.295 . . . . 50.0 113.856 -164.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.23 -4.01 19.7 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.467 0.914 . . . . 50.0 113.467 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -97.56 15.69 22.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.148 0.979 . . . . 50.0 110.397 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.99 130.37 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.292 0.637 . . . . 50.0 109.564 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HD2' ' CE3' ' A' ' 15' ' ' TRP . 25.0 ttmm -112.47 122.07 46.64 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.712 0.805 . . . . 75.0 109.094 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.516 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -65.63 126.79 29.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.911 -0.403 . . . . 50.0 109.911 176.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.955 0.902 . . . . 50.0 109.895 -179.106 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.853 0.686 . . . . 75.0 112.853 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 33.0 m -70.96 142.6 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 114.949 -1.023 . . . . 50.0 110.425 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.67 9.37 81.37 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.79 -1.005 . . . . 50.0 114.28 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.43 124.66 23.81 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.447 1.124 . . . . 50.0 110.249 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.5 m -71.61 114.4 9.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.13 0.572 . . . . 50.0 110.739 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.9 m -135.98 178.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.28 1.032 . . . . 50.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.409 ' HE3' ' HD3' ' A' ' 57' ' ' LYS . 34.5 m0 -126.77 153.2 45.87 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.9 1.28 . . . . 50.0 108.348 174.32 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.16 105.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 107.439 -1.319 . . . . 50.0 107.439 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.689 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 76.2 ttt180 -81.12 92.36 6.26 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.91 -1.041 . . . . 75.0 109.821 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 . . . . . 0 C--O 1.243 0.742 0 CA-C-N 115.421 -0.809 . . . . 75.0 110.316 -176.811 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.42 -0.215 . . . . 75.0 110.42 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.689 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 61.9 p-90 -74.01 150.06 40.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.977 0.511 . . . . 50.0 110.887 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.29 143.99 49.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.091 0.957 . . . . 75.0 108.624 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.9 -177.08 25.27 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 111.603 -0.599 . . . . 50.0 111.603 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.16 121.65 6.83 Favored 'Cis proline' 0 C--N 1.37 1.664 0 CA-C-N 119.564 1.682 . . . . 50.0 111.855 -9.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -106.99 170.2 8.09 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.522 0.729 . . . . 50.0 110.003 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -150.81 115.79 5.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.157 0.583 . . . . 50.0 111.498 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.67 127.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.104 0.562 . . . . 50.0 111.49 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 77.2 mt -95.49 -38.31 10.5 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.492 1.117 . . . . 50.0 110.475 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.4 tp -145.24 149.22 34.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.445 0.698 . . . . 50.0 110.06 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.456 HG22 HD22 ' A' ' 42' ' ' LEU . 37.1 p -112.97 130.4 56.14 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.744 0.818 . . . . 50.0 109.337 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -127.54 148.54 67.02 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.51 117.43 2.34 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.624 2.216 . . . . 50.0 113.031 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 m 75.58 -2.28 2.83 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.514 1.525 . . . . 50.0 112.812 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.821 -0.549 . . . . 50.0 110.586 -173.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 37' ' ' THR . 46.0 mt -108.75 125.23 51.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.927 0.491 . . . . 50.0 109.676 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.7 ttmm -83.91 110.89 18.76 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.862 -0.792 . . . . 75.0 108.862 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.34 146.14 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.822 1.249 . . . . 50.0 109.333 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.07 127.73 33.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.947 0.899 . . . . 50.0 109.771 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.25 -0.93 50.49 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.817 -0.629 . . . . 50.0 112.485 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.52 148.94 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.738 0.815 . . . . 50.0 109.242 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.07 86.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.182 0.993 . . . . 50.0 112.506 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.28 -58.03 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.327 0.251 . . . . 50.0 111.382 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.507 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.8 m-90 -143.76 147.13 33.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.241 0.616 . . . . 50.0 111.382 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.0 mm -101.55 138.71 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 107.968 -1.123 . . . . 50.0 107.968 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.25 119.55 8.12 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 107.721 -1.214 . . . . 50.0 107.721 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.11 20.94 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.266 1.426 . . . . 50.0 114.593 -164.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.48 -2.77 14.97 Favored 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 113.197 0.814 . . . . 50.0 113.197 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -115.76 17.34 16.15 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.525 1.13 . . . . 50.0 110.632 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -117.24 133.59 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.409 ' HD3' ' HE3' ' A' ' 15' ' ' TRP . 64.4 tttp -121.49 121.24 37.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.976 0.911 . . . . 75.0 109.334 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -64.47 118.18 8.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.306 0.642 . . . . 50.0 110.709 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 50.0 109.879 179.878 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 113.04 0.755 . . . . 75.0 113.04 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 35' ' ' LEU . 16.2 m -73.53 137.61 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.232 -1.025 . . . . 50.0 108.232 172.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 90.79 11.02 62.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-O 118.999 -0.89 . . . . 50.0 112.459 -172.334 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 64.0 t0 -57.62 97.74 0.03 OUTLIER 'General case' 0 C--N 1.365 1.275 0 C-N-CA 123.557 0.743 . . . . 50.0 109.062 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 m -71.52 118.59 14.53 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 109.484 -0.561 . . . . 50.0 109.484 -169.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.4 m -135.57 170.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 C-N-CA 125.513 1.525 . . . . 50.0 109.741 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 50.4 m0 -117.68 142.14 47.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.617 1.167 . . . . 50.0 108.082 171.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.23 109.3 27.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 107.298 -1.371 . . . . 50.0 107.298 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 48.6 ttt180 -90.51 100.2 13.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.043 1.337 . . . . 75.0 109.963 -171.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 75.0 111.273 -172.857 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 109.207 -0.664 . . . . 75.0 109.207 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 67.5 p-90 -71.66 158.5 36.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.257 0.623 . . . . 50.0 111.032 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -133.95 149.12 51.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.741 0.816 . . . . 75.0 108.855 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.76 176.82 40.52 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.851 -0.416 . . . . 50.0 112.895 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -92.92 104.77 0.37 Allowed 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 118.601 1.201 . . . . 50.0 112.276 -1.439 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -74.74 161.26 29.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.646 -0.872 . . . . 50.0 108.646 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.635 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 59.7 p -141.5 111.9 6.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.41 0.284 . . . . 50.0 110.321 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 24.1 t -68.37 124.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 C-N-CA 123.41 0.684 . . . . 50.0 110.028 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' VAL . 48.1 mt -99.03 -20.68 16.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.591 1.156 . . . . 50.0 110.895 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 54.0 tp -153.73 137.36 16.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.677 0.791 . . . . 50.0 109.734 175.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 42' ' ' LEU . 38.0 p -112.31 128.96 56.43 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.639 -0.874 . . . . 50.0 108.639 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.7 p -133.39 165.19 38.58 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.439 1.095 . . . . 50.0 109.148 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 6.3 Cg_endo -46.82 108.98 0.17 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.559 2.839 . . . . 50.0 113.523 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.1 p 56.08 20.37 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 126.039 1.736 . . . . 50.0 113.737 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.0 138.83 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.809 -0.811 . . . . 50.0 108.809 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 37' ' ' THR . 64.4 mt -127.89 129.02 46.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.405 -0.591 . . . . 50.0 109.405 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -86.27 107.39 17.92 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.055 -1.461 . . . . 75.0 107.055 168.533 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 21.7 t -104.79 160.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.164 -0.926 . . . . 50.0 108.79 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -66.32 129.04 38.48 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.453 0.701 . . . . 50.0 109.51 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.21 -4.49 86.17 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.586 0.554 . . . . 50.0 113.039 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.95 137.54 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.875 0.87 . . . . 50.0 109.503 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.68 72.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.974 0.91 . . . . 50.0 111.441 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.35 -56.15 0.17 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.583 0.586 . . . . 50.0 112.583 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -141.19 138.24 33.22 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.344 0.52 . . . . 50.0 111.801 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.3 mm -120.45 127.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.191 -1.411 . . . . 50.0 107.191 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -56.64 122.84 13.0 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.221 -0.659 . . . . 50.0 109.221 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.39 -21.37 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.735 1.614 . . . . 50.0 114.817 -166.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.11 65.4 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.301 0.852 . . . . 50.0 113.301 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -87.74 -12.53 44.97 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.856 0.462 . . . . 50.0 111.218 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.6 t -101.76 139.83 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 50.0 109.81 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -138.99 129.75 26.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 75.0 109.62 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.547 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.4 126.54 29.6 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.277 0.631 . . . . 50.0 112.342 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 C-N-CA 124.474 1.11 . . . . 50.0 111.304 -179.105 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.055 0.455 . . . . 75.0 111.478 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.8 m -67.87 135.54 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.265 -0.879 . . . . 50.0 111.053 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.57 62.63 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.672 -0.516 . . . . 50.0 112.613 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.1 t0 -65.57 115.98 6.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.694 0.798 . . . . 50.0 110.601 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.41 HG22 ' HB3' ' A' ' 59' ' ' ALA . 38.3 m -73.31 111.88 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.218 0.607 . . . . 50.0 110.328 -173.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.2 m -136.37 -176.56 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.818 1.247 . . . . 50.0 110.616 -174.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.7 m0 -131.95 157.71 43.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.516 1.526 . . . . 50.0 107.814 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.12 104.37 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.536 -0.913 . . . . 50.0 108.536 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 57' ' ' LYS . 67.5 ttt180 -79.01 96.53 5.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.466 1.106 . . . . 75.0 110.44 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.098 0.475 . . . . 75.0 111.833 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 110.017 -0.364 . . . . 75.0 110.017 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -81.35 153.18 27.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.498 0.666 . . . . 50.0 110.711 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -127.62 137.87 52.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.574 -1.269 . . . . 75.0 107.574 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.91 38.05 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.306 -0.473 . . . . 50.0 112.79 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.14 122.09 5.86 Favored 'Cis proline' 0 CA--C 1.559 1.756 0 C-N-CA 123.753 -1.353 . . . . 50.0 112.878 -4.113 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.18 178.97 7.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.576 0.75 . . . . 50.0 110.0 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 25.6 p -138.15 113.34 9.33 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.908 0.483 . . . . 50.0 110.983 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.5 t -64.99 135.82 27.65 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 CA-C-O 121.242 0.544 . . . . 50.0 109.666 170.256 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 66.5 mt -104.53 -44.98 4.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.085 -0.961 . . . . 50.0 109.258 173.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.4 tp -142.19 147.67 36.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.727 -0.67 . . . . 50.0 109.765 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.445 HG22 HD22 ' A' ' 42' ' ' LEU . 30.9 p -104.63 144.27 31.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.781 0.833 . . . . 50.0 109.164 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -140.35 149.07 56.45 Favored Pre-proline 0 CA--C 1.556 1.198 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -39.56 121.61 0.83 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.044 2.496 . . . . 50.0 114.021 170.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t 53.07 14.48 0.48 Allowed 'General case' 0 N--CA 1.504 2.261 0 C-N-CA 126.745 2.018 . . . . 50.0 114.826 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -153.82 124.58 7.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.794 0.438 . . . . 50.0 110.465 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD12 ' HB ' ' A' ' 56' ' ' VAL . 86.8 mt -103.0 126.05 50.02 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.269 -0.641 . . . . 50.0 109.269 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 51.5 tttm -86.85 108.96 18.98 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 108.706 -0.85 . . . . 75.0 108.706 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 34' ' ' VAL . 58.4 t -116.31 141.65 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.822 -1.081 . . . . 50.0 109.345 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.95 137.64 57.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.393 0.677 . . . . 50.0 110.768 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.75 21.65 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.563 -0.744 . . . . 50.0 111.928 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 51' ' ' ILE . 50.1 mm -87.0 146.77 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.975 0.91 . . . . 50.0 109.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.56 -49.43 64.96 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.225 1.01 . . . . 50.0 111.151 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -151.17 -59.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.16 0.287 . . . . 50.0 111.519 167.47 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.473 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 18.0 m-90 -135.5 144.95 46.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.931 -0.481 . . . . 50.0 112.0 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 47' ' ' ILE . 35.9 mm -110.76 137.6 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.145 -1.428 . . . . 50.0 107.145 163.972 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -57.07 129.21 40.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.79 -32.44 65.67 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.048 1.129 . . . . 50.0 114.048 -163.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 -11.35 60.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.313 0.645 . . . . 50.0 112.415 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -102.39 22.8 12.8 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.406 1.082 . . . . 50.0 111.044 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 42' ' ' LEU . 59.8 t -135.72 125.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.206 -0.664 . . . . 50.0 109.206 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD2' ' HD2' ' A' ' 17' ' ' ARG . 48.2 mtpt -114.45 129.82 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.601 0.761 . . . . 75.0 109.783 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.63 120.88 15.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.583 0.353 . . . . 50.0 110.181 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.251 0.62 . . . . 50.0 110.281 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.497 0.189 . . . . 75.0 111.495 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.406 ' HB ' HD22 ' A' ' 35' ' ' LEU . 21.3 m -69.46 139.26 20.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 116.045 -0.525 . . . . 50.0 109.888 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 101.11 9.78 44.17 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.559 -0.579 . . . . 50.0 112.875 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.5 t0 -58.28 109.39 0.76 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.026 0.53 . . . . 50.0 110.622 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.6 m -71.62 111.66 7.1 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.142 0.496 . . . . 50.0 109.843 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.15 -175.1 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.565 1.146 . . . . 50.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 31.0 m0 -124.38 156.77 36.52 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.053 1.341 . . . . 50.0 107.722 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 52.2 t -109.75 114.58 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.417 -0.956 . . . . 50.0 108.417 171.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 55' ' ' HIS . 39.3 ttm180 -76.97 123.77 26.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.158 0.983 . . . . 75.0 110.108 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 108.854 -0.795 . . . . 75.0 108.854 168.246 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 108.834 -0.802 . . . . 75.0 108.834 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -146.21 163.34 35.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.383 0.673 . . . . 50.0 110.296 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -131.31 161.12 33.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.726 -0.842 . . . . 75.0 108.726 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -170.91 -177.55 40.9 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-O 119.402 -0.666 . . . . 50.0 111.896 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.32 116.73 3.64 Favored 'Cis proline' 0 C--N 1.376 2.013 0 CA-C-N 119.408 1.604 . . . . 50.0 113.117 -4.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HB3' HG11 ' A' ' 44' ' ' VAL . 77.9 m-85 -80.45 169.41 17.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.825 0.85 . . . . 50.0 110.408 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.523 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.9 p -140.28 110.49 6.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.422 0.689 . . . . 50.0 110.685 -176.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 65.3 t -73.38 130.45 35.78 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 123.064 0.546 . . . . 50.0 109.743 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.406 HD22 ' HB ' ' A' ' 10' ' ' VAL . 41.1 mt -98.22 -54.66 3.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.302 -0.863 . . . . 50.0 109.393 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 28.9 tp -110.26 139.63 45.24 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.18 0.592 . . . . 50.0 109.651 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.432 HG22 HD22 ' A' ' 42' ' ' LEU . 69.0 p -127.89 129.25 46.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.353 0.661 . . . . 50.0 109.353 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -145.15 161.09 43.65 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.094 1.358 . . . . 50.0 108.454 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -43.62 109.0 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.662 2.908 . . . . 50.0 114.832 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m 65.08 13.15 8.5 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.03 1.332 . . . . 50.0 112.456 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.85 121.89 14.64 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.705 -0.622 . . . . 50.0 110.012 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.485 HD12 HG11 ' A' ' 56' ' ' VAL . 62.1 mt -121.8 122.19 38.93 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.818 -1.179 . . . . 50.0 107.818 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 82.9 tttt -93.85 111.46 23.17 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.261 -0.644 . . . . 75.0 109.261 176.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 32' ' ' TYR . 76.7 t -86.49 156.24 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 O-C-N 124.347 1.03 . . . . 50.0 109.385 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.35 116.2 4.1 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.89 0.876 . . . . 50.0 110.706 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.44 -14.81 32.79 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.226 -0.443 . . . . 50.0 113.214 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 51' ' ' ILE . 39.5 mm -77.96 143.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.532 0.733 . . . . 50.0 111.24 -177.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.4 -50.7 69.06 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.648 1.179 . . . . 50.0 112.259 -176.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.31 -58.1 0.18 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.219 0.451 . . . . 50.0 112.219 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -143.92 150.03 37.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.683 0.393 . . . . 50.0 111.111 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 47' ' ' ILE . 33.1 mm -112.98 122.27 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.439 -0.949 . . . . 50.0 108.439 166.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.54 124.78 22.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.855 -1.535 . . . . 50.0 106.855 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.32 -18.75 7.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.259 1.577 . . . . 50.0 115.259 -160.624 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.65 -4.93 34.04 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.537 0.735 . . . . 50.0 112.352 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 97.7 m-70 -104.11 17.35 24.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.099 0.96 . . . . 50.0 109.967 169.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG11 HD12 ' A' ' 42' ' ' LEU . 54.6 t -124.61 136.34 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.771 0.428 . . . . 50.0 109.902 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 52.7 mtpt -133.67 115.39 14.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 75.0 108.202 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.39 121.51 12.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 50.0 111.364 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 123.702 0.801 . . . . 50.0 111.252 -175.69 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.907 -0.405 . . . . 75.0 109.907 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.7 m -57.27 136.36 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.945 0.898 . . . . 50.0 110.861 -175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.17 9.62 61.86 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 118.855 -0.97 . . . . 50.0 114.115 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.7 t0 -55.11 114.92 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.784 0.834 . . . . 50.0 111.645 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 m -74.82 107.59 7.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.31 165.49 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.46 0.704 . . . . 50.0 110.948 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.585 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -116.53 131.27 56.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.411 1.084 . . . . 50.0 108.188 172.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 56' ' ' VAL . 58.2 t -107.35 110.27 31.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.887 -1.153 . . . . 50.0 107.887 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 59.4 ttp180 -85.5 106.08 16.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 75.0 110.714 -174.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 N--CA 1.472 0.651 0 C-N-CA 124.707 1.203 . . . . 75.0 111.183 -177.154 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.925 -0.398 . . . . 75.0 109.925 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 69.0 p-90 -73.91 142.25 45.97 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.359 -0.608 . . . . 50.0 109.359 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.29 143.83 50.77 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.325 -0.991 . . . . 75.0 108.325 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.585 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 171.01 -173.87 44.72 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.683 -0.77 . . . . 50.0 113.555 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -88.02 115.98 3.22 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 118.446 1.123 . . . . 50.0 113.099 4.49 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -76.59 166.49 23.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.781 0.833 . . . . 50.0 110.672 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.582 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 69.4 p -129.96 111.42 12.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.983 0.513 . . . . 50.0 110.701 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 40.1 t -71.97 129.42 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 108.724 -0.843 . . . . 50.0 108.724 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 76.9 mt -105.77 -33.56 7.96 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.787 0.835 . . . . 50.0 109.789 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.8 tp -146.5 152.2 38.6 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.422 -0.808 . . . . 50.0 110.019 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -132.02 128.53 38.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.123 0.969 . . . . 50.0 108.985 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -123.56 162.88 37.89 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.501 1.52 . . . . 50.0 107.895 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.35 108.44 0.15 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.928 2.418 . . . . 50.0 113.777 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 m 73.98 0.02 3.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.854 1.662 . . . . 50.0 113.01 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -133.99 124.67 26.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.426 0.69 . . . . 50.0 110.119 -173.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.75 121.6 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 50.0 109.269 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.2 tttt -84.91 108.61 17.63 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 107.328 -1.36 . . . . 75.0 107.328 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 34' ' ' VAL . 57.3 t -117.51 146.39 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.578 -1.192 . . . . 50.0 109.482 -171.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.99 137.36 47.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.586 0.754 . . . . 50.0 109.558 173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.51 4.49 80.1 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.666 0.604 . . . . 50.0 112.784 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -117.13 147.91 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.62 1.168 . . . . 50.0 109.292 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.41 -51.41 64.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.996 0.919 . . . . 50.0 112.145 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.06 -57.59 0.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.589 0.356 . . . . 50.0 111.267 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.475 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 14.8 m-90 -142.16 157.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.633 0.773 . . . . 50.0 110.947 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 47' ' ' ILE . 34.8 mm -123.13 134.82 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.579 1.152 . . . . 50.0 108.454 168.366 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -61.49 113.47 2.69 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 108.034 -1.098 . . . . 50.0 108.034 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.61 -19.85 4.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.188 1.551 . . . . 50.0 115.188 -163.515 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.77 -29.85 69.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.73 0.812 . . . . 50.0 112.772 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -71.19 -24.72 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.252 0.621 . . . . 50.0 111.579 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 16' ' ' VAL . 98.4 t -96.6 138.27 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.283 0.633 . . . . 50.0 110.678 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -134.67 143.42 47.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.638 -1.245 . . . . 75.0 107.638 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.994 0.518 . . . . 50.0 110.79 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 123.531 0.732 . . . . 50.0 109.397 178.035 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 119.668 -0.206 . . . . 75.0 110.567 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.21 140.06 20.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 N-CA-C 109.211 -0.663 . . . . 50.0 109.211 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.762 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 82.9 11.14 81.97 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-O 118.657 -1.079 . . . . 50.0 113.176 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 53.2 t0 -50.13 119.86 3.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.688 0.744 . . . . 50.0 110.438 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 59' ' ' ALA . 35.3 m -73.66 110.86 8.28 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.693 -0.685 . . . . 50.0 109.259 -169.591 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.13 157.25 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.057 0.943 . . . . 50.0 110.279 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 30.7 m0 -101.2 143.11 31.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.279 -1.008 . . . . 50.0 108.279 168.465 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.91 112.95 42.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 N-CA-C 109.086 -0.709 . . . . 50.0 109.086 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.2 ttm180 -65.6 109.32 2.34 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.9 1.68 . . . . 75.0 110.745 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 124.175 0.99 . . . . 75.0 110.169 179.099 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 110.447 -0.205 . . . . 75.0 110.447 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 61.9 p-90 -76.08 151.69 37.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.657 0.383 . . . . 50.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -141.07 163.76 32.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.1 0.56 . . . . 75.0 109.743 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -167.93 -162.14 19.19 Favored Glycine 0 CA--C 1.538 1.471 0 N-CA-C 110.985 -0.846 . . . . 50.0 110.985 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.36 114.55 3.1 Favored 'Cis proline' 0 C--N 1.368 1.586 0 CA-C-N 119.365 1.583 . . . . 50.0 112.973 -2.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' HG11 ' A' ' 44' ' ' VAL . 74.5 m-85 -77.67 166.93 22.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.431 0.693 . . . . 50.0 110.072 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.762 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 17.2 p -140.33 111.87 7.34 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.285 0.634 . . . . 50.0 111.283 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.51 HG22 HG22 ' A' ' 44' ' ' VAL . 60.0 t -84.03 125.43 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 122.888 0.475 . . . . 50.0 110.31 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.97 -45.47 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.746 0.818 . . . . 50.0 110.262 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 48.8 tp -132.58 153.71 50.74 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.438 -0.801 . . . . 50.0 109.486 -173.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.483 HG22 HD22 ' A' ' 42' ' ' LEU . 60.5 p -125.65 148.6 48.94 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.148 0.579 . . . . 50.0 110.027 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 40.3 p -140.03 165.93 27.32 Favored Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 125.372 1.469 . . . . 50.0 107.869 175.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.7 Cg_endo -51.92 108.18 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.572 2.182 . . . . 50.0 112.993 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 64.25 20.91 12.36 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.512 1.525 . . . . 50.0 112.581 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.57 129.44 11.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 HG11 ' A' ' 56' ' ' VAL . 33.8 mt -112.95 130.72 56.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.963 -0.46 . . . . 50.0 109.984 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -84.95 109.23 18.01 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.859 -0.793 . . . . 75.0 108.859 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 47' ' ' ILE . 86.7 t -97.26 149.05 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 113.984 -1.462 . . . . 50.0 109.277 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.45 130.2 42.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.885 0.874 . . . . 50.0 111.008 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.88 -7.31 70.22 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.051 -0.522 . . . . 50.0 112.959 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.513 HG13 ' HB ' ' A' ' 44' ' ' VAL . 49.0 mm -90.53 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.701 0.8 . . . . 50.0 110.056 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.75 -46.99 81.07 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.935 0.894 . . . . 50.0 111.813 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.79 -58.38 0.17 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.074 0.398 . . . . 50.0 112.074 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -143.28 156.92 44.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.888 0.475 . . . . 50.0 111.806 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 38.6 mm -120.44 118.24 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.109 1.364 . . . . 50.0 107.346 165.365 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -68.54 151.71 46.39 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.705 0.802 . . . . 50.0 109.268 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.3 61.02 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 115.846 1.795 . . . . 50.0 115.846 -161.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.57 -19.79 60.79 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.448 0.536 . . . . 50.0 112.448 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.27 -14.96 58.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.721 0.409 . . . . 50.0 110.446 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 42' ' ' LEU . 40.5 t -99.22 137.75 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.992 0.425 . . . . 50.0 110.068 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 51.4 mtpt -136.38 137.52 40.62 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.379 1.072 . . . . 75.0 108.208 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 136.58 57.48 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.857 0.463 . . . . 50.0 110.491 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' HG22 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.111 0.965 . . . . 50.0 110.868 -175.373 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.674 -0.491 . . . . 75.0 109.674 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 3.3 m -63.45 106.27 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.128 -0.693 . . . . 50.0 109.128 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.08 9.08 12.42 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.061 -0.855 . . . . 50.0 113.166 -167.353 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 52.7 t0 -62.12 132.1 51.72 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 117.747 0.773 . . . . 50.0 111.434 -175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 59' ' ' ALA . 19.2 m -82.44 106.56 14.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.478 0.711 . . . . 50.0 110.825 -173.709 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 24.6 m -131.76 -177.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.591 1.156 . . . . 50.0 109.874 177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.461 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.6 m0 -128.1 154.22 45.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.411 1.484 . . . . 50.0 107.542 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.8 t -108.13 107.92 23.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.831 -1.174 . . . . 50.0 107.831 171.762 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 50.9 ttp180 -82.43 94.16 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.583 1.153 . . . . 75.0 109.422 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 109.432 -0.581 . . . . 75.0 109.432 -178.563 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.8 -0.815 . . . . 75.0 108.8 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.3 p-90 -86.84 152.59 22.34 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.033 0.444 . . . . 50.0 111.679 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -136.09 164.05 28.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.745 1.218 . . . . 75.0 107.916 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.09 -159.98 32.71 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.563 -0.576 . . . . 50.0 112.608 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.74 120.05 6.52 Favored 'Cis proline' 0 C--N 1.376 2.02 0 CA-C-N 119.144 1.472 . . . . 50.0 112.964 -2.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' HB3' HG11 ' A' ' 44' ' ' VAL . 84.5 m-85 -81.98 154.39 25.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.987 0.915 . . . . 50.0 109.666 172.858 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 40.9 p -114.6 110.75 20.27 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.737 0.415 . . . . 50.0 111.442 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 44' ' ' VAL . 79.4 t -70.69 130.71 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.153 0.581 . . . . 50.0 109.498 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 62.4 mt -103.43 -58.66 1.84 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.043 0.937 . . . . 50.0 109.266 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 59.6 tp -123.65 155.97 36.75 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.215 -0.902 . . . . 50.0 109.659 -172.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.504 HG22 HD22 ' A' ' 42' ' ' LEU . 69.2 p -125.97 130.05 50.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.905 0.882 . . . . 50.0 109.724 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -140.07 95.28 8.53 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 124.247 1.019 . . . . 50.0 108.976 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -27.28 127.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 1 C-N-CA 125.632 4.221 . . . . 50.0 116.471 -166.268 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.8 m 86.79 -12.22 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.499 1.919 . . . . 50.0 111.65 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -152.23 149.77 29.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.762 -0.586 . . . . 50.0 110.861 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.681 HD12 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -120.42 134.45 55.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.536 -0.913 . . . . 50.0 108.536 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.8 tttm -83.47 108.9 16.92 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.604 -0.887 . . . . 75.0 108.604 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 34' ' ' VAL . 63.0 t -108.86 135.9 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.627 1.171 . . . . 50.0 109.512 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.454 ' HB2' HD11 ' A' ' 35' ' ' LEU . 23.7 t70 -68.02 143.27 55.62 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.607 0.763 . . . . 50.0 110.646 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.59 -19.17 49.49 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.366 -0.379 . . . . 50.0 112.394 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -94.0 159.06 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.254 1.022 . . . . 50.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.44 -52.13 60.42 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 123.841 0.856 . . . . 50.0 111.538 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.12 -57.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.271 0.357 . . . . 50.0 111.666 169.391 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.1 m-90 -136.47 134.76 37.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.902 0.481 . . . . 50.0 111.74 -173.098 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.7 mm -94.72 125.24 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 166.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -64.28 136.62 57.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.548 -1.279 . . . . 50.0 107.548 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -28.65 64.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.793 1.405 . . . . 50.0 114.793 -160.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.9 27.19 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.451 0.537 . . . . 50.0 112.451 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -109.57 9.13 25.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.933 0.893 . . . . 50.0 110.201 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.681 HG11 HD12 ' A' ' 42' ' ' LEU . 37.2 t -105.86 125.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.597 -0.52 . . . . 50.0 109.597 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -125.24 110.94 14.65 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.425 -0.954 . . . . 75.0 108.425 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -58.98 117.46 4.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.53 0.732 . . . . 50.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . . . . . . 0 C--O 1.24 0.56 0 N-CA-C 109.674 -0.491 . . . . 50.0 109.674 -175.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 109.685 -0.487 . . . . 75.0 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.0 131.12 28.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 122.653 0.381 . . . . 50.0 110.103 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.671 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.46 11.69 59.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.3 -0.722 . . . . 50.0 113.342 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 56.7 t0 -51.52 113.47 0.98 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.855 0.862 . . . . 50.0 111.314 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 31' ' ' PRO . 95.5 m -73.11 115.63 12.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.369 0.668 . . . . 50.0 110.51 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.3 168.74 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.689 1.196 . . . . 50.0 110.328 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -112.5 130.75 55.89 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.271 -1.011 . . . . 50.0 108.271 169.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 56' ' ' VAL . 70.6 t -110.65 115.41 49.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.238 -0.653 . . . . 50.0 109.238 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.9 ttm180 -89.29 123.07 33.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.399 1.479 . . . . 75.0 110.438 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 107.763 -1.199 . . . . 75.0 107.763 174.91 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 109.469 -0.567 . . . . 75.0 109.469 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.4 p-90 -96.65 156.55 16.3 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.757 0.423 . . . . 50.0 110.711 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -138.13 172.0 13.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.92 0.888 . . . . 75.0 109.458 167.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.12 46.27 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 115.391 -0.822 . . . . 50.0 111.468 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HB2' HG23 ' A' ' 13' ' ' THR . 89.4 Cg_endo -88.37 106.28 0.71 Allowed 'Cis proline' 0 C--N 1.368 1.596 0 CA-C-N 119.286 1.543 . . . . 50.0 112.479 -2.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB3' HG11 ' A' ' 44' ' ' VAL . 53.0 m-85 -64.69 162.03 16.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.552 0.741 . . . . 50.0 110.384 172.465 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 14.0 p -134.01 111.14 10.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.009 0.524 . . . . 50.0 110.748 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 44' ' ' VAL . 21.7 t -81.91 130.1 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.357 0.663 . . . . 50.0 109.553 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.9 mt -103.56 -32.74 9.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.421 0.689 . . . . 50.0 110.765 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.7 tp -142.89 143.26 31.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.13 -0.693 . . . . 50.0 109.13 -172.769 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.9 p -136.96 132.14 33.96 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.339 0.59 . . . . 50.0 111.01 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -117.42 164.99 16.88 Favored Pre-proline 0 CA--C 1.57 1.739 0 C-N-CA 126.068 1.747 . . . . 50.0 108.585 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -48.75 111.44 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.404 2.736 . . . . 50.0 113.541 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.71 12.24 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.936 1.694 . . . . 50.0 112.961 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -136.58 119.64 16.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.46 119.23 38.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.166 -1.05 . . . . 50.0 108.166 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 81.0 tttt -86.66 106.57 17.7 Favored 'General case' 0 C--O 1.255 1.347 0 N-CA-C 109.222 -0.659 . . . . 75.0 109.222 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 34' ' ' VAL . 38.8 t -91.43 155.33 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 114.378 -1.283 . . . . 50.0 108.976 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.15 123.21 17.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 50.0 111.093 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.93 65.67 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.684 -0.689 . . . . 50.0 113.637 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.8 mm -89.05 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.409 0.684 . . . . 50.0 110.344 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.09 59.92 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.642 1.177 . . . . 50.0 112.04 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.19 -56.75 0.14 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.42 0.45 . . . . 50.0 111.345 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.417 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 20.6 m-90 -144.64 157.08 44.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.11 0.564 . . . . 50.0 111.173 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 mm -118.11 136.09 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.238 1.015 . . . . 50.0 108.355 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -64.24 127.94 33.64 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.474 -0.936 . . . . 50.0 108.474 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.85 -23.11 16.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.86 1.43 . . . . 50.0 114.86 -164.016 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.36 81.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.234 0.614 . . . . 50.0 111.95 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -77.54 2.11 17.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.456 0.702 . . . . 50.0 112.616 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 16' ' ' VAL . 61.3 t -120.07 135.65 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -127.17 143.34 51.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.831 0.853 . . . . 75.0 108.865 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.45 122.35 16.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.14 0.576 . . . . 50.0 110.636 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.508 0.723 . . . . 50.0 110.37 176.63 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 C--O 1.242 0.7 0 N-CA-C 109.37 -0.604 . . . . 75.0 109.37 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.91 144.6 13.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 108.686 -0.857 . . . . 50.0 108.686 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.82 7.81 52.55 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.704 -0.498 . . . . 50.0 112.92 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . 0.762 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -68.0 110.75 4.05 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.399 0.679 . . . . 50.0 109.998 -175.757 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -71.31 117.19 12.53 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.301 0.572 . . . . 50.0 110.049 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.53 -175.67 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.478 1.111 . . . . 50.0 109.844 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 30.8 m0 -128.63 151.37 49.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.755 1.222 . . . . 50.0 107.738 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -109.53 104.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.368 -0.975 . . . . 50.0 108.368 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.1 ttp180 -88.61 93.62 9.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.579 -1.191 . . . . 75.0 110.29 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 115.905 -0.588 . . . . 75.0 110.363 -172.989 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.093 -0.706 . . . . 75.0 109.093 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 66.3 p-90 -93.91 146.64 23.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.615 0.721 . . . . 50.0 112.156 -177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -113.42 157.42 21.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.826 -1.534 . . . . 75.0 108.378 166.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.08 170.96 33.86 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 124.232 0.957 . . . . 50.0 110.934 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.48 161.25 76.77 Favored 'Cis proline' 0 C--N 1.366 1.491 0 CA-C-N 119.355 1.577 . . . . 50.0 111.73 -9.166 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.01 176.49 8.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.462 1.105 . . . . 50.0 110.196 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 t -152.27 111.88 3.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.63 -0.714 . . . . 50.0 111.372 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.762 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 89.9 t -67.83 124.23 22.83 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 C-N-CA 123.887 0.875 . . . . 50.0 109.345 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.95 -18.37 14.06 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.166 -0.924 . . . . 50.0 110.736 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 36.2 tp -145.73 138.65 25.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.89 0.476 . . . . 50.0 110.055 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -107.35 137.15 45.92 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.207 1.003 . . . . 50.0 108.597 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 m -141.16 148.83 53.16 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.115 -1.069 . . . . 50.0 108.115 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.74 108.4 0.15 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.125 1.883 . . . . 50.0 112.949 170.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m 70.45 17.74 6.79 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.516 1.526 . . . . 50.0 112.177 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -154.59 144.81 21.97 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.07 -0.514 . . . . 50.0 110.645 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.04 121.24 23.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.66 -0.867 . . . . 50.0 108.66 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 26.9 ttpp -85.44 109.38 18.41 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.081 -1.081 . . . . 75.0 108.081 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 34' ' ' VAL . 95.5 t -103.75 155.62 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 125.066 1.346 . . . . 50.0 108.902 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.04 121.26 11.99 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.299 0.639 . . . . 50.0 110.994 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.95 24.63 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.862 -0.608 . . . . 50.0 112.879 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.435 HG21 HG12 ' A' ' 51' ' ' ILE . 33.9 mm -76.72 147.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.702 0.801 . . . . 50.0 110.594 -176.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.38 74.11 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 123.688 0.618 . . . . 50.0 111.607 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 -58.21 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.183 0.438 . . . . 50.0 112.183 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 21.2 m-90 -146.42 145.75 30.35 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.219 0.607 . . . . 50.0 112.206 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 47' ' ' ILE . 28.3 mm -106.99 125.68 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.824 0.85 . . . . 50.0 108.899 168.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.36 122.06 12.34 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.266 -1.013 . . . . 50.0 108.266 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.41 -19.19 8.42 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.025 1.491 . . . . 50.0 115.025 -162.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.58 9.84 2.03 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.578 0.751 . . . . 50.0 112.363 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.27 18.63 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 50.0 109.909 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.86 125.33 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.724 0.409 . . . . 50.0 110.149 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 5.7 mtpm? -108.6 110.96 22.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.976 -0.749 . . . . 75.0 108.976 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.04 120.5 14.38 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.234 0.614 . . . . 50.0 111.448 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 123.634 0.773 . . . . 50.0 110.612 -176.571 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.836 0.351 . . . . 75.0 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.4 m -65.54 136.56 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.801 -0.636 . . . . 50.0 110.662 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.09 9.06 82.96 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-O 119.539 -0.59 . . . . 50.0 113.785 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -65.89 106.31 1.52 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.229 -0.656 . . . . 50.0 109.229 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.4 m -72.09 123.53 23.05 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.522 0.677 . . . . 50.0 111.062 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.7 m -139.1 -177.67 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.691 1.196 . . . . 50.0 110.165 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -123.23 158.66 30.39 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.457 1.103 . . . . 50.0 108.194 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.45 102.48 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 56.0 ttp180 -74.08 93.16 2.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.969 1.308 . . . . 75.0 109.789 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 . . . . . 0 CA--C 1.558 1.281 0 C-N-CA 124.333 1.053 . . . . 75.0 109.08 176.916 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 120.522 0.201 . . . . 75.0 110.612 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 70.1 p-90 -73.6 139.7 45.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 167.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -121.04 147.97 44.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.801 0.84 . . . . 75.0 108.759 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.46 175.41 36.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 123.785 0.678 . . . . 50.0 112.49 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -85.34 141.2 30.69 Favored 'Cis proline' 0 C--N 1.374 1.898 0 CA-C-N 119.036 1.418 . . . . 50.0 112.901 -4.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 78.1 m-85 -120.93 171.13 8.85 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.242 1.017 . . . . 50.0 109.569 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 p -151.59 114.0 4.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 50.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 44' ' ' VAL . 57.4 t -59.21 121.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 109.537 -0.542 . . . . 50.0 109.537 170.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 86.3 mt -98.51 -41.14 7.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.664 0.785 . . . . 50.0 109.712 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 40.8 tp -131.57 145.21 51.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.397 0.679 . . . . 50.0 110.252 -176.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 42' ' ' LEU . 42.2 p -115.38 140.59 48.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 50.0 110.079 174.523 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.7 p -139.23 158.03 69.87 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 106.945 -1.502 . . . . 50.0 106.945 165.578 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.32 109.45 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.627 2.218 . . . . 50.0 113.769 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m 74.51 5.33 4.52 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.712 1.605 . . . . 50.0 113.135 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.8 124.22 16.77 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.824 -0.548 . . . . 50.0 110.046 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.546 HD22 HG22 ' A' ' 37' ' ' THR . 66.6 mt -113.0 125.49 54.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.164 -0.68 . . . . 50.0 109.164 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 62.5 tttm -84.08 108.69 17.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.549 -1.278 . . . . 75.0 107.549 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 34' ' ' VAL . 40.9 t -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.106 -0.952 . . . . 50.0 109.227 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.05 138.36 55.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.163 0.585 . . . . 50.0 110.577 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.45 -38.54 3.06 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.92 -0.872 . . . . 50.0 110.92 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.58 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -80.67 151.62 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.871 0.869 . . . . 50.0 110.026 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.12 61.99 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.744 0.653 . . . . 50.0 112.602 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 -50.73 0.14 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.229 0.826 . . . . 50.0 113.229 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -143.92 154.63 43.53 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 119.191 0.905 . . . . 50.0 112.55 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.58 HG12 HG21 ' A' ' 47' ' ' ILE . 27.7 mm -129.34 133.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.579 1.552 . . . . 50.0 107.536 163.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 124.65 21.35 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.057 -1.09 . . . . 50.0 108.057 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.15 -19.39 13.22 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.851 1.426 . . . . 50.0 114.851 -164.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.51 -13.18 62.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.653 0.612 . . . . 50.0 112.653 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.74 -3.66 48.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.579 0.752 . . . . 50.0 110.983 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.5 129.0 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.054 -0.721 . . . . 50.0 109.054 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -124.9 122.1 36.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 75.0 109.323 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -59.62 123.59 17.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.463 0.705 . . . . 50.0 111.104 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 123.581 0.753 . . . . 50.0 111.011 -174.028 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 C--O 1.244 0.784 0 N-CA-C 109.037 -0.727 . . . . 75.0 109.037 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 35' ' ' LEU . 10.4 m -75.07 148.64 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.444 0.698 . . . . 50.0 109.173 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 86.89 10.53 72.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.97 -0.633 . . . . 50.0 112.407 -174.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -62.14 115.43 4.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.409 0.684 . . . . 50.0 110.26 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 m -73.38 114.61 11.79 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.988 0.423 . . . . 50.0 110.65 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.5 m -132.29 -177.55 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.915 1.286 . . . . 50.0 110.022 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -124.35 142.4 51.31 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.861 1.264 . . . . 50.0 107.677 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.29 106.58 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.031 -1.1 . . . . 50.0 108.031 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.4 ttp180 -84.66 93.64 8.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.505 -1.225 . . . . 75.0 110.635 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.725 1.21 . . . . 75.0 109.891 -175.175 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 C--O 1.245 0.854 0 N-CA-C 109.359 -0.608 . . . . 75.0 109.359 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TRP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 58.6 p-90 -80.77 146.45 30.98 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.912 0.387 . . . . 50.0 110.832 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -119.78 141.52 49.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.613 -1.255 . . . . 75.0 107.613 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.87 164.99 36.76 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 119.665 -0.52 . . . . 50.0 112.127 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.55 136.97 19.25 Favored 'Cis proline' 0 C--N 1.373 1.865 0 CA-C-N 119.45 1.625 . . . . 50.0 112.946 -1.855 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -111.35 174.1 6.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.443 1.097 . . . . 50.0 110.151 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.538 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.6 p -142.34 112.72 7.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.642 0.777 . . . . 50.0 110.436 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.72 122.72 19.43 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 N-CA-C 109.32 -0.622 . . . . 50.0 109.32 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 10' ' ' VAL . 62.2 mt -93.64 -42.01 9.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.964 -1.016 . . . . 50.0 109.943 172.583 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LEU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 19.1 tp -133.54 144.52 49.41 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 122.107 -0.37 . . . . 50.0 110.65 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.6 m -119.2 129.16 54.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.138 0.975 . . . . 50.0 109.519 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 p -139.84 158.77 67.0 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.397 1.079 . . . . 50.0 108.81 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.53 108.91 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.284 2.656 . . . . 50.0 114.416 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 62.11 17.5 9.19 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.568 1.547 . . . . 50.0 113.051 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.69 134.18 24.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.494 0.718 . . . . 50.0 109.303 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.62 124.74 41.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.138 -0.69 . . . . 50.0 109.138 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -83.84 109.65 17.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.078 -1.453 . . . . 75.0 107.078 172.371 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.4 136.45 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.678 -1.146 . . . . 50.0 108.474 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.06 139.1 58.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.481 -0.562 . . . . 50.0 109.481 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -15.39 63.17 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.964 -0.455 . . . . 50.0 111.964 -172.574 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . 0.605 HG21 HG12 ' A' ' 51' ' ' ILE . 46.5 mm -101.58 147.73 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.287 1.035 . . . . 50.0 109.382 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.01 -49.75 65.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.015 0.926 . . . . 50.0 112.344 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.45 -58.76 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.141 0.423 . . . . 50.0 112.141 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -143.18 157.22 44.7 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 123.174 0.59 . . . . 50.0 110.962 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.605 HG12 HG21 ' A' ' 47' ' ' ILE . 35.4 mm -126.56 139.95 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 108.246 -1.02 . . . . 50.0 108.246 167.173 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -64.42 139.74 58.8 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.545 0.738 . . . . 50.0 109.014 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.89 -22.13 61.96 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.478 1.288 . . . . 50.0 114.478 -168.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.89 -15.67 62.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.724 0.639 . . . . 50.0 112.724 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.3 24.12 11.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.903 0.881 . . . . 50.0 110.848 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.1 136.12 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.607 -1.257 . . . . 50.0 107.607 165.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -136.65 135.89 38.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.853 -0.795 . . . . 75.0 108.853 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.04 138.19 57.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.656 0.782 . . . . 50.0 112.201 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 125.142 1.377 . . . . 50.0 109.068 174.566 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.142 -0.318 . . . . 75.0 110.142 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.84 62.08 1.2 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.37 1.081 . . . . 75.0 109.774 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -102.23 122.1 43.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.77 -1.105 . . . . 75.0 108.913 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -125.27 154.35 41.83 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.63 0.772 . . . . 75.0 110.217 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -166.56 170.73 12.44 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.56 1.144 . . . . 75.0 108.281 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.75 89.04 0.15 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.931 0.872 . . . . 75.0 110.54 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.664 ' HB3' HD22 ' A' ' 80' ' ' LEU . 31.1 t -107.06 -176.43 3.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.41 1.484 . . . . 75.0 108.893 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -87.4 155.63 19.94 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.341 -0.985 . . . . 75.0 108.341 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -58.8 141.37 53.28 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 124.009 0.818 . . . . 75.0 111.017 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -61.57 108.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.491 ' HA2' HG21 ' A' ' 70' ' ' THR . . . 117.13 11.28 9.1 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 118.755 -1.025 . . . . 50.0 114.278 -169.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.678 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 59.8 t0 -60.02 110.7 1.26 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.508 0.654 . . . . 50.0 109.418 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 m -74.32 108.77 7.31 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.021 0.528 . . . . 50.0 109.635 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 58' ' ' ALA . 34.6 m -131.48 172.96 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.903 1.281 . . . . 50.0 109.716 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -119.24 154.59 33.19 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.694 1.197 . . . . 50.0 107.999 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.51 108.44 25.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.1 -1.074 . . . . 50.0 108.1 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -82.55 92.32 7.08 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.338 -2.21 . . . . 75.0 108.635 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -145.3 148.93 33.99 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.773 0.429 . . . . 75.0 110.506 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.755 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 40.2 t-80 -155.5 136.78 13.94 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.545 -0.539 . . . . 75.0 109.545 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -61.76 142.17 57.44 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.042 -0.725 . . . . 75.0 109.042 172.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -66.34 85.43 0.1 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.71 0.767 . . . . 75.0 111.342 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -114.16 3.94 15.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.006 1.323 . . . . 75.0 110.845 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.1 t30 70.19 5.12 5.17 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.206 1.402 . . . . 75.0 111.729 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 mt -93.16 158.39 15.79 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.935 0.894 . . . . 75.0 109.517 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.89 145.99 97.39 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.072 0.949 . . . . 75.0 112.517 -170.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.755 ' HA ' ' HB2' ' A' ' 19' ' ' HIS . 31.9 Cg_endo -61.8 134.83 52.44 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 123.216 2.611 . . . . 50.0 112.838 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -110.66 130.67 55.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.585 0.754 . . . . 75.0 110.456 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -78.93 143.79 35.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.852 0.358 . . . . 50.0 110.821 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -130.48 152.49 49.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.894 -1.15 . . . . 75.0 107.894 164.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.94 -174.32 38.71 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.792 -0.718 . . . . 50.0 112.983 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -92.43 112.66 1.4 Allowed 'Cis proline' 0 C--N 1.37 1.69 0 C-N-CA 124.184 -1.173 . . . . 50.0 112.696 -2.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -76.95 156.99 31.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.196 0.598 . . . . 50.0 109.392 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.424 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 36.4 p -126.48 112.51 15.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.555 0.342 . . . . 50.0 110.834 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 60.2 t -74.31 123.48 29.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 109.344 -0.613 . . . . 50.0 109.344 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 89.2 mt -93.12 -33.39 14.07 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.411 1.07 . . . . 50.0 110.12 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 55.2 tp -149.87 144.58 26.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.995 0.518 . . . . 50.0 109.626 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.477 HG22 HD22 ' A' ' 42' ' ' LEU . 64.0 p -109.72 144.12 38.55 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -135.86 149.31 68.33 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 105.542 -2.021 . . . . 50.0 105.542 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.78 106.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.209 2.606 . . . . 50.0 113.49 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m 62.15 27.66 16.64 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.662 1.585 . . . . 50.0 112.642 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -159.37 123.61 3.9 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 50.0 109.466 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.477 HD22 HG22 ' A' ' 37' ' ' THR . 44.9 mt -111.37 128.43 55.97 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.68 -0.637 . . . . 50.0 110.194 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 25.3 ttpp -85.85 108.27 18.06 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.722 -1.214 . . . . 75.0 107.722 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 34' ' ' VAL . 60.6 t -115.47 149.05 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.533 1.133 . . . . 50.0 109.045 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.99 133.2 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.524 -0.547 . . . . 50.0 109.524 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.83 -11.68 67.83 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.359 0.412 . . . . 50.0 113.509 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 51' ' ' ILE . 47.2 mm -97.4 151.21 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.879 0.872 . . . . 50.0 110.669 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.58 -51.07 70.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.114 0.965 . . . . 50.0 111.78 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -152.44 -59.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.567 0.347 . . . . 50.0 111.458 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.7 m-90 -142.53 147.92 36.75 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.12 0.568 . . . . 50.0 110.847 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 47' ' ' ILE . 33.2 mm -114.69 130.32 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.503 -1.295 . . . . 50.0 107.503 166.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -55.93 123.51 14.56 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.801 -0.814 . . . . 50.0 108.801 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.45 -18.69 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.674 1.361 . . . . 50.0 114.674 -164.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.56 67.36 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.168 0.587 . . . . 50.0 112.141 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -96.94 15.25 22.81 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.44 1.096 . . . . 50.0 111.123 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.413 HG11 HD12 ' A' ' 42' ' ' LEU . 38.4 t -131.82 152.06 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.852 -1.166 . . . . 50.0 107.852 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -151.96 132.93 14.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.336 -0.986 . . . . 75.0 108.336 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.556 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -60.33 151.72 27.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.854 0.461 . . . . 50.0 111.498 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.24 164.92 22.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.907 0.883 . . . . 50.0 109.915 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -97.87 111.74 59.85 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.465 -0.939 . . . . 75.0 108.465 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.83 -14.61 32.84 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.247 1.965 . . . . 75.0 112.783 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.65 -57.59 5.03 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 111.54 -0.624 . . . . 75.0 111.54 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.94 -166.54 32.5 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 111.159 -0.777 . . . . 75.0 111.159 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.13 -140.42 46.55 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 124.235 0.609 . . . . 75.0 114.519 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 68' ' ' ARG . 6.1 Cg_exo -80.7 41.74 1.2 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.595 2.863 . . . . 75.0 113.323 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -100.34 -68.83 0.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.142 -0.688 . . . . 75.0 109.142 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.5 p -71.72 -24.54 61.81 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.1 0.56 . . . . 75.0 110.975 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 38.9 ttm180 -72.24 -35.59 68.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.353 1.061 . . . . 75.0 112.51 -172.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.86 76.16 5.36 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 120.994 0.426 . . . . 75.0 110.814 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.491 HG21 ' HA2' ' A' ' 11' ' ' GLY . 7.1 m -152.78 154.47 35.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.802 0.841 . . . . 75.0 109.693 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -50.83 119.13 3.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.618 1.167 . . . . 75.0 110.088 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.3 38.79 0.83 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.026 0.931 . . . . 75.0 111.831 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -51.59 -52.51 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.938 1.295 . . . . 75.0 111.808 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' H ' HG21 ' A' ' 10' ' ' VAL . 32.3 mm-40 -131.65 32.61 4.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.285 1.034 . . . . 75.0 110.015 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -69.08 89.88 0.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.849 0.833 . . . . 75.0 109.577 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.6 p -159.94 119.36 2.84 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 113.966 -1.47 . . . . 75.0 108.023 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -87.27 65.48 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.705 0.764 . . . . 75.0 110.279 -173.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -155.33 -58.14 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 114.82 -1.082 . . . . 75.0 109.259 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.65 -36.2 5.18 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.642 1.622 . . . . 75.0 111.787 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 7' ' ' SER . 27.2 mt -106.27 125.25 50.77 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.321 0.648 . . . . 75.0 109.703 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -121.74 142.72 49.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.471 1.108 . . . . 75.0 110.246 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.6 pt -117.83 -171.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.179 0.991 . . . . 75.0 108.729 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -133.2 177.82 7.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.171 0.588 . . . . 75.0 110.117 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.89 122.8 16.32 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.286 0.634 . . . . 75.0 110.945 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 t -68.86 176.96 2.78 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.542 0.737 . . . . 75.0 110.211 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -65.12 -33.8 76.89 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.492 0.553 . . . . 75.0 112.492 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 64.44 89.99 0.09 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.28 0.988 . . . . 75.0 108.807 -168.197 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.43 115.92 10.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.137 0.975 . . . . 75.0 108.691 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--N 1.375 1.962 0 C-N-CA 122.664 2.243 . . . . 75.0 111.741 -179.088 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.489 -0.56 . . . . 75.0 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -140.63 159.38 42.33 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.979 0.512 . . . . 75.0 110.565 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -127.05 119.52 26.8 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.714 0.806 . . . . 75.0 109.993 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -75.26 137.84 41.47 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.385 0.674 . . . . 75.0 109.971 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -143.64 146.77 33.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.743 0.417 . . . . 75.0 111.965 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -115.12 83.39 1.9 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.081 -1.081 . . . . 75.0 108.081 167.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' A' ' 37' ' ' THR . 15.0 m -97.15 169.47 9.78 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.18 -0.918 . . . . 75.0 111.182 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -75.82 131.55 39.82 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 107.595 -1.261 . . . . 75.0 107.595 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.8 ptp -67.77 162.36 24.07 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.462 0.705 . . . . 75.0 112.227 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.91 140.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 114.165 -1.379 . . . . 50.0 113.14 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.28 8.95 42.96 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.475 -0.784 . . . . 50.0 112.568 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -62.59 103.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.483 0.713 . . . . 50.0 110.616 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 m -71.6 110.68 6.33 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.268 -0.642 . . . . 50.0 109.268 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 58' ' ' ALA . 30.1 m -132.83 179.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 50.0 110.292 -175.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -124.26 150.87 44.85 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.545 -1.28 . . . . 50.0 107.545 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.96 107.92 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.374 -0.602 . . . . 50.0 109.374 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -76.28 137.83 40.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.247 1.419 . . . . 75.0 110.401 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -134.67 113.51 11.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.283 0.633 . . . . 75.0 109.667 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -74.91 106.27 6.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.234 -1.024 . . . . 75.0 108.234 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.9 -62.01 1.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.883 0.739 . . . . 75.0 111.034 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.2 p -140.12 175.46 9.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.929 0.891 . . . . 75.0 109.076 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.33 -21.82 66.26 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.015 0.526 . . . . 75.0 110.766 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -83.44 -58.29 2.89 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.405 0.682 . . . . 75.0 109.617 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.4 113.59 11.81 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.159 0.584 . . . . 75.0 110.708 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.77 157.49 28.51 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.654 1.182 . . . . 75.0 111.712 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -57.82 124.46 16.05 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 123.16 2.573 . . . . 50.0 114.062 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -111.28 127.55 55.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.551 1.14 . . . . 75.0 109.258 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -103.7 163.41 12.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.572 0.749 . . . . 50.0 111.816 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.92 161.0 34.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.93 1.292 . . . . 75.0 108.635 172.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.64 -175.97 42.6 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.578 -0.568 . . . . 50.0 112.847 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -88.58 128.12 8.57 Favored 'Cis proline' 0 C--N 1.373 1.861 0 CA-C-N 119.276 1.538 . . . . 50.0 112.526 -6.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -93.96 176.46 6.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.043 0.937 . . . . 50.0 110.048 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 28.3 p -140.34 115.9 10.11 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.723 0.809 . . . . 50.0 110.102 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.2 t -72.42 133.48 31.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 109.127 -0.694 . . . . 50.0 109.127 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -97.26 -43.26 7.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.711 -1.131 . . . . 50.0 109.875 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.6 tp -141.73 141.05 33.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 116.048 -0.523 . . . . 50.0 109.739 -175.305 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.495 ' H ' ' HB3' ' A' ' 7' ' ' SER . 73.0 p -112.67 128.44 56.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.541 -0.54 . . . . 50.0 109.541 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -126.82 162.71 45.74 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.122 0.969 . . . . 50.0 109.263 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -43.44 114.96 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.582 2.855 . . . . 50.0 113.918 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t 63.23 5.68 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.132 2.173 . . . . 50.0 114.459 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -148.85 135.31 19.49 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.658 0.383 . . . . 50.0 110.01 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.76 124.93 50.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.01 0.524 . . . . 50.0 109.646 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.0 ttmm -83.89 107.99 16.62 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.27 -1.011 . . . . 75.0 108.27 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 34' ' ' VAL . 47.1 t -107.77 149.93 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.869 1.268 . . . . 50.0 108.22 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.33 140.85 54.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.85 0.46 . . . . 50.0 110.092 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 4.56 73.9 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.24 -0.436 . . . . 50.0 113.033 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HG12 ' A' ' 51' ' ' ILE . 51.3 mm -116.74 150.49 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.16 0.984 . . . . 50.0 110.278 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.04 -51.53 68.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.957 0.903 . . . . 50.0 112.22 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.34 -56.81 0.17 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.516 -0.311 . . . . 50.0 111.312 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.541 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 16.8 m-90 -143.06 158.31 43.72 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.996 0.519 . . . . 50.0 111.403 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.464 HG12 HG21 ' A' ' 47' ' ' ILE . 33.7 mm -122.32 118.59 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 106.802 -1.555 . . . . 50.0 106.802 165.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -56.91 127.24 30.83 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.385 -0.968 . . . . 50.0 108.385 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -23.75 18.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.846 1.795 . . . . 50.0 115.846 -158.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 -10.45 59.03 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.199 0.444 . . . . 50.0 112.199 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.11 17.66 22.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.756 1.222 . . . . 50.0 111.162 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.35 146.9 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.651 -0.87 . . . . 50.0 108.651 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -146.41 133.64 20.56 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.637 -0.875 . . . . 75.0 108.637 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -60.48 142.41 55.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.907 0.883 . . . . 50.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.87 148.1 51.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.943 . . . . 50.0 110.807 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -85.29 121.25 73.83 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.389 -0.967 . . . . 75.0 108.389 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -63.76 -23.31 69.3 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.41 2.073 . . . . 75.0 112.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.68 -44.11 1.99 Allowed Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.936 -0.575 . . . . 75.0 112.054 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.28 42.16 0.73 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.691 -0.964 . . . . 75.0 110.691 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.55 178.37 53.97 Favored Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.676 -0.514 . . . . 75.0 113.367 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.88 167.28 26.35 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.08 2.52 . . . . 75.0 112.949 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -67.76 -27.59 66.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.525 0.73 . . . . 75.0 110.833 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.3 m -148.27 -61.38 0.25 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.656 0.783 . . . . 75.0 109.945 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 161.58 36.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.659 0.783 . . . . 75.0 109.35 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.5 mt -80.73 -76.64 0.23 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.015 -0.365 . . . . 75.0 110.015 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -169.33 112.9 0.52 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.314 1.045 . . . . 75.0 108.789 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -141.98 -60.55 0.46 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.103 0.961 . . . . 75.0 108.857 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp-105 62.48 81.97 0.19 Allowed 'General case' 0 C--N 1.364 1.213 0 C-N-CA 125.071 1.349 . . . . 75.0 111.237 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.4 t -106.62 -48.51 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.107 0.563 . . . . 75.0 109.612 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.692 ' HG2' ' HG ' ' A' ' 80' ' ' LEU . 54.0 tp60 -97.55 97.0 8.69 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.525 -0.546 . . . . 75.0 109.525 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -56.91 2.35 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.454 -0.943 . . . . 75.0 108.454 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -76.94 164.38 25.83 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.932 0.893 . . . . 75.0 111.187 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.2 tt0 59.9 57.29 3.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.706 1.202 . . . . 75.0 110.926 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 24.7 t30 65.23 118.07 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 114.94 -1.027 . . . . 75.0 111.768 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 71.1 Cg_endo -70.77 147.98 57.57 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.741 1.627 . . . . 75.0 111.027 174.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.692 ' HG ' ' HG2' ' A' ' 74' ' ' GLN . 84.7 mt -78.73 169.53 18.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.778 0.431 . . . . 75.0 110.342 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.21 116.89 0.85 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.05 -1.092 . . . . 75.0 108.05 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 pt -110.3 174.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.367 -0.605 . . . . 75.0 109.367 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -155.97 88.56 1.11 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.195 0.998 . . . . 75.0 109.514 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.7 mt -115.79 88.45 2.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.61 0.764 . . . . 75.0 109.331 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 p -114.41 113.19 24.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.956 0.902 . . . . 75.0 108.949 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -109.8 127.25 54.53 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.827 -0.805 . . . . 75.0 108.827 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.98 105.92 12.85 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.487 1.115 . . . . 75.0 109.158 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -66.41 123.74 86.31 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 115.036 -0.984 . . . . 75.0 110.736 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 24.5 Cg_exo . . . . . 0 C--N 1.378 2.089 0 C-N-CA 123.438 2.759 . . . . 75.0 112.477 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.818 0.342 . . . . 75.0 110.35 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -132.08 127.92 37.1 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.211 1.004 . . . . 75.0 109.676 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -163.93 131.18 3.33 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.485 0.714 . . . . 75.0 110.417 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -130.45 125.14 33.69 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.74 -0.837 . . . . 75.0 108.74 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -127.85 169.18 14.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.176 0.59 . . . . 75.0 111.892 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -74.4 112.55 10.68 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.027 -0.988 . . . . 75.0 108.472 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.0 m -145.29 178.1 8.33 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.951 0.501 . . . . 75.0 112.049 -170.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -69.62 161.29 29.93 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.064 -0.971 . . . . 75.0 109.147 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.433 ' HB2' ' NE1' ' A' ' 71' ' ' TRP . 24.6 ptt? -59.23 133.5 56.15 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 123.688 0.617 . . . . 75.0 109.874 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.731 HG11 ' HB ' ' A' ' 73' ' ' VAL . 28.8 m -63.62 133.04 29.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.252 0.549 . . . . 50.0 111.182 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.596 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 95.22 9.93 57.65 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.203 -0.908 . . . . 50.0 113.028 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 66.3 t0 -54.29 117.27 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.603 0.761 . . . . 50.0 111.351 -176.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 59' ' ' ALA . 29.6 m -73.42 113.88 11.01 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.997 0.519 . . . . 50.0 110.194 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.22 176.5 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.231 1.013 . . . . 50.0 110.146 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.508 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 35.4 m0 -123.9 136.48 54.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.31 1.044 . . . . 50.0 108.239 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.88 107.24 22.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 108.239 -1.023 . . . . 50.0 108.239 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 43.2 ttm180 -77.27 111.5 12.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.019 -1.446 . . . . 75.0 109.838 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -106.14 152.82 22.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.581 0.752 . . . . 75.0 109.222 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 26' ' ' PRO . 93.1 m-70 -48.73 -55.69 10.72 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.098 0.874 . . . . 75.0 112.043 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.65 ' HG3' ' HB3' ' A' ' 27' ' ' ARG . 13.6 mm100 61.36 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.716 1.207 . . . . 75.0 109.919 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 p -78.09 164.44 25.01 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.059 1.343 . . . . 75.0 111.007 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.81 -51.7 6.24 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.986 0.514 . . . . 75.0 111.963 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -118.54 -21.25 8.05 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 75.0 111.848 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 165.12 22.67 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 120.705 0.288 . . . . 75.0 110.283 174.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -53.85 122.62 35.24 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.273 1.029 . . . . 75.0 110.87 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 19' ' ' HIS . 18.4 Cg_endo -56.81 138.9 87.47 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.053 2.502 . . . . 50.0 111.441 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ARG . . . . . 0.65 ' HB3' ' HG3' ' A' ' 20' ' ' GLN . 39.8 ttm-85 -99.41 130.98 45.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.421 0.688 . . . . 75.0 111.078 -171.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 64.1 p-90 -75.88 143.98 41.44 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.441 0.696 . . . . 50.0 110.78 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -126.56 159.89 32.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.295 -1.002 . . . . 75.0 108.295 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.44 -172.6 44.14 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.475 -0.625 . . . . 50.0 112.428 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.59 115.38 3.51 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 119.137 1.469 . . . . 50.0 112.982 1.271 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB3' HG11 ' A' ' 44' ' ' VAL . 78.2 m-85 -75.35 162.71 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.579 0.752 . . . . 50.0 110.766 172.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.596 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.5 p -131.63 111.5 11.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.091 0.556 . . . . 50.0 111.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 59.5 t -79.77 125.77 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.754 0.822 . . . . 50.0 110.404 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.4 -33.38 11.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.27 0.628 . . . . 50.0 110.251 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 42.7 tp -135.63 140.5 44.6 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.407 -0.361 . . . . 50.0 110.271 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -128.83 129.55 45.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.063 0.545 . . . . 50.0 110.096 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -134.96 163.12 53.52 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.19 1.396 . . . . 50.0 108.57 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -46.18 110.42 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.308 2.672 . . . . 50.0 114.543 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m 68.96 8.99 7.18 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 124.674 1.189 . . . . 50.0 112.59 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -146.97 121.93 10.02 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.788 -0.57 . . . . 50.0 110.133 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD12 HG11 ' A' ' 56' ' ' VAL . 22.6 mt -119.07 121.86 40.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.582 -0.895 . . . . 50.0 108.582 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 86.6 tttt -86.2 113.38 22.18 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.027 0.531 . . . . 75.0 110.977 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 74.1 t -88.61 149.22 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.887 1.275 . . . . 50.0 109.509 168.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.41 128.29 35.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.313 0.645 . . . . 50.0 110.374 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -27.78 16.68 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.014 -0.539 . . . . 50.0 111.959 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -74.53 146.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.565 0.746 . . . . 50.0 109.991 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.19 76.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.071 0.948 . . . . 50.0 112.413 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.22 -55.61 0.19 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.222 0.453 . . . . 50.0 112.222 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.6 m-90 -145.6 157.65 43.95 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.633 0.605 . . . . 50.0 112.633 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mm -112.64 135.66 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.845 1.258 . . . . 50.0 108.668 165.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -66.78 124.89 24.19 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.329 -0.989 . . . . 50.0 108.329 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.65 -19.42 63.8 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.733 1.213 . . . . 50.0 114.081 -164.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.85 -12.12 58.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.435 0.694 . . . . 50.0 112.374 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -98.0 -11.99 22.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.452 0.701 . . . . 50.0 111.251 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG11 HD12 ' A' ' 42' ' ' LEU . 76.1 t -96.86 124.34 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 122.681 0.392 . . . . 50.0 110.596 -170.273 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -118.33 120.05 36.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.505 1.122 . . . . 75.0 108.986 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.48 106.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.41 0.684 . . . . 50.0 110.4 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 13' ' ' THR . . . -96.31 141.77 29.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.815 0.846 . . . . 50.0 110.947 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -102.09 110.51 62.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.361 -0.977 . . . . 75.0 108.361 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -86.17 4.76 6.3 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 123.001 2.467 . . . . 75.0 112.772 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.25 33.21 6.35 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.2 -1.16 . . . . 75.0 110.2 -167.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.07 -77.33 1.53 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 111.576 -0.61 . . . . 75.0 111.576 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.84 57.7 8.48 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 119.123 -0.821 . . . . 75.0 114.462 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -94.54 109.88 0.16 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.817 2.344 . . . . 75.0 112.205 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.1 p -159.88 -77.56 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.879 0.472 . . . . 75.0 111.079 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -71.94 -24.66 61.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.295 1.038 . . . . 75.0 111.535 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.48 -6.24 59.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.978 -0.556 . . . . 75.0 112.278 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.2 mt -81.69 58.47 3.79 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.624 0.726 . . . . 75.0 111.201 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.6 m -152.09 -54.49 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.553 1.141 . . . . 75.0 108.276 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 74' ' ' GLN . 10.2 m-90 54.05 49.86 17.9 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.12 -1.4 . . . . 75.0 111.613 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -57.25 -30.08 64.33 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.312 1.045 . . . . 75.0 113.352 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.731 ' HB ' HG11 ' A' ' 10' ' ' VAL . 40.1 t -77.95 -31.45 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.17 0.588 . . . . 75.0 110.346 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.496 ' HG2' HG13 ' A' ' 10' ' ' VAL . 31.0 mm-40 -83.36 -4.79 58.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.548 0.739 . . . . 75.0 111.501 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.444 HH21 HD12 ' A' ' 80' ' ' LEU . 2.2 mmp_? -72.93 72.67 1.12 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.147 -0.686 . . . . 75.0 109.147 170.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -144.91 -94.75 0.1 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 108.718 -0.845 . . . . 75.0 108.718 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -84.93 -31.12 23.8 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.911 -0.774 . . . . 75.0 108.911 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.0 t30 70.55 92.97 0.05 OUTLIER Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.196 1.398 . . . . 75.0 110.721 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.59 14.3 1.69 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.671 2.914 . . . . 75.0 112.376 171.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.444 HD12 HH21 ' A' ' 75' ' ' ARG . 79.3 mt -74.53 108.15 7.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.103 0.961 . . . . 75.0 110.324 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -95.92 149.37 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.246 0.618 . . . . 75.0 110.293 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 pt -66.18 108.81 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.573 0.749 . . . . 75.0 110.587 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -93.95 142.56 27.24 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.555 -0.748 . . . . 75.0 109.758 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.26 83.74 1.04 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.506 0.722 . . . . 75.0 109.87 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.3 m -100.07 138.11 37.59 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.606 -1.179 . . . . 75.0 110.193 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -75.49 89.53 2.69 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 75.0 110.663 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 96.69 10.79 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.241 -0.89 . . . . 75.0 109.839 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.41 77.82 19.29 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.252 0.621 . . . . 75.0 109.534 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo . . . . . 0 C--N 1.376 1.991 0 C-N-CA 123.161 2.574 . . . . 75.0 112.104 177.466 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.4 m80 . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.067 -0.716 . . . . 75.0 109.067 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -80.25 89.75 5.5 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.85 0.86 . . . . 75.0 109.987 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -77.54 -31.02 53.06 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.43 0.692 . . . . 75.0 109.772 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.1 t60 77.06 -31.03 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.965 1.706 . . . . 75.0 112.55 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -66.87 113.55 5.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.809 0.443 . . . . 75.0 110.438 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -64.46 127.84 33.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.339 1.055 . . . . 75.0 109.503 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.447 ' HA ' ' OG1' ' A' ' 37' ' ' THR . 27.5 t -96.48 167.87 10.89 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.67 0.606 . . . . 75.0 112.299 -169.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -76.45 159.86 30.05 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.691 -0.855 . . . . 75.0 108.691 165.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm -52.55 134.71 35.15 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.144 0.903 . . . . 75.0 111.623 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.544 HG22 HD21 ' A' ' 80' ' ' LEU . 13.8 m -67.04 117.64 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.799 -0.815 . . . . 50.0 108.799 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 102.25 10.23 39.67 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.645 -1.086 . . . . 50.0 113.245 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -57.75 102.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 118.56 1.18 . . . . 50.0 109.906 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.407 HG21 ' HG3' ' A' ' 61' ' ' PRO . 28.4 m -72.71 113.29 9.58 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-O 121.492 0.663 . . . . 50.0 110.221 -169.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.58 -179.86 2.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 113.933 -1.485 . . . . 50.0 109.05 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -125.0 150.66 46.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.994 -1.484 . . . . 50.0 106.994 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.21 104.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.246 -1.391 . . . . 50.0 107.246 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' ' HB2' ' A' ' 26' ' ' PRO . 37.9 ttt180 -81.33 92.4 6.39 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 112.686 -2.052 . . . . 75.0 109.651 -173.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -84.32 125.56 32.39 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.408 0.683 . . . . 75.0 111.424 -170.851 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -118.98 109.54 16.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.904 0.882 . . . . 75.0 109.957 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -90.98 -56.8 3.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.866 0.467 . . . . 75.0 111.19 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.1 p -119.68 146.3 45.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.96 0.504 . . . . 75.0 111.223 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.94 -35.0 76.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.809 1.244 . . . . 75.0 112.385 -171.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.84 -29.57 70.54 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.732 0.645 . . . . 75.0 111.53 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -99.32 154.1 18.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.571 0.748 . . . . 75.0 111.006 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.32 145.94 69.45 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 75.0 109.739 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 15.1 Cg_exo -67.4 130.06 21.6 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.513 2.142 . . . . 50.0 111.316 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -97.5 116.86 30.51 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.622 0.769 . . . . 75.0 110.11 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.7 p-90 -68.27 143.11 55.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.298 0.639 . . . . 50.0 111.359 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mtmp? -121.5 146.54 46.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.06 0.944 . . . . 75.0 108.804 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.88 175.44 35.87 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.756 -0.469 . . . . 50.0 112.849 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.79 126.8 6.37 Favored 'Cis proline' 0 CA--C 1.564 2.007 0 CA-C-N 118.754 1.277 . . . . 50.0 113.215 -3.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.07 163.29 12.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 50.0 109.369 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.9 p -145.86 114.02 6.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.803 0.441 . . . . 50.0 111.15 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 44' ' ' VAL . 24.2 t -67.99 133.07 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 50.0 110.781 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.82 -41.58 4.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.991 0.916 . . . . 50.0 109.936 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HB3' ' HD3' ' A' ' 43' ' ' LYS . 56.7 tp -135.26 151.2 50.35 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.401 -0.963 . . . . 50.0 108.401 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.46 HG22 HD22 ' A' ' 42' ' ' LEU . 69.6 p -124.32 153.19 42.14 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.865 -0.522 . . . . 50.0 111.048 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -136.44 147.65 60.81 Favored Pre-proline 0 CA--C 1.561 1.401 0 N-CA-C 106.501 -1.666 . . . . 50.0 106.501 171.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -40.85 109.72 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.288 2.659 . . . . 50.0 114.442 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 67.9 17.43 9.64 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.337 1.455 . . . . 50.0 112.903 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -156.42 121.61 4.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.42 0.688 . . . . 50.0 109.943 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.667 HD12 HG11 ' A' ' 56' ' ' VAL . 27.5 mt -106.09 133.94 50.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.984 0.514 . . . . 50.0 110.308 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 54.8 tttp -85.57 107.53 17.54 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.799 -1.186 . . . . 75.0 107.799 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 34' ' ' VAL . 44.8 t -109.78 154.63 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.486 -1.234 . . . . 50.0 109.452 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.67 130.19 45.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.992 0.917 . . . . 50.0 110.789 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.01 79.55 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.16 -0.473 . . . . 50.0 113.782 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 HG12 ' A' ' 51' ' ' ILE . 40.8 mm -91.8 151.35 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.077 0.951 . . . . 50.0 110.539 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.08 73.56 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.194 0.998 . . . . 50.0 111.614 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.04 -57.53 0.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.047 0.388 . . . . 50.0 112.047 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.522 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.6 m-90 -143.35 153.3 42.58 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.029 0.531 . . . . 50.0 111.653 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 47' ' ' ILE . 33.1 mm -123.44 120.22 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.699 1.2 . . . . 50.0 107.816 168.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -61.12 141.46 57.43 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.248 0.619 . . . . 50.0 109.469 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.82 48.81 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.566 1.691 . . . . 50.0 115.566 -162.514 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.041 0.536 . . . . 50.0 112.216 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -96.44 23.9 6.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.059 0.944 . . . . 50.0 110.661 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.667 HG11 HD12 ' A' ' 42' ' ' LEU . 57.8 t -123.39 152.14 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.15 0.98 . . . . 50.0 108.555 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -155.87 110.6 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.982 0.513 . . . . 75.0 109.95 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.29 53.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.142 0.577 . . . . 50.0 111.327 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.05 114.94 0.95 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.153 0.981 . . . . 50.0 109.192 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -78.98 126.48 82.04 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.076 0.95 . . . . 75.0 110.488 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HG3' HG21 ' A' ' 13' ' ' THR . 9.0 Cg_exo -70.72 -22.03 28.24 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.075 2.516 . . . . 75.0 112.749 174.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.8 74.63 0.06 OUTLIER Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.587 -0.605 . . . . 75.0 111.587 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.28 -0.65 63.96 Favored Glycine 0 C--N 1.351 1.406 0 C-N-CA 123.296 0.474 . . . . 75.0 112.845 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.12 158.63 29.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.345 -0.697 . . . . 75.0 111.97 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.17 90.72 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.162 1.908 . . . . 75.0 111.082 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -61.86 -31.14 71.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.312 -0.858 . . . . 75.0 109.789 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -65.45 129.34 39.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.882 0.873 . . . . 75.0 110.563 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -67.1 116.93 8.46 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 123.589 0.556 . . . . 75.0 109.821 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 mt -92.33 3.12 56.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.972 0.909 . . . . 75.0 110.851 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 t -141.87 178.24 7.64 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.953 1.701 . . . . 75.0 107.597 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -68.28 -62.88 1.2 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.971 -0.381 . . . . 75.0 109.971 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.56 ' HB3' ' HG2' ' A' ' 74' ' ' GLN . 99.1 mtt180 -139.57 -79.7 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.245 0.618 . . . . 75.0 109.465 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t 60.44 9.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 124.902 1.281 . . . . 75.0 111.451 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.56 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 13.9 pt20 -81.63 -0.69 43.63 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.522 1.129 . . . . 75.0 111.209 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -89.55 -4.57 57.82 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.734 1.214 . . . . 75.0 111.261 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -83.35 62.9 6.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.725 0.81 . . . . 75.0 111.128 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 58.9 44.9 15.96 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 75.0 111.432 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.2 m120 57.06 71.9 1.04 Allowed Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 124.4 1.08 . . . . 75.0 112.348 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -67.41 -53.06 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.053 2.502 . . . . 75.0 112.553 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD21 HG22 ' A' ' 10' ' ' VAL . 91.4 mt -63.16 99.74 0.19 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.3 1.0 . . . . 75.0 111.146 -172.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -130.58 155.84 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.792 1.237 . . . . 75.0 108.969 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.9 pt -85.37 16.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.705 0.802 . . . . 75.0 112.462 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -80.12 73.62 6.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.34 0.59 . . . . 75.0 109.491 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.94 128.02 33.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.375 -0.829 . . . . 75.0 109.222 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -73.28 178.83 4.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.063 0.545 . . . . 75.0 109.89 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -136.75 -83.7 0.36 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.493 0.588 . . . . 75.0 111.094 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -159.8 148.34 17.42 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.862 0.363 . . . . 75.0 110.853 -166.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.69 132.41 4.94 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.711 1.204 . . . . 75.0 107.842 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo . . . . . 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 75.0 110.797 174.14 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.064 -0.347 . . . . 75.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -97.65 130.16 44.68 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.509 -0.922 . . . . 75.0 108.509 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -64.89 133.72 52.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.854 0.862 . . . . 75.0 110.709 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 94.1 m-70 -98.7 144.01 28.44 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.66 1.184 . . . . 75.0 110.326 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -154.41 -174.42 4.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.51 0.724 . . . . 75.0 109.845 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -61.35 111.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.178 0.591 . . . . 75.0 110.092 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.3 m -141.02 -172.97 3.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.137 0.975 . . . . 75.0 109.861 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -83.54 150.22 26.1 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.259 -1.015 . . . . 75.0 108.259 167.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ptm -60.46 140.97 57.0 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.04 0.838 . . . . 75.0 110.892 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.549 HG11 ' HB ' ' A' ' 73' ' ' VAL . 3.4 m -60.56 123.09 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.296 0.638 . . . . 50.0 110.533 174.681 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.509 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 93.37 9.36 60.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.057 -0.857 . . . . 50.0 113.466 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.705 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 51.2 t0 -56.02 106.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.942 0.871 . . . . 50.0 110.728 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 m -72.44 106.66 4.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.291 0.567 . . . . 50.0 110.012 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.97 173.86 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.527 1.131 . . . . 50.0 110.814 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.447 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.4 m0 -117.05 150.7 38.21 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.9 1.28 . . . . 50.0 108.168 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.43 109.31 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.052 -1.092 . . . . 50.0 108.052 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.613 ' HG2' ' HB2' ' A' ' 26' ' ' PRO . 38.8 ttp180 -87.12 90.61 8.42 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.116 -1.402 . . . . 75.0 109.808 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -98.17 127.71 44.26 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.449 1.1 . . . . 75.0 110.043 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 39.7 p-80 -67.68 138.65 56.48 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.147 0.279 . . . . 75.0 110.38 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -83.59 -47.36 11.37 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.252 -1.018 . . . . 75.0 108.252 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.516 ' HB ' ' H ' ' A' ' 24' ' ' LEU . 18.9 m -140.63 175.76 9.34 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 106.735 -1.58 . . . . 75.0 106.735 174.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -73.57 -36.34 65.59 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.216 -0.661 . . . . 75.0 109.216 167.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.43 ' H ' HG22 ' A' ' 21' ' ' THR . 2.1 m-20 -65.78 -59.85 3.47 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 114.786 -1.097 . . . . 75.0 110.405 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' H ' ' HB ' ' A' ' 21' ' ' THR . 79.4 mt -68.84 136.73 53.14 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.391 0.676 . . . . 75.0 110.037 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.9 145.35 89.02 Favored Pre-proline 0 CA--C 1.552 1.029 0 O-C-N 123.812 0.695 . . . . 75.0 111.045 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 45.2 Cg_exo -57.46 118.65 5.56 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.015 2.477 . . . . 50.0 112.831 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -87.13 120.19 28.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 75.0 110.524 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 62.5 p-90 -73.85 149.33 41.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.739 0.816 . . . . 50.0 111.088 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -139.61 153.26 47.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.791 0.836 . . . . 75.0 109.649 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -168.0 179.39 41.26 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 119.894 -0.392 . . . . 50.0 113.492 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.71 133.72 19.12 Favored 'Cis proline' 0 C--N 1.378 2.103 0 CA-C-N 119.139 1.47 . . . . 50.0 113.838 0.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' HB3' HG11 ' A' ' 44' ' ' VAL . 76.0 m-85 -108.48 168.3 9.42 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.895 1.278 . . . . 50.0 109.396 169.411 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.9 p -148.0 113.62 5.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.275 0.63 . . . . 50.0 110.883 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.4 t -73.21 134.32 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.756 0.822 . . . . 50.0 110.417 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 mt -106.58 -31.75 8.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.37 0.668 . . . . 50.0 110.812 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -149.59 159.2 44.52 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.777 -0.823 . . . . 50.0 108.777 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 p -139.38 163.7 31.81 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.559 0.695 . . . . 50.0 111.259 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.3 p -141.98 164.33 34.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 126.12 1.768 . . . . 50.0 107.695 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 107.85 0.17 Allowed 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.789 2.326 . . . . 50.0 113.47 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.69 22.15 12.54 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.432 1.493 . . . . 50.0 112.855 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.45 121.94 9.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.128 -0.693 . . . . 50.0 109.128 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.515 HD12 ' HB ' ' A' ' 56' ' ' VAL . 23.3 mt -106.69 123.5 48.22 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.243 1.017 . . . . 50.0 108.749 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -86.85 106.84 18.02 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 109.349 -0.611 . . . . 75.0 109.349 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 48.0 t -96.25 154.75 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.309 -1.314 . . . . 50.0 109.153 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.2 135.33 48.96 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.499 -0.556 . . . . 50.0 109.499 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.78 76.31 Favored Glycine 0 C--N 1.34 0.787 0 O-C-N 123.761 0.663 . . . . 50.0 112.798 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -92.66 147.67 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.171 0.588 . . . . 50.0 109.939 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.44 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.435 1.094 . . . . 50.0 111.38 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.19 -59.59 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.951 0.352 . . . . 50.0 111.951 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -145.31 158.65 43.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.297 0.639 . . . . 50.0 111.187 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.88 133.89 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.598 -1.26 . . . . 50.0 107.598 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -63.79 142.24 58.47 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 50.0 108.294 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -36.75 64.99 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 115.076 1.51 . . . . 50.0 115.076 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.27 1.32 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 112.33 0.493 . . . . 50.0 112.33 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.32 12.42 36.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.018 0.527 . . . . 50.0 109.816 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' HB ' HD12 ' A' ' 42' ' ' LEU . 99.1 t -139.15 140.75 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -138.17 152.17 48.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.56 -0.904 . . . . 75.0 108.56 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.32 126.85 28.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.667 0.787 . . . . 50.0 110.845 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.52 143.16 31.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.817 -0.809 . . . . 50.0 108.817 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -77.06 111.85 19.19 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 108.712 -0.848 . . . . 75.0 108.712 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -84.57 -4.44 10.03 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.496 2.131 . . . . 75.0 112.271 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.15 79.24 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.644 0.59 . . . . 75.0 112.889 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.46 67.91 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-O 119.886 -0.397 . . . . 75.0 112.82 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.02 79.64 0.22 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 111.141 -0.784 . . . . 75.0 111.141 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.23 -20.21 37.78 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 124.094 3.196 . . . . 75.0 113.552 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m 63.54 30.66 15.09 Favored 'General case' 0 C--N 1.363 1.159 0 C-N-CA 124.393 1.077 . . . . 75.0 111.575 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -140.02 159.75 41.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.448 0.699 . . . . 75.0 110.438 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -69.21 102.7 1.75 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.142 0.577 . . . . 75.0 109.517 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 11' ' ' GLY . 79.3 mt -128.14 -13.99 4.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.64 1.176 . . . . 75.0 110.186 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.7 m -79.7 87.3 5.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.818 0.818 . . . . 75.0 109.901 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -135.63 144.59 46.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.665 -1.152 . . . . 75.0 108.596 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -93.84 45.34 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.251 0.621 . . . . 75.0 110.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.549 ' HB ' HG11 ' A' ' 10' ' ' VAL . 69.7 t -61.58 -61.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.481 -0.782 . . . . 75.0 109.39 174.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -82.78 81.05 8.68 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.444 -0.947 . . . . 75.0 108.444 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -142.07 85.26 1.92 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.118 -1.438 . . . . 75.0 107.118 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.591 ' HB3' ' HB2' ' A' ' 4' ' ' HIS . 13.8 p -92.45 -53.02 4.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.021 . . . . 75.0 109.117 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -153.92 -45.87 0.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.401 -1.272 . . . . 75.0 108.916 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -106.28 109.96 63.55 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.161 0.985 . . . . 75.0 109.95 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.17 130.3 17.41 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.295 1.997 . . . . 75.0 110.729 169.202 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.85 -9.41 59.46 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.82 1.044 . . . . 75.0 113.82 -166.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.89 92.8 3.12 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 108.595 -0.891 . . . . 75.0 108.595 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 pt -92.76 -178.96 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 C-N-CA 124.182 0.993 . . . . 75.0 110.486 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -66.53 149.71 50.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.614 -0.721 . . . . 75.0 110.6 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 64.1 mt -78.74 179.47 7.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.991 -0.55 . . . . 75.0 110.65 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.1 p -76.69 78.95 3.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.684 0.793 . . . . 75.0 111.932 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -141.87 127.83 19.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.208 1.003 . . . . 75.0 109.029 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -82.82 102.8 11.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.331 0.652 . . . . 75.0 110.045 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.32 146.56 9.43 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.085 0.954 . . . . 75.0 109.175 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--N 1.381 2.247 0 C-N-CA 123.547 2.831 . . . . 75.0 113.434 179.152 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.619 0.247 . . . . 75.0 110.591 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -115.39 69.69 0.73 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.896 -0.779 . . . . 75.0 108.896 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -166.87 94.55 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.429 -1.259 . . . . 75.0 108.713 175.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -159.87 137.65 9.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.507 0.723 . . . . 75.0 110.428 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -171.73 151.32 2.85 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.294 0.997 . . . . 75.0 109.764 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -127.13 151.02 49.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.263 1.025 . . . . 75.0 109.074 172.338 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . 0.458 ' HB3' ' NE2' ' A' ' 74' ' ' GLN . 7.8 t -166.4 -174.89 3.02 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.273 -1.01 . . . . 75.0 108.273 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -67.41 139.88 57.14 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.141 -1.059 . . . . 75.0 108.141 171.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -48.87 132.89 18.25 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 124.757 1.286 . . . . 75.0 112.73 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' A' ' 72' ' ' ARG . 30.3 m -62.1 150.64 8.15 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 115.076 -0.965 . . . . 50.0 110.828 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 11.37 69.83 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.995 -0.621 . . . . 50.0 112.49 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.4 t0 -62.1 111.83 2.11 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.355 0.577 . . . . 50.0 109.853 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.8 m -71.34 112.28 7.35 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.249 -0.649 . . . . 50.0 109.249 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 58' ' ' ALA . 30.2 m -136.38 164.2 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.797 -0.638 . . . . 50.0 111.124 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.453 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 41.8 m0 -122.39 145.56 48.16 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.235 1.014 . . . . 50.0 108.315 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.69 105.26 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.0 ttm180 -89.34 138.01 31.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.028 1.331 . . . . 75.0 110.378 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -150.41 139.01 20.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.607 0.363 . . . . 75.0 110.471 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -61.75 120.09 9.99 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.097 0.559 . . . . 75.0 110.746 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.66 -47.73 84.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.949 0.881 . . . . 75.0 108.839 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 23' ' ' ASN . 38.9 m -148.21 156.61 42.77 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.732 -1.576 . . . . 75.0 107.053 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.93 -27.72 66.01 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.614 0.643 . . . . 75.0 110.957 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.575 ' H ' HG22 ' A' ' 21' ' ' THR . 25.8 t-20 -70.47 -37.03 74.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.9 0.88 . . . . 75.0 110.68 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -90.15 174.09 7.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.367 0.667 . . . . 75.0 110.365 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.84 156.97 55.22 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.21 0.604 . . . . 75.0 109.886 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.28 165.27 32.96 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.669 2.246 . . . . 50.0 113.249 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -143.61 136.65 27.68 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.635 -0.876 . . . . 75.0 108.635 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.2 p-90 -96.35 163.7 12.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.537 0.735 . . . . 50.0 111.763 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -135.66 149.92 49.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.153 0.981 . . . . 75.0 108.586 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -175.77 179.2 47.07 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.256 -0.497 . . . . 50.0 112.618 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.02 148.72 21.57 Favored 'Cis proline' 0 C--N 1.368 1.573 0 CA-C-N 118.616 1.208 . . . . 50.0 113.834 0.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -120.54 176.0 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.91 1.284 . . . . 50.0 109.449 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 7.0 p -142.24 116.68 9.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.196 0.598 . . . . 50.0 111.381 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 44' ' ' VAL . 23.3 t -73.95 139.93 18.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.111 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 70' ' ' THR . 80.5 mt -113.02 -45.82 3.15 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.681 1.238 . . . . 50.0 109.984 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 61.8 tp -127.89 145.55 50.91 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.519 -0.764 . . . . 50.0 109.363 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.479 HG22 HD22 ' A' ' 42' ' ' LEU . 69.6 p -129.74 129.48 44.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.782 0.833 . . . . 50.0 109.189 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -126.29 162.63 45.09 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.618 1.167 . . . . 50.0 108.231 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -47.81 118.31 2.98 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.968 2.445 . . . . 50.0 114.261 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p 61.59 10.92 3.55 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.279 1.832 . . . . 50.0 113.972 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -149.09 123.32 9.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.17 0.441 . . . . 50.0 110.176 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 37' ' ' THR . 38.0 mt -110.87 124.54 52.27 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.422 -0.584 . . . . 50.0 109.422 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -85.92 108.63 18.27 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.657 -0.868 . . . . 75.0 108.657 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 34' ' ' VAL . 18.4 t -109.99 146.87 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.338 -1.301 . . . . 50.0 108.606 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 132.78 46.7 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.82 -8.11 57.8 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.528 0.517 . . . . 50.0 111.976 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.557 HG21 HG12 ' A' ' 51' ' ' ILE . 40.6 mm -105.17 150.2 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.951 0.901 . . . . 50.0 110.403 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 -51.09 71.07 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.044 0.938 . . . . 50.0 111.966 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.22 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.248 0.342 . . . . 50.0 111.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 20.1 m-90 -142.9 149.89 39.07 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.743 0.417 . . . . 50.0 110.959 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.557 HG12 HG21 ' A' ' 47' ' ' ILE . 26.8 mm -121.52 128.32 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 167.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -59.97 136.1 57.91 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.903 0.481 . . . . 50.0 110.011 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.79 -33.59 49.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.009 1.485 . . . . 50.0 115.009 -163.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.45 67.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.396 0.517 . . . . 50.0 112.396 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -68.76 -25.03 64.52 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.648 0.379 . . . . 50.0 111.233 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -96.89 125.39 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 122.519 0.328 . . . . 50.0 110.444 -168.3 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -106.61 126.23 52.01 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.875 0.87 . . . . 75.0 108.809 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -77.68 106.51 9.54 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.424 -0.584 . . . . 50.0 109.424 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.88 118.66 29.62 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 50.0 109.074 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -56.28 116.06 11.6 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.359 0.663 . . . . 75.0 109.968 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.75 -43.46 46.23 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.897 3.064 . . . . 75.0 112.772 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.6 -81.64 0.16 Allowed Glycine 0 C--N 1.356 1.64 0 O-C-N 124.056 0.848 . . . . 75.0 112.469 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.01 148.87 19.24 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.556 -1.018 . . . . 75.0 110.556 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 65' ' ' PRO . . . 93.49 111.73 2.16 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.27 -0.739 . . . . 75.0 111.606 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 3.5 Cg_exo -82.24 30.97 0.52 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.42 2.746 . . . . 75.0 113.533 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -76.09 6.58 5.12 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.355 1.062 . . . . 75.0 112.384 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -74.58 -1.71 22.73 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.411 1.084 . . . . 75.0 112.908 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 73.84 87.46 0.1 Allowed 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.707 1.603 . . . . 75.0 110.009 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.7 93.18 0.37 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.733 -0.469 . . . . 75.0 109.733 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.588 ' HB ' HD21 ' A' ' 35' ' ' LEU . 5.5 m -77.81 149.22 34.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.812 -0.81 . . . . 75.0 108.812 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -63.45 144.72 56.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.953 0.501 . . . . 75.0 111.063 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.67 ' HA ' HG21 ' A' ' 10' ' ' VAL . 53.6 mtt180 -67.06 92.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.791 0.682 . . . . 75.0 110.868 -176.204 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.61 -36.99 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.969 -1.014 . . . . 75.0 110.79 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 79' ' ' PRO . 75.7 mt-30 -78.39 80.17 4.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.533 0.682 . . . . 75.0 110.977 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -112.67 148.54 34.45 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.769 -1.105 . . . . 75.0 108.498 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.485 ' HB3' ' HG3' ' A' ' 79' ' ' PRO . 43.0 t -174.0 -66.1 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.385 -1.709 . . . . 75.0 106.385 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -147.3 -58.5 0.26 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 107.946 -1.131 . . . . 75.0 107.946 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -157.31 62.24 2.58 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 123.836 0.854 . . . . 75.0 110.249 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HG3' ' HB3' ' A' ' 76' ' ' SER . 9.9 Cg_exo -73.62 -30.73 9.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.834 2.356 . . . . 75.0 113.175 -174.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.02 127.97 34.05 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.209 -0.905 . . . . 75.0 109.981 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -88.24 150.84 23.05 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.565 -0.743 . . . . 75.0 109.969 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.9 pt -90.74 165.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.006 0.522 . . . . 75.0 110.893 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -139.12 100.03 3.91 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.989 -0.745 . . . . 75.0 108.989 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.2 mt -98.77 132.75 43.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.267 -0.879 . . . . 75.0 108.875 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.7 m 68.59 100.26 0.06 Allowed 'General case' 0 CA--C 1.556 1.173 0 O-C-N 124.299 0.999 . . . . 75.0 111.327 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 87' ' ' GLU . 50.7 ttt180 -80.32 165.2 22.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.601 0.76 . . . . 75.0 109.05 169.178 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 3.2 mp0 -63.17 87.99 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.73 0.812 . . . . 75.0 110.081 174.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.77 126.14 33.62 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.3 0.64 . . . . 75.0 109.525 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 C--N 1.376 1.995 0 C-N-CA 122.945 2.43 . . . . 75.0 112.458 177.803 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.8 p80 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 111.362 0.134 . . . . 75.0 111.362 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -143.93 126.2 15.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.405 0.621 . . . . 75.0 109.595 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -156.63 28.27 0.33 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.925 1.29 . . . . 75.0 108.031 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -88.34 161.77 16.94 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.141 0.976 . . . . 75.0 108.712 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 71.13 93.76 0.08 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.511 1.124 . . . . 75.0 109.602 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -68.1 127.39 32.72 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.693 -0.855 . . . . 75.0 108.693 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.1 t -145.74 179.88 7.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.902 0.881 . . . . 75.0 111.237 -164.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -70.68 160.14 33.16 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.965 0.906 . . . . 75.0 108.68 164.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ptm -59.54 137.93 57.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.108 0.88 . . . . 75.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.699 HG21 ' HA ' ' A' ' 72' ' ' ARG . 30.7 m -63.97 125.74 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.439 -0.578 . . . . 50.0 109.439 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 108.53 8.5 28.52 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.296 -0.725 . . . . 50.0 112.484 -172.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -67.68 113.71 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.938 0.495 . . . . 50.0 109.885 -173.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 59' ' ' ALA . 91.3 m -77.86 127.23 32.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.696 0.399 . . . . 50.0 111.236 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.402 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 33.6 m -139.22 -178.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 50.0 109.645 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 33.9 m0 -116.7 157.5 25.35 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.961 1.304 . . . . 50.0 108.478 169.181 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.38 103.32 15.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 106.463 -1.68 . . . . 50.0 106.463 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -78.94 91.03 4.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.077 -1.42 . . . . 75.0 108.872 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -117.68 148.07 42.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.826 0.85 . . . . 75.0 111.73 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -175.42 147.91 0.9 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.857 1.663 . . . . 75.0 107.42 170.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.17 -67.3 0.8 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.593 -0.521 . . . . 75.0 109.593 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.5 p -81.75 140.86 34.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.752 0.821 . . . . 75.0 110.997 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -75.7 -20.49 58.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.43 1.092 . . . . 75.0 110.825 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -64.22 -35.28 80.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.484 0.713 . . . . 75.0 110.346 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -87.35 144.82 26.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.308 -0.627 . . . . 75.0 109.308 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.98 147.26 86.21 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.076 0.95 . . . . 75.0 111.236 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -64.98 104.02 0.54 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.298 1.999 . . . . 50.0 110.752 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -83.43 164.55 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.052 -1.092 . . . . 75.0 108.052 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 60.9 p-90 -130.61 153.92 48.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.693 0.679 . . . . 50.0 110.521 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -126.71 148.23 49.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 75.0 108.714 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.502 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -164.58 -176.63 36.52 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.555 -0.58 . . . . 50.0 112.378 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.89 115.81 2.13 Favored 'Cis proline' 0 CA--C 1.564 1.998 0 CA-C-N 118.91 1.355 . . . . 50.0 112.786 -5.237 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -84.79 154.08 22.59 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.755 0.822 . . . . 50.0 111.918 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.595 HG23 ' HA2' ' A' ' 11' ' ' GLY . 98.3 m -107.08 117.77 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 50.0 110.201 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 46.8 t -95.24 136.52 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.119 0.968 . . . . 50.0 109.209 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.16 -28.74 8.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.827 . . . . 50.0 110.689 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 46.4 tp -146.95 144.46 29.23 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.767 -0.457 . . . . 50.0 109.767 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.9 p -132.4 128.89 38.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.936 0.894 . . . . 50.0 109.63 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -134.38 158.42 75.23 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.855 0.862 . . . . 50.0 109.226 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -48.16 124.67 10.67 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.271 2.647 . . . . 50.0 112.81 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m 75.34 -13.83 0.82 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.25 1.42 . . . . 50.0 112.953 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.39 122.01 11.82 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.429 -0.794 . . . . 50.0 110.693 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.479 HD12 HG11 ' A' ' 56' ' ' VAL . 32.0 mt -114.9 123.68 49.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.306 0.642 . . . . 50.0 109.343 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.3 tttp -84.46 107.16 16.57 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.68 0.752 . . . . 75.0 109.247 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.604 HG22 HG22 ' A' ' 34' ' ' VAL . 34.5 t -101.81 142.84 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.963 -1.472 . . . . 50.0 108.047 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.34 136.54 58.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.411 0.684 . . . . 50.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.32 32.39 Favored Glycine 0 C--N 1.345 1.074 0 O-C-N 123.676 0.61 . . . . 50.0 113.096 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.66 153.92 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.583 0.753 . . . . 50.0 110.744 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.32 -51.16 56.81 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.058 1.343 . . . . 50.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.08 -56.18 0.14 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.485 0.49 . . . . 50.0 110.53 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -141.17 157.1 45.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.92 0.488 . . . . 50.0 110.91 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.99 130.88 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.83 1.252 . . . . 50.0 107.997 167.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -58.07 128.44 37.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.702 -0.851 . . . . 50.0 108.702 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -23.36 58.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.349 1.241 . . . . 50.0 114.349 -163.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.82 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 50.0 112.055 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -100.19 21.18 13.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.604 1.162 . . . . 50.0 110.514 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG11 HD12 ' A' ' 42' ' ' LEU . 61.2 t -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.743 -0.836 . . . . 50.0 108.743 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -129.81 109.99 11.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.444 -0.947 . . . . 75.0 108.444 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -57.46 131.86 51.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.091 0.956 . . . . 50.0 112.23 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB3' HG22 ' A' ' 13' ' ' THR . . . -119.93 144.72 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.372 0.669 . . . . 50.0 110.074 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -86.28 118.41 70.31 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.302 -0.999 . . . . 75.0 108.302 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.16 -24.63 76.5 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.711 2.274 . . . . 75.0 112.374 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' A' ' 86' ' ' ARG . . . 78.27 68.34 1.51 Allowed Glycine 0 C--N 1.344 1.017 0 O-C-N 124.007 0.817 . . . . 75.0 111.574 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.529 ' HA3' ' HG3' ' A' ' 89' ' ' PRO . . . 82.36 158.8 24.4 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.032 0.489 . . . . 75.0 112.2 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.46 113.01 3.59 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.393 -1.226 . . . . 75.0 110.234 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HG2' HD11 ' A' ' 69' ' ' LEU . 31.2 Cg_exo -61.47 142.67 96.01 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.945 2.43 . . . . 75.0 112.963 -176.315 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -66.64 -26.4 67.05 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.784 0.677 . . . . 75.0 110.495 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -75.81 142.13 42.34 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.077 0.951 . . . . 75.0 110.803 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -74.65 98.96 3.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.694 0.798 . . . . 75.0 109.131 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.411 HD11 ' HG2' ' A' ' 65' ' ' PRO . 84.3 mt -64.26 -54.14 38.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.592 0.757 . . . . 75.0 110.866 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -157.33 179.73 8.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.25 -0.886 . . . . 75.0 109.289 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -79.65 153.11 29.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.668 0.787 . . . . 75.0 109.874 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.699 ' HA ' HG21 ' A' ' 10' ' ' VAL . 61.9 mtp180 -78.96 100.07 7.11 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.141 -1.059 . . . . 75.0 108.141 170.026 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.5 -68.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.047 0.539 . . . . 75.0 109.908 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 72.97 5.12 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.472 -0.936 . . . . 75.0 108.472 170.108 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -71.69 89.23 1.01 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.913 -0.773 . . . . 75.0 108.913 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.3 p 176.03 136.8 0.05 Allowed 'General case' 0 C--O 1.245 0.832 0 C-N-CA 125.637 1.575 . . . . 75.0 108.98 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -91.57 72.59 5.94 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.725 0.774 . . . . 75.0 109.263 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.448 ' HB3' ' HD3' ' A' ' 79' ' ' PRO . 16.7 t-20 -159.86 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.705 -1.134 . . . . 75.0 110.477 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 78' ' ' ASN . 9.2 Cg_exo -74.19 -42.34 0.74 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.943 1.762 . . . . 75.0 111.71 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.38 127.08 31.68 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.778 0.674 . . . . 75.0 111.337 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -106.19 119.79 40.15 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.105 0.962 . . . . 75.0 108.885 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.2 pt -67.72 143.71 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.538 -0.756 . . . . 75.0 110.542 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -109.02 137.53 46.8 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.92 0.888 . . . . 75.0 109.576 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.75 120.74 14.02 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.401 0.68 . . . . 75.0 109.925 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -114.42 178.11 4.4 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.107 0.963 . . . . 75.0 110.049 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.665 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 53.5 mtp85 -63.9 105.21 0.8 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.541 0.21 . . . . 75.0 110.953 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -65.7 121.69 15.56 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.765 -1.198 . . . . 75.0 107.765 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.14 84.54 0.17 Allowed Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.933 1.293 . . . . 75.0 109.776 -169.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HG3' ' HA3' ' A' ' 63' ' ' GLY . 97.8 Cg_exo . . . . . 0 C--N 1.384 2.404 0 C-N-CA 123.912 3.075 . . . . 75.0 113.107 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.89 -0.411 . . . . 75.0 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -74.88 150.59 39.13 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.353 1.061 . . . . 75.0 110.188 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -56.95 112.31 1.29 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.585 1.154 . . . . 75.0 111.024 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -78.71 161.78 26.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.299 0.639 . . . . 75.0 110.184 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -141.79 5.59 1.77 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.696 0.798 . . . . 75.0 109.198 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -156.74 108.19 2.42 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 123.724 0.81 . . . . 75.0 109.614 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 m -92.53 -168.95 2.08 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.092 0.957 . . . . 75.0 108.675 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -54.94 127.48 28.97 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.594 -0.891 . . . . 75.0 108.594 164.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.3 ptp -59.05 132.84 55.24 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.275 0.985 . . . . 75.0 110.511 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.54 HG11 ' HB ' ' A' ' 73' ' ' VAL . 35.9 m -63.25 135.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.748 1.219 . . . . 50.0 110.277 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.717 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 94.33 11.12 57.63 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.222 -0.766 . . . . 50.0 113.504 -171.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.773 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -51.66 113.22 0.92 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.184 0.994 . . . . 50.0 111.342 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.432 HG22 ' HB3' ' A' ' 59' ' ' ALA . 23.3 m -72.85 108.2 5.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 50.0 110.289 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 34.3 m -132.39 179.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.19 0.996 . . . . 50.0 110.791 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.428 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -129.99 154.13 47.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.407 1.483 . . . . 50.0 108.23 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.5 104.56 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 121.625 0.726 . . . . 50.0 109.536 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -81.95 104.92 12.65 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.883 1.673 . . . . 75.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.3 ttm105 -128.51 133.29 48.41 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.608 -0.682 . . . . 75.0 112.13 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -124.23 141.95 51.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.868 1.267 . . . . 75.0 108.994 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.597 ' HB2' HD12 ' A' ' 24' ' ' LEU . 14.7 mm100 -67.39 -44.96 77.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.855 0.462 . . . . 75.0 110.299 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 t -137.64 171.61 14.2 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.587 0.755 . . . . 75.0 109.303 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -56.95 -43.41 81.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.444 1.098 . . . . 75.0 111.622 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -76.14 -27.38 57.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.205 1.002 . . . . 75.0 111.817 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 20' ' ' GLN . 70.8 mt -75.45 148.17 39.28 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.695 0.283 . . . . 75.0 111.053 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 40.2 mt-10 -61.46 128.55 90.08 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.47 1.108 . . . . 75.0 111.047 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' GLU . 8.7 Cg_exo -72.71 84.05 1.28 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.067 2.512 . . . . 50.0 111.138 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -71.93 116.34 12.22 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.275 1.03 . . . . 75.0 109.929 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.77 141.83 33.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.99 0.516 . . . . 50.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -113.04 158.16 20.66 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.464 -0.939 . . . . 75.0 108.464 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -173.63 170.21 43.34 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.015 -0.612 . . . . 50.0 113.589 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.02 160.85 70.11 Favored 'Cis proline' 0 C--N 1.376 1.985 0 C-N-CA 123.93 -1.279 . . . . 50.0 112.978 -5.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' HB3' HG11 ' A' ' 44' ' ' VAL . 79.7 m-85 -129.8 164.02 24.97 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.028 1.331 . . . . 50.0 109.361 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.717 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 57.6 p -137.05 111.7 8.72 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.516 0.726 . . . . 50.0 110.566 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.773 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.8 t -79.12 119.24 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 50.0 109.427 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.34 -21.11 22.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.553 0.741 . . . . 50.0 110.983 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 80' ' ' LEU . 62.5 tp -156.11 140.2 16.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.622 0.369 . . . . 50.0 110.786 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.629 HG22 HD22 ' A' ' 42' ' ' LEU . 40.2 p -107.38 128.9 54.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.725 . . . . 50.0 109.877 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.3 p -125.82 165.18 28.54 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 124.382 1.073 . . . . 50.0 109.018 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -49.83 116.76 2.56 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.134 2.556 . . . . 50.0 112.194 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 t 54.74 17.22 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.996 2.118 . . . . 50.0 114.533 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -148.55 140.57 23.93 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.973 0.509 . . . . 50.0 110.054 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.701 HD12 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -115.11 123.0 47.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.023 0.529 . . . . 50.0 109.69 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.51 108.48 17.95 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.504 -0.924 . . . . 75.0 108.504 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 34' ' ' VAL . 55.0 t -110.13 143.36 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.675 1.19 . . . . 50.0 109.938 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.9 135.27 57.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.452 1.101 . . . . 50.0 110.231 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.92 -21.99 27.72 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 123.195 0.426 . . . . 50.0 112.991 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 51' ' ' ILE . 40.2 mm -82.18 153.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.551 1.14 . . . . 50.0 109.707 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.89 68.04 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.186 0.594 . . . . 50.0 111.407 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.42 -60.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.133 0.42 . . . . 50.0 112.133 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.487 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.5 m-90 -143.34 138.54 29.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.876 0.47 . . . . 50.0 110.944 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 47' ' ' ILE . 42.9 mm -103.76 117.09 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 106.976 -1.49 . . . . 50.0 106.976 164.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -58.7 145.51 39.86 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.514 -0.55 . . . . 50.0 109.514 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.58 -34.82 52.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.853 1.261 . . . . 50.0 113.726 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -24.96 61.51 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.198 0.999 . . . . 50.0 113.035 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -107.31 24.56 12.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.5 1.12 . . . . 50.0 110.708 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.701 HG11 HD12 ' A' ' 42' ' ' LEU . 24.9 t -128.28 149.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -133.77 122.65 23.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.26 -1.015 . . . . 75.0 108.26 166.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 109.77 1.33 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.477 0.711 . . . . 50.0 109.69 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . -85.36 142.7 29.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.767 0.827 . . . . 50.0 110.223 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -72.92 116.92 55.26 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.935 -0.765 . . . . 75.0 108.935 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.08 -5.12 16.64 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.473 2.115 . . . . 75.0 112.849 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.94 13.26 81.55 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.445 -0.343 . . . . 75.0 112.349 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 -76.06 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.398 -1.081 . . . . 75.0 110.398 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.0 126.59 0.95 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-O 118.79 -1.006 . . . . 75.0 111.618 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.428 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 67.7 Cg_endo -83.78 5.49 6.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.083 2.522 . . . . 75.0 112.324 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.0 p -47.14 -49.71 21.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.462 1.905 . . . . 75.0 113.366 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.4 t -65.56 -20.43 66.32 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.485 0.714 . . . . 75.0 112.317 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -111.01 -2.77 15.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.847 0.859 . . . . 75.0 112.835 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 65' ' ' PRO . 97.4 mt -70.05 88.87 0.6 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.509 0.595 . . . . 75.0 110.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.9 p -79.59 -15.62 57.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.672 0.789 . . . . 75.0 111.465 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -58.89 130.56 47.58 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.689 0.618 . . . . 75.0 109.644 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 12.3 ptp180 -125.35 78.84 1.76 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 122.028 0.918 . . . . 75.0 109.244 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.54 ' HB ' HG11 ' A' ' 10' ' ' VAL . 21.5 t -106.86 150.71 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 CA-C-N 114.759 -1.109 . . . . 75.0 108.586 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.507 ' HB2' HD12 ' A' ' 80' ' ' LEU . 45.8 tt0 65.51 40.65 4.5 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.467 1.507 . . . . 75.0 111.067 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 10.9 mmm180 -100.44 64.04 1.13 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.37 0.605 . . . . 75.0 111.273 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.7 p -172.83 -168.74 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.767 1.227 . . . . 75.0 108.774 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -74.79 79.35 2.08 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.162 0.506 . . . . 75.0 110.574 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.517 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.7 OUTLIER 49.8 66.0 6.2 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.525 1.53 . . . . 75.0 112.17 176.673 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.03 -21.91 20.13 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.459 2.106 . . . . 75.0 112.014 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 74' ' ' GLN . 78.7 mt -113.97 99.75 7.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.253 1.021 . . . . 75.0 108.485 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -75.37 91.51 2.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.921 -0.581 . . . . 75.0 109.71 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.4 pt -72.36 87.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.433 -0.803 . . . . 75.0 110.486 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -73.57 92.7 1.95 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.427 0.632 . . . . 75.0 110.164 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.59 155.93 24.2 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.762 -0.654 . . . . 75.0 109.843 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 m -57.06 128.22 35.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.068 0.947 . . . . 75.0 111.404 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -71.34 141.37 50.43 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.954 0.901 . . . . 75.0 110.133 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 155.17 41.03 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.076 -0.713 . . . . 75.0 109.076 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 54.37 74.25 0.77 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 124.279 1.031 . . . . 75.0 110.97 -172.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.152 2.568 . . . . 75.0 111.75 176.61 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 109.44 -0.578 . . . . 75.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 51.8 p-80 -157.85 148.83 21.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.798 0.839 . . . . 75.0 109.178 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -84.35 179.65 7.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.514 0.726 . . . . 75.0 111.539 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.563 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 14.8 m170 -146.59 -160.78 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.585 1.154 . . . . 75.0 109.962 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -57.41 135.98 56.59 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.71 1.204 . . . . 75.0 110.811 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.42 117.54 5.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.583 0.753 . . . . 75.0 110.483 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 p -99.91 -171.7 2.1 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.555 1.142 . . . . 75.0 109.181 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -61.24 133.15 55.6 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.235 -1.024 . . . . 75.0 108.235 167.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -63.48 134.08 55.02 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.968 0.793 . . . . 75.0 110.414 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 72' ' ' ARG . 6.5 m -61.3 108.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.251 -1.018 . . . . 50.0 108.251 168.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.576 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.19 9.69 11.61 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.262 -0.743 . . . . 50.0 113.005 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.668 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.2 t0 -59.77 113.76 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.13 0.572 . . . . 50.0 109.556 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -72.56 114.1 10.32 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.587 . . . . 50.0 109.414 -172.119 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.13 176.57 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.906 1.282 . . . . 50.0 109.743 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.407 ' CE3' ' HD2' ' A' ' 57' ' ' LYS . 47.9 m0 -125.01 148.85 48.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.935 -1.506 . . . . 50.0 106.935 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.19 104.77 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 42.7 ttm180 -69.16 93.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.636 1.175 . . . . 75.0 109.496 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.45 119.72 28.01 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 116.052 -0.522 . . . . 75.0 109.803 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -98.53 109.28 22.07 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.856 0.862 . . . . 75.0 109.313 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.09 -70.9 0.36 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.92 0.488 . . . . 75.0 110.685 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 p -117.09 156.11 28.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.292 0.637 . . . . 75.0 109.94 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -72.08 -28.15 63.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.023 0.929 . . . . 75.0 111.026 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -72.17 -35.67 69.06 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.139 0.576 . . . . 75.0 111.299 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.04 161.42 13.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.128 0.571 . . . . 75.0 110.783 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.37 152.25 87.81 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.311 -0.859 . . . . 75.0 110.459 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 98.6 Cg_endo -77.64 146.81 24.36 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.363 2.042 . . . . 50.0 111.848 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -117.35 130.18 56.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.087 -0.709 . . . . 75.0 109.087 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 60.9 p-90 -76.67 149.17 36.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.101 0.477 . . . . 50.0 110.024 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -126.73 141.06 51.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.529 -1.286 . . . . 75.0 107.529 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.97 175.4 47.48 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.4 -0.667 . . . . 50.0 113.12 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -89.77 120.16 4.31 Favored 'Cis proline' 0 C--N 1.377 2.063 0 CA-C-N 119.112 1.456 . . . . 50.0 114.14 4.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.83 179.33 6.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.7 1.2 . . . . 50.0 111.512 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.576 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 41.4 p -138.81 113.75 9.29 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.944 0.898 . . . . 50.0 111.096 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.668 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.8 t -68.09 122.76 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 50.0 109.89 170.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 67.7 mt -93.87 -26.23 16.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.145 -0.934 . . . . 50.0 110.523 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 67.7 tp -152.29 144.04 23.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.254 0.549 . . . . 50.0 111.402 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.6 m -110.29 145.82 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 50.0 109.199 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 p -146.58 162.38 34.29 Favored Pre-proline 0 C--O 1.25 1.079 0 C-N-CA 124.717 1.207 . . . . 50.0 108.777 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 83' ' ' ARG . 9.5 Cg_endo -53.27 108.85 0.3 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.629 2.219 . . . . 50.0 112.728 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 65.61 23.48 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.864 1.666 . . . . 50.0 112.137 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -153.42 158.89 42.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.054 0.454 . . . . 50.0 110.957 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.8 123.63 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.569 1.148 . . . . 50.0 108.326 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.1 tttp -84.25 109.61 17.91 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.903 -1.147 . . . . 75.0 107.903 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 97.3 t -92.62 156.67 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.415 -1.266 . . . . 50.0 108.603 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.55 134.08 56.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.932 0.893 . . . . 50.0 110.094 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.53 73.29 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.42 -0.655 . . . . 50.0 113.682 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -85.83 144.98 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 117.739 0.77 . . . . 50.0 110.188 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.09 70.32 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.115 1.366 . . . . 50.0 111.79 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.91 -58.39 0.22 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.728 0.27 . . . . 50.0 111.728 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 8.6 m-90 -144.76 157.54 44.14 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.161 0.505 . . . . 50.0 111.752 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.8 mm -121.65 129.39 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.027 -1.471 . . . . 50.0 107.027 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -55.46 127.67 30.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.596 -0.89 . . . . 50.0 108.596 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.64 -38.66 55.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.937 1.295 . . . . 50.0 113.856 -164.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.23 -4.01 19.7 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.467 0.914 . . . . 50.0 113.467 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -97.56 15.69 22.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.148 0.979 . . . . 50.0 110.397 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.99 130.37 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.292 0.637 . . . . 50.0 109.564 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HD2' ' CE3' ' A' ' 15' ' ' TRP . 25.0 ttmm -112.47 122.07 46.64 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.712 0.805 . . . . 75.0 109.094 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.516 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -65.63 126.79 29.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.911 -0.403 . . . . 50.0 109.911 176.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.04 145.01 40.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.955 0.902 . . . . 50.0 109.895 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -89.64 112.97 54.94 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.574 0.75 . . . . 75.0 109.145 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 -9.56 23.86 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.795 2.33 . . . . 75.0 112.769 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.41 30.01 2.16 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 123.577 0.608 . . . . 75.0 111.735 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.63 -51.4 0.77 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.925 -0.87 . . . . 75.0 110.925 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.84 -89.64 0.11 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.793 -0.923 . . . . 75.0 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.59 31.44 0.51 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.204 2.603 . . . . 75.0 113.27 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 p -73.52 -26.79 61.03 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.704 0.801 . . . . 75.0 110.71 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.8 t -91.15 -77.05 0.43 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.671 0.789 . . . . 75.0 109.011 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -148.72 172.73 14.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.126 0.971 . . . . 75.0 110.004 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.48 136.01 34.99 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.304 -0.628 . . . . 75.0 109.304 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.0 p -79.06 127.55 32.14 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.59 0.756 . . . . 75.0 110.591 -176.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -72.86 126.72 30.6 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.098 -0.704 . . . . 75.0 109.098 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.622 ' HA ' HG21 ' A' ' 10' ' ' VAL . 23.1 ptt-85 -80.53 58.76 3.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.533 1.133 . . . . 75.0 112.134 -171.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.35 -28.74 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.069 0.948 . . . . 75.0 112.807 -172.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -131.98 18.6 4.58 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.378 0.671 . . . . 75.0 110.904 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.447 ' HD3' ' HB3' ' A' ' 79' ' ' PRO . 75.2 mmt-85 -122.52 6.21 9.54 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.987 0.515 . . . . 75.0 111.421 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -73.25 -33.35 65.24 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.08 0.552 . . . . 75.0 111.329 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -163.73 134.23 4.39 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.67 0.788 . . . . 75.0 109.527 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 45.01 68.6 3.14 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 125.155 1.382 . . . . 75.0 112.646 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 53.1 Cg_exo -58.44 121.01 9.26 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 75.0 111.804 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 36' ' ' LEU . 60.9 mt -53.0 123.77 12.49 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.405 1.065 . . . . 75.0 110.112 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.84 140.26 45.65 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.466 0.706 . . . . 75.0 111.205 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 pt -110.04 154.33 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.51 -0.768 . . . . 75.0 110.817 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' ARG . . . . . 0.483 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . 72.2 mtp180 -138.47 164.25 29.86 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.925 0.89 . . . . 75.0 109.909 169.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.9 mt 51.6 61.39 3.25 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.17 1.388 . . . . 75.0 110.329 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.6 m -73.49 81.88 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.793 -1.549 . . . . 75.0 109.721 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -84.55 98.37 10.1 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.625 -1.17 . . . . 75.0 109.359 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.39 107.09 1.02 Allowed 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.868 -1.16 . . . . 75.0 107.868 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.86 91.44 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.963 0.905 . . . . 75.0 109.52 -165.762 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 C--N 1.376 2.002 0 C-N-CA 123.212 2.608 . . . . 75.0 112.856 -177.747 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.424 -0.584 . . . . 75.0 109.424 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -133.91 135.92 43.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.59 0.756 . . . . 75.0 109.368 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 46.5 m80 -141.51 155.28 45.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.61 0.764 . . . . 75.0 110.013 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' HIS . . . . . 0.508 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 82.8 t60 -89.15 161.83 16.27 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.396 0.679 . . . . 75.0 110.475 173.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -133.27 129.28 37.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.38 0.672 . . . . 75.0 109.675 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -84.73 93.02 8.35 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.688 -0.486 . . . . 75.0 109.688 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.1 p -166.56 -175.76 3.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.338 0.655 . . . . 75.0 110.5 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.21 101.97 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.415 -1.328 . . . . 75.0 107.415 164.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp -73.88 170.65 14.92 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.481 1.112 . . . . 75.0 112.853 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 ' H ' ' A' ' 72' ' ' ARG . 33.0 m -70.96 142.6 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 114.949 -1.023 . . . . 50.0 110.425 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.67 9.37 81.37 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.79 -1.005 . . . . 50.0 114.28 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.43 124.66 23.81 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.447 1.124 . . . . 50.0 110.249 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.5 m -71.61 114.4 9.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.13 0.572 . . . . 50.0 110.739 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.9 m -135.98 178.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.28 1.032 . . . . 50.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.409 ' HE3' ' HD3' ' A' ' 57' ' ' LYS . 34.5 m0 -126.77 153.2 45.87 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.9 1.28 . . . . 50.0 108.348 174.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.16 105.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 107.439 -1.319 . . . . 50.0 107.439 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.689 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 76.2 ttt180 -81.12 92.36 6.26 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.91 -1.041 . . . . 75.0 109.821 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -82.87 119.98 25.08 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.421 -0.809 . . . . 75.0 110.316 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 80.8 t60 -84.42 108.87 17.47 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.431 -0.804 . . . . 75.0 109.101 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -66.24 -72.51 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.42 0.688 . . . . 75.0 111.069 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.4 m -127.1 154.11 45.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.209 1.003 . . . . 75.0 108.309 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -60.9 -37.83 83.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.026 0.93 . . . . 75.0 111.752 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -87.82 9.63 21.23 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.117 0.567 . . . . 75.0 112.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -121.72 168.49 11.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.026 0.93 . . . . 75.0 109.836 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.87 148.85 65.86 Favored Pre-proline 0 CA--C 1.553 1.073 0 CA-C-N 115.708 -0.678 . . . . 75.0 111.278 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 Cg_exo -75.57 109.83 2.98 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.892 2.395 . . . . 50.0 111.3 169.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.307 0.643 . . . . 75.0 110.42 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.689 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 61.9 p-90 -74.01 150.06 40.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.977 0.511 . . . . 50.0 110.887 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.29 143.99 49.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.091 0.957 . . . . 75.0 108.624 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.9 -177.08 25.27 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 111.603 -0.599 . . . . 50.0 111.603 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.16 121.65 6.83 Favored 'Cis proline' 0 C--N 1.37 1.664 0 CA-C-N 119.564 1.682 . . . . 50.0 111.855 -9.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -106.99 170.2 8.09 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.522 0.729 . . . . 50.0 110.003 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 65' ' ' PRO . 17.7 p -150.81 115.79 5.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.157 0.583 . . . . 50.0 111.498 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.67 127.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.104 0.562 . . . . 50.0 111.49 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 77.2 mt -95.49 -38.31 10.5 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.492 1.117 . . . . 50.0 110.475 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.563 HD22 HD13 ' A' ' 80' ' ' LEU . 38.4 tp -145.24 149.22 34.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.445 0.698 . . . . 50.0 110.06 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.456 HG22 HD22 ' A' ' 42' ' ' LEU . 37.1 p -112.97 130.4 56.14 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.744 0.818 . . . . 50.0 109.337 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -127.54 148.54 67.02 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.51 117.43 2.34 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.624 2.216 . . . . 50.0 113.031 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 m 75.58 -2.28 2.83 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.514 1.525 . . . . 50.0 112.812 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.821 -0.549 . . . . 50.0 110.586 -173.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 37' ' ' THR . 46.0 mt -108.75 125.23 51.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.927 0.491 . . . . 50.0 109.676 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.7 ttmm -83.91 110.89 18.76 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.862 -0.792 . . . . 75.0 108.862 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.34 146.14 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.822 1.249 . . . . 50.0 109.333 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.07 127.73 33.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.947 0.899 . . . . 50.0 109.771 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.25 -0.93 50.49 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.817 -0.629 . . . . 50.0 112.485 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.52 148.94 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.738 0.815 . . . . 50.0 109.242 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.07 86.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.182 0.993 . . . . 50.0 112.506 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.28 -58.03 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.327 0.251 . . . . 50.0 111.382 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.507 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.8 m-90 -143.76 147.13 33.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.241 0.616 . . . . 50.0 111.382 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.0 mm -101.55 138.71 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 107.968 -1.123 . . . . 50.0 107.968 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.25 119.55 8.12 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 107.721 -1.214 . . . . 50.0 107.721 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.11 20.94 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.266 1.426 . . . . 50.0 114.593 -164.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.48 -2.77 14.97 Favored 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 113.197 0.814 . . . . 50.0 113.197 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 57.7 m80 -115.76 17.34 16.15 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.525 1.13 . . . . 50.0 110.632 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -117.24 133.59 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.409 ' HD3' ' HE3' ' A' ' 15' ' ' TRP . 64.4 tttp -121.49 121.24 37.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.976 0.911 . . . . 75.0 109.334 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -64.47 118.18 8.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.306 0.642 . . . . 50.0 110.709 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.89 166.45 11.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 50.0 109.879 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -74.29 117.0 58.26 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.459 0.704 . . . . 75.0 110.126 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.29 3.67 1.59 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.163 2.575 . . . . 75.0 114.364 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 92.98 0.06 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.489 0.566 . . . . 75.0 111.728 170.413 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 -63.89 0.4 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 109.424 -1.47 . . . . 75.0 109.424 -169.534 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.05 -164.85 54.79 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.714 -0.492 . . . . 75.0 113.686 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.52 ' HB3' HG21 ' A' ' 33' ' ' THR . 73.2 Cg_endo -76.95 111.82 3.31 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.521 2.148 . . . . 75.0 111.932 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -70.56 -19.38 62.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.591 0.756 . . . . 75.0 110.641 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -91.65 133.49 35.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.39 1.076 . . . . 75.0 110.209 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -74.28 103.04 4.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.013 -0.736 . . . . 75.0 109.013 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.64 -170.06 2.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.107 0.963 . . . . 75.0 111.092 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.2 p -64.36 98.82 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.606 -0.516 . . . . 75.0 109.606 172.22 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -73.53 114.54 11.88 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.417 -0.81 . . . . 75.0 110.547 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.674 ' H ' HG21 ' A' ' 10' ' ' VAL . 82.9 mtt180 56.52 77.6 0.25 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.122 1.369 . . . . 75.0 111.857 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.485 ' H ' HG11 ' A' ' 10' ' ' VAL . 57.9 t -65.45 -41.42 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 122.112 0.958 . . . . 75.0 108.454 167.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' HB3' HD12 ' A' ' 80' ' ' LEU . 17.5 pt20 -99.36 118.15 35.37 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.074 -1.421 . . . . 75.0 109.247 173.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -107.45 -175.23 2.73 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.512 -0.921 . . . . 75.0 108.512 173.599 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.2 t -65.61 176.88 1.35 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.25 0.62 . . . . 75.0 110.729 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.71 82.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.598 -1.26 . . . . 75.0 107.598 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -32.47 93.93 0.06 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 126.61 1.964 . . . . 75.0 113.62 -164.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -90.81 -19.73 0.95 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.122 2.548 . . . . 75.0 113.425 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.563 HD13 HD22 ' A' ' 36' ' ' LEU . 85.0 mt -141.33 143.54 34.08 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.871 1.268 . . . . 75.0 108.772 -168.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.63 118.32 29.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.025 0.53 . . . . 75.0 109.97 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 pt -103.21 132.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.665 0.786 . . . . 75.0 109.567 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -170.68 108.06 0.31 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.537 0.735 . . . . 75.0 109.746 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.66 94.17 6.9 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.897 -0.779 . . . . 75.0 108.897 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.2 p -77.62 73.66 4.19 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.556 0.742 . . . . 75.0 110.419 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -85.63 98.05 10.45 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.406 -0.961 . . . . 75.0 108.406 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.39 148.88 21.66 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.887 0.875 . . . . 75.0 110.198 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.34 118.05 49.61 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.676 0.79 . . . . 75.0 110.475 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 122.828 2.352 . . . . 75.0 113.184 -178.757 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.71 -0.478 . . . . 75.0 109.71 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -129.77 138.6 51.16 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.178 0.991 . . . . 75.0 109.173 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.44 159.58 41.35 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 124.083 0.953 . . . . 75.0 110.196 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -68.5 163.97 22.24 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.417 -0.811 . . . . 75.0 109.305 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -132.55 -62.67 0.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.433 -0.58 . . . . 75.0 109.433 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 76' ' ' SER . 81.4 t60 59.91 31.34 20.67 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.522 1.153 . . . . 75.0 109.676 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -99.11 179.16 4.7 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.203 -1.362 . . . . 75.0 109.582 -172.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -65.66 156.98 31.22 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.668 -0.493 . . . . 75.0 109.668 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.534 ' HB2' HD23 ' A' ' 80' ' ' LEU . 25.3 ptt? -48.22 133.27 15.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.838 1.255 . . . . 75.0 113.04 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 35' ' ' LEU . 16.2 m -73.53 137.61 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.232 -1.025 . . . . 50.0 108.232 172.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 90.79 11.02 62.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-O 118.999 -0.89 . . . . 50.0 112.459 -172.334 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 64.0 t0 -57.62 97.74 0.03 OUTLIER 'General case' 0 C--N 1.365 1.275 0 C-N-CA 123.557 0.743 . . . . 50.0 109.062 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 m -71.52 118.59 14.53 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 109.484 -0.561 . . . . 50.0 109.484 -169.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.4 m -135.57 170.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 C-N-CA 125.513 1.525 . . . . 50.0 109.741 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 50.4 m0 -117.68 142.14 47.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.617 1.167 . . . . 50.0 108.082 171.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.23 109.3 27.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 107.298 -1.371 . . . . 50.0 107.298 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 48.6 ttt180 -90.51 100.2 13.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.043 1.337 . . . . 75.0 109.963 -171.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -99.46 144.11 28.93 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 75.0 111.273 -172.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 2.2 p80 -151.69 137.81 18.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.718 0.807 . . . . 75.0 110.326 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.47 -48.1 57.44 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.159 0.584 . . . . 75.0 110.734 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 p -127.02 164.74 20.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.151 0.98 . . . . 75.0 109.146 172.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -72.56 -24.98 61.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.912 0.485 . . . . 75.0 110.754 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -64.25 -36.91 85.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.227 0.611 . . . . 75.0 110.682 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -79.74 130.21 35.15 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.894 -0.409 . . . . 75.0 109.894 171.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 38.7 mt-10 -67.83 130.43 92.89 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.437 0.695 . . . . 75.0 110.003 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 19' ' ' HIS . 6.9 Cg_exo -71.62 123.53 9.52 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.101 2.534 . . . . 50.0 112.244 -172.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -100.15 125.63 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 75.0 109.207 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 67.5 p-90 -71.66 158.5 36.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.257 0.623 . . . . 50.0 111.032 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -133.95 149.12 51.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.741 0.816 . . . . 75.0 108.855 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.76 176.82 40.52 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.851 -0.416 . . . . 50.0 112.895 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -92.92 104.77 0.37 Allowed 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 118.601 1.201 . . . . 50.0 112.276 -1.439 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -74.74 161.26 29.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.646 -0.872 . . . . 50.0 108.646 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.635 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 59.7 p -141.5 111.9 6.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.41 0.284 . . . . 50.0 110.321 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 24.1 t -68.37 124.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 C-N-CA 123.41 0.684 . . . . 50.0 110.028 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' VAL . 48.1 mt -99.03 -20.68 16.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.591 1.156 . . . . 50.0 110.895 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 54.0 tp -153.73 137.36 16.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.677 0.791 . . . . 50.0 109.734 175.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 42' ' ' LEU . 38.0 p -112.31 128.96 56.43 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.639 -0.874 . . . . 50.0 108.639 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.7 p -133.39 165.19 38.58 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.439 1.095 . . . . 50.0 109.148 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 6.3 Cg_endo -46.82 108.98 0.17 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.559 2.839 . . . . 50.0 113.523 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.1 p 56.08 20.37 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 126.039 1.736 . . . . 50.0 113.737 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.0 138.83 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.809 -0.811 . . . . 50.0 108.809 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 37' ' ' THR . 64.4 mt -127.89 129.02 46.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.405 -0.591 . . . . 50.0 109.405 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -86.27 107.39 17.92 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.055 -1.461 . . . . 75.0 107.055 168.533 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 21.7 t -104.79 160.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.164 -0.926 . . . . 50.0 108.79 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -66.32 129.04 38.48 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.453 0.701 . . . . 50.0 109.51 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.21 -4.49 86.17 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.586 0.554 . . . . 50.0 113.039 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.95 137.54 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.875 0.87 . . . . 50.0 109.503 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.68 72.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.974 0.91 . . . . 50.0 111.441 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.35 -56.15 0.17 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.583 0.586 . . . . 50.0 112.583 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -141.19 138.24 33.22 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.344 0.52 . . . . 50.0 111.801 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.3 mm -120.45 127.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.191 -1.411 . . . . 50.0 107.191 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -56.64 122.84 13.0 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.221 -0.659 . . . . 50.0 109.221 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.39 -21.37 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.735 1.614 . . . . 50.0 114.817 -166.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.11 65.4 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.301 0.852 . . . . 50.0 113.301 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -87.74 -12.53 44.97 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.856 0.462 . . . . 50.0 111.218 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.6 t -101.76 139.83 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 50.0 109.81 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -138.99 129.75 26.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 75.0 109.62 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.547 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.4 126.54 29.6 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.277 0.631 . . . . 50.0 112.342 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.85 160.15 16.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.474 1.11 . . . . 50.0 111.304 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -97.21 117.59 65.49 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.808 -1.182 . . . . 75.0 107.808 173.321 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.26 -29.35 14.25 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.573 2.182 . . . . 75.0 113.41 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 -76.15 0.77 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 110.105 -1.198 . . . . 75.0 110.105 -163.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.7 -77.38 0.73 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 110.481 -1.048 . . . . 75.0 110.481 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.0 -123.4 33.0 Favored Glycine 0 CA--C 1.545 1.935 0 N-CA-C 114.846 0.699 . . . . 75.0 114.846 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.37 96.7 1.05 Allowed 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.299 2.666 . . . . 75.0 113.143 -171.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -114.58 -71.58 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.901 -0.777 . . . . 75.0 108.901 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 t -81.97 68.52 8.39 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.714 1.205 . . . . 75.0 111.152 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -168.35 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.628 1.171 . . . . 75.0 109.583 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.1 12.88 3.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.91 0.884 . . . . 75.0 112.893 -172.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -56.84 -22.33 35.92 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.285 1.434 . . . . 75.0 113.166 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.73 148.46 51.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.932 0.893 . . . . 75.0 112.028 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 12.6 ptp180 -95.76 59.24 2.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.828 1.299 . . . . 75.0 110.441 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -94.37 -17.0 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 113.988 -1.46 . . . . 75.0 108.874 171.158 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.39 27.25 1.1 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.501 1.12 . . . . 75.0 111.994 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HD3' ' HB2' ' A' ' 72' ' ' ARG . 22.9 mmm180 -62.49 94.91 0.06 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.83 0.852 . . . . 75.0 111.536 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 6' ' ' HIS . 33.0 t -162.57 -171.15 2.64 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.527 1.531 . . . . 75.0 108.493 -177.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -61.89 -63.33 1.29 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.549 0.74 . . . . 75.0 110.646 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -169.24 79.77 0.7 Allowed Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.963 0.905 . . . . 75.0 109.257 171.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 76' ' ' SER . 74.2 Cg_endo -75.04 -26.53 10.77 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.757 2.305 . . . . 75.0 112.753 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 9' ' ' MET . 76.5 mt -78.89 172.96 13.04 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.556 0.693 . . . . 75.0 111.623 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -151.63 141.74 22.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.704 1.202 . . . . 75.0 108.516 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.2 pt -65.82 147.32 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.979 0.419 . . . . 75.0 110.012 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -122.39 10.78 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.598 0.759 . . . . 75.0 109.831 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.1 mt 58.36 19.71 6.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.234 1.414 . . . . 75.0 112.19 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -84.13 143.88 29.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.672 0.789 . . . . 75.0 109.481 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -74.62 96.38 2.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.561 0.744 . . . . 75.0 109.49 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.4 -57.37 3.39 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.836 0.854 . . . . 75.0 109.443 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.14 141.26 80.9 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.705 -0.479 . . . . 75.0 109.705 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.564 2.012 0 C-N-CA 122.343 2.029 . . . . 75.0 111.132 176.582 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 120.568 0.223 . . . . 75.0 110.841 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' HIS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 89' ' ' PRO . 12.4 p-80 -160.68 148.55 16.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.901 1.28 . . . . 75.0 109.368 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -162.15 142.87 10.36 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.95 0.156 . . . . 75.0 110.772 -174.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -80.33 165.71 22.02 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.868 0.867 . . . . 75.0 112.005 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -153.46 123.53 6.95 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.621 -0.881 . . . . 75.0 108.621 167.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.36 72.54 8.4 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.301 1.048 . . . . 75.0 110.23 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.5 t -161.36 -171.1 2.86 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.511 -1.222 . . . . 75.0 109.283 -171.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -68.64 126.28 29.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.665 0.786 . . . . 75.0 109.796 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.6 ptp -92.42 174.65 7.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.254 0.622 . . . . 75.0 111.478 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.8 m -67.87 135.54 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.265 -0.879 . . . . 50.0 111.053 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.57 62.63 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.672 -0.516 . . . . 50.0 112.613 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.1 t0 -65.57 115.98 6.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.694 0.798 . . . . 50.0 110.601 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.41 HG22 ' HB3' ' A' ' 59' ' ' ALA . 38.3 m -73.31 111.88 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.218 0.607 . . . . 50.0 110.328 -173.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.2 m -136.37 -176.56 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.818 1.247 . . . . 50.0 110.616 -174.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.7 m0 -131.95 157.71 43.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.516 1.526 . . . . 50.0 107.814 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.12 104.37 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.536 -0.913 . . . . 50.0 108.536 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 57' ' ' LYS . 67.5 ttt180 -79.01 96.53 5.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.466 1.106 . . . . 75.0 110.44 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -98.43 119.18 36.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.098 0.475 . . . . 75.0 111.833 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -107.09 94.08 4.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.104 0.962 . . . . 75.0 108.409 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -57.94 -70.02 0.15 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.755 0.822 . . . . 75.0 111.912 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.7 p -117.36 173.97 6.4 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.536 0.734 . . . . 75.0 109.069 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -70.93 -21.57 62.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.705 0.802 . . . . 75.0 111.851 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -92.29 -31.73 15.28 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.864 0.466 . . . . 75.0 110.991 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.54 162.93 27.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.653 0.381 . . . . 75.0 110.751 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.98 159.26 54.74 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.879 0.872 . . . . 75.0 110.993 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.76 76.1 4.71 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.991 2.461 . . . . 50.0 110.673 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -76.61 116.54 17.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.175 -0.921 . . . . 75.0 110.017 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -81.35 153.18 27.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.498 0.666 . . . . 50.0 110.711 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -127.62 137.87 52.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.574 -1.269 . . . . 75.0 107.574 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.91 38.05 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.306 -0.473 . . . . 50.0 112.79 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.14 122.09 5.86 Favored 'Cis proline' 0 CA--C 1.559 1.756 0 C-N-CA 123.753 -1.353 . . . . 50.0 112.878 -4.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.18 178.97 7.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.576 0.75 . . . . 50.0 110.0 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 25.6 p -138.15 113.34 9.33 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.908 0.483 . . . . 50.0 110.983 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.5 t -64.99 135.82 27.65 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 CA-C-O 121.242 0.544 . . . . 50.0 109.666 170.256 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 66.5 mt -104.53 -44.98 4.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.085 -0.961 . . . . 50.0 109.258 173.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.4 tp -142.19 147.67 36.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.727 -0.67 . . . . 50.0 109.765 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.445 HG22 HD22 ' A' ' 42' ' ' LEU . 30.9 p -104.63 144.27 31.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.781 0.833 . . . . 50.0 109.164 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -140.35 149.07 56.45 Favored Pre-proline 0 CA--C 1.556 1.198 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -39.56 121.61 0.83 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.044 2.496 . . . . 50.0 114.021 170.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t 53.07 14.48 0.48 Allowed 'General case' 0 N--CA 1.504 2.261 0 C-N-CA 126.745 2.018 . . . . 50.0 114.826 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -153.82 124.58 7.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.794 0.438 . . . . 50.0 110.465 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD12 ' HB ' ' A' ' 56' ' ' VAL . 86.8 mt -103.0 126.05 50.02 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.269 -0.641 . . . . 50.0 109.269 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 51.5 tttm -86.85 108.96 18.98 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 108.706 -0.85 . . . . 75.0 108.706 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 34' ' ' VAL . 58.4 t -116.31 141.65 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.822 -1.081 . . . . 50.0 109.345 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.95 137.64 57.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.393 0.677 . . . . 50.0 110.768 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.75 21.65 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.563 -0.744 . . . . 50.0 111.928 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 51' ' ' ILE . 50.1 mm -87.0 146.77 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.975 0.91 . . . . 50.0 109.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.56 -49.43 64.96 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.225 1.01 . . . . 50.0 111.151 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -151.17 -59.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.16 0.287 . . . . 50.0 111.519 167.47 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.473 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 18.0 m-90 -135.5 144.95 46.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.931 -0.481 . . . . 50.0 112.0 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 47' ' ' ILE . 35.9 mm -110.76 137.6 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.145 -1.428 . . . . 50.0 107.145 163.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -57.07 129.21 40.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.79 -32.44 65.67 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.048 1.129 . . . . 50.0 114.048 -163.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 -11.35 60.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.313 0.645 . . . . 50.0 112.415 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -102.39 22.8 12.8 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.406 1.082 . . . . 50.0 111.044 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 42' ' ' LEU . 59.8 t -135.72 125.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.206 -0.664 . . . . 50.0 109.206 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD2' ' HD2' ' A' ' 17' ' ' ARG . 48.2 mtpt -114.45 129.82 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.601 0.761 . . . . 75.0 109.783 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.63 120.88 15.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.583 0.353 . . . . 50.0 110.181 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . -86.15 157.71 19.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.251 0.62 . . . . 50.0 110.281 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -78.14 117.8 68.27 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.69 0.796 . . . . 75.0 109.971 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 52.8 Cg_exo -59.22 -17.67 40.44 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.27 2.647 . . . . 75.0 113.632 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.92 87.32 0.08 OUTLIER Glycine 0 C--N 1.347 1.188 0 CA-C-N 116.246 -0.434 . . . . 75.0 113.247 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.0 -13.78 0.31 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.457 0.551 . . . . 75.0 112.377 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.7 -73.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.481 -0.622 . . . . 75.0 112.154 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' HG3' HD11 ' A' ' 69' ' ' LEU . 35.9 Cg_exo -59.73 112.85 1.4 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.109 2.539 . . . . 75.0 112.386 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -64.08 -49.99 70.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.465 0.706 . . . . 75.0 109.91 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -151.16 -69.56 0.17 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 75.0 109.036 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -118.7 133.04 56.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.862 0.865 . . . . 75.0 109.789 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 65' ' ' PRO . 90.9 mt -94.98 -71.01 0.69 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.932 0.493 . . . . 75.0 109.786 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -86.49 147.84 25.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.843 -0.617 . . . . 75.0 109.812 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -86.0 -63.49 1.31 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.488 0.715 . . . . 75.0 109.268 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.499 HH12 ' HB3' ' A' ' 2' ' ' HIS . 79.1 mtp180 -151.75 150.04 29.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.104 1.362 . . . . 75.0 109.101 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.502 HG11 HD22 ' A' ' 35' ' ' LEU . 35.6 m -120.12 -6.15 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 112.832 0.679 . . . . 75.0 112.832 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' NE2' HD12 ' A' ' 80' ' ' LEU . 2.7 pt20 -68.59 -27.3 65.92 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.386 0.539 . . . . 75.0 112.24 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.01 -20.66 66.26 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.16 0.584 . . . . 75.0 111.005 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -89.11 -30.41 18.66 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.03 0.932 . . . . 75.0 112.024 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -161.28 -35.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.566 0.58 . . . . 75.0 112.566 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 7.1 t30 75.56 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 125.036 1.334 . . . . 75.0 111.491 -176.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -81.23 -2.94 11.93 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.154 2.57 . . . . 75.0 111.7 169.075 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 87' ' ' GLU . 43.0 mt -85.07 13.01 6.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.011 . . . . 75.0 112.493 -172.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.58 -10.45 58.21 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.406 0.683 . . . . 75.0 112.525 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.5 pt -85.05 -173.47 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.999 0.52 . . . . 75.0 109.905 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.76 -38.44 85.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.28 0.632 . . . . 75.0 111.668 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.528 HD22 HH21 ' A' ' 86' ' ' ARG . 72.4 mt -81.63 87.76 6.26 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.533 0.682 . . . . 75.0 109.354 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 9.3 t -113.48 64.19 0.65 Allowed 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 122.701 1.238 . . . . 75.0 110.288 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ARG . . . . . 0.528 HH21 HD22 ' A' ' 84' ' ' LEU . 72.6 mtm180 -147.51 132.65 18.33 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.022 -0.99 . . . . 75.0 110.335 -174.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' HG3' HD11 ' A' ' 80' ' ' LEU . 61.8 mt-10 -129.76 -80.69 0.55 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.828 0.851 . . . . 75.0 109.583 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -167.25 167.85 7.11 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 123.525 0.73 . . . . 75.0 110.076 -172.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HA ' ' HB2' ' A' ' 2' ' ' HIS . 18.2 Cg_exo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 122.962 2.441 . . . . 75.0 112.4 167.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.386 -0.598 . . . . 75.0 109.386 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -144.6 114.54 7.35 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.191 0.996 . . . . 75.0 109.503 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -157.24 52.07 0.48 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.194 0.597 . . . . 75.0 110.446 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.08 81.77 0.33 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.316 0.646 . . . . 75.0 110.446 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -76.63 -82.12 0.08 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.426 0.691 . . . . 75.0 109.154 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -168.62 142.8 3.19 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.052 0.541 . . . . 75.0 109.807 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -148.03 -173.92 4.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.338 0.655 . . . . 75.0 110.966 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -86.28 161.17 18.89 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.118 0.967 . . . . 75.0 108.731 171.216 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.44 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 27.2 ptt? -53.1 132.65 38.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.518 0.727 . . . . 75.0 111.495 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.652 HG11 ' HB ' ' A' ' 73' ' ' VAL . 21.3 m -69.46 139.26 20.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 116.045 -0.525 . . . . 50.0 109.888 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 101.11 9.78 44.17 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.559 -0.579 . . . . 50.0 112.875 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.5 t0 -58.28 109.39 0.76 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.026 0.53 . . . . 50.0 110.622 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.6 m -71.62 111.66 7.1 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.142 0.496 . . . . 50.0 109.843 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.15 -175.1 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.565 1.146 . . . . 50.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 31.0 m0 -124.38 156.77 36.52 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.053 1.341 . . . . 50.0 107.722 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 52.2 t -109.75 114.58 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.417 -0.956 . . . . 50.0 108.417 171.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 55' ' ' HIS . 39.3 ttm180 -76.97 123.77 26.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.158 0.983 . . . . 75.0 110.108 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -138.29 140.38 39.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.854 -0.795 . . . . 75.0 108.854 168.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 10.9 m170 -57.95 -45.66 86.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.458 0.703 . . . . 75.0 111.897 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 65.99 -70.2 0.1 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 124.666 1.229 . . . . 75.0 109.735 -170.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 24' ' ' LEU . 33.4 p -80.6 137.15 36.35 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.913 1.285 . . . . 75.0 109.2 168.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -61.94 -52.1 65.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.95 0.9 . . . . 75.0 112.905 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -108.03 -15.69 14.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.933 0.893 . . . . 75.0 112.415 -169.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 21' ' ' THR . 68.2 mt -80.52 172.97 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 110.553 -0.166 . . . . 75.0 110.553 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -56.27 127.22 70.5 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.888 0.875 . . . . 75.0 111.847 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 52.1 Cg_exo -56.16 124.72 16.95 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.256 2.637 . . . . 50.0 112.434 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -93.67 179.61 5.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.184 0.993 . . . . 75.0 108.834 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -146.21 163.34 35.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.383 0.673 . . . . 50.0 110.296 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -131.31 161.12 33.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.726 -0.842 . . . . 75.0 108.726 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -170.91 -177.55 40.9 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-O 119.402 -0.666 . . . . 50.0 111.896 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.32 116.73 3.64 Favored 'Cis proline' 0 C--N 1.376 2.013 0 CA-C-N 119.408 1.604 . . . . 50.0 113.117 -4.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HB3' HG11 ' A' ' 44' ' ' VAL . 77.9 m-85 -80.45 169.41 17.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.825 0.85 . . . . 50.0 110.408 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.523 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.9 p -140.28 110.49 6.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.422 0.689 . . . . 50.0 110.685 -176.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 65.3 t -73.38 130.45 35.78 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 123.064 0.546 . . . . 50.0 109.743 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.406 HD22 ' HB ' ' A' ' 10' ' ' VAL . 41.1 mt -98.22 -54.66 3.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.302 -0.863 . . . . 50.0 109.393 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 28.9 tp -110.26 139.63 45.24 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.18 0.592 . . . . 50.0 109.651 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.432 HG22 HD22 ' A' ' 42' ' ' LEU . 69.0 p -127.89 129.25 46.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.353 0.661 . . . . 50.0 109.353 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -145.15 161.09 43.65 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.094 1.358 . . . . 50.0 108.454 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -43.62 109.0 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.662 2.908 . . . . 50.0 114.832 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m 65.08 13.15 8.5 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.03 1.332 . . . . 50.0 112.456 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.85 121.89 14.64 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.705 -0.622 . . . . 50.0 110.012 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.485 HD12 HG11 ' A' ' 56' ' ' VAL . 62.1 mt -121.8 122.19 38.93 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.818 -1.179 . . . . 50.0 107.818 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 82.9 tttt -93.85 111.46 23.17 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.261 -0.644 . . . . 75.0 109.261 176.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 32' ' ' TYR . 76.7 t -86.49 156.24 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 O-C-N 124.347 1.03 . . . . 50.0 109.385 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.35 116.2 4.1 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.89 0.876 . . . . 50.0 110.706 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.44 -14.81 32.79 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.226 -0.443 . . . . 50.0 113.214 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 51' ' ' ILE . 39.5 mm -77.96 143.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.532 0.733 . . . . 50.0 111.24 -177.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.4 -50.7 69.06 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.648 1.179 . . . . 50.0 112.259 -176.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.31 -58.1 0.18 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.219 0.451 . . . . 50.0 112.219 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -143.92 150.03 37.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.683 0.393 . . . . 50.0 111.111 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 47' ' ' ILE . 33.1 mm -112.98 122.27 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.439 -0.949 . . . . 50.0 108.439 166.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.54 124.78 22.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.855 -1.535 . . . . 50.0 106.855 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.32 -18.75 7.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.259 1.577 . . . . 50.0 115.259 -160.624 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.65 -4.93 34.04 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.537 0.735 . . . . 50.0 112.352 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 97.7 m-70 -104.11 17.35 24.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.099 0.96 . . . . 50.0 109.967 169.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG11 HD12 ' A' ' 42' ' ' LEU . 54.6 t -124.61 136.34 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.771 0.428 . . . . 50.0 109.902 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 52.7 mtpt -133.67 115.39 14.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 75.0 108.202 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.39 121.51 12.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 50.0 111.364 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.17 155.6 20.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.702 0.801 . . . . 50.0 111.252 -175.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -100.43 113.83 65.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.195 0.998 . . . . 75.0 108.446 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.06 -17.37 13.59 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.639 2.226 . . . . 75.0 112.931 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.29 -63.25 4.45 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.745 -0.942 . . . . 75.0 110.745 -168.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.65 -117.51 0.44 Allowed Glycine 0 C--O 1.238 0.388 0 N-CA-C 109.107 -1.597 . . . . 75.0 109.107 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.25 64.97 3.9 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-O 119.554 -0.581 . . . . 75.0 113.787 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.455 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 64.0 Cg_endo -88.8 -0.09 6.4 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.766 2.311 . . . . 75.0 113.165 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -49.62 -60.93 2.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.279 1.431 . . . . 75.0 114.122 -166.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -77.27 -13.57 59.91 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.353 0.661 . . . . 75.0 111.309 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -98.97 2.04 46.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.87 0.868 . . . . 75.0 111.844 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 65' ' ' PRO . 80.7 mt -71.22 -2.75 17.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.742 0.817 . . . . 75.0 112.712 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -65.86 -62.72 1.35 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.809 0.843 . . . . 75.0 111.423 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.488 ' HD1' HG22 ' A' ' 10' ' ' VAL . 7.3 m0 51.95 37.0 19.88 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.66 1.184 . . . . 75.0 113.594 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -69.84 -28.69 65.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 75.0 112.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.652 ' HB ' HG11 ' A' ' 10' ' ' VAL . 44.6 t -77.75 -21.61 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.538 0.735 . . . . 75.0 110.384 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.44 ' HG3' HD21 ' A' ' 80' ' ' LEU . 30.7 mm-40 -81.89 5.19 19.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.344 1.057 . . . . 75.0 112.186 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -81.3 75.65 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.739 0.78 . . . . 75.0 109.918 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -153.93 -141.0 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 106.354 -1.721 . . . . 75.0 106.354 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -63.93 109.81 1.9 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.164 -1.791 . . . . 75.0 106.164 160.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.66 108.14 1.27 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.914 0.886 . . . . 75.0 112.027 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.66 -1.83 6.6 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.609 2.872 . . . . 75.0 112.556 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 74' ' ' GLN . 94.5 mt -75.62 90.45 2.8 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 123.412 0.685 . . . . 75.0 109.408 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -98.43 103.31 15.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.942 -0.762 . . . . 75.0 108.942 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.1 pt -73.76 100.24 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-O 122.124 0.964 . . . . 75.0 110.926 -174.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -88.74 -178.69 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.976 -1.011 . . . . 75.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.21 72.47 10.16 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.176 0.59 . . . . 75.0 110.642 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -86.28 134.67 33.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.548 -0.751 . . . . 75.0 109.363 174.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -71.94 90.64 1.15 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.485 0.714 . . . . 75.0 109.606 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -91.37 141.41 28.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.216 1.006 . . . . 75.0 110.648 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 102.44 45.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.514 0.726 . . . . 75.0 109.596 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.38 2.198 0 C-N-CA 123.206 2.604 . . . . 75.0 112.766 175.454 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.046 -0.724 . . . . 75.0 109.046 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -84.21 146.58 27.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.038 0.535 . . . . 75.0 109.899 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -157.65 148.95 21.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.992 0.917 . . . . 75.0 109.414 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -155.28 176.41 12.6 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.424 0.63 . . . . 75.0 111.184 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -130.16 -177.81 4.47 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.747 1.219 . . . . 75.0 107.981 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -80.47 79.21 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.805 -1.183 . . . . 75.0 107.805 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 m -109.1 -174.59 2.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.274 -1.33 . . . . 75.0 113.001 -162.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 73.4 m80 -71.95 141.57 49.44 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.441 -1.318 . . . . 75.0 107.441 161.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' MET . . . . . 0.503 ' HG2' HG23 ' A' ' 82' ' ' ILE . 24.6 ptt? -67.1 150.34 49.32 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 109.907 -0.405 . . . . 75.0 109.907 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 HE21 ' A' ' 74' ' ' GLN . 34.7 m -57.27 136.36 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.945 0.898 . . . . 50.0 110.861 -175.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.17 9.62 61.86 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 118.855 -0.97 . . . . 50.0 114.115 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.7 t0 -55.11 114.92 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.784 0.834 . . . . 50.0 111.645 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.556 HG21 ' HB3' ' A' ' 61' ' ' PRO . 3.7 m -74.82 107.59 7.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 -175.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.31 165.49 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.46 0.704 . . . . 50.0 110.948 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.585 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -116.53 131.27 56.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.411 1.084 . . . . 50.0 108.188 172.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 56' ' ' VAL . 58.2 t -107.35 110.27 31.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.887 -1.153 . . . . 50.0 107.887 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 59.4 ttp180 -85.5 106.08 16.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 75.0 110.714 -174.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -92.65 139.37 30.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.707 1.203 . . . . 75.0 111.183 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -72.89 95.08 1.91 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.726 -0.842 . . . . 75.0 108.726 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -67.61 -36.04 80.09 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.577 -0.897 . . . . 75.0 108.577 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -140.29 147.71 40.32 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.275 1.43 . . . . 75.0 107.544 167.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.02 -47.71 19.92 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.249 0.62 . . . . 75.0 111.095 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -77.99 -20.3 52.86 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.279 0.474 . . . . 75.0 112.279 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 40.8 mt -95.87 161.03 14.18 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.691 -0.485 . . . . 75.0 109.691 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 38.2 mt-10 -67.63 131.71 92.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.018 0.527 . . . . 75.0 111.213 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.586 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 2.7 Cg_exo -74.35 153.73 45.39 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.197 2.598 . . . . 50.0 113.018 -171.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -98.06 123.94 42.33 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.144 0.978 . . . . 75.0 109.925 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 69.0 p-90 -73.91 142.25 45.97 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.359 -0.608 . . . . 50.0 109.359 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.29 143.83 50.77 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.325 -0.991 . . . . 75.0 108.325 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.585 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 171.01 -173.87 44.72 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.683 -0.77 . . . . 50.0 113.555 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -88.02 115.98 3.22 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 118.446 1.123 . . . . 50.0 113.099 4.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -76.59 166.49 23.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.781 0.833 . . . . 50.0 110.672 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.582 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 69.4 p -129.96 111.42 12.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.983 0.513 . . . . 50.0 110.701 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 40.1 t -71.97 129.42 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 108.724 -0.843 . . . . 50.0 108.724 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 76.9 mt -105.77 -33.56 7.96 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.787 0.835 . . . . 50.0 109.789 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.8 tp -146.5 152.2 38.6 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.422 -0.808 . . . . 50.0 110.019 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -132.02 128.53 38.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.123 0.969 . . . . 50.0 108.985 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -123.56 162.88 37.89 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.501 1.52 . . . . 50.0 107.895 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.35 108.44 0.15 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.928 2.418 . . . . 50.0 113.777 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 m 73.98 0.02 3.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.854 1.662 . . . . 50.0 113.01 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -133.99 124.67 26.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.426 0.69 . . . . 50.0 110.119 -173.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.75 121.6 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 50.0 109.269 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.2 tttt -84.91 108.61 17.63 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 107.328 -1.36 . . . . 75.0 107.328 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 34' ' ' VAL . 57.3 t -117.51 146.39 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.578 -1.192 . . . . 50.0 109.482 -171.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.99 137.36 47.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.586 0.754 . . . . 50.0 109.558 173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.51 4.49 80.1 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.666 0.604 . . . . 50.0 112.784 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -117.13 147.91 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.62 1.168 . . . . 50.0 109.292 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.41 -51.41 64.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.996 0.919 . . . . 50.0 112.145 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.06 -57.59 0.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.589 0.356 . . . . 50.0 111.267 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.475 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 14.8 m-90 -142.16 157.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.633 0.773 . . . . 50.0 110.947 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 47' ' ' ILE . 34.8 mm -123.13 134.82 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.579 1.152 . . . . 50.0 108.454 168.366 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -61.49 113.47 2.69 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 108.034 -1.098 . . . . 50.0 108.034 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.61 -19.85 4.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.188 1.551 . . . . 50.0 115.188 -163.515 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.77 -29.85 69.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.73 0.812 . . . . 50.0 112.772 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -71.19 -24.72 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.252 0.621 . . . . 50.0 111.579 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 16' ' ' VAL . 98.4 t -96.6 138.27 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.283 0.633 . . . . 50.0 110.678 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -134.67 143.42 47.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.638 -1.245 . . . . 75.0 107.638 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.994 0.518 . . . . 50.0 110.79 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.26 26.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.531 0.732 . . . . 50.0 109.397 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -101.46 104.25 32.64 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.38 0.672 . . . . 75.0 109.248 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HB3' HG21 ' A' ' 13' ' ' THR . 36.2 Cg_endo -89.12 -5.86 5.64 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.814 2.343 . . . . 75.0 112.636 174.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.75 -40.82 1.68 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 110.058 -1.217 . . . . 75.0 110.058 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.54 144.4 3.94 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 112.11 -0.396 . . . . 75.0 112.11 175.256 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -168.33 50.13 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.678 -0.512 . . . . 75.0 113.372 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.62 155.17 31.36 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.133 2.555 . . . . 75.0 112.898 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.484 ' HB3' HG22 ' A' ' 33' ' ' THR . 23.2 t -83.6 -47.45 11.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.314 0.646 . . . . 75.0 109.333 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -83.05 167.74 17.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.523 0.729 . . . . 75.0 111.0 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.56 136.65 34.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.641 -0.874 . . . . 75.0 108.641 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.1 28.58 0.6 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.134 0.974 . . . . 75.0 112.63 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.8 p -73.07 -34.42 66.23 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.77 0.828 . . . . 75.0 111.308 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -68.04 110.65 4.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.963 0.905 . . . . 75.0 111.554 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 75' ' ' ARG . 98.2 mtt180 -84.0 62.2 6.89 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.912 0.885 . . . . 75.0 110.053 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.9 t -80.15 -41.9 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.608 -1.256 . . . . 75.0 107.608 168.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.46 HE21 HG22 ' A' ' 10' ' ' VAL . 19.4 pt20 -85.23 11.11 10.64 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.329 -1.305 . . . . 75.0 113.235 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 13.4 ptm180 -58.36 120.41 8.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.45 0.7 . . . . 75.0 111.921 -172.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -157.12 -168.83 2.75 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.401 0.68 . . . . 75.0 109.616 -171.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -65.98 -43.39 87.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.499 0.72 . . . . 75.0 109.862 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -122.29 145.49 44.47 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.171 . . . . 75.0 109.338 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.44 149.21 62.2 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.373 2.049 . . . . 75.0 110.654 169.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 mt -77.49 171.2 15.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.332 0.653 . . . . 75.0 109.716 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -138.21 143.48 40.18 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.878 0.371 . . . . 75.0 111.131 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.503 HG23 ' HG2' ' A' ' 9' ' ' MET . 27.2 pt -123.22 154.26 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.337 1.055 . . . . 75.0 108.651 170.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -131.59 94.08 3.46 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.458 -0.941 . . . . 75.0 108.458 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.95 93.07 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.692 -0.855 . . . . 75.0 108.692 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -70.34 141.85 52.24 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.366 -0.833 . . . . 75.0 110.373 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -74.01 94.71 2.4 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.989 0.424 . . . . 75.0 110.438 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.83 142.55 36.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.717 -0.674 . . . . 75.0 109.776 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.47 123.4 80.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.713 -0.661 . . . . 75.0 109.686 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 122.935 2.423 . . . . 75.0 111.952 -175.334 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.032 -0.359 . . . . 75.0 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -80.03 91.3 5.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.187 -0.672 . . . . 75.0 109.187 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 39.6 p-80 -151.13 128.63 11.4 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.403 -0.591 . . . . 75.0 109.403 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -139.65 173.33 11.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.493 1.117 . . . . 75.0 109.286 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 22.7 m170 -147.18 170.24 17.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.533 0.733 . . . . 75.0 110.67 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.559 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 23.3 m-70 -74.77 93.32 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.872 -1.058 . . . . 75.0 108.24 171.422 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -113.07 -176.68 2.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.48 0.657 . . . . 75.0 111.511 -168.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.65 163.14 25.71 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 114.508 -1.224 . . . . 75.0 108.402 169.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -49.02 136.9 13.82 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.643 0.777 . . . . 75.0 110.567 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.21 140.06 20.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 N-CA-C 109.211 -0.663 . . . . 50.0 109.211 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.762 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 82.9 11.14 81.97 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-O 118.657 -1.079 . . . . 50.0 113.176 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 53.2 t0 -50.13 119.86 3.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.688 0.744 . . . . 50.0 110.438 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 59' ' ' ALA . 35.3 m -73.66 110.86 8.28 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.693 -0.685 . . . . 50.0 109.259 -169.591 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.13 157.25 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.057 0.943 . . . . 50.0 110.279 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 30.7 m0 -101.2 143.11 31.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.279 -1.008 . . . . 50.0 108.279 168.465 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.91 112.95 42.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 N-CA-C 109.086 -0.709 . . . . 50.0 109.086 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.2 ttm180 -65.6 109.32 2.34 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.9 1.68 . . . . 75.0 110.745 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -119.32 142.53 48.03 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.175 0.99 . . . . 75.0 110.169 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.46 -78.32 0.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.869 0.467 . . . . 75.0 110.221 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 56.08 22.44 5.95 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.366 1.066 . . . . 75.0 111.944 -168.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 p -144.26 142.97 30.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.012 1.325 . . . . 75.0 108.281 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.83 -35.16 20.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.797 0.439 . . . . 75.0 111.974 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -131.12 -29.57 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.083 0.553 . . . . 75.0 111.347 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.16 157.32 29.03 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.556 0.217 . . . . 75.0 110.592 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.87 144.76 96.69 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.892 0.877 . . . . 75.0 112.122 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.19 114.41 3.6 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.775 2.317 . . . . 50.0 111.643 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -93.92 128.72 40.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.017 1.327 . . . . 75.0 110.447 -171.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 61.9 p-90 -76.08 151.69 37.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.657 0.383 . . . . 50.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -141.07 163.76 32.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.1 0.56 . . . . 75.0 109.743 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -167.93 -162.14 19.19 Favored Glycine 0 CA--C 1.538 1.471 0 N-CA-C 110.985 -0.846 . . . . 50.0 110.985 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.36 114.55 3.1 Favored 'Cis proline' 0 C--N 1.368 1.586 0 CA-C-N 119.365 1.583 . . . . 50.0 112.973 -2.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' HG11 ' A' ' 44' ' ' VAL . 74.5 m-85 -77.67 166.93 22.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.431 0.693 . . . . 50.0 110.072 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.762 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 17.2 p -140.33 111.87 7.34 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.285 0.634 . . . . 50.0 111.283 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.51 HG22 HG22 ' A' ' 44' ' ' VAL . 60.0 t -84.03 125.43 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 122.888 0.475 . . . . 50.0 110.31 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' HB3' HG21 ' A' ' 73' ' ' VAL . 81.0 mt -98.97 -45.47 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.746 0.818 . . . . 50.0 110.262 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 48.8 tp -132.58 153.71 50.74 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.438 -0.801 . . . . 50.0 109.486 -173.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.483 HG22 HD22 ' A' ' 42' ' ' LEU . 60.5 p -125.65 148.6 48.94 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.148 0.579 . . . . 50.0 110.027 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 40.3 p -140.03 165.93 27.32 Favored Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 125.372 1.469 . . . . 50.0 107.869 175.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.7 Cg_endo -51.92 108.18 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.572 2.182 . . . . 50.0 112.993 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 64.25 20.91 12.36 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.512 1.525 . . . . 50.0 112.581 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.57 129.44 11.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 HG11 ' A' ' 56' ' ' VAL . 33.8 mt -112.95 130.72 56.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.963 -0.46 . . . . 50.0 109.984 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -84.95 109.23 18.01 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.859 -0.793 . . . . 75.0 108.859 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 47' ' ' ILE . 86.7 t -97.26 149.05 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 113.984 -1.462 . . . . 50.0 109.277 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.45 130.2 42.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.885 0.874 . . . . 50.0 111.008 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.88 -7.31 70.22 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.051 -0.522 . . . . 50.0 112.959 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.513 HG13 ' HB ' ' A' ' 44' ' ' VAL . 49.0 mm -90.53 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.701 0.8 . . . . 50.0 110.056 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.75 -46.99 81.07 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.935 0.894 . . . . 50.0 111.813 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.79 -58.38 0.17 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.074 0.398 . . . . 50.0 112.074 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -143.28 156.92 44.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.888 0.475 . . . . 50.0 111.806 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 38.6 mm -120.44 118.24 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.109 1.364 . . . . 50.0 107.346 165.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -68.54 151.71 46.39 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.705 0.802 . . . . 50.0 109.268 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.3 61.02 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 115.846 1.795 . . . . 50.0 115.846 -161.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.57 -19.79 60.79 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.448 0.536 . . . . 50.0 112.448 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.27 -14.96 58.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.721 0.409 . . . . 50.0 110.446 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 42' ' ' LEU . 40.5 t -99.22 137.75 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.992 0.425 . . . . 50.0 110.068 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 51.4 mtpt -136.38 137.52 40.62 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.379 1.072 . . . . 75.0 108.208 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 136.58 57.48 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.857 0.463 . . . . 50.0 110.491 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' HG22 ' A' ' 13' ' ' THR . . . -122.5 158.46 29.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.111 0.965 . . . . 50.0 110.868 -175.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -93.8 112.55 57.43 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 75.0 109.847 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.94 -15.14 7.09 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.565 2.177 . . . . 75.0 113.707 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.4 37.77 95.34 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 123.34 0.4 . . . . 75.0 112.175 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.33 -112.15 4.31 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 110.898 -0.881 . . . . 75.0 110.898 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.97 65.54 2.89 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-O 119.498 -0.612 . . . . 75.0 114.317 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -98.12 29.07 0.15 Allowed 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.823 3.015 . . . . 75.0 112.855 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.4 p -63.73 -30.67 71.74 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.328 0.862 . . . . 75.0 113.328 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -149.47 -21.88 0.28 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.303 0.483 . . . . 75.0 112.303 -170.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.55 -9.5 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.983 0.734 . . . . 75.0 112.983 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.46 -4.54 34.35 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.564 0.745 . . . . 75.0 112.201 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.7 m -64.29 -45.39 88.19 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.998 0.519 . . . . 75.0 110.134 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 7.3 m0 50.18 40.41 21.94 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.164 0.986 . . . . 75.0 112.059 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -59.7 -34.44 72.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.432 -0.804 . . . . 75.0 112.795 -170.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 35' ' ' LEU . 46.5 t -76.75 -31.49 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.069 0.548 . . . . 75.0 110.067 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HG3' HD21 ' A' ' 80' ' ' LEU . 31.1 mm-40 -86.8 -2.68 58.75 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.596 -0.729 . . . . 75.0 111.723 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 2.9 mmp_? -66.48 -25.05 66.52 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.684 0.394 . . . . 75.0 111.716 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.4 m -71.52 -8.11 51.85 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.561 0.949 . . . . 75.0 113.561 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.38 -52.13 0.09 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.133 -0.691 . . . . 75.0 109.133 -177.828 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 t30 70.79 74.92 0.25 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.402 1.481 . . . . 75.0 110.446 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.559 ' HG3' ' HA ' ' A' ' 6' ' ' HIS . 42.7 Cg_endo -91.27 20.55 0.91 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.44 2.76 . . . . 75.0 111.574 171.178 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD21 ' HG3' ' A' ' 74' ' ' GLN . 92.0 mt -75.72 100.32 4.65 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.425 1.09 . . . . 75.0 110.537 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -72.59 125.62 27.91 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.411 -1.268 . . . . 75.0 109.565 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.4 pt -72.84 79.94 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 122.139 0.971 . . . . 75.0 110.417 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -73.85 171.14 13.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.961 -1.018 . . . . 75.0 111.406 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.38 65.7 7.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.997 0.904 . . . . 75.0 110.377 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m -109.72 94.92 5.28 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.667 -1.152 . . . . 75.0 108.053 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.15 107.27 1.51 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.277 -0.874 . . . . 75.0 110.733 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.82 143.62 54.52 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.172 -0.922 . . . . 75.0 110.89 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.54 87.17 45.23 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.654 -0.869 . . . . 75.0 108.654 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 C--N 1.375 1.94 0 C-N-CA 123.205 2.603 . . . . 75.0 110.9 -178.551 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.04 0.448 . . . . 75.0 110.57 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.3 101.02 13.14 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.809 -0.811 . . . . 75.0 108.809 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -134.75 158.4 44.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.623 0.769 . . . . 75.0 110.106 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -151.06 155.16 38.41 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.309 1.044 . . . . 75.0 109.894 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -161.86 43.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.454 -0.943 . . . . 75.0 108.454 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 77' ' ' GLN . 48.6 t-80 67.08 152.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.462 -1.245 . . . . 75.0 110.865 -170.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.5 p -158.89 179.56 8.97 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.481 0.657 . . . . 75.0 111.717 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -69.32 161.9 28.36 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 114.3 -1.318 . . . . 75.0 107.714 159.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -54.02 132.63 42.84 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.674 -0.491 . . . . 75.0 109.674 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.634 HG11 ' HB ' ' A' ' 73' ' ' VAL . 3.3 m -63.45 106.27 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.128 -0.693 . . . . 50.0 109.128 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.08 9.08 12.42 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.061 -0.855 . . . . 50.0 113.166 -167.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 52.7 t0 -62.12 132.1 51.72 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 117.747 0.773 . . . . 50.0 111.434 -175.259 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 59' ' ' ALA . 19.2 m -82.44 106.56 14.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.478 0.711 . . . . 50.0 110.825 -173.709 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 24.6 m -131.76 -177.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.591 1.156 . . . . 50.0 109.874 177.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.461 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.6 m0 -128.1 154.22 45.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.411 1.484 . . . . 50.0 107.542 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.8 t -108.13 107.92 23.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.831 -1.174 . . . . 50.0 107.831 171.762 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 50.9 ttp180 -82.43 94.16 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.583 1.153 . . . . 75.0 109.422 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -77.31 112.16 13.73 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.432 -0.581 . . . . 75.0 109.432 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -76.92 130.95 38.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.199 -0.667 . . . . 75.0 109.199 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -79.38 -155.51 0.1 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.328 -0.619 . . . . 75.0 109.328 173.297 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 22' ' ' LYS . 2.0 m -68.34 173.6 4.73 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.766 -0.584 . . . . 75.0 111.338 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 21' ' ' THR . 43.0 mtmt -52.36 -50.4 62.45 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.235 1.014 . . . . 75.0 112.722 -174.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -81.74 2.05 31.61 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.835 -0.621 . . . . 75.0 111.647 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -112.71 157.39 21.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.04 0.936 . . . . 75.0 110.359 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -94.43 162.55 25.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 124.726 1.211 . . . . 75.0 110.756 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 78.1 Cg_endo -83.2 172.06 10.93 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.604 2.203 . . . . 50.0 113.756 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -154.6 129.59 9.49 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.22 1.008 . . . . 75.0 108.8 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.3 p-90 -86.84 152.59 22.34 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.033 0.444 . . . . 50.0 111.679 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -136.09 164.05 28.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.745 1.218 . . . . 75.0 107.916 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.09 -159.98 32.71 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.563 -0.576 . . . . 50.0 112.608 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.74 120.05 6.52 Favored 'Cis proline' 0 C--N 1.376 2.02 0 CA-C-N 119.144 1.472 . . . . 50.0 112.964 -2.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' HB3' HG11 ' A' ' 44' ' ' VAL . 84.5 m-85 -81.98 154.39 25.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.987 0.915 . . . . 50.0 109.666 172.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 40.9 p -114.6 110.75 20.27 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.737 0.415 . . . . 50.0 111.442 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 44' ' ' VAL . 79.4 t -70.69 130.71 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.153 0.581 . . . . 50.0 109.498 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 62.4 mt -103.43 -58.66 1.84 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.043 0.937 . . . . 50.0 109.266 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 59.6 tp -123.65 155.97 36.75 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.215 -0.902 . . . . 50.0 109.659 -172.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.504 HG22 HD22 ' A' ' 42' ' ' LEU . 69.2 p -125.97 130.05 50.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.905 0.882 . . . . 50.0 109.724 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -140.07 95.28 8.53 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 124.247 1.019 . . . . 50.0 108.976 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -27.28 127.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 1 C-N-CA 125.632 4.221 . . . . 50.0 116.471 -166.268 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.8 m 86.79 -12.22 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.499 1.919 . . . . 50.0 111.65 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -152.23 149.77 29.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.762 -0.586 . . . . 50.0 110.861 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.681 HD12 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -120.42 134.45 55.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.536 -0.913 . . . . 50.0 108.536 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.8 tttm -83.47 108.9 16.92 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.604 -0.887 . . . . 75.0 108.604 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 34' ' ' VAL . 63.0 t -108.86 135.9 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.627 1.171 . . . . 50.0 109.512 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.454 ' HB2' HD11 ' A' ' 35' ' ' LEU . 23.7 t70 -68.02 143.27 55.62 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.607 0.763 . . . . 50.0 110.646 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.59 -19.17 49.49 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.366 -0.379 . . . . 50.0 112.394 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -94.0 159.06 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.254 1.022 . . . . 50.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.44 -52.13 60.42 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 123.841 0.856 . . . . 50.0 111.538 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.12 -57.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.271 0.357 . . . . 50.0 111.666 169.391 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.1 m-90 -136.47 134.76 37.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.902 0.481 . . . . 50.0 111.74 -173.098 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.7 mm -94.72 125.24 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 166.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -64.28 136.62 57.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.548 -1.279 . . . . 50.0 107.548 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -28.65 64.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.793 1.405 . . . . 50.0 114.793 -160.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.9 27.19 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.451 0.537 . . . . 50.0 112.451 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -109.57 9.13 25.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.933 0.893 . . . . 50.0 110.201 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.681 HG11 HD12 ' A' ' 42' ' ' LEU . 37.2 t -105.86 125.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.597 -0.52 . . . . 50.0 109.597 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -125.24 110.94 14.65 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.425 -0.954 . . . . 75.0 108.425 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -58.98 117.46 4.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.53 0.732 . . . . 50.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . -81.42 154.05 26.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.674 -0.491 . . . . 50.0 109.674 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -103.47 97.5 10.52 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.36 0.664 . . . . 75.0 109.287 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -88.92 -3.39 6.28 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.572 2.181 . . . . 75.0 112.87 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.78 -75.86 0.87 Allowed Glycine 0 C--N 1.354 1.565 0 N-CA-C 110.56 -1.016 . . . . 75.0 110.56 -168.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.01 -80.66 1.12 Allowed Glycine 0 C--N 1.345 1.076 0 N-CA-C 110.219 -1.153 . . . . 75.0 110.219 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.64 -137.23 9.52 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.485 -1.175 . . . . 75.0 111.815 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 110.88 3.07 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.328 2.018 . . . . 75.0 110.769 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.5 p -65.71 -27.38 68.29 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.326 0.65 . . . . 75.0 111.387 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -82.16 9.84 7.88 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.584 -0.735 . . . . 75.0 111.316 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 49.34 40.82 19.33 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.058 1.743 . . . . 75.0 113.197 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.56 83.58 0.6 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.579 -1.191 . . . . 75.0 110.708 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.7 p -110.55 151.16 27.93 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.701 1.2 . . . . 75.0 108.493 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -67.18 -19.14 65.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.625 0.77 . . . . 75.0 112.02 -175.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 53.61 29.53 9.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 126.15 1.78 . . . . 75.0 113.46 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.634 ' HB ' HG11 ' A' ' 10' ' ' VAL . 61.2 t -70.07 -51.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.301 0.641 . . . . 75.0 109.997 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.489 ' HG2' HD11 ' A' ' 80' ' ' LEU . 5.8 tp-100 -86.55 84.72 7.35 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.414 0.626 . . . . 75.0 109.871 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -114.5 1.16 14.24 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.04 0.936 . . . . 75.0 109.506 167.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 m -67.97 -67.87 0.43 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.262 1.025 . . . . 75.0 110.479 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' A' ' 6' ' ' HIS . 22.8 tp60 -85.89 80.26 8.96 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.362 -0.977 . . . . 75.0 108.362 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.05 140.43 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.842 1.657 . . . . 75.0 111.807 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.8 107.58 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.878 1.719 . . . . 75.0 110.264 166.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD11 ' HG2' ' A' ' 74' ' ' GLN . 67.5 mt -66.81 145.24 55.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.569 0.747 . . . . 75.0 111.816 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.1 140.93 57.76 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.34 1.025 . . . . 75.0 110.663 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.41 7.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.253 1.021 . . . . 75.0 112.392 -173.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 73.26 -5.04 2.04 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.865 1.666 . . . . 75.0 112.483 171.704 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -78.84 156.52 28.66 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.22 0.533 . . . . 75.0 110.775 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 t -76.24 -161.15 0.17 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.661 1.184 . . . . 75.0 109.454 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -60.3 137.61 58.1 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-N 118.989 0.813 . . . . 75.0 110.773 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.57 147.04 25.76 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.211 -1.033 . . . . 75.0 108.211 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.11 94.22 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.426 1.09 . . . . 75.0 109.992 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo . . . . . 0 C--N 1.379 2.173 0 C-N-CA 122.852 2.368 . . . . 75.0 111.837 -179.551 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.39 -0.596 . . . . 75.0 109.39 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -136.54 116.03 12.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.064 0.946 . . . . 75.0 109.02 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -149.9 82.09 1.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.86 0.838 . . . . 75.0 109.514 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -88.95 141.05 28.82 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.693 0.797 . . . . 75.0 110.179 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -136.52 177.27 7.98 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.487 0.715 . . . . 75.0 110.513 -175.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -70.76 91.24 0.82 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.464 -0.939 . . . . 75.0 108.464 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -118.83 174.14 6.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.821 0.848 . . . . 75.0 111.228 -172.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -73.49 160.22 32.04 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.504 -0.554 . . . . 75.0 109.504 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -56.03 133.29 51.72 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.648 0.779 . . . . 75.0 109.685 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.0 131.12 28.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 122.653 0.381 . . . . 50.0 110.103 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.671 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.46 11.69 59.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.3 -0.722 . . . . 50.0 113.342 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 56.7 t0 -51.52 113.47 0.98 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.855 0.862 . . . . 50.0 111.314 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 31' ' ' PRO . 95.5 m -73.11 115.63 12.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.369 0.668 . . . . 50.0 110.51 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.3 168.74 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.689 1.196 . . . . 50.0 110.328 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -112.5 130.75 55.89 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.271 -1.011 . . . . 50.0 108.271 169.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 56' ' ' VAL . 70.6 t -110.65 115.41 49.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.238 -0.653 . . . . 50.0 109.238 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.9 ttm180 -89.29 123.07 33.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.399 1.479 . . . . 75.0 110.438 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -120.22 148.41 43.71 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.763 -1.199 . . . . 75.0 107.763 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 26' ' ' PRO . 7.9 t-160 -61.63 -53.27 58.43 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 122.828 0.451 . . . . 75.0 111.045 -169.521 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 60.65 13.88 4.6 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.081 0.952 . . . . 75.0 113.407 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 p -148.32 -179.71 7.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.099 0.96 . . . . 75.0 110.401 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.81 -53.46 2.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.884 . . . . 75.0 110.227 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -132.73 15.58 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.823 0.849 . . . . 75.0 111.492 -172.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.32 179.38 4.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.079 0.551 . . . . 75.0 110.065 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 45.0 mt-10 -72.0 149.8 92.42 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.801 0.84 . . . . 75.0 111.831 -174.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 19' ' ' HIS . 7.0 Cg_exo -74.64 130.04 13.29 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.072 2.515 . . . . 50.0 111.22 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -93.59 132.8 37.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.469 -0.567 . . . . 75.0 109.469 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.4 p-90 -96.65 156.55 16.3 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.757 0.423 . . . . 50.0 110.711 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -138.13 172.0 13.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.92 0.888 . . . . 75.0 109.458 167.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.12 46.27 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 115.391 -0.822 . . . . 50.0 111.468 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HB2' HG23 ' A' ' 13' ' ' THR . 89.4 Cg_endo -88.37 106.28 0.71 Allowed 'Cis proline' 0 C--N 1.368 1.596 0 CA-C-N 119.286 1.543 . . . . 50.0 112.479 -2.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB3' HG11 ' A' ' 44' ' ' VAL . 53.0 m-85 -64.69 162.03 16.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.552 0.741 . . . . 50.0 110.384 172.465 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 14.0 p -134.01 111.14 10.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.009 0.524 . . . . 50.0 110.748 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 44' ' ' VAL . 21.7 t -81.91 130.1 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.357 0.663 . . . . 50.0 109.553 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.9 mt -103.56 -32.74 9.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.421 0.689 . . . . 50.0 110.765 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.7 tp -142.89 143.26 31.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.13 -0.693 . . . . 50.0 109.13 -172.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.9 p -136.96 132.14 33.96 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.339 0.59 . . . . 50.0 111.01 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -117.42 164.99 16.88 Favored Pre-proline 0 CA--C 1.57 1.739 0 C-N-CA 126.068 1.747 . . . . 50.0 108.585 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -48.75 111.44 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.404 2.736 . . . . 50.0 113.541 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.71 12.24 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.936 1.694 . . . . 50.0 112.961 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -136.58 119.64 16.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.46 119.23 38.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.166 -1.05 . . . . 50.0 108.166 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 81.0 tttt -86.66 106.57 17.7 Favored 'General case' 0 C--O 1.255 1.347 0 N-CA-C 109.222 -0.659 . . . . 75.0 109.222 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 34' ' ' VAL . 38.8 t -91.43 155.33 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 114.378 -1.283 . . . . 50.0 108.976 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.15 123.21 17.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 50.0 111.093 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.93 65.67 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.684 -0.689 . . . . 50.0 113.637 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.8 mm -89.05 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.409 0.684 . . . . 50.0 110.344 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.09 59.92 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.642 1.177 . . . . 50.0 112.04 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.19 -56.75 0.14 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.42 0.45 . . . . 50.0 111.345 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.417 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 20.6 m-90 -144.64 157.08 44.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.11 0.564 . . . . 50.0 111.173 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 mm -118.11 136.09 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.238 1.015 . . . . 50.0 108.355 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -64.24 127.94 33.64 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.474 -0.936 . . . . 50.0 108.474 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.85 -23.11 16.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.86 1.43 . . . . 50.0 114.86 -164.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.36 81.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.234 0.614 . . . . 50.0 111.95 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -77.54 2.11 17.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.456 0.702 . . . . 50.0 112.616 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 16' ' ' VAL . 61.3 t -120.07 135.65 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -127.17 143.34 51.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.831 0.853 . . . . 75.0 108.865 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.45 122.35 16.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.14 0.576 . . . . 50.0 110.636 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 156.92 19.62 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.508 0.723 . . . . 50.0 110.37 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -94.5 116.14 66.07 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.292 1.037 . . . . 75.0 109.782 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.58 -11.27 9.37 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.93 2.42 . . . . 75.0 113.442 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.59 -67.76 3.09 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 111.005 -0.838 . . . . 75.0 111.005 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.01 -105.76 0.25 Allowed Glycine 0 N--CA 1.454 -0.108 0 N-CA-C 109.21 -1.556 . . . . 75.0 109.21 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.42 62.01 5.21 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.243 -0.754 . . . . 75.0 114.854 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -86.16 105.46 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.5 2.133 . . . . 75.0 109.981 171.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -147.97 -82.87 0.12 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.669 0.387 . . . . 75.0 110.86 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 t -70.77 -24.84 62.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.26 0.624 . . . . 75.0 111.097 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HG2' ' HA3' ' A' ' 11' ' ' GLY . 33.6 mtm180 -73.49 -24.42 60.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.089 0.956 . . . . 75.0 112.501 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.83 -18.06 58.62 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.374 0.67 . . . . 75.0 112.553 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.409 HG21 ' NH1' ' A' ' 72' ' ' ARG . 48.4 m -55.97 -51.92 66.0 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.541 1.136 . . . . 75.0 111.43 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TRP . . . . . 0.474 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 10.1 m0 49.4 27.89 2.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.916 1.45 . . . . 75.0 114.916 174.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.409 ' NH1' HG21 ' A' ' 70' ' ' THR . 14.5 ptt-85 -63.56 -28.51 69.99 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.566 0.95 . . . . 75.0 113.566 -174.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -78.65 -28.15 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.312 0.577 . . . . 75.0 109.804 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -81.65 -11.95 58.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.649 0.779 . . . . 75.0 110.624 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 71' ' ' TRP . 3.4 mmp_? -81.89 66.57 7.52 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.468 0.707 . . . . 75.0 110.11 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -157.93 -76.53 0.08 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.33 1.052 . . . . 75.0 108.852 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -96.68 -25.55 15.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.895 0.878 . . . . 75.0 110.042 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.31 83.9 0.2 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.98 1.312 . . . . 75.0 110.969 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.45 4.24 6.49 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.962 2.441 . . . . 75.0 112.052 167.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.428 HD12 ' NH2' ' A' ' 75' ' ' ARG . 60.2 mt -75.47 84.08 2.56 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.04 0.936 . . . . 75.0 110.051 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -84.56 125.11 32.14 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.827 -0.805 . . . . 75.0 108.827 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.38 121.79 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.79 0.805 . . . . 75.0 111.3 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -116.99 137.43 52.23 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.6 1.16 . . . . 75.0 108.678 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.07 82.52 1.27 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.548 -0.908 . . . . 75.0 108.548 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.5 m -87.03 138.3 31.61 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.063 -1.426 . . . . 75.0 107.782 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -68.1 84.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.947 0.403 . . . . 75.0 110.523 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.66 108.12 11.84 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.249 -1.019 . . . . 75.0 108.249 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.72 80.74 24.43 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.488 0.715 . . . . 75.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--N 1.377 2.053 0 C-N-CA 122.894 2.396 . . . . 75.0 112.101 -177.721 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.8 m80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.555 0.217 . . . . 75.0 110.475 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -110.11 100.87 9.72 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.035 -1.098 . . . . 75.0 108.035 168.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -76.88 71.62 3.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.931 0.893 . . . . 75.0 110.861 -171.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -154.45 132.95 12.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.303 1.441 . . . . 75.0 108.762 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' HIS . . . . . 0.523 ' NE2' ' HB2' ' A' ' 67' ' ' SER . 11.4 p80 -173.88 86.17 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.666 1.186 . . . . 75.0 108.62 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -87.35 -25.62 23.78 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.665 -0.647 . . . . 75.0 109.315 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.5 m -78.84 -171.15 2.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.551 -1.204 . . . . 75.0 110.231 165.557 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -68.0 157.36 35.29 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.089 0.555 . . . . 75.0 111.281 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -135.1 176.77 8.36 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.141 0.976 . . . . 75.0 109.37 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -71.91 144.6 13.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 108.686 -0.857 . . . . 50.0 108.686 176.371 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' HA3' ' HG2' ' A' ' 65' ' ' PRO . . . 99.82 7.81 52.55 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.704 -0.498 . . . . 50.0 112.92 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . 0.762 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -68.0 110.75 4.05 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.399 0.679 . . . . 50.0 109.998 -175.757 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -71.31 117.19 12.53 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.301 0.572 . . . . 50.0 110.049 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.53 -175.67 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.478 1.111 . . . . 50.0 109.844 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 30.8 m0 -128.63 151.37 49.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.755 1.222 . . . . 50.0 107.738 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -109.53 104.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.368 -0.975 . . . . 50.0 108.368 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.716 ' HG2' ' HB2' ' A' ' 26' ' ' PRO . 44.1 ttp180 -88.61 93.62 9.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.579 -1.191 . . . . 75.0 110.29 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -94.08 128.09 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.905 -0.588 . . . . 75.0 110.363 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -90.75 114.81 27.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.958 0.903 . . . . 75.0 109.13 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.04 -71.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.164 0.585 . . . . 75.0 110.738 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.3 p -111.42 153.51 25.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 75.0 110.126 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.81 -25.61 65.66 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.757 0.823 . . . . 75.0 111.335 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -66.33 -52.39 47.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.794 0.838 . . . . 75.0 110.084 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.98 159.38 24.89 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.863 -0.608 . . . . 75.0 110.623 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.17 154.85 72.42 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.553 0.741 . . . . 75.0 109.614 172.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.716 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 42.1 Cg_endo -63.82 126.19 16.9 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.482 2.122 . . . . 50.0 112.208 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -100.06 129.31 46.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.601 0.76 . . . . 75.0 109.093 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 66.3 p-90 -93.91 146.64 23.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.615 0.721 . . . . 50.0 112.156 -177.747 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -113.42 157.42 21.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.826 -1.534 . . . . 75.0 108.378 166.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.08 170.96 33.86 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 124.232 0.957 . . . . 50.0 110.934 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.48 161.25 76.77 Favored 'Cis proline' 0 C--N 1.366 1.491 0 CA-C-N 119.355 1.577 . . . . 50.0 111.73 -9.166 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.01 176.49 8.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.462 1.105 . . . . 50.0 110.196 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 t -152.27 111.88 3.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.63 -0.714 . . . . 50.0 111.372 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.762 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 89.9 t -67.83 124.23 22.83 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 C-N-CA 123.887 0.875 . . . . 50.0 109.345 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.95 -18.37 14.06 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.166 -0.924 . . . . 50.0 110.736 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 36.2 tp -145.73 138.65 25.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.89 0.476 . . . . 50.0 110.055 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -107.35 137.15 45.92 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.207 1.003 . . . . 50.0 108.597 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 m -141.16 148.83 53.16 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.115 -1.069 . . . . 50.0 108.115 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.74 108.4 0.15 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.125 1.883 . . . . 50.0 112.949 170.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m 70.45 17.74 6.79 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.516 1.526 . . . . 50.0 112.177 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -154.59 144.81 21.97 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.07 -0.514 . . . . 50.0 110.645 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.04 121.24 23.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.66 -0.867 . . . . 50.0 108.66 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 26.9 ttpp -85.44 109.38 18.41 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.081 -1.081 . . . . 75.0 108.081 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 34' ' ' VAL . 95.5 t -103.75 155.62 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 125.066 1.346 . . . . 50.0 108.902 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.04 121.26 11.99 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.299 0.639 . . . . 50.0 110.994 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.95 24.63 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.862 -0.608 . . . . 50.0 112.879 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.435 HG21 HG12 ' A' ' 51' ' ' ILE . 33.9 mm -76.72 147.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.702 0.801 . . . . 50.0 110.594 -176.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.38 74.11 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 123.688 0.618 . . . . 50.0 111.607 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 -58.21 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.183 0.438 . . . . 50.0 112.183 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 21.2 m-90 -146.42 145.75 30.35 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.219 0.607 . . . . 50.0 112.206 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 47' ' ' ILE . 28.3 mm -106.99 125.68 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.824 0.85 . . . . 50.0 108.899 168.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.36 122.06 12.34 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.266 -1.013 . . . . 50.0 108.266 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 84' ' ' LEU . . . -55.41 -19.19 8.42 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.025 1.491 . . . . 50.0 115.025 -162.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.58 9.84 2.03 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.578 0.751 . . . . 50.0 112.363 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.27 18.63 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 50.0 109.909 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.86 125.33 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.724 0.409 . . . . 50.0 110.149 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 5.7 mtpm? -108.6 110.96 22.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.976 -0.749 . . . . 75.0 108.976 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.04 120.5 14.38 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.234 0.614 . . . . 50.0 111.448 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.25 137.95 47.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.634 0.773 . . . . 50.0 110.612 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -93.05 113.39 59.75 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.365 0.666 . . . . 75.0 110.046 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -90.12 -0.08 5.5 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.053 2.502 . . . . 75.0 113.588 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.06 -103.46 1.48 Allowed Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.347 -0.701 . . . . 75.0 111.347 -170.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.61 92.81 1.79 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.462 -0.655 . . . . 75.0 111.462 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.6 -151.66 7.71 Favored Glycine 0 CA--C 1.544 1.903 0 CA-C-O 119.292 -0.726 . . . . 75.0 113.889 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.407 ' HG2' ' HA3' ' A' ' 11' ' ' GLY . 52.6 Cg_exo -57.31 -27.01 73.34 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.732 2.955 . . . . 75.0 114.731 -174.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 m 62.85 22.96 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.097 0.959 . . . . 75.0 113.241 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.523 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 8.5 t 67.27 13.8 9.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.19 1.396 . . . . 75.0 111.674 -175.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -84.81 -42.76 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.611 0.764 . . . . 75.0 109.02 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -92.82 19.65 7.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.366 -0.834 . . . . 75.0 111.369 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' THR . . . . . 0.598 HG22 HG22 ' A' ' 10' ' ' VAL . 75.6 p -106.45 106.08 16.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.095 0.558 . . . . 75.0 110.43 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -86.3 -80.25 0.24 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.201 0.601 . . . . 75.0 109.817 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -166.79 106.93 0.63 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.628 0.771 . . . . 75.0 110.482 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.7 t -137.9 -63.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.612 0.765 . . . . 75.0 109.185 170.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -121.76 41.4 3.38 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.659 0.742 . . . . 75.0 110.688 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -87.97 59.36 5.29 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 122.126 0.965 . . . . 75.0 108.569 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 m -89.03 177.61 6.61 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.23 -1.35 . . . . 75.0 111.76 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -69.81 -33.77 72.79 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.772 -0.649 . . . . 75.0 109.608 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -111.89 112.84 52.89 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 108.838 -0.801 . . . . 75.0 108.838 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.32 135.23 28.61 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.808 2.339 . . . . 75.0 111.123 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.07 99.2 6.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.812 0.845 . . . . 75.0 112.134 -166.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -81.36 91.38 6.25 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.173 0.589 . . . . 75.0 109.956 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.522 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 45.6 pt -76.74 139.91 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 109.665 -0.494 . . . . 75.0 109.665 168.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -108.81 32.56 4.8 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.703 0.801 . . . . 75.0 109.413 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.522 ' HG ' ' HB ' ' A' ' 82' ' ' ILE . 74.9 mt -81.13 68.75 7.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.19 0.996 . . . . 75.0 110.764 -172.504 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.6 p -114.11 76.29 0.98 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.663 1.185 . . . . 75.0 108.723 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -90.86 -41.16 11.34 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.722 0.409 . . . . 75.0 111.132 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.64 72.47 5.16 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.297 1.039 . . . . 75.0 111.871 -168.313 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -177.34 59.43 0.15 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.241 1.816 . . . . 75.0 107.545 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo . . . . . 0 C--N 1.389 2.672 0 C-N-CA 122.574 2.182 . . . . 75.0 112.058 -175.107 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.6 t60 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.25 -1.018 . . . . 75.0 108.25 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -66.09 145.34 55.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.383 0.673 . . . . 75.0 111.366 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 66.15 17.67 10.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.781 1.232 . . . . 75.0 111.944 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -141.96 36.46 1.58 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.67 0.788 . . . . 75.0 109.99 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -68.67 -64.56 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.087 0.555 . . . . 75.0 111.476 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -161.59 123.52 2.91 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.42 0.288 . . . . 75.0 111.488 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.5 m -81.71 178.58 8.25 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.052 0.941 . . . . 75.0 110.567 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.539 ' H ' HG21 ' A' ' 37' ' ' THR . 4.7 m170 -82.09 148.65 28.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.359 -0.608 . . . . 75.0 109.359 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ptm -92.09 175.23 6.94 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.652 0.381 . . . . 75.0 111.136 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.4 m -65.54 136.56 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.801 -0.636 . . . . 50.0 110.662 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.09 9.06 82.96 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-O 119.539 -0.59 . . . . 50.0 113.785 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -65.89 106.31 1.52 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.229 -0.656 . . . . 50.0 109.229 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' THR . . . . . 0.469 HG21 ' HB3' ' A' ' 61' ' ' PRO . 53.4 m -72.09 123.53 23.05 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.522 0.677 . . . . 50.0 111.062 -168.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.7 m -139.1 -177.67 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.691 1.196 . . . . 50.0 110.165 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -123.23 158.66 30.39 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.457 1.103 . . . . 50.0 108.194 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.45 102.48 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 56.0 ttp180 -74.08 93.16 2.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.969 1.308 . . . . 75.0 109.789 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -94.82 170.31 9.53 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.333 1.053 . . . . 75.0 109.08 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 80.26 113.99 0.06 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.878 1.671 . . . . 75.0 110.519 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.1 mm-40 -74.43 113.58 11.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.655 -0.702 . . . . 75.0 110.71 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 t -77.39 94.01 4.17 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.769 0.828 . . . . 75.0 110.927 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -109.15 -52.43 2.77 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.273 0.629 . . . . 75.0 110.465 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -131.33 -3.09 3.87 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.339 1.056 . . . . 75.0 109.481 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.17 163.18 24.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.496 1.118 . . . . 75.0 109.774 -173.309 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.12 142.59 64.18 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.572 0.749 . . . . 75.0 110.93 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.6 137.36 6.73 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.959 2.439 . . . . 50.0 111.671 176.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -97.56 108.05 20.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.522 0.329 . . . . 75.0 110.612 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 70.1 p-90 -73.6 139.7 45.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 167.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -121.04 147.97 44.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.801 0.84 . . . . 75.0 108.759 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.46 175.41 36.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 123.785 0.678 . . . . 50.0 112.49 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -85.34 141.2 30.69 Favored 'Cis proline' 0 C--N 1.374 1.898 0 CA-C-N 119.036 1.418 . . . . 50.0 112.901 -4.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 78.1 m-85 -120.93 171.13 8.85 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.242 1.017 . . . . 50.0 109.569 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 p -151.59 114.0 4.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 50.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 44' ' ' VAL . 57.4 t -59.21 121.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 109.537 -0.542 . . . . 50.0 109.537 170.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 86.3 mt -98.51 -41.14 7.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.664 0.785 . . . . 50.0 109.712 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 40.8 tp -131.57 145.21 51.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.397 0.679 . . . . 50.0 110.252 -176.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 42' ' ' LEU . 42.2 p -115.38 140.59 48.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 50.0 110.079 174.523 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.7 p -139.23 158.03 69.87 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 106.945 -1.502 . . . . 50.0 106.945 165.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.32 109.45 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.627 2.218 . . . . 50.0 113.769 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m 74.51 5.33 4.52 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.712 1.605 . . . . 50.0 113.135 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.8 124.22 16.77 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.824 -0.548 . . . . 50.0 110.046 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.546 HD22 HG22 ' A' ' 37' ' ' THR . 66.6 mt -113.0 125.49 54.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.164 -0.68 . . . . 50.0 109.164 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 62.5 tttm -84.08 108.69 17.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.549 -1.278 . . . . 75.0 107.549 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 34' ' ' VAL . 40.9 t -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.106 -0.952 . . . . 50.0 109.227 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.05 138.36 55.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.163 0.585 . . . . 50.0 110.577 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.45 -38.54 3.06 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.92 -0.872 . . . . 50.0 110.92 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.58 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -80.67 151.62 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.871 0.869 . . . . 50.0 110.026 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.12 61.99 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.744 0.653 . . . . 50.0 112.602 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 -50.73 0.14 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.229 0.826 . . . . 50.0 113.229 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -143.92 154.63 43.53 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 119.191 0.905 . . . . 50.0 112.55 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.58 HG12 HG21 ' A' ' 47' ' ' ILE . 27.7 mm -129.34 133.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.579 1.552 . . . . 50.0 107.536 163.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 124.65 21.35 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.057 -1.09 . . . . 50.0 108.057 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.15 -19.39 13.22 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.851 1.426 . . . . 50.0 114.851 -164.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.51 -13.18 62.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.653 0.612 . . . . 50.0 112.653 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 17' ' ' ARG . 72.5 m80 -94.74 -3.66 48.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.579 0.752 . . . . 50.0 110.983 173.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.5 129.0 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.054 -0.721 . . . . 50.0 109.054 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -124.9 122.1 36.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 75.0 109.323 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -59.62 123.59 17.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.463 0.705 . . . . 50.0 111.104 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.52 138.24 52.16 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.581 0.753 . . . . 50.0 111.011 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -92.45 119.16 68.2 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.767 0.827 . . . . 75.0 109.297 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 13' ' ' THR . 59.2 Cg_endo -87.18 -5.02 7.7 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.949 2.433 . . . . 75.0 113.842 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.99 15.73 80.11 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.322 0.389 . . . . 75.0 112.413 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.42 -87.18 0.07 OUTLIER Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.545 -0.622 . . . . 75.0 111.545 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.37 -165.52 36.49 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.356 -0.691 . . . . 75.0 112.243 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.85 107.67 0.47 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.128 2.552 . . . . 75.0 111.554 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.5 m -81.52 1.04 35.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.475 0.71 . . . . 75.0 111.82 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -124.24 163.17 22.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.185 0.594 . . . . 75.0 110.514 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -86.78 90.81 8.42 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.201 -1.037 . . . . 75.0 108.201 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.49 -175.36 5.69 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.274 0.63 . . . . 75.0 110.842 -175.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.6 p -83.39 68.75 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.83 -0.804 . . . . 75.0 108.83 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -64.78 -23.43 67.24 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.609 -1.178 . . . . 75.0 112.764 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -70.15 -53.35 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.637 -0.697 . . . . 75.0 110.882 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 36' ' ' LEU . 91.8 t 63.14 -59.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.117 1.367 . . . . 75.0 113.906 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -50.45 85.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.275 1.43 . . . . 75.0 111.748 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -149.99 -4.34 0.36 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.387 1.075 . . . . 75.0 111.553 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -155.4 99.56 2.06 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.806 0.299 . . . . 75.0 111.806 -172.439 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 63.89 31.41 13.94 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.558 1.143 . . . . 75.0 112.364 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 58.65 71.09 1.04 Allowed Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.75 1.22 . . . . 75.0 111.61 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.41 -35.95 1.45 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.461 2.107 . . . . 75.0 111.967 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.74 176.08 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.196 0.598 . . . . 75.0 111.14 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp 65.52 32.16 9.6 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.47 1.108 . . . . 75.0 110.61 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.04 5.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 123.631 0.772 . . . . 75.0 112.383 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -72.56 67.75 0.78 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.427 1.091 . . . . 75.0 109.709 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.77 115.53 22.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.835 -1.075 . . . . 75.0 108.572 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.1 p -68.79 -64.01 0.95 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.918 0.761 . . . . 75.0 109.382 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 71.25 168.76 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.07 1.348 . . . . 75.0 111.229 -173.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.75 157.51 42.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.593 0.757 . . . . 75.0 109.897 173.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.64 -51.54 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.468 -0.777 . . . . 75.0 111.111 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.384 2.412 0 CA-C-N 120.86 1.343 . . . . 75.0 111.527 167.572 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.447 -0.946 . . . . 75.0 108.447 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -126.72 87.4 2.65 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.324 0.583 . . . . 75.0 111.217 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.78 140.85 8.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.765 -1.107 . . . . 75.0 109.173 167.679 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -154.57 138.46 16.28 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.917 0.887 . . . . 75.0 110.062 -171.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -160.68 154.24 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.316 0.646 . . . . 75.0 109.729 170.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -71.54 122.36 20.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.764 -0.458 . . . . 75.0 109.764 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.6 t -143.86 -170.85 3.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.949 0.9 . . . . 75.0 108.669 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 36' ' ' LEU . 52.5 p-80 -62.12 141.28 58.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.398 0.679 . . . . 75.0 110.274 172.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp -79.44 133.61 36.53 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.037 -0.727 . . . . 75.0 109.037 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.727 HG11 ' H ' ' A' ' 73' ' ' VAL . 10.4 m -75.07 148.64 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.444 0.698 . . . . 50.0 109.173 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 86.89 10.53 72.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.97 -0.633 . . . . 50.0 112.407 -174.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -62.14 115.43 4.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.409 0.684 . . . . 50.0 110.26 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 m -73.38 114.61 11.79 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.988 0.423 . . . . 50.0 110.65 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.5 m -132.29 -177.55 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.915 1.286 . . . . 50.0 110.022 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -124.35 142.4 51.31 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.861 1.264 . . . . 50.0 107.677 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.29 106.58 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.031 -1.1 . . . . 50.0 108.031 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.4 ttp180 -84.66 93.64 8.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.505 -1.225 . . . . 75.0 110.635 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -80.25 152.88 28.85 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.725 1.21 . . . . 75.0 109.891 -175.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 15.0 p80 -125.32 126.52 45.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.125 0.57 . . . . 75.0 110.528 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.07 -43.9 10.74 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.731 -0.84 . . . . 75.0 108.731 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.5 m -126.76 125.0 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.649 -1.159 . . . . 75.0 108.122 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -70.51 -24.16 62.78 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.314 0.646 . . . . 75.0 111.639 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -73.72 -28.04 61.5 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.618 0.767 . . . . 75.0 111.42 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.2 mt -93.47 173.36 7.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.65 . . . . 75.0 110.723 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.49 126.19 92.2 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 115.722 -0.672 . . . . 75.0 110.34 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 67.2 Cg_endo -71.45 133.69 23.02 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.418 2.079 . . . . 50.0 110.057 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -94.55 128.78 41.4 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.84 0.856 . . . . 75.0 109.359 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TRP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 58.6 p-90 -80.77 146.45 30.98 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.912 0.387 . . . . 50.0 110.832 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -119.78 141.52 49.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.613 -1.255 . . . . 75.0 107.613 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.87 164.99 36.76 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 119.665 -0.52 . . . . 50.0 112.127 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.55 136.97 19.25 Favored 'Cis proline' 0 C--N 1.373 1.865 0 CA-C-N 119.45 1.625 . . . . 50.0 112.946 -1.855 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -111.35 174.1 6.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.443 1.097 . . . . 50.0 110.151 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.538 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.6 p -142.34 112.72 7.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.642 0.777 . . . . 50.0 110.436 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.72 122.72 19.43 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 N-CA-C 109.32 -0.622 . . . . 50.0 109.32 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 73' ' ' VAL . 62.2 mt -93.64 -42.01 9.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.964 -1.016 . . . . 50.0 109.943 172.583 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LEU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 19.1 tp -133.54 144.52 49.41 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 122.107 -0.37 . . . . 50.0 110.65 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.6 m -119.2 129.16 54.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.138 0.975 . . . . 50.0 109.519 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 p -139.84 158.77 67.0 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.397 1.079 . . . . 50.0 108.81 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.53 108.91 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.284 2.656 . . . . 50.0 114.416 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 62.11 17.5 9.19 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.568 1.547 . . . . 50.0 113.051 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.69 134.18 24.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.494 0.718 . . . . 50.0 109.303 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.62 124.74 41.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.138 -0.69 . . . . 50.0 109.138 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -83.84 109.65 17.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.078 -1.453 . . . . 75.0 107.078 172.371 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.4 136.45 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.678 -1.146 . . . . 50.0 108.474 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.06 139.1 58.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.481 -0.562 . . . . 50.0 109.481 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -15.39 63.17 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.964 -0.455 . . . . 50.0 111.964 -172.574 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . 0.605 HG21 HG12 ' A' ' 51' ' ' ILE . 46.5 mm -101.58 147.73 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.287 1.035 . . . . 50.0 109.382 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.01 -49.75 65.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.015 0.926 . . . . 50.0 112.344 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.45 -58.76 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.141 0.423 . . . . 50.0 112.141 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -143.18 157.22 44.7 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 123.174 0.59 . . . . 50.0 110.962 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.605 HG12 HG21 ' A' ' 47' ' ' ILE . 35.4 mm -126.56 139.95 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 108.246 -1.02 . . . . 50.0 108.246 167.173 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -64.42 139.74 58.8 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.545 0.738 . . . . 50.0 109.014 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.89 -22.13 61.96 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.478 1.288 . . . . 50.0 114.478 -168.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -71.89 -15.67 62.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.724 0.639 . . . . 50.0 112.724 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.3 24.12 11.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.903 0.881 . . . . 50.0 110.848 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.1 136.12 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.607 -1.257 . . . . 50.0 107.607 165.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -136.65 135.89 38.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.853 -0.795 . . . . 75.0 108.853 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.04 138.19 57.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.656 0.782 . . . . 50.0 112.201 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.02 169.33 9.49 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.142 1.377 . . . . 50.0 109.068 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -56.83 115.62 10.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-O 118.596 -0.716 . . . . 75.0 109.715 173.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -56.14 -19.2 26.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.807 3.005 . . . . 75.0 114.782 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.81 -6.51 72.7 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.413 -0.358 . . . . 75.0 113.869 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.06 -27.3 41.25 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 123.462 0.553 . . . . 75.0 112.51 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.37 -161.53 27.22 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 119.485 -0.619 . . . . 75.0 112.027 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.81 90.21 0.43 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.687 2.258 . . . . 75.0 112.256 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.2 t -74.14 -22.03 59.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.694 0.797 . . . . 75.0 110.656 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -70.99 -17.98 62.62 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.497 0.719 . . . . 75.0 110.752 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 62.5 88.12 0.1 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.36 1.464 . . . . 75.0 110.871 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.03 -54.04 25.51 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.077 0.465 . . . . 75.0 109.964 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.3 m -92.67 144.3 25.45 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.323 -0.853 . . . . 75.0 108.952 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -86.33 -56.53 3.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.657 -0.868 . . . . 75.0 108.657 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 88.8 mtm180 -148.07 115.14 6.15 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.013 -1.449 . . . . 75.0 108.433 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' VAL . . . . . 0.727 ' H ' HG11 ' A' ' 10' ' ' VAL . 7.5 p -65.61 -44.6 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.21 0.604 . . . . 75.0 109.908 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 1.9 mp0 -102.72 148.12 26.0 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.599 -1.26 . . . . 75.0 107.599 169.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -111.31 -26.03 9.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.543 0.737 . . . . 75.0 110.271 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 153.81 36.71 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.184 0.994 . . . . 75.0 112.095 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -73.41 -35.3 65.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.03 0.932 . . . . 75.0 111.974 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.11 -54.06 12.64 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-O 118.407 -0.806 . . . . 75.0 112.7 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.14 -34.87 12.54 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 121.819 1.679 . . . . 75.0 112.114 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 74' ' ' GLN . 64.6 mt -75.07 85.67 2.33 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.137 0.494 . . . . 75.0 109.795 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.8 176.47 10.37 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.183 -0.917 . . . . 75.0 109.958 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.7 pt -134.31 174.12 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.018 0.927 . . . . 75.0 109.739 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -156.06 150.3 25.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.684 -1.598 . . . . 75.0 106.684 162.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.57 82.31 0.41 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.437 0.637 . . . . 75.0 109.92 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.6 p -70.53 151.15 45.39 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.748 -1.114 . . . . 75.0 109.268 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -103.65 145.52 29.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.9 -0.778 . . . . 75.0 108.9 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -62.57 127.42 31.23 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.231 -0.655 . . . . 75.0 109.231 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 54' ' ' ALA . . . -73.88 127.53 88.14 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-O 118.663 -0.684 . . . . 75.0 110.372 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo . . . . . 0 C--N 1.379 2.163 0 C-N-CA 123.408 2.738 . . . . 75.0 113.062 -178.94 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.1 ptt? . . . . . 0 N--CA 1.481 1.12 0 CA-C-O 120.039 -0.029 . . . . 75.0 111.017 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -61.57 108.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.424 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 117.13 11.28 9.1 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 118.755 -1.025 . . . . 50.0 114.278 -169.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.678 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 59.8 t0 -60.02 110.7 1.26 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.508 0.654 . . . . 50.0 109.418 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 m -74.32 108.77 7.31 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.021 0.528 . . . . 50.0 109.635 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 58' ' ' ALA . 34.6 m -131.48 172.96 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.903 1.281 . . . . 50.0 109.716 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -119.24 154.59 33.19 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.694 1.197 . . . . 50.0 107.999 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.51 108.44 25.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.1 -1.074 . . . . 50.0 108.1 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -82.55 92.32 7.08 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.338 -2.21 . . . . 75.0 108.635 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 . . . . . 0 N--CA 1.473 0.692 0 C-N-CA 122.773 0.429 . . . . 75.0 110.506 -171.244 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 . . . . . 0 N--CA 1.479 0.983 0 N-CA-C 110.456 -0.201 . . . . 75.0 110.456 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -78.93 143.79 35.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.852 0.358 . . . . 50.0 110.821 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -130.48 152.49 49.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.894 -1.15 . . . . 75.0 107.894 164.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.94 -174.32 38.71 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.792 -0.718 . . . . 50.0 112.983 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -92.43 112.66 1.4 Allowed 'Cis proline' 0 C--N 1.37 1.69 0 C-N-CA 124.184 -1.173 . . . . 50.0 112.696 -2.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -76.95 156.99 31.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.196 0.598 . . . . 50.0 109.392 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.424 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 36.4 p -126.48 112.51 15.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.555 0.342 . . . . 50.0 110.834 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 60.2 t -74.31 123.48 29.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 109.344 -0.613 . . . . 50.0 109.344 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 89.2 mt -93.12 -33.39 14.07 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.411 1.07 . . . . 50.0 110.12 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 55.2 tp -149.87 144.58 26.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.995 0.518 . . . . 50.0 109.626 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.477 HG22 HD22 ' A' ' 42' ' ' LEU . 64.0 p -109.72 144.12 38.55 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -135.86 149.31 68.33 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 105.542 -2.021 . . . . 50.0 105.542 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.78 106.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.209 2.606 . . . . 50.0 113.49 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m 62.15 27.66 16.64 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.662 1.585 . . . . 50.0 112.642 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -159.37 123.61 3.9 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 50.0 109.466 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.477 HD22 HG22 ' A' ' 37' ' ' THR . 44.9 mt -111.37 128.43 55.97 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.68 -0.637 . . . . 50.0 110.194 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 25.3 ttpp -85.85 108.27 18.06 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.722 -1.214 . . . . 75.0 107.722 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 34' ' ' VAL . 60.6 t -115.47 149.05 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.533 1.133 . . . . 50.0 109.045 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.99 133.2 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.524 -0.547 . . . . 50.0 109.524 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.83 -11.68 67.83 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.359 0.412 . . . . 50.0 113.509 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 51' ' ' ILE . 47.2 mm -97.4 151.21 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.879 0.872 . . . . 50.0 110.669 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.58 -51.07 70.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.114 0.965 . . . . 50.0 111.78 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -152.44 -59.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.567 0.347 . . . . 50.0 111.458 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.408 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.7 m-90 -142.53 147.92 36.75 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.12 0.568 . . . . 50.0 110.847 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 47' ' ' ILE . 33.2 mm -114.69 130.32 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.503 -1.295 . . . . 50.0 107.503 166.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -55.93 123.51 14.56 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.801 -0.814 . . . . 50.0 108.801 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.45 -18.69 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.674 1.361 . . . . 50.0 114.674 -164.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.56 67.36 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.168 0.587 . . . . 50.0 112.141 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -96.94 15.25 22.81 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.44 1.096 . . . . 50.0 111.123 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.413 HG11 HD12 ' A' ' 42' ' ' LEU . 38.4 t -131.82 152.06 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.852 -1.166 . . . . 50.0 107.852 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -151.96 132.93 14.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.336 -0.986 . . . . 75.0 108.336 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.556 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -60.33 151.72 27.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.854 0.461 . . . . 50.0 111.498 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.897 0 C-N-CA 123.907 0.883 . . . . 50.0 109.915 -177.722 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.8 ptp . . . . . 0 C--O 1.242 0.689 0 CA-C-O 121.434 0.635 . . . . 75.0 112.227 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.91 140.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 114.165 -1.379 . . . . 50.0 113.14 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.28 8.95 42.96 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.475 -0.784 . . . . 50.0 112.568 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -62.59 103.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.483 0.713 . . . . 50.0 110.616 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 m -71.6 110.68 6.33 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.268 -0.642 . . . . 50.0 109.268 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 58' ' ' ALA . 30.1 m -132.83 179.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 50.0 110.292 -175.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -124.26 150.87 44.85 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.545 -1.28 . . . . 50.0 107.545 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.96 107.92 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.374 -0.602 . . . . 50.0 109.374 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -76.28 137.83 40.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.247 1.419 . . . . 75.0 110.401 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.283 0.633 . . . . 75.0 109.667 179.214 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 . . . . . 0 CA--C 1.544 0.734 0 N-CA-C 109.258 -0.645 . . . . 75.0 109.258 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -103.7 163.41 12.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.572 0.749 . . . . 50.0 111.816 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.92 161.0 34.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.93 1.292 . . . . 75.0 108.635 172.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.64 -175.97 42.6 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.578 -0.568 . . . . 50.0 112.847 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -88.58 128.12 8.57 Favored 'Cis proline' 0 C--N 1.373 1.861 0 CA-C-N 119.276 1.538 . . . . 50.0 112.526 -6.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -93.96 176.46 6.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.043 0.937 . . . . 50.0 110.048 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 28.3 p -140.34 115.9 10.11 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.723 0.809 . . . . 50.0 110.102 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.2 t -72.42 133.48 31.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 109.127 -0.694 . . . . 50.0 109.127 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -97.26 -43.26 7.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.711 -1.131 . . . . 50.0 109.875 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.6 tp -141.73 141.05 33.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 116.048 -0.523 . . . . 50.0 109.739 -175.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.0 p -112.67 128.44 56.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.541 -0.54 . . . . 50.0 109.541 174.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -126.82 162.71 45.74 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.122 0.969 . . . . 50.0 109.263 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -43.44 114.96 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.582 2.855 . . . . 50.0 113.918 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t 63.23 5.68 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.132 2.173 . . . . 50.0 114.459 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -148.85 135.31 19.49 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.658 0.383 . . . . 50.0 110.01 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.76 124.93 50.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.01 0.524 . . . . 50.0 109.646 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.0 ttmm -83.89 107.99 16.62 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.27 -1.011 . . . . 75.0 108.27 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 34' ' ' VAL . 47.1 t -107.77 149.93 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.869 1.268 . . . . 50.0 108.22 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.33 140.85 54.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.85 0.46 . . . . 50.0 110.092 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 4.56 73.9 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.24 -0.436 . . . . 50.0 113.033 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HG12 ' A' ' 51' ' ' ILE . 51.3 mm -116.74 150.49 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.16 0.984 . . . . 50.0 110.278 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.04 -51.53 68.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.957 0.903 . . . . 50.0 112.22 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.34 -56.81 0.17 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.516 -0.311 . . . . 50.0 111.312 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.541 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 16.8 m-90 -143.06 158.31 43.72 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.996 0.519 . . . . 50.0 111.403 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.464 HG12 HG21 ' A' ' 47' ' ' ILE . 33.7 mm -122.32 118.59 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 106.802 -1.555 . . . . 50.0 106.802 165.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -56.91 127.24 30.83 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.385 -0.968 . . . . 50.0 108.385 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -23.75 18.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.846 1.795 . . . . 50.0 115.846 -158.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 -10.45 59.03 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.199 0.444 . . . . 50.0 112.199 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.11 17.66 22.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.756 1.222 . . . . 50.0 111.162 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.35 146.9 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.651 -0.87 . . . . 50.0 108.651 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -146.41 133.64 20.56 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.637 -0.875 . . . . 75.0 108.637 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -60.48 142.41 55.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.907 0.883 . . . . 50.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.943 . . . . 50.0 110.807 -176.356 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 CA--C 1.547 0.843 0 N-CA-C 109.874 -0.417 . . . . 75.0 109.874 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 28.8 m -63.62 133.04 29.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.252 0.549 . . . . 50.0 111.182 -177.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.596 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 95.22 9.93 57.65 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.203 -0.908 . . . . 50.0 113.028 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 66.3 t0 -54.29 117.27 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.603 0.761 . . . . 50.0 111.351 -176.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 59' ' ' ALA . 29.6 m -73.42 113.88 11.01 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.997 0.519 . . . . 50.0 110.194 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.22 176.5 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.231 1.013 . . . . 50.0 110.146 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.508 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 35.4 m0 -123.9 136.48 54.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.31 1.044 . . . . 50.0 108.239 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.88 107.24 22.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 108.239 -1.023 . . . . 50.0 108.239 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 43.2 ttm180 -77.27 111.5 12.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.019 -1.446 . . . . 75.0 109.838 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 . . . . . 0 N--CA 1.474 0.739 0 C-N-CA 123.581 0.752 . . . . 75.0 109.222 178.832 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.8 ttm-85 . . . . . 0 N--CA 1.473 0.703 0 CA-C-O 120.354 0.121 . . . . 75.0 111.078 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 64.1 p-90 -75.88 143.98 41.44 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.441 0.696 . . . . 50.0 110.78 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -126.56 159.89 32.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.295 -1.002 . . . . 75.0 108.295 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.44 -172.6 44.14 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.475 -0.625 . . . . 50.0 112.428 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.59 115.38 3.51 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 119.137 1.469 . . . . 50.0 112.982 1.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB3' HG11 ' A' ' 44' ' ' VAL . 78.2 m-85 -75.35 162.71 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.579 0.752 . . . . 50.0 110.766 172.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.596 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.5 p -131.63 111.5 11.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.091 0.556 . . . . 50.0 111.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 59.5 t -79.77 125.77 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.754 0.822 . . . . 50.0 110.404 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.4 -33.38 11.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.27 0.628 . . . . 50.0 110.251 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 42.7 tp -135.63 140.5 44.6 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.407 -0.361 . . . . 50.0 110.271 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -128.83 129.55 45.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.063 0.545 . . . . 50.0 110.096 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -134.96 163.12 53.52 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.19 1.396 . . . . 50.0 108.57 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -46.18 110.42 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.308 2.672 . . . . 50.0 114.543 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m 68.96 8.99 7.18 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 124.674 1.189 . . . . 50.0 112.59 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -146.97 121.93 10.02 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.788 -0.57 . . . . 50.0 110.133 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD12 HG11 ' A' ' 56' ' ' VAL . 22.6 mt -119.07 121.86 40.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.582 -0.895 . . . . 50.0 108.582 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 86.6 tttt -86.2 113.38 22.18 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.027 0.531 . . . . 75.0 110.977 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 74.1 t -88.61 149.22 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.887 1.275 . . . . 50.0 109.509 168.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.41 128.29 35.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.313 0.645 . . . . 50.0 110.374 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -27.78 16.68 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.014 -0.539 . . . . 50.0 111.959 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -74.53 146.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.565 0.746 . . . . 50.0 109.991 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.19 76.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.071 0.948 . . . . 50.0 112.413 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.22 -55.61 0.19 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.222 0.453 . . . . 50.0 112.222 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.6 m-90 -145.6 157.65 43.95 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.633 0.605 . . . . 50.0 112.633 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mm -112.64 135.66 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.845 1.258 . . . . 50.0 108.668 165.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -66.78 124.89 24.19 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.329 -0.989 . . . . 50.0 108.329 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.65 -19.42 63.8 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.733 1.213 . . . . 50.0 114.081 -164.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.85 -12.12 58.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.435 0.694 . . . . 50.0 112.374 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -98.0 -11.99 22.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.452 0.701 . . . . 50.0 111.251 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.484 HG11 HD12 ' A' ' 42' ' ' LEU . 76.1 t -96.86 124.34 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 122.681 0.392 . . . . 50.0 110.596 -170.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -118.33 120.05 36.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.505 1.122 . . . . 75.0 108.986 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.48 106.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.41 0.684 . . . . 50.0 110.4 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.471 0.588 0 C-N-CA 123.815 0.846 . . . . 50.0 110.947 -176.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm . . . . . 0 N--CA 1.477 0.882 0 N-CA-C 111.623 0.231 . . . . 75.0 111.623 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 13.8 m -67.04 117.64 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.799 -0.815 . . . . 50.0 108.799 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 102.25 10.23 39.67 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.645 -1.086 . . . . 50.0 113.245 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -57.75 102.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 118.56 1.18 . . . . 50.0 109.906 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 28.4 m -72.71 113.29 9.58 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-O 121.492 0.663 . . . . 50.0 110.221 -169.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.58 -179.86 2.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 113.933 -1.485 . . . . 50.0 109.05 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -125.0 150.66 46.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.994 -1.484 . . . . 50.0 106.994 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.21 104.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.246 -1.391 . . . . 50.0 107.246 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.587 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 37.9 ttt180 -81.33 92.4 6.39 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 112.686 -2.052 . . . . 75.0 109.651 -173.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 . . . . . 0 N--CA 1.478 0.931 0 C-N-CA 123.408 0.683 . . . . 75.0 111.424 -170.851 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 110.11 -0.33 . . . . 75.0 110.11 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.7 p-90 -68.27 143.11 55.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.298 0.639 . . . . 50.0 111.359 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mtmp? -121.5 146.54 46.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.06 0.944 . . . . 75.0 108.804 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.88 175.44 35.87 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.756 -0.469 . . . . 50.0 112.849 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.79 126.8 6.37 Favored 'Cis proline' 0 CA--C 1.564 2.007 0 CA-C-N 118.754 1.277 . . . . 50.0 113.215 -3.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.07 163.29 12.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 50.0 109.369 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.9 p -145.86 114.02 6.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.803 0.441 . . . . 50.0 111.15 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 44' ' ' VAL . 24.2 t -67.99 133.07 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 50.0 110.781 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.82 -41.58 4.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.991 0.916 . . . . 50.0 109.936 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HB3' ' HD3' ' A' ' 43' ' ' LYS . 56.7 tp -135.26 151.2 50.35 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.401 -0.963 . . . . 50.0 108.401 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.46 HG22 HD22 ' A' ' 42' ' ' LEU . 69.6 p -124.32 153.19 42.14 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.865 -0.522 . . . . 50.0 111.048 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -136.44 147.65 60.81 Favored Pre-proline 0 CA--C 1.561 1.401 0 N-CA-C 106.501 -1.666 . . . . 50.0 106.501 171.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -40.85 109.72 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.288 2.659 . . . . 50.0 114.442 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 67.9 17.43 9.64 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.337 1.455 . . . . 50.0 112.903 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -156.42 121.61 4.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.42 0.688 . . . . 50.0 109.943 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.667 HD12 HG11 ' A' ' 56' ' ' VAL . 27.5 mt -106.09 133.94 50.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.984 0.514 . . . . 50.0 110.308 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 54.8 tttp -85.57 107.53 17.54 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.799 -1.186 . . . . 75.0 107.799 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 34' ' ' VAL . 44.8 t -109.78 154.63 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.486 -1.234 . . . . 50.0 109.452 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.67 130.19 45.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.992 0.917 . . . . 50.0 110.789 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.01 79.55 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.16 -0.473 . . . . 50.0 113.782 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 HG12 ' A' ' 51' ' ' ILE . 40.8 mm -91.8 151.35 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.077 0.951 . . . . 50.0 110.539 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.08 73.56 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.194 0.998 . . . . 50.0 111.614 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.04 -57.53 0.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.047 0.388 . . . . 50.0 112.047 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.522 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.6 m-90 -143.35 153.3 42.58 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.029 0.531 . . . . 50.0 111.653 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 47' ' ' ILE . 33.1 mm -123.44 120.22 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.699 1.2 . . . . 50.0 107.816 168.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -61.12 141.46 57.43 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.248 0.619 . . . . 50.0 109.469 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.82 48.81 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.566 1.691 . . . . 50.0 115.566 -162.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.041 0.536 . . . . 50.0 112.216 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -96.44 23.9 6.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.059 0.944 . . . . 50.0 110.661 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.667 HG11 HD12 ' A' ' 42' ' ' LEU . 57.8 t -123.39 152.14 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.15 0.98 . . . . 50.0 108.555 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -155.87 110.6 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.982 0.513 . . . . 75.0 109.95 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.29 53.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.142 0.577 . . . . 50.0 111.327 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.936 0 C-N-CA 124.153 0.981 . . . . 50.0 109.192 -175.404 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ptm . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 120.533 0.206 . . . . 75.0 110.892 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.446 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 3.4 m -60.56 123.09 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.296 0.638 . . . . 50.0 110.533 174.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 93.37 9.36 60.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.057 -0.857 . . . . 50.0 113.466 -174.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.705 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 51.2 t0 -56.02 106.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.942 0.871 . . . . 50.0 110.728 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 m -72.44 106.66 4.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.291 0.567 . . . . 50.0 110.012 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.97 173.86 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.527 1.131 . . . . 50.0 110.814 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.447 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.4 m0 -117.05 150.7 38.21 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.9 1.28 . . . . 50.0 108.168 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.43 109.31 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.052 -1.092 . . . . 50.0 108.052 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.549 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 38.8 ttp180 -87.12 90.61 8.42 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.116 -1.402 . . . . 75.0 109.808 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 . . . . . 0 N--CA 1.479 1.01 0 C-N-CA 124.449 1.1 . . . . 75.0 110.043 -176.565 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 . . . . . 0 N--CA 1.471 0.595 0 CA-C-O 120.489 0.185 . . . . 75.0 110.524 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 62.5 p-90 -73.85 149.33 41.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.739 0.816 . . . . 50.0 111.088 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -139.61 153.26 47.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.791 0.836 . . . . 75.0 109.649 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -168.0 179.39 41.26 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 119.894 -0.392 . . . . 50.0 113.492 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.71 133.72 19.12 Favored 'Cis proline' 0 C--N 1.378 2.103 0 CA-C-N 119.139 1.47 . . . . 50.0 113.838 0.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.43 ' HB3' HG11 ' A' ' 44' ' ' VAL . 76.0 m-85 -108.48 168.3 9.42 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.895 1.278 . . . . 50.0 109.396 169.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.9 p -148.0 113.62 5.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.275 0.63 . . . . 50.0 110.883 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.4 t -73.21 134.32 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.756 0.822 . . . . 50.0 110.417 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 mt -106.58 -31.75 8.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.37 0.668 . . . . 50.0 110.812 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -149.59 159.2 44.52 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.777 -0.823 . . . . 50.0 108.777 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 p -139.38 163.7 31.81 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.559 0.695 . . . . 50.0 111.259 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.3 p -141.98 164.33 34.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 126.12 1.768 . . . . 50.0 107.695 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 107.85 0.17 Allowed 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.789 2.326 . . . . 50.0 113.47 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.69 22.15 12.54 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.432 1.493 . . . . 50.0 112.855 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.45 121.94 9.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.128 -0.693 . . . . 50.0 109.128 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.515 HD12 ' HB ' ' A' ' 56' ' ' VAL . 23.3 mt -106.69 123.5 48.22 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.243 1.017 . . . . 50.0 108.749 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -86.85 106.84 18.02 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 109.349 -0.611 . . . . 75.0 109.349 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 48.0 t -96.25 154.75 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.309 -1.314 . . . . 50.0 109.153 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.2 135.33 48.96 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.499 -0.556 . . . . 50.0 109.499 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.78 76.31 Favored Glycine 0 C--N 1.34 0.787 0 O-C-N 123.761 0.663 . . . . 50.0 112.798 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -92.66 147.67 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.171 0.588 . . . . 50.0 109.939 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.44 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.435 1.094 . . . . 50.0 111.38 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.19 -59.59 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.951 0.352 . . . . 50.0 111.951 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -145.31 158.65 43.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.297 0.639 . . . . 50.0 111.187 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.88 133.89 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.598 -1.26 . . . . 50.0 107.598 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -63.79 142.24 58.47 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 50.0 108.294 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -36.75 64.99 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 115.076 1.51 . . . . 50.0 115.076 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.27 1.32 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 112.33 0.493 . . . . 50.0 112.33 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.32 12.42 36.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.018 0.527 . . . . 50.0 109.816 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.515 ' HB ' HD12 ' A' ' 42' ' ' LEU . 99.1 t -139.15 140.75 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -138.17 152.17 48.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.56 -0.904 . . . . 75.0 108.56 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.32 126.85 28.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.667 0.787 . . . . 50.0 110.845 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.679 0 N-CA-C 108.817 -0.809 . . . . 50.0 108.817 174.297 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ptt? . . . . . 0 CA--C 1.549 0.937 0 N-CA-C 112.73 0.641 . . . . 75.0 112.73 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.3 m -62.1 150.64 8.15 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 115.076 -0.965 . . . . 50.0 110.828 176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 11.37 69.83 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.995 -0.621 . . . . 50.0 112.49 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.4 t0 -62.1 111.83 2.11 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.355 0.577 . . . . 50.0 109.853 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.8 m -71.34 112.28 7.35 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.249 -0.649 . . . . 50.0 109.249 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 58' ' ' ALA . 30.2 m -136.38 164.2 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.797 -0.638 . . . . 50.0 111.124 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.453 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 41.8 m0 -122.39 145.56 48.16 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.235 1.014 . . . . 50.0 108.315 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.69 105.26 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.0 ttm180 -89.34 138.01 31.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.028 1.331 . . . . 75.0 110.378 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 . . . . . 0 N--CA 1.469 0.483 0 C-N-CA 122.607 0.363 . . . . 75.0 110.471 -178.43 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 C--O 1.238 0.459 0 N-CA-C 108.635 -0.876 . . . . 75.0 108.635 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.2 p-90 -96.35 163.7 12.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.537 0.735 . . . . 50.0 111.763 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -135.66 149.92 49.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.153 0.981 . . . . 75.0 108.586 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -175.77 179.2 47.07 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.256 -0.497 . . . . 50.0 112.618 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.02 148.72 21.57 Favored 'Cis proline' 0 C--N 1.368 1.573 0 CA-C-N 118.616 1.208 . . . . 50.0 113.834 0.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -120.54 176.0 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.91 1.284 . . . . 50.0 109.449 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 7.0 p -142.24 116.68 9.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.196 0.598 . . . . 50.0 111.381 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 44' ' ' VAL . 23.3 t -73.95 139.93 18.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.111 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 80.5 mt -113.02 -45.82 3.15 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.681 1.238 . . . . 50.0 109.984 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 61.8 tp -127.89 145.55 50.91 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.519 -0.764 . . . . 50.0 109.363 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.479 HG22 HD22 ' A' ' 42' ' ' LEU . 69.6 p -129.74 129.48 44.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.782 0.833 . . . . 50.0 109.189 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -126.29 162.63 45.09 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.618 1.167 . . . . 50.0 108.231 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -47.81 118.31 2.98 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.968 2.445 . . . . 50.0 114.261 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p 61.59 10.92 3.55 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.279 1.832 . . . . 50.0 113.972 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -149.09 123.32 9.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.17 0.441 . . . . 50.0 110.176 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 37' ' ' THR . 38.0 mt -110.87 124.54 52.27 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.422 -0.584 . . . . 50.0 109.422 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -85.92 108.63 18.27 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.657 -0.868 . . . . 75.0 108.657 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 34' ' ' VAL . 18.4 t -109.99 146.87 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.338 -1.301 . . . . 50.0 108.606 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 132.78 46.7 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.82 -8.11 57.8 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.528 0.517 . . . . 50.0 111.976 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.557 HG21 HG12 ' A' ' 51' ' ' ILE . 40.6 mm -105.17 150.2 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.951 0.901 . . . . 50.0 110.403 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 -51.09 71.07 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.044 0.938 . . . . 50.0 111.966 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.22 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.248 0.342 . . . . 50.0 111.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.421 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 20.1 m-90 -142.9 149.89 39.07 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.743 0.417 . . . . 50.0 110.959 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.557 HG12 HG21 ' A' ' 47' ' ' ILE . 26.8 mm -121.52 128.32 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 167.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -59.97 136.1 57.91 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.903 0.481 . . . . 50.0 110.011 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.79 -33.59 49.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.009 1.485 . . . . 50.0 115.009 -163.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.45 67.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.396 0.517 . . . . 50.0 112.396 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -68.76 -25.03 64.52 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.648 0.379 . . . . 50.0 111.233 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -96.89 125.39 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 122.519 0.328 . . . . 50.0 110.444 -168.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -106.61 126.23 52.01 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.875 0.87 . . . . 75.0 108.809 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -77.68 106.51 9.54 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.424 -0.584 . . . . 50.0 109.424 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 50.0 109.074 178.351 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ptm . . . . . 0 CA--C 1.545 0.769 0 CA-C-O 120.661 0.267 . . . . 75.0 111.273 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 30.7 m -63.97 125.74 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.439 -0.578 . . . . 50.0 109.439 174.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.595 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 108.53 8.5 28.52 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.296 -0.725 . . . . 50.0 112.484 -172.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -67.68 113.71 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.938 0.495 . . . . 50.0 109.885 -173.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 59' ' ' ALA . 91.3 m -77.86 127.23 32.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.696 0.399 . . . . 50.0 111.236 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.402 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 33.6 m -139.22 -178.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 50.0 109.645 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 33.9 m0 -116.7 157.5 25.35 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.961 1.304 . . . . 50.0 108.478 169.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.38 103.32 15.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 106.463 -1.68 . . . . 50.0 106.463 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -78.94 91.03 4.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.077 -1.42 . . . . 75.0 108.872 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 . . . . . 0 CA--C 1.545 0.777 0 C-N-CA 123.826 0.85 . . . . 75.0 111.73 -171.001 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 . . . . . 0 N--CA 1.478 0.934 0 N-CA-C 108.052 -1.092 . . . . 75.0 108.052 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 60.9 p-90 -130.61 153.92 48.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.693 0.679 . . . . 50.0 110.521 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -126.71 148.23 49.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 75.0 108.714 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.502 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -164.58 -176.63 36.52 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.555 -0.58 . . . . 50.0 112.378 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.89 115.81 2.13 Favored 'Cis proline' 0 CA--C 1.564 1.998 0 CA-C-N 118.91 1.355 . . . . 50.0 112.786 -5.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -84.79 154.08 22.59 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.755 0.822 . . . . 50.0 111.918 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.595 HG23 ' HA2' ' A' ' 11' ' ' GLY . 98.3 m -107.08 117.77 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 50.0 110.201 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 46.8 t -95.24 136.52 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.119 0.968 . . . . 50.0 109.209 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.16 -28.74 8.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.827 . . . . 50.0 110.689 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 46.4 tp -146.95 144.46 29.23 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.767 -0.457 . . . . 50.0 109.767 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.9 p -132.4 128.89 38.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.936 0.894 . . . . 50.0 109.63 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -134.38 158.42 75.23 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.855 0.862 . . . . 50.0 109.226 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -48.16 124.67 10.67 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.271 2.647 . . . . 50.0 112.81 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m 75.34 -13.83 0.82 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.25 1.42 . . . . 50.0 112.953 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.39 122.01 11.82 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.429 -0.794 . . . . 50.0 110.693 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.479 HD12 HG11 ' A' ' 56' ' ' VAL . 32.0 mt -114.9 123.68 49.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.306 0.642 . . . . 50.0 109.343 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.3 tttp -84.46 107.16 16.57 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.68 0.752 . . . . 75.0 109.247 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.604 HG22 HG22 ' A' ' 34' ' ' VAL . 34.5 t -101.81 142.84 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.963 -1.472 . . . . 50.0 108.047 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.34 136.54 58.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.411 0.684 . . . . 50.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.32 32.39 Favored Glycine 0 C--N 1.345 1.074 0 O-C-N 123.676 0.61 . . . . 50.0 113.096 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.66 153.92 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.583 0.753 . . . . 50.0 110.744 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.32 -51.16 56.81 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.058 1.343 . . . . 50.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.08 -56.18 0.14 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.485 0.49 . . . . 50.0 110.53 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -141.17 157.1 45.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.92 0.488 . . . . 50.0 110.91 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.99 130.88 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.83 1.252 . . . . 50.0 107.997 167.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -58.07 128.44 37.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.702 -0.851 . . . . 50.0 108.702 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -23.36 58.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.349 1.241 . . . . 50.0 114.349 -163.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.82 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 50.0 112.055 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -100.19 21.18 13.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.604 1.162 . . . . 50.0 110.514 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG11 HD12 ' A' ' 42' ' ' LEU . 61.2 t -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.743 -0.836 . . . . 50.0 108.743 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -129.81 109.99 11.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.444 -0.947 . . . . 75.0 108.444 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -57.46 131.86 51.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.091 0.956 . . . . 50.0 112.23 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB3' HG22 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.474 0.759 0 C-N-CA 123.372 0.669 . . . . 50.0 110.074 -178.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.3 ptp . . . . . 0 CA--C 1.544 0.729 0 CA-C-O 120.728 0.299 . . . . 75.0 110.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.25 135.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.748 1.219 . . . . 50.0 110.277 -177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.717 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 94.33 11.12 57.63 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.222 -0.766 . . . . 50.0 113.504 -171.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.773 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -51.66 113.22 0.92 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.184 0.994 . . . . 50.0 111.342 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.432 HG22 ' HB3' ' A' ' 59' ' ' ALA . 23.3 m -72.85 108.2 5.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 50.0 110.289 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 34.3 m -132.39 179.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.19 0.996 . . . . 50.0 110.791 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.428 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -129.99 154.13 47.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.407 1.483 . . . . 50.0 108.23 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.5 104.56 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 121.625 0.726 . . . . 50.0 109.536 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -81.95 104.92 12.65 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.883 1.673 . . . . 75.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.3 ttm105 . . . . . 0 N--CA 1.484 1.267 0 O-C-N 121.608 -0.682 . . . . 75.0 112.13 -172.343 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 . . . . . 0 C--O 1.239 0.545 0 N-CA-C 109.929 -0.397 . . . . 75.0 109.929 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.77 141.83 33.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.99 0.516 . . . . 50.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -113.04 158.16 20.66 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.464 -0.939 . . . . 75.0 108.464 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -173.63 170.21 43.34 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.015 -0.612 . . . . 50.0 113.589 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.02 160.85 70.11 Favored 'Cis proline' 0 C--N 1.376 1.985 0 C-N-CA 123.93 -1.279 . . . . 50.0 112.978 -5.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.405 ' HB3' HG11 ' A' ' 44' ' ' VAL . 79.7 m-85 -129.8 164.02 24.97 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.028 1.331 . . . . 50.0 109.361 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.717 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 57.6 p -137.05 111.7 8.72 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.516 0.726 . . . . 50.0 110.566 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.773 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.8 t -79.12 119.24 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 50.0 109.427 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.34 -21.11 22.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.553 0.741 . . . . 50.0 110.983 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 62.5 tp -156.11 140.2 16.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.622 0.369 . . . . 50.0 110.786 177.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.629 HG22 HD22 ' A' ' 42' ' ' LEU . 40.2 p -107.38 128.9 54.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.725 . . . . 50.0 109.877 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.3 p -125.82 165.18 28.54 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 124.382 1.073 . . . . 50.0 109.018 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -49.83 116.76 2.56 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.134 2.556 . . . . 50.0 112.194 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 t 54.74 17.22 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.996 2.118 . . . . 50.0 114.533 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -148.55 140.57 23.93 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.973 0.509 . . . . 50.0 110.054 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.701 HD12 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -115.11 123.0 47.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.023 0.529 . . . . 50.0 109.69 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.51 108.48 17.95 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.504 -0.924 . . . . 75.0 108.504 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 34' ' ' VAL . 55.0 t -110.13 143.36 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.675 1.19 . . . . 50.0 109.938 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.9 135.27 57.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.452 1.101 . . . . 50.0 110.231 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.92 -21.99 27.72 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 123.195 0.426 . . . . 50.0 112.991 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 51' ' ' ILE . 40.2 mm -82.18 153.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.551 1.14 . . . . 50.0 109.707 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.89 68.04 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.186 0.594 . . . . 50.0 111.407 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.42 -60.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.133 0.42 . . . . 50.0 112.133 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.487 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.5 m-90 -143.34 138.54 29.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.876 0.47 . . . . 50.0 110.944 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 47' ' ' ILE . 42.9 mm -103.76 117.09 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 106.976 -1.49 . . . . 50.0 106.976 164.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -58.7 145.51 39.86 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.514 -0.55 . . . . 50.0 109.514 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.58 -34.82 52.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.853 1.261 . . . . 50.0 113.726 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -24.96 61.51 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.198 0.999 . . . . 50.0 113.035 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -107.31 24.56 12.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.5 1.12 . . . . 50.0 110.708 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.701 HG11 HD12 ' A' ' 42' ' ' LEU . 24.9 t -128.28 149.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -133.77 122.65 23.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.26 -1.015 . . . . 75.0 108.26 166.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 109.77 1.33 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.477 0.711 . . . . 50.0 109.69 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.472 0.632 0 C-N-CA 123.767 0.827 . . . . 50.0 110.223 -175.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ptt? . . . . . 0 CA--C 1.539 0.557 0 N-CA-C 110.414 -0.217 . . . . 75.0 110.414 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.571 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 6.5 m -61.3 108.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.251 -1.018 . . . . 50.0 108.251 168.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.576 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.19 9.69 11.61 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.262 -0.743 . . . . 50.0 113.005 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.668 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.2 t0 -59.77 113.76 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.13 0.572 . . . . 50.0 109.556 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -72.56 114.1 10.32 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.587 . . . . 50.0 109.414 -172.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.13 176.57 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.906 1.282 . . . . 50.0 109.743 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.407 ' CE3' ' HD2' ' A' ' 57' ' ' LYS . 47.9 m0 -125.01 148.85 48.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.935 -1.506 . . . . 50.0 106.935 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.19 104.77 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 42.7 ttm180 -69.16 93.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.636 1.175 . . . . 75.0 109.496 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 . . . . . 0 C--O 1.244 0.802 0 CA-C-N 116.052 -0.522 . . . . 75.0 109.803 -176.582 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 . . . . . 0 C--O 1.24 0.558 0 N-CA-C 109.087 -0.709 . . . . 75.0 109.087 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 60.9 p-90 -76.67 149.17 36.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.101 0.477 . . . . 50.0 110.024 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -126.73 141.06 51.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.529 -1.286 . . . . 75.0 107.529 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.97 175.4 47.48 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.4 -0.667 . . . . 50.0 113.12 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -89.77 120.16 4.31 Favored 'Cis proline' 0 C--N 1.377 2.063 0 CA-C-N 119.112 1.456 . . . . 50.0 114.14 4.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.83 179.33 6.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.7 1.2 . . . . 50.0 111.512 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.576 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 41.4 p -138.81 113.75 9.29 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.944 0.898 . . . . 50.0 111.096 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.668 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.8 t -68.09 122.76 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 50.0 109.89 170.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 67.7 mt -93.87 -26.23 16.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.145 -0.934 . . . . 50.0 110.523 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 67.7 tp -152.29 144.04 23.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.254 0.549 . . . . 50.0 111.402 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.6 m -110.29 145.82 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 50.0 109.199 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 p -146.58 162.38 34.29 Favored Pre-proline 0 C--O 1.25 1.079 0 C-N-CA 124.717 1.207 . . . . 50.0 108.777 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo -53.27 108.85 0.3 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.629 2.219 . . . . 50.0 112.728 177.534 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 65.61 23.48 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.864 1.666 . . . . 50.0 112.137 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -153.42 158.89 42.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.054 0.454 . . . . 50.0 110.957 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.8 123.63 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.569 1.148 . . . . 50.0 108.326 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.1 tttp -84.25 109.61 17.91 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.903 -1.147 . . . . 75.0 107.903 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 97.3 t -92.62 156.67 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.415 -1.266 . . . . 50.0 108.603 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.55 134.08 56.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.932 0.893 . . . . 50.0 110.094 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.53 73.29 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.42 -0.655 . . . . 50.0 113.682 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -85.83 144.98 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 117.739 0.77 . . . . 50.0 110.188 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.09 70.32 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.115 1.366 . . . . 50.0 111.79 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.91 -58.39 0.22 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.728 0.27 . . . . 50.0 111.728 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 8.6 m-90 -144.76 157.54 44.14 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.161 0.505 . . . . 50.0 111.752 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.8 mm -121.65 129.39 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.027 -1.471 . . . . 50.0 107.027 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -55.46 127.67 30.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.596 -0.89 . . . . 50.0 108.596 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.64 -38.66 55.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.937 1.295 . . . . 50.0 113.856 -164.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.23 -4.01 19.7 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.467 0.914 . . . . 50.0 113.467 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -97.56 15.69 22.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.148 0.979 . . . . 50.0 110.397 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.99 130.37 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.292 0.637 . . . . 50.0 109.564 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HD2' ' CE3' ' A' ' 15' ' ' TRP . 25.0 ttmm -112.47 122.07 46.64 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.712 0.805 . . . . 75.0 109.094 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.516 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -65.63 126.79 29.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.911 -0.403 . . . . 50.0 109.911 176.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.883 0 C-N-CA 123.955 0.902 . . . . 50.0 109.895 -179.106 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp . . . . . 0 N--CA 1.474 0.731 0 N-CA-C 112.853 0.686 . . . . 75.0 112.853 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.487 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 33.0 m -70.96 142.6 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 114.949 -1.023 . . . . 50.0 110.425 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.67 9.37 81.37 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.79 -1.005 . . . . 50.0 114.28 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.43 124.66 23.81 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.447 1.124 . . . . 50.0 110.249 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.5 m -71.61 114.4 9.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.13 0.572 . . . . 50.0 110.739 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.9 m -135.98 178.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.28 1.032 . . . . 50.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.409 ' HE3' ' HD3' ' A' ' 57' ' ' LYS . 34.5 m0 -126.77 153.2 45.87 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.9 1.28 . . . . 50.0 108.348 174.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.16 105.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 107.439 -1.319 . . . . 50.0 107.439 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.689 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 76.2 ttt180 -81.12 92.36 6.26 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.91 -1.041 . . . . 75.0 109.821 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 . . . . . 0 C--O 1.243 0.742 0 CA-C-N 115.421 -0.809 . . . . 75.0 110.316 -176.811 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 . . . . . 0 N--CA 1.477 0.912 0 N-CA-C 110.42 -0.215 . . . . 75.0 110.42 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.689 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 61.9 p-90 -74.01 150.06 40.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.977 0.511 . . . . 50.0 110.887 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.29 143.99 49.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.091 0.957 . . . . 75.0 108.624 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.9 -177.08 25.27 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 111.603 -0.599 . . . . 50.0 111.603 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.16 121.65 6.83 Favored 'Cis proline' 0 C--N 1.37 1.664 0 CA-C-N 119.564 1.682 . . . . 50.0 111.855 -9.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -106.99 170.2 8.09 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.522 0.729 . . . . 50.0 110.003 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.7 p -150.81 115.79 5.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.157 0.583 . . . . 50.0 111.498 -171.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.67 127.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.104 0.562 . . . . 50.0 111.49 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 77.2 mt -95.49 -38.31 10.5 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.492 1.117 . . . . 50.0 110.475 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.459 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.4 tp -145.24 149.22 34.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.445 0.698 . . . . 50.0 110.06 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.456 HG22 HD22 ' A' ' 42' ' ' LEU . 37.1 p -112.97 130.4 56.14 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.744 0.818 . . . . 50.0 109.337 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -127.54 148.54 67.02 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.51 117.43 2.34 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.624 2.216 . . . . 50.0 113.031 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 m 75.58 -2.28 2.83 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.514 1.525 . . . . 50.0 112.812 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.821 -0.549 . . . . 50.0 110.586 -173.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 37' ' ' THR . 46.0 mt -108.75 125.23 51.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.927 0.491 . . . . 50.0 109.676 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.7 ttmm -83.91 110.89 18.76 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.862 -0.792 . . . . 75.0 108.862 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.34 146.14 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.822 1.249 . . . . 50.0 109.333 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.07 127.73 33.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.947 0.899 . . . . 50.0 109.771 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.25 -0.93 50.49 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.817 -0.629 . . . . 50.0 112.485 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.52 148.94 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.738 0.815 . . . . 50.0 109.242 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.07 86.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.182 0.993 . . . . 50.0 112.506 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.28 -58.03 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.327 0.251 . . . . 50.0 111.382 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.507 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.8 m-90 -143.76 147.13 33.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.241 0.616 . . . . 50.0 111.382 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.0 mm -101.55 138.71 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 107.968 -1.123 . . . . 50.0 107.968 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.25 119.55 8.12 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 107.721 -1.214 . . . . 50.0 107.721 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.11 20.94 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.266 1.426 . . . . 50.0 114.593 -164.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.48 -2.77 14.97 Favored 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 113.197 0.814 . . . . 50.0 113.197 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -115.76 17.34 16.15 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.525 1.13 . . . . 50.0 110.632 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -117.24 133.59 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.409 ' HD3' ' HE3' ' A' ' 15' ' ' TRP . 64.4 tttp -121.49 121.24 37.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.976 0.911 . . . . 75.0 109.334 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -64.47 118.18 8.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.306 0.642 . . . . 50.0 110.709 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 50.0 109.879 179.878 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.3 ptt? . . . . . 0 N--CA 1.482 1.163 0 N-CA-C 113.04 0.755 . . . . 75.0 113.04 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 35' ' ' LEU . 16.2 m -73.53 137.61 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.232 -1.025 . . . . 50.0 108.232 172.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 90.79 11.02 62.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-O 118.999 -0.89 . . . . 50.0 112.459 -172.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 64.0 t0 -57.62 97.74 0.03 OUTLIER 'General case' 0 C--N 1.365 1.275 0 C-N-CA 123.557 0.743 . . . . 50.0 109.062 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 m -71.52 118.59 14.53 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 109.484 -0.561 . . . . 50.0 109.484 -169.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.4 m -135.57 170.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 C-N-CA 125.513 1.525 . . . . 50.0 109.741 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 50.4 m0 -117.68 142.14 47.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.617 1.167 . . . . 50.0 108.082 171.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.23 109.3 27.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 107.298 -1.371 . . . . 50.0 107.298 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 48.6 ttt180 -90.51 100.2 13.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.043 1.337 . . . . 75.0 109.963 -171.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 . . . . . 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 75.0 111.273 -172.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 . . . . . 0 N--CA 1.469 0.504 0 N-CA-C 109.207 -0.664 . . . . 75.0 109.207 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 67.5 p-90 -71.66 158.5 36.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.257 0.623 . . . . 50.0 111.032 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -133.95 149.12 51.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.741 0.816 . . . . 75.0 108.855 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.76 176.82 40.52 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.851 -0.416 . . . . 50.0 112.895 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -92.92 104.77 0.37 Allowed 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 118.601 1.201 . . . . 50.0 112.276 -1.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -74.74 161.26 29.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.646 -0.872 . . . . 50.0 108.646 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.635 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 59.7 p -141.5 111.9 6.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.41 0.284 . . . . 50.0 110.321 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 24.1 t -68.37 124.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 C-N-CA 123.41 0.684 . . . . 50.0 110.028 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' VAL . 48.1 mt -99.03 -20.68 16.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.591 1.156 . . . . 50.0 110.895 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 54.0 tp -153.73 137.36 16.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.677 0.791 . . . . 50.0 109.734 175.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 42' ' ' LEU . 38.0 p -112.31 128.96 56.43 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.639 -0.874 . . . . 50.0 108.639 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.7 p -133.39 165.19 38.58 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.439 1.095 . . . . 50.0 109.148 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 6.3 Cg_endo -46.82 108.98 0.17 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.559 2.839 . . . . 50.0 113.523 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.1 p 56.08 20.37 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 126.039 1.736 . . . . 50.0 113.737 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.0 138.83 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.809 -0.811 . . . . 50.0 108.809 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 37' ' ' THR . 64.4 mt -127.89 129.02 46.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.405 -0.591 . . . . 50.0 109.405 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -86.27 107.39 17.92 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.055 -1.461 . . . . 75.0 107.055 168.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 21.7 t -104.79 160.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.164 -0.926 . . . . 50.0 108.79 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -66.32 129.04 38.48 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.453 0.701 . . . . 50.0 109.51 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.21 -4.49 86.17 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.586 0.554 . . . . 50.0 113.039 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.95 137.54 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.875 0.87 . . . . 50.0 109.503 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.68 72.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.974 0.91 . . . . 50.0 111.441 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.35 -56.15 0.17 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.583 0.586 . . . . 50.0 112.583 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -141.19 138.24 33.22 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.344 0.52 . . . . 50.0 111.801 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.3 mm -120.45 127.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.191 -1.411 . . . . 50.0 107.191 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -56.64 122.84 13.0 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.221 -0.659 . . . . 50.0 109.221 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.39 -21.37 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.735 1.614 . . . . 50.0 114.817 -166.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.11 65.4 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.301 0.852 . . . . 50.0 113.301 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -87.74 -12.53 44.97 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.856 0.462 . . . . 50.0 111.218 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.6 t -101.76 139.83 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 50.0 109.81 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -138.99 129.75 26.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 75.0 109.62 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.547 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.4 126.54 29.6 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.277 0.631 . . . . 50.0 112.342 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 C-N-CA 124.474 1.11 . . . . 50.0 111.304 -179.105 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.6 ptp . . . . . 0 N--CA 1.482 1.138 0 CA-C-O 121.055 0.455 . . . . 75.0 111.478 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.8 m -67.87 135.54 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.265 -0.879 . . . . 50.0 111.053 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.57 62.63 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.672 -0.516 . . . . 50.0 112.613 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.1 t0 -65.57 115.98 6.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.694 0.798 . . . . 50.0 110.601 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.41 HG22 ' HB3' ' A' ' 59' ' ' ALA . 38.3 m -73.31 111.88 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.218 0.607 . . . . 50.0 110.328 -173.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.2 m -136.37 -176.56 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.818 1.247 . . . . 50.0 110.616 -174.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.7 m0 -131.95 157.71 43.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.516 1.526 . . . . 50.0 107.814 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.12 104.37 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.536 -0.913 . . . . 50.0 108.536 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 57' ' ' LYS . 67.5 ttt180 -79.01 96.53 5.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.466 1.106 . . . . 75.0 110.44 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 . . . . . 0 N--CA 1.478 0.947 0 CA-C-O 121.098 0.475 . . . . 75.0 111.833 -173.526 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 110.017 -0.364 . . . . 75.0 110.017 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -81.35 153.18 27.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.498 0.666 . . . . 50.0 110.711 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -127.62 137.87 52.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.574 -1.269 . . . . 75.0 107.574 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.91 38.05 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.306 -0.473 . . . . 50.0 112.79 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.14 122.09 5.86 Favored 'Cis proline' 0 CA--C 1.559 1.756 0 C-N-CA 123.753 -1.353 . . . . 50.0 112.878 -4.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.18 178.97 7.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.576 0.75 . . . . 50.0 110.0 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 25.6 p -138.15 113.34 9.33 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.908 0.483 . . . . 50.0 110.983 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.5 t -64.99 135.82 27.65 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 CA-C-O 121.242 0.544 . . . . 50.0 109.666 170.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 66.5 mt -104.53 -44.98 4.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.085 -0.961 . . . . 50.0 109.258 173.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.4 tp -142.19 147.67 36.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.727 -0.67 . . . . 50.0 109.765 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.445 HG22 HD22 ' A' ' 42' ' ' LEU . 30.9 p -104.63 144.27 31.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.781 0.833 . . . . 50.0 109.164 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -140.35 149.07 56.45 Favored Pre-proline 0 CA--C 1.556 1.198 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -39.56 121.61 0.83 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.044 2.496 . . . . 50.0 114.021 170.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t 53.07 14.48 0.48 Allowed 'General case' 0 N--CA 1.504 2.261 0 C-N-CA 126.745 2.018 . . . . 50.0 114.826 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -153.82 124.58 7.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.794 0.438 . . . . 50.0 110.465 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD12 ' HB ' ' A' ' 56' ' ' VAL . 86.8 mt -103.0 126.05 50.02 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.269 -0.641 . . . . 50.0 109.269 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 51.5 tttm -86.85 108.96 18.98 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 108.706 -0.85 . . . . 75.0 108.706 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 34' ' ' VAL . 58.4 t -116.31 141.65 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.822 -1.081 . . . . 50.0 109.345 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.95 137.64 57.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.393 0.677 . . . . 50.0 110.768 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.75 21.65 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.563 -0.744 . . . . 50.0 111.928 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 51' ' ' ILE . 50.1 mm -87.0 146.77 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.975 0.91 . . . . 50.0 109.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.56 -49.43 64.96 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.225 1.01 . . . . 50.0 111.151 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -151.17 -59.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.16 0.287 . . . . 50.0 111.519 167.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.473 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 18.0 m-90 -135.5 144.95 46.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.931 -0.481 . . . . 50.0 112.0 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 47' ' ' ILE . 35.9 mm -110.76 137.6 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.145 -1.428 . . . . 50.0 107.145 163.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -57.07 129.21 40.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.79 -32.44 65.67 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.048 1.129 . . . . 50.0 114.048 -163.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 -11.35 60.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.313 0.645 . . . . 50.0 112.415 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -102.39 22.8 12.8 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.406 1.082 . . . . 50.0 111.044 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 42' ' ' LEU . 59.8 t -135.72 125.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.206 -0.664 . . . . 50.0 109.206 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD2' ' HD2' ' A' ' 17' ' ' ARG . 48.2 mtpt -114.45 129.82 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.601 0.761 . . . . 75.0 109.783 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.57 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.63 120.88 15.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.583 0.353 . . . . 50.0 110.181 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . . . . . . 0 N--CA 1.477 0.916 0 C-N-CA 123.251 0.62 . . . . 50.0 110.281 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.2 ptt? . . . . . 0 N--CA 1.48 1.047 0 CA-C-O 120.497 0.189 . . . . 75.0 111.495 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.406 ' HB ' HD22 ' A' ' 35' ' ' LEU . 21.3 m -69.46 139.26 20.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 116.045 -0.525 . . . . 50.0 109.888 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 101.11 9.78 44.17 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.559 -0.579 . . . . 50.0 112.875 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.5 t0 -58.28 109.39 0.76 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.026 0.53 . . . . 50.0 110.622 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.6 m -71.62 111.66 7.1 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.142 0.496 . . . . 50.0 109.843 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.15 -175.1 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.565 1.146 . . . . 50.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 31.0 m0 -124.38 156.77 36.52 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.053 1.341 . . . . 50.0 107.722 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 52.2 t -109.75 114.58 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.417 -0.956 . . . . 50.0 108.417 171.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 55' ' ' HIS . 39.3 ttm180 -76.97 123.77 26.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.158 0.983 . . . . 75.0 110.108 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 N--CA 1.471 0.588 0 N-CA-C 108.854 -0.795 . . . . 75.0 108.854 168.246 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 . . . . . 0 CA--C 1.549 0.939 0 N-CA-C 108.834 -0.802 . . . . 75.0 108.834 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -146.21 163.34 35.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.383 0.673 . . . . 50.0 110.296 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -131.31 161.12 33.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.726 -0.842 . . . . 75.0 108.726 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -170.91 -177.55 40.9 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-O 119.402 -0.666 . . . . 50.0 111.896 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.32 116.73 3.64 Favored 'Cis proline' 0 C--N 1.376 2.013 0 CA-C-N 119.408 1.604 . . . . 50.0 113.117 -4.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HB3' HG11 ' A' ' 44' ' ' VAL . 77.9 m-85 -80.45 169.41 17.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.825 0.85 . . . . 50.0 110.408 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.523 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.9 p -140.28 110.49 6.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.422 0.689 . . . . 50.0 110.685 -176.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 65.3 t -73.38 130.45 35.78 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 123.064 0.546 . . . . 50.0 109.743 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.406 HD22 ' HB ' ' A' ' 10' ' ' VAL . 41.1 mt -98.22 -54.66 3.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.302 -0.863 . . . . 50.0 109.393 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 28.9 tp -110.26 139.63 45.24 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.18 0.592 . . . . 50.0 109.651 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.432 HG22 HD22 ' A' ' 42' ' ' LEU . 69.0 p -127.89 129.25 46.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.353 0.661 . . . . 50.0 109.353 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -145.15 161.09 43.65 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.094 1.358 . . . . 50.0 108.454 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -43.62 109.0 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.662 2.908 . . . . 50.0 114.832 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m 65.08 13.15 8.5 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.03 1.332 . . . . 50.0 112.456 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.85 121.89 14.64 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.705 -0.622 . . . . 50.0 110.012 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.485 HD12 HG11 ' A' ' 56' ' ' VAL . 62.1 mt -121.8 122.19 38.93 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.818 -1.179 . . . . 50.0 107.818 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 82.9 tttt -93.85 111.46 23.17 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.261 -0.644 . . . . 75.0 109.261 176.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 32' ' ' TYR . 76.7 t -86.49 156.24 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 O-C-N 124.347 1.03 . . . . 50.0 109.385 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.35 116.2 4.1 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.89 0.876 . . . . 50.0 110.706 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.44 -14.81 32.79 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.226 -0.443 . . . . 50.0 113.214 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 51' ' ' ILE . 39.5 mm -77.96 143.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.532 0.733 . . . . 50.0 111.24 -177.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.4 -50.7 69.06 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.648 1.179 . . . . 50.0 112.259 -176.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.31 -58.1 0.18 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.219 0.451 . . . . 50.0 112.219 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -143.92 150.03 37.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.683 0.393 . . . . 50.0 111.111 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 47' ' ' ILE . 33.1 mm -112.98 122.27 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.439 -0.949 . . . . 50.0 108.439 166.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.54 124.78 22.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.855 -1.535 . . . . 50.0 106.855 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.32 -18.75 7.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.259 1.577 . . . . 50.0 115.259 -160.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.65 -4.93 34.04 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.537 0.735 . . . . 50.0 112.352 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 97.7 m-70 -104.11 17.35 24.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.099 0.96 . . . . 50.0 109.967 169.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.485 HG11 HD12 ' A' ' 42' ' ' LEU . 54.6 t -124.61 136.34 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.771 0.428 . . . . 50.0 109.902 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 52.7 mtpt -133.67 115.39 14.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 75.0 108.202 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.39 121.51 12.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 50.0 111.364 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.129 0 C-N-CA 123.702 0.801 . . . . 50.0 111.252 -175.69 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.6 ptt? . . . . . 0 N--CA 1.483 1.223 0 N-CA-C 109.907 -0.405 . . . . 75.0 109.907 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.414 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.7 m -57.27 136.36 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.945 0.898 . . . . 50.0 110.861 -175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.17 9.62 61.86 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 118.855 -0.97 . . . . 50.0 114.115 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.7 t0 -55.11 114.92 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.784 0.834 . . . . 50.0 111.645 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 3.7 m -74.82 107.59 7.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.31 165.49 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.46 0.704 . . . . 50.0 110.948 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.585 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -116.53 131.27 56.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.411 1.084 . . . . 50.0 108.188 172.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 56' ' ' VAL . 58.2 t -107.35 110.27 31.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.887 -1.153 . . . . 50.0 107.887 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 59.4 ttp180 -85.5 106.08 16.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 75.0 110.714 -174.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 . . . . . 0 N--CA 1.472 0.651 0 C-N-CA 124.707 1.203 . . . . 75.0 111.183 -177.154 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 . . . . . 0 N--CA 1.479 0.978 0 N-CA-C 109.925 -0.398 . . . . 75.0 109.925 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 69.0 p-90 -73.91 142.25 45.97 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.359 -0.608 . . . . 50.0 109.359 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.29 143.83 50.77 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.325 -0.991 . . . . 75.0 108.325 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.585 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 171.01 -173.87 44.72 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.683 -0.77 . . . . 50.0 113.555 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -88.02 115.98 3.22 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 118.446 1.123 . . . . 50.0 113.099 4.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -76.59 166.49 23.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.781 0.833 . . . . 50.0 110.672 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.582 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 69.4 p -129.96 111.42 12.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.983 0.513 . . . . 50.0 110.701 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 40.1 t -71.97 129.42 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 108.724 -0.843 . . . . 50.0 108.724 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 76.9 mt -105.77 -33.56 7.96 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.787 0.835 . . . . 50.0 109.789 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.8 tp -146.5 152.2 38.6 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.422 -0.808 . . . . 50.0 110.019 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -132.02 128.53 38.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.123 0.969 . . . . 50.0 108.985 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -123.56 162.88 37.89 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.501 1.52 . . . . 50.0 107.895 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.35 108.44 0.15 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.928 2.418 . . . . 50.0 113.777 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 m 73.98 0.02 3.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.854 1.662 . . . . 50.0 113.01 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -133.99 124.67 26.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.426 0.69 . . . . 50.0 110.119 -173.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.75 121.6 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 50.0 109.269 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.2 tttt -84.91 108.61 17.63 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 107.328 -1.36 . . . . 75.0 107.328 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 34' ' ' VAL . 57.3 t -117.51 146.39 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.578 -1.192 . . . . 50.0 109.482 -171.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.99 137.36 47.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.586 0.754 . . . . 50.0 109.558 173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.51 4.49 80.1 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.666 0.604 . . . . 50.0 112.784 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -117.13 147.91 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.62 1.168 . . . . 50.0 109.292 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.41 -51.41 64.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.996 0.919 . . . . 50.0 112.145 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.06 -57.59 0.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.589 0.356 . . . . 50.0 111.267 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.475 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 14.8 m-90 -142.16 157.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.633 0.773 . . . . 50.0 110.947 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 47' ' ' ILE . 34.8 mm -123.13 134.82 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.579 1.152 . . . . 50.0 108.454 168.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -61.49 113.47 2.69 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 108.034 -1.098 . . . . 50.0 108.034 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.61 -19.85 4.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.188 1.551 . . . . 50.0 115.188 -163.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.77 -29.85 69.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.73 0.812 . . . . 50.0 112.772 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -71.19 -24.72 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.252 0.621 . . . . 50.0 111.579 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 16' ' ' VAL . 98.4 t -96.6 138.27 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.283 0.633 . . . . 50.0 110.678 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -134.67 143.42 47.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.638 -1.245 . . . . 75.0 107.638 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.994 0.518 . . . . 50.0 110.79 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.704 0 C-N-CA 123.531 0.732 . . . . 50.0 109.397 178.035 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptt? . . . . . 0 N--CA 1.486 1.338 0 CA-C-O 119.668 -0.206 . . . . 75.0 110.567 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.21 140.06 20.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 N-CA-C 109.211 -0.663 . . . . 50.0 109.211 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.762 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 82.9 11.14 81.97 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-O 118.657 -1.079 . . . . 50.0 113.176 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 53.2 t0 -50.13 119.86 3.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.688 0.744 . . . . 50.0 110.438 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 59' ' ' ALA . 35.3 m -73.66 110.86 8.28 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.693 -0.685 . . . . 50.0 109.259 -169.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.13 157.25 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.057 0.943 . . . . 50.0 110.279 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 30.7 m0 -101.2 143.11 31.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.279 -1.008 . . . . 50.0 108.279 168.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.91 112.95 42.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 N-CA-C 109.086 -0.709 . . . . 50.0 109.086 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.2 ttm180 -65.6 109.32 2.34 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.9 1.68 . . . . 75.0 110.745 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 . . . . . 0 N--CA 1.48 1.068 0 C-N-CA 124.175 0.99 . . . . 75.0 110.169 179.099 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 . . . . . 0 N--CA 1.471 0.615 0 N-CA-C 110.447 -0.205 . . . . 75.0 110.447 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 61.9 p-90 -76.08 151.69 37.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.657 0.383 . . . . 50.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -141.07 163.76 32.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.1 0.56 . . . . 75.0 109.743 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.404 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -167.93 -162.14 19.19 Favored Glycine 0 CA--C 1.538 1.471 0 N-CA-C 110.985 -0.846 . . . . 50.0 110.985 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.36 114.55 3.1 Favored 'Cis proline' 0 C--N 1.368 1.586 0 CA-C-N 119.365 1.583 . . . . 50.0 112.973 -2.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' HG11 ' A' ' 44' ' ' VAL . 74.5 m-85 -77.67 166.93 22.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.431 0.693 . . . . 50.0 110.072 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.762 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 17.2 p -140.33 111.87 7.34 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.285 0.634 . . . . 50.0 111.283 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.51 HG22 HG22 ' A' ' 44' ' ' VAL . 60.0 t -84.03 125.43 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 122.888 0.475 . . . . 50.0 110.31 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.97 -45.47 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.746 0.818 . . . . 50.0 110.262 177.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 48.8 tp -132.58 153.71 50.74 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.438 -0.801 . . . . 50.0 109.486 -173.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.483 HG22 HD22 ' A' ' 42' ' ' LEU . 60.5 p -125.65 148.6 48.94 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.148 0.579 . . . . 50.0 110.027 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 40.3 p -140.03 165.93 27.32 Favored Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 125.372 1.469 . . . . 50.0 107.869 175.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.7 Cg_endo -51.92 108.18 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.572 2.182 . . . . 50.0 112.993 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 64.25 20.91 12.36 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.512 1.525 . . . . 50.0 112.581 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.57 129.44 11.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 HG11 ' A' ' 56' ' ' VAL . 33.8 mt -112.95 130.72 56.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.963 -0.46 . . . . 50.0 109.984 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -84.95 109.23 18.01 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.859 -0.793 . . . . 75.0 108.859 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 47' ' ' ILE . 86.7 t -97.26 149.05 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 113.984 -1.462 . . . . 50.0 109.277 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.45 130.2 42.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.885 0.874 . . . . 50.0 111.008 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.88 -7.31 70.22 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.051 -0.522 . . . . 50.0 112.959 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.513 HG13 ' HB ' ' A' ' 44' ' ' VAL . 49.0 mm -90.53 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.701 0.8 . . . . 50.0 110.056 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.75 -46.99 81.07 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.935 0.894 . . . . 50.0 111.813 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.79 -58.38 0.17 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.074 0.398 . . . . 50.0 112.074 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -143.28 156.92 44.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.888 0.475 . . . . 50.0 111.806 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 38.6 mm -120.44 118.24 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.109 1.364 . . . . 50.0 107.346 165.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -68.54 151.71 46.39 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.705 0.802 . . . . 50.0 109.268 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.3 61.02 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 115.846 1.795 . . . . 50.0 115.846 -161.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.57 -19.79 60.79 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.448 0.536 . . . . 50.0 112.448 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.27 -14.96 58.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.721 0.409 . . . . 50.0 110.446 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 42' ' ' LEU . 40.5 t -99.22 137.75 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.992 0.425 . . . . 50.0 110.068 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 51.4 mtpt -136.38 137.52 40.62 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.379 1.072 . . . . 75.0 108.208 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 136.58 57.48 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.857 0.463 . . . . 50.0 110.491 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' HG22 ' A' ' 13' ' ' THR . . . . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.111 0.965 . . . . 50.0 110.868 -175.373 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 ptt? . . . . . 0 N--CA 1.48 1.072 0 N-CA-C 109.674 -0.491 . . . . 75.0 109.674 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.603 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 3.3 m -63.45 106.27 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.128 -0.693 . . . . 50.0 109.128 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.08 9.08 12.42 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.061 -0.855 . . . . 50.0 113.166 -167.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 52.7 t0 -62.12 132.1 51.72 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 117.747 0.773 . . . . 50.0 111.434 -175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 59' ' ' ALA . 19.2 m -82.44 106.56 14.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.478 0.711 . . . . 50.0 110.825 -173.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 24.6 m -131.76 -177.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.591 1.156 . . . . 50.0 109.874 177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.461 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.6 m0 -128.1 154.22 45.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.411 1.484 . . . . 50.0 107.542 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.8 t -108.13 107.92 23.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.831 -1.174 . . . . 50.0 107.831 171.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 50.9 ttp180 -82.43 94.16 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.583 1.153 . . . . 75.0 109.422 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 109.432 -0.581 . . . . 75.0 109.432 -178.563 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 108.8 -0.815 . . . . 75.0 108.8 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.3 p-90 -86.84 152.59 22.34 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.033 0.444 . . . . 50.0 111.679 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -136.09 164.05 28.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.745 1.218 . . . . 75.0 107.916 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.09 -159.98 32.71 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.563 -0.576 . . . . 50.0 112.608 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.74 120.05 6.52 Favored 'Cis proline' 0 C--N 1.376 2.02 0 CA-C-N 119.144 1.472 . . . . 50.0 112.964 -2.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.418 ' HB3' HG11 ' A' ' 44' ' ' VAL . 84.5 m-85 -81.98 154.39 25.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.987 0.915 . . . . 50.0 109.666 172.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 40.9 p -114.6 110.75 20.27 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.737 0.415 . . . . 50.0 111.442 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 44' ' ' VAL . 79.4 t -70.69 130.71 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.153 0.581 . . . . 50.0 109.498 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 62.4 mt -103.43 -58.66 1.84 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.043 0.937 . . . . 50.0 109.266 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 59.6 tp -123.65 155.97 36.75 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.215 -0.902 . . . . 50.0 109.659 -172.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.504 HG22 HD22 ' A' ' 42' ' ' LEU . 69.2 p -125.97 130.05 50.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.905 0.882 . . . . 50.0 109.724 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -140.07 95.28 8.53 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 124.247 1.019 . . . . 50.0 108.976 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -27.28 127.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 1 C-N-CA 125.632 4.221 . . . . 50.0 116.471 -166.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.8 m 86.79 -12.22 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.499 1.919 . . . . 50.0 111.65 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -152.23 149.77 29.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.762 -0.586 . . . . 50.0 110.861 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.681 HD12 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -120.42 134.45 55.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.536 -0.913 . . . . 50.0 108.536 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.8 tttm -83.47 108.9 16.92 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.604 -0.887 . . . . 75.0 108.604 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 34' ' ' VAL . 63.0 t -108.86 135.9 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.627 1.171 . . . . 50.0 109.512 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.454 ' HB2' HD11 ' A' ' 35' ' ' LEU . 23.7 t70 -68.02 143.27 55.62 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.607 0.763 . . . . 50.0 110.646 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.59 -19.17 49.49 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.366 -0.379 . . . . 50.0 112.394 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -94.0 159.06 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.254 1.022 . . . . 50.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.44 -52.13 60.42 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 123.841 0.856 . . . . 50.0 111.538 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.12 -57.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.271 0.357 . . . . 50.0 111.666 169.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.1 m-90 -136.47 134.76 37.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.902 0.481 . . . . 50.0 111.74 -173.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.7 mm -94.72 125.24 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 166.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -64.28 136.62 57.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.548 -1.279 . . . . 50.0 107.548 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -28.65 64.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.793 1.405 . . . . 50.0 114.793 -160.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.9 27.19 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.451 0.537 . . . . 50.0 112.451 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -109.57 9.13 25.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.933 0.893 . . . . 50.0 110.201 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.681 HG11 HD12 ' A' ' 42' ' ' LEU . 37.2 t -105.86 125.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.597 -0.52 . . . . 50.0 109.597 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -125.24 110.94 14.65 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.425 -0.954 . . . . 75.0 108.425 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -58.98 117.46 4.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.53 0.732 . . . . 50.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.512 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . . . . . . 0 C--O 1.24 0.56 0 N-CA-C 109.674 -0.491 . . . . 50.0 109.674 -175.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptt? . . . . . 0 CA--C 1.545 0.777 0 N-CA-C 109.685 -0.487 . . . . 75.0 109.685 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.0 131.12 28.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 122.653 0.381 . . . . 50.0 110.103 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.671 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.46 11.69 59.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.3 -0.722 . . . . 50.0 113.342 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 56.7 t0 -51.52 113.47 0.98 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.855 0.862 . . . . 50.0 111.314 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 31' ' ' PRO . 95.5 m -73.11 115.63 12.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.369 0.668 . . . . 50.0 110.51 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.3 168.74 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.689 1.196 . . . . 50.0 110.328 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -112.5 130.75 55.89 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.271 -1.011 . . . . 50.0 108.271 169.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 56' ' ' VAL . 70.6 t -110.65 115.41 49.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.238 -0.653 . . . . 50.0 109.238 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.9 ttm180 -89.29 123.07 33.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.399 1.479 . . . . 75.0 110.438 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 . . . . . 0 C--O 1.245 0.847 0 N-CA-C 107.763 -1.199 . . . . 75.0 107.763 174.91 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 . . . . . 0 N--CA 1.477 0.894 0 N-CA-C 109.469 -0.567 . . . . 75.0 109.469 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.4 p-90 -96.65 156.55 16.3 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.757 0.423 . . . . 50.0 110.711 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -138.13 172.0 13.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.92 0.888 . . . . 75.0 109.458 167.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.12 46.27 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 115.391 -0.822 . . . . 50.0 111.468 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HB2' HG23 ' A' ' 13' ' ' THR . 89.4 Cg_endo -88.37 106.28 0.71 Allowed 'Cis proline' 0 C--N 1.368 1.596 0 CA-C-N 119.286 1.543 . . . . 50.0 112.479 -2.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB3' HG11 ' A' ' 44' ' ' VAL . 53.0 m-85 -64.69 162.03 16.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.552 0.741 . . . . 50.0 110.384 172.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 14.0 p -134.01 111.14 10.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.009 0.524 . . . . 50.0 110.748 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 44' ' ' VAL . 21.7 t -81.91 130.1 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.357 0.663 . . . . 50.0 109.553 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.9 mt -103.56 -32.74 9.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.421 0.689 . . . . 50.0 110.765 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.7 tp -142.89 143.26 31.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.13 -0.693 . . . . 50.0 109.13 -172.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.9 p -136.96 132.14 33.96 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.339 0.59 . . . . 50.0 111.01 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -117.42 164.99 16.88 Favored Pre-proline 0 CA--C 1.57 1.739 0 C-N-CA 126.068 1.747 . . . . 50.0 108.585 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -48.75 111.44 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.404 2.736 . . . . 50.0 113.541 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.71 12.24 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.936 1.694 . . . . 50.0 112.961 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -136.58 119.64 16.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.46 119.23 38.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.166 -1.05 . . . . 50.0 108.166 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 81.0 tttt -86.66 106.57 17.7 Favored 'General case' 0 C--O 1.255 1.347 0 N-CA-C 109.222 -0.659 . . . . 75.0 109.222 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 34' ' ' VAL . 38.8 t -91.43 155.33 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 114.378 -1.283 . . . . 50.0 108.976 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.15 123.21 17.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 50.0 111.093 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.93 65.67 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.684 -0.689 . . . . 50.0 113.637 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.8 mm -89.05 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.409 0.684 . . . . 50.0 110.344 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.09 59.92 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.642 1.177 . . . . 50.0 112.04 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.19 -56.75 0.14 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.42 0.45 . . . . 50.0 111.345 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.417 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 20.6 m-90 -144.64 157.08 44.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.11 0.564 . . . . 50.0 111.173 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 mm -118.11 136.09 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.238 1.015 . . . . 50.0 108.355 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -64.24 127.94 33.64 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.474 -0.936 . . . . 50.0 108.474 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.85 -23.11 16.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.86 1.43 . . . . 50.0 114.86 -164.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.36 81.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.234 0.614 . . . . 50.0 111.95 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -77.54 2.11 17.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.456 0.702 . . . . 50.0 112.616 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 16' ' ' VAL . 61.3 t -120.07 135.65 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -127.17 143.34 51.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.831 0.853 . . . . 75.0 108.865 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.45 122.35 16.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.14 0.576 . . . . 50.0 110.636 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.121 0 C-N-CA 123.508 0.723 . . . . 50.0 110.37 176.63 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.7 ptt? . . . . . 0 C--O 1.242 0.7 0 N-CA-C 109.37 -0.604 . . . . 75.0 109.37 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -71.91 144.6 13.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 108.686 -0.857 . . . . 50.0 108.686 176.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 99.82 7.81 52.55 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.704 -0.498 . . . . 50.0 112.92 -177.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . 0.762 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -68.0 110.75 4.05 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.399 0.679 . . . . 50.0 109.998 -175.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -71.31 117.19 12.53 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.301 0.572 . . . . 50.0 110.049 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.53 -175.67 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.478 1.111 . . . . 50.0 109.844 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 30.8 m0 -128.63 151.37 49.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.755 1.222 . . . . 50.0 107.738 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -109.53 104.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.368 -0.975 . . . . 50.0 108.368 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.633 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.1 ttp180 -88.61 93.62 9.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.579 -1.191 . . . . 75.0 110.29 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 . . . . . 0 CA--C 1.544 0.714 0 CA-C-N 115.905 -0.588 . . . . 75.0 110.363 -172.989 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 109.093 -0.706 . . . . 75.0 109.093 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 66.3 p-90 -93.91 146.64 23.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.615 0.721 . . . . 50.0 112.156 -177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -113.42 157.42 21.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.826 -1.534 . . . . 75.0 108.378 166.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.08 170.96 33.86 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 124.232 0.957 . . . . 50.0 110.934 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.48 161.25 76.77 Favored 'Cis proline' 0 C--N 1.366 1.491 0 CA-C-N 119.355 1.577 . . . . 50.0 111.73 -9.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.01 176.49 8.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.462 1.105 . . . . 50.0 110.196 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 t -152.27 111.88 3.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.63 -0.714 . . . . 50.0 111.372 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.762 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 89.9 t -67.83 124.23 22.83 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 C-N-CA 123.887 0.875 . . . . 50.0 109.345 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.95 -18.37 14.06 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.166 -0.924 . . . . 50.0 110.736 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 36.2 tp -145.73 138.65 25.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.89 0.476 . . . . 50.0 110.055 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -107.35 137.15 45.92 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.207 1.003 . . . . 50.0 108.597 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 m -141.16 148.83 53.16 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.115 -1.069 . . . . 50.0 108.115 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.74 108.4 0.15 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.125 1.883 . . . . 50.0 112.949 170.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m 70.45 17.74 6.79 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.516 1.526 . . . . 50.0 112.177 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -154.59 144.81 21.97 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.07 -0.514 . . . . 50.0 110.645 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.04 121.24 23.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.66 -0.867 . . . . 50.0 108.66 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 26.9 ttpp -85.44 109.38 18.41 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.081 -1.081 . . . . 75.0 108.081 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 34' ' ' VAL . 95.5 t -103.75 155.62 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 125.066 1.346 . . . . 50.0 108.902 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.04 121.26 11.99 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.299 0.639 . . . . 50.0 110.994 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.95 24.63 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.862 -0.608 . . . . 50.0 112.879 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.435 HG21 HG12 ' A' ' 51' ' ' ILE . 33.9 mm -76.72 147.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.702 0.801 . . . . 50.0 110.594 -176.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.38 74.11 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 123.688 0.618 . . . . 50.0 111.607 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 -58.21 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.183 0.438 . . . . 50.0 112.183 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . 0.574 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 21.2 m-90 -146.42 145.75 30.35 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.219 0.607 . . . . 50.0 112.206 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 47' ' ' ILE . 28.3 mm -106.99 125.68 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.824 0.85 . . . . 50.0 108.899 168.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.36 122.06 12.34 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.266 -1.013 . . . . 50.0 108.266 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.41 -19.19 8.42 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.025 1.491 . . . . 50.0 115.025 -162.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.58 9.84 2.03 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.578 0.751 . . . . 50.0 112.363 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.27 18.63 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 50.0 109.909 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.86 125.33 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.724 0.409 . . . . 50.0 110.149 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 5.7 mtpm? -108.6 110.96 22.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.976 -0.749 . . . . 75.0 108.976 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.04 120.5 14.38 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.234 0.614 . . . . 50.0 111.448 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.195 0 C-N-CA 123.634 0.773 . . . . 50.0 110.612 -176.571 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ptm . . . . . 0 N--CA 1.479 0.994 0 CA-C-O 120.836 0.351 . . . . 75.0 111.136 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.4 m -65.54 136.56 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.801 -0.636 . . . . 50.0 110.662 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.09 9.06 82.96 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-O 119.539 -0.59 . . . . 50.0 113.785 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -65.89 106.31 1.52 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.229 -0.656 . . . . 50.0 109.229 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 53.4 m -72.09 123.53 23.05 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.522 0.677 . . . . 50.0 111.062 -168.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.7 m -139.1 -177.67 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.691 1.196 . . . . 50.0 110.165 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -123.23 158.66 30.39 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.457 1.103 . . . . 50.0 108.194 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.45 102.48 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 56.0 ttp180 -74.08 93.16 2.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.969 1.308 . . . . 75.0 109.789 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 . . . . . 0 CA--C 1.558 1.281 0 C-N-CA 124.333 1.053 . . . . 75.0 109.08 176.916 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 . . . . . 0 N--CA 1.475 0.775 0 CA-C-O 120.522 0.201 . . . . 75.0 110.612 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 70.1 p-90 -73.6 139.7 45.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 167.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -121.04 147.97 44.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.801 0.84 . . . . 75.0 108.759 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.46 175.41 36.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 123.785 0.678 . . . . 50.0 112.49 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -85.34 141.2 30.69 Favored 'Cis proline' 0 C--N 1.374 1.898 0 CA-C-N 119.036 1.418 . . . . 50.0 112.901 -4.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 78.1 m-85 -120.93 171.13 8.85 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.242 1.017 . . . . 50.0 109.569 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 p -151.59 114.0 4.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 50.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 44' ' ' VAL . 57.4 t -59.21 121.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 109.537 -0.542 . . . . 50.0 109.537 170.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 86.3 mt -98.51 -41.14 7.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.664 0.785 . . . . 50.0 109.712 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 40.8 tp -131.57 145.21 51.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.397 0.679 . . . . 50.0 110.252 -176.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 42' ' ' LEU . 42.2 p -115.38 140.59 48.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 50.0 110.079 174.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.7 p -139.23 158.03 69.87 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 106.945 -1.502 . . . . 50.0 106.945 165.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.32 109.45 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.627 2.218 . . . . 50.0 113.769 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m 74.51 5.33 4.52 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.712 1.605 . . . . 50.0 113.135 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.8 124.22 16.77 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.824 -0.548 . . . . 50.0 110.046 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.546 HD22 HG22 ' A' ' 37' ' ' THR . 66.6 mt -113.0 125.49 54.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.164 -0.68 . . . . 50.0 109.164 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 62.5 tttm -84.08 108.69 17.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.549 -1.278 . . . . 75.0 107.549 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 34' ' ' VAL . 40.9 t -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.106 -0.952 . . . . 50.0 109.227 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.05 138.36 55.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.163 0.585 . . . . 50.0 110.577 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.45 -38.54 3.06 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.92 -0.872 . . . . 50.0 110.92 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.58 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -80.67 151.62 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.871 0.869 . . . . 50.0 110.026 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.12 61.99 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.744 0.653 . . . . 50.0 112.602 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 -50.73 0.14 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.229 0.826 . . . . 50.0 113.229 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -143.92 154.63 43.53 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 119.191 0.905 . . . . 50.0 112.55 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.58 HG12 HG21 ' A' ' 47' ' ' ILE . 27.7 mm -129.34 133.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.579 1.552 . . . . 50.0 107.536 163.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 124.65 21.35 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.057 -1.09 . . . . 50.0 108.057 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.15 -19.39 13.22 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.851 1.426 . . . . 50.0 114.851 -164.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.51 -13.18 62.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.653 0.612 . . . . 50.0 112.653 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.74 -3.66 48.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.579 0.752 . . . . 50.0 110.983 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.5 129.0 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.054 -0.721 . . . . 50.0 109.054 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -124.9 122.1 36.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 75.0 109.323 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -59.62 123.59 17.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.463 0.705 . . . . 50.0 111.104 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.925 0 C-N-CA 123.581 0.753 . . . . 50.0 111.011 -174.028 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp . . . . . 0 C--O 1.244 0.784 0 N-CA-C 109.037 -0.727 . . . . 75.0 109.037 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.486 HG12 ' O ' ' A' ' 35' ' ' LEU . 10.4 m -75.07 148.64 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.444 0.698 . . . . 50.0 109.173 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 86.89 10.53 72.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.97 -0.633 . . . . 50.0 112.407 -174.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -62.14 115.43 4.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.409 0.684 . . . . 50.0 110.26 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 m -73.38 114.61 11.79 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.988 0.423 . . . . 50.0 110.65 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.5 m -132.29 -177.55 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.915 1.286 . . . . 50.0 110.022 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -124.35 142.4 51.31 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.861 1.264 . . . . 50.0 107.677 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.29 106.58 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.031 -1.1 . . . . 50.0 108.031 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.4 ttp180 -84.66 93.64 8.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.505 -1.225 . . . . 75.0 110.635 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 . . . . . 0 N--CA 1.475 0.788 0 C-N-CA 124.725 1.21 . . . . 75.0 109.891 -175.175 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 . . . . . 0 C--O 1.245 0.854 0 N-CA-C 109.359 -0.608 . . . . 75.0 109.359 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TRP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 58.6 p-90 -80.77 146.45 30.98 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.912 0.387 . . . . 50.0 110.832 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -119.78 141.52 49.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.613 -1.255 . . . . 75.0 107.613 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.87 164.99 36.76 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 119.665 -0.52 . . . . 50.0 112.127 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.55 136.97 19.25 Favored 'Cis proline' 0 C--N 1.373 1.865 0 CA-C-N 119.45 1.625 . . . . 50.0 112.946 -1.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -111.35 174.1 6.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.443 1.097 . . . . 50.0 110.151 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.538 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.6 p -142.34 112.72 7.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.642 0.777 . . . . 50.0 110.436 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.72 122.72 19.43 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 N-CA-C 109.32 -0.622 . . . . 50.0 109.32 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.486 ' O ' HG12 ' A' ' 10' ' ' VAL . 62.2 mt -93.64 -42.01 9.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.964 -1.016 . . . . 50.0 109.943 172.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 19.1 tp -133.54 144.52 49.41 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 122.107 -0.37 . . . . 50.0 110.65 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.6 m -119.2 129.16 54.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.138 0.975 . . . . 50.0 109.519 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 p -139.84 158.77 67.0 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.397 1.079 . . . . 50.0 108.81 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.53 108.91 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.284 2.656 . . . . 50.0 114.416 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 62.11 17.5 9.19 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.568 1.547 . . . . 50.0 113.051 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.69 134.18 24.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.494 0.718 . . . . 50.0 109.303 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.62 124.74 41.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.138 -0.69 . . . . 50.0 109.138 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -83.84 109.65 17.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.078 -1.453 . . . . 75.0 107.078 172.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.4 136.45 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.678 -1.146 . . . . 50.0 108.474 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.06 139.1 58.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.481 -0.562 . . . . 50.0 109.481 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -15.39 63.17 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.964 -0.455 . . . . 50.0 111.964 -172.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . 0.605 HG21 HG12 ' A' ' 51' ' ' ILE . 46.5 mm -101.58 147.73 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.287 1.035 . . . . 50.0 109.382 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.01 -49.75 65.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.015 0.926 . . . . 50.0 112.344 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.45 -58.76 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.141 0.423 . . . . 50.0 112.141 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -143.18 157.22 44.7 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 123.174 0.59 . . . . 50.0 110.962 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.605 HG12 HG21 ' A' ' 47' ' ' ILE . 35.4 mm -126.56 139.95 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 108.246 -1.02 . . . . 50.0 108.246 167.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -64.42 139.74 58.8 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.545 0.738 . . . . 50.0 109.014 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.89 -22.13 61.96 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.478 1.288 . . . . 50.0 114.478 -168.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -71.89 -15.67 62.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.724 0.639 . . . . 50.0 112.724 177.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.3 24.12 11.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.903 0.881 . . . . 50.0 110.848 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.1 136.12 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.607 -1.257 . . . . 50.0 107.607 165.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -136.65 135.89 38.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.853 -0.795 . . . . 75.0 108.853 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.04 138.19 57.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.656 0.782 . . . . 50.0 112.201 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.826 0 C-N-CA 125.142 1.377 . . . . 50.0 109.068 174.566 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 65.3 m80 . . . . . 0 N--CA 1.482 1.175 0 N-CA-C 110.142 -0.318 . . . . 75.0 110.142 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -146.84 62.08 1.2 Allowed 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 122.37 1.081 . . . . 75.0 109.774 179.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 47.8 m170 -102.23 122.1 43.53 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.77 -1.105 . . . . 75.0 108.913 174.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 55.9 p-80 -125.27 154.35 41.83 Favored 'General case' 0 C--O 1.241 0.606 0 C-N-CA 123.63 0.772 . . . . 75.0 110.217 -179.455 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -166.56 170.73 12.44 Favored 'General case' 0 C--O 1.241 0.617 0 C-N-CA 124.56 1.144 . . . . 75.0 108.281 168.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 -66.75 89.04 0.15 Allowed 'General case' 0 N--CA 1.476 0.828 0 CA-C-O 121.931 0.872 . . . . 75.0 110.54 178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.664 ' HB3' HD22 ' A' ' 80' ' ' LEU . 31.1 t -107.06 -176.43 3.07 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.41 1.484 . . . . 75.0 108.893 176.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 25.1 m170 -87.4 155.63 19.94 Favored 'General case' 0 C--O 1.245 0.865 0 N-CA-C 108.341 -0.985 . . . . 75.0 108.341 169.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.1 ptt? -58.8 141.37 53.28 Favored 'General case' 0 N--CA 1.481 1.12 0 O-C-N 124.009 0.818 . . . . 75.0 111.017 -174.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.512 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.7 m -61.57 108.6 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.358 0.941 0 N-CA-C 108.418 -0.956 . . . . 50.0 108.418 174.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.491 ' HA2' HG21 ' A' ' 70' ' ' THR . . . 117.13 11.28 9.1 Favored Glycine 0 C--N 1.342 0.882 0 CA-C-O 118.755 -1.025 . . . . 50.0 114.278 -169.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.678 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 59.8 t0 -60.02 110.7 1.26 Allowed 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 117.508 0.654 . . . . 50.0 109.418 178.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 63.6 m -74.32 108.77 7.31 Favored 'General case' 0 C--N 1.346 0.426 0 C-N-CA 123.021 0.528 . . . . 50.0 109.635 -174.802 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 HG12 ' HA ' ' A' ' 58' ' ' ALA . 34.6 m -131.48 172.96 15.4 Favored 'Isoleucine or valine' 0 C--O 1.24 0.596 0 C-N-CA 124.903 1.281 . . . . 50.0 109.716 -177.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 41.2 m0 -119.24 154.59 33.19 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 124.694 1.197 . . . . 50.0 107.999 171.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 45.3 t -106.51 108.44 25.14 Favored 'Isoleucine or valine' 0 C--O 1.242 0.671 0 N-CA-C 108.1 -1.074 . . . . 50.0 108.1 176.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -82.55 92.32 7.08 Favored 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 112.338 -2.21 . . . . 75.0 108.635 -178.663 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.1 ttt180 -145.3 148.93 33.99 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 122.773 0.429 . . . . 75.0 110.506 -171.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.755 ' HB2' ' HA ' ' A' ' 26' ' ' PRO . 40.2 t-80 -155.5 136.78 13.94 Favored 'General case' 0 C--O 1.239 0.51 0 N-CA-C 109.545 -0.539 . . . . 75.0 109.545 179.292 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.6 mm100 -61.76 142.17 57.44 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 109.042 -0.725 . . . . 75.0 109.042 172.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 41.3 p -66.34 85.43 0.1 Allowed 'General case' 0 CA--C 1.553 1.073 0 CA-C-O 121.71 0.767 . . . . 75.0 111.342 -171.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.0 mttm -114.16 3.94 15.39 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 125.006 1.323 . . . . 75.0 110.845 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 67.1 t30 70.19 5.12 5.17 Favored 'General case' 0 N--CA 1.497 1.89 0 C-N-CA 125.206 1.402 . . . . 75.0 111.729 -171.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.513 ' HB2' ' CE1' ' A' ' 19' ' ' HIS . 57.4 mt -93.16 158.39 15.79 Favored 'General case' 0 CA--C 1.55 0.964 0 C-N-CA 123.935 0.894 . . . . 75.0 109.517 179.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -63.89 145.99 97.39 Favored Pre-proline 0 CA--C 1.565 1.551 0 C-N-CA 124.072 0.949 . . . . 75.0 112.517 -170.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.755 ' HA ' ' HB2' ' A' ' 19' ' ' HIS . 31.9 Cg_endo -61.8 134.83 52.44 Favored 'Trans proline' 0 C--N 1.391 2.793 0 C-N-CA 123.216 2.611 . . . . 50.0 112.838 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 14.3 ttm180 -110.66 130.67 55.51 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 123.585 0.754 . . . . 75.0 110.456 -172.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 55.2 p-90 -78.93 143.79 35.48 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 120.852 0.358 . . . . 50.0 110.821 179.636 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.1 mtmm -130.48 152.49 49.81 Favored 'General case' 0 N--CA 1.482 1.149 0 N-CA-C 107.894 -1.15 . . . . 75.0 107.894 164.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -170.94 -174.32 38.71 Favored Glycine 0 CA--C 1.528 0.86 0 C-N-CA 120.792 -0.718 . . . . 50.0 112.983 179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -92.43 112.66 1.4 Allowed 'Cis proline' 0 C--N 1.37 1.69 0 C-N-CA 124.184 -1.173 . . . . 50.0 112.696 -2.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -76.95 156.99 31.58 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.196 0.598 . . . . 50.0 109.392 174.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.424 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 36.4 p -126.48 112.51 15.66 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 122.555 0.342 . . . . 50.0 110.834 -177.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.678 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 60.2 t -74.31 123.48 29.79 Favored 'Isoleucine or valine' 0 C--O 1.246 0.886 0 N-CA-C 109.344 -0.613 . . . . 50.0 109.344 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.512 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 89.2 mt -93.12 -33.39 14.07 Favored 'General case' 0 CA--C 1.543 0.702 0 O-C-N 124.411 1.07 . . . . 50.0 110.12 177.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 55.2 tp -149.87 144.58 26.03 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 122.995 0.518 . . . . 50.0 109.626 -178.51 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.477 HG22 HD22 ' A' ' 42' ' ' LEU . 64.0 p -109.72 144.12 38.55 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 174.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 58.1 m -135.86 149.31 68.33 Favored Pre-proline 0 CA--C 1.559 1.312 0 N-CA-C 105.542 -2.021 . . . . 50.0 105.542 176.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -41.78 106.29 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.506 0 C-N-CA 123.209 2.606 . . . . 50.0 113.49 175.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 4.5 m 62.15 27.66 16.64 Favored 'General case' 0 CA--C 1.565 1.525 0 C-N-CA 125.662 1.585 . . . . 50.0 112.642 175.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.408 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -159.37 123.61 3.9 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.643 0.777 . . . . 50.0 109.466 179.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.477 HD22 HG22 ' A' ' 37' ' ' THR . 44.9 mt -111.37 128.43 55.97 Favored 'General case' 0 N--CA 1.475 0.792 0 O-C-N 121.68 -0.637 . . . . 50.0 110.194 -175.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 25.3 ttpp -85.85 108.27 18.06 Favored 'General case' 0 C--O 1.244 0.81 0 N-CA-C 107.722 -1.214 . . . . 75.0 107.722 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.506 HG22 HG22 ' A' ' 34' ' ' VAL . 60.6 t -115.47 149.05 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.533 1.133 . . . . 50.0 109.045 -173.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.1 t70 -61.99 133.2 55.04 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 109.524 -0.547 . . . . 50.0 109.524 171.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 95.83 -11.68 67.83 Favored Glycine 0 C--N 1.343 0.97 0 O-C-N 123.359 0.412 . . . . 50.0 113.509 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 51' ' ' ILE . 47.2 mm -97.4 151.21 4.31 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.879 0.872 . . . . 50.0 110.669 -177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.58 -51.07 70.97 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 124.114 0.965 . . . . 50.0 111.78 179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.412 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -152.44 -59.02 0.15 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 122.567 0.347 . . . . 50.0 111.458 173.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.408 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.7 m-90 -142.53 147.92 36.75 Favored 'General case' 0 N--CA 1.487 1.404 0 C-N-CA 123.12 0.568 . . . . 50.0 110.847 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 47' ' ' ILE . 33.2 mm -114.69 130.32 69.28 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 N-CA-C 107.503 -1.295 . . . . 50.0 107.503 166.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.4 t-80 -55.93 123.51 14.56 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 108.801 -0.814 . . . . 50.0 108.801 174.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.45 -18.69 30.54 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 114.674 1.361 . . . . 50.0 114.674 -164.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -64.18 -23.56 67.36 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.168 0.587 . . . . 50.0 112.141 174.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -96.94 15.25 22.81 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.44 1.096 . . . . 50.0 111.123 177.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.413 HG11 HD12 ' A' ' 42' ' ' LEU . 38.4 t -131.82 152.06 36.31 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.852 -1.166 . . . . 50.0 107.852 173.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 21.0 ttpp -151.96 132.93 14.24 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.336 -0.986 . . . . 75.0 108.336 177.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.556 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -60.33 151.72 27.03 Favored 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 122.854 0.461 . . . . 50.0 111.498 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.24 164.92 22.41 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.907 0.883 . . . . 50.0 109.915 -177.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.0 t0 -97.87 111.74 59.85 Favored Pre-proline 0 CA--C 1.544 0.717 0 N-CA-C 108.465 -0.939 . . . . 75.0 108.465 171.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -70.83 -14.61 32.84 Favored 'Trans proline' 0 C--N 1.371 1.712 0 C-N-CA 122.247 1.965 . . . . 75.0 112.783 176.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.65 -57.59 5.03 Favored Glycine 0 C--N 1.349 1.28 0 N-CA-C 111.54 -0.624 . . . . 75.0 111.54 -175.037 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 154.94 -166.54 32.5 Favored Glycine 0 C--N 1.341 0.809 0 N-CA-C 111.159 -0.777 . . . . 75.0 111.159 175.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 58.13 -140.42 46.55 Favored Glycine 0 CA--C 1.536 1.386 0 O-C-N 124.235 0.609 . . . . 75.0 114.519 175.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.454 ' HA ' ' HB3' ' A' ' 68' ' ' ARG . 6.1 Cg_exo -80.7 41.74 1.2 Allowed 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.595 2.863 . . . . 75.0 113.323 -178.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 32.1 t -100.34 -68.83 0.79 Allowed 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 109.142 -0.688 . . . . 75.0 109.142 174.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.5 p -71.72 -24.54 61.81 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.1 0.56 . . . . 75.0 110.975 175.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.454 ' HB3' ' HA ' ' A' ' 65' ' ' PRO . 38.9 ttm180 -72.24 -35.59 68.86 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.353 1.061 . . . . 75.0 112.51 -172.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.2 mt -78.86 76.16 5.36 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-O 120.994 0.426 . . . . 75.0 110.814 -177.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.491 HG21 ' HA2' ' A' ' 11' ' ' GLY . 7.1 m -152.78 154.47 35.25 Favored 'General case' 0 C--O 1.243 0.724 0 C-N-CA 123.802 0.841 . . . . 75.0 109.693 177.297 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -50.83 119.13 3.61 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.618 1.167 . . . . 75.0 110.088 173.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.5 ptt180 -87.3 38.79 0.83 Allowed 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.026 0.931 . . . . 75.0 111.831 -172.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 58.5 t -51.59 -52.51 20.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 124.938 1.295 . . . . 75.0 111.808 -174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.461 ' H ' HG21 ' A' ' 10' ' ' VAL . 32.3 mm-40 -131.65 32.61 4.11 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.285 1.034 . . . . 75.0 110.015 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.7 tpp85 -69.08 89.88 0.45 Allowed 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 121.849 0.833 . . . . 75.0 109.577 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 13.6 p -159.94 119.36 2.84 Favored 'General case' 0 C--O 1.243 0.745 0 CA-C-N 113.966 -1.47 . . . . 75.0 108.023 -175.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.3 mm100 -87.27 65.48 8.79 Favored 'General case' 0 CA--C 1.545 0.769 0 CA-C-O 121.705 0.764 . . . . 75.0 110.279 -173.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 26.0 t-20 -155.33 -58.14 0.02 OUTLIER Pre-proline 0 CA--C 1.559 1.318 0 CA-C-N 114.82 -1.082 . . . . 75.0 109.259 179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -72.65 -36.2 5.18 Favored 'Trans proline' 0 C--N 1.401 3.302 0 CA-C-N 121.642 1.622 . . . . 75.0 111.787 173.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.664 HD22 ' HB3' ' A' ' 7' ' ' SER . 27.2 mt -106.27 125.25 50.77 Favored 'General case' 0 C--N 1.35 0.623 0 C-N-CA 123.321 0.648 . . . . 75.0 109.703 -177.427 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 27.0 mtpp -121.74 142.72 49.9 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.471 1.108 . . . . 75.0 110.246 -177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 32.6 pt -117.83 -171.0 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.17 0 C-N-CA 124.179 0.991 . . . . 75.0 108.729 170.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptp180 -133.2 177.82 7.38 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.171 0.588 . . . . 75.0 110.117 177.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 86.2 mt -61.89 122.8 16.32 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.286 0.634 . . . . 75.0 110.945 -179.287 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 13.4 t -68.86 176.96 2.78 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 123.542 0.737 . . . . 75.0 110.211 175.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 30.8 mtp180 -65.12 -33.8 76.89 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 112.492 0.553 . . . . 75.0 112.492 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 64.44 89.99 0.09 Allowed 'General case' 0 CA--C 1.552 1.027 0 O-C-N 124.28 0.988 . . . . 75.0 108.807 -168.197 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -136.43 115.92 10.87 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 124.137 0.975 . . . . 75.0 108.691 -178.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 C--N 1.375 1.962 0 C-N-CA 122.664 2.243 . . . . 75.0 111.741 -179.088 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 79.5 t60 . . . . . 0 N--CA 1.481 1.116 0 N-CA-C 109.489 -0.56 . . . . 75.0 109.489 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -140.63 159.38 42.33 Favored 'General case' 0 C--N 1.352 0.699 0 C-N-CA 122.979 0.512 . . . . 75.0 110.565 179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 74.7 t60 -127.05 119.52 26.8 Favored 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.714 0.806 . . . . 75.0 109.993 -179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 53.6 t-80 -75.26 137.84 41.47 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.385 0.674 . . . . 75.0 109.971 174.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 20.3 p-80 -143.64 146.77 33.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 122.743 0.417 . . . . 75.0 111.965 -172.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 50.0 m170 -115.12 83.39 1.9 Allowed 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 108.081 -1.081 . . . . 75.0 108.081 167.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.495 ' HB3' ' H ' ' A' ' 37' ' ' THR . 15.0 m -97.15 169.47 9.78 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 115.18 -0.918 . . . . 75.0 111.182 -174.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 36.4 t-80 -75.82 131.55 39.82 Favored 'General case' 0 C--N 1.349 0.571 0 N-CA-C 107.595 -1.261 . . . . 75.0 107.595 168.503 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 17.8 ptp -67.77 162.36 24.07 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.462 0.705 . . . . 75.0 112.227 -174.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 21.3 m -60.91 140.69 18.35 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.851 0 CA-C-N 114.165 -1.379 . . . . 50.0 113.14 -174.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 102.28 8.95 42.96 Favored Glycine 0 C--N 1.344 0.974 0 CA-C-N 115.475 -0.784 . . . . 50.0 112.568 175.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.614 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -62.59 103.24 0.4 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.483 0.713 . . . . 50.0 110.616 -176.255 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 56.2 m -71.6 110.68 6.33 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 109.268 -0.642 . . . . 50.0 109.268 -176.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.532 HG12 ' HA ' ' A' ' 58' ' ' ALA . 30.1 m -132.83 179.24 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 C-N-CA 124.847 1.259 . . . . 50.0 110.292 -175.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 35.0 m0 -124.26 150.87 44.85 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 107.545 -1.28 . . . . 50.0 107.545 172.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 60.7 t -107.96 107.92 23.99 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.796 0 N-CA-C 109.374 -0.602 . . . . 50.0 109.374 178.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.2 ttm180 -76.28 137.83 40.16 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 125.247 1.419 . . . . 75.0 110.401 177.917 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 14.8 ttm180 -134.67 113.51 11.77 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.283 0.633 . . . . 75.0 109.667 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.1 t-160 -74.91 106.27 6.34 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 108.234 -1.024 . . . . 75.0 108.234 172.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 -63.9 -62.01 1.91 Allowed 'General case' 0 N--CA 1.472 0.649 0 O-C-N 123.883 0.739 . . . . 75.0 111.034 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.2 p -140.12 175.46 9.57 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 123.929 0.891 . . . . 75.0 109.076 173.027 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -66.33 -21.82 66.26 Favored 'General case' 0 N--CA 1.481 1.093 0 C-N-CA 123.015 0.526 . . . . 75.0 110.766 176.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 28.2 t-20 -83.44 -58.29 2.89 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.405 0.682 . . . . 75.0 109.617 173.009 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.2 mt -74.4 113.59 11.81 Favored 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.159 0.584 . . . . 75.0 110.708 -176.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.77 157.49 28.51 Favored Pre-proline 0 CA--C 1.563 1.463 0 C-N-CA 124.654 1.182 . . . . 75.0 111.712 179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 26.0 Cg_endo -57.82 124.46 16.05 Favored 'Trans proline' 0 C--N 1.383 2.378 0 C-N-CA 123.16 2.573 . . . . 50.0 114.062 -173.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 39.4 ttt180 -111.28 127.55 55.66 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.551 1.14 . . . . 75.0 109.258 174.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 68.3 p-90 -103.7 163.41 12.34 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 123.572 0.749 . . . . 50.0 111.816 -178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 98.0 mttt -131.92 161.0 34.11 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.93 1.292 . . . . 75.0 108.635 172.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -174.64 -175.97 42.6 Favored Glycine 0 CA--C 1.534 1.264 0 CA-C-O 119.578 -0.568 . . . . 50.0 112.847 179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -88.58 128.12 8.57 Favored 'Cis proline' 0 C--N 1.373 1.861 0 CA-C-N 119.276 1.538 . . . . 50.0 112.526 -6.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -93.96 176.46 6.33 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.043 0.937 . . . . 50.0 110.048 173.657 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.432 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 28.3 p -140.34 115.9 10.11 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.723 0.809 . . . . 50.0 110.102 178.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.614 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.2 t -72.42 133.48 31.68 Favored 'Isoleucine or valine' 0 C--O 1.252 1.213 0 N-CA-C 109.127 -0.694 . . . . 50.0 109.127 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 81.4 mt -97.26 -43.26 7.42 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.711 -1.131 . . . . 50.0 109.875 176.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.426 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 38.6 tp -141.73 141.05 33.26 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 116.048 -0.523 . . . . 50.0 109.739 -175.305 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.495 ' H ' ' HB3' ' A' ' 7' ' ' SER . 73.0 p -112.67 128.44 56.39 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.541 -0.54 . . . . 50.0 109.541 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 42.0 p -126.82 162.71 45.74 Favored Pre-proline 0 CA--C 1.561 1.401 0 C-N-CA 124.122 0.969 . . . . 50.0 109.263 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_exo -43.44 114.96 0.54 Allowed 'Trans proline' 0 C--N 1.381 2.248 0 C-N-CA 123.582 2.855 . . . . 50.0 113.918 175.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.3 t 63.23 5.68 2.07 Favored 'General case' 0 N--CA 1.494 1.771 0 C-N-CA 127.132 2.173 . . . . 50.0 114.459 174.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.541 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -148.85 135.31 19.49 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.658 0.383 . . . . 50.0 110.01 -173.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 39.0 mt -116.76 124.93 50.83 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.01 0.524 . . . . 50.0 109.646 -176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.426 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.0 ttmm -83.89 107.99 16.62 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 108.27 -1.011 . . . . 75.0 108.27 177.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG22 HG22 ' A' ' 34' ' ' VAL . 47.1 t -107.77 149.93 10.76 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.869 1.268 . . . . 50.0 108.22 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.33 140.85 54.34 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 122.85 0.46 . . . . 50.0 110.092 173.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.29 4.56 73.9 Favored Glycine 0 C--N 1.34 0.805 0 CA-C-N 116.24 -0.436 . . . . 50.0 113.033 -176.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.464 HG21 HG12 ' A' ' 51' ' ' ILE . 51.3 mm -116.74 150.49 18.72 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 C-N-CA 124.16 0.984 . . . . 50.0 110.278 -175.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.04 -51.53 68.88 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 123.957 0.903 . . . . 50.0 112.22 -178.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.34 -56.81 0.17 Allowed 'General case' 0 N--CA 1.475 0.811 0 CA-C-N 116.516 -0.311 . . . . 50.0 111.312 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.541 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 16.8 m-90 -143.06 158.31 43.72 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 122.996 0.519 . . . . 50.0 111.403 -177.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.464 HG12 HG21 ' A' ' 47' ' ' ILE . 33.7 mm -122.32 118.59 55.82 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.556 0 N-CA-C 106.802 -1.555 . . . . 50.0 106.802 165.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -56.91 127.24 30.83 Favored 'General case' 0 CA--C 1.547 0.849 0 N-CA-C 108.385 -0.968 . . . . 50.0 108.385 -179.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.57 -23.75 18.11 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 115.846 1.795 . . . . 50.0 115.846 -158.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.32 -10.45 59.03 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 112.199 0.444 . . . . 50.0 112.199 177.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -102.11 17.66 22.73 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 124.756 1.222 . . . . 50.0 111.162 175.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 81.3 t -132.35 146.9 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 N-CA-C 108.651 -0.87 . . . . 50.0 108.651 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 19.7 ttpp -146.41 133.64 20.56 Favored 'General case' 0 C--N 1.35 0.609 0 N-CA-C 108.637 -0.875 . . . . 75.0 108.637 172.056 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.532 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -60.48 142.41 55.23 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 123.907 0.883 . . . . 50.0 111.614 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -129.87 148.1 51.7 Favored 'General case' 0 N--CA 1.477 0.887 0 C-N-CA 124.059 0.943 . . . . 50.0 110.807 -176.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -85.29 121.25 73.83 Favored Pre-proline 0 CA--C 1.548 0.881 0 N-CA-C 108.389 -0.967 . . . . 75.0 108.389 176.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -63.76 -23.31 69.3 Favored 'Trans proline' 0 C--N 1.379 2.183 0 C-N-CA 122.41 2.073 . . . . 75.0 112.713 173.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.68 -44.11 1.99 Allowed Glycine 0 C--N 1.352 1.438 0 CA-C-N 115.936 -0.575 . . . . 75.0 112.054 -178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -151.28 42.16 0.73 Allowed Glycine 0 C--N 1.339 0.743 0 N-CA-C 110.691 -0.964 . . . . 75.0 110.691 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.55 178.37 53.97 Favored Glycine 0 C--N 1.352 1.44 0 CA-C-O 119.676 -0.514 . . . . 75.0 113.367 -178.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -70.88 167.28 26.35 Favored 'Trans proline' 0 C--N 1.368 1.589 0 C-N-CA 123.08 2.52 . . . . 75.0 112.949 -174.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 28.7 t -67.76 -27.59 66.9 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 123.525 0.73 . . . . 75.0 110.833 177.078 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.3 m -148.27 -61.38 0.25 Allowed 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.656 0.783 . . . . 75.0 109.945 -176.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -158.8 161.58 36.95 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.659 0.783 . . . . 75.0 109.35 178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.5 mt -80.73 -76.64 0.23 Allowed 'General case' 0 N--CA 1.477 0.914 0 N-CA-C 110.015 -0.365 . . . . 75.0 110.015 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.1 t -169.33 112.9 0.52 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.314 1.045 . . . . 75.0 108.789 178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 94.5 m95 -141.98 -60.55 0.46 Allowed 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 124.103 0.961 . . . . 75.0 108.857 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 34.3 mtp-105 62.48 81.97 0.19 Allowed 'General case' 0 C--N 1.364 1.213 0 C-N-CA 125.071 1.349 . . . . 75.0 111.237 -176.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 85.4 t -106.62 -48.51 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.047 0 C-N-CA 123.107 0.563 . . . . 75.0 109.612 175.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.692 ' HG2' ' HG ' ' A' ' 80' ' ' LEU . 54.0 tp60 -97.55 97.0 8.69 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.525 -0.546 . . . . 75.0 109.525 176.487 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.56 -56.91 2.35 Favored 'General case' 0 N--CA 1.474 0.775 0 N-CA-C 108.454 -0.943 . . . . 75.0 108.454 173.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 59.5 m -76.94 164.38 25.83 Favored 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 123.932 0.893 . . . . 75.0 111.187 178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 59.9 57.29 3.15 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 124.706 1.202 . . . . 75.0 110.926 176.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.402 HD22 ' HD2' ' A' ' 79' ' ' PRO . 3.6 t-20 65.23 118.07 0.02 OUTLIER Pre-proline 0 CA--C 1.555 1.147 0 CA-C-N 114.94 -1.027 . . . . 75.0 111.768 -178.326 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.402 ' HD2' HD22 ' A' ' 78' ' ' ASN . 71.1 Cg_endo -70.77 147.98 57.57 Favored 'Trans proline' 0 C--N 1.372 1.812 0 C-N-CA 121.741 1.627 . . . . 75.0 111.027 174.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.692 ' HG ' ' HG2' ' A' ' 74' ' ' GLN . 84.7 mt -78.73 169.53 18.08 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.778 0.431 . . . . 75.0 110.342 177.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -167.21 116.89 0.85 Allowed 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 108.05 -1.092 . . . . 75.0 108.05 178.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 24.5 pt -110.3 174.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 109.367 -0.605 . . . . 75.0 109.367 177.043 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.1 ptp180 -155.97 88.56 1.11 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.195 0.998 . . . . 75.0 109.514 179.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 97.7 mt -115.79 88.45 2.89 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.61 0.764 . . . . 75.0 109.331 -177.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 58.5 p -114.41 113.19 24.18 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.956 0.902 . . . . 75.0 108.949 178.149 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 57.0 mtp180 -109.8 127.25 54.53 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 108.827 -0.805 . . . . 75.0 108.827 175.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -116.98 105.92 12.85 Favored 'General case' 0 C--O 1.242 0.709 0 C-N-CA 124.487 1.115 . . . . 75.0 109.158 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.422 ' HA ' ' HD3' ' A' ' 89' ' ' PRO . . . -66.41 123.74 86.31 Favored Pre-proline 0 CA--C 1.551 1.019 0 CA-C-N 115.036 -0.984 . . . . 75.0 110.736 -178.544 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.422 ' HD3' ' HA ' ' A' ' 88' ' ' ALA . 24.5 Cg_exo . . . . . 0 C--N 1.378 2.089 0 C-N-CA 123.438 2.759 . . . . 75.0 112.477 -177.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.5 m-70 . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.818 0.342 . . . . 75.0 110.35 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 5.3 m-70 -132.08 127.92 37.1 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.211 1.004 . . . . 75.0 109.676 178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -163.93 131.18 3.33 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 123.485 0.714 . . . . 75.0 110.417 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 63.3 m-70 -130.45 125.14 33.69 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 108.74 -0.837 . . . . 75.0 108.74 178.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 31.6 m80 -127.85 169.18 14.2 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.176 0.59 . . . . 75.0 111.892 -174.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -74.4 112.55 10.68 Favored 'General case' 0 N--CA 1.475 0.796 0 CA-C-N 115.027 -0.988 . . . . 75.0 108.472 176.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 68.0 m -145.29 178.1 8.33 Favored 'General case' 0 C--O 1.241 0.654 0 C-N-CA 122.951 0.501 . . . . 75.0 112.049 -170.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.4 m170 -69.62 161.29 29.93 Favored 'General case' 0 C--O 1.246 0.886 0 CA-C-N 115.064 -0.971 . . . . 75.0 109.147 169.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.433 ' HB2' ' NE1' ' A' ' 71' ' ' TRP . 24.6 ptt? -59.23 133.5 56.15 Favored 'General case' 0 CA--C 1.547 0.843 0 O-C-N 123.688 0.617 . . . . 75.0 109.874 178.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.731 HG11 ' HB ' ' A' ' 73' ' ' VAL . 28.8 m -63.62 133.04 29.58 Favored 'Isoleucine or valine' 0 C--O 1.243 0.743 0 CA-C-O 121.252 0.549 . . . . 50.0 111.182 -177.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.596 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 95.22 9.93 57.65 Favored Glycine 0 CA--C 1.53 1.012 0 CA-C-N 115.203 -0.908 . . . . 50.0 113.028 -174.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.55 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 66.3 t0 -54.29 117.27 3.15 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.603 0.761 . . . . 50.0 111.351 -176.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.496 HG22 ' HB3' ' A' ' 59' ' ' ALA . 29.6 m -73.42 113.88 11.01 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 122.997 0.519 . . . . 50.0 110.194 -173.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.8 m -136.22 176.5 8.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.572 0 C-N-CA 124.231 1.013 . . . . 50.0 110.146 179.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.508 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 35.4 m0 -123.9 136.48 54.38 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.31 1.044 . . . . 50.0 108.239 174.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.9 t -108.88 107.24 22.35 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 108.239 -1.023 . . . . 50.0 108.239 177.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.669 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 43.2 ttm180 -77.27 111.5 12.98 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.019 -1.446 . . . . 75.0 109.838 177.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.3 ttm180 -106.14 152.82 22.95 Favored 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 123.581 0.752 . . . . 75.0 109.222 178.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.56 ' HA ' ' HB3' ' A' ' 26' ' ' PRO . 93.1 m-70 -48.73 -55.69 10.72 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.098 0.874 . . . . 75.0 112.043 -179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.65 ' HG3' ' HB3' ' A' ' 27' ' ' ARG . 13.6 mm100 61.36 -74.8 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 124.716 1.207 . . . . 75.0 109.919 -177.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 39.1 p -78.09 164.44 25.01 Favored 'General case' 0 CA--C 1.552 1.033 0 C-N-CA 125.059 1.343 . . . . 75.0 111.007 169.278 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -85.81 -51.7 6.24 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 122.986 0.514 . . . . 75.0 111.963 -173.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 17.9 m120 -118.54 -21.25 8.05 Favored 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 123.31 0.644 . . . . 75.0 111.848 -175.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.0 mt -70.12 165.12 22.67 Favored 'General case' 0 C--O 1.247 0.932 0 CA-C-O 120.705 0.288 . . . . 75.0 110.283 174.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -53.85 122.62 35.24 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.273 1.029 . . . . 75.0 110.87 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.56 ' HB3' ' HA ' ' A' ' 19' ' ' HIS . 18.4 Cg_endo -56.81 138.9 87.47 Favored 'Trans proline' 0 C--N 1.373 1.844 0 C-N-CA 123.053 2.502 . . . . 50.0 111.441 176.579 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . 0.65 ' HB3' ' HG3' ' A' ' 20' ' ' GLN . 39.8 ttm-85 -99.41 130.98 45.72 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.421 0.688 . . . . 75.0 111.078 -171.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.669 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 64.1 p-90 -75.88 143.98 41.44 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.441 0.696 . . . . 50.0 110.78 177.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -126.56 159.89 32.19 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.295 -1.002 . . . . 75.0 108.295 169.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.44 -172.6 44.14 Favored Glycine 0 CA--C 1.531 1.053 0 CA-C-O 119.475 -0.625 . . . . 50.0 112.428 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -84.59 115.38 3.51 Favored 'Cis proline' 0 C--N 1.371 1.733 0 CA-C-N 119.137 1.469 . . . . 50.0 112.982 1.271 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.427 ' HB3' HG11 ' A' ' 44' ' ' VAL . 78.2 m-85 -75.35 162.71 28.16 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.579 0.752 . . . . 50.0 110.766 172.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.596 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.5 p -131.63 111.5 11.77 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 123.091 0.556 . . . . 50.0 111.295 -177.338 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.55 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 59.5 t -79.77 125.77 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.704 0 C-N-CA 123.754 0.822 . . . . 50.0 110.404 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -97.4 -33.38 11.43 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 123.27 0.628 . . . . 50.0 110.251 174.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.634 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 42.7 tp -135.63 140.5 44.6 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 116.407 -0.361 . . . . 50.0 110.271 -173.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.2 p -128.83 129.55 45.76 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.063 0.545 . . . . 50.0 110.096 176.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 25.8 p -134.96 163.12 53.52 Favored Pre-proline 0 CA--C 1.563 1.477 0 C-N-CA 125.19 1.396 . . . . 50.0 108.57 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -46.18 110.42 0.27 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 C-N-CA 123.308 2.672 . . . . 50.0 114.543 -179.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 9.1 m 68.96 8.99 7.18 Favored 'General case' 0 CA--C 1.568 1.638 0 C-N-CA 124.674 1.189 . . . . 50.0 112.59 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.476 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -146.97 121.93 10.02 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 121.788 -0.57 . . . . 50.0 110.133 -178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD12 HG11 ' A' ' 56' ' ' VAL . 22.6 mt -119.07 121.86 40.8 Favored 'General case' 0 N--CA 1.472 0.64 0 N-CA-C 108.582 -0.895 . . . . 50.0 108.582 -175.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.634 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 86.6 tttt -86.2 113.38 22.18 Favored 'General case' 0 C--O 1.248 0.984 0 C-N-CA 123.027 0.531 . . . . 75.0 110.977 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.473 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 74.1 t -88.61 149.22 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.119 0 C-N-CA 124.887 1.275 . . . . 50.0 109.509 168.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -65.41 128.29 35.28 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 123.313 0.645 . . . . 50.0 110.374 174.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 105.6 -27.78 16.68 Favored Glycine 0 C--N 1.343 0.924 0 CA-C-N 116.014 -0.539 . . . . 50.0 111.959 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.2 mm -74.53 146.79 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.774 0 C-N-CA 123.565 0.746 . . . . 50.0 109.991 178.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.76 -49.19 76.01 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 124.071 0.948 . . . . 50.0 112.413 -175.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.22 -55.61 0.19 Allowed 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 112.222 0.453 . . . . 50.0 112.222 177.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.476 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.6 m-90 -145.6 157.65 43.95 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 112.633 0.605 . . . . 50.0 112.633 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 34.0 mm -112.64 135.66 51.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 C-N-CA 124.845 1.258 . . . . 50.0 108.668 165.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -66.78 124.89 24.19 Favored 'General case' 0 CA--C 1.549 0.913 0 N-CA-C 108.329 -0.989 . . . . 50.0 108.329 176.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -62.65 -19.42 63.8 Favored 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 124.733 1.213 . . . . 50.0 114.081 -164.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.85 -12.12 58.01 Favored 'General case' 0 N--CA 1.484 1.25 0 C-N-CA 123.435 0.694 . . . . 50.0 112.374 176.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 99.8 m-70 -98.0 -11.99 22.42 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 123.452 0.701 . . . . 50.0 111.251 177.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.484 HG11 HD12 ' A' ' 42' ' ' LEU . 76.1 t -96.86 124.34 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.881 0 C-N-CA 122.681 0.392 . . . . 50.0 110.596 -170.273 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 51.4 mtpt -118.33 120.05 36.45 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.505 1.122 . . . . 75.0 108.986 179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -58.48 106.85 0.43 Allowed 'General case' 0 CA--C 1.547 0.847 0 C-N-CA 123.41 0.684 . . . . 50.0 110.4 176.688 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB3' HG22 ' A' ' 13' ' ' THR . . . -96.31 141.77 29.24 Favored 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 123.815 0.846 . . . . 50.0 110.947 -176.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -102.09 110.51 62.63 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 108.361 -0.977 . . . . 75.0 108.361 174.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -86.17 4.76 6.3 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 123.001 2.467 . . . . 75.0 112.772 178.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 96.25 33.21 6.35 Favored Glycine 0 C--N 1.345 1.045 0 N-CA-C 110.2 -1.16 . . . . 75.0 110.2 -167.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.07 -77.33 1.53 Allowed Glycine 0 C--N 1.352 1.446 0 N-CA-C 111.576 -0.61 . . . . 75.0 111.576 -172.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 67.84 57.7 8.48 Favored Glycine 0 CA--C 1.546 1.98 0 CA-C-O 119.123 -0.821 . . . . 75.0 114.462 177.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -94.54 109.88 0.16 Allowed 'Trans proline' 0 C--N 1.377 2.045 0 C-N-CA 122.817 2.344 . . . . 75.0 112.205 177.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 22.1 p -159.88 -77.56 0.06 Allowed 'General case' 0 CA--C 1.553 1.07 0 C-N-CA 122.879 0.472 . . . . 75.0 111.079 179.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 44.2 t -71.94 -24.66 61.66 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 124.295 1.038 . . . . 75.0 111.535 -177.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 88.7 mtm180 -85.48 -6.24 59.21 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-N 115.978 -0.556 . . . . 75.0 112.278 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 89.2 mt -81.69 58.47 3.79 Favored 'General case' 0 N--CA 1.484 1.234 0 CA-C-O 121.624 0.726 . . . . 75.0 111.201 -177.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 97.6 m -152.09 -54.49 0.13 Allowed 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.553 1.141 . . . . 75.0 108.276 -176.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.476 ' HB3' ' HB2' ' A' ' 74' ' ' GLN . 10.2 m-90 54.05 49.86 17.9 Favored 'General case' 0 C--N 1.355 0.825 0 CA-C-N 114.12 -1.4 . . . . 75.0 111.613 177.603 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ptt180 -57.25 -30.08 64.33 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.312 1.045 . . . . 75.0 113.352 -176.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.731 ' HB ' HG11 ' A' ' 10' ' ' VAL . 40.1 t -77.95 -31.45 16.85 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.995 0 C-N-CA 123.17 0.588 . . . . 75.0 110.346 177.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.496 ' HG2' HG13 ' A' ' 10' ' ' VAL . 31.0 mm-40 -83.36 -4.79 58.81 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.548 0.739 . . . . 75.0 111.501 176.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.444 HH21 HD12 ' A' ' 80' ' ' LEU . 2.2 mmp_? -72.93 72.67 1.12 Allowed 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 109.147 -0.686 . . . . 75.0 109.147 170.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.3 m -144.91 -94.75 0.1 Allowed 'General case' 0 CA--C 1.55 0.969 0 N-CA-C 108.718 -0.845 . . . . 75.0 108.718 -176.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.0 tm0? -84.93 -31.12 23.8 Favored 'General case' 0 C--N 1.355 0.812 0 N-CA-C 108.911 -0.774 . . . . 75.0 108.911 167.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 6.0 t30 70.55 92.97 0.05 OUTLIER Pre-proline 0 CA--C 1.551 0.988 0 C-N-CA 125.196 1.398 . . . . 75.0 110.721 -178.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -92.59 14.3 1.69 Allowed 'Trans proline' 0 C--N 1.369 1.638 0 C-N-CA 123.671 2.914 . . . . 75.0 112.376 171.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.444 HD12 HH21 ' A' ' 75' ' ' ARG . 79.3 mt -74.53 108.15 7.12 Favored 'General case' 0 C--O 1.239 0.526 0 C-N-CA 124.103 0.961 . . . . 75.0 110.324 -178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 94.0 mttt -95.92 149.37 21.63 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 123.246 0.618 . . . . 75.0 110.293 -179.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 pt -66.18 108.81 1.02 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.782 0 C-N-CA 123.573 0.749 . . . . 75.0 110.587 177.465 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 62.4 mtp180 -93.95 142.56 27.24 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.555 -0.748 . . . . 75.0 109.758 -178.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 73.3 mt -72.26 83.74 1.04 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 123.506 0.722 . . . . 75.0 109.87 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 21.3 m -100.07 138.11 37.59 Favored 'General case' 0 C--O 1.243 0.72 0 CA-C-N 114.606 -1.179 . . . . 75.0 110.193 -176.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 64.6 mtt-85 -75.49 89.53 2.69 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-O 121.334 0.588 . . . . 75.0 110.663 177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -88.85 96.69 10.79 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 115.241 -0.89 . . . . 75.0 109.839 178.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -141.41 77.82 19.29 Favored Pre-proline 0 N--CA 1.474 0.757 0 C-N-CA 123.252 0.621 . . . . 75.0 109.534 176.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo . . . . . 0 C--N 1.376 1.991 0 C-N-CA 123.161 2.574 . . . . 75.0 112.104 177.466 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 56.4 m80 . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.067 -0.716 . . . . 75.0 109.067 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 53.3 t-80 -80.25 89.75 5.5 Favored 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 123.85 0.86 . . . . 75.0 109.987 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 83.1 m-70 -77.54 -31.02 53.06 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.43 0.692 . . . . 75.0 109.772 173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 47.1 t60 77.06 -31.03 0.17 Allowed 'General case' 0 N--CA 1.484 1.263 0 C-N-CA 125.965 1.706 . . . . 75.0 112.55 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.3 t-80 -66.87 113.55 5.02 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 122.809 0.443 . . . . 75.0 110.438 177.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 37.3 m-70 -64.46 127.84 33.21 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.339 1.055 . . . . 75.0 109.503 176.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.447 ' HA ' ' OG1' ' A' ' 37' ' ' THR . 27.5 t -96.48 167.87 10.89 Favored 'General case' 0 CA--C 1.542 0.648 0 O-C-N 123.67 0.606 . . . . 75.0 112.299 -169.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.5 m170 -76.45 159.86 30.05 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 108.691 -0.855 . . . . 75.0 108.691 165.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 25.1 ptm -52.55 134.71 35.15 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 124.144 0.903 . . . . 75.0 111.623 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.544 HG22 HD21 ' A' ' 80' ' ' LEU . 13.8 m -67.04 117.64 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.772 0 N-CA-C 108.799 -0.815 . . . . 50.0 108.799 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 102.25 10.23 39.67 Favored Glycine 0 CA--C 1.537 1.429 0 CA-C-O 118.645 -1.086 . . . . 50.0 113.245 -170.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.52 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -57.75 102.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.116 0 CA-C-N 118.56 1.18 . . . . 50.0 109.906 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.407 HG21 ' HG3' ' A' ' 61' ' ' PRO . 28.4 m -72.71 113.29 9.58 Favored 'General case' 0 C--N 1.348 0.541 0 CA-C-O 121.492 0.663 . . . . 50.0 110.221 -169.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.7 m -124.58 -179.86 2.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 CA-C-N 113.933 -1.485 . . . . 50.0 109.05 178.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 37.5 m0 -125.0 150.66 46.49 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 106.994 -1.484 . . . . 50.0 106.994 174.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 83.6 t -105.21 104.46 16.97 Favored 'Isoleucine or valine' 0 C--O 1.242 0.689 0 N-CA-C 107.246 -1.391 . . . . 50.0 107.246 176.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.629 ' HG2' ' HB2' ' A' ' 26' ' ' PRO . 37.9 ttt180 -81.33 92.4 6.39 Favored 'General case' 0 CA--C 1.549 0.904 0 CA-C-N 112.686 -2.052 . . . . 75.0 109.651 -173.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 79.6 ttt180 -84.32 125.56 32.39 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.408 0.683 . . . . 75.0 111.424 -170.851 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -118.98 109.54 16.07 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.904 0.882 . . . . 75.0 109.957 -179.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -90.98 -56.8 3.03 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 122.866 0.467 . . . . 75.0 111.19 -178.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.1 p -119.68 146.3 45.71 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 122.96 0.504 . . . . 75.0 111.223 -179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 95.2 mttt -68.94 -35.0 76.28 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.809 1.244 . . . . 75.0 112.385 -171.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 27.2 p-10 -64.84 -29.57 70.54 Favored 'General case' 0 N--CA 1.478 0.95 0 O-C-N 123.732 0.645 . . . . 75.0 111.53 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -99.32 154.1 18.44 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.571 0.748 . . . . 75.0 111.006 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -78.32 145.94 69.45 Favored Pre-proline 0 CA--C 1.549 0.925 0 CA-C-N 114.782 -1.099 . . . . 75.0 109.739 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.629 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 15.1 Cg_exo -67.4 130.06 21.6 Favored 'Trans proline' 0 C--N 1.372 1.796 0 C-N-CA 122.513 2.142 . . . . 50.0 111.316 178.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 18.0 ttm180 -97.5 116.86 30.51 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 123.622 0.769 . . . . 75.0 110.11 -178.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.587 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.7 p-90 -68.27 143.11 55.37 Favored 'General case' 0 N--CA 1.477 0.888 0 C-N-CA 123.298 0.639 . . . . 50.0 111.359 177.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.9 mtmp? -121.5 146.54 46.82 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 124.06 0.944 . . . . 75.0 108.804 172.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -158.88 175.44 35.87 Favored Glycine 0 CA--C 1.533 1.166 0 CA-C-O 119.756 -0.469 . . . . 50.0 112.849 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -90.79 126.8 6.37 Favored 'Cis proline' 0 CA--C 1.564 2.007 0 CA-C-N 118.754 1.277 . . . . 50.0 113.215 -3.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -103.07 163.29 12.31 Favored 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.808 0.843 . . . . 50.0 109.369 172.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.47 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.9 p -145.86 114.02 6.6 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.803 0.441 . . . . 50.0 111.15 -176.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 44' ' ' VAL . 24.2 t -67.99 133.07 32.22 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 C-N-CA 123.841 0.856 . . . . 50.0 110.781 176.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 48.8 mt -108.82 -41.58 4.72 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 123.991 0.916 . . . . 50.0 109.936 -179.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.419 ' HB3' ' HD3' ' A' ' 43' ' ' LYS . 56.7 tp -135.26 151.2 50.35 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 108.401 -0.963 . . . . 50.0 108.401 178.147 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.46 HG22 HD22 ' A' ' 42' ' ' LEU . 69.6 p -124.32 153.19 42.14 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 121.865 -0.522 . . . . 50.0 111.048 179.257 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.4 m -136.44 147.65 60.81 Favored Pre-proline 0 CA--C 1.561 1.401 0 N-CA-C 106.501 -1.666 . . . . 50.0 106.501 171.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_exo -40.85 109.72 0.11 Allowed 'Trans proline' 0 C--N 1.387 2.561 0 C-N-CA 123.288 2.659 . . . . 50.0 114.442 176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 67.9 17.43 9.64 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 125.337 1.455 . . . . 50.0 112.903 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -156.42 121.61 4.71 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.42 0.688 . . . . 50.0 109.943 174.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.667 HD12 HG11 ' A' ' 56' ' ' VAL . 27.5 mt -106.09 133.94 50.01 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 122.984 0.514 . . . . 50.0 110.308 -171.028 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.419 ' HD3' ' HB3' ' A' ' 36' ' ' LEU . 54.8 tttp -85.57 107.53 17.54 Favored 'General case' 0 C--O 1.247 0.939 0 N-CA-C 107.799 -1.186 . . . . 75.0 107.799 173.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 34' ' ' VAL . 44.8 t -109.78 154.63 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 CA-C-N 114.486 -1.234 . . . . 50.0 109.452 -172.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -60.67 130.19 45.31 Favored 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.992 0.917 . . . . 50.0 110.789 174.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 88.05 -8.01 79.55 Favored Glycine 0 C--N 1.348 1.203 0 CA-C-N 116.16 -0.473 . . . . 50.0 113.782 178.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.461 HG21 HG12 ' A' ' 51' ' ' ILE . 40.8 mm -91.8 151.35 3.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.077 0.951 . . . . 50.0 110.539 -178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -61.95 -50.08 73.56 Favored 'General case' 0 C--N 1.355 0.841 0 C-N-CA 124.194 0.998 . . . . 50.0 111.614 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.04 -57.53 0.16 Allowed 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 112.047 0.388 . . . . 50.0 112.047 175.013 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.522 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.6 m-90 -143.35 153.3 42.58 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 123.029 0.531 . . . . 50.0 111.653 -177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 47' ' ' ILE . 33.1 mm -123.44 120.22 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.814 0 C-N-CA 124.699 1.2 . . . . 50.0 107.816 168.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.4 t-80 -61.12 141.46 57.43 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.248 0.619 . . . . 50.0 109.469 178.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.82 48.81 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 115.566 1.691 . . . . 50.0 115.566 -162.514 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.93 -26.95 67.1 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 123.041 0.536 . . . . 50.0 112.216 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 -96.44 23.9 6.35 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 124.059 0.944 . . . . 50.0 110.661 177.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.667 HG11 HD12 ' A' ' 42' ' ' LEU . 57.8 t -123.39 152.14 28.26 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.873 0 C-N-CA 124.15 0.98 . . . . 50.0 108.555 173.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -155.87 110.6 2.9 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 122.982 0.513 . . . . 75.0 109.95 173.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -67.49 147.29 53.02 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.142 0.577 . . . . 50.0 111.327 -178.714 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -166.05 114.94 0.95 Allowed 'General case' 0 N--CA 1.478 0.936 0 C-N-CA 124.153 0.981 . . . . 50.0 109.192 -175.404 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 53.3 t0 -78.98 126.48 82.04 Favored Pre-proline 0 CA--C 1.56 1.36 0 C-N-CA 124.076 0.95 . . . . 75.0 110.488 -176.368 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.407 ' HG3' HG21 ' A' ' 13' ' ' THR . 9.0 Cg_exo -70.72 -22.03 28.24 Favored 'Trans proline' 0 C--N 1.386 2.522 0 C-N-CA 123.075 2.516 . . . . 75.0 112.749 174.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 137.8 74.63 0.06 OUTLIER Glycine 0 C--N 1.348 1.207 0 N-CA-C 111.587 -0.605 . . . . 75.0 111.587 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 95.28 -0.65 63.96 Favored Glycine 0 C--N 1.351 1.406 0 C-N-CA 123.296 0.474 . . . . 75.0 112.845 -178.36 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.12 158.63 29.9 Favored Glycine 0 C--N 1.346 1.124 0 CA-C-O 119.345 -0.697 . . . . 75.0 111.97 -179.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_exo -67.17 90.72 0.31 Allowed 'Trans proline' 0 C--N 1.37 1.672 0 C-N-CA 122.162 1.908 . . . . 75.0 111.082 172.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.1 t -61.86 -31.14 71.38 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.312 -0.858 . . . . 75.0 109.789 175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 39.4 m -65.45 129.34 39.41 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 123.882 0.873 . . . . 75.0 110.563 172.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 7.9 ppt_? -67.1 116.93 8.46 Favored 'General case' 0 CA--C 1.55 0.952 0 O-C-N 123.589 0.556 . . . . 75.0 109.821 173.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.6 mt -92.33 3.12 56.05 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 123.972 0.909 . . . . 75.0 110.851 178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.4 t -141.87 178.24 7.64 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 125.953 1.701 . . . . 75.0 107.597 175.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 97.9 m95 -68.28 -62.88 1.2 Allowed 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 109.971 -0.381 . . . . 75.0 109.971 177.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.56 ' HB3' ' HG2' ' A' ' 74' ' ' GLN . 99.1 mtt180 -139.57 -79.7 0.31 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 123.245 0.618 . . . . 75.0 109.465 174.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.6 t 60.44 9.14 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.57 1.723 0 C-N-CA 124.902 1.281 . . . . 75.0 111.451 -172.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.56 ' HG2' ' HB3' ' A' ' 72' ' ' ARG . 13.9 pt20 -81.63 -0.69 43.63 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 124.522 1.129 . . . . 75.0 111.209 -179.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 66.9 mtp180 -89.55 -4.57 57.82 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 124.734 1.214 . . . . 75.0 111.261 176.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -83.35 62.9 6.97 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.725 0.81 . . . . 75.0 111.128 -176.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.6 mm-40 58.9 44.9 15.96 Favored 'General case' 0 N--CA 1.481 1.082 0 C-N-CA 124.358 1.063 . . . . 75.0 111.432 177.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.2 m120 57.06 71.9 1.04 Allowed Pre-proline 0 N--CA 1.486 1.368 0 C-N-CA 124.4 1.08 . . . . 75.0 112.348 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -67.41 -53.06 0.5 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.053 2.502 . . . . 75.0 112.553 174.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.544 HD21 HG22 ' A' ' 10' ' ' VAL . 91.4 mt -63.16 99.74 0.19 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 124.3 1.0 . . . . 75.0 111.146 -172.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -130.58 155.84 45.85 Favored 'General case' 0 N--CA 1.47 0.565 0 C-N-CA 124.792 1.237 . . . . 75.0 108.969 177.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 30.9 pt -85.37 16.96 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.705 0.802 . . . . 75.0 112.462 -171.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 77.3 mtt-85 -80.12 73.62 6.94 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-O 121.34 0.59 . . . . 75.0 109.491 171.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.7 mt -77.94 128.02 33.26 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 115.375 -0.829 . . . . 75.0 109.222 176.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.5 p -73.28 178.83 4.25 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.063 0.545 . . . . 75.0 109.89 172.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 66.8 ttt-85 -136.75 -83.7 0.36 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.493 0.588 . . . . 75.0 111.094 175.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -159.8 148.34 17.42 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-O 120.862 0.363 . . . . 75.0 110.853 -166.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -158.69 132.41 4.94 Favored Pre-proline 0 CA--C 1.547 0.828 0 C-N-CA 124.711 1.204 . . . . 75.0 107.842 171.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_exo . . . . . 0 C--N 1.373 1.862 0 C-N-CA 122.421 2.08 . . . . 75.0 110.797 174.14 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 . . . . . 0 N--CA 1.481 1.075 0 N-CA-C 110.064 -0.347 . . . . 75.0 110.064 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 14.4 t60 -97.65 130.16 44.68 Favored 'General case' 0 C--O 1.241 0.653 0 N-CA-C 108.509 -0.922 . . . . 75.0 108.509 176.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 77.1 m-70 -64.89 133.72 52.46 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.854 0.862 . . . . 75.0 110.709 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.591 ' HB2' ' HB3' ' A' ' 76' ' ' SER . 94.1 m-70 -98.7 144.01 28.44 Favored 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 124.66 1.184 . . . . 75.0 110.326 -170.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 17.4 p80 -154.41 -174.42 4.96 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.51 0.724 . . . . 75.0 109.845 -174.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 34.3 m170 -61.35 111.89 1.94 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 123.178 0.591 . . . . 75.0 110.092 174.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 25.3 m -141.02 -172.97 3.59 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 124.137 0.975 . . . . 75.0 109.861 -174.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 19.2 m170 -83.54 150.22 26.1 Favored 'General case' 0 N--CA 1.477 0.922 0 N-CA-C 108.259 -1.015 . . . . 75.0 108.259 167.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 27.7 ptm -60.46 140.97 57.0 Favored 'General case' 0 N--CA 1.475 0.775 0 O-C-N 124.04 0.838 . . . . 75.0 110.892 -175.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.549 HG11 ' HB ' ' A' ' 73' ' ' VAL . 3.4 m -60.56 123.09 12.56 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.783 0 C-N-CA 123.296 0.638 . . . . 50.0 110.533 174.681 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.509 ' O ' HD13 ' A' ' 69' ' ' LEU . . . 93.37 9.36 60.43 Favored Glycine 0 CA--C 1.533 1.168 0 CA-C-O 119.057 -0.857 . . . . 50.0 113.466 -174.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.705 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 51.2 t0 -56.02 106.3 0.26 Allowed 'General case' 0 N--CA 1.491 1.594 0 CA-C-N 117.942 0.871 . . . . 50.0 110.728 -176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 38.2 m -72.44 106.66 4.63 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-O 121.291 0.567 . . . . 50.0 110.012 -170.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.0 m -128.97 173.86 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 C-N-CA 124.527 1.131 . . . . 50.0 110.814 -173.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.447 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.4 m0 -117.05 150.7 38.21 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 124.9 1.28 . . . . 50.0 108.168 171.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 55.6 t -107.43 109.31 27.72 Favored 'Isoleucine or valine' 0 C--O 1.239 0.52 0 N-CA-C 108.052 -1.092 . . . . 50.0 108.052 174.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.613 ' HG2' ' HB2' ' A' ' 26' ' ' PRO . 38.8 ttp180 -87.12 90.61 8.42 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 114.116 -1.402 . . . . 75.0 109.808 -177.616 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 41.4 ttt180 -98.17 127.71 44.26 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.449 1.1 . . . . 75.0 110.043 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.741 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 39.7 p-80 -67.68 138.65 56.48 Favored 'General case' 0 C--N 1.354 0.762 0 O-C-N 123.147 0.279 . . . . 75.0 110.38 -179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 21.9 mm-40 -83.59 -47.36 11.37 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 108.252 -1.018 . . . . 75.0 108.252 173.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.516 ' HB ' ' H ' ' A' ' 24' ' ' LEU . 18.9 m -140.63 175.76 9.34 Favored 'General case' 0 CA--C 1.552 1.041 0 N-CA-C 106.735 -1.58 . . . . 75.0 106.735 174.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -73.57 -36.34 65.59 Favored 'General case' 0 N--CA 1.476 0.86 0 N-CA-C 109.216 -0.661 . . . . 75.0 109.216 167.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.43 ' H ' HG22 ' A' ' 21' ' ' THR . 2.1 m-20 -65.78 -59.85 3.47 Favored 'General case' 0 C--N 1.352 0.685 0 CA-C-N 114.786 -1.097 . . . . 75.0 110.405 176.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.516 ' H ' ' HB ' ' A' ' 21' ' ' THR . 79.4 mt -68.84 136.73 53.14 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 123.391 0.676 . . . . 75.0 110.037 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -60.9 145.35 89.02 Favored Pre-proline 0 CA--C 1.552 1.029 0 O-C-N 123.812 0.695 . . . . 75.0 111.045 -179.071 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.741 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 45.2 Cg_exo -57.46 118.65 5.56 Favored 'Trans proline' 0 C--N 1.376 2.014 0 C-N-CA 123.015 2.477 . . . . 50.0 112.831 176.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 45.8 ttt180 -87.13 120.19 28.15 Favored 'General case' 0 N--CA 1.471 0.595 0 C-N-CA 124.694 1.198 . . . . 75.0 110.524 -176.037 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.549 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 62.5 p-90 -73.85 149.33 41.64 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.739 0.816 . . . . 50.0 111.088 177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 52.6 mtmt -139.61 153.26 47.32 Favored 'General case' 0 N--CA 1.488 1.453 0 C-N-CA 123.791 0.836 . . . . 75.0 109.649 172.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.447 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -168.0 179.39 41.26 Favored Glycine 0 CA--C 1.537 1.449 0 CA-C-O 119.894 -0.392 . . . . 50.0 113.492 178.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 76.7 Cg_endo -84.71 133.72 19.12 Favored 'Cis proline' 0 C--N 1.378 2.103 0 CA-C-N 119.139 1.47 . . . . 50.0 113.838 0.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.43 ' HB3' HG11 ' A' ' 44' ' ' VAL . 76.0 m-85 -108.48 168.3 9.42 Favored 'General case' 0 N--CA 1.477 0.906 0 C-N-CA 124.895 1.278 . . . . 50.0 109.396 169.411 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.9 p -148.0 113.62 5.68 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.275 0.63 . . . . 50.0 110.883 -174.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.705 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 97.4 t -73.21 134.32 29.97 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.756 0.822 . . . . 50.0 110.417 177.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.446 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 60.9 mt -106.58 -31.75 8.35 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.37 0.668 . . . . 50.0 110.812 175.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 46.1 tp -149.59 159.2 44.52 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 108.777 -0.823 . . . . 50.0 108.777 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 33.2 p -139.38 163.7 31.81 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-O 121.559 0.695 . . . . 50.0 111.259 173.835 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 23.3 p -141.98 164.33 34.72 Favored Pre-proline 0 CA--C 1.556 1.176 0 C-N-CA 126.12 1.768 . . . . 50.0 107.695 174.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -49.12 107.85 0.17 Allowed 'Trans proline' 0 C--N 1.389 2.704 0 C-N-CA 122.789 2.326 . . . . 50.0 113.47 177.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.69 22.15 12.54 Favored 'General case' 0 CA--C 1.566 1.571 0 C-N-CA 125.432 1.493 . . . . 50.0 112.855 175.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -147.45 121.94 9.74 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.128 -0.693 . . . . 50.0 109.128 171.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.515 HD12 ' HB ' ' A' ' 56' ' ' VAL . 23.3 mt -106.69 123.5 48.22 Favored 'General case' 0 C--O 1.243 0.726 0 C-N-CA 124.243 1.017 . . . . 50.0 108.749 -172.39 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.2 tttp -86.85 106.84 18.02 Favored 'General case' 0 C--O 1.249 1.077 0 N-CA-C 109.349 -0.611 . . . . 75.0 109.349 177.366 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.579 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 48.0 t -96.25 154.75 3.52 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.796 0 CA-C-N 114.309 -1.314 . . . . 50.0 109.153 177.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -70.2 135.33 48.96 Favored 'General case' 0 C--O 1.24 0.566 0 N-CA-C 109.499 -0.556 . . . . 50.0 109.499 176.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 92.32 -3.78 76.31 Favored Glycine 0 C--N 1.34 0.787 0 O-C-N 123.761 0.663 . . . . 50.0 112.798 -177.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -92.66 147.67 5.22 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 C-N-CA 123.171 0.588 . . . . 50.0 109.939 178.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.76 -49.44 73.12 Favored 'General case' 0 C--N 1.358 0.972 0 C-N-CA 124.435 1.094 . . . . 50.0 111.38 179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.19 -59.59 0.19 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 111.951 0.352 . . . . 50.0 111.951 176.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 22.3 m-90 -145.31 158.65 43.78 Favored 'General case' 0 N--CA 1.494 1.732 0 C-N-CA 123.297 0.639 . . . . 50.0 111.187 179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 26.7 mm -123.88 133.89 68.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 N-CA-C 107.598 -1.26 . . . . 50.0 107.598 167.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.0 t-80 -63.79 142.24 58.47 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 108.294 -1.002 . . . . 50.0 108.294 -177.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.69 -36.75 64.99 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 115.076 1.51 . . . . 50.0 115.076 -161.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -80.27 1.32 29.06 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 112.33 0.493 . . . . 50.0 112.33 -175.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 94.7 m-70 -99.32 12.42 36.33 Favored 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.018 0.527 . . . . 50.0 109.816 169.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.515 ' HB ' HD12 ' A' ' 42' ' ' LEU . 99.1 t -139.15 140.75 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 N-CA-C 108.692 -0.855 . . . . 50.0 108.692 176.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -138.17 152.17 48.42 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 108.56 -0.904 . . . . 75.0 108.56 172.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.32 126.85 28.84 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 123.667 0.787 . . . . 50.0 110.845 176.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -101.52 143.16 31.86 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 108.817 -0.809 . . . . 50.0 108.817 174.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -77.06 111.85 19.19 Favored Pre-proline 0 N--CA 1.477 0.921 0 N-CA-C 108.712 -0.848 . . . . 75.0 108.712 177.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -84.57 -4.44 10.03 Favored 'Trans proline' 0 C--N 1.377 2.07 0 C-N-CA 122.496 2.131 . . . . 75.0 112.271 178.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.31 8.15 79.24 Favored Glycine 0 C--N 1.356 1.648 0 O-C-N 123.644 0.59 . . . . 75.0 112.889 -175.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.37 -5.46 67.91 Favored Glycine 0 C--N 1.357 1.716 0 CA-C-O 119.886 -0.397 . . . . 75.0 112.82 -171.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -147.02 79.64 0.22 Allowed Glycine 0 C--N 1.349 1.278 0 N-CA-C 111.141 -0.784 . . . . 75.0 111.141 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -57.23 -20.21 37.78 Favored 'Trans proline' 0 C--N 1.387 2.57 0 C-N-CA 124.094 3.196 . . . . 75.0 113.552 175.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.7 m 63.54 30.66 15.09 Favored 'General case' 0 C--N 1.363 1.159 0 C-N-CA 124.393 1.077 . . . . 75.0 111.575 176.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 32.6 t -140.02 159.75 41.47 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.448 0.699 . . . . 75.0 110.438 -174.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -69.21 102.7 1.75 Allowed 'General case' 0 C--N 1.348 0.537 0 C-N-CA 123.142 0.577 . . . . 75.0 109.517 175.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.509 HD13 ' O ' ' A' ' 11' ' ' GLY . 79.3 mt -128.14 -13.99 4.97 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 124.64 1.176 . . . . 75.0 110.186 175.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 59.7 m -79.7 87.3 5.23 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.818 0.818 . . . . 75.0 109.901 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.7 OUTLIER -135.63 144.59 46.17 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.665 -1.152 . . . . 75.0 108.596 171.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 ptt180 -93.84 45.34 1.15 Allowed 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.251 0.621 . . . . 75.0 110.828 -177.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.549 ' HB ' HG11 ' A' ' 10' ' ' VAL . 69.7 t -61.58 -61.92 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.677 0 CA-C-N 115.481 -0.782 . . . . 75.0 109.39 174.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 60.1 tp60 -82.78 81.05 8.68 Favored 'General case' 0 CA--C 1.545 0.769 0 N-CA-C 108.444 -0.947 . . . . 75.0 108.444 171.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -142.07 85.26 1.92 Allowed 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 107.118 -1.438 . . . . 75.0 107.118 175.762 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.591 ' HB3' ' HB2' ' A' ' 4' ' ' HIS . 13.8 p -92.45 -53.02 4.38 Favored 'General case' 0 C--O 1.237 0.402 0 CA-C-N 114.953 -1.021 . . . . 75.0 109.117 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -153.92 -45.87 0.09 Allowed 'General case' 0 CA--C 1.544 0.723 0 CA-C-N 114.401 -1.272 . . . . 75.0 108.916 179.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -106.28 109.96 63.55 Favored Pre-proline 0 N--CA 1.474 0.748 0 C-N-CA 124.161 0.985 . . . . 75.0 109.95 -179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -71.17 130.3 17.41 Favored 'Trans proline' 0 C--N 1.373 1.862 0 C-N-CA 122.295 1.997 . . . . 75.0 110.729 169.202 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 69.6 mt -78.85 -9.41 59.46 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 113.82 1.044 . . . . 75.0 113.82 -166.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 87.6 tttt -75.89 92.8 3.12 Favored 'General case' 0 C--N 1.353 0.728 0 N-CA-C 108.595 -0.891 . . . . 75.0 108.595 174.355 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.7 pt -92.76 -178.96 0.45 Allowed 'Isoleucine or valine' 0 C--O 1.245 0.826 0 C-N-CA 124.182 0.993 . . . . 75.0 110.486 -178.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.9 ptm180 -66.53 149.71 50.05 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-N 115.614 -0.721 . . . . 75.0 110.6 176.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 64.1 mt -78.74 179.47 7.17 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.991 -0.55 . . . . 75.0 110.65 179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 43.1 p -76.69 78.95 3.33 Favored 'General case' 0 CA--C 1.556 1.188 0 C-N-CA 123.684 0.793 . . . . 75.0 111.932 -171.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 42.7 mtm180 -141.87 127.83 19.48 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.208 1.003 . . . . 75.0 109.029 176.986 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -82.82 102.8 11.84 Favored 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.331 0.652 . . . . 75.0 110.045 176.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -162.32 146.56 9.43 Favored Pre-proline 0 CA--C 1.544 0.746 0 C-N-CA 124.085 0.954 . . . . 75.0 109.175 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_exo . . . . . 0 C--N 1.381 2.247 0 C-N-CA 123.547 2.831 . . . . 75.0 113.434 179.152 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.619 0.247 . . . . 75.0 110.591 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.7 m-70 -115.39 69.69 0.73 Allowed 'General case' 0 C--O 1.24 0.577 0 N-CA-C 108.896 -0.779 . . . . 75.0 108.896 170.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.5 t-80 -166.87 94.55 0.49 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 114.429 -1.259 . . . . 75.0 108.713 175.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 27.0 t-80 -159.87 137.65 9.94 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.507 0.723 . . . . 75.0 110.428 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 1.8 p80 -171.73 151.32 2.85 Favored 'General case' 0 N--CA 1.472 0.673 0 O-C-N 124.294 0.997 . . . . 75.0 109.764 175.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.415 ' CE1' ' HA ' ' A' ' 79' ' ' PRO . 34.1 m-70 -127.13 151.02 49.21 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.263 1.025 . . . . 75.0 109.074 172.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . 0.458 ' HB3' ' NE2' ' A' ' 74' ' ' GLN . 7.8 t -166.4 -174.89 3.02 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.273 -1.01 . . . . 75.0 108.273 175.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 64.0 t-80 -67.41 139.88 57.14 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.141 -1.059 . . . . 75.0 108.141 171.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.6 ptt? -48.87 132.89 18.25 Favored 'General case' 0 CA--C 1.549 0.937 0 O-C-N 124.757 1.286 . . . . 75.0 112.73 -171.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.67 HG21 ' HA ' ' A' ' 72' ' ' ARG . 30.3 m -62.1 150.64 8.15 Favored 'Isoleucine or valine' 0 C--O 1.246 0.882 0 CA-C-N 115.076 -0.965 . . . . 50.0 110.828 176.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 87.14 11.37 69.83 Favored Glycine 0 CA--C 1.524 0.642 0 C-N-CA 120.995 -0.621 . . . . 50.0 112.49 -179.803 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.528 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.4 t0 -62.1 111.83 2.11 Favored 'General case' 0 N--CA 1.488 1.442 0 CA-C-N 117.355 0.577 . . . . 50.0 109.853 -176.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.8 m -71.34 112.28 7.35 Favored 'General case' 0 C--N 1.344 0.347 0 N-CA-C 109.249 -0.649 . . . . 50.0 109.249 -175.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.554 HG12 ' HA ' ' A' ' 58' ' ' ALA . 30.2 m -136.38 164.2 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.491 0 CA-C-N 115.797 -0.638 . . . . 50.0 111.124 -174.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.453 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 41.8 m0 -122.39 145.56 48.16 Favored 'General case' 0 C--O 1.239 0.523 0 C-N-CA 124.235 1.014 . . . . 50.0 108.315 174.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 62.8 t -107.69 105.26 18.45 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 109.04 -0.726 . . . . 50.0 109.04 -177.058 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.536 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.0 ttm180 -89.34 138.01 31.82 Favored 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 125.028 1.331 . . . . 75.0 110.378 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -150.41 139.01 20.63 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 122.607 0.363 . . . . 75.0 110.471 -178.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.6 m80 -61.75 120.09 9.99 Favored 'General case' 0 N--CA 1.473 0.699 0 C-N-CA 123.097 0.559 . . . . 75.0 110.746 176.851 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -61.66 -47.73 84.04 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.949 0.881 . . . . 75.0 108.839 171.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 23' ' ' ASN . 38.9 m -148.21 156.61 42.77 Favored 'General case' 0 CA--C 1.552 1.045 0 CA-C-N 113.732 -1.576 . . . . 75.0 107.053 171.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 46.0 mtpt -68.93 -27.72 66.01 Favored 'General case' 0 N--CA 1.485 1.315 0 CA-C-N 118.614 0.643 . . . . 75.0 110.957 175.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.575 ' H ' HG22 ' A' ' 21' ' ' THR . 25.8 t-20 -70.47 -37.03 74.2 Favored 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.9 0.88 . . . . 75.0 110.68 173.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.9 mt -90.15 174.09 7.81 Favored 'General case' 0 N--CA 1.474 0.732 0 C-N-CA 123.367 0.667 . . . . 75.0 110.365 179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -86.84 156.97 55.22 Favored Pre-proline 0 CA--C 1.55 0.966 0 C-N-CA 123.21 0.604 . . . . 75.0 109.886 174.188 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -71.28 165.27 32.96 Favored 'Trans proline' 0 C--N 1.374 1.918 0 C-N-CA 122.669 2.246 . . . . 50.0 113.249 177.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -143.61 136.65 27.68 Favored 'General case' 0 C--O 1.238 0.459 0 N-CA-C 108.635 -0.876 . . . . 75.0 108.635 -179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.536 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.2 p-90 -96.35 163.7 12.96 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.537 0.735 . . . . 50.0 111.763 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -135.66 149.92 49.45 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 124.153 0.981 . . . . 75.0 108.586 171.291 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.453 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -175.77 179.2 47.07 Favored Glycine 0 C--N 1.342 0.906 0 C-N-CA 121.256 -0.497 . . . . 50.0 112.618 178.559 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -90.02 148.72 21.57 Favored 'Cis proline' 0 C--N 1.368 1.573 0 CA-C-N 118.616 1.208 . . . . 50.0 113.834 0.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 66.8 m-85 -120.54 176.0 5.72 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.91 1.284 . . . . 50.0 109.449 177.794 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.453 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 7.0 p -142.24 116.68 9.62 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.196 0.598 . . . . 50.0 111.381 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 44' ' ' VAL . 23.3 t -73.95 139.93 18.53 Favored 'Isoleucine or valine' 0 C--O 1.25 1.111 0 N-CA-C 109.766 -0.457 . . . . 50.0 109.766 176.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.588 HD21 ' HB ' ' A' ' 70' ' ' THR . 80.5 mt -113.02 -45.82 3.15 Favored 'General case' 0 N--CA 1.473 0.711 0 O-C-N 124.681 1.238 . . . . 50.0 109.984 -179.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.54 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 61.8 tp -127.89 145.55 50.91 Favored 'General case' 0 N--CA 1.476 0.874 0 CA-C-N 115.519 -0.764 . . . . 50.0 109.363 -177.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.479 HG22 HD22 ' A' ' 42' ' ' LEU . 69.6 p -129.74 129.48 44.21 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 123.782 0.833 . . . . 50.0 109.189 177.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 37.6 p -126.29 162.63 45.09 Favored Pre-proline 0 CA--C 1.555 1.142 0 C-N-CA 124.618 1.167 . . . . 50.0 108.231 175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 93.2 Cg_exo -47.81 118.31 2.98 Favored 'Trans proline' 0 C--N 1.376 1.992 0 C-N-CA 122.968 2.445 . . . . 50.0 114.261 178.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 39.3 p 61.59 10.92 3.55 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 126.279 1.832 . . . . 50.0 113.972 177.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.421 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -149.09 123.32 9.55 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 118.17 0.441 . . . . 50.0 110.176 -176.357 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.479 HD22 HG22 ' A' ' 37' ' ' THR . 38.0 mt -110.87 124.54 52.27 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.422 -0.584 . . . . 50.0 109.422 -175.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.54 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -85.92 108.63 18.27 Favored 'General case' 0 C--O 1.25 1.095 0 N-CA-C 108.657 -0.868 . . . . 75.0 108.657 175.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.611 HG22 HG22 ' A' ' 34' ' ' VAL . 18.4 t -109.99 146.87 14.77 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.602 0 CA-C-N 114.338 -1.301 . . . . 50.0 108.606 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -69.68 132.78 46.7 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 109.757 -0.46 . . . . 50.0 109.757 174.178 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 100.82 -8.11 57.8 Favored Glycine 0 C--N 1.34 0.754 0 O-C-N 123.528 0.517 . . . . 50.0 111.976 -174.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.557 HG21 HG12 ' A' ' 51' ' ' ILE . 40.6 mm -105.17 150.2 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.837 0 C-N-CA 123.951 0.901 . . . . 50.0 110.403 -179.181 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -57.96 -51.09 71.07 Favored 'General case' 0 C--N 1.359 0.987 0 C-N-CA 124.044 0.938 . . . . 50.0 111.966 -177.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.75 -57.22 0.17 Allowed 'General case' 0 N--CA 1.474 0.771 0 O-C-N 123.248 0.342 . . . . 50.0 111.558 174.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.421 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 20.1 m-90 -142.9 149.89 39.07 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 122.743 0.417 . . . . 50.0 110.959 -178.964 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.557 HG12 HG21 ' A' ' 47' ' ' ILE . 26.8 mm -121.52 128.32 75.81 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.788 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 167.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.6 t-80 -59.97 136.1 57.91 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 122.903 0.481 . . . . 50.0 110.011 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.79 -33.59 49.59 Favored 'General case' 0 N--CA 1.486 1.331 0 N-CA-C 115.009 1.485 . . . . 50.0 115.009 -163.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -66.73 -27.45 67.63 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.396 0.517 . . . . 50.0 112.396 -176.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 -68.76 -25.03 64.52 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 122.648 0.379 . . . . 50.0 111.233 174.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 59.4 t -96.89 125.39 49.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 122.519 0.328 . . . . 50.0 110.444 -168.3 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -106.61 126.23 52.01 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 123.875 0.87 . . . . 75.0 108.809 170.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.554 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -77.68 106.51 9.54 Favored 'General case' 0 C--O 1.239 0.515 0 N-CA-C 109.424 -0.584 . . . . 50.0 109.424 172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -89.88 118.66 29.62 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.791 0.836 . . . . 50.0 109.074 178.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -56.28 116.06 11.6 Favored Pre-proline 0 CA--C 1.557 1.24 0 C-N-CA 123.359 0.663 . . . . 75.0 109.968 176.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -50.75 -43.46 46.23 Favored 'Trans proline' 0 C--N 1.386 2.507 0 C-N-CA 123.897 3.064 . . . . 75.0 112.772 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 67.6 -81.64 0.16 Allowed Glycine 0 C--N 1.356 1.64 0 O-C-N 124.056 0.848 . . . . 75.0 112.469 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -157.01 148.87 19.24 Favored Glycine 0 CA--C 1.524 0.632 0 N-CA-C 110.556 -1.018 . . . . 75.0 110.556 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.401 ' HA2' ' HD3' ' A' ' 65' ' ' PRO . . . 93.49 111.73 2.16 Favored Glycine 0 C--N 1.347 1.187 0 CA-C-O 119.27 -0.739 . . . . 75.0 111.606 -176.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.401 ' HD3' ' HA2' ' A' ' 64' ' ' GLY . 3.5 Cg_exo -82.24 30.97 0.52 Allowed 'Trans proline' 0 C--N 1.37 1.686 0 C-N-CA 123.42 2.746 . . . . 75.0 113.533 -177.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 18.3 m -76.09 6.58 5.12 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.355 1.062 . . . . 75.0 112.384 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 11.8 m -74.58 -1.71 22.73 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 124.411 1.084 . . . . 75.0 112.908 177.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 73.84 87.46 0.1 Allowed 'General case' 0 C--N 1.36 1.042 0 C-N-CA 125.707 1.603 . . . . 75.0 110.009 -172.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 88.5 mt -67.7 93.18 0.37 Allowed 'General case' 0 C--N 1.353 0.733 0 N-CA-C 109.733 -0.469 . . . . 75.0 109.733 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.588 ' HB ' HD21 ' A' ' 35' ' ' LEU . 5.5 m -77.81 149.22 34.44 Favored 'General case' 0 C--O 1.243 0.76 0 N-CA-C 108.812 -0.81 . . . . 75.0 108.812 173.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 37.5 m95 -63.45 144.72 56.74 Favored 'General case' 0 N--CA 1.473 0.719 0 C-N-CA 122.953 0.501 . . . . 75.0 111.063 -172.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.67 ' HA ' HG21 ' A' ' 10' ' ' VAL . 53.6 mtt180 -67.06 92.05 0.23 Allowed 'General case' 0 N--CA 1.468 0.431 0 O-C-N 123.791 0.682 . . . . 75.0 110.868 -176.204 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 59.5 t -62.61 -36.99 77.76 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.522 0 CA-C-N 114.969 -1.014 . . . . 75.0 110.79 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.46 ' HB3' ' HB2' ' A' ' 79' ' ' PRO . 75.7 mt-30 -78.39 80.17 4.79 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.533 0.682 . . . . 75.0 110.977 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -112.67 148.54 34.45 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 114.769 -1.105 . . . . 75.0 108.498 166.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.485 ' HB3' ' HG3' ' A' ' 79' ' ' PRO . 43.0 t -174.0 -66.1 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.385 -1.709 . . . . 75.0 106.385 176.318 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -147.3 -58.5 0.26 Allowed 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 107.946 -1.131 . . . . 75.0 107.946 173.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 19.4 p-10 -157.31 62.24 2.58 Favored Pre-proline 0 CA--C 1.561 1.403 0 C-N-CA 123.836 0.854 . . . . 75.0 110.249 176.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.485 ' HG3' ' HB3' ' A' ' 76' ' ' SER . 9.9 Cg_exo -73.62 -30.73 9.42 Favored 'Trans proline' 0 C--N 1.381 2.276 0 C-N-CA 122.834 2.356 . . . . 75.0 113.175 -174.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.6 mt -83.02 127.97 34.05 Favored 'General case' 0 C--O 1.238 0.456 0 CA-C-N 115.209 -0.905 . . . . 75.0 109.981 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 9.9 mtmp? -88.24 150.84 23.05 Favored 'General case' 0 C--O 1.242 0.687 0 CA-C-N 115.565 -0.743 . . . . 75.0 109.969 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 28.9 pt -90.74 165.94 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 C-N-CA 123.006 0.522 . . . . 75.0 110.893 -179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 58.4 ttt180 -139.12 100.03 3.91 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 108.989 -0.745 . . . . 75.0 108.989 176.388 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 48.2 mt -98.77 132.75 43.9 Favored 'General case' 0 N--CA 1.472 0.67 0 CA-C-N 115.267 -0.879 . . . . 75.0 108.875 -179.123 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 70.7 m 68.59 100.26 0.06 Allowed 'General case' 0 CA--C 1.556 1.173 0 O-C-N 124.299 0.999 . . . . 75.0 111.327 -178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.43 ' HG2' ' N ' ' A' ' 87' ' ' GLU . 50.7 ttt180 -80.32 165.2 22.53 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 123.601 0.76 . . . . 75.0 109.05 169.178 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.43 ' N ' ' HG2' ' A' ' 86' ' ' ARG . 3.2 mp0 -63.17 87.99 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.854 0 C-N-CA 123.73 0.812 . . . . 75.0 110.081 174.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -102.77 126.14 33.62 Favored Pre-proline 0 N--CA 1.473 0.714 0 C-N-CA 123.3 0.64 . . . . 75.0 109.525 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo . . . . . 0 C--N 1.376 1.995 0 C-N-CA 122.945 2.43 . . . . 75.0 112.458 177.803 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 22.8 p80 . . . . . 0 N--CA 1.488 1.443 0 N-CA-C 111.362 0.134 . . . . 75.0 111.362 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 45.6 p-80 -143.93 126.2 15.66 Favored 'General case' 0 CA--C 1.544 0.749 0 CA-C-O 121.405 0.621 . . . . 75.0 109.595 172.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.8 p-80 -156.63 28.27 0.33 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.925 1.29 . . . . 75.0 108.031 175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 10.1 t-80 -88.34 161.77 16.94 Favored 'General case' 0 C--O 1.241 0.628 0 C-N-CA 124.141 0.976 . . . . 75.0 108.712 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 71.13 93.76 0.08 Allowed 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 124.511 1.124 . . . . 75.0 109.602 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 -68.1 127.39 32.72 Favored 'General case' 0 CA--C 1.54 0.571 0 N-CA-C 108.693 -0.855 . . . . 75.0 108.693 177.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 41.1 t -145.74 179.88 7.14 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.902 0.881 . . . . 75.0 111.237 -164.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.3 m170 -70.68 160.14 33.16 Favored 'General case' 0 C--O 1.245 0.862 0 C-N-CA 123.965 0.906 . . . . 75.0 108.68 164.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.0 ptm -59.54 137.93 57.86 Favored 'General case' 0 CA--C 1.545 0.769 0 O-C-N 124.108 0.88 . . . . 75.0 111.273 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.699 HG21 ' HA ' ' A' ' 72' ' ' ARG . 30.7 m -63.97 125.74 21.26 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 N-CA-C 109.439 -0.578 . . . . 50.0 109.439 174.262 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.595 ' HA2' HG23 ' A' ' 33' ' ' THR . . . 108.53 8.5 28.52 Favored Glycine 0 C--N 1.341 0.811 0 CA-C-O 119.296 -0.725 . . . . 50.0 112.484 -172.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.62 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.6 t0 -67.68 113.71 5.7 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 122.938 0.495 . . . . 50.0 109.885 -173.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.492 HG22 ' HB3' ' A' ' 59' ' ' ALA . 91.3 m -77.86 127.23 32.05 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 122.696 0.399 . . . . 50.0 111.236 -175.198 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.402 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 33.6 m -139.22 -178.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 123.84 0.856 . . . . 50.0 109.645 176.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 33.9 m0 -116.7 157.5 25.35 Favored 'General case' 0 C--O 1.244 0.778 0 C-N-CA 124.961 1.304 . . . . 50.0 108.478 169.181 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.9 t -105.38 103.32 15.17 Favored 'Isoleucine or valine' 0 C--O 1.244 0.785 0 N-CA-C 106.463 -1.68 . . . . 50.0 106.463 173.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -78.94 91.03 4.77 Favored 'General case' 0 CA--C 1.542 0.664 0 CA-C-N 114.077 -1.42 . . . . 75.0 108.872 -179.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 47.2 ttt-85 -117.68 148.07 42.33 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.826 0.85 . . . . 75.0 111.73 -171.001 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -175.42 147.91 0.9 Allowed 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 125.857 1.663 . . . . 75.0 107.42 170.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 27.8 mm-40 -83.17 -67.3 0.8 Allowed 'General case' 0 N--CA 1.474 0.772 0 N-CA-C 109.593 -0.521 . . . . 75.0 109.593 178.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 19.5 p -81.75 140.86 34.02 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 123.752 0.821 . . . . 75.0 110.997 -179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -75.7 -20.49 58.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 124.43 1.092 . . . . 75.0 110.825 178.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.2 m-20 -64.22 -35.28 80.29 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.484 0.713 . . . . 75.0 110.346 174.241 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.9 mt -87.35 144.82 26.59 Favored 'General case' 0 C--O 1.241 0.655 0 N-CA-C 109.308 -0.627 . . . . 75.0 109.308 172.099 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -60.98 147.26 86.21 Favored Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.076 0.95 . . . . 75.0 111.236 -177.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -64.98 104.02 0.54 Allowed 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 122.298 1.999 . . . . 50.0 110.752 169.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -83.43 164.55 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.052 -1.092 . . . . 75.0 108.052 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.524 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 60.9 p-90 -130.61 153.92 48.4 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 118.693 0.679 . . . . 50.0 110.521 174.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 49.1 mtmt -126.71 148.23 49.88 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.845 0.858 . . . . 75.0 108.714 169.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.502 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -164.58 -176.63 36.52 Favored Glycine 0 CA--C 1.525 0.669 0 CA-C-O 119.555 -0.58 . . . . 50.0 112.378 177.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -92.89 115.81 2.13 Favored 'Cis proline' 0 CA--C 1.564 1.998 0 CA-C-N 118.91 1.355 . . . . 50.0 112.786 -5.237 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 56.4 m-85 -84.79 154.08 22.59 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.755 0.822 . . . . 50.0 111.918 -179.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.595 HG23 ' HA2' ' A' ' 11' ' ' GLY . 98.3 m -107.08 117.77 34.94 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.694 1.198 . . . . 50.0 110.201 -176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.62 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 46.8 t -95.24 136.52 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 124.119 0.968 . . . . 50.0 109.209 176.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 88.0 mt -111.16 -28.74 8.15 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.766 0.827 . . . . 50.0 110.689 -177.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.633 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 46.4 tp -146.95 144.46 29.23 Favored 'General case' 0 N--CA 1.483 1.192 0 N-CA-C 109.767 -0.457 . . . . 50.0 109.767 -177.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 36.9 p -132.4 128.89 38.53 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.936 0.894 . . . . 50.0 109.63 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.8 p -134.38 158.42 75.23 Favored Pre-proline 0 CA--C 1.555 1.168 0 C-N-CA 123.855 0.862 . . . . 50.0 109.226 173.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_exo -48.16 124.67 10.67 Favored 'Trans proline' 0 C--N 1.385 2.488 0 C-N-CA 123.271 2.647 . . . . 50.0 112.81 175.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 27.4 m 75.34 -13.83 0.82 Allowed 'General case' 0 CA--C 1.561 1.391 0 C-N-CA 125.25 1.42 . . . . 50.0 112.953 175.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -144.39 122.01 11.82 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 121.429 -0.794 . . . . 50.0 110.693 -172.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.479 HD12 HG11 ' A' ' 56' ' ' VAL . 32.0 mt -114.9 123.68 49.76 Favored 'General case' 0 N--CA 1.474 0.726 0 C-N-CA 123.306 0.642 . . . . 50.0 109.343 -178.227 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.633 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.3 tttp -84.46 107.16 16.57 Favored 'General case' 0 C--O 1.254 1.299 0 CA-C-O 121.68 0.752 . . . . 75.0 109.247 178.796 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.604 HG22 HG22 ' A' ' 34' ' ' VAL . 34.5 t -101.81 142.84 15.57 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 CA-C-N 113.963 -1.472 . . . . 50.0 108.047 176.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -60.34 136.54 58.07 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.411 0.684 . . . . 50.0 110.261 174.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.2 -24.32 32.39 Favored Glycine 0 C--N 1.345 1.074 0 O-C-N 123.676 0.61 . . . . 50.0 113.096 -178.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.6 mm -81.66 153.92 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 C-N-CA 123.583 0.753 . . . . 50.0 110.744 -175.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.32 -51.16 56.81 Favored 'General case' 0 C--N 1.363 1.189 0 C-N-CA 125.058 1.343 . . . . 50.0 111.337 179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.08 -56.18 0.14 Allowed 'General case' 0 CA--C 1.539 0.539 0 O-C-N 123.485 0.49 . . . . 50.0 110.53 168.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 6.9 m-90 -141.17 157.1 45.73 Favored 'General case' 0 N--CA 1.488 1.458 0 C-N-CA 122.92 0.488 . . . . 50.0 110.91 -176.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.6 mm -112.99 130.88 66.05 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 C-N-CA 124.83 1.252 . . . . 50.0 107.997 167.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.0 t-80 -58.07 128.44 37.14 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 108.702 -0.851 . . . . 50.0 108.702 174.308 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -58.65 -23.36 58.98 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 114.349 1.241 . . . . 50.0 114.349 -163.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.44 -15.17 61.82 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 122.872 0.469 . . . . 50.0 112.055 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.9 m-70 -100.19 21.18 13.31 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.604 1.162 . . . . 50.0 110.514 173.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG11 HD12 ' A' ' 42' ' ' LEU . 61.2 t -125.47 133.06 70.16 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 108.743 -0.836 . . . . 50.0 108.743 175.104 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -129.81 109.99 11.37 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 108.444 -0.947 . . . . 75.0 108.444 176.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.4 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -57.46 131.86 51.4 Favored 'General case' 0 N--CA 1.484 1.252 0 C-N-CA 124.091 0.956 . . . . 50.0 112.23 -172.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.492 ' HB3' HG22 ' A' ' 13' ' ' THR . . . -119.93 144.72 47.29 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.372 0.669 . . . . 50.0 110.074 -178.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 57.0 t0 -86.28 118.41 70.31 Favored Pre-proline 0 CA--C 1.549 0.932 0 N-CA-C 108.302 -0.999 . . . . 75.0 108.302 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -62.16 -24.63 76.5 Favored 'Trans proline' 0 C--N 1.387 2.591 0 C-N-CA 122.711 2.274 . . . . 75.0 112.374 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . 0.665 ' HA2' ' HB2' ' A' ' 86' ' ' ARG . . . 78.27 68.34 1.51 Allowed Glycine 0 C--N 1.344 1.017 0 O-C-N 124.007 0.817 . . . . 75.0 111.574 -178.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.529 ' HA3' ' HG3' ' A' ' 89' ' ' PRO . . . 82.36 158.8 24.4 Favored Glycine 0 C--N 1.343 0.939 0 O-C-N 124.032 0.489 . . . . 75.0 112.2 -172.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -78.46 113.01 3.59 Favored Glycine 0 CA--C 1.53 1.016 0 CA-C-O 118.393 -1.226 . . . . 75.0 110.234 170.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.411 ' HG2' HD11 ' A' ' 69' ' ' LEU . 31.2 Cg_exo -61.47 142.67 96.01 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.945 2.43 . . . . 75.0 112.963 -176.315 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 20.3 m -66.64 -26.4 67.05 Favored 'General case' 0 CA--C 1.547 0.854 0 O-C-N 123.784 0.677 . . . . 75.0 110.495 174.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 50.3 m -75.81 142.13 42.34 Favored 'General case' 0 C--O 1.242 0.703 0 C-N-CA 124.077 0.951 . . . . 75.0 110.803 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 23.9 tpp180 -74.65 98.96 3.53 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 123.694 0.798 . . . . 75.0 109.131 177.139 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.411 HD11 ' HG2' ' A' ' 65' ' ' PRO . 84.3 mt -64.26 -54.14 38.04 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.592 0.757 . . . . 75.0 110.866 -179.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 12.4 t -157.33 179.73 8.99 Favored 'General case' 0 CA--C 1.545 0.781 0 CA-C-N 115.25 -0.886 . . . . 75.0 109.289 -173.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 61.9 m95 -79.65 153.11 29.58 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.668 0.787 . . . . 75.0 109.874 176.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.699 ' HA ' HG21 ' A' ' 10' ' ' VAL . 61.9 mtp180 -78.96 100.07 7.11 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.141 -1.059 . . . . 75.0 108.141 170.026 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 16.3 t -68.5 -68.31 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.549 0.904 0 C-N-CA 123.047 0.539 . . . . 75.0 109.908 -175.201 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -78.56 72.97 5.12 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.472 -0.936 . . . . 75.0 108.472 170.108 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.0 tmm_? -71.69 89.23 1.01 Allowed 'General case' 0 CA--C 1.546 0.797 0 N-CA-C 108.913 -0.773 . . . . 75.0 108.913 -175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.3 p 176.03 136.8 0.05 Allowed 'General case' 0 C--O 1.245 0.832 0 C-N-CA 125.637 1.575 . . . . 75.0 108.98 -176.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -91.57 72.59 5.94 Favored 'General case' 0 CA--C 1.548 0.898 0 CA-C-O 121.725 0.774 . . . . 75.0 109.263 176.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.448 ' HB3' ' HD3' ' A' ' 79' ' ' PRO . 16.7 t-20 -159.86 -53.56 0.01 OUTLIER Pre-proline 0 CA--C 1.558 1.263 0 CA-C-N 114.705 -1.134 . . . . 75.0 110.477 -177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 78' ' ' ASN . 9.2 Cg_exo -74.19 -42.34 0.74 Allowed 'Trans proline' 0 C--N 1.398 3.167 0 C-N-CA 121.943 1.762 . . . . 75.0 111.71 174.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 84.3 mt -73.38 127.08 31.68 Favored 'General case' 0 CA--C 1.539 0.555 0 O-C-N 123.778 0.674 . . . . 75.0 111.337 -176.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 33.3 mmtp -106.19 119.79 40.15 Favored 'General case' 0 C--O 1.241 0.65 0 C-N-CA 124.105 0.962 . . . . 75.0 108.885 171.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.2 pt -67.72 143.71 15.12 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 CA-C-N 115.538 -0.756 . . . . 75.0 110.542 179.177 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 57.7 ttt180 -109.02 137.53 46.8 Favored 'General case' 0 C--O 1.24 0.558 0 C-N-CA 123.92 0.888 . . . . 75.0 109.576 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.75 120.74 14.02 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 123.401 0.68 . . . . 75.0 109.925 179.292 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -114.42 178.11 4.4 Favored 'General case' 0 CA--C 1.547 0.855 0 C-N-CA 124.107 0.963 . . . . 75.0 110.049 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.665 ' HB2' ' HA2' ' A' ' 62' ' ' GLY . 53.5 mtp85 -63.9 105.21 0.8 Allowed 'General case' 0 N--CA 1.476 0.837 0 CA-C-O 120.541 0.21 . . . . 75.0 110.953 175.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -65.7 121.69 15.56 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 107.765 -1.198 . . . . 75.0 107.765 161.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.14 84.54 0.17 Allowed Pre-proline 0 CA--C 1.555 1.173 0 C-N-CA 124.933 1.293 . . . . 75.0 109.776 -169.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.529 ' HG3' ' HA3' ' A' ' 63' ' ' GLY . 97.8 Cg_exo . . . . . 0 C--N 1.384 2.404 0 C-N-CA 123.912 3.075 . . . . 75.0 113.107 173.507 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 109.89 -0.411 . . . . 75.0 109.89 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 82.7 t60 -74.88 150.59 39.13 Favored 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 124.353 1.061 . . . . 75.0 110.188 177.142 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -56.95 112.31 1.29 Allowed 'General case' 0 N--CA 1.478 0.948 0 C-N-CA 124.585 1.154 . . . . 75.0 111.024 173.892 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 67.8 m-70 -78.71 161.78 26.64 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.299 0.639 . . . . 75.0 110.184 178.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 23.3 t-80 -141.79 5.59 1.77 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.696 0.798 . . . . 75.0 109.198 169.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -156.74 108.19 2.42 Favored 'General case' 0 C--N 1.356 0.852 0 C-N-CA 123.724 0.81 . . . . 75.0 109.614 -178.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 46.8 m -92.53 -168.95 2.08 Favored 'General case' 0 C--O 1.246 0.895 0 C-N-CA 124.092 0.957 . . . . 75.0 108.675 167.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 9.4 m-70 -54.94 127.48 28.97 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.594 -0.891 . . . . 75.0 108.594 164.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.3 ptp -59.05 132.84 55.24 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 124.275 0.985 . . . . 75.0 110.511 -176.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.54 HG11 ' HB ' ' A' ' 73' ' ' VAL . 35.9 m -63.25 135.58 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.613 0 C-N-CA 124.748 1.219 . . . . 50.0 110.277 -177.19 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.717 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 94.33 11.12 57.63 Favored Glycine 0 C--N 1.342 0.875 0 CA-C-O 119.222 -0.766 . . . . 50.0 113.504 -171.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.773 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -51.66 113.22 0.92 Allowed 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.184 0.994 . . . . 50.0 111.342 -176.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.432 HG22 ' HB3' ' A' ' 59' ' ' ALA . 23.3 m -72.85 108.2 5.68 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 123.188 0.595 . . . . 50.0 110.289 -169.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.481 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 34.3 m -132.39 179.86 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.04 0 C-N-CA 124.19 0.996 . . . . 50.0 110.791 -178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.428 ' CD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -129.99 154.13 47.7 Favored 'General case' 0 N--CA 1.471 0.614 0 C-N-CA 125.407 1.483 . . . . 50.0 108.23 177.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 85.5 t -109.5 104.56 17.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 CA-C-O 121.625 0.726 . . . . 50.0 109.536 177.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 48.9 ttt180 -81.95 104.92 12.65 Favored 'General case' 0 CA--C 1.552 1.043 0 C-N-CA 125.883 1.673 . . . . 75.0 109.652 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 46.3 ttm105 -128.51 133.29 48.41 Favored 'General case' 0 N--CA 1.484 1.267 0 O-C-N 121.608 -0.682 . . . . 75.0 112.13 -172.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -124.23 141.95 51.64 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 124.868 1.267 . . . . 75.0 108.994 176.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.597 ' HB2' HD12 ' A' ' 24' ' ' LEU . 14.7 mm100 -67.39 -44.96 77.59 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 122.855 0.462 . . . . 75.0 110.299 177.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 14.0 t -137.64 171.61 14.2 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.587 0.755 . . . . 75.0 109.303 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 40.6 mtmt -56.95 -43.41 81.51 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.444 1.098 . . . . 75.0 111.622 -174.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 12.3 t30 -76.14 -27.38 57.0 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 124.205 1.002 . . . . 75.0 111.817 -173.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.597 HD12 ' HB2' ' A' ' 20' ' ' GLN . 70.8 mt -75.45 148.17 39.28 Favored 'General case' 0 N--CA 1.482 1.161 0 CA-C-O 120.695 0.283 . . . . 75.0 111.053 175.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.447 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 40.2 mt-10 -61.46 128.55 90.08 Favored Pre-proline 0 CA--C 1.548 0.877 0 C-N-CA 124.47 1.108 . . . . 75.0 111.047 -179.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 25' ' ' GLU . 8.7 Cg_exo -72.71 84.05 1.28 Allowed 'Trans proline' 0 C--N 1.375 1.929 0 C-N-CA 123.067 2.512 . . . . 50.0 111.138 175.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 12.0 ttm180 -71.93 116.34 12.22 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 124.275 1.03 . . . . 75.0 109.929 -173.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 63.7 p-90 -81.77 141.83 33.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 122.99 0.516 . . . . 50.0 110.452 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -113.04 158.16 20.66 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.464 -0.939 . . . . 75.0 108.464 170.339 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.428 ' HA3' ' CD1' ' A' ' 15' ' ' TRP . . . -173.63 170.21 43.34 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 121.015 -0.612 . . . . 50.0 113.589 179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -84.02 160.85 70.11 Favored 'Cis proline' 0 C--N 1.376 1.985 0 C-N-CA 123.93 -1.279 . . . . 50.0 112.978 -5.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.405 ' HB3' HG11 ' A' ' 44' ' ' VAL . 79.7 m-85 -129.8 164.02 24.97 Favored 'General case' 0 N--CA 1.477 0.882 0 C-N-CA 125.028 1.331 . . . . 50.0 109.361 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.717 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 57.6 p -137.05 111.7 8.72 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.516 0.726 . . . . 50.0 110.566 -174.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.773 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 48.8 t -79.12 119.24 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 C-N-CA 123.532 0.733 . . . . 50.0 109.427 179.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 77.9 mt -90.34 -21.11 22.18 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 123.553 0.741 . . . . 50.0 110.983 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.423 HD22 HD13 ' A' ' 80' ' ' LEU . 62.5 tp -156.11 140.2 16.43 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.622 0.369 . . . . 50.0 110.786 177.225 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.629 HG22 HD22 ' A' ' 42' ' ' LEU . 40.2 p -107.38 128.9 54.88 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.511 0.725 . . . . 50.0 109.877 174.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.441 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.3 p -125.82 165.18 28.54 Favored Pre-proline 0 CA--C 1.558 1.287 0 C-N-CA 124.382 1.073 . . . . 50.0 109.018 -179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.441 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.2 Cg_endo -49.83 116.76 2.56 Favored 'Trans proline' 0 C--N 1.392 2.86 0 C-N-CA 123.134 2.556 . . . . 50.0 112.194 179.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.8 t 54.74 17.22 1.65 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.996 2.118 . . . . 50.0 114.533 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.487 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -148.55 140.57 23.93 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 122.973 0.509 . . . . 50.0 110.054 -178.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.701 HD12 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -115.11 123.0 47.83 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.023 0.529 . . . . 50.0 109.69 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -85.51 108.48 17.95 Favored 'General case' 0 C--O 1.249 1.053 0 N-CA-C 108.504 -0.924 . . . . 75.0 108.504 177.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.626 HG22 HG22 ' A' ' 34' ' ' VAL . 55.0 t -110.13 143.36 20.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.666 0 C-N-CA 124.675 1.19 . . . . 50.0 109.938 -172.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -62.9 135.27 57.22 Favored 'General case' 0 N--CA 1.477 0.881 0 C-N-CA 124.452 1.101 . . . . 50.0 110.231 173.701 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 89.92 -21.99 27.72 Favored Glycine 0 C--N 1.345 1.066 0 C-N-CA 123.195 0.426 . . . . 50.0 112.991 -179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.46 HG21 HG12 ' A' ' 51' ' ' ILE . 40.2 mm -82.18 153.81 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.81 0 C-N-CA 124.551 1.14 . . . . 50.0 109.707 177.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.73 -51.89 68.04 Favored 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 123.186 0.594 . . . . 50.0 111.407 -178.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.42 -60.72 0.17 Allowed 'General case' 0 N--CA 1.48 1.025 0 N-CA-C 112.133 0.42 . . . . 50.0 112.133 175.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.487 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.5 m-90 -143.34 138.54 29.54 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 122.876 0.47 . . . . 50.0 110.944 -175.867 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.46 HG12 HG21 ' A' ' 47' ' ' ILE . 42.9 mm -103.76 117.09 48.71 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 N-CA-C 106.976 -1.49 . . . . 50.0 106.976 164.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.2 t-80 -58.7 145.51 39.86 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 109.514 -0.55 . . . . 50.0 109.514 178.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -52.58 -34.82 52.33 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 124.853 1.261 . . . . 50.0 113.726 -169.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -58.4 -24.96 61.51 Favored 'General case' 0 N--CA 1.491 1.584 0 C-N-CA 124.198 0.999 . . . . 50.0 113.035 178.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 95.6 m-70 -107.31 24.56 12.66 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 124.5 1.12 . . . . 50.0 110.708 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.701 HG11 HD12 ' A' ' 42' ' ' LEU . 24.9 t -128.28 149.45 33.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 N-CA-C 109.655 -0.498 . . . . 50.0 109.655 178.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 39.5 ttmt -133.77 122.65 23.61 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.26 -1.015 . . . . 75.0 108.26 166.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -61.77 109.77 1.33 Allowed 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.477 0.711 . . . . 50.0 109.69 176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.481 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . -85.36 142.7 29.12 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 123.767 0.827 . . . . 50.0 110.223 -175.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 57.3 t0 -72.92 116.92 55.26 Favored Pre-proline 0 CA--C 1.548 0.872 0 N-CA-C 108.935 -0.765 . . . . 75.0 108.935 176.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_exo -73.08 -5.12 16.64 Favored 'Trans proline' 0 C--N 1.375 1.938 0 C-N-CA 122.473 2.115 . . . . 75.0 112.849 177.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 80.94 13.26 81.55 Favored Glycine 0 C--N 1.349 1.266 0 CA-C-N 116.445 -0.343 . . . . 75.0 112.349 -176.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 155.15 -76.06 0.22 Allowed Glycine 0 C--N 1.349 1.285 0 N-CA-C 110.398 -1.081 . . . . 75.0 110.398 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.0 126.59 0.95 Allowed Glycine 0 C--N 1.343 0.937 0 CA-C-O 118.79 -1.006 . . . . 75.0 111.618 177.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.428 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 67.7 Cg_endo -83.78 5.49 6.33 Favored 'Trans proline' 0 C--N 1.376 1.978 0 C-N-CA 123.083 2.522 . . . . 75.0 112.324 -178.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 35.0 p -47.14 -49.71 21.78 Favored 'General case' 0 C--N 1.36 1.034 0 C-N-CA 126.462 1.905 . . . . 75.0 113.366 -171.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 31.4 t -65.56 -20.43 66.32 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 123.485 0.714 . . . . 75.0 112.317 -176.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 53.1 mtp180 -111.01 -2.77 15.8 Favored 'General case' 0 N--CA 1.476 0.833 0 C-N-CA 123.847 0.859 . . . . 75.0 112.835 -176.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.428 ' HG ' ' O ' ' A' ' 65' ' ' PRO . 97.4 mt -70.05 88.87 0.6 Allowed 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 118.509 0.595 . . . . 75.0 110.331 179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 68.9 p -79.59 -15.62 57.33 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.672 0.789 . . . . 75.0 111.465 -178.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 11.5 m-90 -58.89 130.56 47.58 Favored 'General case' 0 C--N 1.35 0.59 0 O-C-N 123.689 0.618 . . . . 75.0 109.644 173.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.429 ' HB2' ' HG3' ' A' ' 75' ' ' ARG . 12.3 ptp180 -125.35 78.84 1.76 Allowed 'General case' 0 CA--C 1.54 0.585 0 CA-C-O 122.028 0.918 . . . . 75.0 109.244 178.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.54 ' HB ' HG11 ' A' ' 10' ' ' VAL . 21.5 t -106.86 150.71 9.17 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.238 0 CA-C-N 114.759 -1.109 . . . . 75.0 108.586 177.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.507 ' HB2' HD12 ' A' ' 80' ' ' LEU . 45.8 tt0 65.51 40.65 4.5 Favored 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.467 1.507 . . . . 75.0 111.067 -178.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.429 ' HG3' ' HB2' ' A' ' 72' ' ' ARG . 10.9 mmm180 -100.44 64.04 1.13 Allowed 'General case' 0 N--CA 1.482 1.14 0 CA-C-O 121.37 0.605 . . . . 75.0 111.273 -174.408 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 27.7 p -172.83 -168.74 0.51 Allowed 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 124.767 1.227 . . . . 75.0 108.774 176.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.1 tt0 -74.79 79.35 2.08 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-O 121.162 0.506 . . . . 75.0 110.574 -178.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.517 ' N ' HD22 ' A' ' 78' ' ' ASN . 0.7 OUTLIER 49.8 66.0 6.2 Favored Pre-proline 0 CA--C 1.556 1.197 0 C-N-CA 125.525 1.53 . . . . 75.0 112.17 176.673 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 77.7 Cg_endo -73.03 -21.91 20.13 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 122.459 2.106 . . . . 75.0 112.014 179.18 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.507 HD12 ' HB2' ' A' ' 74' ' ' GLN . 78.7 mt -113.97 99.75 7.89 Favored 'General case' 0 C--O 1.238 0.493 0 C-N-CA 124.253 1.021 . . . . 75.0 108.485 -177.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 46.9 mmtm -75.37 91.51 2.72 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.921 -0.581 . . . . 75.0 109.71 -179.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 29.4 pt -72.36 87.78 0.42 Allowed 'Isoleucine or valine' 0 CA--C 1.551 0.99 0 CA-C-N 115.433 -0.803 . . . . 75.0 110.486 177.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -73.57 92.7 1.95 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.427 0.632 . . . . 75.0 110.164 -179.714 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 69.0 mt -82.59 155.93 24.2 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 115.762 -0.654 . . . . 75.0 109.843 177.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 33.0 m -57.06 128.22 35.87 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 124.068 0.947 . . . . 75.0 111.404 -176.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 39.1 ttp180 -71.34 141.37 50.43 Favored 'General case' 0 C--O 1.244 0.768 0 C-N-CA 123.954 0.901 . . . . 75.0 110.133 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.3 155.17 41.03 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 109.076 -0.713 . . . . 75.0 109.076 169.555 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 54.37 74.25 0.77 Allowed Pre-proline 0 CA--C 1.554 1.134 0 C-N-CA 124.279 1.031 . . . . 75.0 110.97 -172.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_exo . . . . . 0 C--N 1.376 1.987 0 C-N-CA 123.152 2.568 . . . . 75.0 111.75 176.61 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.6 t60 . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 109.44 -0.578 . . . . 75.0 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 19.5 p80 -157.85 148.83 21.12 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.798 0.839 . . . . 75.0 109.178 174.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 57.6 m170 -84.35 179.65 7.39 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.514 0.726 . . . . 75.0 111.539 -175.622 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.563 ' HB2' ' HD2' ' A' ' 79' ' ' PRO . 14.8 m170 -146.59 -160.78 1.2 Allowed 'General case' 0 N--CA 1.481 1.075 0 C-N-CA 124.585 1.154 . . . . 75.0 109.962 -178.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 34.9 t60 -57.41 135.98 56.59 Favored 'General case' 0 C--N 1.357 0.899 0 C-N-CA 124.71 1.204 . . . . 75.0 110.811 178.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 76.1 t60 -61.42 117.54 5.81 Favored 'General case' 0 CA--C 1.544 0.725 0 C-N-CA 123.583 0.753 . . . . 75.0 110.483 177.469 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 27.5 p -99.91 -171.7 2.1 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 124.555 1.142 . . . . 75.0 109.181 173.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.5 m-70 -61.24 133.15 55.6 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 108.235 -1.024 . . . . 75.0 108.235 167.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -63.48 134.08 55.02 Favored 'General case' 0 CA--C 1.539 0.557 0 O-C-N 123.968 0.793 . . . . 75.0 110.414 -176.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 72' ' ' ARG . 6.5 m -61.3 108.45 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 N-CA-C 108.251 -1.018 . . . . 50.0 108.251 168.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.576 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.19 9.69 11.61 Favored Glycine 0 CA--C 1.525 0.715 0 CA-C-O 119.262 -0.743 . . . . 50.0 113.005 -170.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.668 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.2 t0 -59.77 113.76 2.43 Favored 'General case' 0 N--CA 1.488 1.438 0 C-N-CA 123.13 0.572 . . . . 50.0 109.556 179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 88.7 m -72.56 114.1 10.32 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.414 -0.587 . . . . 50.0 109.414 -172.119 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.516 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.13 176.57 5.94 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 124.906 1.282 . . . . 50.0 109.743 -176.622 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.407 ' CE3' ' HD2' ' A' ' 57' ' ' LYS . 47.9 m0 -125.01 148.85 48.27 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 106.935 -1.506 . . . . 50.0 106.935 171.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 91.6 t -108.19 104.77 17.61 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.734 0 N-CA-C 108.779 -0.823 . . . . 50.0 108.779 176.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 42.7 ttm180 -69.16 93.72 0.63 Allowed 'General case' 0 CA--C 1.547 0.853 0 C-N-CA 124.636 1.175 . . . . 75.0 109.496 174.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 31.7 ttt180 -87.45 119.72 28.01 Favored 'General case' 0 C--O 1.244 0.802 0 CA-C-N 116.052 -0.522 . . . . 75.0 109.803 -176.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -98.53 109.28 22.07 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.856 0.862 . . . . 75.0 109.313 -179.842 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.1 mm100 -74.09 -70.9 0.36 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 122.92 0.488 . . . . 75.0 110.685 179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 70.5 p -117.09 156.11 28.13 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.292 0.637 . . . . 75.0 109.94 179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 45.9 mtmt -72.08 -28.15 63.13 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.023 0.929 . . . . 75.0 111.026 178.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.7 m120 -72.17 -35.67 69.06 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.139 0.576 . . . . 75.0 111.299 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.5 mt -100.04 161.42 13.62 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.128 0.571 . . . . 75.0 110.783 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -74.37 152.25 87.81 Favored Pre-proline 0 CA--C 1.552 1.031 0 CA-C-N 115.311 -0.859 . . . . 75.0 110.459 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.436 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 98.6 Cg_endo -77.64 146.81 24.36 Favored 'Trans proline' 0 C--N 1.369 1.626 0 C-N-CA 122.363 2.042 . . . . 50.0 111.848 173.552 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 55.7 ttm-85 -117.35 130.18 56.35 Favored 'General case' 0 C--O 1.24 0.558 0 N-CA-C 109.087 -0.709 . . . . 75.0 109.087 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.534 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 60.9 p-90 -76.67 149.17 36.48 Favored 'General case' 0 C--O 1.24 0.558 0 CA-C-O 121.101 0.477 . . . . 50.0 110.024 178.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 24.6 mtpp -126.73 141.06 51.95 Favored 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 107.529 -1.286 . . . . 75.0 107.529 171.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.97 175.4 47.48 Favored Glycine 0 CA--C 1.53 1.009 0 CA-C-O 119.4 -0.667 . . . . 50.0 113.12 -178.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -89.77 120.16 4.31 Favored 'Cis proline' 0 C--N 1.377 2.063 0 CA-C-N 119.112 1.456 . . . . 50.0 114.14 4.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -87.83 179.33 6.49 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.7 1.2 . . . . 50.0 111.512 171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.576 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 41.4 p -138.81 113.75 9.29 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 123.944 0.898 . . . . 50.0 111.096 -177.265 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.668 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.8 t -68.09 122.76 19.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.885 0 C-N-CA 123.113 0.565 . . . . 50.0 109.89 170.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.571 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 67.7 mt -93.87 -26.23 16.99 Favored 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 115.145 -0.934 . . . . 50.0 110.523 174.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.643 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 67.7 tp -152.29 144.04 23.6 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 121.254 0.549 . . . . 50.0 111.402 -175.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 97.6 m -110.29 145.82 36.74 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.2 1.0 . . . . 50.0 109.199 173.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 9.2 p -146.58 162.38 34.29 Favored Pre-proline 0 C--O 1.25 1.079 0 C-N-CA 124.717 1.207 . . . . 50.0 108.777 -178.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.483 ' HD3' ' HB2' ' A' ' 83' ' ' ARG . 9.5 Cg_endo -53.27 108.85 0.3 Allowed 'Trans proline' 0 C--N 1.379 2.166 0 C-N-CA 122.629 2.219 . . . . 50.0 112.728 177.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 65.61 23.48 11.7 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 125.864 1.666 . . . . 50.0 112.137 177.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.535 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -153.42 158.89 42.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.054 0.454 . . . . 50.0 110.957 -178.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -138.8 123.63 18.76 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.569 1.148 . . . . 50.0 108.326 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.1 tttp -84.25 109.61 17.91 Favored 'General case' 0 C--O 1.236 0.352 0 N-CA-C 107.903 -1.147 . . . . 75.0 107.903 170.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 97.3 t -92.62 156.67 3.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.908 0 CA-C-N 114.415 -1.266 . . . . 50.0 108.603 173.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -59.55 134.08 56.68 Favored 'General case' 0 C--O 1.241 0.639 0 C-N-CA 123.932 0.893 . . . . 50.0 110.094 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 86.12 -8.53 73.29 Favored Glycine 0 C--N 1.344 1.013 0 CA-C-O 119.42 -0.655 . . . . 50.0 113.682 179.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.0 mm -85.83 144.98 8.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.991 0 CA-C-N 117.739 0.77 . . . . 50.0 110.188 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.23 -50.09 70.32 Favored 'General case' 0 C--N 1.358 0.936 0 C-N-CA 125.115 1.366 . . . . 50.0 111.79 -176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -148.91 -58.39 0.22 Allowed 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 111.728 0.27 . . . . 50.0 111.728 173.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.535 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 8.6 m-90 -144.76 157.54 44.14 Favored 'General case' 0 N--CA 1.487 1.378 0 CA-C-O 121.161 0.505 . . . . 50.0 111.752 -177.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.8 mm -121.65 129.39 75.55 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.667 0 N-CA-C 107.027 -1.471 . . . . 50.0 107.027 166.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.2 t-80 -55.46 127.67 30.72 Favored 'General case' 0 N--CA 1.48 1.039 0 N-CA-C 108.596 -0.89 . . . . 50.0 108.596 177.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.64 -38.66 55.74 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 124.937 1.295 . . . . 50.0 113.856 -164.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.23 -4.01 19.7 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 113.467 0.914 . . . . 50.0 113.467 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 84.7 m-70 -97.56 15.69 22.57 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 124.148 0.979 . . . . 50.0 110.397 170.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 60.3 t -132.99 130.37 58.38 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.925 0 C-N-CA 123.292 0.637 . . . . 50.0 109.564 -178.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.407 ' HD2' ' CE3' ' A' ' 15' ' ' TRP . 25.0 ttmm -112.47 122.07 46.64 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 123.712 0.805 . . . . 75.0 109.094 175.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.516 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -65.63 126.79 29.48 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 109.911 -0.403 . . . . 50.0 109.911 176.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -112.04 145.01 40.45 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 123.955 0.902 . . . . 50.0 109.895 -179.106 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 65.6 t0 -89.64 112.97 54.94 Favored Pre-proline 0 CA--C 1.55 0.954 0 C-N-CA 123.574 0.75 . . . . 75.0 109.145 177.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -72.85 -9.56 23.86 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.795 2.33 . . . . 75.0 112.769 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 116.41 30.01 2.16 Favored Glycine 0 C--N 1.345 1.068 0 C-N-CA 123.577 0.608 . . . . 75.0 111.735 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 119.63 -51.4 0.77 Allowed Glycine 0 C--N 1.35 1.309 0 N-CA-C 110.925 -0.87 . . . . 75.0 110.925 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 160.84 -89.64 0.11 Allowed Glycine 0 C--N 1.347 1.169 0 N-CA-C 110.793 -0.923 . . . . 75.0 110.793 179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_endo -81.59 31.44 0.51 Allowed 'Trans proline' 0 C--N 1.38 2.199 0 C-N-CA 123.204 2.603 . . . . 75.0 113.27 178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 16.0 p -73.52 -26.79 61.03 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.704 0.801 . . . . 75.0 110.71 174.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 43.8 t -91.15 -77.05 0.43 Allowed 'General case' 0 CA--C 1.545 0.762 0 C-N-CA 123.671 0.789 . . . . 75.0 109.011 173.602 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 87.7 mtt180 -148.72 172.73 14.13 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.126 0.971 . . . . 75.0 110.004 -177.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 96.0 mt -82.48 136.01 34.99 Favored 'General case' 0 C--O 1.24 0.578 0 N-CA-C 109.304 -0.628 . . . . 75.0 109.304 171.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.478 ' HB ' ' O ' ' A' ' 10' ' ' VAL . 65.0 p -79.06 127.55 32.14 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 123.59 0.756 . . . . 75.0 110.591 -176.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 72.2 m95 -72.86 126.72 30.6 Favored 'General case' 0 N--CA 1.478 0.962 0 N-CA-C 109.098 -0.704 . . . . 75.0 109.098 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.622 ' HA ' HG21 ' A' ' 10' ' ' VAL . 23.1 ptt-85 -80.53 58.76 3.3 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.533 1.133 . . . . 75.0 112.134 -171.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 30.8 m -60.35 -28.74 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 C-N-CA 124.069 0.948 . . . . 75.0 112.807 -172.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.1 mm-40 -131.98 18.6 4.58 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 123.378 0.671 . . . . 75.0 110.904 177.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.447 ' HD3' ' HB3' ' A' ' 79' ' ' PRO . 75.2 mmt-85 -122.52 6.21 9.54 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 122.987 0.515 . . . . 75.0 111.421 -178.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.1 m -73.25 -33.35 65.24 Favored 'General case' 0 N--CA 1.481 1.098 0 C-N-CA 123.08 0.552 . . . . 75.0 111.329 176.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 28.0 pt20 -163.73 134.23 4.39 Favored 'General case' 0 C--O 1.239 0.539 0 C-N-CA 123.67 0.788 . . . . 75.0 109.527 -177.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 11.2 m-20 45.01 68.6 3.14 Favored Pre-proline 0 N--CA 1.482 1.174 0 C-N-CA 125.155 1.382 . . . . 75.0 112.646 178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.563 ' HD2' ' HB2' ' A' ' 4' ' ' HIS . 53.1 Cg_exo -58.44 121.01 9.26 Favored 'Trans proline' 0 C--N 1.377 2.069 0 C-N-CA 122.752 2.301 . . . . 75.0 111.804 177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.401 ' HB2' HD13 ' A' ' 36' ' ' LEU . 60.9 mt -53.0 123.77 12.49 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 124.405 1.065 . . . . 75.0 110.112 -178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.4 mmmm -73.84 140.26 45.65 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.466 0.706 . . . . 75.0 111.205 -167.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.1 pt -110.04 154.33 11.58 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 115.51 -0.768 . . . . 75.0 110.817 -169.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . 0.483 ' HB2' ' HD3' ' A' ' 39' ' ' PRO . 72.2 mtp180 -138.47 164.25 29.86 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 123.925 0.89 . . . . 75.0 109.909 169.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 55.9 mt 51.6 61.39 3.25 Favored 'General case' 0 C--N 1.355 0.84 0 C-N-CA 125.17 1.388 . . . . 75.0 110.329 -176.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 81.6 m -73.49 81.88 1.46 Allowed 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 113.793 -1.549 . . . . 75.0 109.721 -179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 85.1 mtt180 -84.55 98.37 10.1 Favored 'General case' 0 C--O 1.238 0.494 0 CA-C-N 114.625 -1.17 . . . . 75.0 109.359 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -63.39 107.09 1.02 Allowed 'General case' 0 C--N 1.352 0.675 0 N-CA-C 107.868 -1.16 . . . . 75.0 107.868 172.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 61.86 91.44 0.08 OUTLIER Pre-proline 0 CA--C 1.549 0.939 0 C-N-CA 123.963 0.905 . . . . 75.0 109.52 -165.762 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo . . . . . 0 C--N 1.376 2.002 0 C-N-CA 123.212 2.608 . . . . 75.0 112.856 -177.747 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.2 m-70 . . . . . 0 N--CA 1.481 1.101 0 N-CA-C 109.424 -0.584 . . . . 75.0 109.424 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -133.91 135.92 43.93 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.59 0.756 . . . . 75.0 109.368 179.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 75' ' ' ARG . 46.5 m80 -141.51 155.28 45.82 Favored 'General case' 0 N--CA 1.476 0.856 0 C-N-CA 123.61 0.764 . . . . 75.0 110.013 -176.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . 0.508 ' HA ' ' HD3' ' A' ' 72' ' ' ARG . 82.8 t60 -89.15 161.83 16.27 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.396 0.679 . . . . 75.0 110.475 173.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 10.7 t-80 -133.27 129.28 37.4 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 123.38 0.672 . . . . 75.0 109.675 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 93.8 m-70 -84.73 93.02 8.35 Favored 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 109.688 -0.486 . . . . 75.0 109.688 178.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 89.1 p -166.56 -175.76 3.3 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.338 0.655 . . . . 75.0 110.5 -176.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.2 t60 -59.21 101.97 0.12 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 107.415 -1.328 . . . . 75.0 107.415 164.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.5 ptp -73.88 170.65 14.92 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.481 1.112 . . . . 75.0 112.853 -165.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.674 HG21 ' H ' ' A' ' 72' ' ' ARG . 33.0 m -70.96 142.6 15.39 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.806 0 CA-C-N 114.949 -1.023 . . . . 50.0 110.425 176.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.67 9.37 81.37 Favored Glycine 0 C--N 1.343 0.938 0 CA-C-O 118.79 -1.005 . . . . 50.0 114.28 176.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 51.9 t0 -67.43 124.66 23.81 Favored 'General case' 0 N--CA 1.487 1.382 0 CA-C-N 118.447 1.124 . . . . 50.0 110.249 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 29.5 m -71.61 114.4 9.65 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.13 0.572 . . . . 50.0 110.739 -169.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.523 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.9 m -135.98 178.47 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 C-N-CA 124.28 1.032 . . . . 50.0 110.621 -179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.409 ' HE3' ' HD3' ' A' ' 57' ' ' LYS . 34.5 m0 -126.77 153.2 45.87 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.9 1.28 . . . . 50.0 108.348 174.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.7 t -108.16 105.19 18.33 Favored 'Isoleucine or valine' 0 C--O 1.243 0.726 0 N-CA-C 107.439 -1.319 . . . . 50.0 107.439 173.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.689 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 76.2 ttt180 -81.12 92.36 6.26 Favored 'General case' 0 CA--C 1.549 0.917 0 CA-C-N 114.91 -1.041 . . . . 75.0 109.821 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 37.4 ttt180 -82.87 119.98 25.08 Favored 'General case' 0 C--O 1.243 0.742 0 CA-C-N 115.421 -0.809 . . . . 75.0 110.316 -176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.445 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 80.8 t60 -84.42 108.87 17.47 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-N 115.431 -0.804 . . . . 75.0 109.101 175.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.4 mm100 -66.24 -72.51 0.16 Allowed 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 123.42 0.688 . . . . 75.0 111.069 -178.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 68.4 m -127.1 154.11 45.14 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 124.209 1.003 . . . . 75.0 108.309 -177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 34.8 mtmm -60.9 -37.83 83.61 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 124.026 0.93 . . . . 75.0 111.752 -176.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.5 m120 -87.82 9.63 21.23 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 123.117 0.567 . . . . 75.0 112.193 178.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 86.4 mt -121.72 168.49 11.75 Favored 'General case' 0 N--CA 1.482 1.174 0 C-N-CA 124.026 0.93 . . . . 75.0 109.836 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -80.87 148.85 65.86 Favored Pre-proline 0 CA--C 1.553 1.073 0 CA-C-N 115.708 -0.678 . . . . 75.0 111.278 -177.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.445 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 5.5 Cg_exo -75.57 109.83 2.98 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 122.892 2.395 . . . . 50.0 111.3 169.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 35.4 ttt180 -91.4 127.63 36.91 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.307 0.643 . . . . 75.0 110.42 -177.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.689 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 61.9 p-90 -74.01 150.06 40.91 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 122.977 0.511 . . . . 50.0 110.887 177.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 65.6 mttm -133.29 143.99 49.4 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 124.091 0.957 . . . . 75.0 108.624 175.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.9 -177.08 25.27 Favored Glycine 0 CA--C 1.535 1.342 0 N-CA-C 111.603 -0.599 . . . . 50.0 111.603 179.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -85.16 121.65 6.83 Favored 'Cis proline' 0 C--N 1.37 1.664 0 CA-C-N 119.564 1.682 . . . . 50.0 111.855 -9.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 79.9 m-85 -106.99 170.2 8.09 Favored 'General case' 0 N--CA 1.486 1.329 0 C-N-CA 123.522 0.729 . . . . 50.0 110.003 176.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.52 HG21 ' HB3' ' A' ' 65' ' ' PRO . 17.7 p -150.81 115.79 5.29 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 123.157 0.583 . . . . 50.0 111.498 -171.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 85.0 t -66.67 127.9 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.133 0 C-N-CA 123.104 0.562 . . . . 50.0 111.49 175.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 77.2 mt -95.49 -38.31 10.5 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.492 1.117 . . . . 50.0 110.475 172.258 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.563 HD22 HD13 ' A' ' 80' ' ' LEU . 38.4 tp -145.24 149.22 34.51 Favored 'General case' 0 N--CA 1.487 1.422 0 C-N-CA 123.445 0.698 . . . . 50.0 110.06 -178.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.456 HG22 HD22 ' A' ' 42' ' ' LEU . 37.1 p -112.97 130.4 56.14 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.744 0.818 . . . . 50.0 109.337 171.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 59.4 m -127.54 148.54 67.02 Favored Pre-proline 0 CA--C 1.554 1.107 0 N-CA-C 107.497 -1.297 . . . . 50.0 107.497 176.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_endo -47.51 117.43 2.34 Favored 'Trans proline' 0 C--N 1.384 2.413 0 C-N-CA 122.624 2.216 . . . . 50.0 113.031 173.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.8 m 75.58 -2.28 2.83 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 125.514 1.525 . . . . 50.0 112.812 175.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.507 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -149.35 121.87 8.54 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 121.821 -0.549 . . . . 50.0 110.586 -173.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.456 HD22 HG22 ' A' ' 37' ' ' THR . 46.0 mt -108.75 125.23 51.7 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 122.927 0.491 . . . . 50.0 109.676 -178.246 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.459 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 23.7 ttmm -83.91 110.89 18.76 Favored 'General case' 0 N--CA 1.467 0.386 0 N-CA-C 108.862 -0.792 . . . . 75.0 108.862 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 97.1 t -113.34 146.14 18.36 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 124.822 1.249 . . . . 50.0 109.333 -177.239 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -71.07 127.73 33.55 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 123.947 0.899 . . . . 50.0 109.771 176.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 102.25 -0.93 50.49 Favored Glycine 0 C--N 1.342 0.879 0 CA-C-N 115.817 -0.629 . . . . 50.0 112.485 -173.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.4 mm -113.52 148.94 16.08 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 C-N-CA 123.738 0.815 . . . . 50.0 109.242 -178.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.14 -46.07 86.3 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.182 0.993 . . . . 50.0 112.506 -175.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.28 -58.03 0.18 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 122.327 0.251 . . . . 50.0 111.382 172.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.507 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 17.8 m-90 -143.76 147.13 33.73 Favored 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 123.241 0.616 . . . . 50.0 111.382 -177.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 31.0 mm -101.55 138.71 24.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 N-CA-C 107.968 -1.123 . . . . 50.0 107.968 162.827 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -60.25 119.55 8.12 Favored 'General case' 0 CA--C 1.55 0.968 0 N-CA-C 107.721 -1.214 . . . . 50.0 107.721 175.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.27 -27.11 20.94 Favored 'General case' 0 N--CA 1.497 1.889 0 C-N-CA 125.266 1.426 . . . . 50.0 114.593 -164.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.48 -2.77 14.97 Favored 'General case' 0 CA--C 1.557 1.222 0 N-CA-C 113.197 0.814 . . . . 50.0 113.197 177.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -115.76 17.34 16.15 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.525 1.13 . . . . 50.0 110.632 177.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 41.4 t -117.24 133.59 63.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.051 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 177.568 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.409 ' HD3' ' HE3' ' A' ' 15' ' ' TRP . 64.4 tttp -121.49 121.24 37.07 Favored 'General case' 0 N--CA 1.468 0.452 0 C-N-CA 123.976 0.911 . . . . 75.0 109.334 179.149 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.523 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -64.47 118.18 8.4 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 123.306 0.642 . . . . 50.0 110.709 178.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.89 166.45 11.06 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.628 0.771 . . . . 50.0 109.879 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -74.29 117.0 58.26 Favored Pre-proline 0 CA--C 1.556 1.187 0 C-N-CA 123.459 0.704 . . . . 75.0 110.126 -178.088 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -67.29 3.67 1.59 Allowed 'Trans proline' 0 C--N 1.385 2.472 0 C-N-CA 123.163 2.575 . . . . 75.0 114.364 175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -60.09 92.98 0.06 OUTLIER Glycine 0 C--N 1.352 1.431 0 C-N-CA 123.489 0.566 . . . . 75.0 111.728 170.413 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.09 -63.89 0.4 Allowed Glycine 0 N--CA 1.466 0.682 0 N-CA-C 109.424 -1.47 . . . . 75.0 109.424 -169.534 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 74.05 -164.85 54.79 Favored Glycine 0 C--N 1.353 1.475 0 CA-C-O 119.714 -0.492 . . . . 75.0 113.686 173.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.52 ' HB3' HG21 ' A' ' 33' ' ' THR . 73.2 Cg_endo -76.95 111.82 3.31 Favored 'Trans proline' 0 C--N 1.371 1.746 0 C-N-CA 122.521 2.148 . . . . 75.0 111.932 175.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 50.7 m -70.56 -19.38 62.88 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 123.591 0.756 . . . . 75.0 110.641 173.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.3 m -91.65 133.49 35.52 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 124.39 1.076 . . . . 75.0 110.209 177.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtp180 -74.28 103.04 4.53 Favored 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.013 -0.736 . . . . 75.0 109.013 171.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.5 mt -83.64 -170.06 2.87 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 124.107 0.963 . . . . 75.0 111.092 -176.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 17.2 p -64.36 98.82 0.26 Allowed 'General case' 0 CA--C 1.543 0.692 0 N-CA-C 109.606 -0.516 . . . . 75.0 109.606 172.22 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 66.6 t-105 -73.53 114.54 11.88 Favored 'General case' 0 C--N 1.35 0.622 0 CA-C-N 115.417 -0.81 . . . . 75.0 110.547 -172.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.674 ' H ' HG21 ' A' ' 10' ' ' VAL . 82.9 mtt180 56.52 77.6 0.25 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 125.122 1.369 . . . . 75.0 111.857 -179.324 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.485 ' H ' HG11 ' A' ' 10' ' ' VAL . 57.9 t -65.45 -41.42 91.0 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.797 0 CA-C-O 122.112 0.958 . . . . 75.0 108.454 167.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' HB3' HD12 ' A' ' 80' ' ' LEU . 17.5 pt20 -99.36 118.15 35.37 Favored 'General case' 0 CA--C 1.546 0.799 0 CA-C-N 114.074 -1.421 . . . . 75.0 109.247 173.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.489 ' HB3' ' HB2' ' A' ' 3' ' ' HIS . 0.0 OUTLIER -107.45 -175.23 2.73 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 108.512 -0.921 . . . . 75.0 108.512 173.599 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.2 t -65.61 176.88 1.35 Allowed 'General case' 0 CA--C 1.561 1.389 0 C-N-CA 123.25 0.62 . . . . 75.0 110.729 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER 61.71 82.79 0.16 Allowed 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 107.598 -1.26 . . . . 75.0 107.598 -176.306 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -32.47 93.93 0.06 OUTLIER Pre-proline 0 N--CA 1.496 1.855 0 C-N-CA 126.61 1.964 . . . . 75.0 113.62 -164.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -90.81 -19.73 0.95 Allowed 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.122 2.548 . . . . 75.0 113.425 179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.563 HD13 HD22 ' A' ' 36' ' ' LEU . 85.0 mt -141.33 143.54 34.08 Favored 'General case' 0 C--O 1.243 0.748 0 C-N-CA 124.871 1.268 . . . . 75.0 108.772 -168.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -90.63 118.32 29.99 Favored 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 123.025 0.53 . . . . 75.0 109.97 -178.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 39.3 pt -103.21 132.68 48.95 Favored 'Isoleucine or valine' 0 C--O 1.243 0.725 0 C-N-CA 123.665 0.786 . . . . 75.0 109.567 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.9 ttt180 -170.68 108.06 0.31 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.537 0.735 . . . . 75.0 109.746 177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 89.4 mt -81.66 94.17 6.9 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 108.897 -0.779 . . . . 75.0 108.897 171.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 26.2 p -77.62 73.66 4.19 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.556 0.742 . . . . 75.0 110.419 178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 34.0 ttp180 -85.63 98.05 10.45 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 108.406 -0.961 . . . . 75.0 108.406 176.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -93.39 148.88 21.66 Favored 'General case' 0 C--O 1.239 0.548 0 C-N-CA 123.887 0.875 . . . . 75.0 110.198 -177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -66.34 118.05 49.61 Favored Pre-proline 0 CA--C 1.549 0.924 0 C-N-CA 123.676 0.79 . . . . 75.0 110.475 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo . . . . . 0 C--N 1.382 2.313 0 C-N-CA 122.828 2.352 . . . . 75.0 113.184 -178.757 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 14.9 p-80 . . . . . 0 N--CA 1.479 0.992 0 N-CA-C 109.71 -0.478 . . . . 75.0 109.71 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 83.1 t60 -129.77 138.6 51.16 Favored 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 124.178 0.991 . . . . 75.0 109.173 -176.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -136.44 159.58 41.35 Favored 'General case' 0 C--O 1.249 1.031 0 C-N-CA 124.083 0.953 . . . . 75.0 110.196 177.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 36.6 m80 -68.5 163.97 22.24 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-N 115.417 -0.811 . . . . 75.0 109.305 169.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 54.0 m80 -132.55 -62.67 0.82 Allowed 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 109.433 -0.58 . . . . 75.0 109.433 174.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.565 ' HA ' ' HB2' ' A' ' 76' ' ' SER . 44.2 t-80 59.91 31.34 20.67 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-O 122.522 1.153 . . . . 75.0 109.676 -175.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 21.0 t -99.11 179.16 4.7 Favored 'General case' 0 C--O 1.245 0.849 0 CA-C-N 114.203 -1.362 . . . . 75.0 109.582 -172.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 -65.66 156.98 31.22 Favored 'General case' 0 CA--C 1.553 1.076 0 N-CA-C 109.668 -0.493 . . . . 75.0 109.668 177.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.534 ' HB2' HD23 ' A' ' 80' ' ' LEU . 25.3 ptt? -48.22 133.27 15.65 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.838 1.255 . . . . 75.0 113.04 -170.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.443 HG12 ' O ' ' A' ' 35' ' ' LEU . 16.2 m -73.53 137.61 22.95 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.592 0 N-CA-C 108.232 -1.025 . . . . 50.0 108.232 172.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.635 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 90.79 11.02 62.38 Favored Glycine 0 C--O 1.24 0.48 0 CA-C-O 118.999 -0.89 . . . . 50.0 112.459 -172.334 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.69 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 64.0 t0 -57.62 97.74 0.03 OUTLIER 'General case' 0 C--N 1.365 1.275 0 C-N-CA 123.557 0.743 . . . . 50.0 109.062 179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 36.6 m -71.52 118.59 14.53 Favored 'General case' 0 C--N 1.345 0.383 0 N-CA-C 109.484 -0.561 . . . . 50.0 109.484 -169.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.4 m -135.57 170.8 18.43 Favored 'Isoleucine or valine' 0 C--O 1.251 1.148 0 C-N-CA 125.513 1.525 . . . . 50.0 109.741 -175.207 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 50.4 m0 -117.68 142.14 47.58 Favored 'General case' 0 C--O 1.242 0.686 0 C-N-CA 124.617 1.167 . . . . 50.0 108.082 171.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 96.6 t -107.23 109.3 27.67 Favored 'Isoleucine or valine' 0 C--O 1.243 0.747 0 N-CA-C 107.298 -1.371 . . . . 50.0 107.298 178.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.636 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 48.6 ttt180 -90.51 100.2 13.08 Favored 'General case' 0 CA--C 1.547 0.83 0 C-N-CA 125.043 1.337 . . . . 75.0 109.963 -171.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -99.46 144.11 28.93 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 124.47 1.108 . . . . 75.0 111.273 -172.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.517 ' HB3' ' HA ' ' A' ' 26' ' ' PRO . 2.2 p80 -151.69 137.81 18.29 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 123.718 0.807 . . . . 75.0 110.326 171.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 18.8 mm100 -70.47 -48.1 57.44 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.159 0.584 . . . . 75.0 110.734 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 46.9 p -127.02 164.74 20.85 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.151 0.98 . . . . 75.0 109.146 172.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 44.8 mtmt -72.56 -24.98 61.19 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 122.912 0.485 . . . . 75.0 110.754 174.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -64.25 -36.91 85.64 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.227 0.611 . . . . 75.0 110.682 173.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.8 mt -79.74 130.21 35.15 Favored 'General case' 0 C--O 1.242 0.682 0 N-CA-C 109.894 -0.409 . . . . 75.0 109.894 171.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 38.7 mt-10 -67.83 130.43 92.89 Favored Pre-proline 0 CA--C 1.553 1.065 0 C-N-CA 123.437 0.695 . . . . 75.0 110.003 -179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.517 ' HA ' ' HB3' ' A' ' 19' ' ' HIS . 6.9 Cg_exo -71.62 123.53 9.52 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 123.101 2.534 . . . . 50.0 112.244 -172.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -100.15 125.63 46.3 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.528 0.731 . . . . 75.0 109.207 178.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.636 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 67.5 p-90 -71.66 158.5 36.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.257 0.623 . . . . 50.0 111.032 176.267 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 44.9 mtmt -133.95 149.12 51.25 Favored 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 123.741 0.816 . . . . 75.0 108.855 168.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -164.76 176.82 40.52 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 119.851 -0.416 . . . . 50.0 112.895 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -92.92 104.77 0.37 Allowed 'Cis proline' 0 C--N 1.374 1.89 0 CA-C-N 118.601 1.201 . . . . 50.0 112.276 -1.439 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 38.9 m-85 -74.74 161.26 29.79 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 108.646 -0.872 . . . . 50.0 108.646 174.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.635 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 59.7 p -141.5 111.9 6.96 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 122.41 0.284 . . . . 50.0 110.321 -176.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.69 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 24.1 t -68.37 124.43 23.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.917 0 C-N-CA 123.41 0.684 . . . . 50.0 110.028 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.443 ' O ' HG12 ' A' ' 10' ' ' VAL . 48.1 mt -99.03 -20.68 16.6 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 124.591 1.156 . . . . 50.0 110.895 -178.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.617 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 54.0 tp -153.73 137.36 16.02 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.677 0.791 . . . . 50.0 109.734 175.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.55 HG22 HD22 ' A' ' 42' ' ' LEU . 38.0 p -112.31 128.96 56.43 Favored 'General case' 0 CA--C 1.548 0.875 0 N-CA-C 108.639 -0.874 . . . . 50.0 108.639 176.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 38.7 p -133.39 165.19 38.58 Favored Pre-proline 0 CA--C 1.565 1.543 0 C-N-CA 124.439 1.095 . . . . 50.0 109.148 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.436 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 6.3 Cg_endo -46.82 108.98 0.17 Allowed 'Trans proline' 0 C--N 1.388 2.649 0 C-N-CA 123.559 2.839 . . . . 50.0 113.523 178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 41.1 p 56.08 20.37 4.34 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 126.039 1.736 . . . . 50.0 113.737 176.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.0 138.83 19.85 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 108.809 -0.811 . . . . 50.0 108.809 -176.444 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.55 HD22 HG22 ' A' ' 37' ' ' THR . 64.4 mt -127.89 129.02 46.19 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 109.405 -0.591 . . . . 50.0 109.405 -175.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.617 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -86.27 107.39 17.92 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 107.055 -1.461 . . . . 75.0 107.055 168.533 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.554 ' HA ' ' HA ' ' A' ' 34' ' ' VAL . 21.7 t -104.79 160.07 5.2 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 CA-C-N 115.164 -0.926 . . . . 50.0 108.79 -178.13 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -66.32 129.04 38.48 Favored 'General case' 0 C--O 1.24 0.585 0 C-N-CA 123.453 0.701 . . . . 50.0 109.51 177.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.21 -4.49 86.17 Favored Glycine 0 C--N 1.344 0.987 0 O-C-N 123.586 0.554 . . . . 50.0 113.039 -176.641 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 28.1 mm -95.95 137.54 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 C-N-CA 123.875 0.87 . . . . 50.0 109.503 178.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -58.62 -50.68 72.94 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.974 0.91 . . . . 50.0 111.441 -174.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.35 -56.15 0.17 Allowed 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 112.583 0.586 . . . . 50.0 112.583 174.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 15.6 m-90 -141.19 138.24 33.22 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 118.344 0.52 . . . . 50.0 111.801 -173.632 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 41.3 mm -120.45 127.32 75.9 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 N-CA-C 107.191 -1.411 . . . . 50.0 107.191 163.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.7 t-80 -56.64 122.84 13.0 Favored 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 109.221 -0.659 . . . . 50.0 109.221 177.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.39 -21.37 5.79 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 125.735 1.614 . . . . 50.0 114.817 -166.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -67.57 -22.11 65.4 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 113.301 0.852 . . . . 50.0 113.301 -177.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 83.7 m-70 -87.74 -12.53 44.97 Favored 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 122.856 0.462 . . . . 50.0 111.218 176.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 52.6 t -101.76 139.83 21.91 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.766 0 C-N-CA 123.891 0.876 . . . . 50.0 109.81 -175.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 13.4 ptmm? -138.99 129.75 26.17 Favored 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.8 0.84 . . . . 75.0 109.62 -177.44 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.547 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.4 126.54 29.6 Favored 'General case' 0 N--CA 1.484 1.225 0 C-N-CA 123.277 0.631 . . . . 50.0 112.342 -171.817 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.85 160.15 16.61 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 124.474 1.11 . . . . 50.0 111.304 -179.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.8 t0 -97.21 117.59 65.49 Favored Pre-proline 0 C--O 1.243 0.747 0 N-CA-C 107.808 -1.182 . . . . 75.0 107.808 173.321 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -72.26 -29.35 14.25 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.573 2.182 . . . . 75.0 113.41 -177.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.26 -76.15 0.77 Allowed Glycine 0 C--N 1.353 1.485 0 N-CA-C 110.105 -1.198 . . . . 75.0 110.105 -163.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -114.7 -77.38 0.73 Allowed Glycine 0 C--N 1.346 1.132 0 N-CA-C 110.481 -1.048 . . . . 75.0 110.481 169.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 60.0 -123.4 33.0 Favored Glycine 0 CA--C 1.545 1.935 0 N-CA-C 114.846 0.699 . . . . 75.0 114.846 171.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -75.37 96.7 1.05 Allowed 'Trans proline' 0 C--N 1.382 2.328 0 C-N-CA 123.299 2.666 . . . . 75.0 113.143 -171.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.7 t -114.58 -71.58 0.74 Allowed 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 108.901 -0.777 . . . . 75.0 108.901 173.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 t -81.97 68.52 8.39 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 124.714 1.205 . . . . 75.0 111.152 -173.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ttm180 -168.35 -34.76 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.628 1.171 . . . . 75.0 109.583 -174.051 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 79.1 mt -82.1 12.88 3.79 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.91 0.884 . . . . 75.0 112.893 -172.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 9.5 t -56.84 -22.33 35.92 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 125.285 1.434 . . . . 75.0 113.166 176.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -65.73 148.46 51.73 Favored 'General case' 0 CA--C 1.546 0.808 0 C-N-CA 123.932 0.893 . . . . 75.0 112.028 178.684 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.468 ' HB2' ' HD3' ' A' ' 75' ' ' ARG . 12.6 ptp180 -95.76 59.24 2.04 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-O 122.828 1.299 . . . . 75.0 110.441 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 61.3 t -94.37 -17.0 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.047 0 CA-C-N 113.988 -1.46 . . . . 75.0 108.874 171.158 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.39 27.25 1.1 Allowed 'General case' 0 CA--C 1.556 1.21 0 C-N-CA 124.501 1.12 . . . . 75.0 111.994 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.468 ' HD3' ' HB2' ' A' ' 72' ' ' ARG . 22.9 mmm180 -62.49 94.91 0.06 Allowed 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 123.83 0.852 . . . . 75.0 111.536 -174.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . 0.565 ' HB2' ' HA ' ' A' ' 6' ' ' HIS . 33.0 t -162.57 -171.15 2.64 Favored 'General case' 0 C--O 1.243 0.735 0 C-N-CA 125.527 1.531 . . . . 75.0 108.493 -177.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -61.89 -63.33 1.29 Allowed 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.549 0.74 . . . . 75.0 110.646 178.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 56.8 t30 -169.24 79.77 0.7 Allowed Pre-proline 0 N--CA 1.483 1.185 0 C-N-CA 123.963 0.905 . . . . 75.0 109.257 171.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 76' ' ' SER . 74.2 Cg_endo -75.04 -26.53 10.77 Favored 'Trans proline' 0 C--N 1.378 2.128 0 C-N-CA 122.757 2.305 . . . . 75.0 112.753 179.319 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.534 HD23 ' HB2' ' A' ' 9' ' ' MET . 76.5 mt -78.89 172.96 13.04 Favored 'General case' 0 N--CA 1.478 0.949 0 CA-C-O 121.556 0.693 . . . . 75.0 111.623 -178.63 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.7 ttmm -151.63 141.74 22.22 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.704 1.202 . . . . 75.0 108.516 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.2 pt -65.82 147.32 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.929 0 CA-C-O 120.979 0.419 . . . . 75.0 110.012 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 31.6 ttm180 -122.39 10.78 9.91 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 123.598 0.759 . . . . 75.0 109.831 -177.105 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 90.1 mt 58.36 19.71 6.64 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 125.234 1.414 . . . . 75.0 112.19 -179.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.0 t -84.13 143.88 29.38 Favored 'General case' 0 C--O 1.239 0.552 0 C-N-CA 123.672 0.789 . . . . 75.0 109.481 -176.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -74.62 96.38 2.98 Favored 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 123.561 0.744 . . . . 75.0 109.49 -179.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -82.4 -57.37 3.39 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.836 0.854 . . . . 75.0 109.443 176.032 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -73.14 141.26 80.9 Favored Pre-proline 0 CA--C 1.549 0.935 0 N-CA-C 109.705 -0.479 . . . . 75.0 109.705 175.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo . . . . . 0 CA--C 1.564 2.012 0 C-N-CA 122.343 2.029 . . . . 75.0 111.132 176.582 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 32.5 m170 . . . . . 0 CA--C 1.544 0.738 0 CA-C-O 120.568 0.223 . . . . 75.0 110.841 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . 0.523 ' HB2' ' HA ' ' A' ' 89' ' ' PRO . 12.4 p-80 -160.68 148.55 16.05 Favored 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.901 1.28 . . . . 75.0 109.368 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.8 t-80 -162.15 142.87 10.36 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 122.95 0.156 . . . . 75.0 110.772 -174.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 32.1 m-70 -80.33 165.71 22.02 Favored 'General case' 0 N--CA 1.489 1.503 0 C-N-CA 123.868 0.867 . . . . 75.0 112.005 -178.67 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 7.5 p-80 -153.46 123.53 6.95 Favored 'General case' 0 CA--C 1.548 0.873 0 N-CA-C 108.621 -0.881 . . . . 75.0 108.621 167.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -81.36 72.54 8.4 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.301 1.048 . . . . 75.0 110.23 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 23.5 t -161.36 -171.1 2.86 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.511 -1.222 . . . . 75.0 109.283 -171.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -68.64 126.28 29.2 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.665 0.786 . . . . 75.0 109.796 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 20.6 ptp -92.42 174.65 7.18 Favored 'General case' 0 N--CA 1.482 1.138 0 C-N-CA 123.254 0.622 . . . . 75.0 111.478 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.658 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 34.8 m -67.87 135.54 28.28 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.138 0 CA-C-N 115.265 -0.879 . . . . 50.0 111.053 178.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 92.34 8.57 62.63 Favored Glycine 0 C--N 1.347 1.173 0 CA-C-O 119.672 -0.516 . . . . 50.0 112.613 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.539 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.1 t0 -65.57 115.98 6.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 123.694 0.798 . . . . 50.0 110.601 -176.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.41 HG22 ' HB3' ' A' ' 59' ' ' ALA . 38.3 m -73.31 111.88 8.85 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 123.218 0.607 . . . . 50.0 110.328 -173.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.57 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.2 m -136.37 -176.56 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.798 0 C-N-CA 124.818 1.247 . . . . 50.0 110.616 -174.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 32.7 m0 -131.95 157.71 43.32 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 125.516 1.526 . . . . 50.0 107.814 177.115 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 94.0 t -111.12 104.37 16.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.536 -0.913 . . . . 50.0 108.536 172.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.459 ' HD2' ' HD2' ' A' ' 57' ' ' LYS . 67.5 ttt180 -79.01 96.53 5.79 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.466 1.106 . . . . 75.0 110.44 -178.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 28.3 ttm-85 -98.43 119.18 36.69 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.098 0.475 . . . . 75.0 111.833 -173.526 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 79.7 t60 -107.09 94.08 4.9 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 124.104 0.962 . . . . 75.0 108.409 176.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -57.94 -70.02 0.15 Allowed 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.755 0.822 . . . . 75.0 111.912 -172.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 52.7 p -117.36 173.97 6.4 Favored 'General case' 0 N--CA 1.471 0.611 0 C-N-CA 123.536 0.734 . . . . 75.0 109.069 177.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 50.3 mttp -70.93 -21.57 62.34 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.705 0.802 . . . . 75.0 111.851 -178.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.5 p-10 -92.29 -31.73 15.28 Favored 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 122.864 0.466 . . . . 75.0 110.991 178.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -75.54 162.93 27.88 Favored 'General case' 0 N--CA 1.482 1.17 0 C-N-CA 122.653 0.381 . . . . 75.0 110.751 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -85.98 159.26 54.74 Favored Pre-proline 0 CA--C 1.555 1.145 0 C-N-CA 123.879 0.872 . . . . 75.0 110.993 -174.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -79.76 76.1 4.71 Favored 'Trans proline' 0 C--N 1.379 2.17 0 C-N-CA 122.991 2.461 . . . . 50.0 110.673 173.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 47.9 ttt85 -76.61 116.54 17.38 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 115.175 -0.921 . . . . 75.0 110.017 -175.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 65.9 p-90 -81.35 153.18 27.15 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 121.498 0.666 . . . . 50.0 110.711 177.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.5 mtpm? -127.62 137.87 52.68 Favored 'General case' 0 N--CA 1.469 0.484 0 N-CA-C 107.574 -1.269 . . . . 75.0 107.574 170.124 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -165.29 -177.91 38.05 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 121.306 -0.473 . . . . 50.0 112.79 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -88.14 122.09 5.86 Favored 'Cis proline' 0 CA--C 1.559 1.756 0 C-N-CA 123.753 -1.353 . . . . 50.0 112.878 -4.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -85.18 178.97 7.33 Favored 'General case' 0 N--CA 1.477 0.892 0 C-N-CA 123.576 0.75 . . . . 50.0 110.0 170.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.491 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 25.6 p -138.15 113.34 9.33 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 122.908 0.483 . . . . 50.0 110.983 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.539 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 76.5 t -64.99 135.82 27.65 Favored 'Isoleucine or valine' 0 C--O 1.249 1.033 0 CA-C-O 121.242 0.544 . . . . 50.0 109.666 170.256 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.658 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 66.5 mt -104.53 -44.98 4.76 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-N 115.085 -0.961 . . . . 50.0 109.258 173.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 45.4 tp -142.19 147.67 36.96 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.727 -0.67 . . . . 50.0 109.765 -173.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.445 HG22 HD22 ' A' ' 42' ' ' LEU . 30.9 p -104.63 144.27 31.94 Favored 'General case' 0 CA--C 1.542 0.669 0 C-N-CA 123.781 0.833 . . . . 50.0 109.164 175.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 91.8 m -140.35 149.07 56.45 Favored Pre-proline 0 CA--C 1.556 1.198 0 N-CA-C 107.955 -1.128 . . . . 50.0 107.955 176.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_exo -39.56 121.61 0.83 Allowed 'Trans proline' 0 C--N 1.379 2.16 0 C-N-CA 123.044 2.496 . . . . 50.0 114.021 170.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.1 t 53.07 14.48 0.48 Allowed 'General case' 0 N--CA 1.504 2.261 0 C-N-CA 126.745 2.018 . . . . 50.0 114.826 179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -153.82 124.58 7.21 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 122.794 0.438 . . . . 50.0 110.465 -175.205 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD12 ' HB ' ' A' ' 56' ' ' VAL . 86.8 mt -103.0 126.05 50.02 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 109.269 -0.641 . . . . 50.0 109.269 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.533 ' HG3' ' O ' ' A' ' 49' ' ' ALA . 51.5 tttm -86.85 108.96 18.98 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 108.706 -0.85 . . . . 75.0 108.706 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 34' ' ' VAL . 58.4 t -116.31 141.65 33.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 CA-C-N 114.822 -1.081 . . . . 50.0 109.345 -170.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -65.95 137.64 57.28 Favored 'General case' 0 CA--C 1.543 0.706 0 C-N-CA 123.393 0.677 . . . . 50.0 110.768 175.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 97.39 -26.75 21.65 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.563 -0.744 . . . . 50.0 111.928 -174.14 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 51' ' ' ILE . 50.1 mm -87.0 146.77 5.89 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.975 0.91 . . . . 50.0 109.834 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -52.56 -49.43 64.96 Favored 'General case' 0 C--N 1.361 1.068 0 C-N-CA 124.225 1.01 . . . . 50.0 111.151 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' A' ' 43' ' ' LYS . . . -151.17 -59.26 0.17 Allowed 'General case' 0 N--CA 1.471 0.596 0 O-C-N 123.16 0.287 . . . . 50.0 111.519 167.47 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.473 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 18.0 m-90 -135.5 144.95 46.63 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.931 -0.481 . . . . 50.0 112.0 -174.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 47' ' ' ILE . 35.9 mm -110.76 137.6 42.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 107.145 -1.428 . . . . 50.0 107.145 163.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 63.6 t-80 -57.07 129.21 40.74 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 108.992 -0.744 . . . . 50.0 108.992 174.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.79 -32.44 65.67 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.048 1.129 . . . . 50.0 114.048 -163.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -68.97 -11.35 60.65 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.313 0.645 . . . . 50.0 112.415 178.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 85.8 m-70 -102.39 22.8 12.8 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 124.406 1.082 . . . . 50.0 111.044 174.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.512 ' HB ' HD12 ' A' ' 42' ' ' LEU . 59.8 t -135.72 125.4 41.22 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 N-CA-C 109.206 -0.664 . . . . 50.0 109.206 175.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.459 ' HD2' ' HD2' ' A' ' 17' ' ' ARG . 48.2 mtpt -114.45 129.82 56.68 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.601 0.761 . . . . 75.0 109.783 178.212 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.57 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.63 120.88 15.34 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 122.583 0.353 . . . . 50.0 110.181 177.315 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . -86.15 157.71 19.95 Favored 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.251 0.62 . . . . 50.0 110.281 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 58.0 t0 -78.14 117.8 68.27 Favored Pre-proline 0 CA--C 1.548 0.871 0 C-N-CA 123.69 0.796 . . . . 75.0 109.971 -179.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.405 ' HB3' ' HB2' ' A' ' 65' ' ' PRO . 52.8 Cg_exo -59.22 -17.67 40.44 Favored 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 123.27 2.647 . . . . 75.0 113.632 173.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -64.92 87.32 0.08 OUTLIER Glycine 0 C--N 1.347 1.188 0 CA-C-N 116.246 -0.434 . . . . 75.0 113.247 178.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 157.0 -13.78 0.31 Allowed Glycine 0 C--N 1.342 0.906 0 C-N-CA 123.457 0.551 . . . . 75.0 112.377 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.7 -73.33 0.02 OUTLIER Glycine 0 C--N 1.35 1.354 0 CA-C-O 119.481 -0.622 . . . . 75.0 112.154 -179.455 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.47 ' HG3' HD11 ' A' ' 69' ' ' LEU . 35.9 Cg_exo -59.73 112.85 1.4 Allowed 'Trans proline' 0 C--N 1.368 1.57 0 C-N-CA 123.109 2.539 . . . . 75.0 112.386 177.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 33.2 t -64.08 -49.99 70.11 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.465 0.706 . . . . 75.0 109.91 178.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.3 m -151.16 -69.56 0.17 Allowed 'General case' 0 CA--C 1.547 0.828 0 C-N-CA 124.454 1.102 . . . . 75.0 109.036 171.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 19.0 ptp180 -118.7 133.04 56.14 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.862 0.865 . . . . 75.0 109.789 -175.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.47 HD11 ' HG3' ' A' ' 65' ' ' PRO . 90.9 mt -94.98 -71.01 0.69 Allowed 'General case' 0 C--O 1.24 0.573 0 C-N-CA 122.932 0.493 . . . . 75.0 109.786 -179.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 7.0 m -86.49 147.84 25.8 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.843 -0.617 . . . . 75.0 109.812 -177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 12.9 m-90 -86.0 -63.49 1.31 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.488 0.715 . . . . 75.0 109.268 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.499 HH12 ' HB3' ' A' ' 2' ' ' HIS . 79.1 mtp180 -151.75 150.04 29.73 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 125.104 1.362 . . . . 75.0 109.101 179.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.502 HG11 HD22 ' A' ' 35' ' ' LEU . 35.6 m -120.12 -6.15 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 N-CA-C 112.832 0.679 . . . . 75.0 112.832 -175.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' NE2' HD12 ' A' ' 80' ' ' LEU . 2.7 pt20 -68.59 -27.3 65.92 Favored 'General case' 0 N--CA 1.483 1.179 0 CA-C-N 118.386 0.539 . . . . 75.0 112.24 -174.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 33.6 mmt180 -66.01 -20.66 66.26 Favored 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 123.16 0.584 . . . . 75.0 111.005 -179.786 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.0 t -89.11 -30.41 18.66 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 124.03 0.932 . . . . 75.0 112.024 -178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.5 tp60 -161.28 -35.19 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 112.566 0.58 . . . . 75.0 112.566 -173.39 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 74' ' ' GLN . 7.1 t30 75.56 93.45 0.05 OUTLIER Pre-proline 0 N--CA 1.484 1.236 0 C-N-CA 125.036 1.334 . . . . 75.0 111.491 -176.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 78.7 Cg_endo -81.23 -2.94 11.93 Favored 'Trans proline' 0 C--N 1.375 1.93 0 C-N-CA 123.154 2.57 . . . . 75.0 111.7 169.075 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.576 HD11 ' HG3' ' A' ' 87' ' ' GLU . 43.0 mt -85.07 13.01 6.64 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 124.229 1.011 . . . . 75.0 112.493 -172.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 14.2 ptmm? -69.58 -10.45 58.21 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.406 0.683 . . . . 75.0 112.525 179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.5 pt -85.05 -173.47 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 C-N-CA 122.999 0.52 . . . . 75.0 109.905 170.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 75.6 ttt180 -60.76 -38.44 85.24 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.28 0.632 . . . . 75.0 111.668 178.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.528 HD22 HH21 ' A' ' 86' ' ' ARG . 72.4 mt -81.63 87.76 6.26 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 121.533 0.682 . . . . 75.0 109.354 -179.047 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.513 ' HA ' ' HB3' ' A' ' 80' ' ' LEU . 9.3 t -113.48 64.19 0.65 Allowed 'General case' 0 CA--C 1.552 1.027 0 CA-C-O 122.701 1.238 . . . . 75.0 110.288 -176.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . 0.528 HH21 HD22 ' A' ' 84' ' ' LEU . 72.6 mtm180 -147.51 132.65 18.33 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.022 -0.99 . . . . 75.0 110.335 -174.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . 0.576 ' HG3' HD11 ' A' ' 80' ' ' LEU . 61.8 mt-10 -129.76 -80.69 0.55 Allowed 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 123.828 0.851 . . . . 75.0 109.583 175.493 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -167.25 167.85 7.11 Favored Pre-proline 0 N--CA 1.481 1.107 0 C-N-CA 123.525 0.73 . . . . 75.0 110.076 -172.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . 0.523 ' HA ' ' HB2' ' A' ' 2' ' ' HIS . 18.2 Cg_exo . . . . . 0 C--N 1.38 2.219 0 C-N-CA 122.962 2.441 . . . . 75.0 112.4 167.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 . . . . . 0 N--CA 1.478 0.963 0 N-CA-C 109.386 -0.598 . . . . 75.0 109.386 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 36.1 m80 -144.6 114.54 7.35 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.191 0.996 . . . . 75.0 109.503 -176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 29.9 p-80 -157.24 52.07 0.48 Allowed 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 123.194 0.597 . . . . 75.0 110.446 177.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 13.7 m-70 -69.08 81.77 0.33 Allowed 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.316 0.646 . . . . 75.0 110.446 177.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -76.63 -82.12 0.08 Allowed 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.426 0.691 . . . . 75.0 109.154 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.9 t-80 -168.62 142.8 3.19 Favored 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 123.052 0.541 . . . . 75.0 109.807 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 75.3 m -148.03 -173.92 4.43 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 123.338 0.655 . . . . 75.0 110.966 -178.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -86.28 161.17 18.89 Favored 'General case' 0 C--O 1.245 0.838 0 C-N-CA 124.118 0.967 . . . . 75.0 108.731 171.216 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.44 ' HA ' ' OE1' ' A' ' 74' ' ' GLN . 27.2 ptt? -53.1 132.65 38.49 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.518 0.727 . . . . 75.0 111.495 179.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.652 HG11 ' HB ' ' A' ' 73' ' ' VAL . 21.3 m -69.46 139.26 20.65 Favored 'Isoleucine or valine' 0 C--O 1.244 0.803 0 CA-C-N 116.045 -0.525 . . . . 50.0 109.888 -178.896 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.523 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 101.11 9.78 44.17 Favored Glycine 0 C--N 1.34 0.75 0 CA-C-O 119.559 -0.579 . . . . 50.0 112.875 -174.329 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.573 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 61.5 t0 -58.28 109.39 0.76 Allowed 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.026 0.53 . . . . 50.0 110.622 -177.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 75.6 m -71.62 111.66 7.1 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.142 0.496 . . . . 50.0 109.843 -173.361 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 35.1 m -132.15 -175.1 1.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.725 0 C-N-CA 124.565 1.146 . . . . 50.0 109.806 179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.437 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 31.0 m0 -124.38 156.77 36.52 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.053 1.341 . . . . 50.0 107.722 173.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.444 ' HA ' ' O ' ' A' ' 55' ' ' HIS . 52.2 t -109.75 114.58 47.38 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.614 0 N-CA-C 108.417 -0.956 . . . . 50.0 108.417 171.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.414 ' HB3' ' HA ' ' A' ' 55' ' ' HIS . 39.3 ttm180 -76.97 123.77 26.8 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 124.158 0.983 . . . . 75.0 110.108 175.54 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -138.29 140.38 39.55 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 108.854 -0.795 . . . . 75.0 108.854 168.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.639 ' HA ' ' HA ' ' A' ' 26' ' ' PRO . 10.9 m170 -57.95 -45.66 86.3 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.458 0.703 . . . . 75.0 111.897 -178.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 65.99 -70.2 0.1 Allowed 'General case' 0 N--CA 1.487 1.413 0 O-C-N 124.666 1.229 . . . . 75.0 109.735 -170.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.426 ' OG1' ' HB2' ' A' ' 24' ' ' LEU . 33.4 p -80.6 137.15 36.35 Favored 'General case' 0 CA--C 1.554 1.106 0 C-N-CA 124.913 1.285 . . . . 75.0 109.2 168.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -61.94 -52.1 65.42 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.95 0.9 . . . . 75.0 112.905 -168.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -108.03 -15.69 14.46 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.933 0.893 . . . . 75.0 112.415 -169.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.426 ' HB2' ' OG1' ' A' ' 21' ' ' THR . 68.2 mt -80.52 172.97 13.07 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 110.553 -0.166 . . . . 75.0 110.553 179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -56.27 127.22 70.5 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 123.888 0.875 . . . . 75.0 111.847 -174.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.639 ' HA ' ' HA ' ' A' ' 19' ' ' HIS . 52.1 Cg_exo -56.16 124.72 16.95 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 123.256 2.637 . . . . 50.0 112.434 177.335 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 20.4 ttm-85 -93.67 179.61 5.31 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 124.184 0.993 . . . . 75.0 108.834 -175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . . . . . . . . . 61.0 p-90 -146.21 163.34 35.73 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.383 0.673 . . . . 50.0 110.296 175.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 25.7 mtmm -131.31 161.12 33.05 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 108.726 -0.842 . . . . 75.0 108.726 169.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.424 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -170.91 -177.55 40.9 Favored Glycine 0 CA--C 1.538 1.529 0 CA-C-O 119.402 -0.666 . . . . 50.0 111.896 178.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -87.32 116.73 3.64 Favored 'Cis proline' 0 C--N 1.376 2.013 0 CA-C-N 119.408 1.604 . . . . 50.0 113.117 -4.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.453 ' HB3' HG11 ' A' ' 44' ' ' VAL . 77.9 m-85 -80.45 169.41 17.74 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 123.825 0.85 . . . . 50.0 110.408 170.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.523 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 22.9 p -140.28 110.49 6.59 Favored 'General case' 0 CA--C 1.549 0.934 0 C-N-CA 123.422 0.689 . . . . 50.0 110.685 -176.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.573 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 65.3 t -73.38 130.45 35.78 Favored 'Isoleucine or valine' 0 C--O 1.248 0.998 0 C-N-CA 123.064 0.546 . . . . 50.0 109.743 176.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.406 HD22 ' HB ' ' A' ' 10' ' ' VAL . 41.1 mt -98.22 -54.66 3.0 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 115.302 -0.863 . . . . 50.0 109.393 173.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.616 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 28.9 tp -110.26 139.63 45.24 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.18 0.592 . . . . 50.0 109.651 -173.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.432 HG22 HD22 ' A' ' 42' ' ' LEU . 69.0 p -127.89 129.25 46.57 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.353 0.661 . . . . 50.0 109.353 178.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.1 p -145.15 161.09 43.65 Favored Pre-proline 0 CA--C 1.562 1.436 0 C-N-CA 125.094 1.358 . . . . 50.0 108.454 -179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_exo -43.62 109.0 0.13 Allowed 'Trans proline' 0 C--N 1.385 2.456 0 C-N-CA 123.662 2.908 . . . . 50.0 114.832 176.138 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 6.9 m 65.08 13.15 8.5 Favored 'General case' 0 CA--C 1.572 1.803 0 C-N-CA 125.03 1.332 . . . . 50.0 112.456 174.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.85 121.89 14.64 Favored 'General case' 0 N--CA 1.478 0.926 0 O-C-N 121.705 -0.622 . . . . 50.0 110.012 -179.257 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.485 HD12 HG11 ' A' ' 56' ' ' VAL . 62.1 mt -121.8 122.19 38.93 Favored 'General case' 0 N--CA 1.468 0.426 0 N-CA-C 107.818 -1.179 . . . . 50.0 107.818 176.972 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.616 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 82.9 tttt -93.85 111.46 23.17 Favored 'General case' 0 C--O 1.243 0.724 0 N-CA-C 109.261 -0.644 . . . . 75.0 109.261 176.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.453 HG11 ' HB3' ' A' ' 32' ' ' TYR . 76.7 t -86.49 156.24 3.33 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.989 0 O-C-N 124.347 1.03 . . . . 50.0 109.385 174.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -60.35 116.2 4.1 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 123.89 0.876 . . . . 50.0 110.706 174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 109.44 -14.81 32.79 Favored Glycine 0 C--N 1.345 1.048 0 CA-C-N 116.226 -0.443 . . . . 50.0 113.214 -179.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.432 HG21 HG12 ' A' ' 51' ' ' ILE . 39.5 mm -77.96 143.02 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.114 0 C-N-CA 123.532 0.733 . . . . 50.0 111.24 -177.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -55.4 -50.7 69.06 Favored 'General case' 0 C--N 1.361 1.073 0 C-N-CA 124.648 1.179 . . . . 50.0 112.259 -176.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.31 -58.1 0.18 Allowed 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 112.219 0.451 . . . . 50.0 112.219 176.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 10.2 m-90 -143.92 150.03 37.75 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 122.683 0.393 . . . . 50.0 111.111 -177.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.432 HG12 HG21 ' A' ' 47' ' ' ILE . 33.1 mm -112.98 122.27 66.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 N-CA-C 108.439 -0.949 . . . . 50.0 108.439 166.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 61.6 t-80 -63.54 124.78 22.24 Favored 'General case' 0 CA--C 1.543 0.698 0 N-CA-C 106.855 -1.535 . . . . 50.0 106.855 174.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -55.32 -18.75 7.0 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 115.259 1.577 . . . . 50.0 115.259 -160.624 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -72.65 -4.93 34.04 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.537 0.735 . . . . 50.0 112.352 176.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . 0.444 ' O ' ' HA ' ' A' ' 16' ' ' VAL . 97.7 m-70 -104.11 17.35 24.29 Favored 'General case' 0 N--CA 1.478 0.934 0 C-N-CA 124.099 0.96 . . . . 50.0 109.967 169.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.485 HG11 HD12 ' A' ' 42' ' ' LEU . 54.6 t -124.61 136.34 60.96 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.258 0 C-N-CA 122.771 0.428 . . . . 50.0 109.902 178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.437 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 52.7 mtpt -133.67 115.39 14.56 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 108.202 -1.036 . . . . 75.0 108.202 175.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -60.39 121.51 12.24 Favored 'General case' 0 N--CA 1.482 1.145 0 C-N-CA 123.633 0.773 . . . . 50.0 111.364 -176.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -108.17 155.6 20.25 Favored 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.702 0.801 . . . . 50.0 111.252 -175.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.8 t0 -100.43 113.83 65.57 Favored Pre-proline 0 CA--C 1.547 0.849 0 C-N-CA 124.195 0.998 . . . . 75.0 108.446 177.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_endo -78.06 -17.37 13.59 Favored 'Trans proline' 0 C--N 1.376 2.012 0 C-N-CA 122.639 2.226 . . . . 75.0 112.931 176.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.29 -63.25 4.45 Favored Glycine 0 C--N 1.352 1.457 0 N-CA-C 110.745 -0.942 . . . . 75.0 110.745 -168.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.65 -117.51 0.44 Allowed Glycine 0 C--O 1.238 0.388 0 N-CA-C 109.107 -1.597 . . . . 75.0 109.107 172.074 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 57.25 64.97 3.9 Favored Glycine 0 C--N 1.351 1.383 0 CA-C-O 119.554 -0.581 . . . . 75.0 113.787 179.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.455 ' O ' ' HG ' ' A' ' 69' ' ' LEU . 64.0 Cg_endo -88.8 -0.09 6.4 Favored 'Trans proline' 0 C--N 1.373 1.851 0 C-N-CA 122.766 2.311 . . . . 75.0 113.165 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 31.7 p -49.62 -60.93 2.42 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 125.279 1.431 . . . . 75.0 114.122 -166.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 29.4 t -77.27 -13.57 59.91 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 123.353 0.661 . . . . 75.0 111.309 -177.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 78.9 mtm180 -98.97 2.04 46.04 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.87 0.868 . . . . 75.0 111.844 -179.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.455 ' HG ' ' O ' ' A' ' 65' ' ' PRO . 80.7 mt -71.22 -2.75 17.06 Favored 'General case' 0 N--CA 1.491 1.596 0 C-N-CA 123.742 0.817 . . . . 75.0 112.712 176.534 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 10.3 m -65.86 -62.72 1.35 Allowed 'General case' 0 CA--C 1.552 1.045 0 C-N-CA 123.809 0.843 . . . . 75.0 111.423 -178.694 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.488 ' HD1' HG22 ' A' ' 10' ' ' VAL . 7.3 m0 51.95 37.0 19.88 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.66 1.184 . . . . 75.0 113.594 178.652 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 39.4 ptt180 -69.84 -28.69 65.89 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.689 0.796 . . . . 75.0 112.259 -178.014 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.652 ' HB ' HG11 ' A' ' 10' ' ' VAL . 44.6 t -77.75 -21.61 13.87 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.072 0 C-N-CA 123.538 0.735 . . . . 75.0 110.384 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.44 ' OE1' ' HA ' ' A' ' 9' ' ' MET . 30.7 mm-40 -81.89 5.19 19.72 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.344 1.057 . . . . 75.0 112.186 -177.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -81.3 75.65 8.26 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-O 121.739 0.78 . . . . 75.0 109.918 178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 28.0 m -153.93 -141.0 0.1 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 106.354 -1.721 . . . . 75.0 106.354 -176.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 13.5 tm0? -63.93 109.81 1.9 Allowed 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 106.164 -1.791 . . . . 75.0 106.164 160.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -59.66 108.14 1.27 Allowed Pre-proline 0 N--CA 1.483 1.204 0 C-N-CA 123.914 0.886 . . . . 75.0 112.027 -167.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -88.66 -1.83 6.6 Favored 'Trans proline' 0 C--N 1.375 1.934 0 C-N-CA 123.609 2.872 . . . . 75.0 112.556 176.673 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.44 HD21 ' HG3' ' A' ' 74' ' ' GLN . 94.5 mt -75.62 90.45 2.8 Favored 'General case' 0 C--N 1.345 0.399 0 C-N-CA 123.412 0.685 . . . . 75.0 109.408 -179.214 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -98.43 103.31 15.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.942 -0.762 . . . . 75.0 108.942 -176.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.1 pt -73.76 100.24 1.34 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.104 0 CA-C-O 122.124 0.964 . . . . 75.0 110.926 -174.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 55.1 mtp180 -88.74 -178.69 5.84 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.976 -1.011 . . . . 75.0 110.364 179.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 95.9 mt -83.21 72.47 10.16 Favored 'General case' 0 N--CA 1.476 0.855 0 C-N-CA 123.176 0.59 . . . . 75.0 110.642 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.9 m -86.28 134.67 33.74 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-N 115.548 -0.751 . . . . 75.0 109.363 174.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 63.5 mtt180 -71.94 90.64 1.15 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 123.485 0.714 . . . . 75.0 109.606 174.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -91.37 141.41 28.79 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.216 1.006 . . . . 75.0 110.648 -178.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -107.94 102.44 45.66 Favored Pre-proline 0 CA--C 1.551 1.013 0 C-N-CA 123.514 0.726 . . . . 75.0 109.596 176.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo . . . . . 0 C--N 1.38 2.198 0 C-N-CA 123.206 2.604 . . . . 75.0 112.766 175.454 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 47.5 t-80 . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.046 -0.724 . . . . 75.0 109.046 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -84.21 146.58 27.74 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.038 0.535 . . . . 75.0 109.899 174.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -157.65 148.95 21.58 Favored 'General case' 0 N--CA 1.478 0.944 0 C-N-CA 123.992 0.917 . . . . 75.0 109.414 175.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -155.28 176.41 12.6 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-O 121.424 0.63 . . . . 75.0 111.184 -179.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 61.3 m-70 -130.16 -177.81 4.47 Favored 'General case' 0 C--O 1.244 0.791 0 C-N-CA 124.747 1.219 . . . . 75.0 107.981 176.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -80.47 79.21 7.11 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 107.805 -1.183 . . . . 75.0 107.805 171.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 47.2 m -109.1 -174.59 2.55 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 114.274 -1.33 . . . . 75.0 113.001 -162.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 59.8 m-70 -71.95 141.57 49.44 Favored 'General case' 0 C--O 1.244 0.793 0 N-CA-C 107.441 -1.318 . . . . 75.0 107.441 161.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . 0.503 ' HG2' HG23 ' A' ' 82' ' ' ILE . 24.6 ptt? -67.1 150.34 49.32 Favored 'General case' 0 N--CA 1.483 1.223 0 N-CA-C 109.907 -0.405 . . . . 75.0 109.907 -178.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 HE21 ' A' ' 74' ' ' GLN . 34.7 m -57.27 136.36 20.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.868 0 C-N-CA 123.945 0.898 . . . . 50.0 110.861 -175.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.582 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.17 9.62 61.86 Favored Glycine 0 C--N 1.339 0.74 0 CA-C-O 118.855 -0.97 . . . . 50.0 114.115 178.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.591 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 62.7 t0 -55.11 114.92 1.96 Allowed 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 123.784 0.834 . . . . 50.0 111.645 -176.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.556 HG21 ' HB3' ' A' ' 61' ' ' PRO . 3.7 m -74.82 107.59 7.01 Favored 'General case' 0 CA--C 1.539 0.547 0 N-CA-C 109.307 -0.627 . . . . 50.0 109.307 -175.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.9 m -135.31 165.49 30.46 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 C-N-CA 123.46 0.704 . . . . 50.0 110.948 -177.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.585 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 31.0 m0 -116.53 131.27 56.99 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.411 1.084 . . . . 50.0 108.188 172.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 56' ' ' VAL . 58.2 t -107.35 110.27 31.2 Favored 'Isoleucine or valine' 0 C--O 1.243 0.736 0 N-CA-C 107.887 -1.153 . . . . 50.0 107.887 178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.722 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 59.4 ttp180 -85.5 106.08 16.57 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 123.756 0.822 . . . . 75.0 110.714 -174.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 40.4 ttm180 -92.65 139.37 30.63 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 124.707 1.203 . . . . 75.0 111.183 -177.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 25.4 m170 -72.89 95.08 1.91 Allowed 'General case' 0 N--CA 1.476 0.855 0 N-CA-C 108.726 -0.842 . . . . 75.0 108.726 171.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.6 mm100 -67.61 -36.04 80.09 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 108.577 -0.897 . . . . 75.0 108.577 169.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.488 ' HB ' ' HB2' ' A' ' 24' ' ' LEU . 30.8 m -140.29 147.71 40.32 Favored 'General case' 0 CA--C 1.55 0.958 0 C-N-CA 125.275 1.43 . . . . 75.0 107.544 167.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 36.8 mtmm -77.02 -47.71 19.92 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.249 0.62 . . . . 75.0 111.095 -177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 21.6 m120 -77.99 -20.3 52.86 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.279 0.474 . . . . 75.0 112.279 -176.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.488 ' HB2' ' HB ' ' A' ' 21' ' ' THR . 40.8 mt -95.87 161.03 14.18 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 109.691 -0.485 . . . . 75.0 109.691 173.357 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 38.2 mt-10 -67.63 131.71 92.84 Favored Pre-proline 0 CA--C 1.55 0.974 0 C-N-CA 123.018 0.527 . . . . 75.0 111.213 -177.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.586 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 2.7 Cg_exo -74.35 153.73 45.39 Favored 'Trans proline' 0 C--N 1.373 1.85 0 C-N-CA 123.197 2.598 . . . . 50.0 113.018 -171.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.5 ttm180 -98.06 123.94 42.33 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.144 0.978 . . . . 75.0 109.925 -177.155 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.722 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 69.0 p-90 -73.91 142.25 45.97 Favored 'General case' 0 CA--C 1.54 0.565 0 N-CA-C 109.359 -0.608 . . . . 50.0 109.359 173.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 26.2 mtpp -125.29 143.83 50.77 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 108.325 -0.991 . . . . 75.0 108.325 178.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.585 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 171.01 -173.87 44.72 Favored Glycine 0 CA--C 1.531 1.052 0 C-N-CA 120.683 -0.77 . . . . 50.0 113.555 176.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -88.02 115.98 3.22 Favored 'Cis proline' 0 C--N 1.375 1.936 0 CA-C-N 118.446 1.123 . . . . 50.0 113.099 4.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 78.6 m-85 -76.59 166.49 23.33 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.781 0.833 . . . . 50.0 110.672 171.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.582 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 69.4 p -129.96 111.42 12.52 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 122.983 0.513 . . . . 50.0 110.701 -178.611 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.591 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 40.1 t -71.97 129.42 35.47 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 108.724 -0.843 . . . . 50.0 108.724 175.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.414 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 76.9 mt -105.77 -33.56 7.96 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 123.787 0.835 . . . . 50.0 109.789 179.556 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.601 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.8 tp -146.5 152.2 38.6 Favored 'General case' 0 CA--C 1.54 0.566 0 CA-C-N 115.422 -0.808 . . . . 50.0 110.019 -176.786 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 93.1 m -132.02 128.53 38.52 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 124.123 0.969 . . . . 50.0 108.985 178.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.5 p -123.56 162.88 37.89 Favored Pre-proline 0 CA--C 1.56 1.332 0 C-N-CA 125.501 1.52 . . . . 50.0 107.895 177.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.2 Cg_exo -46.35 108.44 0.15 Allowed 'Trans proline' 0 C--N 1.388 2.606 0 C-N-CA 122.928 2.418 . . . . 50.0 113.777 177.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 5.8 m 73.98 0.02 3.49 Favored 'General case' 0 N--CA 1.489 1.493 0 C-N-CA 125.854 1.662 . . . . 50.0 113.01 173.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.475 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -133.99 124.67 26.69 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.426 0.69 . . . . 50.0 110.119 -173.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 71.5 mt -99.75 121.6 41.49 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.443 0.697 . . . . 50.0 109.269 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.2 tttt -84.91 108.61 17.63 Favored 'General case' 0 C--O 1.249 1.076 0 N-CA-C 107.328 -1.36 . . . . 75.0 107.328 171.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.532 HG22 HG22 ' A' ' 34' ' ' VAL . 57.3 t -117.51 146.39 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 CA-C-N 114.578 -1.192 . . . . 50.0 109.482 -171.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -71.99 137.36 47.2 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.586 0.754 . . . . 50.0 109.558 173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 87.51 4.49 80.1 Favored Glycine 0 C--N 1.347 1.178 0 O-C-N 123.666 0.604 . . . . 50.0 112.784 -173.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.48 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -117.13 147.91 20.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.045 0 C-N-CA 124.62 1.168 . . . . 50.0 109.292 -179.497 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -54.41 -51.41 64.98 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 123.996 0.919 . . . . 50.0 112.145 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -151.06 -57.59 0.16 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 122.589 0.356 . . . . 50.0 111.267 174.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.475 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 14.8 m-90 -142.16 157.75 44.52 Favored 'General case' 0 N--CA 1.491 1.591 0 C-N-CA 123.633 0.773 . . . . 50.0 110.947 -177.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.48 HG12 HG21 ' A' ' 47' ' ' ILE . 34.8 mm -123.13 134.82 65.09 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 124.579 1.152 . . . . 50.0 108.454 168.366 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -61.49 113.47 2.69 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 108.034 -1.098 . . . . 50.0 108.034 170.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -53.61 -19.85 4.44 Favored 'General case' 0 N--CA 1.496 1.83 0 N-CA-C 115.188 1.551 . . . . 50.0 115.188 -163.515 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -60.77 -29.85 69.67 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.73 0.812 . . . . 50.0 112.772 177.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 93.5 m-70 -71.19 -24.72 62.28 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.252 0.621 . . . . 50.0 111.579 176.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.567 HG22 HG22 ' A' ' 16' ' ' VAL . 98.4 t -96.6 138.27 22.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.499 0 C-N-CA 123.283 0.633 . . . . 50.0 110.678 -170.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -134.67 143.42 47.23 Favored 'General case' 0 C--O 1.24 0.603 0 N-CA-C 107.638 -1.245 . . . . 75.0 107.638 176.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -62.59 120.66 11.59 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 122.994 0.518 . . . . 50.0 110.79 179.813 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -86.79 146.26 26.31 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.531 0.732 . . . . 50.0 109.397 178.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.9 t0 -101.46 104.25 32.64 Favored Pre-proline 0 CA--C 1.55 0.965 0 C-N-CA 123.38 0.672 . . . . 75.0 109.248 175.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.556 ' HB3' HG21 ' A' ' 13' ' ' THR . 36.2 Cg_endo -89.12 -5.86 5.64 Favored 'Trans proline' 0 C--N 1.374 1.876 0 C-N-CA 122.814 2.343 . . . . 75.0 112.636 174.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 127.75 -40.82 1.68 Allowed Glycine 0 C--N 1.344 0.994 0 N-CA-C 110.058 -1.217 . . . . 75.0 110.058 -167.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 149.54 144.4 3.94 Favored Glycine 0 C--N 1.35 1.357 0 N-CA-C 112.11 -0.396 . . . . 75.0 112.11 175.256 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.31 -168.33 50.13 Favored Glycine 0 CA--C 1.538 1.511 0 CA-C-O 119.678 -0.512 . . . . 75.0 113.372 179.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -77.62 155.17 31.36 Favored 'Trans proline' 0 C--N 1.375 1.96 0 C-N-CA 123.133 2.555 . . . . 75.0 112.898 -175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.484 ' HB3' HG22 ' A' ' 33' ' ' THR . 23.2 t -83.6 -47.45 11.26 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.314 0.646 . . . . 75.0 109.333 175.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.7 m -83.05 167.74 17.59 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.523 0.729 . . . . 75.0 111.0 178.007 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.8 mmm180 -83.56 136.65 34.17 Favored 'General case' 0 N--CA 1.475 0.782 0 N-CA-C 108.641 -0.874 . . . . 75.0 108.641 173.041 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 80.2 mt -84.1 28.58 0.6 Allowed 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.134 0.974 . . . . 75.0 112.63 -170.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 80.8 p -73.07 -34.42 66.23 Favored 'General case' 0 CA--C 1.549 0.938 0 C-N-CA 123.77 0.828 . . . . 75.0 111.308 -177.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 93.9 m95 -68.04 110.65 4.03 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.963 0.905 . . . . 75.0 111.554 179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 75' ' ' ARG . 98.2 mtt180 -84.0 62.2 6.89 Favored 'General case' 0 C--N 1.353 0.722 0 C-N-CA 123.912 0.885 . . . . 75.0 110.053 175.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 71.9 t -80.15 -41.9 21.36 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.703 0 N-CA-C 107.608 -1.256 . . . . 75.0 107.608 168.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.46 HE21 HG22 ' A' ' 10' ' ' VAL . 19.4 pt20 -85.23 11.11 10.64 Favored 'General case' 0 CA--C 1.551 1.008 0 CA-C-N 114.329 -1.305 . . . . 75.0 113.235 -177.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.641 ' HB3' ' HB3' ' A' ' 72' ' ' ARG . 13.4 ptm180 -58.36 120.41 8.7 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 123.45 0.7 . . . . 75.0 111.921 -172.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 8.7 t -157.12 -168.83 2.75 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 123.401 0.68 . . . . 75.0 109.616 -171.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 58.6 tp60 -65.98 -43.39 87.95 Favored 'General case' 0 N--CA 1.482 1.159 0 C-N-CA 123.499 0.72 . . . . 75.0 109.862 173.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -122.29 145.49 44.47 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.626 1.171 . . . . 75.0 109.338 178.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.44 149.21 62.2 Favored 'Trans proline' 0 C--N 1.376 2.02 0 C-N-CA 122.373 2.049 . . . . 75.0 110.654 169.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 49.4 mt -77.49 171.2 15.26 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.332 0.653 . . . . 75.0 109.716 178.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -138.21 143.48 40.18 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-O 120.878 0.371 . . . . 75.0 111.131 -172.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.503 HG23 ' HG2' ' A' ' 9' ' ' MET . 27.2 pt -123.22 154.26 28.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 124.337 1.055 . . . . 75.0 108.651 170.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 70.4 mtm180 -131.59 94.08 3.46 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 108.458 -0.941 . . . . 75.0 108.458 176.845 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.9 mt -85.95 93.07 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 108.692 -0.855 . . . . 75.0 108.692 179.343 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.1 t -70.34 141.85 52.24 Favored 'General case' 0 CA--C 1.551 0.998 0 CA-C-N 115.366 -0.833 . . . . 75.0 110.373 -175.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 78.8 ttt180 -74.01 94.71 2.4 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-O 120.989 0.424 . . . . 75.0 110.438 -176.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -78.83 142.55 36.79 Favored 'General case' 0 C--O 1.241 0.646 0 CA-C-N 115.717 -0.674 . . . . 75.0 109.776 174.741 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -63.47 123.4 80.85 Favored Pre-proline 0 CA--C 1.55 0.946 0 CA-C-O 118.713 -0.661 . . . . 75.0 109.686 176.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo . . . . . 0 C--N 1.378 2.121 0 C-N-CA 122.935 2.423 . . . . 75.0 111.952 -175.334 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 91.9 m-70 . . . . . 0 N--CA 1.479 1.002 0 N-CA-C 110.032 -0.359 . . . . 75.0 110.032 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 91.1 m-70 -80.03 91.3 5.46 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 109.187 -0.672 . . . . 75.0 109.187 176.702 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -151.13 128.63 11.4 Favored 'General case' 0 N--CA 1.473 0.682 0 N-CA-C 109.403 -0.591 . . . . 75.0 109.403 177.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 74.6 m-70 -139.65 173.33 11.64 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.493 1.117 . . . . 75.0 109.286 179.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 48.7 m-70 -147.18 170.24 17.65 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 123.533 0.733 . . . . 75.0 110.67 177.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.559 ' HA ' ' HG3' ' A' ' 79' ' ' PRO . 23.3 m-70 -74.77 93.32 2.58 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-N 114.872 -1.058 . . . . 75.0 108.24 171.422 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.1 m -113.07 -176.68 2.95 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.48 0.657 . . . . 75.0 111.511 -168.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 10.4 m170 -78.65 163.14 25.71 Favored 'General case' 0 C--O 1.247 0.965 0 CA-C-N 114.508 -1.224 . . . . 75.0 108.402 169.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 26.8 ptt? -49.02 136.9 13.82 Favored 'General case' 0 N--CA 1.486 1.338 0 C-N-CA 123.643 0.777 . . . . 75.0 110.567 174.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.2 m -65.21 140.06 20.34 Favored 'Isoleucine or valine' 0 C--O 1.249 1.07 0 N-CA-C 109.211 -0.663 . . . . 50.0 109.211 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.762 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 82.9 11.14 81.97 Favored Glycine 0 N--CA 1.438 -1.231 0 CA-C-O 118.657 -1.079 . . . . 50.0 113.176 -175.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.481 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 53.2 t0 -50.13 119.86 3.99 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 117.688 0.744 . . . . 50.0 110.438 -176.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.455 HG22 ' HB3' ' A' ' 59' ' ' ALA . 35.3 m -73.66 110.86 8.28 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 115.693 -0.685 . . . . 50.0 109.259 -169.591 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 32.2 m -133.13 157.25 42.78 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.057 0.943 . . . . 50.0 110.279 -179.174 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.514 ' HB3' ' HB2' ' A' ' 28' ' ' TRP . 30.7 m0 -101.2 143.11 31.69 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.279 -1.008 . . . . 50.0 108.279 168.465 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.91 112.95 42.71 Favored 'Isoleucine or valine' 0 C--O 1.246 0.869 0 N-CA-C 109.086 -0.709 . . . . 50.0 109.086 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 39.2 ttm180 -65.6 109.32 2.34 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 125.9 1.68 . . . . 75.0 110.745 174.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 26.7 ttm180 -119.32 142.53 48.03 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 124.175 0.99 . . . . 75.0 110.169 179.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -77.46 -78.32 0.13 Allowed 'General case' 0 CA--C 1.549 0.942 0 C-N-CA 122.869 0.467 . . . . 75.0 110.221 -178.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 56.08 22.44 5.95 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 124.366 1.066 . . . . 75.0 111.944 -168.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 27.8 p -144.26 142.97 30.8 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 125.012 1.325 . . . . 75.0 108.281 -172.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 68.6 mttm -85.83 -35.16 20.82 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 122.797 0.439 . . . . 75.0 111.974 -176.375 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -131.12 -29.57 1.83 Allowed 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 123.083 0.553 . . . . 75.0 111.347 -179.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 70.3 mt -65.16 157.32 29.03 Favored 'General case' 0 N--CA 1.48 1.05 0 CA-C-O 120.556 0.217 . . . . 75.0 110.592 179.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -62.87 144.76 96.69 Favored Pre-proline 0 CA--C 1.558 1.273 0 C-N-CA 123.892 0.877 . . . . 75.0 112.122 -173.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_endo -69.19 114.41 3.6 Favored 'Trans proline' 0 C--N 1.378 2.109 0 C-N-CA 122.775 2.317 . . . . 50.0 111.643 176.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 44.8 ttm180 -93.92 128.72 40.38 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.017 1.327 . . . . 75.0 110.447 -171.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.514 ' HB2' ' HB3' ' A' ' 15' ' ' TRP . 61.9 p-90 -76.08 151.69 37.01 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 122.657 0.383 . . . . 50.0 110.878 176.824 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 35.5 mtmm -141.07 163.76 32.1 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 123.1 0.56 . . . . 75.0 109.743 161.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.404 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . -167.93 -162.14 19.19 Favored Glycine 0 CA--C 1.538 1.471 0 N-CA-C 110.985 -0.846 . . . . 50.0 110.985 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -85.36 114.55 3.1 Favored 'Cis proline' 0 C--N 1.368 1.586 0 CA-C-N 119.365 1.583 . . . . 50.0 112.973 -2.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.468 ' HB3' HG11 ' A' ' 44' ' ' VAL . 74.5 m-85 -77.67 166.93 22.37 Favored 'General case' 0 N--CA 1.474 0.762 0 C-N-CA 123.431 0.693 . . . . 50.0 110.072 169.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.762 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 17.2 p -140.33 111.87 7.34 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.285 0.634 . . . . 50.0 111.283 -168.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.51 HG22 HG22 ' A' ' 44' ' ' VAL . 60.0 t -84.03 125.43 40.2 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 C-N-CA 122.888 0.475 . . . . 50.0 110.31 -178.81 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.542 ' HB3' HG21 ' A' ' 73' ' ' VAL . 81.0 mt -98.97 -45.47 5.94 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 123.746 0.818 . . . . 50.0 110.262 177.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.536 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 48.8 tp -132.58 153.71 50.74 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 115.438 -0.801 . . . . 50.0 109.486 -173.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.483 HG22 HD22 ' A' ' 42' ' ' LEU . 60.5 p -125.65 148.6 48.94 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 123.148 0.579 . . . . 50.0 110.027 176.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . 0.461 ' HB ' ' HD2' ' A' ' 39' ' ' PRO . 40.3 p -140.03 165.93 27.32 Favored Pre-proline 0 CA--C 1.561 1.373 0 C-N-CA 125.372 1.469 . . . . 50.0 107.869 175.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.461 ' HD2' ' HB ' ' A' ' 38' ' ' THR . 9.7 Cg_endo -51.92 108.18 0.23 Allowed 'Trans proline' 0 C--N 1.385 2.47 0 C-N-CA 122.572 2.182 . . . . 50.0 112.993 -179.408 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 1.8 m 64.25 20.91 12.36 Favored 'General case' 0 CA--C 1.559 1.308 0 C-N-CA 125.512 1.525 . . . . 50.0 112.581 174.593 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -151.57 129.44 11.68 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 109.167 -0.679 . . . . 50.0 109.167 178.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.703 HD12 HG11 ' A' ' 56' ' ' VAL . 33.8 mt -112.95 130.72 56.02 Favored 'General case' 0 N--CA 1.477 0.882 0 O-C-N 121.963 -0.46 . . . . 50.0 109.984 -177.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.536 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 87.1 tttt -84.95 109.23 18.01 Favored 'General case' 0 C--O 1.246 0.898 0 N-CA-C 108.859 -0.793 . . . . 75.0 108.859 175.391 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.513 ' HB ' HG13 ' A' ' 47' ' ' ILE . 86.7 t -97.26 149.05 5.14 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.784 0 CA-C-N 113.984 -1.462 . . . . 50.0 109.277 176.36 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 36.3 t70 -67.45 130.2 42.31 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 123.885 0.874 . . . . 50.0 111.008 177.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 94.88 -7.31 70.22 Favored Glycine 0 C--N 1.346 1.131 0 CA-C-N 116.051 -0.522 . . . . 50.0 112.959 -178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.513 HG13 ' HB ' ' A' ' 44' ' ' VAL . 49.0 mm -90.53 149.54 4.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.713 0 C-N-CA 123.701 0.8 . . . . 50.0 110.056 -179.41 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -56.75 -46.99 81.07 Favored 'General case' 0 C--N 1.357 0.893 0 C-N-CA 123.935 0.894 . . . . 50.0 111.813 -178.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.79 -58.38 0.17 Allowed 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 112.074 0.398 . . . . 50.0 112.074 174.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 16.6 m-90 -143.28 156.92 44.84 Favored 'General case' 0 N--CA 1.487 1.419 0 C-N-CA 122.888 0.475 . . . . 50.0 111.806 -176.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 38.6 mm -120.44 118.24 55.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.631 0 C-N-CA 125.109 1.364 . . . . 50.0 107.346 165.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 55.7 t-80 -68.54 151.71 46.39 Favored 'General case' 0 CA--C 1.559 1.295 0 C-N-CA 123.705 0.802 . . . . 50.0 109.268 -172.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -51.09 -43.3 61.02 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 115.846 1.795 . . . . 50.0 115.846 -161.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -73.57 -19.79 60.79 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 112.448 0.536 . . . . 50.0 112.448 -174.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.9 m-70 -79.27 -14.96 58.69 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 122.721 0.409 . . . . 50.0 110.446 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.703 HG11 HD12 ' A' ' 42' ' ' LEU . 40.5 t -99.22 137.75 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-O 120.992 0.425 . . . . 50.0 110.068 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.431 ' HD2' ' NH2' ' A' ' 17' ' ' ARG . 51.4 mtpt -136.38 137.52 40.62 Favored 'General case' 0 N--CA 1.47 0.556 0 C-N-CA 124.379 1.072 . . . . 75.0 108.208 169.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -63.9 136.58 57.48 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 122.857 0.463 . . . . 50.0 110.491 174.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.455 ' HB3' HG22 ' A' ' 13' ' ' THR . . . -122.5 158.46 29.77 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.111 0.965 . . . . 50.0 110.868 -175.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 61.8 t0 -93.8 112.55 57.43 Favored Pre-proline 0 CA--C 1.545 0.782 0 C-N-CA 124.11 0.964 . . . . 75.0 109.847 -178.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -83.94 -15.14 7.09 Favored 'Trans proline' 0 C--N 1.373 1.865 0 C-N-CA 122.565 2.177 . . . . 75.0 113.707 174.778 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 63.4 37.77 95.34 Favored Glycine 0 C--N 1.353 1.525 0 O-C-N 123.34 0.4 . . . . 75.0 112.175 -172.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 101.33 -112.15 4.31 Favored Glycine 0 C--N 1.348 1.239 0 N-CA-C 110.898 -0.881 . . . . 75.0 110.898 -173.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 64.97 65.54 2.89 Favored Glycine 0 CA--C 1.542 1.767 0 CA-C-O 119.498 -0.612 . . . . 75.0 114.317 176.899 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -98.12 29.07 0.15 Allowed 'Trans proline' 0 C--N 1.382 2.299 0 C-N-CA 123.823 3.015 . . . . 75.0 112.855 175.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 78.4 p -63.73 -30.67 71.74 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.328 0.862 . . . . 75.0 113.328 -169.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 47.4 t -149.47 -21.88 0.28 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 112.303 0.483 . . . . 75.0 112.303 -170.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 82.6 mtm180 -70.55 -9.5 56.9 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 112.983 0.734 . . . . 75.0 112.983 -175.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.46 -4.54 34.35 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.564 0.745 . . . . 75.0 112.201 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 30.7 m -64.29 -45.39 88.19 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 122.998 0.519 . . . . 75.0 110.134 173.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 7.3 m0 50.18 40.41 21.94 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.164 0.986 . . . . 75.0 112.059 179.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 28.2 ptt-85 -59.7 -34.44 72.89 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 115.432 -0.804 . . . . 75.0 112.795 -170.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.542 HG21 ' HB3' ' A' ' 35' ' ' LEU . 46.5 t -76.75 -31.49 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.806 0 C-N-CA 123.069 0.548 . . . . 75.0 110.067 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HG3' HD21 ' A' ' 80' ' ' LEU . 31.1 mm-40 -86.8 -2.68 58.75 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 115.596 -0.729 . . . . 75.0 111.723 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.401 ' NE ' ' HA ' ' A' ' 75' ' ' ARG . 2.9 mmp_? -66.48 -25.05 66.52 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 122.684 0.394 . . . . 75.0 111.716 175.571 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 18.4 m -71.52 -8.11 51.85 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 113.561 0.949 . . . . 75.0 113.561 -175.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -155.38 -52.13 0.09 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 109.133 -0.691 . . . . 75.0 109.133 -177.828 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.0 t30 70.79 74.92 0.25 Allowed Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 125.402 1.481 . . . . 75.0 110.446 -172.953 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.559 ' HG3' ' HA ' ' A' ' 6' ' ' HIS . 42.7 Cg_endo -91.27 20.55 0.91 Allowed 'Trans proline' 0 C--N 1.379 2.179 0 C-N-CA 123.44 2.76 . . . . 75.0 111.574 171.178 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.513 HD21 ' HG3' ' A' ' 74' ' ' GLN . 92.0 mt -75.72 100.32 4.65 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.425 1.09 . . . . 75.0 110.537 -172.435 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -72.59 125.62 27.91 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 114.411 -1.268 . . . . 75.0 109.565 -178.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 27.4 pt -72.84 79.94 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.552 1.034 0 CA-C-O 122.139 0.971 . . . . 75.0 110.417 179.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 80.1 mtp180 -73.85 171.14 13.94 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-N 114.961 -1.018 . . . . 75.0 111.406 -177.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 87.6 mt -82.38 65.7 7.63 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.997 0.904 . . . . 75.0 110.377 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 29.7 m -109.72 94.92 5.28 Favored 'General case' 0 C--O 1.242 0.677 0 CA-C-N 114.667 -1.152 . . . . 75.0 108.053 176.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 99.6 mtt180 -65.15 107.27 1.51 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.277 -0.874 . . . . 75.0 110.733 -175.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 -68.82 143.62 54.52 Favored 'General case' 0 C--O 1.241 0.624 0 CA-C-N 115.172 -0.922 . . . . 75.0 110.89 177.301 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -121.54 87.17 45.23 Favored Pre-proline 0 CA--C 1.545 0.768 0 N-CA-C 108.654 -0.869 . . . . 75.0 108.654 172.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo . . . . . 0 C--N 1.375 1.94 0 C-N-CA 123.205 2.603 . . . . 75.0 110.9 -178.551 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 . . . . . 0 N--CA 1.484 1.256 0 CA-C-O 121.04 0.448 . . . . 75.0 110.57 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 81.6 t60 -87.3 101.02 13.14 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 108.809 -0.811 . . . . 75.0 108.809 172.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 12.3 p80 -134.75 158.4 44.24 Favored 'General case' 0 N--CA 1.474 0.751 0 C-N-CA 123.623 0.769 . . . . 75.0 110.106 178.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -151.06 155.16 38.41 Favored 'General case' 0 C--O 1.242 0.702 0 C-N-CA 124.309 1.044 . . . . 75.0 109.894 -179.732 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 75.8 t60 -161.86 43.41 0.15 Allowed 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 108.454 -0.943 . . . . 75.0 108.454 177.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.482 ' HB2' ' HG2' ' A' ' 77' ' ' GLN . 48.6 t-80 67.08 152.9 0.08 Allowed 'General case' 0 N--CA 1.481 1.102 0 CA-C-N 114.462 -1.245 . . . . 75.0 110.865 -170.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 67.5 p -158.89 179.56 8.97 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-O 121.481 0.657 . . . . 75.0 111.717 177.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -69.32 161.9 28.36 Favored 'General case' 0 C--O 1.25 1.117 0 CA-C-N 114.3 -1.318 . . . . 75.0 107.714 159.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 15.0 ptt? -54.02 132.63 42.84 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 109.674 -0.491 . . . . 75.0 109.674 -177.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.634 HG11 ' HB ' ' A' ' 73' ' ' VAL . 3.3 m -63.45 106.27 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.956 0 N-CA-C 109.128 -0.693 . . . . 50.0 109.128 176.271 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.428 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 116.08 9.08 12.42 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-O 119.061 -0.855 . . . . 50.0 113.166 -167.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.48 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 52.7 t0 -62.12 132.1 51.72 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 117.747 0.773 . . . . 50.0 111.434 -175.259 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 59' ' ' ALA . 19.2 m -82.44 106.56 14.41 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 123.478 0.711 . . . . 50.0 110.825 -173.709 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.512 ' HA ' ' H ' ' A' ' 59' ' ' ALA . 24.6 m -131.76 -177.96 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.836 0 C-N-CA 124.591 1.156 . . . . 50.0 109.874 177.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.461 ' HD1' ' HA3' ' A' ' 30' ' ' GLY . 29.6 m0 -128.1 154.22 45.96 Favored 'General case' 0 C--O 1.239 0.512 0 C-N-CA 125.411 1.484 . . . . 50.0 107.542 173.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 69.8 t -108.13 107.92 23.99 Favored 'Isoleucine or valine' 0 C--O 1.24 0.558 0 N-CA-C 107.831 -1.174 . . . . 50.0 107.831 171.762 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.617 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 50.9 ttp180 -82.43 94.16 7.36 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.583 1.153 . . . . 75.0 109.422 178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 65.3 ttt180 -77.31 112.16 13.73 Favored 'General case' 0 C--O 1.241 0.656 0 N-CA-C 109.432 -0.581 . . . . 75.0 109.432 -178.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 14.8 t-80 -76.92 130.95 38.25 Favored 'General case' 0 N--CA 1.468 0.446 0 N-CA-C 109.199 -0.667 . . . . 75.0 109.199 174.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 73.0 mm-40 -79.38 -155.51 0.1 Allowed 'General case' 0 CA--C 1.549 0.905 0 N-CA-C 109.328 -0.619 . . . . 75.0 109.328 173.297 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . 0.49 HG22 ' H ' ' A' ' 22' ' ' LYS . 2.0 m -68.34 173.6 4.73 Favored 'General case' 0 CA--C 1.57 1.739 0 O-C-N 121.766 -0.584 . . . . 75.0 111.338 -175.187 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . 0.49 ' H ' HG22 ' A' ' 21' ' ' THR . 43.0 mtmt -52.36 -50.4 62.45 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.235 1.014 . . . . 75.0 112.722 -174.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 41.0 m-20 -81.74 2.05 31.61 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 115.835 -0.621 . . . . 75.0 111.647 -176.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.7 mt -112.71 157.39 21.34 Favored 'General case' 0 N--CA 1.473 0.725 0 C-N-CA 124.04 0.936 . . . . 75.0 110.359 179.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -94.43 162.55 25.68 Favored Pre-proline 0 CA--C 1.553 1.078 0 C-N-CA 124.726 1.211 . . . . 75.0 110.756 -177.217 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.509 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 78.1 Cg_endo -83.2 172.06 10.93 Favored 'Trans proline' 0 C--N 1.382 2.29 0 C-N-CA 122.604 2.203 . . . . 50.0 113.756 177.256 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 40.9 ttm180 -154.6 129.59 9.49 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.22 1.008 . . . . 75.0 108.8 177.042 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.617 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 63.3 p-90 -86.84 152.59 22.34 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-O 121.033 0.444 . . . . 50.0 111.679 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -136.09 164.05 28.92 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.745 1.218 . . . . 75.0 107.916 167.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.461 ' HA3' ' HD1' ' A' ' 15' ' ' TRP . . . 170.09 -159.98 32.71 Favored Glycine 0 CA--C 1.533 1.203 0 CA-C-O 119.563 -0.576 . . . . 50.0 112.608 178.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -82.74 120.05 6.52 Favored 'Cis proline' 0 C--N 1.376 2.02 0 CA-C-N 119.144 1.472 . . . . 50.0 112.964 -2.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.418 ' HB3' HG11 ' A' ' 44' ' ' VAL . 84.5 m-85 -81.98 154.39 25.74 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.987 0.915 . . . . 50.0 109.666 172.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.478 ' HA ' ' O ' ' A' ' 12' ' ' ASP . 40.9 p -114.6 110.75 20.27 Favored 'General case' 0 CA--C 1.546 0.789 0 C-N-CA 122.737 0.415 . . . . 50.0 111.442 -176.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 44' ' ' VAL . 79.4 t -70.69 130.71 34.82 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 C-N-CA 123.153 0.581 . . . . 50.0 109.498 172.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.603 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 62.4 mt -103.43 -58.66 1.84 Allowed 'General case' 0 C--O 1.236 0.379 0 C-N-CA 124.043 0.937 . . . . 50.0 109.266 176.103 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.578 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 59.6 tp -123.65 155.97 36.75 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.215 -0.902 . . . . 50.0 109.659 -172.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.504 HG22 HD22 ' A' ' 42' ' ' LEU . 69.2 p -125.97 130.05 50.46 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.905 0.882 . . . . 50.0 109.724 -179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 17.0 p -140.07 95.28 8.53 Favored Pre-proline 0 CA--C 1.558 1.274 0 C-N-CA 124.247 1.019 . . . . 50.0 108.976 -177.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_exo -27.28 127.34 0.04 OUTLIER 'Trans proline' 0 C--N 1.388 2.645 1 C-N-CA 125.632 4.221 . . . . 50.0 116.471 -166.268 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 30.8 m 86.79 -12.22 0.56 Allowed 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.499 1.919 . . . . 50.0 111.65 -173.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.433 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -152.23 149.77 29.08 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 121.762 -0.586 . . . . 50.0 110.861 175.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.681 HD12 HG11 ' A' ' 56' ' ' VAL . 38.9 mt -120.42 134.45 55.27 Favored 'General case' 0 N--CA 1.477 0.892 0 N-CA-C 108.536 -0.913 . . . . 50.0 108.536 176.289 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.578 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 60.8 tttm -83.47 108.9 16.92 Favored 'General case' 0 C--O 1.241 0.629 0 N-CA-C 108.604 -0.887 . . . . 75.0 108.604 178.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.508 HG22 HG22 ' A' ' 34' ' ' VAL . 63.0 t -108.86 135.9 46.3 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.707 0 C-N-CA 124.627 1.171 . . . . 50.0 109.512 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.454 ' HB2' HD11 ' A' ' 35' ' ' LEU . 23.7 t70 -68.02 143.27 55.62 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 123.607 0.763 . . . . 50.0 110.646 174.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 91.59 -19.17 49.49 Favored Glycine 0 C--N 1.343 0.947 0 CA-C-N 116.366 -0.379 . . . . 50.0 112.394 -174.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.3 mm -94.0 159.06 2.86 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.254 1.022 . . . . 50.0 110.01 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.44 -52.13 60.42 Favored 'General case' 0 C--N 1.359 0.984 0 C-N-CA 123.841 0.856 . . . . 50.0 111.538 179.688 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -154.12 -57.61 0.11 Allowed 'General case' 0 CA--C 1.548 0.868 0 O-C-N 123.271 0.357 . . . . 50.0 111.666 169.391 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.433 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 19.1 m-90 -136.47 134.76 37.99 Favored 'General case' 0 N--CA 1.49 1.545 0 C-N-CA 122.902 0.481 . . . . 50.0 111.74 -173.098 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 30.7 mm -94.72 125.24 47.39 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 N-CA-C 108.26 -1.015 . . . . 50.0 108.26 166.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -64.28 136.62 57.34 Favored 'General case' 0 N--CA 1.475 0.778 0 N-CA-C 107.548 -1.279 . . . . 50.0 107.548 178.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -57.86 -28.65 64.34 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 114.793 1.405 . . . . 50.0 114.793 -160.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -74.33 -2.9 27.19 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.451 0.537 . . . . 50.0 112.451 179.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -109.57 9.13 25.25 Favored 'General case' 0 N--CA 1.476 0.849 0 C-N-CA 123.933 0.893 . . . . 50.0 110.201 173.396 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.681 HG11 HD12 ' A' ' 42' ' ' LEU . 37.2 t -105.86 125.4 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.597 -0.52 . . . . 50.0 109.597 176.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 22.1 ttmm -125.24 110.94 14.65 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 108.425 -0.954 . . . . 75.0 108.425 176.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.439 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -58.98 117.46 4.69 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 123.53 0.732 . . . . 50.0 110.248 179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.512 ' H ' ' HA ' ' A' ' 14' ' ' VAL . . . -81.42 154.05 26.6 Favored 'General case' 0 C--O 1.24 0.56 0 N-CA-C 109.674 -0.491 . . . . 50.0 109.674 -175.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -103.47 97.5 10.52 Favored Pre-proline 0 N--CA 1.475 0.818 0 C-N-CA 123.36 0.664 . . . . 75.0 109.287 177.389 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -88.92 -3.39 6.28 Favored 'Trans proline' 0 C--N 1.376 1.987 0 C-N-CA 122.572 2.181 . . . . 75.0 112.87 175.746 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 72.78 -75.86 0.87 Allowed Glycine 0 C--N 1.354 1.565 0 N-CA-C 110.56 -1.016 . . . . 75.0 110.56 -168.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -111.01 -80.66 1.12 Allowed Glycine 0 C--N 1.345 1.076 0 N-CA-C 110.219 -1.153 . . . . 75.0 110.219 170.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 128.64 -137.23 9.52 Favored Glycine 0 C--N 1.342 0.911 0 CA-C-O 118.485 -1.175 . . . . 75.0 111.815 179.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -72.31 110.88 3.07 Favored 'Trans proline' 0 C--N 1.374 1.912 0 C-N-CA 122.328 2.018 . . . . 75.0 110.769 174.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 55.5 p -65.71 -27.38 68.29 Favored 'General case' 0 N--CA 1.486 1.339 0 C-N-CA 123.326 0.65 . . . . 75.0 111.387 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 19.3 m -82.16 9.84 7.88 Favored 'General case' 0 CA--C 1.558 1.259 0 CA-C-N 115.584 -0.735 . . . . 75.0 111.316 174.231 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 12.7 ptp180 49.34 40.82 19.33 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 126.058 1.743 . . . . 75.0 113.197 172.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 81.4 mt -70.56 83.58 0.6 Allowed 'General case' 0 CA--C 1.549 0.911 0 CA-C-N 114.579 -1.191 . . . . 75.0 110.708 -175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 31.7 p -110.55 151.16 27.93 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.701 1.2 . . . . 75.0 108.493 176.331 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 52.8 m95 -67.18 -19.14 65.53 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 123.625 0.77 . . . . 75.0 112.02 -175.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 96.0 mtt180 53.61 29.53 9.43 Favored 'General case' 0 N--CA 1.495 1.817 0 C-N-CA 126.15 1.78 . . . . 75.0 113.46 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.634 ' HB ' HG11 ' A' ' 10' ' ' VAL . 61.2 t -70.07 -51.53 38.62 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.892 0 C-N-CA 123.301 0.641 . . . . 75.0 109.997 174.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.489 ' HG2' HD11 ' A' ' 80' ' ' LEU . 5.8 tp-100 -86.55 84.72 7.35 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 121.414 0.626 . . . . 75.0 109.871 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 82.8 mtm180 -114.5 1.16 14.24 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 124.04 0.936 . . . . 75.0 109.506 167.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 14.5 m -67.97 -67.87 0.43 Allowed 'General case' 0 C--N 1.352 0.701 0 C-N-CA 124.262 1.025 . . . . 75.0 110.479 -175.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.482 ' HG2' ' HB2' ' A' ' 6' ' ' HIS . 22.8 tp60 -85.89 80.26 8.96 Favored 'General case' 0 C--O 1.247 0.929 0 N-CA-C 108.362 -0.977 . . . . 75.0 108.362 173.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 66.05 140.43 0.06 OUTLIER Pre-proline 0 CA--C 1.558 1.272 0 C-N-CA 125.842 1.657 . . . . 75.0 111.807 -178.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_exo -64.8 107.58 0.92 Allowed 'Trans proline' 0 C--N 1.371 1.734 0 C-N-CA 121.878 1.719 . . . . 75.0 110.264 166.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.489 HD11 ' HG2' ' A' ' 74' ' ' GLN . 67.5 mt -66.81 145.24 55.71 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.569 0.747 . . . . 75.0 111.816 -172.155 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -61.1 140.93 57.76 Favored 'General case' 0 CA--C 1.547 0.83 0 O-C-N 124.34 1.025 . . . . 75.0 110.663 178.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 26.6 pt -79.41 7.56 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 C-N-CA 124.253 1.021 . . . . 75.0 112.392 -173.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 38.3 ttt-85 73.26 -5.04 2.04 Favored 'General case' 0 N--CA 1.486 1.353 0 C-N-CA 125.865 1.666 . . . . 75.0 112.483 171.704 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 76.5 mt -78.84 156.52 28.66 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-O 121.22 0.533 . . . . 75.0 110.775 -175.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.1 t -76.24 -161.15 0.17 Allowed 'General case' 0 CA--C 1.566 1.587 0 C-N-CA 124.661 1.184 . . . . 75.0 109.454 172.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 10.8 ptm180 -60.3 137.61 58.1 Favored 'General case' 0 C--N 1.362 1.15 0 CA-C-N 118.989 0.813 . . . . 75.0 110.773 177.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.57 147.04 25.76 Favored 'General case' 0 N--CA 1.478 0.964 0 N-CA-C 108.211 -1.033 . . . . 75.0 108.211 179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . 67.11 94.22 0.05 OUTLIER Pre-proline 0 CA--C 1.554 1.132 0 C-N-CA 124.426 1.09 . . . . 75.0 109.992 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo . . . . . 0 C--N 1.379 2.173 0 C-N-CA 122.852 2.368 . . . . 75.0 111.837 -179.551 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 . . . . . 0 N--CA 1.477 0.886 0 N-CA-C 109.39 -0.596 . . . . 75.0 109.39 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -136.54 116.03 12.81 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.064 0.946 . . . . 75.0 109.02 -178.107 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 30.6 p-80 -149.9 82.09 1.39 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 121.86 0.838 . . . . 75.0 109.514 -178.021 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -88.95 141.05 28.82 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.693 0.797 . . . . 75.0 110.179 -178.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 80.5 m80 -136.52 177.27 7.98 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.487 0.715 . . . . 75.0 110.513 -175.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 13.6 m-70 -70.76 91.24 0.82 Allowed 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 108.464 -0.939 . . . . 75.0 108.464 174.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 65.4 m -118.83 174.14 6.46 Favored 'General case' 0 N--CA 1.469 0.506 0 C-N-CA 123.821 0.848 . . . . 75.0 111.228 -172.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 43.1 m170 -73.49 160.22 32.04 Favored 'General case' 0 C--O 1.246 0.901 0 N-CA-C 109.504 -0.554 . . . . 75.0 109.504 173.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.5 ptt? -56.03 133.29 51.72 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 123.648 0.779 . . . . 75.0 109.685 174.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 34.2 m -63.0 131.12 28.36 Favored 'Isoleucine or valine' 0 C--N 1.349 0.581 0 C-N-CA 122.653 0.381 . . . . 50.0 110.103 -178.481 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.671 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 92.46 11.69 59.24 Favored Glycine 0 CA--C 1.532 1.135 0 CA-C-O 119.3 -0.722 . . . . 50.0 113.342 -175.666 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.567 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 56.7 t0 -51.52 113.47 0.98 Allowed 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 123.855 0.862 . . . . 50.0 111.314 -177.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 31' ' ' PRO . 95.5 m -73.11 115.63 12.67 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 123.369 0.668 . . . . 50.0 110.51 -173.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 28.7 m -140.3 168.74 16.8 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 124.689 1.196 . . . . 50.0 110.328 -176.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 50.0 m0 -112.5 130.75 55.89 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 108.271 -1.011 . . . . 50.0 108.271 169.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 56' ' ' VAL . 70.6 t -110.65 115.41 49.73 Favored 'Isoleucine or valine' 0 C--O 1.243 0.762 0 N-CA-C 109.238 -0.653 . . . . 50.0 109.238 178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.693 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.9 ttm180 -89.29 123.07 33.15 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.399 1.479 . . . . 75.0 110.438 176.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 34.5 ttm180 -120.22 148.41 43.71 Favored 'General case' 0 C--O 1.245 0.847 0 N-CA-C 107.763 -1.199 . . . . 75.0 107.763 174.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.535 ' HA ' ' HB3' ' A' ' 26' ' ' PRO . 7.9 t-160 -61.63 -53.27 58.43 Favored 'General case' 0 C--N 1.357 0.923 0 C-N-CA 122.828 0.451 . . . . 75.0 111.045 -169.521 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.9 mm100 60.65 13.88 4.6 Favored 'General case' 0 N--CA 1.488 1.465 0 C-N-CA 124.081 0.952 . . . . 75.0 113.407 174.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 28.3 p -148.32 -179.71 7.14 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.099 0.96 . . . . 75.0 110.401 -171.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 66.1 mttm -107.81 -53.46 2.62 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.911 0.884 . . . . 75.0 110.227 173.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -132.73 15.58 4.36 Favored 'General case' 0 N--CA 1.489 1.491 0 C-N-CA 123.823 0.849 . . . . 75.0 111.492 -172.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 89.0 mt -112.32 179.38 4.01 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.079 0.551 . . . . 75.0 110.065 174.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 26' ' ' PRO . 45.0 mt-10 -72.0 149.8 92.42 Favored Pre-proline 0 CA--C 1.548 0.889 0 C-N-CA 123.801 0.84 . . . . 75.0 111.831 -174.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.535 ' HB3' ' HA ' ' A' ' 19' ' ' HIS . 7.0 Cg_exo -74.64 130.04 13.29 Favored 'Trans proline' 0 C--N 1.375 1.972 0 C-N-CA 123.072 2.515 . . . . 50.0 111.22 177.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 59.8 ttm-85 -93.59 132.8 37.56 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 109.469 -0.567 . . . . 75.0 109.469 -174.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.693 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 68.4 p-90 -96.65 156.55 16.3 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 122.757 0.423 . . . . 50.0 110.711 177.121 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 28.8 mtmm -138.13 172.0 13.57 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.92 0.888 . . . . 75.0 109.458 167.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.65 -176.12 46.27 Favored Glycine 0 CA--C 1.538 1.485 0 CA-C-N 115.391 -0.822 . . . . 50.0 111.468 175.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . 0.454 ' HB2' HG23 ' A' ' 13' ' ' THR . 89.4 Cg_endo -88.37 106.28 0.71 Allowed 'Cis proline' 0 C--N 1.368 1.596 0 CA-C-N 119.286 1.543 . . . . 50.0 112.479 -2.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.436 ' HB3' HG11 ' A' ' 44' ' ' VAL . 53.0 m-85 -64.69 162.03 16.64 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.552 0.741 . . . . 50.0 110.384 172.465 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.671 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 14.0 p -134.01 111.14 10.15 Favored 'General case' 0 CA--C 1.546 0.812 0 C-N-CA 123.009 0.524 . . . . 50.0 110.748 -175.267 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 44' ' ' VAL . 21.7 t -81.91 130.1 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 C-N-CA 123.357 0.663 . . . . 50.0 109.553 -178.23 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 85.9 mt -103.56 -32.74 9.3 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.421 0.689 . . . . 50.0 110.765 -177.783 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.527 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 39.7 tp -142.89 143.26 31.98 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 109.13 -0.693 . . . . 50.0 109.13 -172.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 75.9 p -136.96 132.14 33.96 Favored 'General case' 0 N--CA 1.482 1.175 0 CA-C-O 121.339 0.59 . . . . 50.0 111.01 177.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 41.0 p -117.42 164.99 16.88 Favored Pre-proline 0 CA--C 1.57 1.739 0 C-N-CA 126.068 1.747 . . . . 50.0 108.585 171.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -48.75 111.44 0.47 Allowed 'Trans proline' 0 C--N 1.387 2.589 0 C-N-CA 123.404 2.736 . . . . 50.0 113.541 178.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 64.71 12.24 7.45 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 125.936 1.694 . . . . 50.0 112.961 175.688 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.417 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -136.58 119.64 16.52 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.523 -0.918 . . . . 50.0 108.523 177.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 29.8 mt -111.46 119.23 38.1 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.166 -1.05 . . . . 50.0 108.166 -174.977 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.527 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 81.0 tttt -86.66 106.57 17.7 Favored 'General case' 0 C--O 1.255 1.347 0 N-CA-C 109.222 -0.659 . . . . 75.0 109.222 176.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 HG22 ' A' ' 34' ' ' VAL . 38.8 t -91.43 155.33 3.09 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.797 0 CA-C-N 114.378 -1.283 . . . . 50.0 108.976 176.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.15 123.21 17.05 Favored 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 123.706 0.802 . . . . 50.0 111.093 174.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.21 2.93 65.67 Favored Glycine 0 C--N 1.341 0.823 0 CA-C-N 115.684 -0.689 . . . . 50.0 113.637 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 30.8 mm -89.05 150.97 3.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.88 0 C-N-CA 123.409 0.684 . . . . 50.0 110.344 177.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.17 -52.09 59.92 Favored 'General case' 0 C--N 1.362 1.121 0 C-N-CA 124.642 1.177 . . . . 50.0 112.04 -178.684 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -152.19 -56.75 0.14 Allowed 'General case' 0 N--CA 1.478 0.941 0 O-C-N 123.42 0.45 . . . . 50.0 111.345 171.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.417 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 20.6 m-90 -144.64 157.08 44.36 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.11 0.564 . . . . 50.0 111.173 178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . . . . . . . . . 42.7 mm -118.11 136.09 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.152 0 C-N-CA 124.238 1.015 . . . . 50.0 108.355 168.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 62.6 t-80 -64.24 127.94 33.64 Favored 'General case' 0 CA--C 1.546 0.801 0 N-CA-C 108.474 -0.936 . . . . 50.0 108.474 175.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -54.85 -23.11 16.95 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 114.86 1.43 . . . . 50.0 114.86 -164.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -59.86 -38.36 81.91 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 123.234 0.614 . . . . 50.0 111.95 178.765 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 90.8 m-70 -77.54 2.11 17.4 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.456 0.702 . . . . 50.0 112.616 179.631 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.503 HG22 HG22 ' A' ' 16' ' ' VAL . 61.3 t -120.07 135.65 59.67 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 N-CA-C 109.497 -0.557 . . . . 50.0 109.497 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 46.9 mtpt -127.17 143.34 51.28 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.831 0.853 . . . . 75.0 108.865 174.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -65.45 122.35 16.97 Favored 'General case' 0 N--CA 1.477 0.876 0 C-N-CA 123.14 0.576 . . . . 50.0 110.636 174.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -109.65 156.92 19.62 Favored 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 123.508 0.723 . . . . 50.0 110.37 176.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 62.1 t0 -94.5 116.14 66.07 Favored Pre-proline 0 CA--C 1.551 0.989 0 C-N-CA 124.292 1.037 . . . . 75.0 109.782 -178.333 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -83.58 -11.27 9.37 Favored 'Trans proline' 0 C--N 1.381 2.253 0 C-N-CA 122.93 2.42 . . . . 75.0 113.442 175.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.59 -67.76 3.09 Favored Glycine 0 C--N 1.35 1.323 0 N-CA-C 111.005 -0.838 . . . . 75.0 111.005 -169.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -155.01 -105.76 0.25 Allowed Glycine 0 N--CA 1.454 -0.108 0 N-CA-C 109.21 -1.556 . . . . 75.0 109.21 173.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 65.42 62.01 5.21 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 119.243 -0.754 . . . . 75.0 114.854 176.046 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -86.16 105.46 0.77 Allowed 'Trans proline' 0 C--N 1.374 1.905 0 C-N-CA 122.5 2.133 . . . . 75.0 109.981 171.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 34.0 p -147.97 -82.87 0.12 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 122.669 0.387 . . . . 75.0 110.86 -174.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 37.1 t -70.77 -24.84 62.67 Favored 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 123.26 0.624 . . . . 75.0 111.097 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.574 ' HG2' ' HA3' ' A' ' 11' ' ' GLY . 33.6 mtm180 -73.49 -24.42 60.18 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 124.089 0.956 . . . . 75.0 112.501 179.513 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 94.7 mt -61.83 -18.06 58.62 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.374 0.67 . . . . 75.0 112.553 -178.345 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.409 HG21 ' NH1' ' A' ' 72' ' ' ARG . 48.4 m -55.97 -51.92 66.0 Favored 'General case' 0 CA--C 1.555 1.158 0 C-N-CA 124.541 1.136 . . . . 75.0 111.43 176.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . 0.474 ' O ' ' HG2' ' A' ' 75' ' ' ARG . 10.1 m0 49.4 27.89 2.16 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 114.916 1.45 . . . . 75.0 114.916 174.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.409 ' NH1' HG21 ' A' ' 70' ' ' THR . 14.5 ptt-85 -63.56 -28.51 69.99 Favored 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 113.566 0.95 . . . . 75.0 113.566 -174.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 25.2 t -78.65 -28.15 14.2 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 CA-C-O 121.312 0.577 . . . . 75.0 109.804 175.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 24.5 mm-40 -81.65 -11.95 58.88 Favored 'General case' 0 CA--C 1.551 0.997 0 C-N-CA 123.649 0.779 . . . . 75.0 110.624 177.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.474 ' HG2' ' O ' ' A' ' 71' ' ' TRP . 3.4 mmp_? -81.89 66.57 7.52 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 123.468 0.707 . . . . 75.0 110.11 175.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 66.9 m -157.93 -76.53 0.08 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.33 1.052 . . . . 75.0 108.852 -179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 20.4 tm0? -96.68 -25.55 15.51 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.895 0.878 . . . . 75.0 110.042 179.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 7.6 t30 60.31 83.9 0.2 Allowed Pre-proline 0 N--CA 1.477 0.917 0 C-N-CA 124.98 1.312 . . . . 75.0 110.969 -174.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.45 4.24 6.49 Favored 'Trans proline' 0 C--N 1.373 1.824 0 C-N-CA 122.962 2.441 . . . . 75.0 112.052 167.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.428 HD12 ' NH2' ' A' ' 75' ' ' ARG . 60.2 mt -75.47 84.08 2.56 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.04 0.936 . . . . 75.0 110.051 177.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -84.56 125.11 32.14 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.827 -0.805 . . . . 75.0 108.827 177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 34.4 pt -59.38 121.79 7.91 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.727 0 CA-C-O 121.79 0.805 . . . . 75.0 111.3 -176.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 74.2 mtp180 -116.99 137.43 52.23 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.6 1.16 . . . . 75.0 108.678 176.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 79.4 mt -73.07 82.52 1.27 Allowed 'General case' 0 CA--C 1.536 0.44 0 N-CA-C 108.548 -0.908 . . . . 75.0 108.548 175.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 91.5 m -87.03 138.3 31.61 Favored 'General case' 0 C--O 1.241 0.653 0 CA-C-N 114.063 -1.426 . . . . 75.0 107.782 176.004 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 53.7 mtt180 -68.1 84.41 0.23 Allowed 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.947 0.403 . . . . 75.0 110.523 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -78.66 108.12 11.84 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 108.249 -1.019 . . . . 75.0 108.249 175.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -119.72 80.74 24.43 Favored Pre-proline 0 CA--C 1.545 0.772 0 C-N-CA 123.488 0.715 . . . . 75.0 109.21 -179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_exo . . . . . 0 C--N 1.377 2.053 0 C-N-CA 122.894 2.396 . . . . 75.0 112.101 -177.721 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 80.8 m80 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 120.555 0.217 . . . . 75.0 110.475 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -110.11 100.87 9.72 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 108.035 -1.098 . . . . 75.0 108.035 168.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.3 t-80 -76.88 71.62 3.42 Favored 'General case' 0 CA--C 1.551 1.006 0 C-N-CA 123.931 0.893 . . . . 75.0 110.861 -171.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 50.1 m80 -154.45 132.95 12.02 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 125.303 1.441 . . . . 75.0 108.762 -178.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . 0.523 ' NE2' ' HB2' ' A' ' 67' ' ' SER . 11.4 p80 -173.88 86.17 0.05 OUTLIER 'General case' 0 CA--C 1.555 1.155 0 C-N-CA 124.666 1.186 . . . . 75.0 108.62 -178.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 10.8 t-80 -87.35 -25.62 23.78 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.665 -0.647 . . . . 75.0 109.315 176.448 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 48.5 m -78.84 -171.15 2.45 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.551 -1.204 . . . . 75.0 110.231 165.557 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 14.1 m-70 -68.0 157.36 35.29 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 123.089 0.555 . . . . 75.0 111.281 177.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 22.7 ptt? -135.1 176.77 8.36 Favored 'General case' 0 C--O 1.242 0.7 0 C-N-CA 124.141 0.976 . . . . 75.0 109.37 178.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.598 HG22 HG22 ' A' ' 70' ' ' THR . 0.9 OUTLIER -71.91 144.6 13.05 Favored 'Isoleucine or valine' 0 C--O 1.246 0.919 0 N-CA-C 108.686 -0.857 . . . . 50.0 108.686 176.371 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.407 ' HA3' ' HG2' ' A' ' 65' ' ' PRO . . . 99.82 7.81 52.55 Favored Glycine 0 CA--C 1.531 1.054 0 CA-C-O 119.704 -0.498 . . . . 50.0 112.92 -177.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . 0.762 ' HB3' ' HB ' ' A' ' 34' ' ' VAL . 63.3 t0 -68.0 110.75 4.05 Favored 'General case' 0 N--CA 1.483 1.192 0 C-N-CA 123.399 0.679 . . . . 50.0 109.998 -175.757 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 90.8 m -71.31 117.19 12.53 Favored 'General case' 0 CA--C 1.546 0.808 0 CA-C-O 121.301 0.572 . . . . 50.0 110.049 -175.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.526 HG12 ' HA ' ' A' ' 58' ' ' ALA . 27.5 m -139.53 -175.67 1.07 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.774 0 C-N-CA 124.478 1.111 . . . . 50.0 109.844 -179.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . 0.466 ' HB2' ' HB2' ' A' ' 57' ' ' LYS . 30.8 m0 -128.63 151.37 49.56 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 124.755 1.222 . . . . 50.0 107.738 173.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 70.3 t -109.53 104.37 16.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 N-CA-C 108.368 -0.975 . . . . 50.0 108.368 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.716 ' HG2' ' HB2' ' A' ' 26' ' ' PRO . 44.1 ttp180 -88.61 93.62 9.62 Favored 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.579 -1.191 . . . . 75.0 110.29 -178.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -94.08 128.09 40.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 115.905 -0.588 . . . . 75.0 110.363 -172.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -90.75 114.81 27.25 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.958 0.903 . . . . 75.0 109.13 178.441 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 90.4 mm-40 -82.04 -71.14 0.5 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.164 0.585 . . . . 75.0 110.738 179.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 75.3 p -111.42 153.51 25.99 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.572 0.749 . . . . 75.0 110.126 -179.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 67.3 mttm -67.81 -25.61 65.66 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 123.757 0.823 . . . . 75.0 111.335 177.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.9 t30 -66.33 -52.39 47.62 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.794 0.838 . . . . 75.0 110.084 177.168 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.2 mt -80.98 159.38 24.89 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 115.863 -0.608 . . . . 75.0 110.623 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -81.17 154.85 72.42 Favored Pre-proline 0 CA--C 1.554 1.113 0 C-N-CA 123.553 0.741 . . . . 75.0 109.614 172.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.716 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 42.1 Cg_endo -63.82 126.19 16.9 Favored 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 122.482 2.122 . . . . 50.0 112.208 179.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.4 ttm180 -100.06 129.31 46.09 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 123.601 0.76 . . . . 75.0 109.093 -176.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.633 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 66.3 p-90 -93.91 146.64 23.76 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-O 121.615 0.721 . . . . 50.0 112.156 -177.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 59.0 mttp -113.42 157.42 21.94 Favored 'General case' 0 C--O 1.245 0.839 0 CA-C-N 113.826 -1.534 . . . . 75.0 108.378 166.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -156.08 170.96 33.86 Favored Glycine 0 CA--C 1.537 1.437 0 O-C-N 124.232 0.957 . . . . 50.0 110.934 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -82.48 161.25 76.77 Favored 'Cis proline' 0 C--N 1.366 1.491 0 CA-C-N 119.355 1.577 . . . . 50.0 111.73 -9.166 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 63.7 m-85 -137.01 176.49 8.67 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 124.462 1.105 . . . . 50.0 110.196 177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.4 t -152.27 111.88 3.95 Favored 'General case' 0 CA--C 1.55 0.962 0 CA-C-N 115.63 -0.714 . . . . 50.0 111.372 -173.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.762 ' HB ' ' HB3' ' A' ' 12' ' ' ASP . 89.9 t -67.83 124.23 22.83 Favored 'Isoleucine or valine' 0 C--O 1.251 1.144 0 C-N-CA 123.887 0.875 . . . . 50.0 109.345 172.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 53.9 mt -105.95 -18.37 14.06 Favored 'General case' 0 CA--C 1.546 0.805 0 CA-C-N 115.166 -0.924 . . . . 50.0 110.736 177.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.627 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 36.2 tp -145.73 138.65 25.95 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 122.89 0.476 . . . . 50.0 110.055 172.727 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 80.4 p -107.35 137.15 45.92 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.207 1.003 . . . . 50.0 108.597 175.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 71.4 m -141.16 148.83 53.16 Favored Pre-proline 0 CA--C 1.554 1.109 0 N-CA-C 108.115 -1.069 . . . . 50.0 108.115 -175.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_endo -46.74 108.4 0.15 Allowed 'Trans proline' 0 C--N 1.374 1.902 0 C-N-CA 122.125 1.883 . . . . 50.0 112.949 170.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 7.4 m 70.45 17.74 6.79 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 125.516 1.526 . . . . 50.0 112.177 173.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.574 ' HB1' ' HB3' ' A' ' 50' ' ' TRP . . . -154.59 144.81 21.97 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 116.07 -0.514 . . . . 50.0 110.645 -177.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 96.7 mt -132.04 121.24 23.54 Favored 'General case' 0 C--O 1.242 0.697 0 N-CA-C 108.66 -0.867 . . . . 50.0 108.66 179.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 26.9 ttpp -85.44 109.38 18.41 Favored 'General case' 0 C--O 1.241 0.607 0 N-CA-C 108.081 -1.081 . . . . 75.0 108.081 174.063 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.449 HG22 HG22 ' A' ' 34' ' ' VAL . 95.5 t -103.75 155.62 5.6 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.919 0 C-N-CA 125.066 1.346 . . . . 50.0 108.902 -179.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -61.04 121.26 11.99 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 123.299 0.639 . . . . 50.0 110.994 177.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 108.96 -22.95 24.63 Favored Glycine 0 C--N 1.347 1.143 0 CA-C-N 115.862 -0.608 . . . . 50.0 112.879 -179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.435 HG21 HG12 ' A' ' 51' ' ' ILE . 33.9 mm -76.72 147.11 7.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.862 0 C-N-CA 123.702 0.801 . . . . 50.0 110.594 -176.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.56 -50.38 74.11 Favored 'General case' 0 C--N 1.357 0.898 0 O-C-N 123.688 0.618 . . . . 50.0 111.607 -178.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.18 -58.21 0.21 Allowed 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 112.183 0.438 . . . . 50.0 112.183 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . 0.574 ' HB3' ' HB1' ' A' ' 41' ' ' ALA . 21.2 m-90 -146.42 145.75 30.35 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 123.219 0.607 . . . . 50.0 112.206 178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.435 HG12 HG21 ' A' ' 47' ' ' ILE . 28.3 mm -106.99 125.68 63.05 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 C-N-CA 123.824 0.85 . . . . 50.0 108.899 168.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.1 t-80 -58.36 122.06 12.34 Favored 'General case' 0 CA--C 1.549 0.939 0 N-CA-C 108.266 -1.013 . . . . 50.0 108.266 175.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.408 ' HB2' HD13 ' A' ' 84' ' ' LEU . . . -55.41 -19.19 8.42 Favored 'General case' 0 N--CA 1.502 2.165 0 N-CA-C 115.025 1.491 . . . . 50.0 115.025 -162.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -75.58 9.84 2.03 Favored 'General case' 0 CA--C 1.554 1.1 0 C-N-CA 123.578 0.751 . . . . 50.0 112.363 173.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -123.27 18.63 9.85 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 124.641 1.176 . . . . 50.0 109.909 171.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.7 t -126.86 125.33 66.55 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 122.724 0.409 . . . . 50.0 110.149 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.466 ' HB2' ' HB2' ' A' ' 15' ' ' TRP . 5.7 mtpm? -108.6 110.96 22.54 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 108.976 -0.749 . . . . 75.0 108.976 177.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.526 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -68.04 120.5 14.38 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.234 0.614 . . . . 50.0 111.448 -178.304 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.25 137.95 47.29 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.634 0.773 . . . . 50.0 110.612 -176.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 56.9 t0 -93.05 113.39 59.75 Favored Pre-proline 0 N--CA 1.485 1.31 0 C-N-CA 123.365 0.666 . . . . 75.0 110.046 -177.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -90.12 -0.08 5.5 Favored 'Trans proline' 0 C--N 1.382 2.321 0 C-N-CA 123.053 2.502 . . . . 75.0 113.588 179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 74.06 -103.46 1.48 Allowed Glycine 0 C--N 1.351 1.393 0 N-CA-C 111.347 -0.701 . . . . 75.0 111.347 -170.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -85.61 92.81 1.79 Allowed Glycine 0 CA--C 1.533 1.175 0 N-CA-C 111.462 -0.655 . . . . 75.0 111.462 174.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -80.6 -151.66 7.71 Favored Glycine 0 CA--C 1.544 1.903 0 CA-C-O 119.292 -0.726 . . . . 75.0 113.889 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.407 ' HG2' ' HA3' ' A' ' 11' ' ' GLY . 52.6 Cg_exo -57.31 -27.01 73.34 Favored 'Trans proline' 0 C--N 1.381 2.27 0 C-N-CA 123.732 2.955 . . . . 75.0 114.731 -174.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 39.7 m 62.85 22.96 13.72 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 124.097 0.959 . . . . 75.0 113.241 175.469 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.523 ' HB2' ' NE2' ' A' ' 5' ' ' HIS . 8.5 t 67.27 13.8 9.5 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 125.19 1.396 . . . . 75.0 111.674 -175.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 26.8 tpt180 -84.81 -42.76 14.82 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.611 0.764 . . . . 75.0 109.02 178.474 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 53.5 mt -92.82 19.65 7.39 Favored 'General case' 0 CA--C 1.551 0.983 0 CA-C-N 115.366 -0.834 . . . . 75.0 111.369 -178.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . 0.598 HG22 HG22 ' A' ' 10' ' ' VAL . 75.6 p -106.45 106.08 16.43 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.095 0.558 . . . . 75.0 110.43 -179.471 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 75.9 t-105 -86.3 -80.25 0.24 Allowed 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 123.201 0.601 . . . . 75.0 109.817 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 37.4 ttm180 -166.79 106.93 0.63 Allowed 'General case' 0 N--CA 1.482 1.149 0 C-N-CA 123.628 0.771 . . . . 75.0 110.482 -174.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 68.7 t -137.9 -63.62 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 C-N-CA 123.612 0.765 . . . . 75.0 109.185 170.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -121.76 41.4 3.38 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 121.659 0.742 . . . . 75.0 110.688 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 11.5 mmm180 -87.97 59.36 5.29 Favored 'General case' 0 CA--C 1.545 0.766 0 CA-C-O 122.126 0.965 . . . . 75.0 108.569 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.6 m -89.03 177.61 6.61 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.23 -1.35 . . . . 75.0 111.76 -169.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 8.5 mm100 -69.81 -33.77 72.79 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 115.772 -0.649 . . . . 75.0 109.608 175.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 5.1 t30 -111.89 112.84 52.89 Favored Pre-proline 0 CA--C 1.552 1.039 0 N-CA-C 108.838 -0.801 . . . . 75.0 108.838 171.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo -70.32 135.23 28.61 Favored 'Trans proline' 0 C--N 1.37 1.674 0 C-N-CA 122.808 2.339 . . . . 75.0 111.123 173.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.2 mt -79.07 99.2 6.82 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 123.812 0.845 . . . . 75.0 112.134 -166.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -81.36 91.38 6.25 Favored 'General case' 0 C--O 1.243 0.751 0 C-N-CA 123.173 0.589 . . . . 75.0 109.956 174.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.522 ' HB ' ' HG ' ' A' ' 84' ' ' LEU . 45.6 pt -76.74 139.91 18.03 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.702 0 N-CA-C 109.665 -0.494 . . . . 75.0 109.665 168.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 16.0 ptm180 -108.81 32.56 4.8 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.703 0.801 . . . . 75.0 109.413 176.653 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.522 ' HG ' ' HB ' ' A' ' 82' ' ' ILE . 74.9 mt -81.13 68.75 7.55 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.19 0.996 . . . . 75.0 110.764 -172.504 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.6 p -114.11 76.29 0.98 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 124.663 1.185 . . . . 75.0 108.723 -179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 58.2 ttt-85 -90.86 -41.16 11.34 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 122.722 0.409 . . . . 75.0 111.132 -173.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.64 72.47 5.16 Favored 'General case' 0 CA--C 1.55 0.961 0 C-N-CA 124.297 1.039 . . . . 75.0 111.871 -168.313 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -177.34 59.43 0.15 Allowed Pre-proline 0 CA--C 1.551 0.984 0 C-N-CA 126.241 1.816 . . . . 75.0 107.545 171.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo . . . . . 0 C--N 1.389 2.672 0 C-N-CA 122.574 2.182 . . . . 75.0 112.058 -175.107 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 10.6 t60 . . . . . 0 N--CA 1.481 1.124 0 N-CA-C 108.25 -1.018 . . . . 75.0 108.25 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 92.2 m-70 -66.09 145.34 55.94 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.383 0.673 . . . . 75.0 111.366 -176.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 34.3 m-70 66.15 17.67 10.8 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.781 1.232 . . . . 75.0 111.944 179.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 76.6 m80 -141.96 36.46 1.58 Allowed 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.67 0.788 . . . . 75.0 109.99 -178.739 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 53.3 t60 -68.67 -64.56 0.84 Allowed 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 123.087 0.555 . . . . 75.0 111.476 -175.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 23.5 t-80 -161.59 123.52 2.91 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 122.42 0.288 . . . . 75.0 111.488 -174.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 17.5 m -81.71 178.58 8.25 Favored 'General case' 0 CA--C 1.55 0.978 0 C-N-CA 124.052 0.941 . . . . 75.0 110.567 173.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.539 ' H ' HG21 ' A' ' 37' ' ' THR . 4.7 m170 -82.09 148.65 28.45 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 109.359 -0.608 . . . . 75.0 109.359 178.856 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 24.1 ptm -92.09 175.23 6.94 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 122.652 0.381 . . . . 75.0 111.136 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.45 ' HA ' ' HA ' ' A' ' 35' ' ' LEU . 27.4 m -65.54 136.56 26.49 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.003 0 CA-C-N 115.801 -0.636 . . . . 50.0 110.662 174.077 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 84.09 9.06 82.96 Favored Glycine 0 C--N 1.342 0.903 0 CA-C-O 119.539 -0.59 . . . . 50.0 113.785 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 59.8 t0 -65.89 106.31 1.52 Allowed 'General case' 0 N--CA 1.478 0.952 0 N-CA-C 109.229 -0.656 . . . . 50.0 109.229 179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . 0.469 HG21 ' HB3' ' A' ' 61' ' ' PRO . 53.4 m -72.09 123.53 23.05 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 121.522 0.677 . . . . 50.0 111.062 -168.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.434 HG12 ' HA ' ' A' ' 58' ' ' ALA . 28.7 m -139.1 -177.67 1.61 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.73 0 C-N-CA 124.691 1.196 . . . . 50.0 110.165 -177.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 34.7 m0 -123.23 158.66 30.39 Favored 'General case' 0 C--O 1.244 0.796 0 C-N-CA 124.457 1.103 . . . . 50.0 108.194 169.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 48.0 t -109.45 102.48 14.06 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.482 0 N-CA-C 108.54 -0.911 . . . . 50.0 108.54 169.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.599 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 56.0 ttp180 -74.08 93.16 2.23 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.969 1.308 . . . . 75.0 109.789 172.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 54.6 ttm-85 -94.82 170.31 9.53 Favored 'General case' 0 CA--C 1.558 1.281 0 C-N-CA 124.333 1.053 . . . . 75.0 109.08 176.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 16.1 t-80 80.26 113.99 0.06 Allowed 'General case' 0 N--CA 1.483 1.215 0 C-N-CA 125.878 1.671 . . . . 75.0 110.519 179.412 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 9.9 mm100 -74.43 113.58 11.83 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.655 -0.702 . . . . 75.0 110.71 -171.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 5.3 t -77.39 94.01 4.17 Favored 'General case' 0 CA--C 1.552 1.041 0 C-N-CA 123.769 0.828 . . . . 75.0 110.927 -177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 95.8 mttt -109.15 -52.43 2.77 Favored 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 123.273 0.629 . . . . 75.0 110.465 177.725 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -131.33 -3.09 3.87 Favored 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 124.339 1.056 . . . . 75.0 109.481 175.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.7 mt -127.17 163.18 24.41 Favored 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 124.496 1.118 . . . . 75.0 109.774 -173.309 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -78.12 142.59 64.18 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.572 0.749 . . . . 75.0 110.93 -178.403 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -84.6 137.36 6.73 Favored 'Trans proline' 0 C--N 1.373 1.816 0 C-N-CA 122.959 2.439 . . . . 50.0 111.671 176.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 23.3 ttt180 -97.56 108.05 20.68 Favored 'General case' 0 N--CA 1.475 0.775 0 C-N-CA 122.522 0.329 . . . . 75.0 110.612 -176.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.599 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 70.1 p-90 -73.6 139.7 45.71 Favored 'General case' 0 N--CA 1.469 0.515 0 N-CA-C 109.333 -0.617 . . . . 50.0 109.333 167.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 56.9 mtpt -121.04 147.97 44.77 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.801 0.84 . . . . 75.0 108.759 174.193 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -159.46 175.41 36.35 Favored Glycine 0 CA--C 1.535 1.309 0 O-C-N 123.785 0.678 . . . . 50.0 112.49 179.154 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -85.34 141.2 30.69 Favored 'Cis proline' 0 C--N 1.374 1.898 0 CA-C-N 119.036 1.418 . . . . 50.0 112.901 -4.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.403 ' HB3' ' CG1' ' A' ' 44' ' ' VAL . 78.1 m-85 -120.93 171.13 8.85 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 124.242 1.017 . . . . 50.0 109.569 174.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.0 p -151.59 114.0 4.58 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.507 0.723 . . . . 50.0 110.246 -179.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 44' ' ' VAL . 57.4 t -59.21 121.2 6.27 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.904 0 N-CA-C 109.537 -0.542 . . . . 50.0 109.537 170.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.45 ' HA ' ' HA ' ' A' ' 10' ' ' VAL . 86.3 mt -98.51 -41.14 7.91 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 123.664 0.785 . . . . 50.0 109.712 176.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.711 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 40.8 tp -131.57 145.21 51.61 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.397 0.679 . . . . 50.0 110.252 -176.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.546 HG22 HD22 ' A' ' 42' ' ' LEU . 42.2 p -115.38 140.59 48.99 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 50.0 110.079 174.523 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 38.7 p -139.23 158.03 69.87 Favored Pre-proline 0 CA--C 1.554 1.121 0 N-CA-C 106.945 -1.502 . . . . 50.0 106.945 165.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.32 109.45 0.29 Allowed 'Trans proline' 0 C--N 1.378 2.116 0 C-N-CA 122.627 2.218 . . . . 50.0 113.769 179.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 3.6 m 74.51 5.33 4.52 Favored 'General case' 0 CA--C 1.567 1.597 0 C-N-CA 125.712 1.605 . . . . 50.0 113.135 174.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.8 124.22 16.77 Favored 'General case' 0 N--CA 1.477 0.895 0 O-C-N 121.824 -0.548 . . . . 50.0 110.046 -179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.546 HD22 HG22 ' A' ' 37' ' ' THR . 66.6 mt -113.0 125.49 54.46 Favored 'General case' 0 N--CA 1.472 0.659 0 N-CA-C 109.164 -0.68 . . . . 50.0 109.164 -178.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.711 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 62.5 tttm -84.08 108.69 17.16 Favored 'General case' 0 C--O 1.239 0.503 0 N-CA-C 107.549 -1.278 . . . . 75.0 107.549 174.465 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.411 HG22 HG22 ' A' ' 34' ' ' VAL . 40.9 t -107.81 146.66 13.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 CA-C-N 115.106 -0.952 . . . . 50.0 109.227 -173.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -68.05 138.36 55.75 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 123.163 0.585 . . . . 50.0 110.577 178.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 98.45 -38.54 3.06 Favored Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.92 -0.872 . . . . 50.0 110.92 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.58 HG21 HG12 ' A' ' 51' ' ' ILE . 41.4 mm -80.67 151.62 4.5 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.717 0 C-N-CA 123.871 0.869 . . . . 50.0 110.026 179.737 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -65.63 -51.12 61.99 Favored 'General case' 0 CA--C 1.541 0.624 0 O-C-N 123.744 0.653 . . . . 50.0 112.602 -176.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -149.78 -50.73 0.14 Allowed 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 113.229 0.826 . . . . 50.0 113.229 -174.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 20.4 m-90 -143.92 154.63 43.53 Favored 'General case' 0 N--CA 1.504 2.254 0 CA-C-N 119.191 0.905 . . . . 50.0 112.55 179.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.58 HG12 HG21 ' A' ' 47' ' ' ILE . 27.7 mm -129.34 133.2 65.93 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 125.579 1.552 . . . . 50.0 107.536 163.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 65.7 t-80 -61.94 124.65 21.35 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 108.057 -1.09 . . . . 50.0 108.057 172.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -56.15 -19.39 13.22 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 114.851 1.426 . . . . 50.0 114.851 -164.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . . . . . . . . . . . -70.51 -13.18 62.01 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 112.653 0.612 . . . . 50.0 112.653 178.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -94.74 -3.66 48.78 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.579 0.752 . . . . 50.0 110.983 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.1 t -98.5 129.0 49.44 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.421 0 N-CA-C 109.054 -0.721 . . . . 50.0 109.054 -178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -124.9 122.1 36.39 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.396 0.679 . . . . 75.0 109.323 178.497 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.434 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -59.62 123.59 17.4 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.463 0.705 . . . . 50.0 111.104 178.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -128.52 138.24 52.16 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 123.581 0.753 . . . . 50.0 111.011 -174.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 64.1 t0 -92.45 119.16 68.2 Favored Pre-proline 0 CA--C 1.551 1.015 0 C-N-CA 123.767 0.827 . . . . 75.0 109.297 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HB3' HG21 ' A' ' 13' ' ' THR . 59.2 Cg_endo -87.18 -5.02 7.7 Favored 'Trans proline' 0 C--N 1.38 2.191 0 C-N-CA 122.949 2.433 . . . . 75.0 113.842 179.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 78.99 15.73 80.11 Favored Glycine 0 C--N 1.348 1.207 0 O-C-N 123.322 0.389 . . . . 75.0 112.413 -172.813 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 177.42 -87.18 0.07 OUTLIER Glycine 0 C--N 1.344 1.009 0 N-CA-C 111.545 -0.622 . . . . 75.0 111.545 -179.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 175.37 -165.52 36.49 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 119.356 -0.691 . . . . 75.0 112.243 -178.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -60.85 107.67 0.47 Allowed 'Trans proline' 0 C--N 1.373 1.849 0 C-N-CA 123.128 2.552 . . . . 75.0 111.554 176.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 21.5 m -81.52 1.04 35.27 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 123.475 0.71 . . . . 75.0 111.82 -178.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 21.7 t -124.24 163.17 22.16 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 123.185 0.594 . . . . 75.0 110.514 177.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 8.2 mpt_? -86.78 90.81 8.42 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 108.201 -1.037 . . . . 75.0 108.201 -177.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.9 mt -82.49 -175.36 5.69 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 123.274 0.63 . . . . 75.0 110.842 -175.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 77.6 p -83.39 68.75 9.83 Favored 'General case' 0 CA--C 1.551 1.005 0 N-CA-C 108.83 -0.804 . . . . 75.0 108.83 174.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 2.7 p90 -64.78 -23.43 67.24 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 114.609 -1.178 . . . . 75.0 112.764 -173.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 38.0 ptt180 -70.15 -53.35 17.59 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-O 118.637 -0.697 . . . . 75.0 110.882 -174.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.413 HG11 ' HB2' ' A' ' 36' ' ' LEU . 91.8 t 63.14 -59.64 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.257 0 C-N-CA 125.117 1.367 . . . . 75.0 113.906 179.576 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 26.2 tp60 -50.45 85.8 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 125.275 1.43 . . . . 75.0 111.748 172.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 3.0 mmp_? -149.99 -4.34 0.36 Allowed 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 124.387 1.075 . . . . 75.0 111.553 -174.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.1 t -155.4 99.56 2.06 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 111.806 0.299 . . . . 75.0 111.806 -172.439 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 47.2 mt-30 63.89 31.41 13.94 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.558 1.143 . . . . 75.0 112.364 167.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 76.1 m-20 58.65 71.09 1.04 Allowed Pre-proline 0 N--CA 1.479 1.007 0 C-N-CA 124.75 1.22 . . . . 75.0 111.61 179.34 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 79.1 Cg_endo -77.41 -35.95 1.45 Allowed 'Trans proline' 0 C--N 1.37 1.707 0 C-N-CA 122.461 2.107 . . . . 75.0 111.967 179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 52.8 mt -84.74 176.08 8.77 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 123.196 0.598 . . . . 75.0 111.14 177.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 24.3 ttpp 65.52 32.16 9.6 Favored 'General case' 0 CA--C 1.563 1.445 0 C-N-CA 124.47 1.108 . . . . 75.0 110.61 175.126 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 35.9 pt -80.04 5.96 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 C-N-CA 123.631 0.772 . . . . 75.0 112.383 -179.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -72.56 67.75 0.78 Allowed 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 124.427 1.091 . . . . 75.0 109.709 175.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.77 115.53 22.77 Favored 'General case' 0 C--O 1.239 0.545 0 CA-C-N 114.835 -1.075 . . . . 75.0 108.572 -178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 68.1 p -68.79 -64.01 0.95 Allowed 'General case' 0 CA--C 1.543 0.695 0 O-C-N 123.918 0.761 . . . . 75.0 109.382 -178.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 71.25 168.76 0.31 Allowed 'General case' 0 N--CA 1.487 1.414 0 C-N-CA 125.07 1.348 . . . . 75.0 111.229 -173.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -130.75 157.51 42.63 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.593 0.757 . . . . 75.0 109.897 173.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . . . . . . . . . . . -160.64 -51.54 0.01 OUTLIER Pre-proline 0 CA--C 1.549 0.93 0 CA-C-O 118.468 -0.777 . . . . 75.0 111.111 177.037 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--N 1.384 2.412 0 CA-C-N 120.86 1.343 . . . . 75.0 111.527 167.572 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HIS . . . . . . . . . . . . . 86.0 m-70 . . . . . 0 N--CA 1.485 1.29 0 N-CA-C 108.447 -0.946 . . . . 75.0 108.447 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' HIS . . . . . . . . . . . . . 47.2 m80 -126.72 87.4 2.65 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-O 121.324 0.583 . . . . 75.0 111.217 179.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -162.78 140.85 8.33 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 114.765 -1.107 . . . . 75.0 109.173 167.679 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' HIS . . . . . . . . . . . . . 69.2 t60 -154.57 138.46 16.28 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.917 0.887 . . . . 75.0 110.062 -171.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' HIS . . . . . . . . . . . . . 52.6 p-80 -160.68 154.24 22.2 Favored 'General case' 0 N--CA 1.482 1.173 0 C-N-CA 123.316 0.646 . . . . 75.0 109.729 170.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 42.7 t60 -71.54 122.36 20.35 Favored 'General case' 0 N--CA 1.474 0.734 0 N-CA-C 109.764 -0.458 . . . . 75.0 109.764 178.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 11.6 t -143.86 -170.85 3.42 Favored 'General case' 0 C--O 1.242 0.675 0 C-N-CA 123.949 0.9 . . . . 75.0 108.669 179.428 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.473 ' NE2' ' HA ' ' A' ' 36' ' ' LEU . 52.5 p-80 -62.12 141.28 58.23 Favored 'General case' 0 N--CA 1.476 0.843 0 C-N-CA 123.398 0.679 . . . . 75.0 110.274 172.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' MET . . . . . . . . . . . . . 23.4 ptp -79.44 133.61 36.53 Favored 'General case' 0 C--O 1.244 0.784 0 N-CA-C 109.037 -0.727 . . . . 75.0 109.037 172.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.727 HG11 ' H ' ' A' ' 73' ' ' VAL . 10.4 m -75.07 148.64 7.53 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.747 0 C-N-CA 123.444 0.698 . . . . 50.0 109.173 175.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.538 ' HA2' ' HB ' ' A' ' 33' ' ' THR . . . 86.89 10.53 72.11 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 120.97 -0.633 . . . . 50.0 112.407 -174.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 58.2 t0 -62.14 115.43 4.11 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.409 0.684 . . . . 50.0 110.26 -176.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' THR . . . . . . . . . . . . . 12.2 m -73.38 114.61 11.79 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.988 0.423 . . . . 50.0 110.65 -169.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.457 HG12 ' HA ' ' A' ' 58' ' ' ALA . 29.5 m -132.29 -177.55 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.639 0 C-N-CA 124.915 1.286 . . . . 50.0 110.022 -179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TRP . . . . . . . . . . . . . 33.4 m0 -124.35 142.4 51.31 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.861 1.264 . . . . 50.0 107.677 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 89.1 t -108.29 106.58 20.94 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.675 0 N-CA-C 108.031 -1.1 . . . . 50.0 108.031 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.732 ' HA ' ' HA ' ' A' ' 28' ' ' TRP . 44.4 ttp180 -84.66 93.64 8.45 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 114.505 -1.225 . . . . 75.0 110.635 -173.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -80.25 152.88 28.85 Favored 'General case' 0 N--CA 1.475 0.788 0 C-N-CA 124.725 1.21 . . . . 75.0 109.891 -175.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.42 ' HB3' ' HB3' ' A' ' 26' ' ' PRO . 15.0 p80 -125.32 126.52 45.21 Favored 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.125 0.57 . . . . 75.0 110.528 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 75.3 mm-40 -89.07 -43.9 10.74 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 108.731 -0.84 . . . . 75.0 108.731 172.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' THR . . . . . . . . . . . . . 24.5 m -126.76 125.0 41.02 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-N 114.649 -1.159 . . . . 75.0 108.122 172.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -70.51 -24.16 62.78 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 123.314 0.646 . . . . 75.0 111.639 179.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -73.72 -28.04 61.5 Favored 'General case' 0 N--CA 1.484 1.269 0 C-N-CA 123.618 0.767 . . . . 75.0 111.42 174.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 75.2 mt -93.47 173.36 7.74 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.324 0.65 . . . . 75.0 110.723 176.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -70.49 126.19 92.2 Favored Pre-proline 0 CA--C 1.544 0.747 0 CA-C-N 115.722 -0.672 . . . . 75.0 110.34 178.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' PRO . . . . . 0.465 ' HB2' ' HG2' ' A' ' 17' ' ' ARG . 67.2 Cg_endo -71.45 133.69 23.02 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 122.418 2.079 . . . . 50.0 110.057 176.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -94.55 128.78 41.4 Favored 'General case' 0 C--O 1.245 0.854 0 C-N-CA 123.84 0.856 . . . . 75.0 109.359 -174.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TRP . . . . . 0.732 ' HA ' ' HA ' ' A' ' 17' ' ' ARG . 58.6 p-90 -80.77 146.45 30.98 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 120.912 0.387 . . . . 50.0 110.832 -177.525 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 7.7 mtpm? -119.78 141.52 49.4 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 107.613 -1.255 . . . . 75.0 107.613 174.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -163.87 164.99 36.76 Favored Glycine 0 CA--C 1.537 1.446 0 CA-C-O 119.665 -0.52 . . . . 50.0 112.127 -178.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -86.55 136.97 19.25 Favored 'Cis proline' 0 C--N 1.373 1.865 0 CA-C-N 119.45 1.625 . . . . 50.0 112.946 -1.855 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 46.9 m-85 -111.35 174.1 6.03 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 124.443 1.097 . . . . 50.0 110.151 171.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.538 ' HB ' ' HA2' ' A' ' 11' ' ' GLY . 23.6 p -142.34 112.72 7.16 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.642 0.777 . . . . 50.0 110.436 -172.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.2 t -67.72 122.72 19.43 Favored 'Isoleucine or valine' 0 C--O 1.248 1.019 0 N-CA-C 109.32 -0.622 . . . . 50.0 109.32 170.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 73' ' ' VAL . 62.2 mt -93.64 -42.01 9.42 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-N 114.964 -1.016 . . . . 50.0 109.943 172.583 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . 0.657 ' HB3' ' HB3' ' A' ' 43' ' ' LYS . 19.1 tp -133.54 144.52 49.41 Favored 'General case' 0 N--CA 1.479 0.976 0 O-C-N 122.107 -0.37 . . . . 50.0 110.65 -175.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 53.6 m -119.2 129.16 54.82 Favored 'General case' 0 C--O 1.24 0.602 0 C-N-CA 124.138 0.975 . . . . 50.0 109.519 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' THR . . . . . . . . . . . . . 20.3 p -139.84 158.77 67.0 Favored Pre-proline 0 CA--C 1.566 1.579 0 C-N-CA 124.397 1.079 . . . . 50.0 108.81 175.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 69.2 Cg_exo -46.53 108.91 0.17 Allowed 'Trans proline' 0 C--N 1.384 2.443 0 C-N-CA 123.284 2.656 . . . . 50.0 114.416 178.313 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' THR . . . . . . . . . . . . . 2.4 m 62.11 17.5 9.19 Favored 'General case' 0 N--CA 1.494 1.748 0 C-N-CA 125.568 1.547 . . . . 50.0 113.051 175.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -143.69 134.18 24.8 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 123.494 0.718 . . . . 50.0 109.303 179.089 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 95.8 mt -125.62 124.74 41.85 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 109.138 -0.69 . . . . 50.0 109.138 -179.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.657 ' HB3' ' HB3' ' A' ' 36' ' ' LEU . 58.2 tttp -83.84 109.65 17.73 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 107.078 -1.453 . . . . 75.0 107.078 172.371 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 57.3 t -110.4 136.45 46.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 CA-C-N 114.678 -1.146 . . . . 50.0 108.474 -176.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -66.06 139.1 58.16 Favored 'General case' 0 C--O 1.242 0.704 0 N-CA-C 109.481 -0.562 . . . . 50.0 109.481 172.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 93.73 -15.39 63.17 Favored Glycine 0 N--CA 1.468 0.811 0 N-CA-C 111.964 -0.455 . . . . 50.0 111.964 -172.574 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . 0.605 HG21 HG12 ' A' ' 51' ' ' ILE . 46.5 mm -101.58 147.73 8.14 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.794 0 C-N-CA 124.287 1.035 . . . . 50.0 109.382 177.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -53.01 -49.75 65.61 Favored 'General case' 0 N--CA 1.482 1.131 0 C-N-CA 124.015 0.926 . . . . 50.0 112.344 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -150.45 -58.76 0.18 Allowed 'General case' 0 CA--C 1.55 0.975 0 N-CA-C 112.141 0.423 . . . . 50.0 112.141 176.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TRP . . . . . . . . . . . . . 24.2 m-90 -143.18 157.22 44.7 Favored 'General case' 0 N--CA 1.498 1.945 0 C-N-CA 123.174 0.59 . . . . 50.0 110.962 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.605 HG12 HG21 ' A' ' 47' ' ' ILE . 35.4 mm -126.56 139.95 50.26 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.23 0 N-CA-C 108.246 -1.02 . . . . 50.0 108.246 167.173 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' HIS . . . . . . . . . . . . . 64.9 t-80 -64.42 139.74 58.8 Favored 'General case' 0 CA--C 1.551 1.0 0 C-N-CA 123.545 0.738 . . . . 50.0 109.014 173.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -59.89 -22.13 61.96 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.478 1.288 . . . . 50.0 114.478 -168.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ALA . . . . . 0.471 ' HA ' ' HB2' ' A' ' 88' ' ' ALA . . . -71.89 -15.67 62.11 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.724 0.639 . . . . 50.0 112.724 177.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -116.3 24.12 11.61 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.903 0.881 . . . . 50.0 110.848 177.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 47.5 t -129.1 136.12 60.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.873 0 N-CA-C 107.607 -1.257 . . . . 50.0 107.607 165.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 43.7 mtpt -136.65 135.89 38.67 Favored 'General case' 0 N--CA 1.476 0.865 0 N-CA-C 108.853 -0.795 . . . . 75.0 108.853 176.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.457 ' HA ' HG12 ' A' ' 14' ' ' VAL . . . -67.04 138.19 57.0 Favored 'General case' 0 N--CA 1.475 0.789 0 C-N-CA 123.656 0.782 . . . . 50.0 112.201 -173.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -117.02 169.33 9.49 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.142 1.377 . . . . 50.0 109.068 174.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 63.3 t0 -56.83 115.62 10.83 Favored Pre-proline 0 CA--C 1.558 1.279 0 CA-C-O 118.596 -0.716 . . . . 75.0 109.715 173.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_exo -56.14 -19.2 26.11 Favored 'Trans proline' 0 C--N 1.386 2.533 0 C-N-CA 123.807 3.005 . . . . 75.0 114.782 174.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -73.81 -6.51 72.7 Favored Glycine 0 C--N 1.349 1.286 0 CA-C-N 116.413 -0.358 . . . . 75.0 113.869 173.155 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -83.06 -27.3 41.25 Favored Glycine 0 C--N 1.348 1.248 0 C-N-CA 123.462 0.553 . . . . 75.0 112.51 176.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.37 -161.53 27.22 Favored Glycine 0 N--CA 1.474 1.222 0 CA-C-O 119.485 -0.619 . . . . 75.0 112.027 176.98 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -68.81 90.21 0.43 Allowed 'Trans proline' 0 C--N 1.375 1.923 0 C-N-CA 122.687 2.258 . . . . 75.0 112.256 -178.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 37.2 t -74.14 -22.03 59.62 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.694 0.797 . . . . 75.0 110.656 176.582 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 28.6 m -70.99 -17.98 62.62 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 123.497 0.719 . . . . 75.0 110.752 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 62.5 88.12 0.1 Allowed 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 125.36 1.464 . . . . 75.0 110.871 175.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.5 mt -67.03 -54.04 25.51 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.077 0.465 . . . . 75.0 109.964 -179.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' THR . . . . . . . . . . . . . 27.3 m -92.67 144.3 25.45 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 115.323 -0.853 . . . . 75.0 108.952 174.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TRP . . . . . . . . . . . . . 5.0 m-90 -86.33 -56.53 3.4 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 108.657 -0.868 . . . . 75.0 108.657 173.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.474 ' HB3' ' O ' ' A' ' 74' ' ' GLN . 88.8 mtm180 -148.07 115.14 6.15 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 114.013 -1.449 . . . . 75.0 108.433 -175.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . 0.727 ' H ' HG11 ' A' ' 10' ' ' VAL . 7.5 p -65.61 -44.6 93.65 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.425 0 C-N-CA 123.21 0.604 . . . . 75.0 109.908 177.305 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.474 ' O ' ' HB3' ' A' ' 72' ' ' ARG . 1.9 mp0 -102.72 148.12 26.0 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 107.599 -1.26 . . . . 75.0 107.599 169.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 28.3 mtm180 -111.31 -26.03 9.36 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.543 0.737 . . . . 75.0 110.271 177.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 49.5 m -64.18 153.81 36.71 Favored 'General case' 0 C--N 1.354 0.769 0 C-N-CA 124.184 0.994 . . . . 75.0 112.095 -177.462 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -73.41 -35.3 65.82 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.03 0.932 . . . . 75.0 111.974 -172.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 81.6 m-20 -69.11 -54.06 12.64 Favored Pre-proline 0 CA--C 1.561 1.374 0 CA-C-O 118.407 -0.806 . . . . 75.0 112.7 -173.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 64.0 Cg_endo -70.14 -34.87 12.54 Favored 'Trans proline' 0 C--N 1.392 2.852 0 C-N-CA 121.819 1.679 . . . . 75.0 112.114 179.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.425 HD11 ' O ' ' A' ' 74' ' ' GLN . 64.6 mt -75.07 85.67 2.33 Favored 'General case' 0 C--N 1.356 0.854 0 CA-C-O 121.137 0.494 . . . . 75.0 109.795 176.921 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . . . . . . . . . 17.6 ptpt -148.8 176.47 10.37 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.183 -0.917 . . . . 75.0 109.958 172.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 38.7 pt -134.31 174.12 13.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.397 0 C-N-CA 124.018 0.927 . . . . 75.0 109.739 178.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' ARG . . . . . . . . . . . . . 54.9 ttp180 -156.06 150.3 25.54 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 106.684 -1.598 . . . . 75.0 106.684 162.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 93.7 mt -69.57 82.31 0.41 Allowed 'General case' 0 C--O 1.239 0.532 0 CA-C-O 121.437 0.637 . . . . 75.0 109.92 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 41.6 p -70.53 151.15 45.39 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-N 114.748 -1.114 . . . . 75.0 109.268 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ARG . . . . . . . . . . . . . 35.3 ttp180 -103.65 145.52 29.94 Favored 'General case' 0 C--O 1.24 0.561 0 N-CA-C 108.9 -0.778 . . . . 75.0 108.9 174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -62.57 127.42 31.23 Favored 'General case' 0 C--O 1.242 0.672 0 N-CA-C 109.231 -0.655 . . . . 75.0 109.231 169.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ALA . . . . . 0.471 ' HB2' ' HA ' ' A' ' 54' ' ' ALA . . . -73.88 127.53 88.14 Favored Pre-proline 0 CA--C 1.545 0.768 0 CA-C-O 118.663 -0.684 . . . . 75.0 110.372 178.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_exo . . . . . 0 C--N 1.379 2.163 0 C-N-CA 123.408 2.738 . . . . 75.0 113.062 -178.94 . . . . . . . . 0 0 . 1 stop_ save_